<SEC-DOCUMENT>0001193125-24-081577.txt : 20240329
<SEC-HEADER>0001193125-24-081577.hdr.sgml : 20240329
<ACCEPTANCE-DATETIME>20240329082150
ACCESSION NUMBER:		0001193125-24-081577
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20240507
FILED AS OF DATE:		20240329
DATE AS OF CHANGE:		20240329

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Merus N.V.
		CENTRAL INDEX KEY:			0001651311
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37773
		FILM NUMBER:		24802089

	BUSINESS ADDRESS:	
		STREET 1:		YALELAAN 62
		CITY:			3584 CM UTRECHT
		STATE:			P7
		ZIP:			3584 CM
		BUSINESS PHONE:		31 030 253 8800

	MAIL ADDRESS:	
		STREET 1:		YALELAAN 62
		CITY:			3584 CM UTRECHT
		STATE:			P7
		ZIP:			3584 CM

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Merus B.V.
		DATE OF NAME CHANGE:	20150819
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>d706699dpre14a.htm
<DESCRIPTION>PRE 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:mrus="http://meus.com/20231231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>PRE 14A</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style="line-height:normal;background-color:white;">
<h5><a href="#toc">Table of Contents</a></h5>
<div style="display: none"><ix:header><ix:hidden><ix:nonNumeric name="dei:DocumentType" id="hidden107868301" contextRef="P01_01_2023To12_31_2023">PRE 14A</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="P01_01_2023To12_31_2023" id="ixv-14236">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P01_01_2023To12_31_2023" id="ixv-14237">0001651311</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="mrus-20231231.xsd"/></ix:references><ix:resources><xbrli:context id="P01_01_2023To12_31_2023"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To12_31_2020"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To12_31_2020_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To12_31_2020_PeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:TotalAdjustmentsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To12_31_2020_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:TotalAdjustmentsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To12_31_2020_PeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To12_31_2020_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To12_31_2020_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To12_31_2020_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:AdjustmentForGrantDateValuesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To12_31_2020_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:AdjustmentForGrantDateValuesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To12_31_2020_PeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To12_31_2020_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:TotalAdjustmentsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:TotalAdjustmentsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:AdjustmentForGrantDateValuesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:AdjustmentForGrantDateValuesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:TotalAdjustmentsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:AdjustmentForGrantDateValuesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:AdjustmentForGrantDateValuesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_PeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_PeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_PeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:TotalAdjustmentsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:AdjustmentForGrantDateValuesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:AdjustmentForGrantDateValuesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_PeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_PeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:TotalAdjustmentsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_PeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:TotalAdjustmentsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001651311</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:unit id="Unit_USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_pure"> <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Year"> <xbrli:measure>utr:Year</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_USD_per_Share"> <xbrli:divide> <xbrli:unitNumerator> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unitNumerator> <xbrli:unitDenominator> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unitDenominator> </xbrli:divide> </xbrli:unit></ix:resources></ix:header></div><div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">UNITED STATES SECURITIES AND EXCHANGE COMMISSION </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Washington, DC 20549 </div></div><div style="margin-top: 4pt; margin-bottom: 0pt; font-size: 16pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="-sec-ix-hidden:hidden107868301;display:inline;">SCHEDULE 14A</div> </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">(Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">14a-101)</div> </div></div><div style="margin-top: 4pt; margin-bottom: 0pt; font-size: 12pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">INFORMATION REQUIRED IN PROXY STATEMENT </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">SCHEDULE 14A INFORMATION </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 12pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Proxy Statement Pursuant to Section&#160;14(a) of the </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Securities Exchange Act of 1934 (Amendment No.&#8195;&#8195;) </div></div><div style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the Registrant &#9746; Filed by a Party other than the Registrant &#9744; </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9746;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Preliminary Proxy Statement </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Confidential, for Use of the Commission Only (as permitted by Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">14a-6(e)(2))</div></div></div> </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Definitive Proxy Statement </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Definitive Additional Materials </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Soliciting Material under <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#167;240.14a-12</div> </div></td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 16pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P01_01_2023To12_31_2023" id="ixv-14637">MERUS N.V.</ix:nonNumeric> </div></div><div style="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.50pt solid #000000">&#160;</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">(Name of Registrant as Specified in its Charter) </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check all boxes that apply): </div><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9746;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">No fee required. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:7%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:92%"/></tr>
<tr style="font-size:1px; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; padding-bottom: 0.375pt;"/>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top">&#160;</td></tr></table><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Fee paid previously with preliminary materials. </div></td></tr></table><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">14a-6(i)(1)</div> and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">0-11.</div> </div></td></tr></table><div style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</div></div></div></div></div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman;font-weight:bold">Merus N.V. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:36pt; font-family:Times New Roman"><span style="font-weight:bold">PROXY</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:36pt; font-family:Times New Roman"><span style="font-weight:bold">STATEMENT</span> </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman;font-weight:bold">Annual General Meeting </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman;font-weight:bold">of Shareholders </p> <p style="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:120pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">May&#160;7, 2024 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">15:00 (3:00) p.m. (Central European Summer Time) </p> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">MERUS N.V. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">UPPSALALAAN 17 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">3<sup style="font-size:75%; vertical-align:top">rd</sup>&#160;&amp; 4<sup style="font-size:75%; vertical-align:top">th</sup> FLOOR </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">3584 CT UTRECHT </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">THE NETHERLANDS </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">April [&#8195;], 2024 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">To Our Shareholders: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">You are cordially invited to attend the 2024 Annual General Meeting of Shareholders of Merus N.V. at 15:00 (3:00) p.m. Central European Summer Time, on Tuesday, May&#160;7, 2024, at the offices of NautaDutilh N.V. (Beethovenstraat 400, 1082 PR Amsterdam, the Netherlands). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The Notice of Meeting and Proxy Statement on the following pages describe the matters to be presented at the Annual General Meeting. If you would like to attend the Annual General Meeting, you must inform the Company by <span style="white-space:nowrap">e-mail</span> (addressed to AGM2024@merus.nl) or in writing (addressed to Merus N.V., c/o Company Secretary, Uppsalalaan 17, 3<sup style="font-size:75%; vertical-align:top">rd</sup>&#160;&amp; 4<sup style="font-size:75%; vertical-align:top">th</sup> floor, 3584 CT, Utrecht, the Netherlands) no later than 16:59 (4:59) p.m. Central European Summer Time on May&#160;2, 2024. Please see the section called &#8220;Who Can Attend the Annual General Meeting?&#8221; on page&#160;4 of the proxy statement for more information about how to attend the meeting. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Whether or not you attend the Annual General Meeting, it is important that your shares be voted prior to the Annual General Meeting. Therefore, I urge you to vote your shares prior to the Annual General Meeting by promptly submitting your proxy by phone, via the Internet, or by signing, dating and returning the enclosed proxy card in the enclosed envelope, which will require no postage if mailed in the United States, or by email (addressed to AGM2024@merus.nl). Further instructions will be contained on the proxy card. If you decide to attend the Annual General Meeting, you will be able to vote in person, even if you have previously submitted your proxy. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Thank you for your support. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Sincerely, </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Sven (Bill) Ante Lundberg, M.D. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">President, Chief Executive Officer </p> <p style="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc"><span style="text-decoration:underline">Table of Contents </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:96%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_1">Cautionary Note Regarding Forward-Looking Statements </a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold"></span>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">1</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold"></span>&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_2">Notice of Annual General Meeting of Shareholders</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">2</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_3">Proxy Statement</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold"></span><span style="font-weight:bold"></span>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">1</span><span style="font-weight:bold"></span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold"></span><span style="font-weight:bold"></span>&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_4">Proposals</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_5">Recommendations of the Board</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_6">Information About This Proxy Statement</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_7">Questions and Answers about the Annual General Meeting</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold"></span>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">4</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold"></span>&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_8">Proposals to be Voted On</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold"></span>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">9</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold"></span>&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_9">Proposal 1</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic"><a href="#toc706699_10">Adoption of the Company&#8217;s Dutch statutory annual accounts for the financial year 2023</a></span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_11">Proposal 2</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic"><a href="#toc706699_12">Appointment of KPMG Accountants N.V. as the Company&#8217;s the external auditor for the financial year 2024 for purposes of Dutch law</a></span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_13">Proposal 3</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic"><a href="#toc706699_14">Release of each member of our the Company&#8217;s board of directors from liability for the exercise of their duties during the financial year 2023</a></span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_15">Proposal 4</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic"><a href="#toc706699_16"><span style="white-space:nowrap">Re-appointment</span> of Mark Iwicki as <span style="white-space:nowrap">non-executive</span> director</a></span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_17">Proposal 5</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic"><a href="#toc706699_18"><span style="white-space:nowrap">Re-appointment</span> of Paolo Pucci as <span style="white-space:nowrap">non-executive</span> director</a></span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_19">Proposal 6</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic"><a href="#toc706699_20">Appointment of Jason Haddock as <span style="white-space:nowrap">non-executive</span> director</a></span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">14</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_21">Proposal 7</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic"><a href="#toc706699_22">Article Amendment A &#8211; Approval of the amendment of the Articles of Association to increase the authorized share capital to the amount of EUR 18,900,000 and divided into 105,000,000 common shares and 105,000,000 preferred shares and authorization to implement such amendment</a></span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_23">Proposal 8</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic"><a href="#toc706699_24">Article Amendment B &#8211; Approval of the amendment of Articles of Association to reflect Large Company Regime and authorization to implement such amendment</a></span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">23</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_25">Proposal 9</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic"><a href="#toc706699_26">Granting authorization to the Company&#8217;s board of directors to acquire shares (or depository receipts for such shares) in the Company&#8217;s capital</a></span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_27">Proposal 10</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic"><a href="#toc706699_28">Approval, on an advisory <span style="white-space:nowrap">(non-binding)</span> basis, of the compensation of our named executive officers</a></span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">26</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">i </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:96%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_29">Proposal 11</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic"><a href="#toc706699_30">Approval of the amendment of the Company&#8217;s <span style="white-space:nowrap">Non-Executive</span> Director Compensation Program (&#8220;NED Program&#8221;) to allow the board of directors to determine the number of common shares that may be awarded to a <span style="white-space:nowrap">non-executive</span> director for initial and annual awards under the NED Program to more closely align with the 50th percentile of the Company&#8217;s peer group</a></span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">28</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_31">Proposal 12</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic"><a href="#toc706699_32">Approval of the amendment and restatement of the Company&#8217;s 2016 Incentive Award Plan (the &#8220;2016 Plan&#8221;) to extend the term of the 2016 Plan to December&#160;31, 2031, which includes a corresponding extension to the annual &#8220;evergreen&#8221; feature from and including January&#160;1, 2026 to January&#160;1, 2029, along with other minor amendments updated for best practices</a></span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_33">Report of the Audit Committee of the Board of Directors</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">40</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_34">Independent Registered Public Accounting Firm Fees and Other Matters</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">41</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_35">Executive Officers</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">42</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_36">Corporate Governance</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">44</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_37">General</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">44</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_38">Board Composition</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">44</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_39">Director Independence</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">44</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_40">Director Candidates</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">45</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_41">Communications from Shareholders</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">46</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_42">Board Leadership Structure and Role in Risk Oversight</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">46</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_43">Annual Board Evaluation</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">47</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_44">Code of Business Conduct and Ethics</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">47</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_45">Anti-Hedging Policy</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">48</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_45a">Clawback Policy </a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">48</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_46">Attendance by Members of the Board of Directors at Meetings</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">48</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_47">Committees of the Board</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">49</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_48">Audit Committee</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">49</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_49">Compensation Committee</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">52</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_50">Nomination and Corporate Governance Committee</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">53</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_51">Executive and Director Compensation</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_52">Executive Compensation</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">77</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_53">2023 Summary Compensation Table</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">77</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_54">Outstanding Equity Awards at 2023 Financial Year End</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">79</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_55">Employment and Separation Agreements</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_56">Director Compensation</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">82</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_57">2023 Director Compensation Table</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">83</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_58">Equity Compensation Plan Information</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">88</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_59">Security Ownership of Certain Beneficial Owners and Management</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">89</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_60">Common Shares</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">89</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">ii </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:95%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_61">Certain Relationships</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">92</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_62">Collaboration Agreement with Incyte</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">92</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_63">August 2023 <span style="white-space:nowrap">Follow-On</span> Offering</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">93</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:0.75pt"/>
<td style="height:0.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><a href="#toc706699_64">Indemnification Agreements</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">94</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_65">Shareholders&#8217; Proposals</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">94</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_66">Other Matters</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">95</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_67">Solicitation of Proxies</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">95</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_68">Merus&#8217; Annual Report on Form <span style="white-space:nowrap">10-K</span></a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">96</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_69">Annex A to Proxy Statement: Amendments to Articles of Association to Reflect Large Company Regime</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold"><span style="white-space:nowrap">A-1</span></span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td style="height:1.5pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman;font-weight:bold"><a href="#toc706699_70">Annex B to Proxy Statement: Merus N.V. 2016 Incentive Award Plan (as amended and restated)</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold"><span style="white-space:nowrap">B-1</span></span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">iii </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="font-size:1pt;background-color:#cccccc">
<td style="height:0.75pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#cccccc">
<td style="padding-bottom:1pt ;vertical-align:middle" id="toc706699_1"><span style="font-weight:bold">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">This Proxy Statement contains forward-looking statements. All statements other than statements of historical facts contained in this Proxy Statement are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;contemplate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential&#8221; or &#8220;continue&#8221; or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The forward-looking statements are only predictions and are based largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. These forward-looking statements speak only as of the date of this Proxy Statement and are subject to a number of known and unknown risks, uncertainties and assumptions, including those described in our Annual Report on Form <span style="white-space:nowrap">10-K</span> filed with the United States Securities and Exchange Commission (&#8220;SEC&#8221;) on February&#160;28, 2024 (the &#8220;Annual Report on Form <span style="white-space:nowrap">10-K&#8221;),</span> under the sections entitled &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and elsewhere in the Annual Report on Form <span style="white-space:nowrap">10-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. We intend the forward-looking statements contained in this Proxy Statement to be covered by the safe harbor provisions for forward-looking statements contained in Section&#160;27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="font-size:1pt;background-color:#cccccc">
<td style="height:1.5pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#cccccc">
<td style="vertical-align:top" id="toc706699_2"><span style="font-weight:bold">NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS</span></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">To Be Held Tuesday, May&#160;7, 2024 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">Merus N.V. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">Uppsalalaan 17 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">3<sup style="font-size:75%; vertical-align:top">rd</sup>&#160;&amp; 4<sup style="font-size:75%; vertical-align:top">th</sup> floor </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">3584 CT Utrecht </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">The Netherlands </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The Annual General Meeting of Shareholders (the &#8220;Annual General Meeting&#8221;) of Merus N.V., a public limited liability company (<span style="font-style:italic">naamloze vennootschap</span>) incorporated under the laws of the Netherlands (the &#8220;Company&#8221;), will be held at 15:00 (3:00) p.m. Central European Summer Time on Tuesday, May&#160;7, 2024, at the offices of NautaDutilh N.V. (address: Beethovenstraat 400, 1082 PR Amsterdam, the Netherlands). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The agenda for the Annual General Meeting is as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">1.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Opening </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">2.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Discussion of the Company&#8217;s Dutch statutory annual report over the financial year 2023 <span style="font-style:italic">(discussion item)</span> </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">3.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Adoption of the Company&#8217;s Dutch statutory annual accounts over the financial year 2023 <span style="font-style:italic">(voting item)</span> </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">4.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Explanation of the dividend and reservation policy <span style="font-style:italic">(discussion item)</span> </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">5.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Appointment of the KPMG Accountants N.V. as the Company&#8217;s external auditor for the financial year 2024 for purposes of Dutch law <span style="font-style:italic">(voting item)</span> </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">6.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Release of each member of the Company&#8217;s board of directors from liability for the exercise of their duties during the financial year 2023 <span style="font-style:italic">(voting item)</span> </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">7.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Re-appointment</span> of Mark Iwicki as <span style="white-space:nowrap">non-executive</span> director <span style="font-style:italic">(voting item)</span> </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">8.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Re-appointment</span> of Paolo Pucci as <span style="white-space:nowrap">non-executive</span> director <span style="font-style:italic">(voting item)</span> </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">9.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Appointment of Jason Haddock as <span style="white-space:nowrap">non-executive</span> director (<span style="font-style:italic">voting item</span>) </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">10.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Articles Amendment A &#8211; Approval of the amendment of the Articles of Association to increase the authorized share capital to the amount of EUR 18,900,000 and divided into 105,000,000 common shares and 105,000,000 preferred shares and authorization to implement such amendment <span style="font-style:italic">(voting item)</span> </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">11.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Articles Amendment B &#8211; Approval of the amendment to the Articles of Association to reflect the Large Company Regime and authorization to implement such amendment <span style="font-style:italic">(voting item)</span> </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">12.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Granting authorization to the Company&#8217;s board of directors to acquire shares (or depository receipts for such shares) in the Company&#8217;s capital <span style="font-style:italic">(voting item)</span> </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">13.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Approval, on an advisory <span style="white-space:nowrap">(non-binding)</span> basis, of the compensation of the Company&#8217;s named executive officers <span style="font-style:italic">(voting item)</span> </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">14.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Approval of the amendment of the Company&#8217;s <span style="white-space:nowrap">Non-Executive</span> Director Compensation Program (&#8220;NED Program&#8221;) to allow the board of directors to determine the number of common shares that may be awarded to a <span style="white-space:nowrap">non-executive</span> director for initial and annual awards under the NED Program to more closely align with the 50th percentile of the Company&#8217;s peer group <span style="font-style:italic">(voting item)</span> </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">15.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Approval of the amendment and restatement of the Company&#8217;s 2016 Incentive Award Plan (the &#8220;2016 Plan&#8221;) to extend the term to December&#160;31, 2031, which includes a corresponding extension to the annual &#8220;evergreen&#8221; feature from and including January&#160;1, 2026 to January&#160;1, 2029, along with other minor amendments updated for best practices <span style="font-style:italic">(voting item)</span> </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">16.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Closing </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">No business shall be voted on at the Annual General Meeting, except such items as included in the above-mentioned agenda. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The record date for the Annual General Meeting in respect of common shares in the capital of the Company is April&#160;9, 2024 (the &#8220;Record Date&#8221;). No record date applies in respect of preferred shares in the capital of the Company. Those who are (i)&#160;holders of common shares in the capital of the Company, or who otherwise have voting rights and/or meeting rights with respect to common shares in the Company&#8217;s capital, on the Record Date and (ii)&#160;holders of preferred shares in the capital of the Company, or who otherwise have voting rights and/or meeting rights with respect to preferred shares in the Company&#8217;s capital on the date of the Annual General Meeting, in each case provided that they are recorded as such in the Company&#8217;s shareholders&#8217; register or in the register maintained by the Company&#8217;s U.S. transfer agent, may attend and, if relevant, vote at the Annual General Meeting (the &#8220;Persons with Meeting Rights&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Persons with Meeting Rights who wish to attend the Annual General Meeting, in person or represented by proxy, must notify the Company of their identity and intention to attend the Annual General Meeting by <span style="white-space:nowrap">e-mail</span> (addressed to AGM2024@merus.nl) or in writing (addressed to Merus N.V., c/o Company Secretary, Uppsalalaan 17, 3<sup style="font-size:75%; vertical-align:top">rd</sup>&#160;&amp; 4<sup style="font-size:75%; vertical-align:top">th</sup> floor, 3584 CT Utrecht, the Netherlands). This notice must be received by the Company no later than 16:59 (4:59) p.m. Central European Summer Time on May&#160;2, 2024 (the <span style="white-space:nowrap">&#8220;Cut-off</span> Time&#8221;). Persons with Meeting Rights who have not complied with this requirement may be refused entry to the Annual General Meeting. Persons with Meeting Rights may have themselves represented at the Annual General Meeting through the use of a written or electronically recorded proxy. Proxyholders who wish to attend the Annual General Meeting should present a copy of their proxy upon entry to the Annual General Meeting, failing which the proxyholder concerned </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
may be refused entry to the Annual General Meeting. A proxy form for this purpose can be downloaded from the Company&#8217;s website (http://www.merus.nl). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">It is important that your shares be represented regardless of the number of shares you may hold. We urge you to vote your shares or to submit your proxy prior to the Annual General Meeting. Proxies may be submitted prior to the <span style="white-space:nowrap">Cut-off</span> Time via a toll-free telephone number (call <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">1-800-690-6903)</span></span></span> or over the Internet (visit www.proxyvote.com), as described in further detail in the enclosed materials, or by signing, dating and mailing the proxy card in the enclosed return envelope or emailing the signed and dated proxy card to AGM2024@merus.nl. Voting your shares or submitting your proxy, as applicable, will be important for the presence of a quorum at the Annual General Meeting and will save us the expense of further solicitation. Submitting a proxy will not prevent you from voting your shares at the Annual General Meeting if you desire to do so, as your proxy is revocable at your option. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">By Order of the board of directors </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Peter B. Silverman </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Interim Company Secretary </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Utrecht, the Netherlands </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">April [&#8195;], 2024 </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="font-size:1pt;background-color:#cccccc">
<td style="height:0.75pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#cccccc">
<td style="padding-bottom:1pt ;vertical-align:middle" id="toc706699_3"><span style="font-weight:bold">PROXY STATEMENT</span></td></tr>
</table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">MERUS N.V. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">UPPSALALAAN 17 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">3<sup style="font-size:75%; vertical-align:top">rd</sup>&#160;&amp; 4<sup style="font-size:75%; vertical-align:top">th</sup> FLOOR </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">3584 CT UTRECHT </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">THE NETHERLANDS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">This proxy statement is furnished in connection with the solicitation by the board of directors of Merus N.V. of proxies to be voted in respect of our Annual General Meeting of Shareholders to be held on Tuesday, May&#160;7, 2024 (the &#8220;Annual General Meeting&#8221;), at the offices of NautaDutilh N.V. (address: Beethovenstraat 400, 1082 PR Amsterdam, the Netherlands), at 15:00 (3:00) p.m. Central European Summer Time. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The record date for the Annual General Meeting in respect of common shares in the capital of the Company is April&#160;9, 2024 (the &#8220;Record Date&#8221;). No record date applies in respect of preferred shares (if any are issued) in the capital of the Company. Those who are (i)&#160;holders of common shares in the capital of the Company, or who otherwise have voting rights and/or meeting rights with respect to common shares in the Company&#8217;s capital, on the Record Date and (ii)&#160;holders of preferred shares in the capital of the Company, or who otherwise have voting rights and/or meeting rights with respect to preferred shares in the Company&#8217;s capital on the date of the Annual General Meeting, in each case provided that they are recorded as such in the Company&#8217;s shareholders&#8217; register or in the register maintained by the Company&#8217;s U.S. transfer agent, may attend and, if relevant, vote at the Annual General Meeting (the &#8220;Persons with Meeting Rights&#8221;). As of April&#160;9, 2024, there were [&#8195;&#8195;&#8195;&#8195;] common shares and no preferred shares outstanding. Each common share and each preferred share (if any are issued) is entitled to one vote on any matter presented at the Annual General Meeting as a voting item. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">This proxy statement and the Company&#8217;s annual report on Form <span style="white-space:nowrap">10-K</span> for the fiscal year ended December&#160;31, 2023 (as amended, the &#8220;Annual Report on Form <span style="white-space:nowrap">10-K&#8221;)</span> will be mailed on or about April&#160;15, 2024 to our shareholders of record as of the close of business on the Record Date. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Our principal executive offices are located at Uppsalalaan 17, 3<sup style="font-size:75%; vertical-align:top">rd</sup>&#160;&amp; 4<sup style="font-size:75%; vertical-align:top">th</sup> floor, 3584 CT Utrecht, the Netherlands. In this proxy statement, &#8220;Merus&#8221;, &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, and &#8220;our&#8221; refer to Merus N.V. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE SHAREHOLDER MEETING TO BE HELD ON TUESDAY, MAY&#160;7, 2024 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">This Proxy Statement and the Annual Report on Form <span style="white-space:nowrap">10-K</span> are available at </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">http://www.proxyvote.com/ </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_4">PROPOSALS </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">At the Annual General Meeting, each of the following proposals (the &#8220;Proposals&#8221;) will be on the agenda as a voting item: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">1.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Adoption of the Company&#8217;s Dutch statutory annual accounts over the financial year 2023 </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">2.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Appointment of KPMG Accountants N.V. as the Company&#8217;s external auditor for the financial year 2024 for purposes of Dutch law </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">3.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Release of each member of the Company&#8217;s board of directors from liability for the exercise of their duties during the financial year 2023 </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">4.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Re-appointment</span> of Mark Iwicki as <span style="white-space:nowrap">non-executive</span> director </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">5.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Re-appointment</span> of Paolo Pucci as <span style="white-space:nowrap">non-executive</span> director </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">6.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Appointment of Jason Haddock as <span style="white-space:nowrap">non-executive</span> director </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">7.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Articles Amendment A &#8211; Approval of amendment of the Articles of Association to increase the authorized share capital to the amount of EUR 18,900,000 and divided into 105,000,000 common shares and 105,000,000 preferred shares and authorization to implement such amendment </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">8.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Articles Amendment B &#8211; Approval of the amendment to the Articles of Association to reflect the Large Company Regime and authorization to implement such amendment </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">9.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Granting authorization to acquire shares (or depository receipts for such shares) in the Company&#8217;s capital </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">10.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Approval, on an advisory <span style="white-space:nowrap">(non-binding)</span> basis, of the compensation of the Company&#8217;s named executive officers </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">11.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Approval of the amendment of the Company&#8217;s <span style="white-space:nowrap">Non-Executive</span> Director Compensation program (&#8220;NED Program&#8221;) to allow the board of directors to determine the number of common shares that may be awarded to a <span style="white-space:nowrap">non-executive</span> director for initial and annual awards under the NED Program to more closely align with the 50<sup style="font-size:75%; vertical-align:top">th</sup> percentile of the Company&#8217;s peer group </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">12.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Approval of the amendment and restatement of the Company&#8217;s 2016 Incentive Award Plan (the &#8220;2016 Plan&#8221;) to extend the term of the 2016 Plan to December&#160;31, 2031, which includes a corresponding extension to the annual &#8220;evergreen&#8221; feature from and including January&#160;1, 2026 to January&#160;1, 2029, along with other minor amendments updated for best practices </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">No business shall be voted on at the Annual General Meeting, except for the Proposals. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_5">RECOMMENDATIONS OF THE BOARD </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The board of directors recommends that you vote your shares FOR all Proposals. If you properly submit your proxy your common shares will be voted on your behalf as you direct. If not otherwise specified, the common shares represented by the proxies received prior to 16:59 (4:59) p.m. Central European Summer Time on May&#160;2, 2024 will be voted FOR all Proposals. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_6">INFORMATION ABOUT THIS PROXY STATEMENT </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-weight:bold">Why you received this proxy statement</span>. You have received these proxy materials because Merus&#8217; board of directors is soliciting your proxy for the Annual General Meeting. This proxy statement includes information that we are required to provide to you under the rules of the SEC and that is designed to assist you in voting your shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-weight:bold">Proxy Card. </span>Instructions regarding how you can vote are contained on the proxy card included with these materials. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-weight:bold">Householding</span>. The SEC&#8217;s rules permit us to deliver a single set of proxy materials to one address shared by two or more of our shareholders. This delivery method is referred to as &#8220;householding&#8221; and can result in significant cost savings. To take advantage of this opportunity, we have delivered only one set of proxy materials to multiple shareholders who share an address, unless we received contrary instructions from the impacted shareholders prior to the mailing date. We agree to deliver promptly, upon written or oral request, a separate copy of the proxy materials, as requested, to any shareholder at the shared address to which a single copy of those documents was delivered. If your household received a single set of proxy materials this year, but you would prefer to receive your own copy, or if you currently share an address with another shareholder and wish to receive only one copy of proxy materials in future for your household, please contact Broadridge Householding Department, by calling their toll free number, <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">1-866-540-7095</span></span></span> or by writing to: Broadridge, Householding Department, 51 Mercedes Way, Edgewood, NY 11717. If you have requested to be removed from the householding program, you will be removed within 30 days of receipt of your instructions at which time you will then be sent separate copies of the documents. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#cccccc">
<td style="vertical-align:top">&#8195;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#cccccc">
<td style="padding-bottom:2pt ;vertical-align:middle" id="toc706699_7"><span style="font-weight:bold">QUESTIONS AND ANSWERS ABOUT THE ANNUAL GENERAL MEETING</span></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">WHO IS ENTITLED TO VOTE PRIOR TO THE ANNUAL GENERAL MEETING? </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">We urge you to vote your shares at the Annual General Meeting or to submit your proxy prior to the <span style="white-space:nowrap">Cut-off</span> Time. The Record Date for the Annual General Meeting is April&#160;9, 2024. Persons with Meeting Rights (i.e., (i) holders of common shares or who otherwise have voting rights and/or meeting rights with respect to common shares on the Record Date and (ii)&#160;holders of preferred shares (if any are issued) or who otherwise have voting rights and/or meeting rights with respect to preferred shares on the date of the Annual General Meeting, in each case provided that they are recorded as such in the Company&#8217;s shareholders&#8217; register or in the register maintained by the Company&#8217;s U.S. transfer agent) may attend and, if relevant, vote at the Annual General Meeting. Each outstanding common share and each outstanding preferred share (if any are issued) is entitled to one vote on all matters presented at the Annual General Meeting as voting items. At the close of business on April&#160;9, 2024, there were [&#8195;&#8195;&#8195;&#8195;] common shares and no preferred shares outstanding. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">WHAT IS THE DIFFERENCE BETWEEN BEING A &#8220;RECORD HOLDER&#8221; AND HOLDING SHARES IN &#8220;STREET NAME&#8221;?</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">A record holder holds shares in his or her name. Shares held in &#8220;street name&#8221; means shares that are held in the name of a bank or broker on a person&#8217;s behalf. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">AM I ENTITLED TO VOTE IF MY SHARES ARE HELD IN &#8220;STREET NAME&#8221;? </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Yes. If your shares are held by a bank or a brokerage firm, you are considered the &#8220;beneficial owner&#8221; of those shares held in &#8220;street name.&#8221; If your shares are held in street name, these proxy materials will be provided to you by your bank or brokerage firm, along with a voting instruction card. As the beneficial owner, you have the right to direct your bank or brokerage firm how to vote your shares, and the bank or brokerage firm is required to vote your shares in accordance with your instructions. You will not be able to vote your shares during the Annual General Meeting. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">HOW MANY SHARES MUST BE PRESENT TO HOLD THE ANNUAL GENERAL MEETING? </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">A quorum must be present at the Annual General Meeting for any voting item to be voted on. At the Annual General Meeting at least <span style="white-space:nowrap">one-third</span> of the Company&#8217;s issued and outstanding shares must be represented in order to constitute a quorum. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">WHO CAN ATTEND THE ANNUAL GENERAL MEETING? </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">You may attend the Annual General Meeting if you are a Person with Meeting Rights (see above under &#8220;Who is entitled to vote prior to the Annual General Meeting&#8221;), or if you hold a valid proxy from a Person with Meeting Rights for the Annual General Meeting. If you would like to attend the Annual General Meeting, in person or represented by proxy, you must notify </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
the Company by <span style="white-space:nowrap">e-mail</span> (addressed to AGM2024@merus.nl ) or in writing (addressed to Merus N.V., c/o Company Secretary, Uppsalalaan 17, 3<sup style="font-size:75%; vertical-align:top">rd</sup>&#160;&amp; 4<sup style="font-size:75%; vertical-align:top">th</sup> floor, 3584 CT Utrecht, the Netherlands) of your identity and intention to attend the Annual General Meeting. This notice must be received by the Company no later than 16:59 (4:59) p.m. Central European Summer Time on May&#160;2, 2024 (the <span style="white-space:nowrap">&#8220;Cut-off</span> Time&#8221;). If you do not comply with this requirement, you may be refused entry to the Annual General Meeting. Proxyholders who wish to attend the Annual General Meeting should also present a copy of their proxy upon entry to the Annual General Meeting, failing which the proxyholder concerned may be refused entry to the Annual General Meeting. In order to be admitted into the Annual General Meeting, you may be asked to present government-issued photo identification (such as a driver&#8217;s license). If your bank or broker holds your shares in street name, you may also be required to provide proof of beneficial ownership of our common shares as of the Record Date, such as a bank or brokerage statement or a letter from your bank or broker showing that you owned our common shares at the close of business on the Record Date. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">WHAT IF A QUORUM IS NOT PRESENT AT THE ANNUAL GENERAL MEETING? </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">If the requisite quorum (see above under &#8220;How many shares must be present to hold the Annual General Meeting&#8221;) is not present, then the Annual General Meeting cannot validly pass any of the voting items on the agenda for the Annual General Meeting and a new meeting shall be convened in accordance with applicable law. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">WHAT DOES IT MEAN IF I RECEIVE MORE THAN ONE SET OF PROXY MATERIALS? </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">It means that your common shares are held in more than one account at the transfer agent and/or with banks or brokers. Please vote all of your shares. To ensure that all of your shares are voted, for each set of proxy materials please submit your proxy by phone, via the Internet, or by signing, dating and returning the enclosed proxy card in the enclosed envelope. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">HOW DO I VOTE? </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">We recommend that shareholders submit their proxy before the <span style="white-space:nowrap">Cut-off</span> Time in order to vote their shares, regardless of whether they plan to attend the Annual General Meeting and vote in person. There are four ways to vote by proxy: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">by Telephone&#8212;you can vote by telephone by calling <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">1-800-690-6903</span></span></span> and following the instructions on the proxy card; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">by Internet&#8212;you can vote over the Internet at www.proxyvote.com by following the instructions on the proxy card; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">by Mail&#8212;you can vote by mail by signing, dating and mailing the proxy card; or </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">by Email&#8212;you can vote by email by signing, dating and emailing the proxy card to AGM2024@merus.nl. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Telephone and Internet voting facilities will be available 24 hours a day and will close at the <span style="white-space:nowrap">Cut-off</span> Time. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">If your shares are held in street name through a bank or broker, you will receive instructions on how to vote from the bank or broker. You must follow their instructions in order for your shares to be voted. Telephone and Internet voting also may be offered to shareholders owning shares through certain banks and brokers. If your shares are held in street name and you would like to vote your shares in person at the Annual General Meeting, you should contact your bank or broker to obtain a legal proxy, bring it to the Annual General Meeting in order to vote and notify the Company in writing of your identity and intention to attend the Annual General Meeting (see above under &#8220;Who can attend the Annual General Meeting?&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">CAN I CHANGE MY VOTE AFTER I SUBMIT MY PROXY? </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Yes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">You may revoke your submitted proxy and change your vote prior to the <span style="white-space:nowrap">Cut-off</span> Time: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">by submitting a duly executed proxy bearing a later date; or </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">by granting a subsequent proxy through the Internet or telephone. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Your most recent proxy card or telephone or Internet proxy is the one that will be counted. You may also attend the Annual General Meeting in person and revoke your proxy at the meeting or grant a separate proxy in writing to a representative who may attend the Annual General Meeting in person and revoke your prior proxy at the meeting on your behalf. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">If your shares are held in street name, you may change or revoke your voting instructions by following the specific directions provided to you by your bank or broker, or you may vote in person at the Annual General Meeting by obtaining a legal proxy from your bank or broker, bringing your legal proxy to the Annual General Meeting in order to vote and notifying the Company in writing of your identity and intention to attend the Annual General Meeting (see above under &#8220;Who can attend the Annual General Meeting?&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">WHO WILL COUNT THE VOTES? </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">NautaDutilh N.V., our Dutch legal counsel, will tabulate the votes submitted by proxy prior to the <span style="white-space:nowrap">Cut-off</span> Time as described in this proxy statement and the votes cast at the Annual General Meeting by Persons with Meeting Rights attending in person, if any. This tabulation will be provided to the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">WHAT IF I DO NOT SPECIFY HOW MY SHARES ARE TO BE VOTED? </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">If you submit a proxy but do not indicate any voting instructions, the persons named as proxies will vote in accordance with the recommendations of the board of directors. The board of directors&#8217; recommendations are indicated on page 3 of this proxy statement, as well as with the description of each proposal in this proxy statement. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">WILL ANY OTHER BUSINESS BE CONDUCTED AT THE ANNUAL GENERAL MEETING? </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">No business shall be voted on at the Annual General Meeting, except such items as included in the agenda for the meeting included on page 2 of this proxy statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">HOW MANY VOTES ARE REQUIRED FOR THE APPROVAL OF THE PROPOSALS TO BE VOTED UPON?</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Other than the proposals to <span style="white-space:nowrap">re-appoint</span> Mark Iwicki and Paolo Pucci as <span style="white-space:nowrap">non-executive</span> directors, and to appoint Jason Haddock as a <span style="white-space:nowrap">non-executive</span> director, each voting item on the agenda for the Annual General Meeting requires the affirmative vote of a simple majority of the valid votes cast. The proposals to <span style="white-space:nowrap">re-appoint</span> Mark Iwicki and Paolo Pucci and to appoint Jason Haddock as <span style="white-space:nowrap">non-executive</span> directors are based on a binding nomination proposed by the board of directors. The proposed candidate specified in a binding nomination shall be appointed provided that the requisite quorum is present or represented at the Annual General Meeting, unless the nomination is overruled by the Annual General Meeting which would result if at least a <span style="white-space:nowrap">two-thirds</span> majority of the votes cast, representing more than half of the Company&#8217;s issued share capital, vote against the appointment. Also, at the Annual General Meeting at least <span style="white-space:nowrap">one-third</span> of the Company&#8217;s issued and outstanding shares must be represented in order to constitute a quorum. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">WHAT IS AN ABSTENTION AND HOW WILL ABSTENTIONS BE TREATED? </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">An &#8220;abstention&#8221; represents a shareholder&#8217;s affirmative choice to decline to vote on a proposal. Under Dutch law and our articles of association, shares abstaining from voting will not count as votes cast at the Annual General Meeting, but will count as shares present and entitled to vote for purposes of determining a quorum. Abstentions have no effect on the proposals. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">WHAT ARE BROKER <span style="white-space:nowrap">NON-VOTES</span> AND DO THEY COUNT FOR DETERMINING A QUORUM? </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Generally, broker <span style="white-space:nowrap">non-votes</span> occur when shares held by a broker in &#8220;street name&#8221; for a beneficial owner are not voted with respect to a particular proposal because the broker (1)&#160;has not received voting instructions from the beneficial owner and (2)&#160;lacks discretionary voting power to vote those shares. A broker is entitled to vote shares held for a beneficial owner on routine matters, such as the appointment of our independent registered public accounting firm, without instructions from the beneficial owner of those shares, in which case your shares will count for purposes of determining whether a quorum is present. On the other hand, absent instructions from the beneficial owner of such shares, a broker is not entitled to vote shares held for a beneficial owner on <span style="white-space:nowrap">non-routine</span> matters, which include all proposals other than proposals 2 and 8. Broker <span style="white-space:nowrap">non-votes</span> have no effect on the proposals and do not count for purposes of determining whether a quorum is present or for the purpose of determining the number of votes cast. We do not expect any broker <span style="white-space:nowrap">non-votes</span> in connection with proposals 2 and 8. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">WHERE CAN I FIND THE VOTING RESULTS OF THE ANNUAL GENERAL MEETING? </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">We plan to announce whether the proposals have passed at the Annual General Meeting and we will report the final voting results in a Current Report on Form <span style="white-space:nowrap">8-K,</span> which we intend to file with the SEC after the Annual General Meeting. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#cccccc">
<td style="vertical-align:top">&#8195;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">8 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="font-size:1pt;background-color:#cccccc">
<td style="height:0.75pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#cccccc">
<td style="padding-bottom:1pt ;vertical-align:middle" id="toc706699_8"><span style="font-weight:bold">PROPOSALS TO BE VOTED ON</span></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_9">PROPOSAL 1 <span style="font-style:italic"> </span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_10"><span style="font-style:italic">Adoption of the Company&#8217;s Dutch statutory annual accounts for the financial year 2023</span> </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The Annual General Meeting, as required under Dutch law, will be asked to adopt our Dutch statutory annual accounts for the financial year 2023, which are comprised of our company annual accounts and consolidated annual accounts. This approval also extends to the approval of the use of the English language for the line items in our Dutch statutory annual accounts and the preparation of our annual reports (for this and other financial years). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Our Dutch statutory consolidated annual accounts are prepared in accordance with International Financial Reporting Standards and are different from the consolidated financial statements contained in our Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2023 that were prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) and filed with the SEC. The Dutch statutory annual accounts contain some disclosures that are not required under U.S. GAAP and not contained in our Annual Report on Form <span style="white-space:nowrap">10-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">A copy of our Dutch statutory annual accounts over the financial year 2023 will be included in our Dutch statutory annual report over the financial year 2023, which will be made available on our website at http://www.merus.nl and at our offices located at Uppsalalaan 17, 3<sup style="font-size:75%; vertical-align:top">rd</sup>&#160;&amp; 4<sup style="font-size:75%; vertical-align:top">th</sup> floor, 3584 CT Utrecht, the Netherlands ultimately when we publish a convening notice of the Annual General Meeting in a Dutch daily newspaper with national distribution in accordance with Dutch law. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">VOTE REQUIRED </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">This proposal requires a simple majority of votes cast in favor of the proposal. Abstentions and broker <span style="white-space:nowrap">non-votes</span> are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">RECOMMENDATION OF THE BOARD OF DIRECTORS </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="FONT-FAMILY:'WINGDINGS 3'">u</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">The board of directors unanimously recommends a vote FOR the adoption of our Dutch statutory annual accounts for the financial year 2023.</span> </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">9 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_11">PROPOSAL 2 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_12"><span style="font-style:italic">Appointment of KPMG Accountants N.V. as the Company&#8217;s external auditor for the financial year 2024 for purposes of Dutch law </span></p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Pursuant to Dutch law, our general meeting of shareholders is authorized to appoint an auditor to audit our Dutch annual report, including our statutory annual accounts. Upon the recommendation of the audit committee of our board of directors, our board of directors proposes to appoint and instruct KPMG Accountants N.V. to serve as our external auditor who will audit our Dutch annual report and Dutch statutory annual accounts to be prepared in accordance with Dutch law and, to the extent applicable, our sustainability reporting for the financial year 2024. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">A representative of KPMG Accountants N.V. is expected to attend the Annual General Meeting and to have an opportunity to make a statement and be available to respond to appropriate questions from shareholders. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">VOTE REQUIRED </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">This proposal requires a simple majority of votes cast in favor of the proposal. Abstentions and broker <span style="white-space:nowrap">non-votes</span> are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">RECOMMENDATION OF THE BOARD OF DIRECTORS </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="FONT-FAMILY:'WINGDINGS 3'">u</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">The board of directors unanimously recommends a vote FOR appointment of KPMG Accountants N.V. as the external auditor for the financial year 2024 for purposes of Dutch law.</span> </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">10 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_13">PROPOSAL 3 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_14"><span style="font-style:italic">Release of each member of the Company&#8217;s board of directors from liability for the exercise of their duties during the financial year 2023 </span></p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">As is customary for companies organized under Dutch law, the Annual General Meeting will be asked to release each member of our board of directors in office during the financial year 2023 from liability with respect to the exercise of their respective duties during that year. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The scope of this release from liability extends to the exercise of the respective duties of our board members insofar as these are reflected in our Dutch statutory annual report over financial year 2023, our Dutch statutory annual accounts over the financial year 2023 or in our other public disclosures. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">VOTE REQUIRED </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">This proposal requires a simple majority of votes cast in favor of the proposal. Abstentions and broker <span style="white-space:nowrap">non-votes</span> are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">RECOMMENDATION OF THE BOARD OF DIRECTORS </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="FONT-FAMILY:'WINGDINGS 3'">u</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:left">The board of directors unanimously recommends a vote FOR the release of each member of our board of directors from liability for the exercise of their duties during the financial year 2023. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">11 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_15">PROPOSAL 4 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_16"><span style="font-style:italic"><span style="white-space:nowrap">Re-appointment</span> of Mark Iwicki as <span style="white-space:nowrap">non-executive</span> director</span> </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The board of directors has made a binding nomination to <span style="white-space:nowrap">re-appoint</span> Mark Iwicki as <span style="white-space:nowrap">non-executive</span> director of the Company for a period ending at the end of the annual general meeting of shareholders of the Company to be held in 2026. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Mark Iwicki, age 57, has served as a <span style="white-space:nowrap">non-executive</span> director of our board of directors since&#160;June 2015. From June 2015 until July 2018, Mr.&#160;Iwicki served as the Chairperson of our board of directors. Mr.&#160;Iwicki currently serves as the Chairperson and Chief&#160;Executive Officer of Kala Pharmaceuticals, Inc., a pharmaceutical company, where he has been employed since April 2015. From February 2014 to November 2014 Mr.&#160;Iwicki served as President and Chief Executive Officer of Civitas Therapeutics. From December 2012 to January 2014, Mr.&#160;Iwicki served as President and Chief Executive Officer and director at Blend Therapeutics, Inc. From 2007 to June 2012, Mr.&#160;Iwicki served in several roles, including Chief Commercial Officer, President and Chief Operating Officer and Director and Chief Executive Officer at Sunovion Pharmaceuticals, Inc., formerly Sepracor, Inc., a pharmaceutical company. From 1998 to 2007, Mr.&#160;Iwicki held executive positions, including Vice President and Business Unit Head, at Novartis Pharmaceuticals Corporation, a pharmaceutical company. Mr.&#160;Iwicki currently serves on the boards of directors of publicly held life science companies Akero Therapeutics, Inc. and Kala Pharmaceuticals, Inc. Within the past five years, he also served on the board of directors of the publicly held life science company Aimmune Therapeutics Inc. and Pulmatrix, Inc. Mr.&#160;Iwicki received a B.A. in business administration from Ball State University and an M.B.A. from Loyola University. We believe that Mr.&#160;Iwicki is qualified to serve on our board of directors due to his leadership, commercial and business experience in the biotechnology industry and breadth of knowledge about our business, as well as his tenure as CEO and independent director in several publicly held life science companies. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">VOTE REQUIRED </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The proposal to <span style="white-space:nowrap">re-appoint</span> Mr.&#160;Iwicki as <span style="white-space:nowrap">non-executive</span> director is based on a binding nomination proposed by the board of directors. Consequently, Mr.&#160;Iwicki shall be <span style="white-space:nowrap">re-appointed</span> provided that the requisite quorum is present or represented at the Annual General Meeting, unless the nomination is overruled by the Annual General Meeting which would result if at least <span style="white-space:nowrap">two-thirds</span> of the votes cast, representing more than half of the Company&#8217;s issued share capital, vote against the <span style="white-space:nowrap">re-appointment.</span> Abstentions and broker <span style="white-space:nowrap">non-votes</span> are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">RECOMMENDATION OF THE BOARD OF DIRECTORS </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="FONT-FAMILY:'WINGDINGS 3'">u</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">The board of directors unanimously recommends a vote FOR the <span style="white-space:nowrap">re-appointment</span> of Mark Iwicki as <span style="white-space:nowrap">non-executive</span> director.</span> </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">12 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_17">PROPOSAL 5 <span style="font-style:italic"> </span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_18"><span style="font-style:italic"><span style="white-space:nowrap">Re-appointment</span> of Paolo Pucci as <span style="white-space:nowrap">non-executive</span> director</span> </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The board of directors has made a binding nomination to <span style="white-space:nowrap">re-appoint</span> Paolo Pucci as <span style="white-space:nowrap">non-executive</span> director of the Company for a period ending at the end of the annual general meeting of shareholders of the Company to be held in 2028. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Paolo Pucci, age 62, has served as a <span style="white-space:nowrap">non-executive</span> director of our board of directors since&#160;June 2020. Mr.&#160;Pucci served as the Chief Executive Officer of ArQule, Inc. (ArQule), a biopharmaceutical oncology company engaged in the research and development of targeted therapeutics, from June 2008 until its acquisition by Merck Inc. in January 2020. Prior to joining ArQule, Mr.&#160;Pucci worked at Bayer AG from 2001 to 2008, where he served in a number of leadership capacities including President of the Oncology&#160;&amp; Global Specialty Medicines Business Units and was a member of the Bayer Pharmaceuticals Global Management Committee. Before Bayer, Mr.&#160;Pucci held positions of increasing responsibility with Eli Lilly and Company from July 1991 to April 2001, culminating with his appointment as Managing Director, Eli Lilly Sweden AB. Mr.&#160;Pucci earned an M.S. in economics and accounting from Universit&#224; degli Study di Napoli Federico II and an M.B.A. in marketing and finance from the University of Chicago. Within the past five years, Mr.&#160;Pucci previously served on the boards of directors of Algeta ASA, until its acquisition by Bayer AG, and Dyax Inc., until its acquisition by Shire Plc (which was subsequently acquired by Takeda Pharmaceutical Company Ltd.), New Link Genetics Inc, ArQule Inc., until its acquisition by Merck Inc., and Trillium Therapeutics Inc., until its acquisition by Pfizer Inc. He currently serves on the boards of directors of publicly held life sciences companies West Pharmaceuticals Services, Inc., and Replimmune Group Inc. We believe that Mr.&#160;Pucci is qualified to serve on our board of directors due to his leadership, international business and biotechnology experience in large multinational pharmaceutical corporations as well as his tenure as CEO and independent director in several publicly held life science companies, and breadth of knowledge about our business. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">VOTE REQUIRED </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The proposal to <span style="white-space:nowrap">re-appoint</span> Mr.&#160;Pucci as <span style="white-space:nowrap">non-executive</span> director is based on a binding nomination proposed by the board of directors. Consequently, Mr.&#160;Pucci shall be <span style="white-space:nowrap">re-appointed</span> provided that the requisite quorum is present or represented at the Annual General Meeting, unless the nomination is overruled by the Annual General Meeting which would result if at least <span style="white-space:nowrap">two-thirds</span> of the votes cast, representing more than half of the Company&#8217;s issued share capital, vote against the <span style="white-space:nowrap">re-appointment.</span> Abstentions and broker <span style="white-space:nowrap">non-votes</span> are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">RECOMMENDATION OF THE BOARD OF DIRECTORS </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="FONT-FAMILY:'WINGDINGS 3'">u</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">The board of directors unanimously recommends a vote FOR the <span style="white-space:nowrap">re-appointment</span> of Paolo Pucci as <span style="white-space:nowrap">non-executive</span> director.</span> </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">13 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_19">PROPOSAL 6 <span style="font-style:italic"> </span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_20"><span style="font-style:italic">Appointment of Jason Haddock as <span style="white-space:nowrap">non-executive</span> director</span> </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The board of directors has made a binding nomination to appoint Jason Haddock as <span style="white-space:nowrap">non-executive</span> director of the Company for a period ending at the end of the annual general meeting of shareholders of the Company to be held in 2028. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Jason Haddock, age 54, has more than 20 years of financial and operational experience in the biopharmaceutical industry and currently serves as a board of director of PYC Therapeutics since May 2021 and formerly served on the board of directors of Codiak Biosciences from August 2020 to June 2023. Mr.&#160;Haddock also served as CFO at Archer Dx from May to August 2020 until it was acquired by Invitae Corporation. Prior to that, Mr.&#160;Haddock served as CFO of Array BioPharma, Inc., from 2016 to 2019, where he was responsible for execution of an oncology-focused research, development and commercialization strategy. Prior to that, from 2015 to 2016, he served as CFO and COO of BERG, an artificial intelligence-based analytics biopharma company, and from 2001to 2015, at Bristol-Myers Squibb in a variety of finance, strategic, commercial and business development capacities, including CFO and COO roles for business units in Asia Pacific, Europe and the United States. He holds a BS in accounting from Illinois State University and an Executive MBA from Washington University in St. Louis. We believe that Mr.&#160;Haddock is qualified to serve on our board of directors due to his leadership, international business and biotechnology experience as well as his operational, financial planning and accounting experience and expertise. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">VOTE REQUIRED </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The proposal to appoint Jason Haddock<span style="font-style:italic"> </span>as <span style="white-space:nowrap">non-executive</span> director is based on a binding nomination proposed by the board of directors. Consequently, Jason Haddock<span style="font-style:italic"> </span>shall be appointed provided that the requisite quorum is present or represented at the Annual General Meeting, unless the nomination is overruled by the Annual General Meeting which would result if at least <span style="white-space:nowrap">two-thirds</span> of the votes cast, representing more than half of the Company&#8217;s issued share capital, vote against the <span style="white-space:nowrap">re-appointment.</span> Abstentions and broker <span style="white-space:nowrap">non-votes</span> are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">RECOMMENDATION OF THE BOARD OF DIRECTORS </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="FONT-FAMILY:'WINGDINGS 3'">u</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">The board of directors unanimously recommends a vote FOR the appointment of Jason Haddock as <span style="white-space:nowrap">non-executive</span> director.</span> </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">14 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">OUR BOARD OF DIRECTORS </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">We currently have seven (7)&#160;directors on our board of directors, including one executive director, and six <span style="white-space:nowrap">(6)&#160;non-executive</span> directors. Our current executive director is Sven (Bill) Ante&#160;Lundberg, M.D., who has served on our board of directors since June 2019 and as an executive director since December&#160;31, 2019. Our current <span style="white-space:nowrap">non-executive</span> directors are Mark Iwicki, who has served on our board of directors since June 2015, Len Kanavy, who has served on our board of directors since July 2018, Anand Mehra, M.D., who has served on our board of directors since August 2015, Paolo Pucci, who has served on our board of directors since June 2020, Victor Sandor, M.D.C.M., who has served on our board of directors since&#160;June 2019, and Maxine Gowen, Ph.D., who has served on our board of directors since May 2021. If Mr.&#160;Iwicki and Mr.&#160;Pucci are <span style="white-space:nowrap">re-appointed</span> and Mr.&#160;Haddock is appointed at the Annual General Meeting, the board of directors will consist of eight directors, consisting of one executive director and seven <span style="white-space:nowrap">non-executive</span> directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Each board member is appointed for an initial term of up to four years. A <span style="white-space:nowrap">non-executive</span> director may be <span style="white-space:nowrap">re-appointed</span> for one subsequent term of up to four years followed by up to two subsequent terms of up to two years. An executive director may serve for an unlimited number of consecutive terms of up to four years. The expiration of the current terms of the members of our board of directors and the period each member has served in that term are as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:92%;border:0;margin-left:auto">


<tr>

<td style="width:52%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:23%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:23%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="right" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:right">Year&#160;Current&#160;Term</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:right">Began</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="right" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:right">Year&#160;Current&#160;Term</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:right">Expires</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Mark Iwicki</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">2020</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">2024</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Len Kanavy</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">2022</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">2026</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Sven (Bill) Ante Lundberg, M.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">2023</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">2027</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Anand Mehra, M.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">2023</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">2025</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Paolo Pucci</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">2020</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">2024</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Victor Sandor, M.D.C.M.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">2023</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">2027</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Maxine Gowen, Ph.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">2021</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">2025</td></tr>
</table></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Our articles of association provide that the number of executive and <span style="white-space:nowrap">non-executive</span> directors may only be determined by our board of directors. Our directors are appointed on the basis of a binding nomination prepared by our board of directors. Our general meeting of shareholders may overrule the binding nomination by a resolution passed by a <span style="white-space:nowrap">two-thirds</span> majority of votes cast, provided such majority represents more than half of our issued share capital, in which case our board of directors shall be allowed to make a new binding nomination. Our directors may be dismissed only by a resolution at a general meeting of shareholders. Dismissal of a director by our general meeting of shareholders requires a <span style="white-space:nowrap">two-thirds</span> majority of votes cast, provided such majority represents more than half of our issued share capital, unless the dismissal is proposed by the board of directors, in which case a simple majority of votes cast will suffice to pass the resolution. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">There are no family relationships among any of our executive officers or directors. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">15 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Continuing Members of the Board of Directors </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">In addition to Mark Iwicki and Paolo Pucci, all of the persons whose names and biographies appear below are currently serving as our directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic"><span style="white-space:nowrap">NON-EXECUTIVE</span> DIRECTORS (TERM TO EXPIRE AT THE 2025 ANNUAL GENERAL MEETING) </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The current members of the board of directors whose term will expire at the 2025 annual general meeting of shareholders and who will continue on the board of directors following the Annual General Meeting are as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:55%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Age</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Served&#160;as&#160;a</span><br/><span style="font-weight:bold">Director&#160;Since</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Position(s)&#160;with&#160;Merus</span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Anand Mehra, M.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">48</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2018</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="white-space:nowrap">Non-Executive&#160;Director</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Maxine Gowen, Ph.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">66</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2021</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="white-space:nowrap">Non-Executive</span> Director</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The principal occupations and business experience, for at least the past five years, of the continuing directors whose term will expire at the 2025 annual general meeting of shareholders are as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:51%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:47%"/></tr>


<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #000000;height:1.5pt">&#160;</td>
<td colspan="2" style="BORDER-TOP:0.75pt solid #000000;height:1.5pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="padding-bottom:2pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle"><span style="font-weight:bold">ANAND MEHRA</span></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="right" style="padding-bottom:2pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle"><span style="font-style:italic">Age 48</span></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Anand Mehra, M.D. has served as a <span style="white-space:nowrap">non-executive</span> director since August 2015 and as Chairperson of our board of directors effective since June 2020. Dr.&#160;Mehra held various positions at Sofinnova Investments (f.k.a. Sofinnova Ventures) from 2007 to January 2020, most recently holding the position of a managing general partner, where he focused on working with entrepreneurs to build drug development companies. He led the firm&#8217;s investments in Vicept Therapeutics (acquired by Allergan), Aerie Pharmaceuticals, Inc., Aclaris Therapeutics, Inc. (Aclaris), and Spark Therapeutics. Prior to joining Sofinnova, Dr.&#160;Mehra worked in J.P. Morgan&#8217;s private equity and venture capital group and as a consultant at McKinsey&#160;&amp; Company. He currently serves as a member of the board of directors of the publicly held life science company Aclaris. Within the past five years, he also served on the boards of directors of the publicly held life science companies Marinus Pharmaceuticals, Inc., Spark Therapeutics, Inc. and Aerie Pharmaceuticals. Dr.&#160;Mehra received a B.A. degree in political philosophy from the University of Virginia and an M.D. degree from Columbia University&#8217;s College of Physicians and Surgeons. We believe that Dr.&#160;Mehra&#8217;s extensive experience in the life science industry, his service on the board of directors of other publicly held life science companies and his extensive leadership experience qualify him to serve on our board of directors. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:51%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:47%"/></tr>


<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #000000;height:1.5pt">&#160;</td>
<td colspan="2" style="BORDER-TOP:0.75pt solid #000000;height:1.5pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="padding-bottom:2pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle"><span style="font-weight:bold">MAXINE GOWEN</span></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="right" style="padding-bottom:2pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle"><span style="font-style:italic">Age 66</span></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Maxine Gowen, Ph.D., has served as a non-executive director of our board of directors since May 2021. Dr.&#160;Gowen was the founding President and Chief Executive Officer of Trevena, Inc. (Trevena), from 2007 to October 2018. Prior to this position, Dr.&#160;Gowen held a variety of </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">16 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
leadership roles at GlaxoSmithKline (GSK) over a period of 15 years. As Senior Vice President for the company&#8217;s Center of Excellence for Drug Discovery, she developed an innovative new approach to externalizing drug discovery. Dr.&#160;Gowen was previously President and Managing Partner at SR One, the venture capital subsidiary of GSK, where she led its investments in and served on the boards of directors of numerous companies. Dr.&#160;Gowen also previously served as Vice President, Drug Discovery, Musculoskeletal Diseases at GSK, where she was responsible for drug discovery and early development for osteoporosis, arthritis and metastatic bone disease. Dr.&#160;Gowen currently serves on the boards of directors of publicly held life science companies Aclaris, and Passage Bio, and served on the boards of directors of publicly held life science companies Aceragen, Inc., Akebia Therapeutics (Akebia), Idera Therapeutics, and Trevena. Dr.&#160;Gowen holds a B.Sc. in biochemistry from the University of Bristol, U.K., received a Ph.D. in cell biology from the University of Sheffield, U.K., and received an M.B.A. from the Wharton School of the University of Pennsylvania. We believe that Dr.&#160;Gowen is qualified to serve on our board of directors due to her leadership, experience in the biotechnology industry and in the field of clinical drug development, her scientific experience and her tenure as CEO and independent director at several publicly held life science companies </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic"><span style="white-space:nowrap">NON-EXECUTIVE</span> DIRECTOR (TERM TO EXPIRE AT THE 2026 ANNUAL GENERAL MEETING) </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The current member of the board of directors whose term will expire at the 2026 annual general meeting of shareholders and who will continue on the board of directors following the Annual General Meeting is as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8201;Age&#8201;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Served&#160;as&#160;a</span><br/><span style="font-weight:bold">Director&#160;Since&#8201;</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Position(s)&#160;with&#160;Merus&#8195;&#8195;&#8195;&#8195;</span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Len Kanavy</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">63</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2018</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="white-space:nowrap">Non-Executive&#160;Director&#8195;&#8195;&#8195;&#8195;</span></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The principal occupations and business experience, for at least the past five years, of the continuing director whose term will expire at the 2026 annual general meeting of shareholders are as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:51%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:47%"/></tr>


<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #000000;height:1.5pt">&#160;</td>
<td colspan="2" style="BORDER-TOP:0.75pt solid #000000;height:1.5pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="padding-bottom:2pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle"><span style="font-weight:bold">LEN KANAVY</span></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="right" style="padding-bottom:2pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle"><span style="font-style:italic">Age 63</span></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Len Kanavy has served as a <span style="white-space:nowrap">non-executive</span> director of our board of directors since July 2018. Mr.&#160;Kanavy most recently served as Senior Vice President, Commercial Business Operations at Genentech, a biotechnology company, from September 2006 to September 2016, where he was responsible for strategic decisions for the U.S. commercial business, including product launches, valuation of business development opportunities, clinical development plan options and pricing. From 2014 to 2016, he was a board member of the Genentech Access to Care Foundation. Prior to joining Genentech, Mr.&#160;Kanavy was Vice President, Commercial Operations at Novartis Pharmaceuticals, where he led teams in business analytics, strategy, and product launches. Mr.&#160;Kanavy holds a B.S. in Business Administration and an M.B.A. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">17 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
with a specialization in Finance from the University of Scranton. We believe that Mr.&#160;Kanavy is qualified to serve on our board of directors due to his leadership, business development and commercial experience in the biotechnology industry. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">EXECUTIVE AND <span style="white-space:nowrap">NON-EXECUTIVE</span> DIRECTOR (TERM TO EXPIRE AT THE 2027 ANNUAL GENERAL MEETING) </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The current members of the board of directors whose term will expire at the 2027 annual general meeting of shareholders and who will continue on the board of directors following the Annual General Meeting are as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:43%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8201;Age&#8201;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Served&#160;as&#160;a</span><br/><span style="font-weight:bold">Director&#160;Since</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Position(s)&#160;with&#160;Merus&#8195;&#8195;&#8195;&#8195;&#8195;</span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Sven (Bill) Ante Lundberg, M.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">60</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2019</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Executive&#160;Director&#8195;&#8195;&#8195;&#8195;&#8195;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Victor Sandor, M.D.C.M.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">57</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2019</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="white-space:nowrap">Non-Executive&#160;Director&#8195;&#8195;&#8195;&#8195;&#8195;</span></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The principal occupations and business experience, for at least the past five years, of the continuing directors whose term will expire at the 2027 annual general meeting of shareholders are as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:51%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:47%"/></tr>


<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #000000;height:1.5pt">&#160;</td>
<td colspan="2" style="BORDER-TOP:0.75pt solid #000000;height:1.5pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle"><span style="font-weight:bold">SVEN (BILL) ANTE LUNDBERG</span></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="right" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle"><span style="font-style:italic">Age 60</span></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Bill Lundberg, M.D. served as a <span style="white-space:nowrap">non-executive</span> director of our board of directors from June 2019 to December 2019, and has served as an executive director since December 2019. Since December 2019, Dr.&#160;Lundberg has served as our President, Chief Executive Officer, and served as our Principal Financial Officer from December 2019 until June 2023. From January 2015 to February 2018, Dr.&#160;Lundberg was Chief Scientific Officer of CRISPR Therapeutics AG (CRISPR), a biotechnology company, where he was responsible for establishing and growing research and development in the United States and oversaw CRISPR&#8217;s first CRISPR-based product from inception to regulatory filing for clinical trials. From February 2011 to January 2015, Dr.&#160;Lundberg was Vice President and Head of Translational Medicine at Alexion Pharmaceuticals, Inc. (Alexion), where he oversaw research and development from discovery through early-stage development, and prior to that, he was Director and Chief Medical Officer of Taligen Therapeutics, Inc. (Taligen), a biotechnology company, which was acquired by Alexion in 2011. Prior to Taligen, he held roles of increasing responsibility in clinical drug development and medical affairs at Xanthus/Antisoma, Wyeth (now Pfizer), and Genzyme. Dr.&#160;Lundberg currently serves on the board of directors of the publicly traded life science company Vor Biopharma. Dr.&#160;Lundberg received an M.D. from Stanford University and M.B.A. from the University of Massachusetts. He completed post-doctoral training at the Whitehead Institute/M.I.T., and clinical training in Medicine and Medical Oncology from Harvard and the Dana-Farber Cancer Institute. We believe that Dr.&#160;Lundberg is qualified to serve on our board of directors due to his experience in the field of medicine, clinical drug development, scientific experience, leadership, business experience and breadth of knowledge about our business. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">18 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:51%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:47%"/></tr>


<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #000000;height:1.5pt">&#160;</td>
<td colspan="2" style="BORDER-TOP:0.75pt solid #000000;height:1.5pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle"><span style="font-weight:bold">VICTOR SANDOR</span></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="right" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle"><span style="font-style:italic">Age 57</span></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Victor Sandor, M.D.C.M. has served as a <span style="white-space:nowrap">non-executive</span> director of our board of directors since June 2019. From September 2014 to December 2019, Dr.&#160;Sandor was the Chief Medical Officer at Array BioPharma (Array), a pharmaceutical company, where he oversaw clinical development through regulatory approval of Braftovi<sup style="font-size:75%; vertical-align:top">&#174;</sup> and Mektovi<sup style="font-size:75%; vertical-align:top">&#174;</sup> for the treatment of BRAFV600E/K mutant melanoma and Braftovi for the treatment of BRAFV600E mutant colorectal cancer. Prior to joining Array, from February 2010 to September 2014, he was Senior Vice President for Global Clinical Development at Incyte Corporation (Incyte), a pharmaceutical company, where he oversaw clinical development through regulatory approval of Jakafi<sup style="font-size:75%; vertical-align:top">&#174;</sup> for the treatment of myelofibrosis and polycythemia vera. Prior to joining Incyte, Dr.&#160;Sandor was Vice President and Chief Medical Officer for oncology at Biogen Idec and, prior to that held positions of increasing responsibility in oncology product development at AstraZeneca, where he played a lead role in the registration of Arimidex<sup style="font-size:75%; vertical-align:top">&#174;</sup> (anastrozole) for adjuvant use and the development of early stage programs through <span style="white-space:nowrap"><span style="white-space:nowrap">proof-of-concept.</span></span> Dr.&#160;Sandor received his M.D.C.M. from McGill University in Montreal, Canada, and completed his Fellowship in Medical Oncology at the National Institutes of Health in Bethesda, Maryland. He currently serves on the boards of directors of publicly held life sciences companies ADC Therapeutics, Istari Oncology, Prelude Therapeutics and Kymera Therapeutics. We believe that Dr.&#160;Sandor is qualified to serve on our board of directors due to his experience in the field of medicine, clinical drug development and scientific experience and breadth of knowledge about our business. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">BOARD DIVERSITY MATRIX </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:11pt;width:98%;border:0;margin:0 auto">


<tr>

<td style="width:64%"/>

<td style="vertical-align:bottom"/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/></tr>


<tr style="font-size:1pt">
<td colspan="9" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:1.5pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td colspan="9" align="center" style="padding-bottom:2pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt; padding-right:2pt;vertical-align:middle"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:arial;font-weight:bold;text-align:center">&#8195;&#8195;Board Diversity Matrix (As of April [&#8195;], 2024)</p></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:1.5pt">&#160;</td>
<td colspan="8" style="BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:middle"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:arial">&#8194;Country of Principal Executive Offices</p></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle;white-space:nowrap"><span style="font-family:arial">The Netherlands</span></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:1.5pt">&#160;</td>
<td colspan="8" style="BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:middle"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:arial">&#8194;Foreign Private Issuer</p></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle;white-space:nowrap"><span style="font-family:arial">No</span></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:1.5pt">&#160;</td>
<td colspan="8" style="BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:middle"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:arial">&#8194;Disclosure Prohibited under Home Country Law</p></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle;white-space:nowrap"><span style="font-family:arial">No</span></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:1.5pt">&#160;</td>
<td colspan="8" style="BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:middle"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:arial">&#8194;Total Number of Directors</p></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle;white-space:nowrap"><span style="font-family:arial">7</span></td></tr>
<tr style="font-size:1pt;background-color:#b2b2b2">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:1.5pt">&#160;</td>
<td style="height:1.5pt" colspan="2"/>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td>
<td style="height:1.5pt" colspan="2"/>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:arial; font-size:11pt;background-color:#b2b2b2">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top;white-space:nowrap"><span style="font-weight:bold">Female</span></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top;white-space:nowrap"><span style="font-weight:bold">Male</span></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top;white-space:nowrap"><span style="font-weight:bold"><span style="white-space:nowrap">Non-</span></span><br/> <p style="margin-bottom:1pt; margin-top:0pt; font-size:11pt; font-family:arial;font-weight:bold">Binary</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top;white-space:nowrap"><span style="font-weight:bold">Did Not<br/>Disclose<br/>Gender</span></td></tr>
<tr style="font-size:1pt;background-color:#b2b2b2">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:1.5pt">&#160;</td>
<td colspan="8" style="BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:arial; font-size:10pt;background-color:#b2b2b2">
<td style="padding-bottom:2pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:middle"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:arial;font-weight:bold">&#8194;Part I: Gender Identity</p></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:1.5pt">&#160;</td>
<td style="height:1.5pt" colspan="2"/>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td>
<td style="height:1.5pt" colspan="2"/>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:arial; font-size:11pt">
<td style="padding-bottom:2pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:middle"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:arial">&#8194;Directors</p></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="padding-bottom:2pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle;white-space:nowrap">1</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle;white-space:nowrap">4</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="padding-bottom:2pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle;white-space:nowrap">0</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:middle;white-space:nowrap">2</td></tr>
<tr style="font-size:1pt;background-color:#b2b2b2">
<td colspan="9" style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:1.5pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:arial; font-size:10pt;background-color:#b2b2b2">
<td colspan="9" style="padding-bottom:2pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt; padding-right:2pt;vertical-align:middle"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:arial;font-weight:bold">&#8194;Part II: Demographic Background</p></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:1.5pt">&#160;</td>
<td colspan="8" style="BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:middle"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.50em; font-size:11pt; font-family:arial">Underrepresented Individual in Home Country Jurisdiction</p></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" align="center" style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top;white-space:nowrap"><span style="font-family:arial; font-size:11pt">1</span></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:1.5pt">&#160;</td>
<td colspan="8" style="BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:middle"><span style="font-family:arial; font-size:11pt">&#8194;LGBTQ+</span></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" align="center" style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top;white-space:nowrap"><span style="font-family:arial; font-size:11pt">0</span></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:1.5pt">&#160;</td>
<td colspan="8" style="BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:middle"><span style="font-family:arial; font-size:11pt">&#8194;Did Not Disclose Demographic Background</span></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" align="center" style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top;white-space:nowrap"><span style="font-family:arial; font-size:11pt">3</span></td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">19 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_21">PROPOSAL 7 <span style="font-style:italic"> </span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_22"><span style="font-style:italic">Articles Amendment A &#8211; Approval of the amendment of the Articles of Association to increase the authorized share capital to the amount of EUR 18,900,000 and divided into 105,000,000 common shares and 105,000,000 preferred shares and authorization to implement such amendment</span> </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Our board of directors adopted a resolution to propose to the general meeting to amend the Company&#8217;s articles of association, by increasing our authorized share capital from the amount of EUR 12,150,000 and divided into 67,500,000 common shares and 67,500,000 preferred shares to the amount of EUR 18,900,000 and divided into 105,000,000&#160;common shares and 105,000,000 preferred shares (the &#8220;Share Capital Increase Amendment&#8221;). At the Annual General Meeting, our shareholders will be asked to approve the Share Capital Increase Amendment. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Under Dutch law, the number of shares that may be issued in the share capital of a public limited liability company is limited by such company&#8217;s authorized share capital as included in its articles of association. Our current authorized share capital, in the amount of EUR 12,150,000 and divided into 67,500,000 common shares and 67,500,000 preferred shares as included in articles 4.1 and 4.2 of our articles of association may limit our ability to obtain further equity investments as currently approximately 98&#160;% of the common shares comprised in our authorized share capital has been issued or is reserved for future issuance. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The purpose of the Share Capital Increase Amendment is to increase our flexibility to expand our business and obtain equity investments in the future by allowing the Company to issue additional common shares in connection with acquisitions of other companies or technologies, future financings, joint ventures, stock splits, employee and director benefit programs and other desirable corporate activities, without requiring our Company&#8217;s shareholders to approve an increase in the authorized share capital as contained in our articles of association each time such action is contemplated. From 2018 to 2024, the Company has issued shares, including at premiums of up to approximately 100% of the then trading price in conjunction with collaboration and license agreements, and has also issued share capital in <span style="white-space:nowrap">follow-on</span> offerings to use the net proceeds for advancing the clinical development of our product candidates, for preclinical research and technology development and for working capital and general corporate purposes. We expect the Share Capital Increase Amendment to serve similar purposes. The proposed Share Capital Increase Amendment only increases the maximum number of shares that may be issued under our articles of association and does not result in actual issuances of such shares. Except pursuant to our Open Market Sale Agreement<sup style="font-size:75%; vertical-align:top">SM</sup>, dated February&#160;28, 2024, by and between the Company and Jefferies LLC, and employee and director incentive plans, we presently have no plan, commitment, arrangement, understanding or agreement regarding the issuance of our common shares. While it may be deemed to have potential anti-takeover effects, the Share Capital Increase Amendment is not prompted by any specific effort or takeover threat currently perceived by management. However, as discussed above, if the increase of the authorized share capital is approved by our shareholders, we may in the future issue additional common shares to pursue acquisition and joint venture opportunities and in connection with future financings, including for advancing the clinical </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">20 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
development of our product candidates, potential commercialization of our product candidates, if approved, for preclinical research and technology development and for working capital and general corporate purposes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">Language of the Proposed Amendment </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">In connection with the Share Capital Increase Amendment, our board of directors proposed and we are therefore requesting our shareholders to resolve that articles 4.1 and 4.2 of our articles of association be amended to read as follows: </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">&#8220;4.1 The Company&#8217;s authorised share capital amounts to eighteen million nine hundred thousand euro (EUR 18,900,000). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">4.2 The authorised share capital is divided into: </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">a. one hundred million (105,000,000) common shares; and </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">b. one hundred million (105,000,000) preferred shares, </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">each having a nominal value of nine eurocents (EUR 0.09).&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">In Dutch: </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">&#8220;4.1 Het maatschappelijk kapitaal van de Vennootschap bedraagt achttien miljoen negenhonderdduizend euro (EUR 18.900.000). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">4.2 Het maatschappelijk kapitaal is verdeeld in: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">a. honderd en vijf miljoen (105.000.000) gewone aandelen; en </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">b. honderd en vijf miljoen (105.000.000) preferente aandelen, </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">elk met een nominaal bedrag van negen eurocent (EUR 0,09).&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">A copy of the above proposal to amend our articles of association is available free of charge at our registered office in the Netherlands at Uppsalalaan 17, 3<sup style="font-size:75%; vertical-align:top">rd</sup>&#160;&amp; 4<sup style="font-size:75%; vertical-align:top">th</sup> floor, 3584 CT Utrecht, the Netherlands. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">Effect of the Proposed Amendment </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The approval and implementation of the Share Capital Increase Amendment will result in the increase of our authorized share capital from the amount of EUR 12,150,000 and divided into 67,500,000 common shares and 67,500,000 preferred shares to the amount of EUR 18,900,000 and divided into 105,000,000 common shares and 105,000,000 preferred shares. If shareholders approve the Share Capital Increase Amendment, such resolution shall include the granting of authorization to each civil law notary, candidate civil law notary and lawyer working with NautaDutilh N.V., our Dutch legal counsel, to execute the Dutch notarial deed of amendment to our articles of association in order to implement such resolution. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">21 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">VOTE REQUIRED </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">This proposal requires a simple majority of votes cast in favor of the proposal. Abstentions and broker <span style="white-space:nowrap">non-votes</span> are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">RECOMMENDATION OF THE BOARD OF DIRECTORS </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="FONT-FAMILY:'WINGDINGS 3'">u</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:left">The board of directors unanimously recommends a vote FOR the approval of the amendment of the Articles of Association to increase the authorized share capital as described above (including the authorization of NautaDutilh N.V. to effect such amendment as described above). </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">22 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_23">PROPOSAL 8 <span style="font-style:italic"> </span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_24"><span style="font-style:italic">Articles Amendment B &#8211; Approval of the amendment of the Articles of Association to reflect Large Company Regime and authorization to implement such amendment</span> </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Our board of directors is proposing to the general meeting to amend the Company&#8217;s articles of association to reflect the Dutch large company regime (<span style="font-style:italic">structuurregime</span>) in our articles of association (the &#8220;Large Company Regime Adaptation&#8221;). At the Annual General Meeting, our shareholders will be asked to approve the Large Company Regime Adaptation. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The Company will become subject to the Dutch large company regime (<span style="font-style:italic">structuurregime</span>) by operation of Dutch law on July&#160;28, 2024. The main consequences of the application of this large company regime include the following matters: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">our executive directors will be appointed, and can be suspended or dismissed, by the group of <span style="white-space:nowrap">non-executive</span> directors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">our <span style="white-space:nowrap">non-executive</span> directors will be appointed by our general meeting based on a nomination to be prepared by the group of <span style="white-space:nowrap">non-executive</span> directors, taking into account recommendation rights for our general meeting and our works council; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">for one third of our <span style="white-space:nowrap">non-executive</span> directors (rounded town to the nearest whole number), our works council will have a <span style="white-space:nowrap">so-called</span> enhanced right of recommendation, meaning that such a recommendation must be followed, unless our <span style="white-space:nowrap">non-executive</span> directors believe that the person so recommended would be unfit to serve or that the composition of the group of <span style="white-space:nowrap">non-executive</span> directors would become improper; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">at least one <span style="white-space:nowrap">non-executive</span> director who was appointed based on the works council&#8217;s enhanced right of recommendation must serve on our compensation committee; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">our general meeting will be able to reject nominees for appointment as <span style="white-space:nowrap">non-executive</span> directors by simple majority of votes cast, with these votes representing at least <span style="white-space:nowrap">one-third</span> of our issued share capital; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">our general meeting will only be able to dismiss our <span style="white-space:nowrap">non-executive</span> directors as a collective, which will require a simple majority of votes cast, with these votes representing at least <span style="white-space:nowrap">one-third</span> of our issued share capital; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">our board of directors will have to consist of at least three <span style="white-space:nowrap">non-executive</span> directors (which is presently already the case); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">certain additional director qualification rules will apply to our <span style="white-space:nowrap">non-executive</span> directors; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">certain resolutions of our board of directors will be subject to the approval of the group of <span style="white-space:nowrap">non-executive</span> directors. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The purpose of the Large Company Regime Adaptation is mostly intended to reflect the regime that will become applicable to the Company by operation of Dutch law. In addition, as part of the Large Company Regime Adaptation, our articles of association will be updated to </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">23 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
reflect (i)&#160;the potential replacement of the EURIBOR interest rate by the Euro short-term rate (&#8364;STR), (ii) revisions in Dutch law and (iii)&#160;pending legislation which &#8211; when enacted in its current form &#8211; would allow us to hold fully virtual general meetings. The Large Company Regime Adaptation will be effected on July&#160;28, 2024. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">Language of the Proposed Amendment </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">In connection with the Large Company Regime Adaptation, our board of directors proposed and we are therefore requesting our shareholders to resolve that our articles of association be amended. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The text of these proposed amendments, marked with the proposed changes (additions <span style="text-decoration:underline">underscored</span> and deletions <span style="text-decoration:line-through">struck through</span>), is attached as Annex A to this Proxy Statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">A copy of the above proposal to amend our articles of association is available free of charge at our registered office in the Netherlands at Uppsalalaan 17, 3<sup style="font-size:75%; vertical-align:top">rd</sup>&#160;&amp; 4<sup style="font-size:75%; vertical-align:top">th</sup> floor, 3584 CT Utrecht, the Netherlands. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">Effect of the Proposed Amendment </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The approval and implementation of the Large Company Regime Adaptation will ensure that our articles of association will continue to reflect Dutch law as it will become applicable to us on July&#160;28, 2024, such resolution shall include the granting of authorization to each civil law notary, candidate civil law notary and lawyer working with NautaDutilh N.V., our Dutch legal counsel, to execute the Dutch notarial deed of amendment to our articles of association in order to implement such resolution. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">VOTE REQUIRED </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">This proposal requires a simple majority of votes cast in favor of the proposal. Abstentions and broker <span style="white-space:nowrap">non-votes</span> are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">RECOMMENDATION OF THE BOARD OF DIRECTORS </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold"></span><span style="FONT-FAMILY:'WINGDINGS 3'">u</span><span style="font-weight:bold"></span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">The board of directors unanimously recommends a vote FOR the approval of an amendment of our Articles of Association to reflect the large company regime (and other minor updates) as described above (including the authorization of NautaDutilh N.V. to effect such amendment as described above).</span> </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">24 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_25">PROPOSAL 9 <span style="font-style:italic"> </span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_26"><span style="font-style:italic">Granting authorization to the Company&#8217;s board of directors to acquire shares (or depository receipts for such shares) in the Company&#8217;s capital</span> </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The board of directors has been authorized, for a period ending on November&#160;26, 2024, to resolve for the Company to acquire fully <span style="white-space:nowrap">paid-up</span> shares in the Company&#8217;s capital (or depository receipts for such shares) by any means, including through derivative products, purchases on a stock exchange, private purchases, block trades, or otherwise, for a price per share which is higher than nil and no higher than 110% of the average closing price of the Company&#8217;s common shares on the Nasdaq Global Market (&#8220;Nasdaq&#8221;) (such average closing price being calculated over the five trading days preceding the date the acquisition is agreed upon by the Company), up to 10% of the Company&#8217;s issued share capital. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">It is now proposed to renew the authorization of the board of directors, for a period of 18 months following the date of the Annual General Meeting, to resolve for the Company to acquire fully <span style="white-space:nowrap">paid-up</span> shares in the Company&#8217;s capital (or depository receipts for such shares) by any means, including through derivative products, purchases on a stock exchange, private purchases, block trades, or otherwise, for a price per share which is higher than nil and no higher than 110% of the average closing price of the Company&#8217;s common shares on the Nasdaq (such average closing price being calculated over the five trading days preceding the date the acquisition is agreed upon by the Company), up to 10% of the Company&#8217;s issued share capital (determined as at the close of business on the date of the Annual General Meeting). If this proposal is passed, the proposed authorization shall replace the existing authorization referred to in the previous paragraph. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">VOTE REQUIRED </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">This proposal requires a simple majority of votes cast in favor of the proposal. Abstentions and broker <span style="white-space:nowrap">non-votes</span> are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">RECOMMENDATION OF THE BOARD OF DIRECTORS </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold"></span><span style="FONT-FAMILY:'WINGDINGS 3'">u</span><span style="font-weight:bold"></span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">The board of directors unanimously recommends a vote FOR the granting authorization to acquire shares (or depository receipts for such shares) in the Company&#8217;s capital.</span> </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">25 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_27">PROPOSAL 10 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_28"><span style="font-style:italic">Approval, on an Advisory <span style="white-space:nowrap">(Non-Binding)</span> Basis, of the Compensation of Our Named Executive Officers</span> </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">In accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the &#8220;Dodd-Frank Act&#8221;) and Rule <span style="white-space:nowrap">14a-21</span> under the Exchange Act, we request that our shareholders cast a <span style="white-space:nowrap">non-binding,</span> advisory vote to approve the compensation of our named executive officers identified in the section titled &#8220;Compensation Discussion and Analysis&#8221; set forth below in this proxy statement. This proposal, commonly known as a <span style="white-space:nowrap"><span style="white-space:nowrap">&#8220;say-on-pay&#8221;</span></span> proposal, gives our shareholders the opportunity to express their support of our named executive officers&#8217; compensation. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers described in this proxy statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Accordingly, we ask our shareholders to vote &#8220;FOR&#8221; the following resolution at the Annual General Meeting: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">&#8220;RESOLVED, that the Company&#8217;s shareholders approve, by a <span style="white-space:nowrap">non-binding</span> advisory vote, the compensation of the named executive officers, as disclosed in the Company&#8217;s Proxy Statement for the 2024 Annual General Meeting pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the compensation tables and narrative discussion.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">We believe that our compensation programs and policies for the year ended December&#160;31, 2023 are worthy of shareholder support because they were an effective incentive for the achievement of our business goals, were well-designed to attract and retain highly qualified executives, and aligned with shareholder interest. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">This vote is merely advisory and will not be binding upon us, our board of directors or our compensation committee, nor will it create or imply any change in the duties of us, our board of directors or our compensation committee. The compensation committee will, however, take into account the outcome of the vote when considering future executive compensation decisions. The board of directors values constructive dialogue on executive compensation and other significant governance topics with our shareholders and encourages all shareholders to vote their shares on this important matter. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">At our 2022 annual general meeting of shareholders held on May&#160;31, 2022, our shareholders recommended, on an advisory basis, that the shareholder vote on the compensation of our named executive officers occur every year. In light of the foregoing recommendation, our board of directors determined to hold a <span style="white-space:nowrap"><span style="white-space:nowrap">&#8220;say-on-pay&#8221;</span></span> advisory vote every year. Accordingly, our next advisory <span style="white-space:nowrap"><span style="white-space:nowrap">say-on-pay</span></span> vote (following the <span style="white-space:nowrap">non-binding</span> advisory vote at this Annual General Meeting) is expected to occur at our 2025 annual general meeting of shareholders. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">26 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">VOTE REQUIRED </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">This proposal to approve, on an advisory <span style="white-space:nowrap">(non-binding)</span> basis, the compensation of our named executive officers requires a simple majority of votes cast in favor of the proposal. Abstentions and broker <span style="white-space:nowrap">non-votes</span> are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">RECOMMENDATION OF THE BOARD OF DIRECTORS </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold"></span><span style="FONT-FAMILY:'WINGDINGS 3'">u</span><span style="font-weight:bold"></span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">The board of directors unanimously recommends a vote FOR the approval, on an advisory <span style="white-space:nowrap">(non-binding)</span> basis, of the compensation of our named executive officers.</span> </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">27 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_29">PROPOSAL 11 <span style="font-style:italic"> </span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_30"><span style="font-style:italic">Approval of the amendment of the Company&#8217;s <span style="white-space:nowrap">Non-Executive</span> Director Compensation Program (&#8220;NED Program&#8221;) to allow the board of directors to determine the number of common shares that may be awarded to a <span style="white-space:nowrap">non-executive</span> director for initial and annual awards under the NED Program to more closely align with the 50</span><span style="font-style:italic"><sup style="font-size:75%; vertical-align:top">th</sup></span><span style="font-style:italic"> percentile of the Company&#8217;s peer group. </span> </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Pursuant to, and subject to the terms of, the Company&#8217;s NED Program, upon a <span style="white-space:nowrap">non-executive</span> director&#8217;s initial appointment to our board of directors, a director receives an option to purchase the number of common shares of the Company having an aggregate grant date fair value as set forth in the NED Program, which for 2023 was $493,538 (&#8220;Initial Award&#8221;), which value is determined using a Black-Scholes option pricing model and the valuation assumptions used by the Company in accounting for options as of such date; provided, that the fair market value of the common shares of the Company used in such calculation is based on the average trading price of the common shares of the Company over the preceding thirty day period. If a director has served on our board (including as an observer) for at least six months, and will continue to serve as a <span style="white-space:nowrap">non-executive</span> director immediately following any annual general meeting of shareholders, the director is granted an option to purchase the number of common shares of the Company having an aggregate grant date fair value as set forth in the NED Program, which for 2023 was $246,769 (&#8220;Annual Award&#8221;) which value is determined using a Black-Scholes option pricing model and the same assumptions described above. The aggregate grant date fair value of each Initial Award and Annual Award under the NED Program shall, subject to approval by the board of directors, increase on the first day of each calendar year by an amount of up to 5% of the grant date fair value applicable to Initial Awards and Annual Awards in effect as of the end of the immediately preceding calendar year. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The Company wishes to amend the terms of the NED Program by removing the fixed limitations on the number of Initial Awards and Annual Awards set out above and, instead, allowing our board of directors to evaluate annually and, if deemed necessary, revise the amount of Initial Awards and Annual Awards under the NED Program such that the Company&#8217;s compensation practices for its <span style="white-space:nowrap">non-executive</span> directors continue to be aligned with the 50<sup style="font-size:75%; vertical-align:top">th</sup> percentile of our peer group (as selected by our board of directors). The proposed change to the NED Program would permit the Company to issue options that ensure its compensation packages remain competitive irrespective of share price. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">VOTE REQUIRED </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">This proposal requires a simple majority of votes cast in favor of the proposal. Abstentions and broker <span style="white-space:nowrap">non-votes</span> are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">28 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">RECOMMENDATION OF THE BOARD OF DIRECTORS </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold"></span><span style="FONT-FAMILY:'WINGDINGS 3'">u</span><span style="font-weight:bold"></span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">The board of directors unanimously recommends a vote FOR the approval of the amendment of the NED Program to allow the board of directors to determine the number of common shares that may be awarded to a <span style="white-space:nowrap">non-executive</span> director for </span><span style="font-weight:bold">initial and annual awards under the NED Program to more closely align with the 50<sup style="font-size:75%; vertical-align:top">th</sup> percentile of the Company&#8217;s peer group.</span> </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">29 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_31">PROPOSAL 12 <span style="font-style:italic"> </span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_32"><span style="font-style:italic">Approval of the amendment and restatement of the Company&#8217;s 2016 Incentive Award Plan (the &#8220;2016 Plan&#8221;) to extend the term of the 2016 Plan to December</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;31, 2031, which includes a corresponding extension to the annual &#8220;evergreen&#8221; feature from and including January</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;1, 2026 to January</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;1, 2029, along with other minor amendments updated for best practices</span> </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">Overview </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">We are requesting shareholders approve the amendment and restatement of the Merus N.V. 2016 Incentive Award Plan, or the &#8220;2016 Plan&#8221;, to extend the term of the 2016 Plan to December&#160;31, 2031, which includes a corresponding extension to the annual &#8220;evergreen&#8221; feature. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">The board of directors approved the amendment and restatement of the 2016 Plan on March&#160;27, 2024, subject to and effective upon shareholder approval at the Annual General Meeting. The 2016 Plan, as amended and restated if this Proposal 12 is approved, is described in more detail below. If this Proposal 12 is not approved by our shareholders, the amendment and restatement of the 2016 Plan will not become effective, and the 2016 Plan will remain in effect in accordance with its present terms. However, we may need to consider alternative compensation structures to achieve the objectives for which the 2016 Plan was designed. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">The 2016 Plan is currently scheduled to expire in 2026. The purpose of the amendment and restatement is to permit the Company to continue using the 2016 Plan to achieve the Company&#8217;s performance, recruiting, retention and incentive goals. We believe that the continued use of the 2016 Plan is essential to our success. Providing long-term incentive compensation opportunities in the form of equity awards aligns the interests of the Company&#8217;s employees, directors and consultants with the long-term interests of our shareholders, linking compensation to Company performance. The use of equity awards as compensation also allows the Company to conserve cash resources for other important purposes. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">Accordingly, the board of directors believes that approval of the amendment and restatement of the 2016 Plan is in the best interests of the Company, and the board of directors recommends that shareholders vote for approval of this Proposal 12. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">Shares Available under the 2016 Plan </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">The total number of shares reserved for issuance under the 2016 Plan before giving effect to the amendment and restatement equals the sum of (i) 1,277,778 shares, and (ii)&#160;an annual increase on the first day of each calendar year beginning January&#160;1, 2017 and ending on and including January&#160;1, 2026, equal to the lesser of (A) 4% of the aggregate number of shares outstanding on the final day of the immediately preceding calendar year and (B)&#160;such smaller number of shares as is determined by the board of directors. Pursuant to the annual increase in shares, an aggregate of 10,345,902 shares have been added to the 2016 Plan since 2017. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">30 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">Set forth below is the number of shares available for issuance pursuant to outstanding and future equity awards under the 2016 Plan as of March&#160;12, 2024. The closing price of our common shares on the Nasdaq Global Market on that date was $45.95 per share. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:88%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Shares subject to outstanding options (1)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,331,979</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Shares subject to outstanding restricted stock units (2)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Shares available for issuance pursuant to future awards&#160;(3)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">461,304</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">As of March&#160;12, 2024, options outstanding under the 2016 Plan had a weighted average per share exercise price of $20.21 and a weighted average remaining term of 1.2 years. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">As of March&#160;12, 2024, the weighted average remaining vesting term for restricted stock units was 0.8 years. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">This number does not include the number of shares that may be added to the 2016 Plan pursuant to the annual &#8220;evergreen&#8221; feature that permits an automatic annual increase in the number of shares available for issuance under the 2016 Plan. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">If this Proposal 12 is approved, the amendment and restatement of the 2016 Plan will extend the evergreen feature through January&#160;1, 2029, which we expect to result in an aggregate of approximately 8,100,000 shares being added to the 2016 Plan through the remaining term based on our current outstanding shares. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">2016 Plan Contains Equity Compensation Best Practices </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The 2016 Plan contains a number of provisions that we believe reflect a broad range of compensation and governance best practices. These include: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">Continued broad-based eligibility for equity awards</span></span>. We grant equity awards to a large number of our employees and all of our <span style="white-space:nowrap">non-employee</span> directors. By doing so, we link employee and director interests with shareholder interests throughout the organization and motivate these individuals to act as owners of the business. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">No repricing of awards without shareholder approval.</span></span>&#160;Other than in connection with certain corporate transactions, we may not reduce the exercise price of an option or SAR or cancel an option or SAR in exchange for cash, another award under the 2016 Plan or an option or SAR with an exercise price that is less than the exercise price of the original option or SAR, unless such action is approved by the shareholders. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">No single-trigger vesting of awards</span></span>. The 2016 Plan does not have a single-trigger accelerated vesting provision for a change in control. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">No automatic grants</span></span>. The 2016 Plan does not provide for automatic grants to any individual. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">No tax <span style="white-space:nowrap">gross-ups</span></span></span>. The 2016 Plan does not provide for any tax <span style="white-space:nowrap">gross-ups.</span> </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">31 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">Summary of the 2016 Plan </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">This section summarizes certain principal features of the 2016 Plan, as amended and restated subject to shareholder approval. The summary is qualified in its entirety by reference to the complete text of the amended and restated 2016 Plan, which is attached to this Proxy Statement as Annex B. </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Eligibility and Administration </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">Our employees, consultants, board members, and employees and consultants of our subsidiaries, if any, are eligible to receive awards under the 2016 Plan. As of March&#160;25, 2024, approximately 250 employees, 6 <span style="white-space:nowrap">non-employee</span> directors and approximately 3 consultants were eligible to receive awards under the 2016 Plan. The 2016 Plan is administered by our compensation committee, although the board of directors may exercise any powers and responsibilities assigned to the compensation committee at any time. The board of directors may also delegate its duties and responsibilities under the 2016 Plan to one or more committees of the board of directors and/or officers, subject to the limitations imposed under the 2016 Plan, our Articles of Association and applicable laws. The actual administrator of the 2016 Plan is referred to as the &#8220;plan administrator&#8221; in this Proposal. The plan administrator has the authority to take all actions and make all determinations under the 2016 Plan, to interpret the 2016 Plan and award agreements and to adopt, amend and repeal rules for the administration of the 2016 Plan as it deems advisable. The plan administrator also has the authority to determine which eligible service providers receive awards, grant awards and set the terms and conditions of all awards under the 2016 Plan, including any vesting and vesting acceleration provisions, subject to the conditions and limitations in the 2016 Plan. Notwithstanding the foregoing, all actions taken by the board of directors under the 2016 Plan shall be subject to the conditions and limitations set forth in the rules of procedures for the board of directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Shares Available for Awards </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">If the amendment and restatement of the 2016 Plan is approved, the number of shares reserved for issuance under the 2016 Plan will be equal to 1,277,778 shares. Additionally, the number of shares available for issuance under the 2016 Plan will be increased on January&#160;1 of each calendar year until and including 2029 by an amount equal to the lesser of (A) 4% of the aggregate number of shares outstanding on the final day of the immediately preceding calendar year and (B)&#160;such smaller number of shares as is determined by the board of directors. No more than 1,277,778 shares may be issued under the 2016 Plan upon the exercise of incentive stock options. Shares issued under the 2016 Plan may be authorized but unissued shares, shares purchased on the open market or treasury shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">If an award under the 2016 Plan expires, lapses or is terminated, exchanged for cash, surrendered, repurchased, canceled without having been fully exercised or forfeited, any unused shares subject to the award will again be available for new grants under the 2016 Plan. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">32 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Awards </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">The 2016 Plan provides for the grant of stock options, including incentive stock options, or ISOs, and nonqualified stock options, or NSOs, stock appreciation rights, or SARs, restricted stock, dividend equivalents, restricted stock units, or RSUs, and other stock or cash based awards. Certain awards under the 2016 Plan may constitute or provide for payment of &#8220;nonqualified deferred compensation&#8221; under Section&#160;409A of the Code. All awards under the 2016 Plan will be set forth in award agreements, which will detail the terms and conditions of awards, including any applicable vesting and payment terms and post-termination exercise limitations. A brief description of each award type follows. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left"><span style="font-style:italic">Stock Options and SARs. </span>Stock options provide for the purchase of common shares in the future at an exercise price set on the grant date. ISOs, by contrast to NSOs, may provide tax deferral beyond exercise and favorable capital gains tax treatment to their holders if certain holding period and other requirements of the Code are satisfied. SARs entitle their holder, upon exercise, to receive from us an amount equal to the appreciation of the shares subject to the award between the grant date and the exercise date. The plan administrator will determine the number of shares covered by each option and SAR, the exercise price of each option and SAR and the conditions and limitations applicable to the exercise of each option and SAR. Unless otherwise determined by the plan administrator, the exercise price of a stock option or SAR will not be less than 100% of the fair market value of the underlying share on the grant date (or 110% in the case of ISOs granted to certain significant shareholders), except with respect to certain substitute awards granted in connection with a corporate transaction. The term of a stock option or SAR may not be longer than ten years (or five years in the case of ISOs granted to certain significant shareholders). </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left"><span style="font-style:italic">Restricted Stock and RSUs. </span>Restricted stock is an award of nontransferable common shares that remain forfeitable unless and until specified conditions are met and which may be subject to a purchase price. RSUs are contractual promises to deliver common shares in the future, which may also remain forfeitable unless and until specified conditions are met and may be accompanied by the right to receive the equivalent value of dividends paid on common shares prior to the delivery of the underlying shares. The plan administrator may provide that the delivery of the shares underlying RSUs will be deferred on a mandatory basis or at the election of the participant. The terms and conditions applicable to restricted stock and RSUs will be determined by the plan administrator, subject to the conditions and limitations contained in the 2016 Plan. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left"><span style="font-style:italic">Other Stock or Cash Based Awards. </span>Other stock or cash based awards are awards of cash, fully vested common shares and other awards valued wholly or partially by referring to, or otherwise based on, common shares or other property. Other stock or cash based awards may be granted to participants and may also be available as a payment form in the settlement of other awards, as standalone payments and as </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">33 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
payment in lieu of compensation to which a participant is otherwise entitled. The plan administrator will determine the terms and conditions of other stock or cash based awards, which may include any purchase price, performance goal, transfer restrictions and vesting conditions. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Performance Criteria </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">The plan administrator may select performance criteria for an award to establish performance goals for a performance period. Performance criteria under the 2016 Plan may include, but are not limited to, the following: net earnings or losses (either before or after one or more of interest, taxes, depreciation, amortization, and <span style="white-space:nowrap">non-cash</span> equity-based compensation expense); gross or net sales or revenue or sales or revenue growth; net income (either before or after taxes) or adjusted net income; profits (including but not limited to gross profits, net profits, profit growth, net operation profit or economic profit), profit return ratios or operating margin; budget or operating earnings (either before or after taxes or before or after allocation of corporate overhead and bonus); cash flow (including operating cash flow and free cash flow or cash flow return on capital); return on assets; return on capital or invested capital; cost of capital; return on shareholders&#8217; equity; total shareholder return; return on sales; costs, reductions in costs and cost control measures; expenses; working capital; earnings or loss per share; adjusted earnings or loss per share; price per share or dividends per share (or appreciation in or maintenance of such price or dividends); regulatory achievements or compliance; implementation, completion or attainment of objectives relating to research, development, regulatory, commercial, or strategic milestones or developments; market share; economic value or economic value added models; division, group or corporate financial goals; customer satisfaction/growth; customer service; employee satisfaction; recruitment and maintenance of personnel; human resources management; supervision of litigation and other legal matters; strategic partnerships and transactions; financial ratios (including those measuring liquidity, activity, profitability or leverage); debt levels or reductions; sales-related goals; financing and other capital raising transactions; cash on hand; acquisition activity; investment sourcing activity; and marketing initiatives, any of which may be measured in absolute terms or as compared to any incremental increase or decrease. Such performance goals also may be based solely by reference to the Company&#8217;s performance or the performance of a subsidiary, division, business segment or business unit of the Company or a subsidiary, or based upon performance relative to performance of other companies or upon comparisons of any of the indicators of performance relative to performance of other companies. When determining performance goals, the plan administrator may provide for exclusion of the impact of an event or occurrence which the plan administrator determines should appropriately be excluded, including, without limitation, <span style="white-space:nowrap">non-recurring</span> charges or events, acquisitions or divestitures, changes in the corporate or capital structure, events unrelated to the business or outside of the control of management, foreign exchange considerations, and legal, regulatory, tax or accounting changes. </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Certain Transactions </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">In connection with any <span style="white-space:nowrap">spin-off,</span> change in control, or change in any applicable laws or accounting principles, the plan administrator has broad discretion to take action under the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">34 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
2016 Plan to prevent the dilution or enlargement of intended benefits, facilitate the transaction or event or give effect to the change in applicable laws or accounting principles. This includes canceling awards for cash or property, accelerating the vesting of awards, providing for the assumption or substitution of awards by a successor entity, adjusting the number and type of shares subject to outstanding awards and/or with respect to which awards may be granted under the 2016 Plan and replacing or terminating awards under the 2016 Plan. In addition, in the event of certain <span style="white-space:nowrap">non-reciprocal</span> transactions with our shareholders, the plan administrator will make equitable adjustments to the 2016 Plan and outstanding awards as it deems appropriate to reflect the transaction. </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Plan Amendment, Term and Termination </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">Our board of directors may amend or terminate the 2016 Plan at any time; however, no amendment, other than an amendment that increases the number of shares available under the 2016 Plan, may materially and adversely affect an award outstanding under the 2016 Plan without the consent of the affected participant and shareholder approval will be obtained for any amendment to the extent necessary to comply with our Articles of Association or applicable laws. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">The 2016 Plan will remain in effect until December&#160;31, 2031, unless earlier terminated by the board. No awards may be granted under the 2016 Plan after its termination. </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">No Repricings without Shareholder Approval </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">The plan administrator cannot, without the approval of our shareholders, amend any outstanding stock option or SAR to reduce its price per share or cancel any outstanding stock option or SAR in exchange for cash or another award under the 2016 Plan with an exercise price per share that is less than the exercise price per share of the original stock option or SAR. </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Foreign Participants, Claw-Back Provisions, Transferability and Participant Payments </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">The plan administrator may modify awards granted to participants who are employed outside the Netherlands or establish subplans or procedures to address differences in laws, rules, regulations or customs of such foreign jurisdictions. All awards will be subject to the company&#8217;s Policy for Recovery of Erroneously Awarded Compensation and any other company claw-back, recoupment or forfeiture policy. Except as the plan administrator may determine or provide in an award agreement, awards under the 2016 Plan are generally <span style="white-space:nowrap">non-transferrable,</span> except by will or the laws of descent and distribution, or, subject to the plan administrator&#8217;s consent, pursuant to a domestic relations order, and are generally exercisable only by the participant. With regard to tax withholding obligations arising in connection with awards under the 2016 Plan, and exercise price obligations arising in connection with the exercise of stock options under the 2016 Plan, the plan administrator may, in its discretion, accept cash, wire transfer or check, common shares that meet specified conditions, a promissory note, a &#8220;market sell order,&#8221; such other consideration as the plan administrator deems suitable or any combination of the foregoing. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">35 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">Interests of Certain Persons in the Amendment and Restatement of the 2016 Plan </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">In considering the recommendation of the Board with respect to the approval of the amendment and restatement of the 2016 Plan, shareholders should be aware that, as discussed above, <span style="white-space:nowrap">non-employee</span> directors and executive officers are eligible to receive awards under the amended and restated 2016 Plan. The board of directors recognizes that approval of this proposal may benefit our <span style="white-space:nowrap">non-employee</span> directors and executive officers and their successors. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">Federal Income Tax Consequences </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">The following is a general summary as of this date of the federal income tax consequences to us and to U.S. participants for awards granted under the 2016 Plan. The federal tax laws may change and the tax consequences for any participant will depend upon his or her individual circumstances. Tax consequences for any particular individual may be different. This summary does not purport to be complete, and does not discuss state, local or <span style="white-space:nowrap">non-U.S.</span> tax consequences. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic"><span style="white-space:nowrap">Non-Qualified</span> Options</span>. The grant of a <span style="white-space:nowrap">non-qualified</span> option under the 2016 Plan is not expected to result in any federal income tax consequences to the participant or to the Company. Generally, upon exercise of a <span style="white-space:nowrap">non-qualified</span> option, the participant will realize ordinary income, and the Company will be entitled to a tax deduction, in an amount equal to the difference between the option exercise price and the fair market value of the shares at the time of exercise. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Incentive Stock Options</span>. The grant or exercise of an ISO under the 2016 Plan is not expected to result in any federal income tax consequences to the participant or to the Company. However, the amount by which the fair market value of the shares at the time of exercise exceeds the option price will be an &#8220;item of adjustment&#8221; for participants for purposes of the alternative minimum tax, unless the shares are sold or otherwise disposed of in the same year the ISO is exercised. Gain realized by participants on the sale of shares underlying an ISO is taxable at capital gains rates, and no tax deduction is available to the Company, unless the participant disposes of the shares within (i)&#160;two years after the date of grant of the option or (ii)&#160;within one year of the date the shares were transferred to the participant. If the shares are sold or otherwise disposed of before the end of the <span style="white-space:nowrap">one-year</span> and <span style="white-space:nowrap">two-year</span> periods specified above, the difference between the option exercise price and the fair market value of the shares on the date of the option&#8217;s exercise (or the date of sale, if less) will be taxed at ordinary income rates, and the Company will be entitled to a deduction to the extent that the participant recognizes ordinary income. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Stock Appreciation Rights</span>. The grant of a SAR under the 2016 Plan is not expected to result in any federal income tax consequences to either the participant or the Company. Generally, upon exercise of the SAR, the fair market value of the shares received, determined on the date of exercise of the SAR, or the amount of cash received in lieu of shares, will be treated as compensation taxable as ordinary income to the participant in the year of such exercise. The Company will be entitled to a deduction for compensation paid in the same amount which the participant realized as ordinary income. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Restricted Stock</span>. A participant generally will not have taxable income on the grant of restricted stock under the 2016 Plan, nor will the Company then be entitled to a deduction, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">36 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
unless the participant makes a valid election under Section&#160;83(b) of the Code. However, when restrictions on shares of restricted stock lapse, such that the shares are no longer subject to a substantial risk of forfeiture, the participant generally will recognize ordinary income, and the Company will be entitled to a corresponding deduction, for an amount equal to the difference between the fair market value of the shares on the date such restrictions lapse over the purchase price for the restricted stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Restricted Stock Units</span>. A participant generally will not realize taxable income at the time of the grant of RSUs under the 2016 Plan, and the Company will not be entitled to a deduction at that time. When RSUs are settled, whether in cash or shares, the participant will have ordinary income, and the Company will be entitled to a corresponding deduction. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Stock Awards</span>. If a participant receives a stock award under the 2016 Plan in lieu of a cash payment that would otherwise have been made, the participant generally will be taxed as if the cash payment has been received, and the Company will have a deduction in the same amount. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Dividend Equivalents</span>. A participant generally will not realize taxable income at the time of the grant of dividend equivalents under the 2016 Plan, and the Company will not be entitled to a deduction at that time. When a dividend equivalent is paid, the participant will recognize ordinary income, and the Company will be entitled to a corresponding deduction. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Application of Section</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;409A of the Code</span>. Section&#160;409A of the Code imposes an additional 20% tax and interest on an individual receiving <span style="white-space:nowrap">non-qualified</span> deferred compensation under a plan that fails to satisfy certain requirements. For purposes of Section&#160;409A, <span style="white-space:nowrap">&#8220;non-qualified</span> deferred compensation&#8221; includes equity-based incentive programs, including some options, SARs and RSU programs. Generally speaking, Section&#160;409A does not apply to ISOs, <span style="white-space:nowrap">non-discounted</span> <span style="white-space:nowrap">non-qualified</span> options and SARs if no deferral is provided beyond exercise, or restricted stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">The awards made pursuant to the 2016 Plan are expected to be designed in a manner intended to comply with the requirements of Section&#160;409A to the extent the awards granted under the 2016 Plan are not exempt from Section&#160;409A. However, if the 2016 Plan fails to comply with Section&#160;409A in operation, a participant could be subject to the additional taxes and interest. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Limitations on the Company&#8217;s Compensation Deduction</span>. Section&#160;162(m) of the Code limits the deduction certain employers may take for otherwise deductible compensation payable to certain current and former executive officers of the Company to the extent the compensation paid to such an officer for the year exceeds $1&#160;million. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">Plan Benefits </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">Other than with respect to awards that will be made automatically under our NED Program as described in the footnote to the New Plan Benefits Table below, the benefits or amounts that may be received or allocated to participants under the 2016 Plan are subject to </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">37 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
the discretion of the compensation committee or the board of directors and are not currently determinable. The following table sets forth, with respect to the individuals and groups identified therein, the option awards to be granted under our NED Program. Such awards will be granted irrespective of whether the amendment and restatement of the 2016 Plan is approved by the shareholders. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">New Plan Benefits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:73%"/>

<td style="vertical-align:bottom;width:10%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:10%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom" colspan="8" align="center"><span style="font-size:12pt"><span style="font-weight:bold">Merus N.V. 2016 Incentive Award Plan</span></span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:11pt; font-family:Times New Roman;font-weight:bold">Name and Position</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Dollar&#160;Value</span><br/><span style="font-weight:bold">($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number&#160;of</span><br/><span style="font-weight:bold">Shares</span><br/><span style="font-weight:bold">Subject to</span><br/><span style="font-weight:bold">Options</span><br/><span style="font-weight:bold">(#)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman"><span style="font-style:italic">Named Executive Officers:</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Sven (Bill) Ante Lundberg, M.D., President and Chief Executive Officer</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Hui Liu, Ph.D., Chief Business Officer and Head of Merus US</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Peter Silverman, J.D., Chief Operating Officer and General Counsel</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Andrew Joe, Chief Medical Officer</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Gregory Perry, Chief Financial Officer</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman"><span style="font-style:italic">All Current Executive Officers as a Group (4 persons)</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman"><span style="font-style:italic">All Current <span style="white-space:nowrap">Non-Executive</span> Directors as a Group (6 persons)</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">44,850</td>
<td style="white-space:nowrap;vertical-align:bottom">(1)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman"><span style="font-style:italic">All Current <span style="white-space:nowrap">Non-Executive</span> Officer Employees as a group (229 persons)</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">The number of shares represents annual option awards for our <span style="white-space:nowrap">non-employee</span> directors to be granted under our NED Program. Under the current NED Program, not accounting for Proposal 11, each current <span style="white-space:nowrap">non-employee</span> director will be eligible to receive an annual option grant on the date of the Annual General Meeting, or as soon as practicable thereafter, having an aggregate grant date fair value of $259,107. The actual number of shares subject to the option awards to be granted to our <span style="white-space:nowrap">non-employee</span> directors will be determined using the Black-Scholes option pricing model and the valuation assumptions used by the Company in accounting for options as of such date; provided, that the fair market value of the common shares of the Company used in such calculation is based on the average trading price of the common shares of the Company over the preceding thirty day period. The number of shares shown in the table for these awards are estimated amounts and were calculated based on the Black-Scholes option pricing model described above and using the closing price of our common shares on the Nasdaq Global Market of $45.95 on March&#160;12, 2024. For additional information regarding the annual option awards for our <span style="white-space:nowrap">non-employee</span> directors, see the section of this Proxy Statement entitled &#8220;Director Compensation&#8221;. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">38 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">Additional Prior Award Information </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">The following table sets forth, with respect to the individuals and groups identified therein, the number of shares subject to options and restricted stock units that have been granted to such individuals and groups under the 2016 Plan through March&#160;12, 2024: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:63%"/>

<td style="vertical-align:bottom;width:10%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:10%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:11pt; font-family:Times New Roman;font-weight:bold">Name and Position</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares&#160;Subject&#160;to</span><br/><span style="font-weight:bold">Options (1)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares&#160;Subject&#160;to</span><br/><span style="font-weight:bold">Restricted Stock</span><br/><span style="font-weight:bold">Units (1)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman"><span style="font-style:italic">Named Executive Officers</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Sven (Bill) Ante Lundberg, M.D., President and Chief Executive Officer</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,474,917</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Hui Liu, Ph.D., Chief Business Officer and Head of Merus US</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">552,655</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32,932</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Peter Silverman, J.D., Chief Operating Officer and General Counsel</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">428,114</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Andrew Joe, Chief Medical Officer</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">369,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Gregory Perry, Chief Financial Officer</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">454,826</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman"><span style="font-style:italic">All Current Executive Officers as a Group (4 persons)</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,726,857</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman"><span style="font-style:italic">All Current <span style="white-space:nowrap">Non-Executive</span> Directors as a Group (6 persons)</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">391,275</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman"><span style="font-style:italic">Director Nominees:</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Mark Iwicki</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">64,902</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Paolo Pucci</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">54,400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Jason Haddock</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman"><span style="font-style:italic">Each associate of any such directors, executive officers or nominees</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman"><span style="font-style:italic">Each other person who received or is to receive 5&#160;percent of such options, warrants or rights</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman"><span style="font-style:italic">All <span style="white-space:nowrap">Non-Executive</span> Officer Employees as a Group (331 persons)</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,690,706</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Share numbers shown do not take into account shares subject to awards that have been cancelled, forfeited or expired unexercised. The closing price per common share on the Nasdaq Global Select Market on March&#160;12, 2024 was $45.95. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">VOTE REQUIRED </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">This proposal requires a simple majority of votes cast in favor of the proposal. Abstentions and broker <span style="white-space:nowrap">non-votes</span> are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">RECOMMENDATION OF THE BOARD OF DIRECTORS </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold"></span><span style="FONT-FAMILY:'WINGDINGS 3'">u</span><span style="font-weight:bold"></span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:left">The board of directors unanimously recommends a vote FOR the approval of an amendment and restatement of the 2016 Plan. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">39 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#d8d8d8">
<td style="vertical-align:top" id="toc706699_33"><span style="font-weight:bold">&#8201;REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</span></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The audit committee has reviewed the Company&#8217;s audited financial statements for the financial year ended December&#160;31, 2023 and has discussed these financial statements with management and the Company&#8217;s independent registered public accounting firm. The audit committee has also received from, and discussed with, the Company&#8217;s independent registered public accounting firm various communications that such independent registered public accounting firm is required to provide to the audit committee, including the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;) and the SEC. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The Company&#8217;s independent registered public accounting firm also provided the audit committee with a formal written statement required by the applicable requirements of the PCAOB describing all relationships between the independent registered public accounting firm and the Company, including the disclosures required by the applicable requirements of the PCAOB regarding the independent registered public accounting firm&#8217;s communications with the audit committee concerning independence. In addition, the audit committee discussed with the independent registered public accounting firm its independence from the Company. The audit committee also considered whether the independent registered public accounting firm&#8217;s provision of certain other <span style="white-space:nowrap">non-audit</span> related services to the Company is compatible with maintaining such firm&#8217;s independence. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Based on its discussions with management and the independent registered public accounting firm, and its review of the representations and information provided by management and the independent registered public accounting firm, the audit committee recommended to the board of directors that the audited financial statements be included in the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the financial year ended December&#160;31, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Paolo Pucci (Chair) </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Maxine Gowen, Ph.D. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Anand Mehra, M.D. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0">


<tr>

<td style="width:96%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top;background-color:#d8d8d8">&#8195;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">40 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top;background-color:#d8d8d8"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.20em; font-size:12pt; font-family:Times New Roman;font-weight:bold" id="toc706699_34">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FEES AND OTHER MATTERS</p></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The following table summarizes the fees of KPMG Accountants N.V., our independent registered public accounting firm, billed to us for each of the last two financial years for audit services and billed to us in each of the last two financial years for other services: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:76%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">Fee Category</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="right" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="right" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Audit Fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,406,730</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,289,012</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Audit-Related Fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Tax Fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">All Other Fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Total Fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,406,730</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,289,012</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:14pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">AUDIT FEES </span></p> <p style="margin-top:14pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Audit fees for the financial years 2023 and 2022 consist of fees billed for the audit of our annual consolidated financial statements for our Dutch statutory annual report, which includes the Company&#8217;s annual accounts prepared under Dutch law, the review of the interim consolidated financial statements, and related services that are normally provided in connection with registration statements. Audit fees for the financial year 2023 also included the provision of audit services associated with the Company&#8217;s <span style="white-space:nowrap">follow-on</span> offering in August 2023, and audit services associated with the Company&#8217;s &#8220;at the market&#8221; equity offering program. Audit fees for the financial year 2022 also included the provision of audit services associated with the Company&#8217;s &#8220;at the market&#8221; equity offering program in June and August 2022. </p> <p style="margin-top:14pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">AUDIT-RELATED FEES </span></p> <p style="margin-top:14pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">There were no such fees incurred in 2023 or 2022. </p> <p style="margin-top:14pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">TAX FEES </span></p> <p style="margin-top:14pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">There were no such fees incurred in 2023 or 2022. </p> <p style="margin-top:14pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">ALL OTHER FEES </span></p> <p style="margin-top:14pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">There were no such fees incurred in 2023 or 2022. </p> <p style="margin-top:14pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="text-decoration:underline">AUDIT COMMITTEE <span style="white-space:nowrap">PRE-APPROVAL</span> POLICY AND PROCEDURES </span></p> <p style="margin-top:14pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Pursuant to the charter of the audit committee, the audit committee <span style="white-space:nowrap">pre-approves</span> audit and <span style="white-space:nowrap">non-audit</span> services, provided that de minimis <span style="white-space:nowrap">non-audit</span> services may instead be approved in accordance with the available exceptions under the rules of the SEC. The audit committee delegated its authority to <span style="white-space:nowrap">pre-approve</span> services to the Chairperson of the audit committee on September&#160;19, 2017, and the Chairperson must present any such approvals to the full audit committee at the next audit committee meeting. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">41 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top;background-color:#d8d8d8"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.02em; font-size:12pt; font-family:Times New Roman;font-weight:bold" id="toc706699_35">EXECUTIVE OFFICERS</p></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The following table identifies our current executive officers: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:43%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:46%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Age</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">Position</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Sven (Bill) Ante Lundberg, M.D.(1)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">60&#8201;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">President, Chief Executive Officer</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Peter B. Silverman, J.D. (2)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;white-space:nowrap" align="center">46&#8201;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Chief Operating Officer and General Counsel</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Andrew Joe (3)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">58&#8201;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Chief Medical Officer</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Greg D. Perry (4)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;white-space:nowrap" align="center">63&#8201;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Chief Financial Officer&#160;&amp; Principal Financial Officer</td></tr>
</table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:21%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><sup style="font-size:75%; vertical-align:top">1</sup>&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">See biography on page&#160;18 of this proxy statement. </p></td></tr></table> <p style="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><sup style="font-size:75%; vertical-align:top">2</sup>&#8195;<span style="font-weight:bold">&#8199;&#8195;Peter B. Silverman, J.D.</span> has served the Company since 2014, first as outside counsel, as Chief Operating Officer since January 2023, as Head of Utrecht from April 2020 to January&#160;1, 2023, as General Counsel since February 2018 and Chief Intellectual Property Officer and Head of US Legal from February 2017. His responsibilities include management of the Company&#8217;s legal and intellectual property, company operations, information technology, facilities and human resource matters, and management and operations of the headquarters in Utrecht. Prior to joining the Company, Mr.&#160;Silverman was a Partner at Kirkland&#160;&amp; Ellis LLP, where he represented numerous life sciences companies concerning an array of legal matters and technologies. Previously, Mr.&#160;Silverman was an associate at Kaye Scholer LLP (now Arnold&#160;&amp; Porter Kaye Scholer LLP), and prior to that Mr.&#160;Silverman also served as judicial law clerk to U.S. District Court Judge Anne E. Thompson of the District of New Jersey. He holds a J.D. from Fordham University School of Law, graduating magna cum laude and Order of the Coif. He is admitted to practice law in New York. Mr.&#160;Silverman also holds a B.A. in biology from the University of Rochester. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><sup style="font-size:75%; vertical-align:top">3</sup>&#8195;<span style="font-weight:bold">&#8194;&#8195;Andrew Joe, M.D.</span>, has served as our Chief Medical Officer since July 2020. His responsibilities include overseeing clinical and regulatory strategy and activities at Merus. He brings over 20 years of experience in clinical drug development and translational research within industry and academic medicine. Dr.&#160;Joe served as Vice President, Oncology Department at Sanofi from 2018 to 2020, where he most recently led the immuno-oncology program, which included <span style="white-space:nowrap">co-development</span> of LIBTAYO<sup style="font-size:75%; vertical-align:top">&#174;</sup> (cemiplimab-rwlc) with Regeneron in skin, lung and other cancers. Previously, he served as Executive Medical Director, Global Clinical Development, Oncology at Merck Sharp&#160;&amp; Dohme Corp., from 2015 to 2018, where he led the KEYTRUDA<sup style="font-size:75%; vertical-align:top">&#174;</sup> (pembrolizumab) New Indications Development Team in obtaining the first tumor/histology-agnostic drug approval in Microsatellite Instability-High <span style="white-space:nowrap">(MSI-H)</span> cancer, and the first immune-oncology drug approval in a gynecological malignancy (cervical cancer). Dr.&#160;Joe also played key roles at Novartis in the global approval of Zykadia<sup style="font-size:75%; vertical-align:top">&#174;</sup> (ceritinib) in <span style="white-space:nowrap">ALK-positive</span> lung cancer and at Roche in the global approval of ZELBORAF<sup style="font-size:75%; vertical-align:top">&#174;</sup> (vemurafenib) in BRAF-mutant metastatic melanoma. Dr.&#160;Joe is an Assistant Professor of Medicine at Columbia University Irving Medical Center. He received B.S. degrees in chemistry and biology from the Massachusetts Institute of Technology and an M.D. from the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">42 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
Mount Sinai School of Medicine. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><sup style="font-size:75%; vertical-align:top">4</sup>&#8195;&#8194;&#8195;Greg D. Perry, served as a <span style="white-space:nowrap">non-executive</span> director of our board of directors from May 2016 and Vice Chairman of our board of directors from August 2018 until starting his position as our Chief Financial Officer (CFO) in June 2023. His CFO responsibilities include serving as the Principal Financial Officer and overseeing the finance and quality functions of our organization. From May 2018 until his retirement in April 2022, Mr.&#160;Perry served as the Chief Financial Officer at Finch Therapeutics Group. Mr.&#160;Perry served as the Chief Financial and Administrative Officer of Novelion Therapeutics Inc. from November 2016 to December 2017. Prior to Novelion, Mr.&#160;Perry was Chief Financial Officer of Aegerion Pharmaceuticals Inc. from July 2015 until its merger with Novelion in November 2016. He has also served as CFO of several additional biotechnology companies, and earlier in his career he held various financial leadership roles within ImmunoGen, Domantis Ltd., Transkaryotic Therapeutics, Honeywell and General Electric. Mr.&#160;Perry currently serves on the board of directors of Kala Pharmaceuticals. Mr.&#160;Perry received a B.A. in Economics and Political Science from Amherst College. </p> <p style="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top;background-color:#d8d8d8">&#8195;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">43 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="padding-bottom:2pt ;vertical-align:top;background-color:#d8d8d8" id="toc706699_36"><span style="font-weight:bold">CORPORATE GOVERNANCE</span></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_37">GENERAL </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Our board of directors has adopted, among other policies, board rules, an Insider Trading Compliance Policy, a Code of Business Conduct and Ethics, an Anti-Corruption Policy and charters for our nomination and corporate governance committee, audit committee, and compensation committee to assist the board of directors in the exercise of its responsibilities and to serve as a framework for the effective governance of the Company. You can access our current committee charters and our board rules in the &#8220;Corporate Governance&#8221; section, under &#8220;Governance Documents&#8221; of the &#8220;Investors&#160;&amp; Media&#8221; page of our website located at www.merus.nl. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_38">BOARD COMPOSITION </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Our board of directors currently consists of seven members: Sven (Bill) Ante Lundberg, M.D., Maxine Gowen, Ph.D., Mark Iwicki, Len Kanavy, Anand Mehra, M.D., Paolo Pucci and Victor Sandor, M.D.C.M. On March&#160;27, 2024, our board of directors nominated Mr.&#160;Iwicki for <span style="white-space:nowrap">re-appointment</span> at the Annual General Meeting as <span style="white-space:nowrap">non-executive</span> director for a term ending immediately after the annual general meeting of shareholders to be held in 2026, and Mr.&#160;Pucci for <span style="white-space:nowrap">re-appointment</span> at the Annual General Meeting as <span style="white-space:nowrap">non-executive</span> director for a term ending immediately after the annual general meeting of shareholders to be held in 2028. Each board member is appointed for an initial term of up to four years. A <span style="white-space:nowrap">non-executive</span> director may be <span style="white-space:nowrap">re-appointed</span> for one subsequent term of up to four years followed by up to two subsequent terms of up to two years. An executive director may serve for an unlimited number of terms of up to four years. Our articles of association provide that the number of executive and <span style="white-space:nowrap">non-executive</span> directors may only be determined by our board of directors. Our directors are appointed on the basis of a binding nomination prepared by our board of directors. Our general meeting of shareholders may overrule the binding nomination by a resolution passed by a <span style="white-space:nowrap">two-thirds</span> majority of votes cast, provided such majority represents more than half of our issued share capital, in which case our board of directors shall be allowed to make a new binding nomination. Our directors may be dismissed only by a resolution at a general meeting of shareholders. Dismissal of a director by our general meeting of shareholders requires a <span style="white-space:nowrap">two-thirds</span> majority of votes cast, provided such majority represents more than half of our issued share capital, unless the dismissal is proposed by the board of directors, in which latter case a simple majority of votes cast will suffice to pass the resolution. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_39">DIRECTOR INDEPENDENCE </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">All of our directors and director nominee, other than Sven (Bill) Ante Lundberg, M.D., qualify as &#8220;independent&#8221; in accordance with Nasdaq listing requirements. The Nasdaq independence definition includes a series of objective tests, including that the director is not, and has not been for at least three years, one of our employees and that neither the director nor any of his or her family members has engaged in various types of business dealings with us. In addition, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">44 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">as required by Nasdaq rules, our board of directors has made a subjective determination as to each independent director that no relationships exist, which, in the opinion of our board of directors, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In making these determinations, our board of directors reviewed and discussed information provided by the directors and us with regard to each director&#8217;s business and personal activities and relationships as they may relate to us and our management. Dr.&#160;Lundberg is not independent because he is the President and Chief Executive Officer of our Company. The board of directors previously determined that Mr.&#160;Perry qualified as an independent director prior to his resignation on June&#160;14, 2023, in connection with his appointment as our Chief Financial Officer. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_40">DIRECTOR CANDIDATES </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The nomination and corporate governance committee is responsible for drawing up selection criteria and appointment procedures for the directors. In searching for qualified director candidates for appointment to the board of directors and filling vacancies on the board of directors, the nomination and corporate governance committee may solicit current directors and executives of the Company for the names of potentially qualified candidates or ask directors and executives to pursue their own business contacts for the names of potentially qualified candidates. The nomination and corporate governance committee may also consult with outside advisors or retain search firms to assist in the search for qualified candidates, or consider director candidates recommended by our shareholders. Once potential candidates are identified, the nomination and corporate governance committee reviews the backgrounds of those candidates, evaluates candidates&#8217; independence from the Company and potential conflicts of interest and determines if candidates meet the qualifications desired by the nomination and corporate governance committee for candidates for appointment as a director. Jason Haddock, a nominee for appointment to our board of directors, was recommended as a potential candidate to serve on our board of directors by a director of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">In evaluating the suitability of individual candidates (both new candidates and current board members), the nomination and corporate governance committee, in recommending candidates for appointment, and the board of directors, in approving (and, in the case of vacancies, appointing), may take into account many factors, including: personal and professional integrity, ethics and values; experience in corporate management, such as serving as an officer or former officer of a publicly held company; strong finance experience; experience relevant to our industry; experience as a board member or executive officer of another publicly held company; experience relevant to an international company; relevant academic expertise or other proficiency in an area of our operations; diversity of expertise and experience in substantive matters pertaining to the Company&#8217;s business relative to other board members; diversity of background and perspective, including, but not limited to, with respect to age, gender, ethnicity, and specialized experience; practical and mature business judgment, including, but not limited to, the ability to make independent analytical inquiries; and any other relevant qualifications, attributes or skills. The board of directors evaluates each individual in the context of the board as a whole, with the objective of assembling a group that can best perpetuate the long-term success and sustainability of the business and further the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">45 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">interests of our stakeholders, including shareholders, through the exercise of sound judgment using its diversity of experience in these various areas. In determining whether to recommend a director for <span style="white-space:nowrap">re-appointment,</span> the nomination and corporate governance committee may also consider the director&#8217;s past attendance at meetings and participation in and contributions to the activities of the board of directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Shareholders may recommend individuals to our nomination and corporate governance committee for consideration as potential director candidates by submitting the names of the recommended individuals, together with appropriate biographical information and background materials, to our nomination and corporate governance committee, c/o Company Secretary, Merus N.V., Uppsalalaan 17, 3rd&#160;&amp; 4th floor, 3584 CT Utrecht, the Netherlands. In the event there is a vacancy, and assuming that appropriate biographical and background material has been provided on a timely basis, the committee will evaluate shareholder-recommended candidates by following substantially the same process, and applying substantially the same criteria, as it follows for candidates submitted by others. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_41">COMMUNICATIONS FROM SHAREHOLDERS </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The board of directors will give appropriate attention to written communications that are submitted by shareholders, and will respond if and as appropriate. Our Secretary and General Counsel are primarily responsible for monitoring communications from shareholders and for providing copies or summaries to the directors as they consider appropriate. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Communications are forwarded to all directors if they relate to important substantive matters and include suggestions or comments that our Company Secretary or General Counsel and Chairperson of the Board consider to be important for the directors to know. In general, communications relating to corporate governance and long-term corporate strategy are more likely to be forwarded than communications relating to ordinary business affairs, personal grievances and matters as to which we tend to receive repetitive or duplicative communications. Shareholders who wish to send communications on any topic to the board of directors should address such communications to the board of directors in writing: c/o Company Secretary, Merus N.V., Uppsalalaan 17, 3<sup style="font-size:75%; vertical-align:top">rd</sup>&#160;&amp; 4<sup style="font-size:75%; vertical-align:top">th</sup> floor, 3584 CT Utrecht, the Netherlands. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_42">BOARD LEADERSHIP STRUCTURE AND ROLE IN RISK OVERSIGHT </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Our board is comprised of individuals with extensive experience within the biotechnology and pharmaceutical industries. Our board rules provide that the Chairperson and the Vice Chairperson of the Board must each be a <span style="white-space:nowrap">non-executive</span> director. Our executive director is charged primarily with the Company&#8217;s <span style="white-space:nowrap"><span style="white-space:nowrap">day-to-day</span></span> business and operations and the implementation of the Company&#8217;s strategy. Our <span style="white-space:nowrap">non-executive</span> directors are charged primarily with the supervision of the performance of the duties of our board of directors. Our board of directors has concluded that our current leadership structure is appropriate at this time. However, our board of directors will continue to periodically review our leadership structure and may make such changes in the future as it deems appropriate. Risk assessment and oversight are an integral part of our governance and management processes. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">46 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Our board of directors encourages management to promote a culture that incorporates risk management into our corporate strategy and <span style="white-space:nowrap"><span style="white-space:nowrap">day-to-day</span></span> business operations. Management discusses strategic and operational risks at regular management meetings and conducts specific strategic planning and review sessions during the year that include a focused discussion and analysis of the risks facing us. Throughout the year, senior management reviews these risks with the board of directors at regular board meetings as part of management presentations that focus on particular business functions, operations or strategies, and presents the steps taken by management to mitigate or eliminate such risks. Our board of directors does not have a standing risk management committee, but rather administers this oversight function directly through the board of directors as a whole, as well as through various standing committees of the board of directors that address risks inherent in their respective areas of oversight. In particular, our board of directors is responsible for monitoring and assessing strategic risk exposure, including with respect to business continuity risks such as risks relating to market volatility, and our audit committee is charged with overseeing the responsibilities of our board of directors with respect to the application of information and communication technology by the Company, including risks relating to cybersecurity. Throughout 2023, the board of directors met on five occasions wherein they reviewed the corporate strategy, enterprise risk management, evaluated impact on operations and supervised the Company enacting risk mitigation planning, business continuity planning, emergency succession planning, the volatility of biopharmaceutical companies&#8217; stock as a result of disruptions and extreme volatility in the global&#160;economy, including rising inflation and interest rates, declines in economic growth, the conflict between Russia and Ukraine and additional measures related to protecting the health and safety of employees. The audit committee also periodically reviews our policies and procedures for investments in view of the prevailing market conditions as well as reviewing and approving or ratifying &#8220;related person transactions&#8221; (defined as transactions required to be disclosed pursuant to Item 404 of Regulation <span style="white-space:nowrap">S-K),</span> including our related person transaction policy, and recommends any changes to our board of directors, and in accordance with our related person transaction policy and the Nasdaq rules, our audit committee conducts appropriate review and oversight of all related person transactions for potential conflict of interest situations on an ongoing basis. Our compensation committee is charged with submitting clear and understandable proposals to our board of directors concerning changes to our compensation policies. The board of directors does not believe that its role in the oversight of our risks adversely affects the board of directors&#8217; leadership. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_43">ANNUAL BOARD EVALUATION </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Our board rules require an annual assessment of the board of directors and its committees and the nomination and corporate governance committee charter requires the nomination and corporate governance committee to oversee such annual assessment. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_44">CODE OF BUSINESS CONDUCT AND ETHICS </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">We have adopted a written Code of Business Conduct and Ethics that applies to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, and others temporarily assigned to perform work or services for us. We have posted a current copy of the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">47 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
Code of Business Conduct and Ethics on our website, www.merus.nl. Our board of directors is responsible for administering the Code of Business Conduct and Ethics. The board of directors is allowed to amend, alter or terminate the Code of Business Conduct and Ethics. In addition, we intend to post on our website all disclosures that are required by law or the Nasdaq rules concerning any amendments to, or waivers from, any provision of the Code of Business Conduct and Ethics. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_45">ANTI-HEDGING POLICY </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Our board of directors has adopted an Insider Trading Compliance Policy, which applies to all of our directors, officers and employees. The policy prohibits our directors, officers and employees and any entities they control from purchasing financial instruments such <span style="white-space:nowrap">zero-cost</span> collars and forward sale contracts, or otherwise engaging in transactions that hedge or offset, or are designed to hedge or offset, any decrease in the market value of the Company&#8217;s equity securities, or that may cause an officer, director, or employee to no longer have the same objectives as the Company&#8217;s other shareholders. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">CLAWBACK POLICY </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">We believe in maintaining best practices for our executive compensation program. We have adopted a compensation recovery policy as required by Rule&#160;10D-1 under the Securities Exchange Act of 1934, as amended, and the corresponding listing standards of Nasdaq. This policy provides for the mandatory recovery (subject to limited exceptions) from current and former officers of incentive-based compensation that was erroneously received during the three years preceding the date that the Company is required to prepare an accounting restatement. Covered restatements include both a restatement to correct an error that is material to previously issued financial statements or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period. The amount required to be recovered is the excess of the amount of incentive-based compensation received over the amount that otherwise would have been received had it been determined based on the restated financial measure. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_46">ATTENDANCE BY MEMBERS OF THE BOARD OF DIRECTORS AT MEETINGS </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">There were five meetings of the board of directors during the financial year ended December&#160;31, 2023. During the financial year ended December&#160;31, 2023, each director attended at least 75% of the aggregate of all meetings of the board of directors and meetings of the committees on which the director served during the period in which he served as a director. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Currently, we do not maintain a formal policy regarding director attendance at the Annual General Meeting; however, due to the location of our Annual General Meetings in the Netherlands, the residence of some of our directors in the United States and the fact that regular board meetings do not take place at or around the time of the annual general meetings of shareholders, we do not require directors to attend annual general meetings of shareholders. One of our then-serving directors attended our 2023 Annual General Meeting held on May&#160;26, 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#d8d8d8">
<td style="vertical-align:top">&#8195;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">48 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="font-size:1pt;background-color:#d8d8d8">
<td style="height:1.5pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#d8d8d8">
<td style="padding-bottom:1pt ;vertical-align:middle"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.20em; font-size:12pt; font-family:Times New Roman;font-weight:bold" id="toc706699_47">COMMITTEES OF THE BOARD</p></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Our board of directors has established an audit committee, compensation committee, and nomination and corporate governance committee, each of which operates under a written charter that has been approved by our board and that are available in the Investors&#160;&amp; Media section of our website at www.merus.nl. All of the members of each of these committees are independent as defined under the Nasdaq rules. Our board of directors has determined that Paolo Pucci, Maxine Gowen, Ph.D. and Anand Mehra, M.D. meet the independence requirements of Rule <span style="white-space:nowrap">10A-3</span> under Exchange Act for participation on the audit committee. All members of the compensation committee meet the heightened standard for independence specific to members of a compensation committee under the Nasdaq rules and each qualifies as a <span style="white-space:nowrap">&#8220;non-employee</span> director&#8221; as defined in Rule <span style="white-space:nowrap">16b-3</span> of the Exchange Act. All members of the nomination and corporate governance committee are independent under the Nasdaq rules. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The members of each of the audit, compensation, nomination and corporate governance committees and the committee Chairs are set forth in the following chart. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto">


<tr>

<td style="width:37%"/>

<td style="vertical-align:bottom;width:15%"/>
<td/>

<td style="vertical-align:bottom;width:15%"/>
<td/>

<td style="vertical-align:bottom;width:15%"/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;Audit&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;Compensation&#8195;</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Nomination&#160;and</span><br/><span style="font-weight:bold">Corporate</span><br/><span style="font-weight:bold">&#8195;Governance&#8195;</span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark Iwicki</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">Chair</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">X</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Len Kanavy</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">X</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">X</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sven (Bill) Lundberg, M.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Anand Mehra, M.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">X</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">Chair</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paolo Pucci</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">Chair</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">X</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Victor Sandor, M.D.C.M.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Maxine Gowen, Ph.D..</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">X</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_48">AUDIT COMMITTEE </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Our audit committee&#8217;s responsibilities include: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">overseeing the responsibilities of the board of directors with respect to: our relationship with, and compliance with recommendations and <span style="white-space:nowrap">follow-up</span> of comments made by, our internal auditor, independent auditor, and, if relevant, other parties involved in the audit of the company&#8217;s sustainability reporting; our funding, the application of information and communication technology by us, including risks relating to cybersecurity, operation of our Code of Business Conduct and Ethics and other internal policies, and our tax policy; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">preparing our internal audit plan in consultation with and for approval by the board of directors; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">reviewing and discussing our independent auditor&#8217;s audit plan with our internal auditor and independent auditor; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">49 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">issuing recommendations concerning the appointment and the dismissal of the senior internal auditor and reviewing and discussing the performance of the internal auditor; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">reviewing and discussing our internal audit results, including with the internal auditor and the independent auditor, including: (i)&#160;any material weaknesses, significant deficiencies or other deficiencies in our internal controls, (ii)&#160;any findings and observations with a material impact on our risk profile; and (iii)&#160;any failings in the <span style="white-space:nowrap">follow-up</span> of recommendations made previously; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">at least annually, reviewing and discussing with our independent auditor the scope and materiality of the independent auditor&#8217;s audit plan and the principal risks of our financial reporting and sustainability reporting identified by the independent auditor in the audit plan and the findings and outcome of our independent auditor&#8217;s audit of our financial statements and our management letter; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">determining whether and, if so, how our independent auditor should be involved in the content and publication of financial reports other than our financial statements; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">reviewing and discussing the effectiveness of the design and operation of our internal controls over financial reporting with the board of directors, including (i)&#160;any identified material failings in the internal controls; and (ii)&#160;any material changes made to, and any material improvements planned for, the internal controls; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">taking, or recommending that the board of directors take, appropriate action to oversee the independence of our independent auditor, including obtaining and reviewing a formal statement from the independent auditor delineating all relationships between the auditor and us, including written disclosures and the letter from the independent auditor required by the PCAOB regarding the independent auditor&#8217;s communications with the audit committee concerning independence, and actively engaging in dialogue with the independent auditor concerning any disclosed relationships or services that might impact the objectivity and independence of the independent auditor; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">advising the board of directors regarding nominating for appointment or reappointment the independent auditor and preparing the selection of the independent auditor for such purpose; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">recommending the compensation for further approval by our board of directors, retention for further approval by our board of directors and oversight of the independent auditor to audit our financial statements, to prepare or issue an audit report, or to perform other audit, review or attest services, including the scope of the audit, the materiality standard to be applied, resolution of disagreements between management and the independent auditor regarding financial and sustainability reporting, and causing us, without further action by our board of directors, </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">50 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
to pay the compensation of our independent auditor as approved by the audit committee, and, when necessary, recommending the termination of the engagement of the independent auditor to our board of directors; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">reviewing and discussing with our management and the independent auditor our audited financial statements, including the matters required to be discussed by applicable PCAOB standards and SEC rules, and receiving and considering the reports and other communications required to be made by the independent auditor; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">requesting the independent auditor to provide relevant information about any inspections of the firm by the PCAOB; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">considering whether it will recommend to the board of directors that our audited financial statements be included in our Annual Report on Form <span style="white-space:nowrap">10-K;</span> </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">preparing an annual committee report for inclusion where necessary in our proxy statement relating to our annual general meeting of shareholders; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">directing the independent auditor to use its best efforts to perform all reviews of interim financial information prior to disclosure by us of such information and to discuss promptly with the audit committee and our principal financial officer any matters identified in connection with the independent auditor&#8217;s review of interim financial information, which are required to be discussed by applicable auditing standards, and directing management to advise the audit committee in the event that we propose to disclose interim financial information prior to completion of the independent auditor&#8217;s review of interim financial information; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">establishing procedures for (i)&#160;the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or auditing matters; and (ii)&#160;the confidential, anonymous submission by our employees of concerns regarding questionable accounting or auditing matters; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">periodically reviewing our policies and procedures for reviewing and approving or ratifying related person transactions (defined as transactions required to be disclosed pursuant to Item 404 of Regulations <span style="white-space:nowrap">S-K),</span> including our Related Person Transaction Policy, and recommending any changes to the board of directors, and in accordance with our Related Person Transaction Policy and the Nasdaq rules, conducting appropriate review and oversight of all related person transactions for potential conflict of interest situations on an ongoing basis; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">engagement of such independent legal, accounting and other advisors as the audit committee deems necessary or appropriate to carry out its responsibilities, including causing us, without further action by the board of directors, to pay the compensation of such advisors as approved by the audit committee; and causing us to pay, without further action by the board of directors, the ordinary administrative expenses </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">51 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
of the audit committee that are necessary or appropriate in carrying out its duties; and </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">conducting or authorizing investigations into any matters within the scope of the audit committee&#8217;s responsibilities as it shall deem appropriate, including the authority to request any of our officers, employees or advisors to meet with the audit committee or any advisors engaged by the audit committee. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The members of the audit committee are Paolo Pucci, Maxine Gowen, Ph.D. and Anand Mehra, M.D. Mr.&#160;Pucci serves as the Chairperson of the committee. The members of our audit committee meet the requirements for financial literacy under the applicable rules of Nasdaq. Our board of directors has determined that Mr.&#160;Pucci is an &#8220;audit committee financial expert&#8221; as defined by Item 407(d)(5)(ii) of Regulation <span style="white-space:nowrap">S-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The audit committee meets as often as one or more members of the audit committee deem necessary, but in any event, meets at least four times per year. The audit committee meets at least once per year with our independent accountant, without our management being present. The audit committee met five times in 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_49">COMPENSATION COMMITTEE </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Our compensation committee is responsible for assisting the board of directors in the discharge of its responsibilities relating to the compensation of our senior management, including our executive officers. In fulfilling its purpose, our compensation committee has the following principal duties: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">submitting clear and understandable proposals to the board of directors concerning changes to our compensation policy; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">submitting proposals to the board of directors concerning the compensation of individual directors and our Chief Executive Officer and senior management, including our executive officers at least covering: the compensation structure; the amount of the fixed and variable compensation components; the applicable performance criteria, if any; the scenario analyses that have been carried out; the pay ratios within our group; and with respect to a director, the relevant director&#8217;s views with regard to the amount and structure of his or her own compensation; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">preparing of our compensation report for the board of directors; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">reviewing and discussing with management the Compensation Discussion and Analysis (&#8220;CD&amp;A&#8221;) included in our proxy statement and considering whether it will recommend to the board of directors that the CD&amp;A be included in the proxy statement; and </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">preparing the annual compensation committee report pursuant to the rules of the Exchange Act. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">52 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The compensation committee has the authority to retain or obtain the advice of compensation consultants, legal counsel and other advisors to assist in carrying out its responsibilities, including being directly responsible for the appointment, oversight and compensation of such consultant, counsel or advisor and the ability to cause us, without further action by the board of directors, to pay the compensation of such consultant, counsel or advisor as approved by the compensation committee, provided, however, that in retaining or obtaining the advice of such consultant, counsel or advisor, other than <span style="white-space:nowrap">in-house</span> legal counsel, the compensation committee shall take into consideration the factors affecting independence required by applicable SEC rules and Nasdaq rules. The compensation committee also has the authority to conduct or authorize investigations into any matters within the scope of its responsibilities as it shall deem appropriate, including the authority to request any officer, employee or advisor of us to meet with the compensation committee or any advisors engaged by the compensation committee. During 2023, the compensation committee engaged Pearl Meyer&#160;&amp; Partners, LLC, and Latham&#160;&amp; Watkins LLP as external advisors. The compensation committee reviewed compensation assessments provided by Pearl Meyer comparing our compensation to that of a group of peer companies within our industry and met with Pearl Meyer to discuss compensation of our executive officers and management team and to receive input and advice. The compensation committee reviewed legal matters addressed by Latham&#160;&amp; Watkins LLP related to the form of compensation of our executive officers, management team members and the employment contracts associated with these officers, employees, and our past and current executive directors, receiving their input and advice. The compensation committee has considered the independence of their advisors, and found them to be so according to the adviser independence factors required under SEC rules as they relate to (i)&#160;additional services, (ii)&#160;total fees as a percentage of total revenue, (iii)&#160;conflict of interest policies, (iv)&#160;business or personal relationships with members of the compensation committee, (v)&#160;stock ownership by compensation advisors, and (vi)&#160;business or personal relationships with executives of the company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The members of our compensation committee are Mark Iwicki, Len Kanavy and Paolo Pucci. Mr.&#160;Iwicki serves as the Chairperson of the compensation committee. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The compensation committee met five times during 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_50">NOMINATION AND CORPORATE GOVERNANCE COMMITTEE </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Our nomination and corporate governance committee&#8217;s responsibilities include: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">drawing up selection criteria and appointment procedures for the directors; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">reviewing the size and composition of the board of directors and submitting proposals for the composition profile of the board of directors; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">reviewing the functioning of individual directors and reporting on such review to the board of directors; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">overseeing the process on annual self-evaluation of the board of directors to determine whether it and its committees are functioning effectively; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">53 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">drawing up a plan for the succession of directors; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">working with our Chief Executive Officer to evaluate our succession plans for our Chief Executive Officer and other executive officers, including an emergency succession plan for our Chief Executive Officer; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">submitting proposals for the appointment or reappointment of directors; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">supervising the policy of the board of directors regarding the selection criteria and appointment procedures for our senior management; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">reviewing the Company&#8217;s practices, goals and risk management regarding sustainability, climate-related, environmental, social and governance matters, and the Company&#8217;s public reporting concerning such matters; and </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">conducting or authorizing investigations into any matters within the scope of its the responsibilities as it shall deem appropriate, including the authority to request any of our officers, employees or advisors to meet with the nomination and corporate governance committee or any advisors engaged by the nomination and corporate governance committee. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The members of our nomination and corporate governance committee are Anand Mehra, M.D., Mark Iwicki and Len Kanavy. Dr.&#160;Mehra serves as the Chairperson of the nomination and corporate governance committee. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The members of the nomination and corporate governance committee met three times during 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#cccccc">
<td style="vertical-align:top">&#8195;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">54 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="font-size:1pt;background-color:#d8d8d8">
<td style="height:0.75pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#d8d8d8">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.33em; font-size:12pt; font-family:Times New Roman;font-weight:bold">COMPENSATION DISCUSSION AND ANALYSIS</p></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">GENERAL </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">In this CD&amp;A, we provide an overview and analysis of the compensation awarded to or earned by our named executive officers identified in the Summary Compensation Table below (each, an &#8220;NEO&#8221;) during fiscal 2023, including the elements of our compensation program for NEOs, material compensation decisions made under that program for fiscal 2023 and the material factors considered in making those decisions. In 2023, our &#8220;named executive officers&#8221; and their positions were as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Sven (Bill) Ante Lundberg, M.D., President, Chief Executive Officer; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Hui Liu, Ph.D., Chief Business Officer, Head of Merus US; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Peter B. Silverman, J.D., Chief Operating Officer and General Counsel; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Andrew Joe, Chief Medical Officer; and </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Greg D. Perry, Chief Financial Officer and Principal Financial Officer. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">EXECUTIVE SUMMARY </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">2023 Performance Highlights and Pay for Performance </span></p> <p style="margin-top:24pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">Our executive compensation programs are designed to deliver pay in accordance with corporate and individual performance, rewarding superior performance and providing consequences for underperformance. We believe that the compensation of our NEOs for fiscal year 2023 was aligned with the Company&#8217;s performance during 2023. Highlights of that performance include: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Advancement of the Company&#8217;s clinical development pipeline, which included: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:17%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left"><span style="font-family:ARIAL"><sup style="font-size:75%; vertical-align:top"><span style="FONT-SIZE:95%">&#9675;</span></sup>&#160;</span></td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">achieving significant enrollment in the phase 2 trial investigating monotherapy petosemtamab in previously treated head and neck squamous cell carcinoma (HNSCC), presenting at the American Association of Clinical Research 2023 on this cohort, obtaining of Fast Track Designation (FTD) for the treatment of patients with recurrent or metastatic HNSCC, achieving initiation of and significant enrollment in petosemtamab monotherapy at the 1100 or 1500 mg dose levels in previously treated HNSCC, as well as initiation and significant enrollment in the phase 2 investigation of petosemtamab in combination with pembrolizumab as front-line therapy for HNSCC </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:17%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left"><span style="font-family:ARIAL"><sup style="font-size:75%; vertical-align:top"><span style="FONT-SIZE:95%">&#9675;</span></sup>&#160;</span></td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">achieving significant enrollment in the eNRGy trial to support a potential registration path for zenocutuzumab in patients with NRG1 fusion (&#8220;NRG1+&#8221;) cancer, presenting at the European Society of Medical </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">55 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:16%">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
Oncology (ESMO) 2023, obtaining Breakthrough Therapy Designation (BTD) for zenocutuzumab (Zeno) for the treatment of patients with advanced unresectable or metastatic NRG1 fusion (NRG1+) <span style="white-space:nowrap">non-small</span> cell lung cancer (NSCLC), following progression with prior systemic therapy, and BTD for the treatment of patients with NRG1+ pancreatic cancer, following progression with prior systemic therapy or in patients who have no satisfactory alternative treatment options; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:12%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left"><span style="font-family:ARIAL"><sup style="font-size:75%; vertical-align:top"><span style="FONT-SIZE:95%">&#9675;</span></sup>&#160;</span></td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">achieving significant enrollment in the Phase 2 trial investigating <span style="white-space:nowrap">MCLA-129</span> in solid tumors, including in combination with Osimertinib in mutant NSCLC, presenting at ESMO Asia 2023; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Advancement of the Company&#8217;s <span style="white-space:nowrap">pre-clinical</span> development pipeline, which included: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:12%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left"><span style="font-family:ARIAL"><sup style="font-size:75%; vertical-align:top"><span style="FONT-SIZE:95%">&#9675;</span></sup>&#160;</span></td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">developing multiple internal, wholly-owned programs planned for potential candidate nomination in 2024, including the development of new capabilities and modalities for the generation of preclinical multispecific antibodies; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:12%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left"><span style="font-family:ARIAL"><sup style="font-size:75%; vertical-align:top"><span style="FONT-SIZE:95%">&#9675;</span></sup>&#160;</span></td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">through the Company&#8217;s collaborations, achieving a candidate nomination milestone under the terms of the collaboration and license agreement between Merus and Incyte (&#8220;Incyte Collaboration&#8221;), with two assets entering the clinic in 2023, and multiple programs in various stages of preclinical development under the Incyte Collaboration, and three active programs under the collaboration and license agreement (the &#8220;Lilly Collaboration Agreement&#8221;) with Eli Lilly and Company, an Indiana corporation (&#8220;Eli Lilly&#8221;); and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:12%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left"><span style="font-family:ARIAL"><sup style="font-size:75%; vertical-align:top"><span style="FONT-SIZE:95%">&#9675;</span></sup>&#160;</span></td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">significant advancement in the Company&#8217;s intellectual property portfolio with over 20 new issuances covering the Company&#8217;s preclinical and clinical candidates and platform technologies. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Execution of Commercial Strategy </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:12%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left"><span style="font-family:ARIAL"><sup style="font-size:75%; vertical-align:top"><span style="FONT-SIZE:95%">&#9675;</span></sup>&#160;</span></td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Establishing a high-level commercial strategy for petosemtamab and <span style="white-space:nowrap">MCLA-129</span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:12%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left"><span style="font-family:ARIAL"><sup style="font-size:75%; vertical-align:top"><span style="FONT-SIZE:95%">&#9675;</span></sup>&#160;</span></td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Performing disease state awareness campaigns and brand preparation activities for zenocutuzumab in NRG1+ cancer, while exploring potential collaborations and license opportunities </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Execution of the Company&#8217;s general and administrative goals including: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:12%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left"><span style="font-family:ARIAL"><sup style="font-size:75%; vertical-align:top"><span style="FONT-SIZE:95%">&#9675;</span></sup>&#160;</span></td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Effectively managed the organization, achieving the Company&#8217;s hiring plan and development and maturation of a variety of functions, including clinical operations, information technology, human resources, medical affairs, and regulatory; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:12%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left"><span style="font-family:ARIAL"><sup style="font-size:75%; vertical-align:top"><span style="FONT-SIZE:95%">&#9675;</span></sup>&#160;</span></td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">maintenance of financial discipline and strong balance sheet, including use of an Open Market Sale Agreement (the &#8220;Sales Agreement&#8221;) with Jefferies LLC (&#8220;Jefferies&#8221;) executed in 2021, under which Jefferies acted as the sales agent to sell common shares pursuant to an <span style="white-space:nowrap"><span style="white-space:nowrap">&#8220;at-the-market&#8221;</span></span> offering in 2023, and </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">56 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:16%">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
successfully completing a public offering of common shares, resulting in aggregate net proceeds from fiscal 2023 of more than $200&#160;million during a period of significant market volatility. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">In order to align pay with performance, a significant portion of our NEOs&#8217; compensation is delivered in the form of equity awards and annual cash incentives, which are variable compensation elements tied to our actual performance. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">2023 Compensation Highlights </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">Consistent with our compensation philosophy, key compensation decisions for 2023 included the following: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left"><span style="font-style:italic">Base Salaries</span>. The 2023 base salaries for our NEOs were increased in order to position base salaries at or near the median of market, based on the market analysis of our independent compensation consultant, as described further below. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left"><span style="font-style:italic">Annual Cash Incentives</span>. For 2023, target annual cash incentive opportunities remained level and were aligned at or near the median of the market. Our compensation committee selected performance goals for our performance-based annual bonus program that were intended to promote our business plan and short-term goals, including with respect to advancement of our clinical and preclinical development pipeline, business development and commercial preparedness goals, and general and administrative goals, as described in more detail below. In light of our achievement of each of the corporate performance goals for 2023, the compensation committee determined we achieved 110% of target performance for the corporate performance objectives of our annual bonus plan. With respect to individual performance for each of our NEOs, other than our CEO who did not have an individual performance component under the annual bonus plan for 2023, the NEOs <span style="white-space:nowrap">out-performed</span> their individual performance goals for 2023. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left"><span style="font-style:italic">Equity-Based Long Term Incentives</span>. In 2023, we granted equity-based compensation in the form of options. We believe that options effectively align the interests of our executives with those of our shareholders by directly linking compensation to the value of our common shares. Options require an increase in shareholder value in order for our NEOs to realize any value. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Our employees are key to achieving our goals and our compensation programs are specifically designed to attract, retain and reward our critical talent, and provide a strong link between pay and performance. We target the 50<sup style="font-size:75%; vertical-align:top">th</sup> percentile of the peer group, with variations as appropriate based on a unique combination of factors such as experience, performance, tenure, and criticality of role, among other relevant factors, with actual compensation received designed to reflect the combination of corporate and individual performance. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">57 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Compensation Governance and Best Practices </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">We are committed to having strong governance standards with respect to our compensation programs, procedures and practices. Our key compensation practices include the following: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:2%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/>

<td style="vertical-align:bottom"/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">What We Do</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:12pt"><span style="font-weight:bold">What We Do Not Do</span></span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">&#10003;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-size:12pt">Emphasize performance-based, at risk compensation.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"><span style="font-size:12pt">&#8199;X</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-size:12pt">Do not grant uncapped cash incentives or guaranteed equity compensation.</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">&#10003;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-size:12pt">Emphasize the use of equity compensation to promote executive retention and reward long-term value creation.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"><span style="font-size:12pt">&#8199;X</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" colspan="3"><span style="font-size:12pt">Do not provide significant perquisites.</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">&#10003;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Weight the overall pay mix towards incentive compensation for senior executives.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">&#8199;X</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" colspan="3">Do not provide any compensation-related <span style="white-space:nowrap">tax&#160;gross-ups.</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">&#10003;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="font-size:12pt">Engage an independent compensation consultant to advise our compensation committee.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"><span style="font-size:12pt">&#8199;X</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" colspan="3"><span style="font-size:12pt">Do not reprice our option awards and our equity incentive plan expressly forbids repricing or exchanging underwater options for cash, other awards or options with an exercise price per share that is less than the exercise price of the original option without shareholder approval.</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">&#10003;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="font-size:12pt">Require double trigger for change in control benefits such that no severance payment or equity acceleration occurs solely as a result of a change in control event.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"><span style="font-size:12pt">&#8199;X</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" colspan="3"><span style="font-size:12pt">Do not include single-trigger acceleration of unvested options.</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">&#10003;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="font-size:12pt">Maintain an independent Compensation Committee.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"><span style="font-size:12pt">&#8199;X</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" colspan="3"><span style="font-size:12pt">Do not permit our directors, officers and employees to engage in transactions that hedge or offset, or are designed to hedge or offset, any decrease in the market value of the Company&#8217;s equity securities, or that may cause an officer, director, or employee to no longer have the same objectives as the Company&#8217;s other shareholders..</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">&#10003;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="font-size:12pt">Maintain a claw back policy consistent with Section&#160;10D of the Exchange Act of 1934, as amended, Rule <span style="white-space:nowrap">10D-1</span></span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"><span style="font-size:12pt">&#8199;X</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" colspan="3"><span style="font-size:12pt">Do not sponsor any defined benefit pension plans or supplemental retirement plans specifically for executives.</span></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">At our 2023 annual general meeting of shareholders, our shareholders voted to approve on a <span style="white-space:nowrap">non-binding</span> advisory basis, the compensation of our NEOs with the support of greater than 98% of the votes cast. Given the level of support received from our shareholders and the compensation committee&#8217;s assessment that our programs continue to effectively support our business objectives, we did not make any material changes to our executive compensation </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">58 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
program as a result of this vote. The compensation committee will review the outcome of future <span style="white-space:nowrap"><span style="white-space:nowrap">say-on-pay</span></span> votes as part of its decision making for our executive compensation programs. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">DETERMINING EXECUTIVE COMPENSATION </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Role of Compensation Consultant </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">Under its charter, our Compensation Committee has the authority to engage the services of a consulting firm to assist the Compensation Committee in fulfilling its duties. During 2023, our compensation committee retained Pearl Meyer as an independent compensation consultant to provide executive compensation advisory services. The compensation committee has evaluated Pearl Meyer&#8217;s independence pursuant to the requirements of Nasdaq and SEC rules and has determined that Pearl Meyer does not have any conflicts of interest in advising the compensation committee. Pearl Meyer did not provide any other services to the Company in 2023 for which the amount of fees exceeded $120,000. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Use of Market Data </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">In designing pay programs and setting pay levels, our Compensation Committee reviews market data from comparable biotechnology companies. There are two primary sources of information: public peer company disclosures and published market compensation survey data. The survey data is used to obtain a general understanding of current compensation practices and not as a basis from which to justify or provide a framework for compensation decisions. Our independent outside compensation consultant assists in determining the peer group companies and provides all relevant peer group compensation data. Separately, we participate in and purchase access to Aon Radford&#8217;s Global Compensation Database, which our Compensation Committee may use as a supplemental data point. Our Compensation Committee uses the market data to help structure a competitive executive compensation program and make individual compensation decisions based on comparable positions at companies with which we compete for talent. While our compensation committee does not establish compensation levels solely based on a review of competitive data or benchmark to any particular level, it believes such data is a useful tool in its deliberations as our compensation policies and practices must be competitive in the marketplace for us to be able to attract, motivate and retain qualified executive officers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">In September 2022, our Compensation Committee approved two peer groups for use in setting target pay opportunities for 2023. The U.S. peer group served as the primary frame of reference and the companies were selected to be comparable to Merus in terms of industry, valuation, stage, and size. In consultation with Pearl Meyer, our Compensation Committee selected the peer group generally using the following criteria: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Industry: biotechnology or pharmaceuticals; </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Valuation: $300M - $3.0B market capitalization; </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Stage: clinical phase 2 or 3; </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Size: 50 &#8211; 500 employees; and </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Operating expense: &lt;$400M. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">59 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">Preference was given, where possible, to companies focused on oncology in phase 2 or 3. The resulting peer group, which we refer to as the 2022 U.S. Peer Group consisted of the following companies: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:99%;border:0;margin:0 auto">


<tr>

<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom"/>
<td style="width:22%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.25em; font-size:12pt; font-family:Times New Roman">Arcturus Therapeutics Holdings Inc.</p></td>
<td style=" BORDER-TOP:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000;vertical-align:top">EQRx, Inc.</td>
<td style=" BORDER-TOP:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000;vertical-align:top">iTeos Therapeutics, Inc.</td>
<td style=" BORDER-TOP:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:top">Replimune Group, Inc.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.25em; font-size:12pt; font-family:Times New Roman">Arcus Biosciences, Inc.</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Erasca, Inc.</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Kura Oncology, Inc.</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:top">Revolution Medicines, Inc.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.25em; font-size:12pt; font-family:Times New Roman">Celldex Therapeutics, Inc.</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">ImmunoGen, Inc.</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Mersana Therapeutics, Inc.</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:top">Scholar Roch Holdings Corp.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.25em; font-size:12pt; font-family:Times New Roman">Crinetics Pharmaceuticals, Inc.</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Inhibrx, Inc.</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">NGM Biopharmaceuticals, Inc.</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:top">Syndax Pharmaceuticals, Inc.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="padding-bottom:3pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.25em; font-size:12pt; font-family:Times New Roman">Day One Biopharmaceuticals, Inc.</p></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top">Iovance Biotherapeutics, Inc.</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top">REGENXBIO Inc.</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:top">Zymeworks Inc.</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">In order to understand the pay practices of comparable European biotech companies, or those with substantial operations in both Europe and the U.S., our Compensation Committee also approved a secondary peer group to be used for reference. This peer group, which we refer to as the 2022 European Peer Group was selected based on the same set of criteria used to select the 2022 U.S. Peer Group companies, except that in certain instances Pearl Meyer relaxed the ranges to ensure a sufficient sample size given the limited number of companies from Europe reporting compensation information. The 2022 European Peer Group consisted of the following companies: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:99%;border:0;margin:0 auto">


<tr>

<td style="width:28%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:23%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:23%"/>

<td style="vertical-align:bottom"/>
<td style="width:21%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.25em; font-size:12pt; font-family:Times New Roman">Adaptimmune Therapeutics plc</p></td>
<td style=" BORDER-TOP:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000;vertical-align:top">COMPASS Pathways plc</td>
<td style=" BORDER-TOP:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000;vertical-align:top">Immunocore Holdings plc</td>
<td style=" BORDER-TOP:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:top">Valneva SE</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.25em; font-size:12pt; font-family:Times New Roman">ADC Therapeutics SA</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Exscientia plc</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Molecular Partners AG</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:top">Zealand Pharma A/S</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.25em; font-size:12pt; font-family:Times New Roman">Affimed N.V.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Formycon AG</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Silence Therapeutics plc</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:top">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="padding-bottom:3pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.25em; font-size:12pt; font-family:Times New Roman">Bicycle Therapeutics plc</p></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top">Immatics N.V.</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top">uniQure N.V.</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:top">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">Subsequently, in September 2023, our Compensation Committee updated the peer groups to reflect our progress and profile. In consultation with Pearl Meyer our Compensation Committee updated the U.S. peer group generally using the following criteria: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Industry: biotechnology or pharmaceuticals; </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Valuation: $300M - $3.0B market capitalization, on a trailing <span style="white-space:nowrap">6-months</span> average basis; </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Stage: clinical-stage; </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Size: 50 &#8211; 500 employees at the last fiscal year end; and </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">&lt;$400M in trailing 12 months operating expense. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">60 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">Preference was given, where possible, to companies in phase 2 or 3 and/or those focused on oncology. As a result, our Compensation Committee determined to make the following changes on the basis of either valuation, stage or size: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Removals: EQRX, Inc., ImmunoGen, Inc., iTeos Therapeutics, Inc., Mersana Therapeutics, Inc., NGM Biopharmaceuticals, Inc., </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Additions: Cogent Biosciences Inc., IDEAYA Biosciences, Inc., Morphic Holdings, Inc., and Zentalis Pharmaceuticals, Inc. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">The resulting peer group, which we refer to as the 2023 U.S. Peer Group consisted of the following companies: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom"/>
<td style="width:22%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.25em; font-size:12pt; font-family:Times New Roman">Arcturus Therapeutics Holdings Inc.</p></td>
<td style=" BORDER-TOP:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000;vertical-align:top">Day One Biopharmaceuticals, Inc.</td>
<td style=" BORDER-TOP:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000;vertical-align:top">Kura Oncology, Inc.</td>
<td style=" BORDER-TOP:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:top">Scholar Rock Holding Corporation</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.25em; font-size:12pt; font-family:Times New Roman">Arcus Biosciences, Inc.</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Erasca, Inc.</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Morphic Holdings, Inc.</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:top">Syndax Pharmaceuticals, Inc.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.25em; font-size:12pt; font-family:Times New Roman">Celldex Therapeutics, Inc.</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">IDEAYA Biosciences, Inc.</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">REGENXBIO Inc.</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:top">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:top">Zentalis Pharmaceuticals, Inc.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.25em; font-size:12pt; font-family:Times New Roman">Cogent Biosciences Inc.</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Inhibrx, Inc.</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Replimune Group, Inc.</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:top">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.25em; font-size:12pt; font-family:Times New Roman">Crinetics Pharmaceuticals, Inc.</p></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top">Iovance Biotherapeutics, Inc.</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top">Revolution Medicines, Inc.</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:top">Zymeworks Inc.</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">Given the lack of meaningful peer group of European biotech companies, the Compensation Committee in consultation with our compensation advisor elected not to use a European peer group in 2023 for purposes of establishing 2024 compensation levels. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">ELEMENTS OF COMPENSATION </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The<span style="font-weight:bold"> </span>primary elements of our<span style="font-weight:bold"> </span>NEOs&#8217; compensation and the main objectives of each are: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left"><span style="font-style:italic">Base Salary</span>. Base salary attracts and retains talented executives, recognizes individual roles and responsibilities, and provides stable income; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left"><span style="font-style:italic">Annual Performance-Based Incentive Compensation</span>. Annual performance bonuses promote short-term performance objectives and reward executives for their contributions toward achieving those objectives; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left"><span style="font-style:italic">Equity Based Long-Term Incentive Compensation</span>. Equity compensation, provided in the form of options during 2023, aligns executives&#8217; interests with our shareholders&#8217; interests, emphasizes long-term financial and operational performance, and helps retain executive talent. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">61 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">In addition, our NEOs are eligible to participate in our health and welfare programs, our 401(k) plan for those in the US, and our retirement pension scheme for those in the Netherlands, in each case, on the same basis as our other employees. Merus US, Inc. has also entered into employment agreements with each of our NEOs, which provide for severance payments and benefits upon certain terminations without cause or resignation for good reason. Our compensation committee believes that these types of arrangements are necessary to attract and retain executive talent and are a customary component of executive compensation. Each of these elements of compensation for 2023 is described further below. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Base Salaries </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">We pay our named executive officers a base salary to compensate them for the satisfactory performance of services rendered to our Company. The base salary payable to each named executive officer is intended to provide a fixed component of compensation reflecting the executive&#8217;s level of responsibility and performance. We annually review market data for base salaries with Pearl Meyer, the Compensation Committee&#8217;s independent compensation consultant, and adjust base salaries periodically based on several factors, including changes in market data, individual performance and experience, or changes in responsibilities. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">In February 2023, the board of directors, based on the recommendation of the Compensation Committee, approved increases to the base salaries of Dr.&#160;Lundberg, Dr.&#160;Liu, Mr.&#160;Silverman and Dr.&#160;Joe to $650,000, $437,750, $495,000, and $473,800 respectively, effective as of January&#160;1, 2023. The 2023 base salary increases were provided based on a number of factors considered by the Compensation Committee, including individual performance, and competitive positioning of these executives with the 50<sup style="font-size:75%; vertical-align:top">th</sup> percentile of our U.S. peer group companies for similar positions. Mr.&#160;Perry&#8217;s base salary was set at $470,000 in connection with his appointment as Chief Financial Officer in June 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Annual Performance-Based Incentive Plan </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">We maintain an annual performance-based incentive plan pursuant to which we may grant our employees, including our named executive officers, incentive cash bonuses based upon corporate and individual performance. We generally pay annual cash bonuses based upon the achievement of set corporate level and personal goals for the period. Achievement of the targets is measured following <span style="white-space:nowrap">year-end</span> and the actual bonus amounts paid to our named executive officers are determined by our board of directors, based on the recommendation of the compensation committee. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Each named executive officer has an annual target bonus that is expressed as a percentage of base salary. The 2023 target bonus amount for each named executive officer, expressed as a percentage of base salary, was 55% for Dr.&#160;Lundberg and 40% for each of our other NEOs. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">At the beginning of each year, the board of directors (considering the recommendations of the compensation committee and management) sets corporate and individual goals and objectives for the year. The corporate objectives for our 2023 performance-based incentive plan </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">62 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
accounted for 100% of the bonus opportunity for Dr.&#160;Lundberg, and 70% of the bonus opportunity for our other NEOs and generally related to factors such as the advancement of lead <span style="white-space:nowrap">pre-clinical</span> and clinical candidates, identification and execution of preparatory commercial development and business development activities, and achievement of certain general and administrative goals. The board of directors, upon recommendation of the compensation committee, determines the level of achievement of corporate goals for each year. There is no bonus earned for a particular corporate performance goal if performance is below 40% of target performance and achievements under the corporate performance goals are capped at 200% of target performance. Individual objectives are established annually and, in 2023, accounted for 0% of Dr.&#160;Lundberg and 30% of each of our other NEO&#8217;s bonus opportunity. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">For each NEO other than Dr.&#160;Lundberg, the individual component of the bonus award for 2023 was based on the achievement of individual objectives related to the NEO&#8217;s area of responsibility within our company; however, the board of directors retains discretion to increase or decrease annual bonus achievement levels based on a subjective assessment of the NEO&#8217;s overall performance of his duties. There is no bonus earned for the individual performance goals if performance is below 40% of target performance and achievements under the individual performance goals are capped at 200% of target performance for each NEO. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Based on the maximum achievement levels under the corporate performance objectives and the relative individual performance weighting for each NEO, each NEO is eligible for a maximum performance bonus equal to 200% of each NEO&#8217;s respective target bonus. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">All final bonus payments to our NEOs are determined by our board of directors, based upon the recommendation of our compensation committee. The actual bonuses awarded in any year, if any, may be more or less than the target, depending on individual performance and the achievement of corporate objectives and may also vary based on other factors at the discretion of the board of directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">2023 Corporate Performance Objectives and Achievement Levels </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The 2023 corporate performance objectives were aggressive and set at challenging levels such that the attainment of target performance was not assured at the time they were set and would require a high level of effort and execution on the part of the executive officers and others in order to achieve the goals. The compensation committee believes that each of these goals is strongly aligned to the creation of long-term value for our shareholders and our other stakeholders. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">63 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The table below provides additional details regarding our 2023 corporate performance objectives, including a description of such objectives, the relative weighting, and the board of director&#8217;s assessment of our actual performance against these objectives: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:21%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:10%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:29%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:21%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:15%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">Objective</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Weighting</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Actual&#160;Performance</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">&#8201;Performance&#8201;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">&#8201;Achievement&#160;Level&#8201;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">&#8199;Weighted&#8199;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">&#8199;Performance&#8199;</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Clinical Development- Advancing each of our clinical assets.</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">45%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company achieved substantial advancement of its clinical development pipeline, including:</p> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;Advancement of the development of <span style="white-space:nowrap">MCLA-158,</span> supporting a planned disclosure at a medical conference in the first half of 2023; and</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;Significant enrollment in the eNRGy trial to support a potential registration path for zenocutuzumab in patients with NRG1+ cancer in NSCLC and pancreatic cancer, and a clinical presentation in the second half of 2023;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;Significant enrollment for each <span style="white-space:nowrap">MCLA-129</span> cohort, a clinical presentation at a medical conference in the second half of 2023 for three or more cohorts.</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">122%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">55%</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="white-space:nowrap">Pre-Clinical</span> Development, Discovery and preclinical research advancement to candidate nomination for internal and collaboration programs; advancement of the Company&#8217;s Multiclonics<sup style="font-size:75%; vertical-align:top">&#174;</sup> platforms with new innovations enhancing multispecific antibody generation.</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">15%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company achieved advancement of its <span style="white-space:nowrap">pre-clinical</span> development pipeline including:</p> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;Development of multiple internal, wholly-owned programs planned for future potential candidate nomination</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;Development of new modalities and methods for the generation of multispecific antibodies</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">100%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">15%</td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">64 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:21%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:10%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:29%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:21%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:15%"/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">Objective</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Weighting</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Actual&#160;Performance</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">&#8201;Performance&#8201;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">&#8201;Achievement&#160;Level&#8201;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">&#8199;Weighted&#8199;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">&#8199;Performance&#8199;</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;Advancement of multiple programs through the Company&#8217;s collaborations, including achieving a candidate nomination milestone under the terms of the Incyte Collaboration, with two assets entering the clinic in 2023;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;Three active programs under the Lilly Collaboration Agreement with Eli Lilly.</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Business development and commercial preparation goals</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">30%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company made substantial advancement in the preparation of its business development and commercial preparation goals, including:</p> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;Building operations and infrastructure for a commercial department in preparation for late stage clinical development and potential approval;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;Establishing a high-level commercial strategy for petosemtamab and <span style="white-space:nowrap">MCLA-129</span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;Performing disease state awareness campaign and brand preparation activities for zenocutuzumab in NRG1+ cancer, while exploring potential collaborations and license opportunities; and</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;Advancing business development activities, including engaging with multiple potential partners on matters</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">67%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">20%</td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">65 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:21%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:10%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:29%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:21%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:15%"/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">Objective</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Weighting</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Actual&#160;Performance</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">&#8201;Performance&#8201;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">&#8201;Achievement&#160;Level&#8201;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">&#8199;Weighted&#8199;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">&#8199;Performance&#8199;</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; font-size:10pt; font-family:Times New Roman">relating to the Company&#8217;s clinical assets as well as its platform technologies.</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">General and administrative goals.</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">10%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company achieved its general and administrative goals including,</p> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;Effectively managed the organization, achieving the Company&#8217;s hiring plan including development and maturation of a variety of functions, including clinical operations, information technology, human resources, medical affairs, regulatory; and</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;maintenance of financial discipline and strong balance sheet , including use of the Sales Agreement with Jefferies executed in 2021, under which Jefferies acted as the sales agent to sell common stock by an <span style="white-space:nowrap"><span style="white-space:nowrap">&#8220;at-the-market&#8221;</span></span> offering in 2023, and successfully completing a public offering of common shares, resulting in an aggregate net proceeds from fiscal 2023 of more than $200&#160;million during a period of significant market volatility; and</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#8226;&#8195;&#8202;Advancement in the Company&#8217;s intellectual property portfolio with over twenty issuances covering the Company&#8217;s preclinical and clinical candidates and platform technologies.</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">200%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">20%</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TOTAL:</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">100%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">66 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">2023 Individual Performance Goals and Achievement Levels </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The table below provides additional details regarding the individual performance goals for our NEOs for 2023, including a description of such goals, the relative weighting, and the board of director&#8217;s assessment of the NEO&#8217;s actual performance against these goals: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:18%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:39%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:27%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:13%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">NEO</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">Objective and Weighting&#8195;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Actual&#160;Performance&#160;and</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Performance&#160;Achievement</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Level</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Weighted</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Performance</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top">Hui Liu</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">Advance business development activities, including engaging with multiple potential partners on matters relating to the Company&#8217;s clinical assets as well as its platform technologies. (55%)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">Overseeing alliances of Company collaboration, supporting financial planning and analysis, and corporate reporting, and continued growth in the organization. (10%)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">Provide leadership to Merus US, Inc. and US office integrating new hires and organizational growth/complexity while maintaining culture. (15%)</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman">Through the above goals, provide leadership, strategic insight and planning, judgment and excellent negotiation to execute on common goals while generating consensus and solution-oriented alignment. (20%)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">115%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">34.5%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top">Andrew Joe</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">Achieve significant advancement in the development of zenocutuzumab in a potentially registrational-directed study; presentation at a scientific conference; obtaining regulatory milestones, including BTDs in NRG1+ NSCLC and pancreatic cancer; significant progress on petosemtamab to support next stage of development; disclosure at a scientific conference; significant progress on <span style="white-space:nowrap">MCLA-129</span> to support next stage of development, and disclosure at a scientific conference. (75%)</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman">Development organization, including regulatory, biometric, clinical</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">115%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">34.5%</td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">67 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:18%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:39%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:27%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:13%"/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">NEO</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">Objective and Weighting&#8195;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Actual&#160;Performance&#160;and</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Performance&#160;Achievement</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Level</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Weighted</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Performance</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">pharmacology, bioanalytical sciences and medical affairs function, and having effective governance meetings. (15%)</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman">Leading department across functions with excellent planning, organization and team dynamics, including leadership and mentorship of the product development teams. (10%)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top">Peter Silverman</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">Enhance compliance consistent with market cap and maturity of clinical pipeline, provision of cross departmental support across general and administrative functions for execution of established objectives and support for the advancement of the clinical and preclinical pipeline and technology enhancement, including through intellectual property capture. (25%).</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">Ensure that appropriate systems and processes are maintained to protect assets and maintain effective control of operations, being finance-ready throughout the year. (25%)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">Meet key objectives for departments within reporting line, as tied to the corporate goals, including enrollment across clinical programs, executing on information technology projects, and protection against cybersecurity threats while maintaining an adequate internal control environment, and meeting the company&#8217;s needs on legal, contracting, compliance and intellectual property demands. (25%)</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman">Provide leadership and vision to company objectives and strategic planning, facilitating cross-functional teams to enhance enterprise value, improve execution, competitive advantage and manage risk, and implementing and updating applicable board policies and policies for Board consideration. (25%)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">175%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">52.5%</td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">68 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:18%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:39%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:27%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:13%"/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">NEO</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">Objective and Weighting&#8195;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Actual&#160;Performance&#160;and</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Performance&#160;Achievement</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Level</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Weighted</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:center">Performance</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top">Greg Perry</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Ensure that financial reporting, internal controls and compliance and quality metrics are effective and at a high standard, being finance-ready throughout the year. (25%) Developing strategic analyses and planning for value creation events on short, middle and long term. (25%) Provide leadership and vision to company objectives for finance accounting, financial planning and quality teams, improve execution, competitive advantage and manage risk. (50%)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">115%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="right">34.5%</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">2023 Annual Incentive Compensation Determination </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:18%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">NEO</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Base</span><br/><span style="font-weight:bold">Salary</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Target</span><br/><span style="font-weight:bold">Bonus</span><br/><span style="font-weight:bold">(as %</span><br/><span style="font-weight:bold">of Base</span><br/><span style="font-weight:bold">Salary)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Corporate</span><br/><span style="font-weight:bold">Performance</span><br/><span style="font-weight:bold">Weighting</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Corporate</span><br/><span style="font-weight:bold">Performance</span><br/><span style="font-weight:bold">Achievement</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Individual</span><br/><span style="font-weight:bold">Performance</span><br/><span style="font-weight:bold">Weighting</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Individual</span><br/><span style="font-weight:bold">Performance</span><br/><span style="font-weight:bold">Achievement</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span><br/><span style="font-weight:bold">Incentive</span><br/><span style="font-weight:bold">Compensation</span><br/><span style="font-weight:bold">Plan Award</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Bill</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Lundberg*</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">650,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">55</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">100%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">110%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(discretionary<br/>addition)&#160;10%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">429,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Hui Liu</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">437,750</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">40</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">70%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">110%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">115%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">195,237</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Andrew</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Joe</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">473,800</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">40</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">70%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">110%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">115%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">211,315</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Peter</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Silverman</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">495,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">40</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">70%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">110%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">175%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">256,410</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Greg</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Perry**</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">470,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">40</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">70%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">110%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">115%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">122,208</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">*While Dr.&#160;Lundberg did not have a <span style="white-space:nowrap">pre-established</span> individual performance metric for his 2023 annual bonus, the Board awarded him a discretionary 10% bonus for exceptional performance in execution and maintenance of a strong balance sheet, and outperformance against industry peers. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">**Mr.&#160;Perry&#8217;s bonus was applied with a proration factor of 58.3% to reflect his partial year of employment with the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The amounts paid to our named executive officers under our performance-based incentive compensation plan for 2023 are set forth below in the Summary Compensation Table in the column entitled <span style="white-space:nowrap">&#8220;Non-Equity</span> Incentive Plan Compensation.&#8221; </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">69 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Long-Term Incentive Plan </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">We view equity-based compensation as a critical component of our balanced total compensation program. Equity-based compensation creates an ownership culture among our employees that provides an incentive to contribute to the continued growth and development of our business and aligns the interests of executives with those of our shareholders. We do not currently have any formal policy for determining the number of equity-based awards to grant to our NEOs. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Our compensation committee believes it is essential to provide equity-based compensation to our executive officers in order to link the interests and risks of our executive officers with those of our shareholders, reinforcing our commitment to ensuring a strong linkage between company performance and pay. We grant options to our named executive officers as the long-term incentive component of their compensation. Our options have an exercise price at least equal to the fair market value of a common share on the date of grant and typically vest as to 25% of the shares subject to the option on the first anniversary of the vesting commencement date and in 36 substantially equal monthly installments thereafter, subject to the holder&#8217;s continued employment with us and potential accelerated vesting in certain circumstances as described below under &#8220;Employment Agreements.&#8221; However the compensation committee may grant different equity awards or awards with different vesting schedules from time to time. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">During 2023, the named executive officers were granted equity awards as set forth in the following table. See the Outstanding Equity Awards at 2023 Financial Year End table below for additional information on these awards. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:22%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:22%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">Named Executive Officer</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number&#160;of&#160;Shares&#160;subject</span><br/><span style="font-weight:bold">to 2023 Options</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number&#160;of&#160;Shares&#160;subject</span><br/><span style="font-weight:bold">to 2023 RSUs</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Sven (Bill) Ante Lundberg, M.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">380,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Hui Liu, Ph.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">104,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Peter Silverman, J.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">124,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Andrew Joe, M.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">104,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Gregory Perry</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">372,924</td>
<td style="white-space:nowrap;vertical-align:bottom">(1)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">(1) Mr.&#160;Perry was also granted an option to purchase 14,414 common shares in June 2023 under our NED Program. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Retirement, Health, Welfare and Additional Benefits </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">We maintain a 401(k) retirement savings plan for employees of Merus US, Inc. employed in the United States who satisfy certain eligibility requirements. Our named executive officers in the United States are eligible to participate in the 401(k) plan on the same terms as other full-time employees. Currently, we match 50% of contributions made by participants in the 401(k) plan up to 3% of the employee&#8217;s contributions, and these matching contributions are fully vested as of the date on which the contribution is made. We believe that providing a vehicle </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">70 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
for <span style="white-space:nowrap">tax-deferred</span> retirement savings adds to the overall desirability of our executive compensation package and further incentivizes our employees, including our named executive officers, in accordance with our compensation policies. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">For our employees employed in the Netherlands, we offer a retirement pension scheme for employees as of 21 years old. At the day that the employee retires, the employee receives a monthly pension for life. We use the career average pay plan. Under this plan the employee will accrue pension benefits based on the employee&#8217;s salary minus the AOW offset, which for 2023 was &#8364;16,322. The AOW pension is a basic state pension provided by the Dutch government to people who have reached AOW pension age. AOW is short for <span style="font-style:italic">Algemene Ouderdomswet</span>, the National Old Age Pensions Act. The employee accrues 1.875% of this base amount each year. The employee can accrue pension benefits up to a maximum salary amount of &#8364;114,866 per year. The employee pays 3% contribution on the employee&#8217;s pension based salary. If an employee dies before the employee&#8217;s retirement date, leaving behind a partner and/or child(ren), the partner will receive a partners pension, ANW gap pension, and the child(ren) will receive an orphans&#8217; benefit. Our costs for this benefit depend on the price and the interest rates and varies each year due to variable return correction. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Our named executive officers are eligible to participate in our employee benefit plans and programs, including health and welfare plans, to the same extent as our other full-time employees, subject to the terms and eligibility requirements of those plans and programs. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">During 2023 we provided a housing allowance to Dr.&#160;Lundberg and Mr.&#160;Silverman in the </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">amount of $25,627 for Dr.&#160;Lundberg and $23,071 for Mr.&#160;Silverman to cover costs </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">associated with housing in the Netherlands, which amounts are reflected in the &#8220;All Other Compensation&#8221; column of the 2023 Summary Compensation Table below. We did not provide any other perquisites to our named executive officers in 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Employment Agreements </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Merus US, Inc. has entered into employment agreements with each of our named executive officers, which provide for severance payments and benefits upon certain terminations without cause or resignation for good reason. Our compensation committee believes that these types of arrangements are necessary to attract and retain executive talent and are a customary component of executive compensation. In particular, such arrangements can mitigate a potential disincentive for our NEOs when they are evaluating a potential acquisition of the Company and can encourage retention through the conclusion of the transaction. The payments and benefits provided under the employment agreements are designed to be competitive with market practices. A description of these agreements is provided below. For information on the estimated payments and benefits that our NEOs would have been eligible to receive upon certain terminations of employment as of December&#160;31, 2023, see &#8220;<span style="font-style:italic">Potential Payments Upon Termination or Change in Control</span>&#8221; below. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">71 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Employment Agreement with Dr.&#160;Lundberg </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">In December 2019, Merus US, Inc. entered into an employment agreement with Dr. Lundberg. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">If Dr.&#160;Lundberg&#8217;s employment is terminated by Merus US, Inc. without cause or due to Dr.&#160;Lundberg&#8217;s resignation for good reason, then subject to his executing a general release of </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">claims and continuing compliance with a proprietary information agreement, Dr.&#160;Lundberg will be entitled to receive (i)&#160;base salary continuation payments for 12 months; (ii)&#160;payment for any earned but unpaid annual bonus for the year prior to the year of termination, and (iii)&#160;direct payment of or reimbursement for continued medical, dental or vision coverage pursuant to COBRA for up to 12 months. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">If Dr.&#160;Lundberg&#8217;s employment is terminated by Merus US, Inc. without cause or due to Dr.&#160;Lundberg&#8217;s resignation for good reason, in either case, within 12 months following a change in control, then subject to his executing a general release of claims and continuing compliance with a proprietary information agreement, Dr.&#160;Lundberg will be entitled to receive, in lieu of the severance payments and benefits described above, (i)&#160;a lump sum payment equal to 1.5 times the sum of his base salary and target annual bonus; (ii)&#160;payment for any earned but unpaid annual bonus for the year prior to the year of termination; (iii)&#160;direct payment of or reimbursement for continued medical, dental or vision coverage pursuant to COBRA for up to 18 months; and (iv)&#160;accelerated vesting of any portion of his time-based equity awards that is unvested as of the date of such termination. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The proprietary information agreement and the release of claims contain restrictive covenants which restrict Dr.&#160;Lundberg&#8217;s ability to compete with the Company for a period of 12 months following his termination of employment or solicit the Company&#8217;s employees, consultants, independent contractors, customers or suppliers for a period of 12 months following termination, subject to Merus US, Inc.&#8217;s obligation to pay Dr.&#160;Lundberg 50% of his highest annualized base salary for the two year period prior to his termination (or the severance described above) if Merus US, Inc. decides to enforce the <span style="white-space:nowrap">non-competition</span> restriction. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Employment Agreement with Dr.&#160;Liu </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">In February 2023, Dr.&#160;Liu entered into a new employment agreement with Merus US, Inc., superseding his prior employment agreement with Merus B.V., pursuant to which, if Dr.&#160;Liu&#8217;s employment is terminated by Merus US, Inc. without cause or due to his resignation for good reason, then subject to him executing a general release of claims and continuing compliance with a proprietary information agreement, Dr.&#160;Liu will be entitled to receive (i)&#160;base salary continuation payments for 12 months; (ii)&#160;payment for any earned but unpaid annual bonus for the year prior to the year of termination, and (iii)&#160;direct payment of or reimbursement for continued medical, dental or vision coverage pursuant to COBRA for up to 12 months. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">If Dr.&#160;Liu&#8217;s employment is terminated by Merus US, Inc. without cause or due to his resignation for good reason, in either case, within 12 months following a change in control, then subject to him executing a general release of claims and continuing compliance with a proprietary information agreement, Dr.&#160;Liu will be entitled to receive, in lieu of the severance </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">72 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
payments described above, (i)&#160;a lump sum payment equal to one times the sum of his base salary and target annual bonus; (ii)&#160;payment for any earned but unpaid annual bonus for the year prior to the year of termination; (iii)&#160;direct payment of or reimbursement for continued medical, dental or vision coverage pursuant to COBRA for up to 12 months; and </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">(iv)&#160;accelerated vesting of any portion of his time-based equity awards that is unvested as of the date of such termination. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The proprietary information agreement and the release of claims contain restrictive covenants which restrict Dr.&#160;Liu&#8217;s ability to compete with the Company for a period of 12 months following his termination of employment or solicit the Company&#8217;s employees, consultants, independent contractors, customers or suppliers for a period of 12 months following termination, subject to Merus US, Inc.&#8217;s obligation to pay Dr.&#160;Liu 50% of his highest annualized base salary for the two year period prior to his termination (or the severance described above) if Merus US, Inc. decides to enforce the <span style="white-space:nowrap">non-competition</span> restriction. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Employment Agreement with Mr.&#160;Silverman </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">In January 2023, Merus US, Inc. entered into an employment agreement with Mr.&#160;Silverman replacing his employment agreement with Merus N.V., pursuant to which, if Mr.&#160;Silverman&#8217;s employment is terminated by Merus US, Inc. without cause or due to his resignation for good reason, then subject to him executing a general release of claims and continuing compliance with a proprietary information agreement, Mr.&#160;Silverman will be entitled to receive (i)&#160;base salary continuation payments for 12 months; (ii)&#160;payment for any earned but unpaid annual bonus for the year prior to the year of termination, and (iii)&#160;direct payment of or reimbursement for continued medical, dental or vision coverage pursuant to COBRA for up to 12 months. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">If Mr.&#160;Silverman&#8217;s employment is terminated by Merus US, Inc. without cause or due to his resignation for good reason, in either case, within 12 months following a change in control, then subject to him executing a general release of claims and continuing compliance with a proprietary information agreement, Mr.&#160;Silverman will be entitled to receive, in lieu of the severance payments described above, (i)&#160;a lump sum payment equal to one times his base salary and target annual bonus (and not less than 40% of his base salary); (ii) payment for any earned but unpaid annual bonus for the year prior to the year of termination; (iii)&#160;direct payment of or reimbursement for continued medical, dental or vision coverage pursuant to COBRA for up to 12 months; and (iv)&#160;accelerated vesting of any portion of his time-based equity awards that is unvested as of the date of such termination. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The proprietary information agreement and the release of claims contain restrictive covenants which, subject to certain professional responsibility rules, restrict Mr.&#160;Silverman&#8217;s ability to compete with the Company for a period of 12 months following his termination of employment or solicit the Company&#8217;s employees, consultants, independent contractors, customers or suppliers for a period of 12 months following termination, subject to Merus US, Inc.&#8217;s obligation to pay Mr.&#160;Silverman 50% of his highest annualized base salary for the two year period prior to his termination (or the severance described above) if Merus US, Inc. decides to enforce the <span style="white-space:nowrap">non-competition</span> restriction. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">73 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Employment Agreement with Dr.&#160;Joe </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">In July 2020, Dr.&#160;Joe entered into an employment agreement with Merus US, Inc., pursuant to which, if Dr.&#160;Joe&#8217;s employment is terminated by Merus US, Inc. without cause or due to his resignation for good reason, then subject to him executing a general release of claims and continuing compliance with a proprietary information agreement, Dr.&#160;Joe will be entitled to receive (i)&#160;base salary continuation payments for 12 months; (ii)&#160;payment for any earned but unpaid annual bonus for the year prior to the year of termination, and (iii)&#160;direct payment of or reimbursement for continued medical, dental or vision coverage pursuant to COBRA for up to 12 months. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">If Dr.&#160;Joe&#8217;s employment is terminated by Merus US, Inc. without cause or due to his resignation for good reason, in either case, within 12 months following a change in control, then subject to him executing a general release of claims and continuing compliance with a proprietary information agreement, Dr.&#160;Joe will be entitled to receive, in lieu of the severance payments described above, (i)&#160;a lump sum payment equal to one times his base salary and target annual bonus; (ii)&#160;payment for any earned but unpaid annual bonus for the year prior to the year of termination; (iii)&#160;direct payment of or reimbursement for continued medical, dental or vision coverage pursuant to COBRA for up to 12 months; and (iv)&#160;accelerated vesting of any portion of his time-based equity awards that is unvested as of the date of such termination. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The proprietary information agreement and the release of claims contain restrictive covenants which restrict Dr.&#160;Joe&#8217;s ability to compete with the Company for a period of 12 months following his termination of employment or solicit the Company&#8217;s employees, consultants, independent contractors, customers or suppliers for a period of 12 months following termination, subject to Merus US, Inc.&#8217;s obligation to pay Dr.&#160;Joe 50% of his highest annualized base salary for the two year period prior to his termination (or the severance described above) if Merus US, Inc. decides to enforce the <span style="white-space:nowrap">non-competition</span> restriction. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Employment Agreement with Mr.&#160;Perry </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">In June 2023, Mr.&#160;Perry entered into an employment agreement with Merus US, Inc., pursuant to which, if Mr.&#160;Perry&#8217;s employment is terminated by Merus US, Inc. without cause or due to his resignation for good reason, then subject to him executing a general release of claims and continuing compliance with a proprietary information agreement, Mr.&#160;Perry will be entitled to receive (i)&#160;base salary continuation payments for 12 months, (ii)&#160;payment for any earned but unpaid annual bonus for the year prior to the year of termination, and (iii)&#160;direct payment of or reimbursement for continued medical, dental or vision coverage pursuant to COBRA for up to 12 months. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">If Mr.&#160;Perry&#8217;s employment is terminated by Merus US, Inc. without cause or due to his resignation for good reason, in either case, within 12 months following a change in control of the Company, then subject to him executing a general release of claims and continuing compliance with a proprietary information agreement, Mr.&#160;Perry will be entitled to receive, in lieu of the severance payments described above, (i)&#160;a lump sum payment equal to one times </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">74 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
his base salary and target annual bonus, (ii)&#160;payment for any earned but unpaid annual bonus for the year prior to the year of termination, (iii)&#160;direct payment of or reimbursement for continued medical, dental or vision coverage pursuant to COBRA for up to 12 months, and (iv)&#160;provided that the date of termination occurs more than 12 months following the date of Mr.&#160;Perry&#8217;s initial service to Merus US, Inc. or the Company (including service on the Board), accelerated vesting of any portion of his time-based equity awards in the Company that is unvested as of the date of such termination, with any awards that vest in whole or in part based on the attainment of performance-vesting conditions being governed by the terms of the applicable award agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The proprietary information agreement and the release of claims contain restrictive covenants which restrict Mr.&#160;Perry&#8217;s ability to compete with the Company for a period of 12 months following his termination of employment or solicit the Company&#8217;s employees, consultants, independent contractors, customers or suppliers for a period of 12 months following termination, subject to Merus US, Inc.&#8217;s obligation to pay Mr.&#160;Perry 50% of his highest annualized base salary for the two year period prior to his termination (or the severance described above) if Merus US, Inc. decides to enforce the <span style="white-space:nowrap">non-competition</span> restriction. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Tax Considerations </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Section</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;409A</span>. The compensation committee takes into account whether components of the compensation for our executive officers will be adversely impacted by the penalty tax imposed by Section&#160;409A of the Code, and aims to structure these components to be compliant with or exempt from Section&#160;409A to avoid such potential adverse tax consequences. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Section</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;162(m)</span>. Section&#160;162(m) of the Code disallows a tax deduction to public companies for compensation in excess of $1&#160;million paid to &#8220;covered employees&#8221;, which generally includes all NEOs. While the compensation committee may take the deductibility of compensation into account when making compensation decisions, the compensation committee will award compensation that it determines to be consistent with the goals of our executive compensation program even if such compensation is not deductible by us. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">75 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">COMPENSATION COMMITTEE REPORT </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The Compensation Committee has reviewed the &#8220;Compensation Discussion and Analysis&#8221; and discussed the analysis with management. Based on its review and discussions with management, the Compensation Committee recommended to the Board of Directors that the &#8220;Compensation Discussion and Analysis&#8221; be included in this Proxy Statement and incorporated by reference in the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the fiscal year ended December&#160;31, 2023, filed with the SEC on February&#160;28, 2024. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Mark Iwicki (Chair) </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Len Kanavy </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Paolo Pucci </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">76 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc706699_52">EXECUTIVE COMPENSATION TABLES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_53">2023 SUMMARY COMPENSATION TABLE </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The following table sets forth information concerning the compensation of our named executive officers for the years ended December&#160;31, 2023, 2022 and 2021. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:31%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name&#160;and&#160;Principal&#160;Position</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Year</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Salary&#160;($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Bonus&#160;($)(4)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Stock</span><br/><span style="font-weight:bold">Awards</span><br/><span style="font-weight:bold">($)(1)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Option</span><br/><span style="font-weight:bold">Awards</span><br/><span style="font-weight:bold">($)(1)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold"><span style="white-space:nowrap">Non-Equity</span></span><br/><span style="font-weight:bold">Incentive Plan</span><br/><span style="font-weight:bold">Compensation</span><br/><span style="font-weight:bold">($)(2)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">All Other</span><br/><span style="font-weight:bold">Compensation</span><br/><span style="font-weight:bold">($)(3)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Total ($)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Sven (Bill) Ante Lundberg, M.D</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><span style="font-style:italic">President, Chief Executive Officer</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2023<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">2022</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">2021</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">650,000<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">599,254</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">581,847</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">35,750</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,556,800<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">4,791,732</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">6,550,400</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">393,250<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">319,702</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">399,988</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">35,527<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">34,106</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">8,700</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,671,327<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">5,744,794</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">7,540,935</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td></tr>
<tr style="font-size:1px">
<td colspan="32" style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Hui Liu, Ph.D.</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><span style="font-style:italic">Chief Business Officer, Head of Merus US</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2023<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">2022</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">2021</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">437,750<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">424,453</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">414,138</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="white-space:nowrap;vertical-align:bottom"> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">&#8212;</p></td>
<td style="white-space:nowrap;vertical-align:bottom"> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">74,300</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">973,440<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">1,367,010</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">1,335,000</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">195,237<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">165,410</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">190,486</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,151<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">7,837</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">1,309</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,687,878<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">1,964,710</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">1,940,933</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td></tr>
<tr style="font-size:1px">
<td colspan="32" style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Peter Silverman, J.D. (4)</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><span style="font-style:italic">Chief Operating Officer and General Counsel</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2023<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">2022</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">2021</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">495,000<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">412,196</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">452,144</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,166,640<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">1,367,010</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">1,443,936</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">256,410<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">181,620</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">225,215</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30,432<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">7,371</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">600</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:0pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/><br/></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,948,482<br/>1,968,197<br/>2,121,895</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/>&#160;<br/>&#160;</td></tr>
<tr style="font-size:1px">
<td colspan="32" style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Greg Perry</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><span style="font-style:italic">Chief Financial Officer</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2023</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">258,143</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,788,420</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">122,208</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">38,751</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,207,522</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td colspan="32" style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Andrew Joe</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><span style="font-style:italic">Chief Medical Officer</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2023<br/>2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">473,800<br/> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">460,307</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">53,400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">973,440<br/> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">1,367,010</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">211,315<br/> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">179,032</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"></p></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,658,555<br/> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">2,059,749</p></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/> <p style="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman">&#160;</p></td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">(1)&#8195;Amounts reflect the full grant date fair value of option awards and restricted stock units calculated in accordance with ASC Topic 718, rather than the amounts paid to or realized by the named executive officer. We provide information regarding the assumptions used to calculate the value of these awards in Note 13 to our consolidated financial statements included in our Annual Report on Form <span style="white-space:nowrap">10-K</span> for the financial year ended December&#160;31, 2023 filed with SEC on February&#160;28, 2024. The amount shown for Mr.&#160;Perry includes $246,769, which is the grant date fair value of the option granted to him on June&#160;8, 2023 under our NED program for service on the board of directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">(2)&#8195;Amounts shown reflect annual bonuses earned under our performance-based incentive plan for 2023. For additional information see &#8220;Elements of Compensation -Annual Performance-Based Incentive Plan&#8221; above. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">(3)&#8195;The amounts shown in the &#8220;All Other Compensation&#8221; column include matching contributions under our 401(k) retirement savings plan for Dr.&#160;Lundberg, Dr.&#160;Liu, Mr.&#160;Silverman and Mr.&#160;Perry. The amounts shown for Dr.&#160;Lundberg and Mr.&#160;Silverman also include payments for housing allowance during 2023 in the amount of $25,627 for Dr.&#160;Lundberg and $23,071 for Mr.&#160;Silverman. The amount shown for Mr.&#160;Perry includes $33,464 for directors fees paid as compensation for his service on the board of directors in 2023. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">77 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">(4) &#8195;The amount represents additional discretionary bonus for Dr.&#160;Lundberg. For additional information see &#8220;Elements of Compensation &#8211; Annual Performance-Based Incentive Plan&#8221; above. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">GRANTS OF PLAN-BASED AWARDS IN FISCAL 2023 </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The following table provides supplemental information relating to grants of plan-based awards made during fiscal 2023 to help explain information provided above in our Summary Compensation Table. This table presents information regarding all grants of plan-based awards occurring during fiscal 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:29%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td rowspan="2" align="center" style="padding-bottom:2pt ;BORDER:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Name</span></td>
<td rowspan="2" style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Grant<br/>Date</span></td>
<td rowspan="2" style=" BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="10" align="center" style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Estimated Future Payouts Under</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">Non-Equity</span> Incentive Plan</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Awards(1)</p></td>
<td style=" BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td rowspan="2" style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">All Other<br/>Stock<br/>Awards(2)</span></td>
<td rowspan="2" style=" BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td rowspan="2" style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">All Other</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Option&#160;Awards:</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number of</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Underlying</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Options (#)(2)</p></td>
<td rowspan="2" style=" BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td rowspan="2" style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exercise</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">or Base</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Price of</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Option</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Awards</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">($/Sh)</p></td>
<td rowspan="2" style=" BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td rowspan="2" style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Grant<br/>Date&#160;Fair</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Value of</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Stock&#160;and</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Option</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Awards</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">($)(3)</p></td>
<td rowspan="2" style=" BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Threshold($)</span></td>
<td style=" BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Target($)</span></td>
<td style=" BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Maximum($)</span></td>
<td style=" BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;BORDER:0.75pt solid #000000; padding-left:8pt;vertical-align:top">Sven (Bill) Ante Lundberg, M.D.</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top" align="right">2/2/2023</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top" align="right">143,000</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top" align="right">357,500</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top" align="right">715,000</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top" align="right">&#8212;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top" align="right">380,000</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top" align="right">16.07</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top" align="right">3,556,800</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;white-space:nowrap;vertical-align:top">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td rowspan="2" style="BORDER:0.75pt solid #000000; padding-left:8pt;vertical-align:top">Hui Liu, Ph.D.</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">2/2/2023</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">70,040</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">175,100</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">350,200</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">104,000</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">16.07</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">973,440</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom" align="right">10/10/2023</td>
<td style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom" align="right">5,000</td>
<td style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom" align="right">74,300</td>
<td style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td rowspan="2" style="BORDER:0.75pt solid #000000; padding-left:8pt;vertical-align:top">Peter Silverman, J.D.</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top" align="right">1/4/2023</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top"><span style="font-size:x-small">&#160;</span></td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top"><span style="font-size:x-small">&#160;</span></td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top"><span style="font-size:x-small">&#160;</span></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top"><span style="font-size:x-small">&#160;</span></td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top"><span style="font-size:x-small">&#160;</span></td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top"><span style="font-size:x-small">&#160;</span></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top"><span style="font-size:x-small">&#160;</span></td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top"><span style="font-size:x-small">&#160;</span></td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top"><span style="font-size:x-small">&#160;</span></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top"><span style="font-size:x-small">&#160;</span></td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top"><span style="font-size:x-small">&#160;</span></td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top"><span style="font-size:x-small">&#160;</span></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top" align="right">20,000</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top" align="right">15.87</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:top" align="right">193,200</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;white-space:nowrap;vertical-align:top">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom" align="right">2/2/2023</td>
<td style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom" align="right">79,200</td>
<td style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom" align="right">198,000</td>
<td style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom" align="right">396,000</td>
<td style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom" align="right">104,000</td>
<td style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom" align="right">16.07</td>
<td style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom" align="right">973,440</td>
<td style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="padding-bottom:2pt ;BORDER:0.75pt solid #000000; padding-left:8pt;vertical-align:top">Andrew Joe</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">2/2/2023</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">75,808</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">189,520</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">379,040</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">104,000</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">16.07</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">973,440</td>
<td style="padding-bottom:2pt ;BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:1.5pt">&#160;</td>
<td colspan="4" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td>
<td colspan="4" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td>
<td colspan="4" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td>
<td colspan="4" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td>
<td colspan="4" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td>
<td colspan="4" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td>
<td colspan="4" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td>
<td colspan="4" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:1.5pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td rowspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top">Greg Perry</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">6/14/2023</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">43,482</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">109,604</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">219,208</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">372,924</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">26.50</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">5,541,651</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">6/8/2023</td>
<td style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:x-small">&#160;</span></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">14,414</td>
<td style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">23.29</td>
<td style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;BORDER-BOTTOM:0.75pt solid #000000;white-space:nowrap;vertical-align:bottom" align="right">246,769</td>
<td style="padding-bottom:2pt ;BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Amounts reflect potential payouts under our 2023 annual bonus program. Please see the description of the annual bonus program under &#8220;<span style="font-style:italic">Annual Performance-Based Incentive Compensation</span>&#8221; in the CD&amp;A above. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">The options vest as to 25% of the shares on January&#160;1, 2024 and in 36 substantially equal monthly installments thereafter, subject to the holder&#8217;s continued service and potential accelerated vesting in certain circumstances as described above under &#8220;Employment Agreements.&#8221; The option granted to Mr.&#160;Perry on June&#160;8, 2023 vests in 12 equal monthly installments. The restricted stock units granted to Dr.&#160;Liu vest in full on January&#160;1, 2025. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Amounts reflect the grant-date fair value in accordance with ASC Topic 718. We provide information regarding the assumptions used to calculate these values in Note 13 to the consolidated financial statements included in in our Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2023. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">78 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_54">OUTSTANDING EQUITY AWARDS AT 2023 FINANCIAL YEAR END </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The following table summarizes the number of common shares underlying outstanding equity incentive plan awards for each named executive officer as of December&#160;31, 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:10%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:12%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:12%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:12%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:12%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:12%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:12%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:11%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Option Awards</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Stock Awards</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Vesting</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Commencement</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number of</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Underlying</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Unexercised</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Options (#)</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exercisable</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number of</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Underlying</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Unexercised</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Options (#)</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Unexercisable</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Option</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exercise</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Price ($)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Option</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Expiration</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number of</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Shares or</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Units of</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Shares That</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Have Not</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Vested (#)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Market&#160;Value&#160;of</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Shares&#160;or&#160;Units&#160;of</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Shares&#160;That&#160;Have</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not&#160;Vested&#160;($)(1)</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top">Sven (Bill) Ante Lundberg, M.D</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">3/19/2019</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">3,797</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">&#8212;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">12.54</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">3/18/2029</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2020 (3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">330,475</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">8,645</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">13.52</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">1/3/2030</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2021(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">268,333</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">99,667</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">24.43</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">1/1/2031</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2022(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">141,354</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">153,646</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">24.61</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">1/1/2032</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2023(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">380,000</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">&#8212;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">16.07</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2/2/2033</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top">Hui Liu, Ph.D.</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2017 (3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">85,156</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">&#8212;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">21.11</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">1/1/2027</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2018 (3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">29,000</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">&#8212;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">17.94</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2/21/2028</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2018 (3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">14,000</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">&#8212;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">18.25</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">4/4/2028</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2019 (3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">70,000</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">&#8212;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">11.16</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2/20/2029</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">07/01/2019 (3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">33,125</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">1,875</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">15.77</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">7/30/2029</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2020 (3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">56,302</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">1,198</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">18.61</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2/14/2030</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2021(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">54,687</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">20,313</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">24.43</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">1/1/2031</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2022(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">39,770</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">43,230</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">24.61</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">1/1/2032</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2023(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">&#8212;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">104,000</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">16.07</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2/2/2033</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">10/10/2023(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">&#8212;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">5,000</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">137,500</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top">Peter Silverman, J.D.</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2017 (3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">50,000</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">&#8212;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">25.9</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2/15/2027</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2018 (3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">22,000</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">&#8212;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">17.94</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2/21/2028</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2019 (3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">3,900</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">&#8212;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">11.16</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">1/1/2029</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2020 (3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">56,302</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">1,198</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">18.61</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2/14/2030</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">04/16/2020 (3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">04/16/2020 (3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">12,833</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">1,167</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">12.37</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">4/16/2030</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2021(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">54,687</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">20,313</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">24.43</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">1/1/2031</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2022(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">39,770</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">43,230</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">24.61</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">1/1/2032</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/01/2023(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">&#8212;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">104,000</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">16.07</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2/2/2033</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">01/04/2023(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">&#8212;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">20,000</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">15.87</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">1/4/2033</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top">Greg Perry</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">5/18/2016(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">17,000</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">0</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">10.04</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">5/18/2026</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">5/24/2017(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">5,650</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">0</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">19.12</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">5/24/2027</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">7/20/2018(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">4,983</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">0</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">23.3</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">7/20/2028</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">6/12/2019(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">8,500</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">0</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">13.35</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">6/12/2029</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">6/30/2020(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">8,631</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">0</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">16.09</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">6/30/2030</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">5/28/2021(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">6,120</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">0</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">21.15</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">5/28/2031</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">5/31/2022(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">16,604</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">0</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">18.56</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">5/31/2032</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">6/8/2023(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">7,207</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">7,207</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">23.29</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">6/8/2033</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">6/14/2023(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">0</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">372,924</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right">26.50</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">6/14/2033</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">79 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:10%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:12%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:12%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:12%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:12%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:12%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:12%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:11%"/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Option Awards</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Stock Awards</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Vesting</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Commencement</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number of</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Underlying</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Unexercised</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Options (#)</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exercisable</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number of</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Underlying</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Unexercised</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Options (#)</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Unexercisable</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Option</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exercise</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Price ($)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Option</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Expiration</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number of</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Shares or</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Units of</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Shares That</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Have Not</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Vested (#)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Market&#160;Value&#160;of</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Shares&#160;or&#160;Units&#160;of</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Shares&#160;That&#160;Have</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not&#160;Vested&#160;($)(1)</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Andrew Joe</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">08/03/2020(3)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">01/01/2021(3)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">01/01/2022(3)</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">01/01/2023(3)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">91,395</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">54,687</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">39,770</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:right">&#8212;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">15,605</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">20,313</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">43,230</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:right">104,000</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="right"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">13.77</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">24.43</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">24.61</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:right">16.07</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:center">8/3/2030</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:center">1/1/2031</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:center">1/1/2032</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:center">2/2/2033</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
</table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The restricted stock units vest 100% on 1/1/2025, subject to the holder&#8217;s continued service. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The option vests in 12 equal monthly installments subject to the holder&#8217;s continued service. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The option vests as to 25% of the shares subject to the option on the first anniversary of the vesting commencement date and in 36 substantially equal monthly installments thereafter, subject to the holder&#8217;s continued service and potential accelerated vesting in certain circumstances as described below under &#8220;Employment and Separation Agreements.&#8221; </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">OPTION EXERCISES AND STOCK VESTED IN FISCAL 2023 </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:8%"/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="BORDER:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom">&#160;&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="3" style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom"> <p style="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Option Awards</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="BORDER:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom"><span style="font-weight:bold">Name</span></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td align="center" style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number&#160;of&#160;Shares</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Acquired on</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exercise (#)</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td align="center" style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Value&#160;Realized&#160;on</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exercise(1)($)</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="BORDER:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Sven (Bill) Ante Lundberg, M.D</p> <p style="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td align="center" style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top;white-space:nowrap">0</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td align="center" style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top;white-space:nowrap">0</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="BORDER:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Hui Liu, Ph.D.</p> <p style="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td align="center" style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top;white-space:nowrap">98,085</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td align="center" style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top;white-space:nowrap">1,797,898</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="BORDER:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Peter Silverman, J.D</p> <p style="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td align="center" style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top;white-space:nowrap">22,386</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td align="center" style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top;white-space:nowrap">565,022</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="BORDER:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Greg Perry</p> <p style="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td align="center" style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top;white-space:nowrap">0</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td align="center" style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top;white-space:nowrap">0</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="padding-bottom:3pt ;BORDER:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Andrew Joe</p> <p style="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td align="center" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top;white-space:nowrap">0</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td align="center" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top;white-space:nowrap">0</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) Amounts are calculated by multiplying the number of shares as to which the option was exercised by the market price of the shares on the exercise date, net the exercise price. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL&#160; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">See &#8220;<span style="font-style:italic">Employment Agreements</span>&#8221; above for a description of the employment agreements with each of our NEOs in place during 2023.</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">80 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Estimated Potential Payments</span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">The following table summarizes the payments that would be made to our NEOs upon the occurrence of certain qualifying terminations of employment or a change in control, in any case, occurring on December&#160;31, 2023. Amounts shown do not include (i)&#160;accrued but unpaid base salary through the date of termination or (ii)&#160;other benefits earned or accrued by the NEO during his employment that are available to all salaried employees, such as accrued vacation.&#8195; </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:18%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:19%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:29%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:28%"/></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:9pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:9pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:9pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:9pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom"><span style="font-weight:bold">Name</span></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td align="center" style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Benefit</span></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td align="center" style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Termination Without Cause or for<br/>Good&#160;Reason&#160;(no&#160;Change&#160;in&#160;Control)<br/>($)</span></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td align="center" style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom"><span style="font-weight:bold">Termination Without Cause or for<br/>Good Reason in Connection with a<br/>Change in Control ($)</span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td rowspan="4" style="BORDER:0.75pt solid #000000; padding-left:8pt;vertical-align:top">Sven (Bill) Ante Lundberg, M.D.</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Cash Compensation</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$ 650,000</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$ 1,511,250</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Equity Acceleration (1)</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">-</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$ 5,214,272</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Continued Healthcare</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$ 32,315</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$ 48,473</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><span style="font-style:italic">Total</span></p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$ 682,315</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$ 6,773,995</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Hui Liu, Ph.D.</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Cash Compensation</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$ 437,750</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$ 612,850</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td rowspan="3" style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top"><span style="font-size:x-small">&#160;</span></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Equity Acceleration (1)</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">-</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$ 1,440,160</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Continued Healthcare</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$ 32,315</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$ 32,315</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><span style="font-style:italic">Total</span></p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$ 470,065</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$ 2,085,325</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td rowspan="2" style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Peter Silverman, J.D.</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Cash Compensation</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$495,000</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$693,000</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Equity Acceleration (1)</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">-</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$1,636,923</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td rowspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top"><span style="font-size:x-small">&#160;</span></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Continued Healthcare</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$32,315</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$32,315</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><span style="font-style:italic">Total</span></p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$527,315</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$2,362,238</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td rowspan="4" style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Andrew Joe</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Cash Compensation</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$473,800</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$663,320</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Equity Acceleration (1)</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">-</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$1,590,272</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Continued Healthcare</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$11,339</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$11,339</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><span style="font-style:italic">Total</span></p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$485,139</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$2,264,931</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td rowspan="4" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Greg Perry</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Cash Compensation</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$470,000</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$658,000</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Equity Acceleration (1)</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">0</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$403,265</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Continued Healthcare</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$22,677</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">$22,677</p> <p style="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-style:italic">Total</span></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap">$492,677</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;white-space:nowrap">$1,083,942</td></tr>
</table> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1)&#8195;With respect to options, the value of equity acceleration was calculated by (i)&#160;multiplying the number of accelerated common shares underlying the options by $27.50, the closing trading price of a common share on December&#160;31, 2023 and (ii)&#160;subtracting the exercise price for the options.</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">81 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_56">DIRECTOR COMPENSATION </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">We maintain a compensation program for our <span style="white-space:nowrap">non-executive</span> directors, the <span style="white-space:nowrap">Non-Executive</span> Director Compensation Program, under which each <span style="white-space:nowrap">non-executive</span> director was eligible to receive the following amounts for their services on our board of directors during 2023. Of note, during 2023, the board of directors made adjustments to the annual cash compensation to more closely align with the market 50<sup style="font-size:75%; vertical-align:top">th</sup> percentile of the peer group: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">Upon the director&#8217;s initial appointment to our board of directors, an option to purchase the number of common shares of the Company having an aggregate grant date fair value of $493,538; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">If the director has served on our board of directors for at least six months as of the date of an annual meeting of shareholders, and will continue to serve as a <span style="white-space:nowrap">non-executive</span> director immediately following such meeting, an option to purchase the number of common shares of the Company having an aggregate grant date fair value of $246,769; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">An annual cash retainer of $41,791 </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">If the director serves on a committee of our board of directors or in the other capacities stated below, an additional annual cash retainer as follows: </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">o</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Chairperson of the Board, $99,754; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">o</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Chairperson of the audit committee, $18,000; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">o</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Audit committee member other than the chairperson, $9,000; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">o</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Chairperson of the compensation committee, $15,000; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">o</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Compensation committee member other than the chairperson, $7,500; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">o</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Chairperson of the nomination and corporate governance committee, $15,000; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">o</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Nomination and corporate governance committee member other than the chairperson, $7,500; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">o</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Chairperson of the research and development committee, $15,000; and </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">o</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:left">Research and development committee member other than the chairperson, $7,500. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Retainers under the program are payable in arrears in four equal quarterly installments within 15 days following the end of each calendar quarter, provided, that the amount of each payment is prorated for any portion of a quarter that a board member is not serving on our board of directors. The program further provides for an automatic increase of the annual retainers on the first day of each calendar year by an amount equal to 3% of the value of such annual retainer in effect as of the end of the immediately preceding calendar year. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">82 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Options granted to our board members under the program have an exercise price equal to the fair market value of our common shares on the date of grant and expire not later than ten years after the date of grant. The options granted upon a director&#8217;s initial appointment vest as to 33% of the shares subject to the award on the first anniversary of the date of grant and in 24 substantially equal monthly installments thereafter. The options granted annually to directors vest in 12 substantially equal monthly installments following the date of grant. In addition, all unvested options vest in full upon the occurrence of a change in control. The grant date fair value of the Initial Award and Annual Award increases by an amount up to 5% each year, subject to approval by our board. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Each board member is entitled to be reimbursed for reasonable travel and other expenses incurred in connection with attending meetings of the board of directors and any committee of the board of directors on which he or she serves. The board of directors may appoint observers to the board of directors, pending their formal appointment as a board member. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Following Dr.&#160;Lundberg&#8217;s appointment as our President, Chief Executive Officer and Principal Financial Officer, he receives no additional compensation for his service on our board of directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_57">2023 DIRECTOR COMPENSATION TABLE </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The following table sets forth the compensation earned by our <span style="white-space:nowrap">non-executive</span> directors for their service on our board of directors during 2023: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:49%"/>

<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Fees&#160;Earned&#160;or</span><br/><span style="font-weight:bold">Paid&#160;in&#160;Cash&#160;($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Option&#160;Awards</span><br/><span style="font-weight:bold">($)(1)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8194;Total&#160;($)&#8195;&#8194;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Mark Iwicki</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">64,291</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">246,769</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">311,060</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Maxine Gowen, Ph.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">58,291</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">246,769</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">305,060</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Len Kanavy</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">56,791</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">246,769</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">303,560</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Anand Mehra, M.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">170,795</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">246,769</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">417,564</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Paolo Pucci</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">62,791</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">246,769</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">309,560</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Victor Sandor, M.D.C.M.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">56,791</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">246,769</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">303,560</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Amounts reflect the full grant-date fair value of options granted during 2023 computed in accordance with ASC Topic 718, rather than the amounts paid to or realized by the named individual. We provide information regarding the assumptions used to calculate the value of all option awards made to our directors in Note 13 to our consolidated financial statements included in our Annual Report on Form <span style="white-space:nowrap">10-K</span> for the financial year ended December&#160;31, 2023, filed with the SEC on February&#160;28, 2024. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The table below shows the aggregate numbers of option awards (exercisable and unexercisable) held as of December&#160;31, 2023 by each <span style="white-space:nowrap">non-employee</span> director. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto">


<tr>

<td style="width:68%"/>

<td style="vertical-align:bottom;width:24%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:11pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="right" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Options&#160;Outstanding&#160;at</span><br/><span style="font-weight:bold">Financial Year End</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Maxine Gowen, Ph.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">51,215</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Mark Iwicki</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">64,902</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Len Kanavy</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">76,087</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Anand Mehra, M.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">81,902</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Paolo Pucci</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">54,400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Victor Sandor, M.D.C.M.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">62,769</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table></div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">83 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">CEO PAY RATIO </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">As required by Section&#160;953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(u) of Regulation <span style="white-space:nowrap">S-K,</span> we are required to disclose the ratio of our Chief Executive Officer&#8217;s annual total compensation to the annual total compensation of our other employees. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">The total compensation for 2023 for our Chief Executive Officer was $4,671,327, as reported in the Summary Compensation Table. The annual total compensation for 2023 for our median employee, identified as discussed below, was $108,480, calculated in accordance with the rules applicable to the Summary Compensation Table. Based on this information, for 2023, the ratio of the annual total compensation of our Chief Executive Officer to the median of the annual total compensation of our other employees was approximately 43 to 1. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Methodology, Assumptions and Estimates Used in Determining our Pay Ratio Disclosure </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">We chose December&#160;31, 2023 as the date for establishing the employee population used in identifying the median employee and used calendar year 2023 as the measurement period. We identified the median employee using the consistently applied compensation measure of salary and annual performance bonus for each employee employed as of December&#160;31, 2023 (other than our Chief Executive Officer). We annualized the compensation measure for permanent employees who joined in 2023. We captured all full-time, part-time, seasonal and temporary employees, consisting of approximately 222 individuals. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">The annual total compensation of the median employee and the annual total compensation of the CEO were calculated in accordance with the requirements of Item 402(c)(2)(x) of Regulation <span style="white-space:nowrap">S-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">The pay ratio reported above is a reasonable estimate calculated in a manner consistent with SEC rules based on our internal records and the methodology described above. Because the SEC rules for identifying the median compensated employee and calculating the pay ratio based on that employee&#8217;s annual total compensation allow companies to adopt a variety of methodologies, to apply certain exclusions, and to make reasonable estimates and assumptions that reflect their employee populations and compensation practices, the pay ratio reported above should not be used as a basis for comparison between companies by other companies. In addition, we expect the Company&#8217;s annually reported pay ratio may vary significantly year over year, given the size of the Company and the potential variability in Company employee compensation. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">84 </p>

</div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>
<div style="display: none"><ix:header><ix:references><link:schemaRef xlink:type="simple" xlink:href="mrus-20231231.xsd"/></ix:references></ix:header></div><div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:nonNumeric name="ecd:PvpTableTextBlock" contextRef="P01_01_2023To12_31_2023" escape="true" continuedAt="TextSelection_107868305" id="ixv-8303"><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">PAY VERSUS PERFORMANCE </div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Pay Versus Performance Table </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The following table sets forth information concerning the compensation of our NEOs for each of the fiscal years ended December&#160;31, 2020, 2021, 2022 and 2023, and our financial performance for each such fiscal year: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:21%"/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:12pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:12pt">&#160;</td>
<td colspan="2" style="BORDER-TOP:0.75pt solid #000000;height:12pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:12pt">&#160;</td>
<td colspan="2" style="BORDER-TOP:0.75pt solid #000000;height:12pt">&#160;</td>
<td colspan="4" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:12pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:12pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-left: 0.75pt solid rgb(0, 0, 0); padding-left: 8pt; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="border-left: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="border-left: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="3" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Year-end</div> value of $100<br/> invested on 12/31/2019 in:</div></div></td>
<td style="border-left: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); padding-right: 2pt; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Summary<br/> Compensation<br/> Table Total for<br/> PEO (1)</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Compensation<br/> Actually&#160;Paid&#160;to<br/> the&#160;PEO</div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">(1)(2)(3)</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Average<br/> Summary<br/> Compensation<br/> Table Total for<br/> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-PEO&#160;NEOs</div></div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">(4)</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Average<br/> Compensation<br/> Actually&#160;Paid&#160;to<br/> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-PEO&#160;NEOs</div><br/> (2)(3)(4)</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">MRUS</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">NASDAQ<br/> Biotech<br/> Index</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Net<br/> Income</div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">(in<br/> millions)</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">$</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">2023</div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14641">4,671,327</ix:nonFraction></td>
<td style=" BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14642">11,843,191</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14643">2,875,609</ix:nonFraction></td>
<td style=" BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14644">4,616,893</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-14645">195.31</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:PeerGroupTotalShareholderRtnAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-14646">118.87</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">-<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="-5" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-14647">154.9</ix:nonFraction></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">2022</div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14648">5,744,794</ix:nonFraction></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">-<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14649">2,256,931</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14650">1,997,552</ix:nonFraction></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">-<ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14651">53,411</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-14652">109.87</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:PeerGroupTotalShareholderRtnAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-14653">113.65</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">-<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-14654">131.2</ix:nonFraction></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">2021</div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14655">7,540,935</ix:nonFraction></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14656">11,523,096</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14657">2,031,414</ix:nonFraction></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14658">3,116,021</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-14659">225.85</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:PeerGroupTotalShareholderRtnAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-14660">126.45</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">-<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-5" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-14661">66.8</ix:nonFraction></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">2020</div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14662">5,049,022</ix:nonFraction></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14663">5,589,212</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14664">1,453,520</ix:nonFraction></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14665">1,380,032</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-14666">124.50</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ecd:PeerGroupTotalShareholderRtnAmt" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-14667">126.42</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">-<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-5" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-14668">85.5</ix:nonFraction></td></tr></table><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">(1) The PEO for all four fiscal years is <ix:nonNumeric name="ecd:PeoName" contextRef="P01_01_2023To12_31_2023" id="ixv-14669">Sven (Bill) Ante Lundberg.</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">(2) Deductions from, and additions to, total compensation in the Summary Compensation Table by year to calculate Compensation Actually Paid include: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><ix:nonNumeric name="ecd:AdjToPeoCompFnTextBlock" contextRef="P01_01_2023To12_31_2023" escape="true" id="ixv-8497"><ix:nonNumeric name="ecd:AdjToNonPeoNeoCompFnTextBlock" contextRef="P01_01_2023To12_31_2023" escape="true" id="ixv-8498">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:28%"/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Non-CEO<br/> NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Non-CEO<br/> NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Non-CEO<br/> NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Non-CEO<br/> NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Compensation from Summary Compensation Table</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14670">4,671,327</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14671">2,875,609</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14672">5,744,794</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14673">1,997,552</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14674">7,540,935</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14675">2,031,414</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14676">5,049,022</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14677">1,453,520</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Adjustments for Equity Awards</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top">Adjustment for grant date values in the Summary Compensation Table</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14678">3,556,800</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14679">2,244,060</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14680">4,791,732</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14681">1,367,010</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14682">6,550,400</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14683">1,389,468</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2020To12_31_2020_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14684">4,062,203</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2020To12_31_2020_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14685">840,427</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Year-end</div> fair value of unvested awards granted in the current year</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_PeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14686">7,479,906</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14687">3,359,964</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_PeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14688">2,381,092</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14689">669,935</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14690">7,516,254</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14691">1,531,846</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2020To12_31_2020_PeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14692">4,598,303</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2020To12_31_2020_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14693">654,243</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top">Year-over-year difference of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">year-end</div> fair values for unvested awards granted in prior years</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_PeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14694">2,154,165</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14695">439,173</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_PeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14696">4,187,745</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14697">949,302</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14698">2,568,931</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14699">739,590</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2020To12_31_2020_PeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14700">14,919</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2020To12_31_2020_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14701">129,725</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top">Difference in fair values between prior <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">year-end</div> fair values and vest</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14702">1,094,592</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14703">186,206</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14704">1,403,339</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14705">404,586</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14706">447,375</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14707">202,639</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2020To12_31_2020_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14708">10,829</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2020To12_31_2020_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14709">17,029</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Adjustments for Equity Awards</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_PeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14710">7,171,864</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14711">1,741,284</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_PeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14712">8,001,725</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14713">2,050,963</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14714">3,982,161</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14715">1,084,607</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2020To12_31_2020_PeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14716">540,190</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2020To12_31_2020_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14717">73,488</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)</div></div>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Compensation Actually Paid (as calculated)</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14718">11,843,191</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14719">4,616,893</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14720">2,256,931</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-14721">53,411</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14722">11,523,096</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14723">3,116,021</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14724">5,589,212</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-14725">1,380,032</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"><ix:exclude>85</ix:exclude> </div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_107868305" continuedAt="TextSelectionAppend_107868305_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_107868305_1" continuedAt="TextSelectionAppend_107868305_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_107868305_2" continuedAt="TextSelectionAppend_107868305_3"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_107868305_3"><div style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">(3a) The following summarizes the valuation assumptions used for stock option awards included as part of Compensation Actually Paid: </div><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Expected life of each stock option is based on the &#8220;simplified method&#8221; using an average of the remaining vest and remaining term, as of the vest/FYE date. </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Strike price is based on each grant date closing price and asset price is based on each vest/FYE closing price. </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Risk free rate is based on the Treasury Constant Maturity rate closest to the remaining expected life as of the vest/FYE date. </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Historical volatility is based on daily price history for each expected life (years) prior to each vest/FYE date. Closing prices provided by S&amp;P Capital IQ are adjusted for dividends and splits. </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Represents annual dividend yield on each vest/FYE date. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">(3b) The following table illustrates the valuation assumptions as of the vesting date for awards that vested in each of 2023, 2022, 2021, 2020: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:22%"/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:15%"/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For Stock Options Vesting in</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For Restricted<br/> Share and<br/> Restricted<br/> Stock Units<br/> Vesting in</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="mrus:StockOptionsVestingExpectedVolatilityMinimum" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-14727">67.42</ix:nonFraction>%&#160;-&#8201;<ix:nonFraction name="mrus:StockOptionsVestingExpectedVolatilityMaximum" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-14728">76.20</ix:nonFraction>%</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="mrus:StockOptionsVestingExpectedVolatilityMinimum" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-14729">68.94</ix:nonFraction>%&#160;-&#8201;<ix:nonFraction name="mrus:StockOptionsVestingExpectedVolatilityMaximum" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-14730">76.55</ix:nonFraction>%</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="mrus:StockOptionsVestingExpectedVolatilityMinimum" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-14731">66.41</ix:nonFraction>%&#160;-&#8201;<ix:nonFraction name="mrus:StockOptionsVestingExpectedVolatilityMaximum" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-14732">74.18</ix:nonFraction>%</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="mrus:StockOptionsVestingExpectedVolatilityMinimum" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-14733">66.60</ix:nonFraction>%&#160;-&#8201;<ix:nonFraction name="mrus:StockOptionsVestingExpectedVolatilityMaximum" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-14734">73.37</ix:nonFraction>%</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:top"/>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:top"/>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><ix:nonFraction name="mrus:StockOptionsVestingExpectedDividendYield" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal" id="ixv-14735">0</ix:nonFraction>%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><ix:nonFraction name="mrus:StockOptionsVestingExpectedDividendYield" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal" id="ixv-14736">0</ix:nonFraction>%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><ix:nonFraction name="mrus:StockOptionsVestingExpectedDividendYield" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal" id="ixv-14737">0</ix:nonFraction>%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><ix:nonFraction name="mrus:StockOptionsVestingExpectedDividendYield" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal" id="ixv-14738">0</ix:nonFraction>%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted&#160;Average Fair&#160;Value&#160;at&#160;vesting</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top;text-align:right;"><ix:nonFraction name="mrus:RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-14739">17.53</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top;text-align:right;"><ix:nonFraction name="mrus:RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-14740">14.14</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term, in years</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><ix:nonNumeric name="mrus:StockOptionsVestingExpectedTermInYearsMinimum" contextRef="P01_01_2023To12_31_2023" format="ixt-sec:duryear" id="ixv-14741">2.8</ix:nonNumeric> - <ix:nonNumeric name="mrus:StockOptionsVestingExpectedTermInYearsMaximum" contextRef="P01_01_2023To12_31_2023" format="ixt-sec:duryear" id="ixv-14742">4.5</ix:nonNumeric> years</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><ix:nonNumeric name="mrus:StockOptionsVestingExpectedTermInYearsMinimum" contextRef="P01_01_2022To12_31_2022" format="ixt-sec:duryear" id="ixv-14743">3.1</ix:nonNumeric> - <ix:nonNumeric name="mrus:StockOptionsVestingExpectedTermInYearsMaximum" contextRef="P01_01_2022To12_31_2022" format="ixt-sec:duryear" id="ixv-14744">4.6</ix:nonNumeric> years</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><ix:nonNumeric name="mrus:StockOptionsVestingExpectedTermInYearsMinimum" contextRef="P01_01_2021To12_31_2021" format="ixt-sec:duryear" id="ixv-14745">3.0</ix:nonNumeric> - <ix:nonNumeric name="mrus:StockOptionsVestingExpectedTermInYearsMaximum" contextRef="P01_01_2021To12_31_2021" format="ixt-sec:duryear" id="ixv-14746">4.6</ix:nonNumeric> years</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><ix:nonNumeric name="mrus:StockOptionsVestingExpectedTermInYearsMinimum" contextRef="P01_01_2020To12_31_2020" format="ixt-sec:duryear" id="ixv-14747">3.0</ix:nonNumeric> - <ix:nonNumeric name="mrus:StockOptionsVestingExpectedTermInYearsMaximum" contextRef="P01_01_2020To12_31_2020" format="ixt-sec:duryear" id="ixv-14748">4.8</ix:nonNumeric> years</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:top"/>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:top"/>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><ix:nonFraction name="mrus:StockOptionsVestingRiskfreeInterestRateMinimum" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-14749">3.48</ix:nonFraction>% - <ix:nonFraction name="mrus:StockOptionsVestingRiskfreeInterestRateMaximum" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-14750">5.01</ix:nonFraction>%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><ix:nonFraction name="mrus:StockOptionsVestingRiskfreeInterestRateMinimum" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-14751">0.97</ix:nonFraction>% - <ix:nonFraction name="mrus:StockOptionsVestingRiskfreeInterestRateMaximum" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-14752">4.56</ix:nonFraction>%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><ix:nonFraction name="mrus:StockOptionsVestingRiskfreeInterestRateMinimum" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-14753">0.17</ix:nonFraction>% - <ix:nonFraction name="mrus:StockOptionsVestingRiskfreeInterestRateMaximum" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-14754">1.27</ix:nonFraction>%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><ix:nonFraction name="mrus:StockOptionsVestingRiskfreeInterestRateMinimum" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-14755">0.11</ix:nonFraction>% - <ix:nonFraction name="mrus:StockOptionsVestingRiskfreeInterestRateMaximum" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-14756">1.69</ix:nonFraction>%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:top"/>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:top"/>
<td style="vertical-align:top"/></tr></table><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div><ix:nonNumeric name="ecd:NamedExecutiveOfficersFnTextBlock" contextRef="P01_01_2023To12_31_2023" escape="true" id="ixv-9345"><div style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">(4) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-PEO</div> NEOs reflect the average Summary Compensation Table total compensation and average Compensation Actually Paid for the following executives by year: </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">2023: Hui Liu, Peter Silverman, Andrew Joe, Greg Perry </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">2022: Hui Liu, Peter Silverman, Andrew Joe </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">2021: Hui Liu, Peter Silverman </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">2020: Hui Liu, Peter Silverman </div></ix:nonNumeric></ix:continuation><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Narrative Disclosure to Pay Versus Performance Table </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Relationship Between Financial Performance Measures </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The illustrations below provide a graphical description of CAP (as calculated in accordance with the SEC rules) and the following measures: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 12pt; text-align: left; line-height: normal;">Merus&#8217; cumulative TSR and Peer Group (NASDAQ Biotechnology Index) cumulative TSR; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 12pt; text-align: left; line-height: normal;">Merus&#8217; Net Loss. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">86 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">TSR amounts reported in the graph assume an initial fixed investment of $100. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center"><ix:nonNumeric name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" contextRef="P01_01_2023To12_31_2023" escape="true" continuedAt="TextSelection_107868308" id="ixv-14757"></ix:nonNumeric></div><ix:continuation id="TextSelection_107868308"><div style="margin-top:0pt;margin-bottom:0pt;text-align:center"></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center"><ix:nonNumeric name="ecd:TotalShareholderRtnVsPeerGroupTextBlock" contextRef="P01_01_2023To12_31_2023" escape="true" continuedAt="TextSelection_107868310" id="ixv-14758"></ix:nonNumeric></div><ix:continuation id="TextSelection_107868310"><div style="margin-top:0pt;margin-bottom:0pt;text-align:center"></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img alt="LOGO" src="g706699g52q25.jpg"/> </div></ix:continuation> <div style="margin-top: 1em; margin-bottom: 1em"></div> <div style="margin-top: 1em; margin-bottom: 1em"></div></ix:continuation> <div style="margin-top: 1em; margin-bottom: 1em"></div> <div style="margin-top: 1em; margin-bottom: 1em"></div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center"><ix:nonNumeric name="ecd:CompActuallyPaidVsNetIncomeTextBlock" contextRef="P01_01_2023To12_31_2023" escape="true" continuedAt="TextSelection_107868309" id="ixv-14759"></ix:nonNumeric></div><ix:continuation id="TextSelection_107868309"><div style="margin-top:0pt;margin-bottom:0pt;text-align:center"></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img alt="LOGO" src="g706699g85y72.jpg"/> </div></ix:continuation> <div style="margin-top: 1em; margin-bottom: 1em"></div> <div style="margin-top: 1em; margin-bottom: 1em"></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">87 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Pay Versus Performance Tabular List </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">As a clinical-oncology company, we do not rely on financial performance measures in determining executive compensation but rely on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-financial</div> performance measures such as the attainment of clinical milestones. Accordingly, the Company-Selected Measure and the Pay Versus Performance Tabular List have been excluded on this basis. </div><div id="toc706699_58" style="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">EQUITY COMPENSATION PLAN INFORMATION </div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><div style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The following table sets forth information as of December&#160;31, 2023 regarding common shares that may be issued under our equity compensation plans, consisting of the Merus N.V. 2010 Employee Option Plan, as amended, and the Merus N.V. 2016 Incentive Award Plan, as amended (the &#8220;2016 Plan&#8221;). We do not have <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">any&#160;non-shareholder&#160;approved</div> equity compensation plans. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:39%"/>
<td style="vertical-align:bottom;width:14%"/>
<td/>
<td style="vertical-align:bottom;width:14%"/>
<td/>
<td style="vertical-align:bottom;width:14%"/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Plan Category</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of&#160;Common<br/> Shares to be<br/> Issued&#160;Upon&#160;Exercise<br/> of Outstanding<br/> Options, Warrants<br/> and Rights (a)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted-<br/> Average<br/> Exercise&#160;Price&#160;of<br/> Outstanding<br/> Options,<br/> Warrants and<br/> Rights (b)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of&#160;Common<br/> Shares<br/> Remaining Available<br/> for Future Issuance<br/> Under<br/> Equity&#160;Compensation<br/> Plans (Excluding<br/> Securities&#160;Reflected&#160;in<br/> Column (a)) (c)</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top">Equity compensation plans approved by shareholders</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center;">7,669,008</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center;">$19.99(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center;">2,002,663(2)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Equity compensation plans not approved by shareholders</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center;">&#8212;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center;">7,669,008</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center;">$19.99</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center;">2,002,663</td></tr></table><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the weighted average exercise price of outstanding options. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Under the terms of our 2016 Plan, the number of common shares that may be issued under the 2016 Plan will automatically increase on January 1st of each year, for a period of ten years, from January&#160;1, 2017 continuing through January&#160;1, 2026, by 4% of the total number of common shares outstanding on December 31st of the preceding calendar year, or a lesser number of shares as may be determined by the board of directors. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div></div></div></div></div></div> <div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">88 </div></div></div></div><div></div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="font-size:1pt;background-color:#cccccc">
<td style="height:0.75pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#cccccc">
<td style="padding-bottom:1pt ;vertical-align:middle"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.17em; font-size:12pt; font-family:Times New Roman;font-weight:bold" id="toc706699_59">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</p></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_60">COMMON SHARES </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The following table sets forth information with respect to the beneficial ownership of our common shares, as of March&#160;15, 2024 by: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">each person or group of affiliated persons known by us to beneficially own more than 5% of common shares; </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">each of our named executive officers and directors (which includes our director nominee); and </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt;text-align:left">all of our executive officers and directors as a group. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The number of shares beneficially owned by each shareholder is determined under rules issued by the SEC. Under these rules, beneficial ownership includes any shares over which the individual or entity has sole or shared voting power or investment power. Applicable percentage ownership is based on 58,650,279 common shares outstanding as of March&#160;15, 2024. In computing the number of shares beneficially owned by an individual or entity and the percentage ownership of that person, common shares subject to options, restricted share units or other rights held by such person that are currently exercisable or will become exercisable or will vest within 60 days of March&#160;15, 2024 are considered outstanding, although these shares are not considered outstanding for purposes of computing the percentage ownership of any other person. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Unless noted otherwise, the address of all listed shareholders is c/o Merus N.V., Uppsalalaan 17, 3<sup style="font-size:75%; vertical-align:top">rd</sup>&#160;&amp; 4<sup style="font-size:75%; vertical-align:top">th</sup> floor, 3584 CT Utrecht, the Netherlands. Each of the shareholders listed has sole voting and investment power with respect to the shares beneficially owned by the shareholder unless noted otherwise, subject to community property laws where applicable. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:66%"/>

<td style="vertical-align:bottom;width:11%"/>
<td/>

<td style="vertical-align:bottom;width:11%"/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="3" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;Shares&#160;beneficially&#160;owned&#8195;&#8195;</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">Name of beneficial owner</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Percent</span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman;font-weight:bold">5% or greater shareholders:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Entities affiliated with Commodore Capital LP <sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">4,747,373</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">8.01%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Incyte Corporation. <sup style="font-size:75%; vertical-align:top">(2)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">4,004,544</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">6.83%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Entities affiliated with Samlyn <sup style="font-size:75%; vertical-align:top">(3)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">3,412,410</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">5.82%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Entities affiliated with Deerfield LP<sup style="font-size:75%; vertical-align:top">(4)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">3,019,901</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">5.15%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman;font-weight:bold">Named Executive Officers and Directors:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Sven (Bill) Ante Lundberg, M.D. <sup style="font-size:75%; vertical-align:top">(5)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">1,100,403</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">1.85%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Hui Liu, Ph.D. <sup style="font-size:75%; vertical-align:top">(6)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">609,629</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">1.03%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Peter B. Silverman, J.D. <sup style="font-size:75%; vertical-align:top">(7)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">298,362</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">*</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Andrew Joe <sup style="font-size:75%; vertical-align:top">(8)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">245,894</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">*</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Mark Iwicki <sup style="font-size:75%; vertical-align:top">(9)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">137,276</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">*</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Len Kanavy <sup style="font-size:75%; vertical-align:top">(10)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">74,885</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">*</td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">89 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:66%"/>

<td style="vertical-align:bottom;width:11%"/>
<td/>

<td style="vertical-align:bottom;width:11%"/>
<td/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="3" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;Shares&#160;beneficially&#160;owned&#8195;&#8195;</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">Name of beneficial owner</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Percent</span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Maxine Gowen, Ph.D. <sup style="font-size:75%; vertical-align:top">(11)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">49,673</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">*</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Anand Mehra, M.D. <sup style="font-size:75%; vertical-align:top">(12)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">80,700</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">*</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Gregory D. Perry <sup style="font-size:75%; vertical-align:top">(13)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">80,700</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">*</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Paolo Pucci <sup style="font-size:75%; vertical-align:top">(14)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">53,198</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">*</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Victor Sandor, M.D.C.M. <sup style="font-size:75%; vertical-align:top">(15)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">61,567</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">*</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">All directors and executive officers as group (11 persons) <sup style="font-size:75%; vertical-align:top">(16)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2,792,287</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">4.57%</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:24%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Indicates beneficial ownership of less than 1% of the total outstanding common shares. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This beneficial ownership information is based solely on a Schedule 13G/A filed with the SEC on February&#160;14, 2024. Commodore Capital LP is the investment manager to Commodore Master LP. Commodore Capital LP and Commodore Master LP have shared voting and dispositive power. Michael Kramarz and Robert Egen Atkinson are the managing partners of Commodore Master LP and exercise investment discretion with respect to these securities. The business address of each of Commodore Capital LP and Commodore Master LP is 444 Madison Avenue, Floor 35, New York, NY 10022. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This beneficial ownership information is based solely on a Schedule 13G/A filed with the SEC on March&#160;25, 2024. The address of Incyte Corporation is 1801 Augustine <span style="white-space:nowrap">Cut-off,</span> Wilmington, Delaware 19803. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This beneficial ownership information is based solely on a Schedule 13G filed with the SEC on February&#160;14, 2024. All shares are directly owned by advisory clients of Samlyn Capital, LLC. Robert Pohly is the managing member of Samlyn GP, LLC. Samlyn GP, LLC is the general partner of Samlyn, LP, which is the sole member of Samlyn Capital LLC. The address of the entities affiliated with Samlyn is c/o Samlyn Capital, LLC, 500 Park Avenue, 2<sup style="font-size:75%; vertical-align:top">nd</sup> Floor, New York, NY 10022. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(4)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This beneficial ownership information is based solely on a Schedule 13G/A filed with the SEC on February&#160;12, 2024. Deerfield Mgmt, L.P. is the general partner of Deerfield Partners. Deerfield Management Company, L.P. (&#8220;Deerfield Management&#8221;) is the investment manager of Deerfield Partners. James E. Flynn is the sole member of the general partner of each of Deerfield Management and Deerfield Mgmt, L.P. Deerfield Mgmt, L.P.&#8217;s address is 345 Park Avenue South, 12th Floor, New York, NY 10010. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(5)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of (a) 40,576 held directly and (b) 111,495 common shares held by three trusts and (c) 948,332 options to purchase common shares held by Dr.&#160;Lundberg that are or will be exercisable within 60 days following March&#160;15, 2024. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(6)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of (a) 156,016 common shares and (b) 453,613 options to purchase common shares that are or will be exercisable within 60 days following March&#160;15, 2024. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(7)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 298,362 options to purchase common shares that are or will be exercisable within 60 days following March&#160;15, 2024. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(8)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 245,894 options to purchase common shares that are or will be exercisable within 60 days following March&#160;15, 2024. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(9)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of (a) 73,576 common shares and (b) 63,700 options to purchase common shares that are or will be exercisable within 60 days following March&#160;15, 2024. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">90 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(10)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 74,885 options to purchase common shares that are or will be exercisable within 60 days following March&#160;15,2024. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(11)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 49,673 options to purchase common shares that are or will be exercisable within 60 days following March&#160;15, 2024. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(12)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 80,700 options to purchase common shares that are or will be exercisable within 60 days following March&#160;15, 2024. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(13)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 80,700 options to purchase common shares that are or will be exercisable within 60 days following March&#160;15, 2024. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(14)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 53,198 options to purchase common shares that are or will be exercisable within 60 days following March&#160;15, 2024. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(15)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 61,567 options to purchase common shares that are or will be exercisable within 60 days following March&#160;15, 2024. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(16)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of (a) 381,663 common shares and (b) 2,410,624 options to purchase common shares that are or will be exercisable within 60 days following March&#160;15, 2024. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">91 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="font-size:1pt;background-color:#cccccc">
<td style="height:0.75pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#cccccc">
<td style="padding-bottom:1pt ;vertical-align:middle"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.17em; font-size:12pt; font-family:Times New Roman;font-weight:bold" id="toc706699_61">CERTAIN RELATIONSHIPS</p></td></tr>
</table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">In addition to the transactions, arrangements and relationships discussed elsewhere in this Proxy Statement, the following are certain transactions, arrangements and relationships with persons who are, or were during the period beginning January&#160;1, 2023, our directors, executive officers or shareholders owning 5% or more of our outstanding common shares, other than equity and other compensation, termination, change in control and other arrangements for our directors and named executive officers, which are described under &#8220;Executive and Director Compensation.&#8221; </p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_62">COLLABORATION AGREEMENT WITH INCYTE </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">We entered into a collaboration and license agreement (the &#8220;Collaboration Agreement&#8221;) with Incyte Corporation (&#8220;Incyte&#8221;). Under the terms of the Collaboration Agreement, we and Incyte agreed to collaborate with respect to the research, discovery and development of bispecific or monospecific antibodies utilizing our proprietary Biclonics<sup style="font-size:75%; vertical-align:top">&#174;</sup> technology platform. The collaboration currently encompasses up to 10 independent programs. We have the option to <span style="white-space:nowrap">co-fund</span> development of products, if any, arising from one specified program, and subject to certain conditions, to a second specified program, in each case in exchange for a share of profits in the United States, as well as the right to participate in a specified proportion of detailing activities in the United States for one of such programs. If we exercise our <span style="white-space:nowrap">co-funding</span> option for a program, we would be responsible for funding 35% of the associated future global development costs and, for certain of such programs, would be responsible for reimbursing Incyte for certain development costs incurred prior to the option exercise. All products as to which we have exercised our option to <span style="white-space:nowrap">co-fund</span> development, if any, would be subject to joint development plans and overseen by a joint development committee, with Incyte having final determination as to such plans in cases of dispute. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">For each program, where we have not elected to <span style="white-space:nowrap">co-fund</span> development or where we do not have such a <span style="white-space:nowrap">co-funding</span> option, Incyte is solely responsible for all costs of global development and commercialization activities. We retain the rights to our Biclonics<sup style="font-size:75%; vertical-align:top">&#174;</sup> technology platform as well as clinical and <span style="white-space:nowrap">pre-clinical</span> candidates and future programs emerging from our platform that are outside the scope of the Collaboration Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">For one of the then current preclinical programs referred to as Program 1, at the inception of the collaboration, we retained the exclusive right to develop and commercialize products and product candidates in the United States, while Incyte had the exclusive right to develop and commercialize products and product candidates arising from such program outside the United States. For Program 1, later designated as <span style="white-space:nowrap">MCLA-145,</span> we and Incyte conducted and shared equally the costs of mutually agreed global development activities. In January 2022, the Company announced that Incyte elected to <span style="white-space:nowrap">opt-out</span> of its <span style="white-space:nowrap">ex-U.S.</span> development of <span style="white-space:nowrap">MCLA-145.</span> Incyte&#8217;s <span style="white-space:nowrap">opt-out</span> of <span style="white-space:nowrap">ex-U.S.</span> rights to <span style="white-space:nowrap">MCLA-145</span> provides us the exclusive right to develop and commercialize potential <span style="white-space:nowrap">MCLA-145</span> products globally. Under the collaboration, Incyte will continue to support the program for a limited time while <span style="white-space:nowrap">ex-U.S.</span> activities are transitioned to us, and Incyte will also retain a right to a residual royalty of up to 4% on sales of future commercialization of <span style="white-space:nowrap">MCLA-145,</span> if approved. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">92 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">In January 2017, upon the Collaboration Agreement becoming effective, Incyte made an upfront <span style="white-space:nowrap">non-refundable</span> payment to us of $120&#160;million for the rights granted under the Collaboration Agreement. For each program as to which we do not have commercialization or <span style="white-space:nowrap">co-development</span> rights, we are eligible to receive up to $100&#160;million in future contingent development and regulatory milestones and up to $250&#160;million in commercialization milestones, as well as tiered royalties ranging from 6% to 10% of global net sales. For each program as to which we have exercised our option to <span style="white-space:nowrap">co-fund</span> development, we are eligible to receive a 50% share of profits (or sustain 50% of any losses) in the United States and tiered royalties ranging from 6% to 10% of net sales of products outside of the United States, if any. If we opt to cease <span style="white-space:nowrap">co-funding</span> a program as to which we exercised our <span style="white-space:nowrap">co-development</span> option, then we will no longer receive a share of profits in the United States, but will be eligible to receive the same milestones from the <span style="white-space:nowrap">co-funding</span> termination date and the same tiered royalties described above with respect to <span style="white-space:nowrap"><span style="white-space:nowrap">non-co-developed</span></span> programs and, depending on the stage at which we choose to cease <span style="white-space:nowrap">co-funding</span> development costs, additional royalties ranging up to 4% of net sales in the United States. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The Collaboration Agreement will continue on a <span style="white-space:nowrap"><span style="white-space:nowrap">program-by-program</span></span> basis until neither party has any royalty payment obligations with respect to such program or, if earlier, the termination of the Collaboration Agreement or any program in accordance with the terms of the Collaboration Agreement. The Collaboration Agreement may be terminated in its entirety, or on a <span style="white-space:nowrap"><span style="white-space:nowrap">program-by-program</span></span> basis, by Incyte for convenience. The Collaboration Agreement may also be terminated by either party under certain other circumstances, including material breach, or on a <span style="white-space:nowrap"><span style="white-space:nowrap">program-by-program</span></span> basis for patent challenges of patents under the applicable program, in each case as set forth in the Collaboration Agreement. If the Collaboration Agreement is terminated in its entirety or with respect to one or more programs, all rights in the terminated programs revert to us, and, depending on the stage of research or development of the terminated program, subject to payment to Incyte of a reverse royalty of up to 4% on sales of future products, if we elect to pursue and are successful in development and commercialization of products arising from the terminated programs. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_63">AUGUST 2023 <span style="white-space:nowrap">FOLLOW-ON</span> OFFERING </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">On August&#160;9, 2023, we entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Jefferies, BofA Securities, Inc., Guggenheim Securities, LLC and William Blair&#160;&amp; Company, L.L.C., as representatives of the several underwriters named therein (collectively, the &#8220;Underwriters&#8221;), in connection with the issuance and sale by us in a public offering of 6,818,182 common shares of the Company, nominal value &#8364;0.09 per share, at a public offering price of $22.00 per share, less underwriting discounts and commissions, pursuant to an effective shelf registration statement on Form <span style="white-space:nowrap">S-3</span> and accompanying prospectus (Registration <span style="white-space:nowrap">No.&#160;333-255903),</span> which became effective upon filing on May&#160;7, 2021, and a prospectus supplement thereunder. Under the terms of the Underwriting Agreement, we also granted the Underwriters an option exercisable for 30&#160;days to purchase up to an additional 1,022,727 common shares at the public offering price, less underwriting discounts and commissions. On August&#160;10, 2023, the Underwriters exercised this option in full. The offering closed on August&#160;14, 2023, and we received net </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">93 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
proceeds of $162.2&#160;million, after deducting underwriting discounts and fees. The following table sets forth the number of common shares purchased in the offering by holders of more than 5% of our common shares: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:51%"/>

<td style="vertical-align:bottom;width:14%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:14%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman;font-weight:bold">Name <sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares&#160;of&#160;Common&#160;Stock<br/>Purchased</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Total&#160;Purchase&#160;Price</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Commodore Capital LP</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,050,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">23,100,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Deerfield Management Company, L.P.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">651,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">14,322,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:24%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Additional details regarding these shareholders and their equity holdings are provided in this Proxy Statement under the caption &#8220;Security Ownership of Certain Beneficial Owners and Management.&#8221; </p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" id="toc706699_64">INDEMNIFICATION AGREEMENTS </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">We have entered into agreements with our board of directors and our executive officers to indemnify them against expenses and liabilities to the fullest extent permitted by law. These agreements provide, subject to certain exceptions, for indemnification for related expenses including, among other expenses, attorneys&#8217; fees, retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees incurred by any of these individuals in any action or proceeding. In addition to such indemnification, we provide our board of directors and executive officers with directors&#8217; and officers&#8217; liability insurance. </p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="font-size:1pt;background-color:#cccccc">
<td style="height:0.75pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#cccccc">
<td style="padding-bottom:1pt ;vertical-align:middle"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.17em; font-size:12pt; font-family:Times New Roman;font-weight:bold" id="toc706699_65">SHAREHOLDERS&#8217; PROPOSALS</p></td></tr>
</table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Rule <span style="white-space:nowrap">14a-8</span> Proposals</span>&#8212;Pursuant to Rule <span style="white-space:nowrap">14a-8</span> under the Exchange Act, shareholders who intend to have a proposal considered for inclusion in our proxy materials for presentation at our 2025 Annual General Meeting must submit the proposal to our Company Secretary at our offices at Uppsalalaan 17, 3<sup style="font-size:75%; vertical-align:top">rd</sup>&#160;&amp; 4<sup style="font-size:75%; vertical-align:top">th</sup> floor, 3584 CT Utrecht, the Netherlands in writing not later than December&#160;16, 2024 unless the date of the 2025 Annual General Meeting is changed by more than 30 days from the date of the 2024 Annual General Meeting, and must satisfy the requirements of the proxy rules promulgated by the SEC. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><span style="font-style:italic">Other Proposals</span>&#8212;Shareholders intending to include a proposal on the agenda for the 2025 Annual General Meeting, irrespective of whether they intend to have the proposal included in our proxy statement, must comply with the requirements under our articles of association and Dutch law. Under Dutch law and our articles of association, only shareholders representing at least 3% of our issued share capital are authorized to make such a proposal, provided that they do so at least 60 days prior to our 2025 Annual General Meeting. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">In addition to satisfying the foregoing requirements under Dutch law and our articles of association, to comply with the SEC&#8217;s universal proxy rules, shareholders who intend to solicit proxies in support of director nominees other than the Company&#8217;s nominees must provide notice that sets forth the information required by Rule <span style="white-space:nowrap">14a-19</span> under the Exchange Act no later than March&#160;10, 2025. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Proposals and nominations that are not received by the dates specified above, or otherwise do not meet all relevant requirements, will be considered untimely or improper, as applicable. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">94 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
You may contact Peter B. Silverman, Interim Company Secretary, at Uppsalalaan 17, 3<sup style="font-size:75%; vertical-align:top">rd</sup>&#160;&amp; 4<sup style="font-size:75%; vertical-align:top">th</sup> floor, 3584 CT Utrecht, the Netherlands, for a copy of the relevant provisions of our articles of association regarding the requirements for making shareholder proposals. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">We reserve the right to reject, rule out of order, or take other appropriate action with respect to any proposal that does not comply with these or other applicable requirements. </p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="font-size:1pt;background-color:#cccccc">
<td style="height:0.75pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#cccccc">
<td style="padding-bottom:1pt ;vertical-align:middle"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.17em; font-size:12pt; font-family:Times New Roman;font-weight:bold" id="toc706699_66">OTHER MATTERS</p></td></tr>
</table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">No business shall be voted on at the Annual General Meeting, except such items as included in the agenda for the Annual General Meeting. </p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="font-size:1pt;background-color:#cccccc">
<td style="height:0.75pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#cccccc">
<td style="padding-bottom:1pt ;vertical-align:middle"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.17em; font-size:12pt; font-family:Times New Roman;font-weight:bold" id="toc706699_67">SOLICITATION OF PROXIES</p></td></tr>
</table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The accompanying proxy is solicited by and on behalf of our board of directors, whose Notice of Annual General Meeting is attached to this proxy statement, and the entire cost of such solicitation will be borne by us. In addition to the use of mail, proxies may be solicited by personal interview, telephone, <span style="white-space:nowrap">e-mail</span> and facsimile by our directors, officers and other employees who will not be specially compensated for these services. We will also request that brokers, nominees, custodians and other fiduciaries forward soliciting materials to the beneficial owners of shares held by such brokers, nominees, custodians and other fiduciaries. We will reimburse such persons for their reasonable expenses in connection therewith. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Certain information contained in this proxy statement relating to the occupations and security holdings of our directors and officers is based upon information received from the individual directors and officers. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">In connection with our solicitation of proxies for our 2025 Annual Meeting, we intend to file a proxy statement and WHITE proxy card with the SEC. Shareholders may obtain our proxy statement (and any amendments and supplements thereto) and other documents as and when filed with the SEC without charge from the SEC&#8217;s website at: www.sec.gov. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">95 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"/></tr>


<tr style="font-size:1pt;background-color:#cccccc">
<td style="height:0.75pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt;background-color:#cccccc">
<td style="padding-bottom:1pt ;vertical-align:middle"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.17em; font-size:12pt; font-family:Times New Roman;font-weight:bold" id="toc706699_68">MERUS&#8217; ANNUAL REPORT ON FORM <span style="white-space:nowrap">10-K</span></p></td></tr>
</table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">A copy of Merus&#8217; Annual Report on Form <span style="white-space:nowrap">10-K</span> for the financial year ended December&#160;31, 2023, including financial statements and schedules thereto but not including exhibits, as filed with the SEC, will be sent to any shareholder of record as of the close of business on April&#160;9, 2024 without charge upon written request addressed to: </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:12pt; font-family:Times New Roman">Merus N.V. </p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:12pt; font-family:Times New Roman">Attention: Company Secretary </p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:12pt; font-family:Times New Roman">Uppsalalaan 17 </p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:12pt; font-family:Times New Roman">3<sup style="font-size:75%; vertical-align:top">rd</sup>&#160;&amp; 4<sup style="font-size:75%; vertical-align:top">th</sup> floor </p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:12pt; font-family:Times New Roman">3584 CT Utrecht </p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:12pt; font-family:Times New Roman">The Netherlands </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">A reasonable fee will be charged for copies of exhibits. You also may access this proxy statement and our Annual Report on Form <span style="white-space:nowrap">10-K</span> at <span style="font-style:italic">www.proxyvote.com</span>. You also may access our Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2023 at <span style="font-style:italic">www.merus.nl</span>. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">WHETHER OR NOT YOU PLAN TO ATTEND THE ANNUAL GENERAL MEETING, WE URGE YOU TO VOTE YOUR SHARES PRIOR TO THE ANNUAL GENERAL MEETING VIA THE TOLL-FREE TELEPHONE NUMBER OR OVER THE INTERNET, AS DESCRIBED IN THIS PROXY STATEMENT OR BY SIGNING, DATING AND MAILING THE PROXY CARD IN THE ENCLOSED RETURN ENVELOPE OR EMILING THE SIGNED AND DATED PROXY CARD TO AGM2024@MERUS.NL. PROMPTLY VOTING YOUR SHARES WILL ENSURE THE PRESENCE OF A QUORUM AT THE ANNUAL GENERAL MEETING AND WILL SAVE US THE EXPENSE OF FURTHER SOLICITATION. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">By Order of the board of directors </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Peter B. Silverman </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Interim Company Secretary </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Utrecht, the Netherlands </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">April [&#8195;], 2024 </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center">96 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:right" id="toc706699_69">Annex A </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLES OF ASSOCIATION </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">DEFINITIONS AND INTERPRETATION </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 1 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">1.1</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>In these articles of association the following definitions shall apply: </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;width:93%;border:0;margin-left:auto">


<tr>

<td style="width:28%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:70%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">&#8364;STR</span></span></span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">The Euro short-term rate published by the European Central Bank (or such other reference rate designated as replacement for such Euro short-term rate by the European Central Bank or the Dutch Central Bank).</span></span></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">Article</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">An article of these articles of association.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">Board of Directors</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The Company&#8217;s board of directors.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">Board Rules</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The internal rules applicable to the Board of Directors, as drawn up by the Board of Directors.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">CEO</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The Company&#8217;s chief executive officer.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">Chairman</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The chairman of the Board of Directors.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">Class&#160;Meeting</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The meeting of holders of shares of a certain class.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">Company</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The company to which these articles of association pertain.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">DCC</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The Dutch Civil Code.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">Dependent Company</span></span></span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">A dependent company of the Company within the meaning of Section&#160;2:152 DCC.</span></span></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">Director</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">A member of the Board of Directors.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">Enterprise Chamber</span></span></span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">The Enterprise Chamber of the Amsterdam Court of Appeals.</span></span></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">EURIBOR</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The EURIBOR interest rate, as published by Thomson Reuters or another institution chosen by the Board of Directors, for loans with a maturity of three, six, nine or twelve months, whichever has had the highest mathematical average over the financial year (or the relevant part thereof) in respect of which the relevant distribution is made, but in any event no less than zero percent.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">Executive Director</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">An executive Director.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">General Meeting</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The Company&#8217;s general meeting of shareholders.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">Group Company</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">An entity or partnership which is organisationally connected with the Company in an economic unit within the meaning of Section&#160;2:24b DCC.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">Indemnified Officer</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">A current or former Director and such other current or former officer or employee of the Company or its Group Companies as designated by the Board of Directors.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">Meeting Rights</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">With respect to the Company, the rights attributed by law to the holders of depository receipts issued for shares with a company&#8217;s cooperation, including the right to attend and address a General Meeting.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap">Non-Executive</span> Director</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">A <span style="white-space:nowrap">non-executive</span> Director.</td></tr></table></div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;width:93%;border:0;margin-left:auto">


<tr>

<td style="width:28%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:70%"/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">Person with Meeting Rights</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">A shareholder, a usufructuary or pledgee with voting rights or a holder of depository receipts for shares issued with the Company&#8217;s cooperation.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">Preferred Distribution</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A distribution on the preferred shares for an amount equal to the Preferred Interest Rate calculated over the aggregate amount paid up on those preferred shares, whereby:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">a.</span>&#8195;&#8201;any amount paid up on those preferred shares (including as a result of an issue of preferred shares) during the financial year (or the relevant part thereof) in respect of which the distribution is made shall only be taken into account proportionate to the number of days that elapsed during that financial year (or the relevant part thereof) after the payment was made on those preferred shares;</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">b.</span>&#8195;&#8202;any reduction of the aggregate amount paid up on preferred shares during the financial year (or the relevant part thereof) in respect of which the distribution is made shall be taken into account proportionate to the number of days that elapsed during that financial year (or the relevant part thereof) until such reduction was effected; and</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">c.</span>&#8195;&#8201;&#8202;if the distribution is made in respect of part of a financial year, the amount of the distribution shall be proportionate to the number of days that elapsed during that part of the financial year.</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">Preferred Interest Rate</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The mathematical average, calculated over the financial year (or the relevant part thereof) in respect of which a distribution is made on preferred shares, of the relevant EURIBOR interest rate <span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">or the &#8364;STR (as selected by the Board of Directors), in each case</span></span> plus a margin not exceeding five hundred basis points (500bps) to be determined by the Board of Directors each time when, or before, preferred shares are issued without preferred shares already forming part of the Company&#8217;s issued share capital.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">Registration Date</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The date of registration for a General Meeting as provided by law.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">Simple Majority</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">More than half of the votes cast.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">Subsidiary</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A subsidiary of the Company within the meaning of Section&#160;2:24a DCC, including:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">a.</span>&#8195;&#8201;an entity in whose general meeting the Company or one or more of its Subsidiaries can exercise, whether or not by virtue of an agreement with other parties with voting rights, individually or collectively, more than half of the voting rights; and</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">b.</span>&#8195;&#8202;an entity of which the Company or one or more of its Subsidiaries are members or shareholders and can appoint or dismiss, whether or not by virtue of an agreement with other parties with voting rights, individually or collectively, more than half of the managing directors or of the supervisory directors, even if all parties with voting rights cast their votes.</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">Works Council</span></span></span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">The works council of the Company&#8217;s business or of the business of a Dependent Company, provided that:</span></span></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">a.</span>&#8195;&#8201;if there is more than one works council, the powers of the Works Council under these articles of association shall be exercised by</span></span></p></td></tr></table></div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;width:93%;border:0;margin-left:auto">


<tr>

<td style="width:28%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:70%"/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:0.00em; font-size:10pt; font-family:Times New Roman"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">those councils separately, except that in case of a nomination as referred to in Article 16.4 the powers of the Works Council under that provision shall be exercised by those works councils jointly;</span></span></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">b.</span>&#8195;&#8202;if a central works council has been established for the relevant business or businesses, the powers of the Works Council under these articles of association vest in the central works council.</span></span></p></td></tr>
</table></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">1.2</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Unless the context requires otherwise, references to &#8220;shares&#8221; or &#8220;shareholders&#8221; without further specification are to any class of shares or to the holders thereof, respectively. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">1.3</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>References to statutory provisions are to those provisions as they are in force from time to time. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">1.4</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Terms that are defined in the singular have a corresponding meaning in the plural. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">1.5</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Words denoting a gender include each other gender. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">1.6</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Except as otherwise required by law, the terms &#8220;written&#8221; and &#8220;in writing&#8221; include the use of electronic means of communication. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">1.7</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>References to shares being &#8220;outstanding&#8221; are to shares that form part of the Company&#8217;s issued share capital which are not held by the Company itself or by a Subsidiary. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">NAME<span style="font-family:Times New Roman;color:#ff0200"><span style="text-decoration:line-through"> AND</span></span><span style="font-family:Times New Roman;color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">,</span></span> OFFICIAL SEAT <span style="font-family:Times New Roman;color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">AND LARGE COMPANY REGIME</span></span> </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 2 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">2.1</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The Company is a limited liability company (<span style="font-style:italic">naamloze vennootschap</span>) and its name is <span style="font-weight:bold">Merus N.V.</span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">2.2</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Company has its official seat in Utrecht. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">2.3</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">The Company is subject to Sections 2:158 through 2:162 DCC and Section&#160;2:164 DCC of the Dutch large company regime.</span></span> </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">OBJECTS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 3 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s objects are: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>to develop products and services in the area of biotechnology; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>to finance Group Companies or other parties; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">c.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>to borrow, to lend to raise funds, including the issue of bonds, promissory notes or other financial instruments or evidence of indebtedness as well as to enter into agreements in connection with the aforementioned; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">d.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>to supply advice and to render services to Group Companies or other parties; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">e.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>to render guarantees, to bind the Company, to provide security, to warrant performance in any other way and to assume liability, whether jointly and severally or otherwise, in respect of obligations of Group Companies or other parties; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">f.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>to incorporate, to participate in any way whatsoever in, to manage, to supervise and to hold any other interest in other entities, companies, partnerships and businesses; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">g.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>to obtain, alienate, encumber, manage and exploit registered property and items of property in general; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">h.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>to trade in currencies, securities and items of property in general; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">i.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>to develop and trade in patent, trademarks, licenses, <span style="white-space:nowrap">know-how</span> and other industrial property rights; and </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">j.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>to perform any and all activity of industrial, financial or commercial nature and to do anything which, in the widest sense of the word, is connected with or may be conducive to the objects described above. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">SHARES - AUTHORISED SHARE CAPITAL AND DEPOSITORY RECEIPTS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 4 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">4.1</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Company&#8217;s authorised share capital amounts to twelve million one hundred fifty thousand euro (EUR&#160;12,150,000). </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">[Drafting note: If Proposal 7 (Articles Amendment A - Approval of amendment of Articles of Association to increase our authorized share capital and authorization to implement such amendment) is adopted, then this Article 4.1 shall be revised to reflect that proposal.] </span></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">4.2</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The authorised share capital is divided into: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">sixty-seven million and five hundred thousand (67,500,000) common shares; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">sixty-seven million and five hundred thousand (67,500,000) preferred shares, </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">each having a nominal value of nine eurocents (EUR 0.09). </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">[Drafting note: If Proposal 7 (Articles Amendment A - Approval of amendment of Articles of Association to increase our authorized share capital and authorization to implement such amendment) is adopted, then this Article 4.2 shall be revised to reflect that proposal.] </span></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">4.3</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Board of Directors may resolve that one or more shares are divided into such number of fractional shares as may be determined by the Board of Directors. Unless specified differently, the provisions of these articles of association concerning shares and shareholders apply mutatis mutandis to fractional shares and the holders thereof, respectively. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">4.4</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Company may cooperate with the issue of depository receipts for shares in its capital. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">SHARES - FORM OF SHARES AND SHARE REGISTER </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 5 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">5.1</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>All shares are registered shares and shall be numbered consecutively, starting from 1 for each class of shares. The Company may issue share certificates for registered shares in such form as may be approved by the Board of Directors. Each Director is authorised to sign any such share certificate on behalf of the Company. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">5.2</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Board of Directors shall keep a register setting out the names and addresses of all holders of shares and all holders of a usufruct or pledge in respect of such shares. The register shall also set out any other particulars that must be included in the register pursuant to applicable law. Part of the register may be kept outside the Netherlands to comply with applicable local law or pursuant to stock exchange rules. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">5.3</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Shareholders, usufructuaries and pledgees shall provide the Board of Directors with the necessary particulars in a timely fashion. Any consequences of not, or incorrectly, notifying such particulars shall be borne by the party concerned. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">5.4</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>All notifications may be sent to shareholders, usufructuaries and pledgees at their respective addresses as set out in the register. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">SHARES - ISSUE </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 6 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">6.1</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Shares can be issued pursuant to a resolution of the General Meeting or of another body authorised by the General Meeting for this purpose for a specified period not exceeding five years. When granting such authorisation, the number of shares that may be issued must be specified. The authorisation may be extended, in each case for a period not exceeding five years. Unless stipulated differently when granting </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td align="left" style="vertical-align:top">
the authorisation, the authorisation cannot be revoked. For as long as and to the extent that another body has been authorised to resolve to issue shares, the General Meeting shall not have this authority. </td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">6.2</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Article 6.1 applies mutatis mutandis to the granting of rights to subscribe for shares, but does not apply in respect of issuing shares to a party exercising a previously acquired right to subscribe for shares. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">6.3</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Company may not subscribe for shares in its own capital. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">SHARES - <span style="white-space:nowrap">PRE-EMPTION</span> RIGHTS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 7 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">7.1</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Upon an issue of shares, each holder of common shares shall have a <span style="white-space:nowrap">pre-emption</span> right in proportion to the aggregate nominal value of his common shares. No <span style="white-space:nowrap">pre-emption</span> rights are attached to preferred shares. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">7.2</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>In deviation of Article 7.1, holders of common shares do not have <span style="white-space:nowrap">pre-emption</span> rights in respect of: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>preferred shares; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>shares issued against <span style="white-space:nowrap">non-cash</span> contribution; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">c.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>shares issued to employees of the Company or of a Group Company. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">7.3</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Company shall announce an issue with <span style="white-space:nowrap">pre-emption</span> rights and the period during which those rights can be exercised in the State Gazette and in a daily newspaper with national distribution, unless the announcement is sent in writing to all shareholders at the addresses submitted by them. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">7.4</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span><span style="white-space:nowrap">Pre-emption</span> rights may be exercised for a period of at least two weeks after the date of announcement in the State Gazette or after the announcement was sent to the shareholders. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">7.5</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span><span style="white-space:nowrap">Pre-emption</span> rights may be limited or excluded by a resolution of the General Meeting or of the body authorised as referred to in Article 6.1, if that body was authorised by the General Meeting for this purpose for a specified period not exceeding five years. The authorisation may be extended, in each case for a period not exceeding five years. Unless stipulated differently when granting the authorisation, the authorisation cannot be revoked. For as long as and to the extent that another body has been authorised to resolve to limit or exclude <span style="white-space:nowrap">pre-emption</span> rights, the General Meeting shall not have this authority. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">7.6</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>A resolution of the General Meeting to limit or exclude <span style="white-space:nowrap">pre-emption</span> rights, or to grant an authorisation as referred to in Article 7.5, shall require a majority of at least two thirds of the votes cast if less than half of the issued share capital is represented at the General Meeting. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">7.7</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The preceding provisions of this Article 7 apply mutatis mutandis to the granting of rights to subscribe for shares, but do not apply in respect of issuing shares to a party exercising a previously acquired right to subscribe for shares. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">SHARES - PAYMENT </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 8 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">8.1</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Without prejudice to Article 8.2, the nominal value of a share and, if the share is subscribed for at a higher price, the difference between these amounts must be paid up upon subscription for that share. However, it may be stipulated that part of the nominal value of a preferred share, not exceeding three quarters thereof, need not be paid up until the Company has called for payment. The Company shall observe a reasonable notice period of at least one month with respect to any such call for payment. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">8.2</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Parties who professionally place shares for their own account may be allowed by virtue of<span style="font-weight:bold"> </span>an agreement to pay up less than the nominal value of the shares subscribed for by them, provided that at least ninety-four percent (94%) of this amount is paid up in cash ultimately upon subscription for those shares. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">8.3</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Shares must be paid up in cash, except to the extent that payment by means of a contribution in another form has been agreed. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">8.4</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Payment in a currency other than the euro may only be made with the Company&#8217;s consent. Where such a payment is made, the payment obligation is satisfied for the amount in euro for which the paid amount can be freely exchanged. Without prejudice to the last sentence of Section&#160;2:80a(3) DCC, the date of the payment determines the exchange rate. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">SHARES - FINANCIAL ASSISTANCE </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 9 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">9.1</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Company may not provide security, give a price guarantee, warrant performance in any other way or commit itself jointly and severally or otherwise with or for others with a view to the subscription for or acquisition of shares or depository receipts for shares in its capital by others. This prohibition applies equally to Subsidiaries. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">9.2</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Company and its Subsidiaries may not provide loans with a view to the subscription for or acquisition of shares or depository receipts for shares in the Company&#8217;s capital by others, unless the Board of Directors resolves to do so and Section&#160;2:98c DCC is observed. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">9.3</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The preceding provisions of this Article 9 do not apply if shares or depository receipts for shares are subscribed for or acquired by or for employees of the Company or of a Group Company. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">SHARES - ACQUISITION OF OWN SHARES </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 10 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">10.1</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The acquisition by the Company of shares in its own capital which have not been fully paid up shall be null and void. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">10.2</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Company may only acquire fully paid up shares in its own capital for no consideration or if and to the extent that the General Meeting has authorised the Board of Directors for this purpose and all other relevant statutory requirements of Section&#160;2:98 DCC are observed. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">10.3</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>An authorisation as referred to in Article 10.2 remains valid for no longer than eighteen months. When granting such authorisation, the General Meeting shall determine the number of shares that may be acquired, how they may be acquired and within which range the acquisition price must be. An authorisation shall not be required for the Company to acquire common shares in its own capital in order to transfer them to employees of the Company or of a Group Company pursuant to an arrangement applicable to them, provided that these common shares are included on the price list of a stock exchange. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">10.4</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Without prejudice to Articles 10.1 through 10.3, the Company may acquire shares in its own capital for cash consideration or for consideration satisfied in the form of assets. In the case of a consideration being satisfied in the form of assets, the value thereof, as determined by the Board of Directors, must be within the range stipulated by the General Meeting as referred to in Article 10.3. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">10.5</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The previous provisions of this Article 10 do not apply to shares acquired by the Company under universal title of succession. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">10.6</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>In this Article 10, references to shares include depository receipts for shares. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">SHARES - REDUCTION OF ISSUED SHARE CAPITAL </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 11 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">11.1</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The General Meeting can resolve to reduce the Company&#8217;s issued share capital by cancelling shares or by reducing the nominal value of shares by virtue of an amendment to these articles of association. The resolution must designate the shares to which the resolution relates and it must provide for the implementation of the resolution. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">11.2</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>A resolution to cancel shares may only relate to: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>shares held by the Company itself or in respect of which the Company holds the depository receipts; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>all preferred shares, with repayment of the amounts paid up in respect thereof and provided that, to the extent allowed under Articles 30.1 and 30.2, a distribution is made on those preferred shares, in proportion to the amounts paid up on those preferred shares, immediately prior to such cancellation becoming effective, for an aggregate amount of: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:12%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left"><span style="font-weight:bold">i.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the total of all Preferred Distributions (or parts thereof) in relation to financial years prior to the financial year in which the cancellation occurs, to the extent that these should have been distributed but have not yet been distributed as described in Article 32.1; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:12%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left"><span style="font-weight:bold">ii.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the Preferred Distribution calculated in respect of the part of the financial year in which the cancellation occurs, for the number of days that have elapsed during such part of the financial year. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">11.3</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>A resolution of the General Meeting to reduce the Company&#8217;s issued share capital shall require a majority of at least two thirds of the votes cast if less than half of the issued share capital is represented at the General Meeting. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">11.4</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>If a resolution of the General Meeting to reduce the Company&#8217;s issued share capital relates to preferred shares, such resolution shall always require the prior or simultaneous approval of the Class&#160;Meeting of preferred shares. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">SHARES - ISSUE AND TRANSFER REQUIREMENTS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 12 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">12.1</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Except as otherwise provided or allowed by Dutch law, the issue or transfer of a share shall require a deed to that effect and, in the case of a transfer and unless the Company itself is a party to the transaction, acknowledgement of the transfer by the Company. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">12.2</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The acknowledgement shall be set out in the deed or shall be made in such other manner as prescribed by law. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">12.3</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>For as long as common shares are admitted to trading on the New York Stock Exchange, the NASDAQ Stock Market or on any other regulated stock exchange operating in the United States of America, the laws of the State of New York shall apply to the property law aspects of the common shares reflected in the register administered by the relevant transfer agent. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">SHARES - USUFRUCT AND PLEDGE </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 13 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">13.1</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Shares can be encumbered with a usufruct or pledge. The creation of a pledge on preferred shares shall require the prior approval of the Board of Directors. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">13.2</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The voting rights attached to a share which is subject to a usufruct or pledge vest in the shareholder concerned. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">13.3</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>In deviation of Article 13.2: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the holder of a usufruct or pledge on common shares shall have the voting rights attached thereto if this was provided when the usufruct or pledge was created; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the holder of a usufruct or pledge on preferred shares shall have the voting rights attached thereto if this was provided when the usufruct or pledge was created and this was approved by the Board of Directors. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">13.4</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Shareholders without voting rights and usufructuaries and pledgees with voting rights will have Meeting Rights. Usufructuaries and pledgees without voting rights shall not have Meeting Rights. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">SHARES - TRANSFER RESTRICTIONS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 14 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">14.1</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>A transfer of preferred shares shall require the prior approval of the Board of Directors. A shareholder wishing to transfer preferred shares must first request the Board of Directors to grant such approval. A transfer of common shares is not subject to transfer restrictions under these articles of association. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">14.2</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>A transfer of the preferred shares to which the request for approval relates must take place within three months after the approval of the Board of Directors has been granted or is deemed to have been granted pursuant to Article 14.3. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">14.3</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The approval of the Board of Directors shall be deemed to have been granted: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>if no resolution granting or denying the approval has been passed by the Board of Directors within three months after the Company has received the request for approval; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>if the Board of Directors, when denying the approval, does not notify the requesting shareholder of the identity of one or more interested parties willing to purchase the relevant preferred shares. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">14.4</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>If the Board of Directors denies the approval and notifies the requesting shareholder of the identity of one or more interested parties, the requesting shareholder shall notify the Board of Directors within two weeks after having received such notice whether: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>he withdraws his request for approval, in which case the requesting shareholder cannot transfer the relevant preferred shares; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>he accepts the interested party(ies), in which case the requesting shareholder shall promptly enter into negotiations with the interested party(ies) regarding the price to be paid for the relevant preferred shares. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">If the requesting shareholder does not notify the Board of Directors of his choice in a timely fashion, he shall be deemed to have withdrawn his request for approval, in which case he cannot transfer the relevant preferred shares. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">14.5</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>If an agreement is reached in the negotiations referred to in Article 14.4 paragraph b. within two weeks after the end of the period referred to in Article 14.4, the relevant preferred shares shall be transferred for the agreed price within three months after such agreement having been reached. If no agreement is reached in these negotiations in a timely fashion: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the requesting shareholder shall promptly notify the Board of Directors thereof; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the price to be paid for the relevant preferred shares shall be equal to the value thereof, as determined by one or more independent experts to be appointed by the requesting shareholder and the interested party(ies) by mutual agreement. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">14.6</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>If no agreement is reached on the appointment of the independent expert(s) as referred to in Article 14.5 paragraph b. within two weeks after the end of the period referred to in Article 14.5: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the requesting shareholder shall promptly notify the Board of Directors thereof; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the requesting shareholder shall promptly request the president of the district court in whose district the Company has its official seat to appoint three independent experts to determine the value of the relevant preferred shares. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">14.7</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>If and when the value of the relevant preferred shares has been determined by the independent expert(s), irrespective of whether he/they was/were appointed by mutual agreement or by the president of the relevant district court, the requesting shareholder shall promptly notify the Board of Directors of the value </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-8 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td align="left" style="vertical-align:top">
so determined. The Board of Directors shall then promptly inform the interested party(ies) of such value, following which the/each interested party may withdraw from the sale procedure by giving notice thereof the Board of Directors within two weeks. </td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">14.8</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>If any interested party withdraws from the sale procedure in accordance with Article 14.7, the Board of Directors: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>shall promptly inform the requesting shareholder and the other interested party(ies), if any, thereof; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>shall give the opportunity to the/each other interested party, if any, to declare to the Board of Directors and the requesting shareholder, within two weeks, his willingness to acquire the preferred shares having become available as a result of the withdrawal, for the price determined by the independent expert(s) (with the Board of Directors being entitled to determine the allocation of such preferred shares among any such willing interested party(ies) at its absolute discretion). </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">14.9</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>If it becomes apparent to the Board of Directors that all relevant preferred shares can be transferred to one or more interested parties for the price determined by the independent expert(s), the Board of Directors shall promptly notify the requesting shareholder and such interested party(ies) thereof. Within three months after sending such notice the relevant preferred shares shall be transferred. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">14.10</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>If it becomes apparent to the Board of Directors that not all relevant preferred shares can be transferred to one or more interested parties for the price determined by the independent expert(s): </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the Board of Directors shall promptly notify the requesting shareholder thereof; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the requesting shareholder shall be free to transfer all relevant preferred shares, provided that the transfer takes place within three months after having received the notice referred to in paragraph a. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">14.11</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Company may only be an interested party under this Article 14 with the consent of the requesting shareholder. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">14.12</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>All notices given pursuant to this Article 14 shall be provided in writing. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">14.13</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The preceding provisions of this Article 14 do not apply: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>to the extent that a shareholder is under a statutory obligation to transfer preferred shares to a previous holder thereof; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>if it concerns a transfer in connection with an enforcement of a pledge pursuant to Section&#160;3:248 DCC in conjunction with Section&#160;3:250 or 3:251 DCC; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">c.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>if it concerns a transfer to the Company, except in the case that the Company acts as an interested party pursuant to Article 14.11. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">14.14</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>This Article 14 applies mutatis mutandis in case of a transfer of rights to subscribe for preferred shares. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">BOARD OF DIRECTORS - COMPOSITION </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 15 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">15.1</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Company has a Board of Directors consisting of: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>one or more Executive Directors, being primarily charged with the Company&#8217;s <span style="white-space:nowrap"><span style="white-space:nowrap">day-to-day</span></span> operations; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#ff0200"><span style="text-decoration:line-through">one</span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">three</span></span> or more <span style="white-space:nowrap">Non-Executive</span> Directors, being primarily charged with the supervision of the performance of the duties of the Directors. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">The Board of Directors shall be composed of individuals. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-9 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">15.2</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"></span></span>The Board of Directors shall determine the number of Executive Directors and the number of Non-Executive Directors <span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">subject to Article 15.1. If there are fewer than three Non-Executive Directors in office, the </span></span>Board of Directors shall <span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">promptly take measures to increase the number of Non-Executive Directors.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">15.3</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">The following individuals cannot be a Non-Executive Director:</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">a.</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">persons employed by the Company;</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">b.</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold"></span>persons employed by a Dependent Company;</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">c.</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold"></span>directors and employees of an employees&#8217; organisation customarily involved in establishing the terms of employment of the persons referred to in paragraphs a. and b. above.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">15.4</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">The Board of Directors shall adopt a profile of its size and composition, taking into account the nature of the business, its activities and the desired expertise and background of the <span style="white-space:nowrap">Non-Executive</span> Directors. The Board of Directors shall discuss the profile in the General Meeting and with the Works Council each time it is amended.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">15.5</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#ff0200"><span style="text-decoration:line-through">15.2 </span></span>The Board of Directors shall elect an Executive Director to be the CEO. The Board of Directors may dismiss the CEO, provided that the CEO so dismissed shall subsequently continue his term of office as an Executive Director without having the title of CEO. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">15.6</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="color:#ff0200"><span style="text-decoration:line-through">15.3 </span></span>The Board of Directors shall elect a <span style="white-space:nowrap">Non-Executive</span> Director to be the Chairman. The Board of Directors may dismiss the Chairman, provided that the Chairman so dismissed shall subsequently continue his term of office as a <span style="white-space:nowrap">Non-Executive</span> Director without having the title of Chairman. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">15.7</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left">If a Director is absent or incapacitated, he may be replaced temporarily by a person whom the Board of Directors has designated for that purpose and, until then, the other Director(s) shall be charged with the management of the Company. If all Directors are absent or incapacitated, the management of the Company shall be attributed to the person who most recently ceased to hold office as the CEO. If such former CEO is unwilling or unable to accept that position, the management of the Company shall be attributed to the person who most recently ceased to hold office as the Chairman. If such former Chairman is also unwilling or unable to accept that position, the management of the Company shall be attributed to one or more persons whom the General Meeting has designated for that purpose. The person(s) charged with the management of the Company in this manner, may designate one or more persons to be charged with the management of the Company in addition to, or together with, such person(s). <span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">This Article 15.7 is subject to Articles 16.14 and 16.15.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">15.8</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#ff0200"><span style="text-decoration:line-through">15.4 </span></span>A Director shall be considered to be unable to act within the meaning of Article <span style="color:#ff0200"><span style="text-decoration:line-through">15.5</span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">15.7</span></span>: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>in a period during which the Company has not been able to contact him (including as a result of illness), provided that such period lasted longer than five consecutive days (or such other period as determined by the Board of Directors on the basis of the facts and circumstances at hand); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>during his suspension; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">c.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>in the deliberations and decision-making of the Board of Directors on matters in relation to which he has declared to have, or in relation to which the Board of Directors has established that he has, a conflict of interests as described in Article 18.7. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">BOARD OF DIRECTORS - APPOINTMENT, SUSPENSION AND DISMISSAL </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 16 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">16.1</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The <span style="color:#ff0200"><span style="text-decoration:line-through">General Meeting</span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">Non-Executive Directors</span></span> shall appoint the <span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">Executive </span></span>Directors and may at any time suspend or dismiss any <span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">Executive</span></span> Director. <span style="color:#ff0200"><span style="text-decoration:line-through">In addition, the Board of</span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">The Non-Executive</span></span> Directors <span style="color:#ff0200"><span style="text-decoration:line-through">may at any time suspend</span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">shall notify the General Meeting of a proposed appointment of</span></span> an Executive Director.<span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"> The Non-Executive Directors shall not dismiss an Executive Director until after the General Meeting has been consulted about the proposed dismissal.</span></span> </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-10 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">16.2</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">Except as provided in Article 16.6, the <span style="white-space:nowrap">Non-Executive</span> Directors shall be appointed by the General Meeting based on a nomination by the <span style="white-space:nowrap">Non-Executive</span> Directors. The nomination must be presented to the General</span></span> <span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">Meeting and the Works Council concurrently. The nomination must be supported with reasons. The</span></span> <span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">nomination shall not be presented to the General Meeting until after the Works Council has been given the opportunity to determine its position on the matter in a timely fashion before the date of the convocation of the General Meeting. The chairperson of the Works Council or a member of the Works Council designated by the chairperson of the Works Council may explain the position of the Works Council in the General Meeting. The absence of that position shall not affect the decision-making on the proposed appointment.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">16.3</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span><span style="color:#ff0200"><span style="text-decoration:line-through">16.2 </span></span>The General Meeting <span style="color:#ff0200"><span style="text-decoration:line-through">can only appoint</span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">and the Works Council may recommend persons to the Non-Executive</span></span> Directors <span style="color:#ff0200"><span style="text-decoration:line-through">upon a</span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">for their</span></span> nomination <span style="color:#ff0200"><span style="text-decoration:line-through">by the Board of Directors. The General Meeting may at any time resolve to render such nomination to be non-binding by a majority of at least two thirds of the votes cast representing more than half of the issued share capital. If a nomination is rendered non-binding, a new nomination shall be made by the Board of Directors. If the nomination comprises one candidate for a vacancy, a resolution concerning the nomination shall result in the appointment of the candidate, unless the nomination is rendered non-binding. A second meeting as referred to in Section 2:120(3) DCC cannot be convened.</span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">of a Non-Executive Director. To this end, the Non-Executive Directors shall inform these bodies in a timely fashion when, why and in accordance with which profile a vacancy in their midst must be filled. If the enhanced right of recommendation set out in Article 16.4 applies to the vacancy, the Non-Executive Directors shall state this as well.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">16.4</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">For one-third of the number of <span style="white-space:nowrap">Non-Executive</span> Directors, the <span style="white-space:nowrap">Non-Executive</span> Directors shall nominate a person recommended by the Works Council, unless the <span style="white-space:nowrap">Non-Executive</span> Directors object to such recommendation based on the expectation that the person recommended will be unfit to fulfil the duties of a <span style="white-space:nowrap">Non-Executive</span> Director or that the group of <span style="white-space:nowrap">Non-Executive</span> Directors will not be properly composed upon the appointment in accordance with the recommendation. If the number of <span style="white-space:nowrap">Non-Executive</span> Directors is not divisible by three, the closest lower number divisible by three shall be used to determine the number of <span style="white-space:nowrap">Non-Executive</span> Directors in respect of which the enhanced right of recommendation applies. At least one <span style="white-space:nowrap">Non-Executive</span> Director appointed pursuant to Article 16.4 shall be part of the compensation committee of the Board of Directors.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">16.5</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">In case of an objection by the <span style="white-space:nowrap">Non-Executive</span> Directors pursuant to Article 16.4, they shall notify the Works Council of their objection, stating their reasons. The <span style="white-space:nowrap">Non-Executive</span> Directors shall promptly consult with the Works Council in an attempt to reach agreement on the nomination. If the <span style="white-space:nowrap">Non-Executive</span> Directors establish that agreement cannot be reached, a representative of the <span style="white-space:nowrap">Non-Executive</span> Directors designated for that purpose shall request the Enterprise Chamber to rule that the objection is well-founded. The application shall not be filed before four weeks have passed after the start of the consultation with the Works Council. If the Enterprise Chamber declares the objection unfounded, the <span style="white-space:nowrap">Non-Executive</span> Directors shall nominate the person recommended. If the Enterprise Chamber declares the objection well-founded, the Works Council may make a new recommendation in accordance with Article 16.4.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">16.6</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">The General Meeting may reject a nomination made pursuant to Article 16.2 by Simple Majority representing at least <span style="white-space:nowrap">one-third</span> of the issued share capital. If the shareholders withhold their support for the candidate by Simple Majority without such majority representing at least <span style="white-space:nowrap">one-third</span> of the issued share capital, a new General Meeting may be convened where the nomination may be rejected by Simple Majority. In that case, the <span style="white-space:nowrap">Non-Executive</span> Directors shall prepare a new nomination. Articles 16.3 through 16.5 shall apply mutatis mutandis. If the General Meeting does not appoint the person nominated and does not pass a resolution rejecting the nomination, the <span style="white-space:nowrap">Non-Executive</span> Directors shall appoint the person nominated.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">16.7</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">The General Meeting may delegate the right vested in it under Article 16.3 to a committee of shareholders designated by it, for a period set by it, in each case for a maximum of two consecutive years. In that case, the <span style="white-space:nowrap">Non-Executive</span> Directors shall make the notification under Article 16.3 to such committee. The General Meeting may revoke the delegation at any time.</span></span> </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-11 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">16.8</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">A <span style="white-space:nowrap">Non-Executive</span> Director shall resign no later than on the day of the first General Meeting held after four years have passed from such <span style="white-space:nowrap">Non-Executive</span> Director&#8217;s most recent appointment. A resigning <span style="white-space:nowrap">Non-Executive</span> Director may be reappointed.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">16.9</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">A <span style="white-space:nowrap">Non-Executive</span> Director may be suspended by the <span style="white-space:nowrap">Non-Executive</span> Directors. Such a suspension shall terminate by operation of law if, within one month after the start of the suspension, the Company has not requested the Enterprise Chamber to dismiss the relevant <span style="white-space:nowrap">Non-Executive</span> Director pursuant to Article&#160;16.10.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">16.10</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">Upon application, the Enterprise Chamber may dismiss a <span style="white-space:nowrap">Non-Executive</span> Director for dereliction of duties, for other important reasons or because of a material change in circumstances as a result of which the Company cannot reasonably be expected to retain such person as a <span style="white-space:nowrap">Non-Executive</span> Director. Such an application may be made by the Company, represented for this purpose by the <span style="white-space:nowrap">Non-Executive</span> Directors, or by a representative of the General Meeting or the Works Council designated for this purpose.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">16.11</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#ff0200"><span style="text-decoration:line-through">16.3 </span></span>At a General Meeting, a resolution to appoint a <span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="white-space:nowrap">Non-Executive</span></span></span> Director can only be passed in respect of candidates whose names are stated for that purpose in the agenda of that General Meeting or the explanatory notes thereto. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#ff0200"><span style="text-decoration:line-through"><span style="font-weight:bold">16.4</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#ff0200"><span style="text-decoration:line-through">Upon the appointment of a person as a Director, the General Meeting shall determine whether that person is appointed as Executive Director or as Non-Executive Director.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#ff0200"><span style="text-decoration:line-through"><span style="font-weight:bold">16.5</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#ff0200"><span style="text-decoration:line-through">A resolution of the General Meeting to suspend or dismiss a Director shall require a majority of at least two thirds of the votes cast representing more than half of the issued share capital, unless the resolution is passed at the proposal of the Board of Directors. A second meeting as referred to in Section 2:120(3) DCC cannot be convened.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#ff0200"><span style="text-decoration:line-through"><span style="font-weight:bold">16.6</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#ff0200"><span style="text-decoration:line-through">If a Director is suspended and the General Meeting does not resolve to dismiss him within three months from the date of such suspension, the suspension shall lapse.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">16.12</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">By Simple Majority representing at least <span style="white-space:nowrap">one-third</span> of the issued share capital, the General Meeting may pass a resolution of <span style="white-space:nowrap">no-confidence</span> in the <span style="white-space:nowrap">Non-Executive</span> Directors. The resolution shall be supported with reasons. The resolution may not be passed in respect of <span style="white-space:nowrap">Non-Executive</span> Directors appointed by the Enterprise Chamber in accordance with Article 16.14.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">16.13</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">A resolution as referred to in Article 16.12 may only be passed after the Board of Directors has notified the Works Council of the proposed resolution and the reasons for it. The notification shall be made at least thirty days prior to the General Meeting at which the proposal is to be considered. If the Works Council has determined its position on the proposal, the Board of Directors shall inform the <span style="white-space:nowrap">Non-Executive</span> Directors and the General Meeting of that position. The Works Council may have its position explained in the General Meeting.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">16.14</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">The resolution referred to in Article 16.12 shall result in the immediate dismissal of all <span style="white-space:nowrap">Non-Executive</span> Directors. In that case, the Executive Directors shall promptly request the Enterprise Chamber to temporarily appoint one or more <span style="white-space:nowrap">Non-Executive</span> Directors. The Enterprise Chamber shall make arrangements in respect of the consequences of the appointment. The temporary <span style="white-space:nowrap">Non-Executive</span> Directors shall cause a new group of <span style="white-space:nowrap">Non-Executive</span> Directors to be appointed in accordance with this Article 16 within a period set by the Enterprise Chamber.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">16.15</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">If there are no <span style="white-space:nowrap">Non-Executive</span> Directors in office, other than as a result of Article 16.12, appointments of <span style="white-space:nowrap">Non-Executive</span> Directors shall be made by the General Meeting in accordance with Section&#160;2:159 DCC.</span></span> </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">BOARD OF DIRECTORS - DUTIES AND ORGANISATION </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 17 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">17.1</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The Board of Directors is charged with the management of the Company, subject to the restrictions contained in these articles of association. <span style="color:#ff0200"><span style="text-decoration:line-through">&#8217;</span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">This includes in any event setting the Company&#8217;s policy and</span></span> </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-12 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td align="left" style="vertical-align:top">
<span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">strategy.</span></span> In performing their duties, Directors shall be guided by the interests of the Company and of the business connected with it. </td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">17.2</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Board of Directors shall draw up Board Rules concerning its organisation, decision-making and other internal matters, with due observance of these articles of association. In performing their duties, the Directors shall act in compliance with the Board Rules. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">17.3</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Directors may allocate their duties amongst themselves in or pursuant to the Board Rules or otherwise pursuant to resolutions adopted by the Board of Directors, provided that: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the Executive Directors shall be charged with the Company&#8217;s <span style="white-space:nowrap"><span style="white-space:nowrap">day-to-day</span></span> operations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the task of supervising the performance of the duties of the Directors cannot be taken away from the <span style="white-space:nowrap">Non-Executive</span> Directors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">c.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the Chairman must be a <span style="white-space:nowrap">Non-Executive</span> Director; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">d.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the making of proposals for the appointment of a Director and the determination of the compensation of the Executive Directors cannot be allocated to an Executive Director. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">17.4</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Board of Directors may determine in writing, in or pursuant to the Board Rules or otherwise pursuant to resolutions adopted by the Board of Directors, that one or more Directors can validly pass resolutions in respect of matters which fall under his/their duties. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">17.5</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Board of Directors shall establish the committees which the Company is required to have and otherwise such committees as are deemed to be appropriate by the Board of Directors. The Board of Directors shall draw up (and/or include in the Board Rules) rules concerning the organisation, decision-making and other internal matters of its committees. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">17.6</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Board of Directors may perform the legal acts referred to in Section&#160;2:94(1) DCC without the prior approval of the General Meeting. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">BOARD OF DIRECTORS - DECISION-MAKING </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 18 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">18.1</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Without prejudice to Article 18.5, each Director may cast one vote in the decision-making of the Board of Directors. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">18.2</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>A Director can be represented by another Director holding a written proxy for the purpose of the deliberations and the decision-making of the Board of Directors. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">18.3</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Resolutions of the Board of Directors and resolutions of the group of <span style="white-space:nowrap">Non-Executive</span> Directors <span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">(including the resolutions of the <span style="white-space:nowrap">Non-Executive</span> Directors described in Article 16 and Article 18.10<span style="font-weight:bold">)</span> </span></span>shall be passed, irrespective of whether this occurs at a meeting or otherwise, by Simple Majority unless the Board Rules provide differently. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">18.4</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Invalid votes, blank votes and abstentions shall not be counted as votes cast. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">18.5</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Where there is a tie in any vote of the Board of Directors, the Chairman shall have a casting vote, provided that there are at least three Directors in office. Otherwise, the relevant resolution shall not have been passed. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">18.6</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Executive Directors shall not participate in the decision-making concerning (i)&#160;the determination of the compensation of Executive Directors and (ii)&#160;the instruction of an auditor to audit the annual accounts if the General Meeting has not granted such instruction. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">18.7</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>A Director shall not participate in the deliberations and decision-making of the Board of Directors on a matter in relation to which he has a direct or indirect personal interest which conflicts with the interests of the Company and of the business connected with it. If, as a result thereof, no resolution can be passed by the Board of Directors, the resolution may nevertheless be passed by the Board of Directors as if none of the Directors has a conflict of interests as described in the previous sentence. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-13 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">18.8</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Meetings of the Board of Directors can be held through audio-communication facilities, unless a Director objects thereto. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">18.9</span></span></span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Resolutions of the Board of Directors may, instead of at a meeting, be passed in writing, provided that all Directors are familiar with the resolution to be passed and none of them objects to this decision-making process. Articles 18.1 through 18.7 apply mutatis mutandis. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">18.10</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">The approval of the <span style="white-space:nowrap">Non-Executive</span> Directors is required for resolutions of the Board of Directors concerning the following matters:</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">a.</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">the issue and acquisition of shares in and debt instruments against the Company or debt instruments against a limited partnership or general partnership of which the Company is a fully liable partner;</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">b.</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">the cooperation with the issue of depository receipts for shares in the Company&#8217;s capital;</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">c.</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"></span></span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">applying for the admission of the securities referred to in paragraphs a. and b. for trading on a trading venue, as referred to in Section&#160;1:1 of the Dutch Financial Supervision Act, or on a system comparable to a trading venue in a state which is not a Member State, or the application for a cancellation of such admission;</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">d.</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"></span></span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">entering into or terminating a long-lasting alliance of the Company or of a Dependent Company either with another entity or partnership, or as a fully liable partner of a limited partnership or general partnership, if this alliance or termination is of significant importance for the Company;</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">e.</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"></span></span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">acquiring an interest in the capital of another company by the Company or by a Dependent Company with a value of at least one fourth of the amount of the issued share capital and the reserves, according to the Company&#8217;s balance sheet with explanatory notes, as well as increasing or decreasing such an interest significantly;</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">f.</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"></span></span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">investments which require an amount equal to at least one fourth of the amount of the issued share capital and the reserves of the Company, according to its balance sheet with explanatory notes;</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">g.</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"></span></span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">a proposal to amend these articles of association;</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">h.</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"></span></span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">a proposal to dissolve the Company;</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">i.</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"></span></span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">application for bankruptcy and requesting a suspension of payments;</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">j.</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">terminating the employment contracts of a considerable number of employees of the Company or of a Dependent Company at the same time or within a short period of time;</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">k.</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"></span></span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">a significant change in the working conditions of a considerable number of employees of the Company or of a Dependent Company;</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">l</span></span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">.</span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">a proposal to reduce the Company&#8217;s issued share capital; and</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">m.</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="font-weight:bold"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"></span></span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">such other resolutions of the Board of Directors as the Board of Directors shall have specified in a resolution to that effect and notified to the Board of Directors.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">18.11</span></span></span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span><span style="color:#ff0200"><span style="text-decoration:line-through">18.9 </span></span>The approval of the<span style="font-weight:bold"><span style="text-decoration:underline"> </span></span>General Meeting is required for resolutions of the Board of Directors concerning a material change to the identity or the character of the Company or the business, including in any event: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>transferring the business or materially all of the business to a third party; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>entering into or terminating a long-lasting alliance of the Company or of a Subsidiary either with another entity or company, or as a fully liable partner of a limited partnership or general partnership, if this alliance or termination is of significant importance for the Company; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">c.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>acquiring or disposing of an interest in the capital of a company by the Company or by a Subsidiary with a value of at least one third of the value of the assets, according to the balance sheet with explanatory notes or, if the Company prepares a consolidated balance sheet, according to the consolidated balance sheet with explanatory notes in the Company&#8217;s most recently adopted annual accounts. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-14 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">18.12</span></span></span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span><span style="color:#ff0200"><span style="text-decoration:line-through">18.10 </span></span>The absence of the approval of the <span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="white-space:nowrap">Non-Executive</span> Directors or the</span></span> General Meeting of a resolution as referred to in Article <span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">18.10 <span style="font-weight:bold">or</span></span></span> <span style="color:#ff0200"><span style="text-decoration:line-through">Article</span></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"> </span></span>18.11<span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">, respectively,</span></span> shall result in the relevant resolution being null and void pursuant to Section&#160;2:14(1) DCC but shall not affect the powers of representation of the Board of Directors or of the Directors. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">BOARD OF DIRECTORS - COMPENSATION </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 19 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">19.1</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The General Meeting shall determine the Company&#8217;s policy concerning the compensation of the Board of Directors with due observance of the relevant statutory requirements. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">19.2</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The compensation of Directors shall be determined by the Board of Directors with due observance of the policy referred to in Article 19.1. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">19.3</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Board of Directors shall submit proposals concerning arrangements in the form of shares or rights to subscribe for shares to the General Meeting for approval. This proposal must at least include the number of shares or rights to subscribe for shares that may be awarded to the Board of Directors and which criteria apply for such awards or changes thereto. The absence of the approval of the General Meeting shall not affect the powers of representation. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">BOARD OF DIRECTORS - REPRESENTATION </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 20 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">20.1</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Board of Directors is entitled to represent the Company. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">20.2</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The power to represent the Company also vests in the CEO individually, as well as in any other two Executive Directors acting jointly. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">20.3</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Company may grant powers of attorney to represent the Company and determine the scope of such powers of attorney. If a power of attorney is granted to an individual, the Board of Directors may grant an appropriate title to such person. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">INDEMNITY </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 21 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">21.1</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Company shall indemnify and hold harmless each of its Indemnified Officers against: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>any financial losses or damages incurred by such Indemnified Officer; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>any expense reasonably paid or incurred by such Indemnified Officer in connection with any threatened, pending or completed suit, claim, action or legal proceedings of a civil, criminal, administrative, investigative or other nature, formal or informal, in which he becomes involved, </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">to the extent this relates to his current or former position with the Company and/or a Group Company and in each case to the fullest extent permitted by applicable law. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">21.2</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>No indemnification shall be given to an Indemnified Officer: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>if a competent court or arbitral tribunal has established, without possibility for appeal, that the acts or omissions of such Indemnified Officer that led to the financial losses, damages, expenses, suit, claim, action or legal proceedings as described in Article 21.1 result from either an improper performance of his duties as an officer of the Company or an unlawful or illegal act; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>to the extent that his financial losses, damages and expenses are covered under an insurance and the relevant insurer has settled, or has provided reimbursement for, these financial losses, damages and expenses (or has irrevocably undertaken to do so); or </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-15 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">c.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>in relation to proceedings brought by such Indemnified Officer against the Company, except for proceedings brought to enforce indemnification to which he is entitled pursuant to these articles of association or an agreement between such Indemnified Officer and the Company which has been approved by the Board of Directors. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">21.3</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Board of Directors may stipulate additional terms, conditions and restrictions in relation to the indemnification referred to in Article 21.1. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">GENERAL MEETING - CONVENING AND HOLDING MEETINGS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 22 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">22.1</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Annually, at least one General Meeting shall be held. This annual General Meeting shall be held within six months after the end of the Company&#8217;s financial year. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">22.2</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>A General Meeting shall also be held: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>within three months after the Board of Directors has considered it to be likely that the Company&#8217;s equity has decreased to an amount equal to or lower than half of its paid up and called up capital, in order to discuss the measures to be taken if so required; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>whenever the Board of Directors so decides. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">22.3</span></span></span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">Subject to Article 22.4<span style="font-weight:bold">,</span> </span></span>General Meetings must be held in the place where the Company has its official seat or in Amsterdam, The Hague, Rotterdam or Schiphol (Haarlemmermeer). </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">22.4</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">If and when allowed pursuant to applicable law, those who convene the General Meeting may also decide whether (and if so, under what conditions) the General Meeting shall also or exclusively be accessible through the use of electronic means. In that case, references in these articles of association to attendance of a General Meeting shall include attendance by electronic means and Article 24.2, with the exception of the first sentence of Article 24.2, shall apply mutatis mutandis in respect of attendance by electronic means.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">22.5</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="color:#ff0200"><span style="text-decoration:line-through">22.3 </span></span>If the Board of Directors has failed to ensure that a General Meeting as referred to in Articles 22.1 or 22.2 paragraph a. is held, each Person with Meeting Rights may be authorised by the court in preliminary relief proceedings to do so. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">22.6</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="color:#ff0200"><span style="text-decoration:line-through">22.4 </span></span>One or more Persons with Meeting Rights who collectively represent at least the part of the Company&#8217;s issued share capital prescribed by law for this purpose may request the Board of Directors in writing to convene a General Meeting, setting out in detail the matters to be discussed. If the Board of Directors has not taken the steps necessary to ensure that the General Meeting could be held within the relevant statutory period after the request, the requesting Person(s) with Meeting Rights may be authorised, at his/their request, by the court in preliminary relief proceedings to convene a General Meeting. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">22.7</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="color:#ff0200"><span style="text-decoration:line-through">22.5 </span></span>Any matter of which the discussion has been requested in writing by one or more Persons with Meeting Rights who, individually or collectively, represent at least the part of the Company&#8217;s issued share capital prescribed by law for this purpose shall be included in the convening notice or announced in the same manner, if the Company has received the substantiated request or a proposal for a resolution no later than on the sixtieth day prior to that of the General Meeting. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">22.8</span></span></span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"><span style="color:#ff0200"><span style="text-decoration:line-through">22.6 </span></span></span>A General Meeting must be convened with due observance of the relevant statutory minimum convening period. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"><span style="font-weight:bold">22.9</span></span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman;text-align:left"><span style="color:#ff0200"><span style="text-decoration:line-through">22.7 </span></span>All Persons with Meeting Rights must be convened for the General Meeting in accordance with applicable law. The holders of shares may be convened for the General Meeting by means of convening letters sent to the addresses of those shareholders in accordance with Article 5.4. The previous sentence does not prejudice the possibility of sending a convening notice by electronic means in accordance with Section&#160;2:113(4) DCC. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-16 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">GENERAL MEETING - PROCEDURAL RULES </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 23 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">23.1</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The General Meeting shall be chaired by one of the following individuals, taking into account the following order of priority: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>by the Chairman, if there is a Chairman and he is present at the General Meeting; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>by the CEO, if there is a CEO and he is present at the General Meeting; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">c.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>by another Director who is chosen by the Directors present at the General Meeting from their midst; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">d.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>by another person appointed by the General Meeting. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">The person who should chair the General Meeting pursuant to paragraphs a. through d. may appoint another person to chair the General Meeting instead of him. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">23.2</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The chairman of the General Meeting shall appoint another person present at the General Meeting to act as secretary and to minute the proceedings at the General Meeting. The minutes of a General Meeting shall be adopted by the chairman of that General Meeting or by the Board of Directors. Where an official report of the proceedings is drawn up by a civil law notary, no minutes need to be prepared. Every Director may instruct a civil law notary to draw up such an official report at the Company&#8217;s expense. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">23.3</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The chairman of the General Meeting shall decide on the admittance to the General Meeting of persons other than: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the persons who have Meeting Rights at that General Meeting, or their proxyholders; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>those who have a statutory right to attend that General Meeting on other grounds. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">23.4</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The holder of a written proxy from a Person with Meeting Rights who is entitled to attend a General Meeting shall only be admitted to that General Meeting if the proxy is determined to be acceptable by the chairman of that General Meeting. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">23.5</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Company may direct that any person, before being admitted to a General Meeting, identify himself by means of a valid passport or driver&#8217;s license and/or should be submitted to such security arrangements as the Company may consider to be appropriate under the given circumstances. Persons who do not comply with these requirements may be refused entry to the General Meeting. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">23.6</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The chairman of the General Meeting has the right to eject any person from the General Meeting if he considers that person to disrupt the orderly proceedings at the General Meeting. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">23.7</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The General Meeting may be conducted in a language other than the Dutch language, if so determined by the chairman of the General Meeting. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">23.8</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The chairman of the General Meeting may limit the amount of time that persons present at the General Meeting are allowed to take in addressing the General Meeting and the number of questions they are allowed to raise, with a view to safeguarding the orderly proceedings at the General Meeting. The chairman of the General Meeting may also adjourn the meeting if he considers that this shall safeguard the orderly proceedings at the General Meeting. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">GENERAL MEETING - EXERCISE OF MEETING AND VOTING RIGHTS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 24 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">24.1</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Each Person with Meeting Rights has the right to attend, address and, if applicable, vote at General Meetings, whether in person or represented by the holder of a written proxy. Holders of fractional shares together constituting the nominal value of a share of the relevant class shall exercise these rights collectively, whether through one of them or through the holder of a written proxy. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-17 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">24.2</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Board of Directors may decide that each Person with Meeting Rights is entitled, whether in person or represented by the holder of a written proxy, to participate in, address and, if applicable, vote at the General Meeting by electronic means of communication. For the purpose of applying the preceding sentence it must be possible, by electronic means of communication, for the Person with Meeting Rights to be identified, to observe in real time the proceedings at the General Meeting and, if applicable, to vote. The Board of Directors may impose conditions on the use of the electronic means of communication, provided that these conditions are reasonable and necessary for the identification of the Person with Meeting Rights and the reliability and security of the communication. Such conditions must be announced in the convening notice. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">24.3</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Board of Directors can also decide that votes cast through electronic means of communication or by means of a letter prior to the General Meeting are considered to be votes that are cast during the General Meeting. These votes shall not be cast prior to the Registration Date. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">24.4</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>For the purpose of Articles 24.1 through 24.3, those who have voting rights and/or Meeting Rights on the Registration Date and are recorded as such in a register designated by the Board of Directors shall be considered to have those rights, irrespective of whoever is entitled to the shares or depository receipts at the time of the General Meeting. Unless Dutch law requires otherwise, the Board of Directors is free to determine, when convening a General Meeting, whether the previous sentence applies. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">24.5</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Each Person with Meeting Rights must notify the Company in writing of his identity and his intention to attend the General Meeting. This notice must be received by the Company ultimately on the seventh day prior to the General Meeting, unless indicated otherwise when such General Meeting is convened. Persons with Meeting Rights that have not complied with this requirement may be refused entry to the General Meeting. When a General Meeting is convened the Board of Directors may stipulate not to apply the previous provisions of this Article 24.5 in respect of the exercise of Meeting Rights and/or voting rights attached to preferred shares at such General Meeting. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">GENERAL MEETING - DECISION-MAKING </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 25 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">25.1</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Each share, irrespective of which class it concerns, shall give the right to cast one vote at the General Meeting. Fractional shares of a certain class, if any, collectively constituting the nominal value of a share of that class shall be considered to be equivalent to such a share. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">25.2</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>No vote may be cast at a General Meeting in respect of a share belonging to the Company or a Subsidiary or in respect of a share for which any of them holds the depository receipts. Usufructuaries and pledgees of shares belonging to the Company or its Subsidiaries are not, however, precluded from exercising their voting rights if the usufruct or pledge was created before the relevant share belonged to the Company or a Subsidiary. Neither the Company nor a Subsidiary may vote shares in respect of which it holds a usufruct or a pledge. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">25.3</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Unless a greater majority is required by law or by these articles of association, all resolutions of the General Meeting shall be passed by Simple Majority. Subject to any provision of mandatory Dutch law and any higher quorum requirement stipulated by these articles of association, if and for as long as the Company is subject to the rules and requirements of a securities exchange and such securities exchange requires the Company to have a quorum for the General Meeting, then the General Meeting can only pass resolutions if at least one third of the issued and outstanding shares in the Company&#8217;s capital are present or represented at such General Meeting. A second meeting as referred to in Section&#160;2:120(3) DCC cannot be convened. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">25.4</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Invalid votes, blank votes and abstentions shall not be counted as votes cast. Shares in respect of which an invalid or blank vote has been cast and shares in respect of which an abstention has been made shall be taken into account when determining the part of the issued share capital that is represented at a General Meeting. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-18 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">25.5</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Where there is a tie in any vote of the General Meeting, the relevant resolution shall not have been passed. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">25.6</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The chairman of the General Meeting shall decide on the method of voting and the voting procedure at the General Meeting. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">25.7</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The determination during the General Meeting made by the chairman of that General Meeting with regard to the results of a vote shall be decisive. If the accuracy of the chairman&#8217;s determination is contested immediately after it has been made, a new vote shall take place if the majority of the General Meeting so requires or, where the original vote did not take place by response to a roll call or in writing, if any party with voting rights who is present so requires. The legal consequences of the original vote shall lapse as a result of the new vote. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">25.8</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Board of Directors shall keep a record of the resolutions passed. The record shall be available at the Company&#8217;s office for inspection by Persons with Meeting Rights. Each of them shall, upon request, be provided with a copy of or extract from the record, at no more than the cost price. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">25.9</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Directors shall, in that capacity, have an advisory vote at the General Meetings. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">GENERAL MEETING - SPECIAL RESOLUTIONS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 26 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">26.1</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The following resolutions can only be passed by the General Meeting at the proposal of the Board of Directors: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the issue of shares or the granting of rights to subscribe for shares; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the limitation or exclusion of <span style="white-space:nowrap">pre-emption</span> rights; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">c.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the designation or granting of an authorisation as referred to in Articles 6.1, 7.5 and 10.2, respectively; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">d.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the reduction of the Company&#8217;s issued share capital; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">e.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the granting of an approval as referred to in Article 18.11; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">f.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the making of a distribution from the Company&#8217;s profits or reserves on the common shares; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">g.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the making of a distribution in the form of shares in the Company&#8217;s capital or in the form of assets, instead of in cash; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">h.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the amendment of these articles of association; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">i.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the entering into of a merger or demerger; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">j.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the instruction of the Board of Directors to apply for the Company&#8217;s bankruptcy; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">k.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the Company&#8217;s dissolution. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">26.2</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>For purposes of Article 26.1, a resolution shall not be considered to have been proposed by the Board of Directors if such resolution has been included in the convening notice or announced in the same manner by or at the request of one or more Persons with Meeting Rights pursuant to Articles <span style="color:#ff0200"><span style="text-decoration:line-through">22.5</span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">22.6</span><span style="text-decoration:line-through"></span> and/or <span style="font-weight:bold"></span><span style="color:#ff0200"><span style="text-decoration:line-through">22.6</span></span><span style="font-weight:bold"></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">22.7</span></span><span style="font-weight:bold"></span>, unless the Board of Directors has expressly indicated its support of such resolution in the agenda of the General Meeting concerned or in the explanatory notes thereto. </span></span></p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">CLASS MEETINGS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 27 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">27.1</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>A Class&#160;Meeting shall be held whenever a resolution of that Class&#160;Meeting is required by Dutch law or under these articles of association and otherwise whenever the Board of Directors so decides. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-19 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">27.2</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Without prejudice to Article 27.1, for Class&#160;Meetings of common shares, the provisions concerning the convening of, drawing up of the agenda for, holding of and decision-making by the General Meeting apply mutatis mutandis. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">27.3</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>For Class&#160;Meetings of preferred shares, the following shall apply: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Articles 22.3, <span style="font-weight:bold"></span><span style="color:#ff0200"><span style="text-decoration:line-through">22.8</span></span><span style="font-weight:bold"></span><span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">22.9</span></span><span style="font-weight:bold"></span>, 23.3, 25.1, 25.2 through 25.9 apply mutatis mutandis; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>a Class&#160;Meeting must be convened no later than on the eighth day prior to that of the meeting; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">c.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>a Class&#160;Meeting shall appoint its own chairman; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">d.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>where the rules laid down by these articles of association in relation to the convening, location of or drawing up of the agenda for a Class&#160;Meeting have not been complied with, legally valid resolutions may still be passed by that Class&#160;Meeting by a unanimous vote at a meeting at which all shares of the relevant class are represented. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">27.4</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Holders of preferred shares may pass resolutions in writing instead of at a meeting by a unanimous vote of all shareholders concerned. The votes may be cast electronically. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">REPORTING - FINANCIAL YEAR, ANNUAL ACCOUNTS AND MANAGEMENT REPORT </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 28 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">28.1</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Company&#8217;s financial year shall coincide with the calendar year. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE;padding-bottom:2pt; margin-bottom:-1pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">28.2</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Annually, within the relevant statutory period, the Board of Directors shall prepare the annual accounts and the management report and deposit them at the Company&#8217;s office for inspection by the shareholders.<span style="color:#1e3aff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline"> The Board of Directors shall also send the annual accounts to the Works Council.</span></span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">28.3</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The annual accounts shall be signed by the Directors. If any of their signatures is missing, this shall be mentioned, stating the reasons. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">28.4</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Company shall ensure that the annual accounts, the management report and the particulars to be added pursuant to Section&#160;2:392(1) DCC shall be available at its offices as from the convening of the General Meeting at which they are to be discussed. The Persons with Meeting Rights are entitled to inspect such documents at that location and to obtain a copy at no cost. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">28.5</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The annual accounts shall be adopted by the General Meeting. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">REPORTING - AUDIT </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 29 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">29.1</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The General Meeting shall instruct an auditor as referred to in Section&#160;2:393 DCC to audit the annual accounts. Where the General Meeting fails to do so, the Board of Directors shall be authorised. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">29.2</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The instruction may be revoked by the General Meeting and, if the Board of Directors has granted the instruction, by the Board of Directors. The instruction can only be revoked for well-founded reasons; a difference of opinion regarding the reporting or auditing methods shall not constitute such a reason. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">DISTRIBUTIONS - GENERAL </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 30 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">30.1</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>A distribution can only be made to the extent that the Company&#8217;s equity exceeds the amount of the paid up and called up part of its capital plus the reserves which must be maintained by law. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">30.2</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>No entitlement to distributions is attached to preferred shares, other than as described in Articles 11.2, 32.1 and 33.3. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-20 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">30.3</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Distributions shall be made in proportion to the aggregate nominal value of the shares. In deviation of the previous sentence, distributions on preferred shares (or to the former holders of preferred shares) shall be made in proportion to the amounts paid up (or formerly paid up) on those preferred shares. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">30.4</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The parties entitled to a distribution shall be the relevant shareholders, usufructuaries and pledgees, as the case may be, at a date to be determined by the Board of Directors for that purpose. This date shall not be earlier than the date on which the distribution was announced. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">30.5</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The General Meeting may resolve, subject to Article 26, that all or part of such distribution, instead of being made in cash, shall be made in the form of shares in the Company&#8217;s capital or in the form of the Company&#8217;s assets. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">30.6</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Board of Directors may resolve to make interim distributions, provided that it appears from interim accounts to be prepared in accordance with Section&#160;2:105(4) DCC that the requirement referred to in Article 30.1 has been met and, if it concerns an interim distribution of profits, taking into account the order of priority described in Article 32.1. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">30.7</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>A distribution shall be payable on such date and, if it concerns a distribution in cash, in such currency as determined by the Board of Directors. If it concerns a distribution in the form of the Company&#8217;s assets, the Board of Directors shall determine the value attributed to such distribution for purposes of recording the distribution in the Company&#8217;s accounts with due observance of applicable law (including the applicable accounting principles). </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">30.8</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>A claim for payment of a distribution shall lapse after five years have expired after the distribution became payable. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">30.9</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>For the purpose of calculating the amount or allocation of any distribution, shares held by the Company in its own capital shall not be taken into account. No distribution shall be made to the Company in respect of shares held by it in its own capital. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">DISTRIBUTIONS - RESERVES </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 31 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">31.1</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>All reserves maintained by the Company shall be attached exclusively to the common shares. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">31.2</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Subject to Article 26, the General Meeting is authorised to resolve to make a distribution from the Company&#8217;s reserves. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">31.3</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Without prejudice to Articles 31.4 and 32.2, distributions from a reserve shall be made exclusively on the class of shares to which such reserve is attached. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">31.4</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>The Board of Directors may resolve to charge amounts to be paid up on shares against the Company&#8217;s reserves, irrespective of whether those shares are issued to existing shareholders. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">DISTRIBUTIONS - PROFITS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 32 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">32.1</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Subject to Article 30.1, the profits shown in the Company&#8217;s annual accounts in respect of a financial year shall be appropriated as follows, and in the following order of priority: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>to the extent that any preferred shares have been cancelled without the distribution described in Article 11.2 paragraph b. having been paid in full and without any such deficit subsequently having been paid in full as described in this Article 32.1 or Article 32.2, an amount equal to any such (remaining) deficit shall be distributed to those who held those preferred shares at the moment of such cancellation becoming effective; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-21 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>to the extent that any Preferred Distribution (or part thereof) in relation to previous financial years has not yet been paid in full as described in this Article 32.1 or Article 32.2, an amount equal to any such (remaining) deficit shall be distributed on the preferred shares; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">c.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the Preferred Distribution shall be distributed on the preferred shares in respect of the financial year to which the annual accounts pertain; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">d.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the Board of Directors shall determine which part of the remaining profits shall be added to the Company&#8217;s reserves; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">e.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>subject Article 26, the remaining profits shall be at the disposal of the General Meeting for distribution on the common shares. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">32.2</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>To the extent that the distributions described in Article 32.1 paragraphs a. through c. (or any part thereof) cannot be paid out of the profits shown in the annual accounts, any such deficit shall be distributed from the Company&#8217;s reserves, subject to Articles 30.1 and 30.2. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">32.3</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>Without prejudice to Article 30.1, a distribution of profits shall be made after the adoption of the annual accounts that show that such distribution is allowed. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">DISSOLUTION AND LIQUIDATION </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 33 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">33.1</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>In the event of the Company being dissolved, the liquidation shall be effected by the Board of Directors, unless the General Meeting decides otherwise. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">33.2</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>To the extent possible, these articles of association shall remain in effect during the liquidation. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">33.3</span><span style="font-weight:bold"></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>To the extent that any assets remain after payment of all of the Company&#8217;s debts, those assets shall be distributed as follows, and in the following order of priority: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">a.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the amounts paid up on the preferred shares shall be repaid on such preferred shares; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">b.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>to the extent that any preferred shares have been cancelled without the distribution described in Article 11.2 paragraph b. having been paid in full and without any such deficit subsequently having been paid in full as described in Articles 32.1 and 32.2, an amount equal to any such (remaining) deficit shall be distributed to those who held those preferred shares at the moment of such cancellation becoming effective; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">c.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>to the extent that any Preferred Distribution (or part thereof) in relation to financial years prior to the financial year in which the distribution referred to in paragraph a. occurs has not yet been paid in full as described in Articles 32.1 and 32.2, an amount equal to any such (remaining) deficit shall be distributed on the preferred shares; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">d.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>the Preferred Distribution shall be paid on the preferred shares calculated in respect of the part of the financial year in which the distribution referred to in paragraph a. is made, for the number of days that have already elapsed during such part of the financial year; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left"><span style="font-weight:bold">e.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>any remaining assets shall be distributed to the holders of common shares. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">33.4</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"></span>After the Company has ceased to exist, its books, records and other information carriers shall be kept for the period prescribed by law by the person designated for that purpose in the resolution of the General Meeting to dissolve the Company. Where the General Meeting has not designated such a person, the liquidators shall do so. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-22 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">FEDERAL FORUM PROVISION </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Article 34 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as otherwise consented to in writing by the Company, the sole and exclusive forum for any complaint asserting a cause of action arising under the United States Securities Act of 1933, as amended, to the fullest extent permitted by applicable law, shall be the federal district courts of the United States of America. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-23 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:right" id="toc706699_70">Annex B </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">MERUS N.V. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">2016 INCENTIVE AWARD PLAN </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="font-family:Times New Roman;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">(A<small style="font-weight:inherit;font-style:unset;text-decoration:unset">S</small> A<small style="font-weight:inherit;font-style:unset;text-decoration:unset">MENDED</small> <small style="font-weight:inherit;font-style:unset;text-decoration:unset">AND</small> R<small style="font-weight:inherit;font-style:unset;text-decoration:unset">ESTATED</small> E<small style="font-weight:inherit;font-style:unset;text-decoration:unset">FFECTIVE</small> [&#8195;&#8195;&#8195;], 2024)</span></span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE I. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">PURPOSE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan&#8217;s purpose is to enhance the Company&#8217;s ability to attract, retain and motivate persons who make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities. Capitalized terms used in the Plan are defined in Article&#160;XI. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE II. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ELIGIBILITY </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Service Providers are eligible to be granted Awards under the Plan, subject to the limitations described herein. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE III. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ADMINISTRATION AND DELEGATION </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 <span style="text-decoration:underline">Administration</span>. The Plan is administered by the Administrator. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <span style="text-decoration:underline">Grant Authority</span>. Subject to the conditions and limitations in the Plan and Applicable Laws, the Board of Directors has authority to grant Awards and set Award terms and conditions for Service Providers. The <span style="white-space:nowrap">non-executive</span> directors of the Board of Directors will be granted Awards in accordance with the Merus N.V. <span style="white-space:nowrap">Non-Executive</span> Directors Compensation Program. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">Administrative Authority.</span></span><span style="font-family:Times New Roman"> The Administrator has the authority to take all actions and make all determinations under the Plan, to interpret the Plan and Award Agreements on behalf of the Company and to adopt, amend and repeal Plan administrative rules, guidelines and practices as it deems advisable. The Administrator may correct defects and ambiguities, supply omissions and reconcile inconsistencies in the Plan or any Award as it deems necessary or appropriate to administer the Plan and any Awards. The Administrator&#8217;s determinations under the Plan are in its sole discretion. Notwithstanding anything in the Plan to the contrary, all actions taken by the Board of Directors under the Plan shall be subject to the conditions and limitations set forth in the Articles and the Board Rules. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4 <span style="text-decoration:underline">Appointment of Committees</span>. To the extent the Articles and Applicable Laws permit, the Board of Directors may delegate any or all of its powers under the Plan to one or more Committees or officers of the Company or any of its Subsidiaries. The Board of Directors, may abolish any Committee it established or <span style="white-space:nowrap">re-vest</span> in itself any previously delegated authority at any time. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE IV. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SHARES AVAILABLE FOR AWARDS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <span style="text-decoration:underline">Number of Shares</span>. Subject to adjustment under Article&#160;VIII and the terms of this Article&#160;IV, Awards may be made under the Plan covering up to the Overall Share Limit. <span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">As of the Plan&#8217;s effective date under Section&#160;10.3, the Company will cease granting awards under the Prior Plans; however, Prior Plan Awards will</span></span><span style="font-family:Times New Roman"> </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">remain subject to the terms of the applicable Prior Plan.</span></span><span style="font-family:Times New Roman"> Shares issued under the Plan may consist of authorized but unissued Shares, Shares purchased on the open market or treasury Shares. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <span style="text-decoration:underline">Share Recycling</span>. If all or any part of an Award expires, lapses or is terminated, exchanged for cash, surrendered, repurchased, canceled without having been fully exercised or forfeited, in any case, in a manner that results in the Company acquiring Shares covered by the Award at a price not greater than the price (as adjusted to reflect any Equity Restructuring) paid by the Participant for such Shares or not issuing any Shares covered by the Award, the unused Shares covered by the Award will again be available for Award grants under the Plan. Further, Shares delivered (either by actual delivery or attestation) to the Company by a Participant to satisfy the applicable exercise or purchase price of an Award and/or to satisfy any applicable tax withholding obligation (including Shares retained by the Company from the Award being exercised or purchased and/or creating the tax obligation) will again be available for Award grants under the Plan. The payment of Dividend Equivalents in cash in conjunction with any outstanding Awards shall not count against the Overall Share Limit. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3 <span style="text-decoration:underline">Substitute Awards</span>. <span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">With due observance of the division of authority described in Section 3.2 hereof,</span></span><span style="font-family:Times New Roman"> </span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">i</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">I</span></span><span style="font-family:Times New Roman">n connection with an entity&#8217;s merger or consolidation with the Company or the Company&#8217;s acquisition of an entity&#8217;s property or stock, the Administrator may grant Awards in substitution for any options or other stock or stock-based awards granted before such merger or consolidation by such entity or its affiliate. Substitute Awards may be granted on such terms as the Administrator deems appropriate, notwithstanding limitations on Awards in the Plan. Substitute Awards will not count against the Overall Share Limit (nor shall Shares subject to a Substitute Award be added to the Shares available for Awards under the Plan as provided above), except that Shares acquired by exercise of substitute Incentive Stock Options will count against the maximum number of Shares that may be issued pursuant to the exercise of Incentive Stock Options under the Plan. Additionally, in the event that a company acquired by the Company or any Subsidiary or with which the Company or any Subsidiary combines has shares available under a <span style="white-space:nowrap">pre-existing</span> plan approved by stockholders and not adopted in contemplation of such acquisition or combination, the shares available for grant pursuant to the terms of such <span style="white-space:nowrap">pre-existing</span> plan (as adjusted, to the extent appropriate, using the exchange ratio or other adjustment or valuation ratio or formula used in such acquisition or combination to determine the consideration payable to the holders of common stock of the entities party to such acquisition or combination) may be used for Awards under the Plan and shall not reduce the Shares authorized for grant under the Plan (and Shares subject to such Awards shall not be added to the Shares available for Awards under the Plan as provided above); provided that Awards using such available shares shall not be made after the date awards or grants could have been made under the terms of the <span style="white-space:nowrap">pre-existing</span> plan, absent the acquisition or combination, and shall only be made to individuals who were not Employees or members of the Board of Directors prior to such acquisition or combination. </span></p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE V. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">STOCK OPTIONS AND STOCK APPRECIATION RIGHTS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 <span style="text-decoration:underline">General</span>. <span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">With due observance of the division of authority described in Section&#160;3.2 hereof,</span></span><span style="font-family:Times New Roman"> </span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">T</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">t</span></span><span style="font-family:Times New Roman">he Administrator (i)&#160;may grant Options or Stock Appreciation Rights to Service Providers subject to the limitations in the Plan, including any limitations in the Plan that apply to Incentive Stock Options, and (ii)&#160;will determine the number of Shares covered by each Option and Stock Appreciation Right, the exercise price of each Option and Stock Appreciation Right and the conditions and limitations applicable to the exercise of each Option and Stock Appreciation Right. A Stock Appreciation Right will entitle the Participant (or other person entitled to exercise the Stock Appreciation Right) to receive from the Company upon exercise of the exercisable portion of the Stock Appreciation Right an amount determined by multiplying the excess, if any, of the Fair Market Value of one Share on the date of exercise over the exercise price per Share of the Stock Appreciation Right by the number of Shares with respect to which the Stock Appreciation Right is exercised, subject to any limitations of the Plan or that the Administrator may impose and payable in cash, Shares valued at Fair Market Value or a combination of the two as the Administrator may determine or provide in the Award Agreement. </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <span style="text-decoration:underline">Exercise Price</span>. The Administrator will establish each Option&#8217;s and Stock Appreciation Right&#8217;s exercise price and specify the exercise price in the Award Agreement. Unless otherwise determined by the Administrator, the exercise price will not be less than 100% of the Fair Market Value on the grant date of the Option or Stock Appreciation Right. Notwithstanding the foregoing, if on the last day of the term of an Option or Stock Appreciation Right the Fair Market Value of one Share exceeds the applicable exercise or base price per Share, the Participant has not exercised the Option or Stock Appreciation Right and remains employed by the Company or one of its Subsidiaries and the Option or Stock Appreciation Right has not expired, the Option or Stock Appreciation Right shall be deemed to have been exercised by the Participant on such day with payment made by withholding Shares otherwise issuable in connection with its exercise. In such event, the Company shall deliver to the Participant the number of Shares for which the Option or Stock Appreciation Right was deemed exercised, less the number of Shares required to be withheld for the payment of the total purchase price and required withholding taxes; provided, however, any fractional Share shall be settled in cash. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <span style="text-decoration:underline">Duration of Options</span>. Each Option or Stock Appreciation Right will be exercisable at such times and as specified in the Award Agreement, provided that the term of an Option or Stock Appreciation Right will not exceed ten (10)&#160;years. Notwithstanding the foregoing and unless determined otherwise by the Company, in the event that on the last business day of the term of an Option or Stock Appreciation Right (other than an Incentive Stock Option)&#160;(i) the exercise of the Option or Stock Appreciation Right is prohibited by Applicable Law, as determined by the Company, or (ii)&#160;Shares may not be purchased or sold by the applicable current or former Service Provider due to any Company insider trading policy (including blackout periods) or a <span style="white-space:nowrap">&#8220;lock-up&#8221;</span> agreement undertaken in connection with an issuance of securities by the Company, the term of the Option or Stock Appreciation Right shall be extended for a period of thirty (30)&#160;days following the end of the legal prohibition, <span style="white-space:nowrap">black-out</span> period or <span style="white-space:nowrap">lock-up</span> agreement, as determined by the Company; provided, however, in no event shall the extension last beyond the ten year term of the applicable Option or Stock Appreciation Right unless the exercise would violate an Applicable Law. Notwithstanding the foregoing, if the Participant, prior to the end of the term of an Option or Stock Appreciation Right, violates the <span style="white-space:nowrap">non-competition,</span> <span style="white-space:nowrap">non-solicitation</span> or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company or any of its Subsidiaries, the right to exercise the Option or Stock Appreciation Right, as applicable, may, as determined by the Administrator, terminate immediately upon such violation. In addition, if, prior to the end of the term of an Option or Stock Appreciation Right, the Participant is given notice by the Company or any of its Subsidiaries of the termination of his or her employment or other service relationship, or the employment or other service relationship is otherwise terminated for Cause, the right to exercise the Option or Stock Appreciation Right, as applicable, shall be suspended from the time of the delivery of such notice or, in the event of other termination, as of the initiation thereof, until the earlier of (i)&#160;such time as it is determined or otherwise agreed that the Participant&#8217;s employment or other relationship shall not be terminated for Cause or (ii)&#160;the effective date of the initiation of such termination of employment or other relationship (in which case the right to exercise the Option or Stock Appreciation Right, as applicable, shall terminate immediately upon the effective date of such termination of employment or other service relationship). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 <span style="text-decoration:underline">Exercise</span>. Options and Stock Appreciation Rights may be exercised by delivering to the Company a written notice of exercise, in a form the Administrator approves (which may be electronic), signed by the person authorized to exercise the Option or Stock Appreciation Right, together with, as applicable, payment in full (i)&#160;as specified in Section&#160;5.5 for the number of Shares for which the Award is exercised and (ii)&#160;as specified in Section&#160;9.4 for any applicable taxes. Unless the Administrator otherwise determines, an Option or Stock Appreciation Right may not be exercised for a fraction of a Share. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5 <span style="text-decoration:underline">Payment Upon Exercise</span>. Subject to Section&#160;10.7, any Company insider trading policy (including blackout periods) and Applicable Laws, the exercise price of an Option must be paid by: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) cash, wire transfer of immediately available funds or by check payable to the order of the Company; provided, that, the Company may limit the use of one of the foregoing exercise methods if one or more of the exercise methods below is permitted; </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) if there is a public market for Shares at the time of exercise, unless the Company otherwise determines, (A)&#160;delivery (including telephonically to the extent permitted by the Company) of an irrevocable and unconditional undertaking by a broker acceptable to the Company to deliver promptly to the Company sufficient funds to pay the exercise price, or (B)&#160;the Participant&#8217;s delivery to the Company of a copy of irrevocable and unconditional instructions to a broker acceptable to the Company to deliver promptly to the Company cash or a check sufficient to pay the exercise price; provided that such amount is paid to the Company at such time as may be required by the Administrator; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) to the extent permitted by the Administrator, delivery (either by actual delivery or attestation) of Shares owned by the Participant valued at their Fair Market Value; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) to the extent permitted by the Administrator, surrendering Shares then issuable upon the Option&#8217;s exercise valued at their Fair Market Value on the exercise date; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) to the extent permitted by the Administrator, delivery of a promissory note or any other property that the Administrator determines is good and valuable consideration; or </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) to the extent permitted by the Company, any combination of the above payment forms approved by the Administrator. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE VI. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">RESTRICTED STOCK; RESTRICTED STOCK UNITS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1 <span style="text-decoration:underline">General</span>. <span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">With due observance of the division of authority described in Section 3.2 hereof, t</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">T</span></span><span style="font-family:Times New Roman">he Administrator may grant Restricted Stock, or the right to purchase Restricted Stock, to any Service Provider, subject to the Company&#8217;s right to repurchase all or part of such shares at their issue price or other stated or formula price from the Participant (or to require forfeiture of such shares) if conditions the Administrator specifies in the Award Agreement are not satisfied before the end of the applicable restriction period or periods that the Administrator establishes for such Award. In addition, the Administrator may grant to Service Providers Restricted Stock Units, which may be subject to vesting and forfeiture conditions during the applicable restriction period or periods, as set forth in an Award Agreement. The Administrator will determine and set forth in the Award Agreement the terms and conditions for each Restricted Stock and Restricted Stock Unit Award, subject to the conditions and limitations contained in the Plan. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2 <span style="text-decoration:underline">Restricted Stock</span>. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <span style="text-decoration:underline">Dividends</span>. Participants holding shares of Restricted Stock will be entitled to all ordinary cash dividends paid with respect to such Shares, unless the Administrator provides otherwise in the Award Agreement. In addition, unless the Administrator provides otherwise, if any dividends or distributions are paid in Shares, or consist of a dividend or distribution to holders of Common Stock of property other than an ordinary cash dividend, the Shares or other property will be subject to the same restrictions on transferability and forfeitability as the shares of Restricted Stock with respect to which they were paid. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <span style="text-decoration:underline">Share Certificates</span>. The Company may require that the Participant deposit in escrow with the Company (or its designee) any share certificates issued in respect of shares of Restricted Stock, together with a share power endorsed in blank. </p> <p style="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.3 <span style="text-decoration:underline">Restricted Stock Units.</span> </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <span style="text-decoration:underline">Settlement</span>. The Administrator may provide that settlement of Restricted Stock Units will occur upon or as soon as reasonably practicable after the Restricted Stock Units vest or will instead be deferred, on a mandatory basis or at the Participant&#8217;s election. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <span style="text-decoration:underline">Shareholder Rights</span>. A Participant will have no rights of a shareholder with respect to Shares subject to any Restricted Stock Unit unless and until the Shares are delivered in settlement of the Restricted Stock Unit. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <span style="text-decoration:underline">Dividend Equivalents</span>. If the Administrator provides, a grant of Restricted Stock Units may provide a Participant with the right to receive Dividend Equivalents. Dividend Equivalents may be paid currently or credited to an account for the Participant, settled in cash or Shares and subject to the same restrictions on transferability and forfeitability as the Restricted Stock Units with respect to which the Dividend Equivalents are granted and subject to other terms and conditions as set forth in the Award Agreement. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE VII. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">OTHER STOCK OR CASH BASED AWARDS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other Stock or Cash Based Awards may be granted to Participants, including Awards entitling Participants to receive Shares to be delivered in the future and including annual or other periodic or long-term cash bonus awards (whether based on specified Performance Criteria or otherwise), in each case subject to any conditions and limitations in the Plan. Such Other Stock or Cash Based Awards will also be available as a payment form in the settlement of other Awards, as standalone payments and as payment in lieu of compensation to which a Participant is otherwise entitled. Other Stock or Cash Based Awards may be paid in Shares, cash or other property, as the Administrator determines. <span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">With due observance of the division of authority described in Section<span style="font-weight:bold"></span> 3.2 hereof and s</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">S</span></span><span style="font-family:Times New Roman">ubject to the provisions of the Plan, the Administrator will determine the terms and conditions of each Other Stock or Cash Based Award, including any purchase price, performance goal (which may be based on the Performance Criteria), transfer restrictions, and vesting conditions, which will be set forth in the applicable Award Agreement. </span></p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE VIII. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ADJUSTMENTS FOR CHANGES IN COMMON STOCK </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">AND CERTAIN OTHER EVENTS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1 <span style="text-decoration:underline">Equity Restructuring</span>. In connection with any Equity Restructuring, notwithstanding anything to the contrary in this Article VIII, <span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">and with due observance of the division of authority described in Section 3.2 hereof,</span></span><span style="font-family:Times New Roman"> the Administrator will equitably adjust each outstanding Award as it deems appropriate to reflect the Equity Restructuring, which may include adjusting the number and type of securities subject to each outstanding Award and/or the Award&#8217;s exercise price or grant price (if applicable), granting new Awards to Participants, and making a cash payment to Participants. The adjustments provided under this Section&#160;8.1 will be nondiscretionary and final and binding on the affected Participant and the Company; provided that the Administrator will determine whether an adjustment is equitable. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2 <span style="text-decoration:underline">Corporate Transactions</span>. In the event of any <span style="white-space:nowrap">spin-off,</span> Change in Control or any change in any Applicable Laws or accounting principles, the Administrator, <span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">with due observance of the division of authority described in Section&#160;3.2 hereof and</span></span><span style="font-family:Times New Roman"> on such terms and conditions as it deems appropriate, either by the terms of the Award or by action taken prior to the occurrence of such transaction or event (except that action to give effect to a change in Applicable Law or accounting principles may be made within a reasonable period of time after such change) and either automatically or upon the Participant&#8217;s request, is hereby authorized to take any one or more of the following actions whenever the Administrator determines that such action is appropriate in order to (x)&#160;prevent dilution or enlargement of the benefits or potential benefits intended by the Company to be made available under the Plan or with respect to any Award granted or issued under the Plan, (y)&#160;to facilitate such transaction or event or (z)&#160;give effect to such changes in Applicable Laws or accounting principles: </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) To provide for the cancellation of any such Award in exchange for either an amount of cash or other property with a value equal to the amount that could have been obtained upon the exercise or settlement of the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
vested portion of such Award or realization of the Participant&#8217;s rights under the vested portion of such Award, as applicable; provided that, if the amount that could have been obtained upon the exercise or settlement of the vested portion of such Award or realization of the Participant&#8217;s rights, in any case, is equal to or less than zero, then the Award may be terminated without payment; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) To provide that such Award shall vest and, to the extent applicable, be exercisable as to all shares covered thereby, notwithstanding anything to the contrary in the Plan or the provisions of such Award; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) To provide that such Award be assumed by the successor or survivor corporation, or a parent or subsidiary thereof, or shall be substituted for by awards covering the stock of the successor or survivor corporation, or a parent or subsidiary thereof, with appropriate adjustments as to the number and kind of shares and/or applicable exercise or purchase price, in all cases, as determined by the Administrator; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) To make adjustments in the number and type of shares of Common Stock (or other securities or property) subject to outstanding Awards and/or with respect to which Awards may be granted under the Plan (including, but not limited to, adjustments of the limitations in Article&#160;IV hereof on the maximum number and kind of shares which may be issued) and/or in the terms and conditions of (including the grant or exercise price), and the criteria included in, outstanding Awards; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) To replace such Award with other rights or property selected by the Administrator; and/or </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) To provide that the Award will terminate and cannot vest, be exercised or become payable after the applicable event. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.3 <span style="text-decoration:underline">Administrative Stand Still</span>. In the event of any pending share dividend, share split, combination or exchange of shares, merger, consolidation or other distribution (other than normal cash dividends) of Company assets to shareholders, or any other extraordinary transaction or change affecting the Shares or the share price of Common Stock, including any Equity Restructuring or any securities offering or other similar transaction, for administrative convenience, the Administrator<span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">, with due observance of the division of authority described in Section<span style="font-weight:bold"></span> 3.2 hereof,</span></span><span style="font-family:Times New Roman"> may refuse to permit the exercise of any Award for up to sixty days before or after such transaction. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.4 <span style="text-decoration:underline">General</span>. Except as expressly provided in the Plan or the Administrator&#8217;s action under the Plan, no Participant will have any rights due to any subdivision or consolidation of Shares of any class, dividend payment, increase or decrease in the number of Shares of any class or dissolution, liquidation, merger, or consolidation of the Company or other corporation. Except as expressly provided with respect to an Equity Restructuring under Section&#160;8.1 above or the Administrator&#8217;s action under the Plan, no issuance by the Company of Shares of any class, or securities convertible into Shares of any class, will affect, and no adjustment will be made regarding, the number of Shares subject to an Award or the Award&#8217;s grant or exercise price. The existence of the Plan, any Award Agreements and the Awards granted hereunder will not affect or restrict in any way the Company&#8217;s right or power to make or authorize (i)&#160;any adjustment, recapitalization, reorganization or other change in the Company&#8217;s capital structure or its business, (ii)&#160;any merger, consolidation dissolution or liquidation of the Company or sale of Company assets or (iii)&#160;any sale or issuance of securities, including securities with rights superior to those of the Shares or securities convertible into or exchangeable for Shares. The Administrator may treat Participants and Awards (or portions thereof) differently under this Article&#160;VIII. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE IX. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">GENERAL PROVISIONS APPLICABLE TO AWARDS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1 <span style="text-decoration:underline">Transferability</span>. Except as the Administrator may determine or provide in an Award Agreement or otherwise for Awards, Awards may not be sold, assigned, transferred, pledged or otherwise encumbered, either </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
voluntarily or by operation of law, except by will or the laws of descent and distribution, or, subject to the Administrator&#8217;s consent, pursuant to a domestic relations order, and, during the life of the Participant, will be exercisable only by the Participant. References to a Participant, to the extent relevant in the context, will include references to a Participant&#8217;s authorized transferee that the Administrator specifically approves. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2 <span style="text-decoration:underline">Documentation</span>. Each Award will be evidenced in an Award Agreement, which may be written or electronic, as the Administrator determines. Each Award may contain terms and conditions in addition to those set forth in the Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3 <span style="text-decoration:underline">Discretion</span>. Except as the Plan otherwise provides, each Award may be made alone or in addition or in relation to any other Award. The terms of each Award to a Participant need not be identical, and the Administrator need not treat Participants or Awards (or portions thereof) uniformly. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.4 <span style="text-decoration:underline">Withholding</span>. Each Participant must pay the Company, or make provision satisfactory to the Administrator for payment of, any taxes required by law to be withheld in connection with such Participant&#8217;s Awards by the date of the event creating the tax liability. The Company may deduct an amount sufficient to satisfy such tax obligations based on the <span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">minimum </span></span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">maximum</span></span><span style="font-family:Times New Roman"> statutory withholding rates (or such other rate as may be determined by the Company after considering any accounting consequences or costs) from any payment of any kind otherwise due to a Participant. Subject to Section&#160;10.7 and any Company insider trading policy (including blackout periods), Participants may satisfy such tax obligations (i)&#160;in cash, by wire transfer of immediately available funds, by check made payable to the order of the Company; provided, that, the Company may limit the use of one of the foregoing methods if one or more of the exercise methods below is permitted, (ii)&#160;to the extent permitted by the Administrator, in whole or in part by delivery of Shares, including Shares retained from the Award creating the tax obligation, valued at their Fair Market Value, (iii)&#160;if there is a public market for Shares at the time the tax obligations are satisfied, unless the Company otherwise determines, (A)&#160;delivery (including telephonically to the extent permitted by the Company) of an irrevocable and unconditional undertaking by a broker acceptable to the Company to deliver promptly to the Company sufficient funds to satisfy the tax obligations, or (B)&#160;delivery by the Participant to the Company of a copy of irrevocable and unconditional instructions to a broker acceptable to the Company to deliver promptly to the Company cash or a check sufficient to satisfy the tax withholding; provided that such amount is paid to the Company at such time as may be required by the Administrator, or (iv)&#160;to the extent permitted by the Company, any combination of the foregoing payment forms approved by the Administrator. If any tax withholding obligation will be satisfied under clause (ii)&#160;of the immediately preceding sentence by the Company&#8217;s retention of Shares from the Award creating the tax obligation and there is a public market for Shares at the time the tax obligation is satisfied, the Company may elect to instruct any brokerage firm determined acceptable to the Company for such purpose to sell on the applicable Participant&#8217;s behalf some or all of the Shares retained and to remit the proceeds of the sale to the Company or its designee, and each Participant&#8217;s acceptance of an Award under the Plan will constitute the Participant&#8217;s authorization to the Company and instruction and authorization to such brokerage firm to complete the transactions described in this sentence. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.5 <span style="text-decoration:underline">Amendment of Award; Repricing</span>. <span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">With due observance of the division of authority described in Section&#160;3.2 hereof, the</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">The</span></span><span style="font-family:Times New Roman"> Administrator may amend, modify or terminate any outstanding Award, including by substituting another Award of the same or a different type, changing the exercise or settlement date, and converting an Incentive Stock Option to a <span style="white-space:nowrap">Non-Qualified</span> Stock Option. The Participant&#8217;s consent to such action will be required unless (i)&#160;the action, taking into account any related action, does not materially and adversely affect the Participant&#8217;s rights under the Award, or (ii)&#160;the change is permitted under Article&#160;VIII. Notwithstanding the foregoing or anything in the Plan to the contrary, the Administrator may not</span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">,</span></span><span style="font-family:Times New Roman"> except pursuant to Article&#160;VIII, without the approval of the shareholders of the Company, reduce the exercise price per share of outstanding Options or Stock Appreciation Rights or cancel outstanding Options or Stock Appreciation Rights in exchange for cash, other Awards or Options or Stock Appreciation Rights with an exercise price per share that is less than the exercise price per share of the original Options or Stock Appreciation Rights. </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.6 <span style="text-decoration:underline">Conditions on Delivery of Shares</span>. The Company will not be obligated to deliver any Shares under the Plan or remove restrictions from Shares previously delivered under the Plan until (i)&#160;all Award conditions have been met or removed to the Company&#8217;s satisfaction, (ii)&#160;as determined by the Company, all other legal matters regarding the issuance and delivery of such Shares have been satisfied, including any applicable securities laws and stock exchange or stock market rules and regulations, and (iii)&#160;the Participant has executed and delivered to the Company such representations or agreements as the Administrator deems necessary or appropriate to satisfy any Applicable Laws. The Company&#8217;s inability to obtain authority from any regulatory body having jurisdiction, which the Administrator determines is necessary to the lawful issuance and sale of any securities, will relieve the Company of any liability for failing to issue or sell such Shares as to which such requisite authority has not been obtained. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.7 <span style="text-decoration:underline">Acceleration</span>. The Administrator may at any time provide that any Award will become immediately vested and fully or partially exercisable, free of some or all restrictions or conditions, or otherwise fully or partially realizable. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.8 <span style="text-decoration:underline">Cash Payments</span>. Cash payments made to Participants under the Plan will be made in the currency the Participant is ordinarily paid in. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE X. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">MISCELLANEOUS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.1 <span style="text-decoration:underline">No Right to Employment or Other Status</span>. No person will have any claim or right to be granted an Award, and the grant of an Award will not be construed as giving a Participant the right to continued employment or any other relationship with the Company. The Company expressly reserves the right at any time to dismiss or otherwise terminate its relationship with a Participant free from any liability or claim under the Plan or any Award, except as expressly provided in an Award Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.2 <span style="text-decoration:underline">No Rights as Shareholder; Certificates</span>. Subject to the Award Agreement, no Participant or Designated Beneficiary will have any rights as a shareholder with respect to any Shares to be distributed under an Award until becoming the record holder of such Shares. Notwithstanding any other provision of the Plan, unless the Administrator otherwise determines or Applicable Laws require, the Company will not be required to deliver to any Participant certificates evidencing Shares issued in connection with any Award and instead such Shares may be recorded in the books of the Company (or, as applicable, its transfer agent or share plan administrator). The Company may place legends on share certificates issued under the Plan that the Administrator deems necessary or appropriate to comply with Applicable Laws. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.3 <span style="text-decoration:underline">Effective Date and Term of Plan</span>. <span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">Unless earlier terminated by the Board of Directors, the</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">The</span></span><span style="font-family:Times New Roman"> Plan</span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">, as amended and restated, shall</span></span><span style="font-family:Times New Roman"> </span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">has</span></span><span style="font-family:Times New Roman"> become effective on the </span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">date the Company&#8217;s shareholders approve this amendment and restatement of the Plan,</span></span><span style="font-family:Times New Roman"> </span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">day prior to the Public Trading Date (the &#8220;Effective Date&#8221;)</span></span><span style="font-family:Times New Roman"> and will remain in effect until </span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">and including December&#160;31, 2031, unless earlier terminated by the Board of Directors, </span></span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">the tenth (10<sup style="font-size:75%; vertical-align:top">th</sup>) anniversary of the earlier of (i)<span style="font-weight:bold"></span>&#160;the date the general meeting of shareholders of the Company adopted the Plan or (ii)<span style="font-weight:bold"></span> the date the Company&#8217;s shareholders approved the Plan, </span></span><span style="font-family:Times New Roman">but Awards previously granted may extend beyond that date in accordance with the Plan. No Awards may be granted under the Plan during any suspension period or after Plan termination. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.4 <span style="text-decoration:underline">Amendment of Plan</span>. The Board of Directors, may amend, suspend or terminate the Plan at any time; provided that no amendment, other than an increase to the Overall Share Limit, may materially and adversely affect any Award outstanding at the time of such amendment without the affected Participant&#8217;s consent. Awards outstanding at the time of any Plan suspension or termination will continue to be governed by the Plan and the Award Agreement, as in effect before such suspension or termination. The Administrator will obtain shareholder approval of any Plan amendment to the extent necessary to comply with the Articles or Applicable Laws. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-8 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.5 <span style="text-decoration:underline">Provisions for Foreign Participants</span>. The Administrator may modify Awards granted to Participants who are employed outside the Netherlands or establish subplans or procedures under the Plan to address differences in laws, rules, regulations or customs of such foreign jurisdictions with respect to tax, securities, currency, employee benefit or other matters. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.6 <span style="text-decoration:underline">Limitations on Liability</span>. Notwithstanding any other provisions of the Plan, no individual acting as a director, officer, other employee or agent of the Company or any Subsidiary will be liable to any Participant, former Participant, spouse, beneficiary, or any other person for any claim, loss, liability, or expense incurred in connection with the Plan or any Award, and such individual will not be personally liable with respect to the Plan because of any contract or other instrument executed in his or her capacity as an Administrator, director, officer, other employee or agent of the Company or any Subsidiary. The Company will indemnify and hold harmless each director, officer, other employee and agent of the Company or any Subsidiary that has been or will be granted or delegated any duty or power relating to the Plan&#8217;s administration or interpretation, against any cost or expense (including attorneys&#8217; fees) or liability (including any sum paid in settlement of a claim with the Administrator&#8217;s approval) arising from any act or omission concerning this Plan unless arising from such person&#8217;s own fraud or bad faith. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.7 <span style="text-decoration:underline"><span style="white-space:nowrap">Lock-Up</span> Period</span>. The Company may, at the request of any underwriter representative or otherwise, in connection with registering the offering of any Company securities under the Securities Act, prohibit Participants from, directly or indirectly, selling or otherwise transferring any Shares or other Company securities during a period of up to one hundred eighty days following the effective date of a Company registration statement filed under the Securities Act, or such longer period as determined by the underwriter. <span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">During any such period and unless determined otherwise by the Administrator, a Participant subject to tax in the Netherlands (i)&#160;shall not sell Shares under any circumstances and may not directly or indirectly assign, transfer, pledge or otherwise encumber any Shares or take any action to avoid the impact of such restriction, (ii)<span style="font-weight:bold"></span>&#160;shall, at the Administrator&#8217;s request, represent to the Company that the Participant has complied with these restrictions so that the Administrator may monitor Participant&#8217;s compliance and (iii)<span style="font-weight:bold"></span>&#160;bear the risk of any potential decrease of the market value of the shares during the Lock-Up period.</span></span><span style="font-family:Times New Roman"> </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.8 <span style="text-decoration:underline">Data Privacy</span>. As a condition for receiving any Award, each Participant <span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">understands and agrees that its personal data will be </span></span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">explicitly and unambiguously consents to the</span></span><span style="font-family:Times New Roman"> collect</span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">ed</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">ion</span></span><span style="font-family:Times New Roman">, use</span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">d</span></span><span style="font-family:Times New Roman"> and transfer</span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">red</span></span><span style="font-family:Times New Roman">, in electronic or other form, </span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">of personal data</span></span><span style="font-family:Times New Roman"> as described in this section by and among the Company and its Subsidiaries and affiliates</span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">. Such processing will</span></span><span style="font-family:Times New Roman"> exclusively for, and to the extent necessary, </span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">take place on the basis of (i)&#160;the explicit and unambiguous consent of the Participant; (ii)<span style="font-weight:bold"></span>&#160;the performance, implementation</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through"><span style="text-decoration:underline">implementing</span></span></span><span style="font-family:Times New Roman">, </span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">administering</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">administration</span></span><span style="font-family:Times New Roman"> and </span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">managing</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">management of</span></span><span style="font-family:Times New Roman"> the Participant&#8217;s participation in the Plan</span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">; and (iii)&#160;compliance with legal obligations to which the Company is subject</span></span><span style="font-family:Times New Roman">. To the extent necessary to execute and administer the Plan, the Company and its Subsidiaries and affiliates may hold certain personal </span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">information </span></span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">data</span></span><span style="font-family:Times New Roman"> about a Participant, including the Participant&#8217;s name, address and telephone number; birthdate; social security, insurance number or other identification number; salary; nationality; job title(s); any Shares held in the Company or its Subsidiaries and affiliates; and Award details, to implement, manage and administer the Plan and Awards (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Data</span></span>&#8221;). The Company and any Subsidiaries and/or affiliates may transfer the Data amongst themselves to the extent necessary </span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">for the performance of the Plan and</span></span><span style="font-family:Times New Roman"> to implement, administer and manage a Participant&#8217;s participation in the Plan, and the Company and its Subsidiaries and affiliates may transfer the Data to third parties assisting the Company with Plan implementation, administration and management. These recipients may be located in the Participant&#8217;s country, or elsewhere, and the recipients&#8217; country may be a country outside the European </span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">Union</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through"> </span></span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">Economic Area</span></span><span style="font-family:Times New Roman"> not offering adequate protection of personal data. </span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">By accepting an Award, each</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">The</span></span><span style="font-family:Times New Roman"> Participant </span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">authorizes</span></span><span style="font-family:Times New Roman"> </span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">understands and explicitly and unambiguously consents</span></span><span style="font-family:Times New Roman"> such recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, to implement, administer and manage the Participant&#8217;s participation in the Plan, including any required Data transfer to a broker or other third party with whom the Company or the Participant may elect to deposit any Shares. The Data related to a Participant will be held only as long as necessary to implement, administer, and manage the Participant&#8217;s participation in the Plan, and in any event no longer than two (2) years </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-9 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
thereafter, unless a longer storage period is required by law or governmental regulations or Company policy. A Participant may, at any time, view the Data that the Company holds, or that was sent by the Company to a recipient, regarding such Participant, request additional information about the storage and processing of the Data regarding such Participant, request any necessary corrections to the Data regarding the Participant or refuse or withdraw the consents in this Section&#160;10.8 in writing, without cost, by contacting the local human resources representative. The Company may cancel Participant&#8217;s ability to participate in the Plan, including any forfeiture of any outstanding Awards, if the Participant refuses or withdraws the consents in this Section 10.8<span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through"> without any justified reason</span></span><span style="font-family:Times New Roman">. For more information on the consequences of refusing or withdrawing consent </span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">and the processing of Data</span></span><span style="font-family:Times New Roman">, Participants may contact their local human resources representative. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.9 <span style="text-decoration:underline">Severability</span>. If any portion of the Plan or any action taken under it is held illegal or invalid for any reason, the illegality or invalidity will not affect the remaining parts of the Plan, and the Plan will be construed and enforced as if the illegal or invalid provisions had been excluded, and the illegal or invalid action will be null and void. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.10 <span style="text-decoration:underline">Governing Documents</span>. If any contradiction occurs between the Plan and any Award Agreement or other written agreement between a Participant and the Company (or any Subsidiary) that the Administrator has approved, the Plan will govern, unless it is expressly specified in such Award Agreement or other written document that a specific provision of the Plan will not apply. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.11 <span style="text-decoration:underline">Governing Law</span>. The Plan and all Awards will be governed by and interpreted in accordance with the laws of the Netherlands, disregarding any state&#8217;s <span style="white-space:nowrap"><span style="white-space:nowrap">choice-of-law</span></span> principles requiring the application of a jurisdiction&#8217;s laws other than the Netherlands. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.12 <span style="text-decoration:underline">Claw-back Provisions</span>. All Awards (including any proceeds, gains or other economic benefit the Participant actually or constructively receives upon receipt or exercise of any Award or the receipt or resale of any Shares underlying the Award) will be subject to <span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">the Company&#8217;s Policy for Recovery of Erroneously Awarded Compensation, adopted effective as of September&#160;27, 2023, as may be amended from time to time, and</span></span><span style="font-family:Times New Roman"> any </span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">other</span></span><span style="font-family:Times New Roman"> Company claw-back</span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">, recoupment, forfeiture or similar policies or provisions of the Company or its subsidiaries.</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">policy, including any claw-back policy adopted to comply with Applicable Laws (including the Corporate Governance Code, the Dodd-Frank Wall Street Reform and Consumer Protection Act and any rules or regulations promulgated thereunder) as set forth in such claw-back policy or as a clause in the Award Agreement.</span></span><span style="font-family:Times New Roman"> </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.13 <span style="text-decoration:underline">Unilateral Amendment</span>. The Administrator reserves the right to unilaterally amend the conditions of the Plan and/or of an Award, subject to the restrictions of the Articles or Applicable Law. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.14 <span style="text-decoration:underline">Titles and Headings</span>. The titles and headings in the Plan are for convenience of reference only and, if any conflict, the Plan&#8217;s text, rather than such titles or headings, will control. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.15 <span style="text-decoration:underline">Conformity to Securities Laws</span>. Participant acknowledges that the Plan is intended to conform to the extent necessary with Applicable Laws. Notwithstanding anything herein to the contrary, the Plan and all Awards will be administered only in conformance with Applicable Laws. To the extent Applicable Laws permit, the Plan and all Award Agreements will be deemed amended as necessary to conform to Applicable Laws. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.16 <span style="text-decoration:underline">Relationship to Other Benefits</span>. No payment under the Plan will be taken into account in determining any benefits under any pension, retirement, savings, profit sharing, group insurance, welfare or other benefit plan of the Company or any Subsidiary except as expressly provided in writing in such other plan or an agreement thereunder. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.17 <span style="text-decoration:underline">Broker-Assisted Sales</span>. In the event of a broker-assisted sale of Shares in connection with the payment of amounts owed by a Participant under or with respect to the Plan or Awards, including amounts to be paid under the final sentence of Section&#160;9.4: (a) any Shares to be sold through the broker-assisted sale will be sold on </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-10 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the day the payment first becomes due, or as soon thereafter as practicable; (b)&#160;such Shares may be sold as part of a block trade with other Participants in the Plan in which all participants receive an average price; (c)&#160;the applicable Participant will be responsible for all broker&#8217;s fees and other costs of sale, and by accepting an Award, each Participant agrees to indemnify and hold the Company harmless from any losses, costs, damages, or expenses relating to any such sale; (d)&#160;to the extent the Company or its designee receives proceeds of such sale that exceed the amount owed, the Company will pay such excess in cash to the applicable Participant as soon as reasonably practicable; (e)&#160;the Company and its designees are under no obligation to arrange for such sale at any particular price; and (f)&#160;in the event the proceeds of such sale are insufficient to satisfy the Participant&#8217;s applicable obligation, the Participant may be required to pay immediately upon demand to the Company or its designee an amount in cash sufficient to satisfy any remaining portion of the Participant&#8217;s obligation. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE XI. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DEFINITIONS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in the Plan, the following words and phrases will have the following meanings: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.1 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Administrator</span></span>&#8221; means the Board of Directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.2 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Applicable Laws</span></span>&#8221; means the requirements relating to the administration of equity incentive plans under the laws of the Netherlands, the applicable rules of any stock exchange or quotation system on which the Common Stock is listed or quoted and the applicable laws and rules of any foreign country or other jurisdiction where Awards are granted. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.3 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Articles</span></span>&#8221; means the Articles of Association of the Company, as amended from time to time. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.4 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Award</span></span>&#8221; means, individually or collectively, a grant under the Plan of Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units or Other Stock or Cash Based Awards. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.5 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Award Agreement</span></span>&#8221; means a written agreement evidencing an Award, which may be electronic, that contains such terms and conditions as the Administrator determines, consistent with and subject to the terms and conditions of the Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.6 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Board of Directors</span></span>&#8221; means the board of directors (<span style="font-style:italic">bestuur</span>) of the Company within the meaning of the Articles. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.7 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Board Rules</span></span>&#8221; means the Merus N.V. Rules of Procedure for the Board of Directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.8 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Cause</span></span>&#8221; means (a)&#160;if Participant is a party to a written employment, consulting or other agreement for service with the Company or any of its Subsidiaries or an Award Agreement in which the term &#8220;cause&#8221; is defined (a &#8220;<span style="font-weight:bold"><span style="font-style:italic">Relevant Agreement</span></span>&#8221;), &#8220;Cause&#8221; as defined in the Relevant Agreement; plus (i)&#160;an urgent cause (<span style="font-style:italic">dringende reden</span>) within the meaning of Section&#160;7:677 <span style="font-style:italic">juncto</span> 7:678 of the DCC; (ii)&#160;a reasonable ground within the meaning of Section&#160;7:669, subsections 3 d, e, f, g and h of the DCC; provided, however with respect to grounds pursuant to 7:669, subsections 3 g and h of the DCC, if such ground(s) is (are) predominantly attributable to the Participant; and (iii)&#160;if the employment, consulting or other agreement for the service of the Participant with the Company or any of its Subsidiaries is governed by Foreign Laws, grounds which are the same or similar to those mentioned under the preceding (a)(i) and(a)(ii); or (b)&#160;if no Relevant Agreement exists, &#8220;Cause&#8221; means (i)&#160;an urgent cause (<span style="font-style:italic">dringende reden</span>) within the meaning of Section&#160;7:677 <span style="font-style:italic">juncto</span> 7:678 of the DCC; (ii)&#160;a reasonable ground within the meaning of Section&#160;7:669, subsections 3 d, e, f, g and h of the DCC; provided, however with respect to grounds pursuant to 7:669, subsections 3 g and h of the DCC, if such ground(s) is (are) predominantly attributable to the Participant; (iii)&#160;if the employment, consulting or other agreement for the service of the Participant with the Company or any of its Subsidiaries is governed by Foreign Laws, grounds which are the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-11 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
same or similar to those mentioned under the preceding (b)(i) and (b)(ii); (iv) Participant&#8217;s failure to substantially perform Participant&#8217;s duties (other than a failure resulting from Participant&#8217;s Disability); (v) Participant&#8217;s failure to carry out, or comply with any lawful and reasonable directive of the Board of Directors or Participant&#8217;s immediate supervisor; (vi)&#160;the occurrence of any act or omission by Participant that could reasonably be expected to result in (or has resulted in) Participant&#8217;s conviction, plea of no contest, plea of nolo contendere, or imposition of unadjudicated probation for any felony or indictable offense or crime involving moral turpitude; (vii)&#160;Participant&#8217;s unlawful use (including being under the influence) or possession of illegal drugs on the premises of the Company or any of its Subsidiaries or while performing Participant&#8217;s duties and responsibilities for the Company or any of its Subsidiaries; or (viii)&#160;Participant&#8217;s commission of an act of fraud, embezzlement, misappropriation, misconduct, or breach of fiduciary duty against the Company or any of its Subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.9 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Change in Control</span></span>&#8221; means and includes each of the following: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) A transaction or series of transactions (other than an offering of Common Stock to the general public through a registration statement filed with the Securities and Exchange Commission or a transaction or series of transactions that meets the requirements of clauses (i)&#160;and (ii)&#160;of subsection&#160;(b) below) whereby any &#8220;person&#8221; or related &#8220;group&#8221; of &#8220;persons&#8221; (as such terms are used in Sections&#160;13(d) and 14(d)(2) of the Exchange Act) (other than the Company, any of its Subsidiaries, an employee benefit plan maintained by the Company or any of its Subsidiaries or a &#8220;person&#8221; that, prior to such transaction, directly or indirectly controls, is controlled by, or is under common control with, the Company) directly or indirectly acquires beneficial ownership (within the meaning of Rule <span style="white-space:nowrap">13d-3</span> under the Exchange Act) of securities of the Company possessing more than 50% of the total combined voting power of the Company&#8217;s securities outstanding immediately after such acquisition; or </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The consummation by the Company (whether directly involving the Company or indirectly involving the Company through one or more intermediaries) of (x)&#160;a merger, consolidation, reorganization, or business combination or (y)&#160;a sale or other disposition of all or substantially all of the Company&#8217;s assets in any single transaction or series of related transactions or (z)&#160;the acquisition of assets or stock of another entity, in each case other than a transaction: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) which results in the Company&#8217;s voting securities outstanding immediately before the transaction continuing to represent (either by remaining outstanding or by being converted into voting securities of the Company or the person that, as a result of the transaction, controls, directly or indirectly, the Company or owns, directly or indirectly, all or substantially all of the Company&#8217;s assets or otherwise succeeds to the business of the Company (the Company or such person, the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Successor Entity</span></span>&#8221;)) directly or indirectly, at least a majority of the combined voting power of the Successor Entity&#8217;s outstanding voting securities immediately after the transaction, and </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) after which no person or group beneficially owns voting securities representing 50% or more of the combined voting power of the Successor Entity; <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">however</span>, that no person or group shall be treated for purposes of this clause (ii)&#160;as beneficially owning 50% or more of the combined voting power of the Successor Entity solely as a result of the voting power held in the Company prior to the consummation of the transaction. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.10 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Code</span></span>&#8221; means the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.11 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Committee</span></span>&#8221; means one or more committees or subcommittees of the Board of Directors, which may include one or more members of the Board of Directors or executive officers, to the extent Applicable Laws permit. To the extent required to comply with the provisions of Rule <span style="white-space:nowrap">16b-3,</span> it is intended that each member of the Committee will be, at the time the Committee takes any action with respect to an Award that is subject to Rule <span style="white-space:nowrap">16b-3,</span> a <span style="white-space:nowrap">&#8220;non-employee</span> director&#8221; within the meaning of Rule <span style="white-space:nowrap">16b-3;</span> however, a Committee member&#8217;s failure to qualify as a <span style="white-space:nowrap">&#8220;non-employee</span> director&#8221; within the meaning of Rule <span style="white-space:nowrap">16b-3</span> will not invalidate any Award granted by the Committee that is otherwise validly granted under the Plan. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-12 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.12 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Common Stock</span></span>&#8221; means the common shares of the Company within the meaning of the Articles. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.13 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Company</span></span>&#8221; means Merus N.V., a Dutch public<span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">,</span></span><span style="font-family:Times New Roman"> limited liability company. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.14 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Consultant</span></span>&#8221; means any person, other than an Employee, or a member of the Board of Directors, including any adviser, engaged directly or indirectly by the Company and/or any Subsidiary to render services to the Company and/or Subsidiary if such person: (i)&#160;renders bona fide services to the Company; (ii)&#160;renders services not in connection with the offer or sale of securities in a capital-raising transaction and does not directly or indirectly promote or maintain a market for the Company&#8217;s securities; and (iii)&#160;is a natural person. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.15 &#8220;<span style="font-weight:bold"><span style="font-style:italic">DCC</span></span>&#8221; means the Dutch Civil Code. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.16 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Designated Beneficiary</span></span>&#8221; means the beneficiary or beneficiaries of the Participant designated pursuant to Applicable Laws, to receive amounts due or exercise the Participant&#8217;s rights if the Participant dies or becomes incapacitated. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.17 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Disability</span></span>&#8221; means disability to perform work due to sickness within the meaning of Section&#160;7:629 subsection 1 of the DCC or if the relevant agreement of a Service Provider is governed by Foreign Laws, the equivalent of Section7:629 subsection 1 of the DCC under such Foreign Laws. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.18 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Dividend Equivalents</span></span>&#8221; means a right granted to a Participant under the Plan to receive the equivalent value (in cash or Shares) of dividends paid on Shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.19 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Employee</span></span>&#8221; means any employee of the Company or its Subsidiaries within the meaning of Applicable Laws. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.20 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Equity Restructuring</span></span>&#8221; means a nonreciprocal transaction between the Company and its shareholders, such as a share dividend, share split, <span style="white-space:nowrap">spin-off</span> or recapitalization through a large, nonrecurring cash dividend, that affects the number or kind of Shares (or other Company securities) or the share price of Common Stock (or other Company securities) and causes a change in the per share value of the Common Stock underlying outstanding Awards. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.21 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Exchange Act</span></span>&#8221; means the United States Securities Exchange Act of 1934, as amended. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.22 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Fair Market Value</span></span>&#8221; means, as of any date, the value of Common Stock determined as follows: (i)&#160;if the Common Stock is listed on any established stock exchange, its Fair Market Value will be the closing sales price for such Common Stock as quoted on such exchange for such date, or if no sale occurred on such date, the last day preceding such date during which a sale occurred, as reported in The Wall Street Journal or another source the Administrator deems reliable; (ii)&#160;if the Common Stock is not traded on a stock exchange but is quoted on a national market or other quotation system, the closing sales price on such date, or if no sales occurred on such date, then on the last date preceding such date during which a sale occurred, as reported in The Wall Street Journal or another source the Administrator deems reliable; or (iii)&#160;without an established market for the Common Stock, the Administrator will determine the Fair Market Value in its discretion. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.23 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Foreign Laws</span></span>&#8221; means the laws of any jurisdiction other than the laws of the Netherlands. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.24 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Incentive Stock Option</span></span>&#8221; means an Option intended to qualify as an &#8220;incentive stock option&#8221; as defined in Section&#160;422 of the Code. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.25 &#8220;<span style="font-weight:bold"><span style="font-style:italic"><span style="white-space:nowrap">Non-Qualified</span> Stock Option</span></span>&#8221; means an Option not intended or not qualifying as an Incentive Stock Option. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-13 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.26 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Option</span></span>&#8221; means an option to purchase Shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.27 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Other Stock or Cash Based Awards</span></span>&#8221; means cash awards, awards of Shares, and other awards valued wholly or partially by referring to, or are otherwise based on, Shares or other property. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.28 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Overall Share Limit</span></span>&#8221; means the sum of (i) 1,277,778 Shares and (ii)&#160;an annual increase on the first day of each calendar year beginning January&#160;1, 2017 and ending on and including January&#160;1, <span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">2026</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">2029</span></span><span style="font-family:Times New Roman">, equal to the least of (A) 4% of the aggregate number of shares of Common Stock outstanding on the final day of the immediately preceding calendar year and (B)&#160;such smaller number of Shares as is determined by the Board of Directors. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.29 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Participant</span></span>&#8221; means a Service Provider who has been granted an Award. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.30 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Performance Criteria</span></span>&#8221; mean the criteria (and adjustments) that the Administrator may select for an Award to establish performance goals for a performance period, which may include the following: net earnings or losses (either before or after one or more of interest, taxes, depreciation, amortization, and <span style="white-space:nowrap">non-cash</span> equity-based compensation expense); gross or net sales or revenue or sales or revenue growth; net income (either before or after taxes) or adjusted net income; profits (including but not limited to gross profits, net profits, profit growth, net operation profit or economic profit), profit return ratios or operating margin; budget or operating earnings (either before or after taxes or before or after allocation of corporate overhead and bonus); cash flow (including operating cash flow and free cash flow or cash flow return on capital); return on assets; return on capital or invested capital; cost of capital; return on shareholders&#8217; equity; total shareholder return; return on sales; costs, reductions in costs and cost control measures; expenses; working capital; earnings or loss per share; adjusted earnings or loss per share; price per share or dividends per share (or appreciation in or maintenance of such price or dividends); regulatory achievements or compliance; implementation, completion or attainment of objectives relating to research, development, regulatory, commercial, or strategic milestones or developments; market share; economic value or economic value added models; division, group or corporate financial goals; customer satisfaction/growth; customer service; employee satisfaction; recruitment and maintenance of personnel; human resources management; supervision of litigation and other legal matters; strategic partnerships and transactions; financial ratios (including those measuring liquidity, activity, profitability or leverage); debt levels or reductions; sales-related goals; financing and other capital raising transactions; cash on hand; acquisition activity; investment sourcing activity; and marketing initiatives, any of which may be measured in absolute terms or as compared to any incremental increase or decrease. Such performance goals also may be based solely by reference to the Company&#8217;s performance or the performance of a Subsidiary, division, business segment or business unit of the Company or a Subsidiary, or based upon performance relative to performance of other companies or upon comparisons of any of the indicators of performance relative to performance of other companies. The Committee may provide for exclusion of the impact of an event or occurrence which the Committee determines should appropriately be excluded, including (a)&#160;restructurings, discontinued operations, extraordinary items, and other unusual, infrequently occurring or <span style="white-space:nowrap">non-recurring</span> charges or events, (b)&#160;asset write-downs, (c)&#160;litigation or claim judgments or settlements, (d)&#160;acquisitions or divestitures, (e)&#160;reorganization or change in the corporate structure or capital structure of the Company, (f)&#160;an event either not directly related to the operations of the Company, Subsidiary, division, business segment or business unit or not within the reasonable control of management, (g)&#160;foreign exchange gains and losses, (h)&#160;a change in the fiscal year of the Company, (i)&#160;the refinancing or repurchase of bank loans or debt securities, (j)&#160;unbudgeted capital expenditures, (k)&#160;the issuance or repurchase of equity securities and other changes in the number of outstanding shares, (l)&#160;conversion of some or all of convertible securities to Common Stock, (m)&#160;any business interruption event (n)&#160;the cumulative effects of tax or accounting changes in accordance with U.S. generally accepted accounting principles, or (o)&#160;the effect of changes in other laws or regulatory rules affecting reported results. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.31 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Plan</span></span>&#8221; means this 2016 Incentive Award Plan<span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">, as it may be amended and/or restated from time to time</span></span><span style="font-family:Times New Roman">. </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-14 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">11.32 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Prior Plans</span></span>&#8221; means, collectively, the Merus B.V. 2010 Employee Option Plan and any prior equity incentive plans of the Company or its predecessor. </span></span><span style="font-family:Times New Roman"> </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">11.33 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Prior Plan Award</span></span>&#8221; means an award outstanding under the Prior Plans as of the Plan&#8217;s effective date in Section&#160;10.3. </span></span><span style="font-family:Times New Roman"> </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">11.34 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Public Trading Date</span></span>&#8221; means the first date upon which the Common Stock is listed (or approved for listing) upon notice of issuance on any securities exchange or designated (or approved for designation) upon notice of issuance as a national market security on an interdealer quotation system, or, if earlier, the date on which the Company becomes a &#8220;publicly held corporation&#8221; for purposes of Treasury Regulation <span style="white-space:nowrap">Section&#160;1.162-27(c)(1).</span> </span></span><span style="font-family:Times New Roman"> </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.3<span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">2</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">5</span></span><span style="font-family:Times New Roman"> &#8220;<span style="font-weight:bold"><span style="font-style:italic">Restricted Stock</span></span>&#8221; means Shares awarded to a Participant under Article&#160;VI subject to certain vesting conditions and other restrictions. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.3<span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">3</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">6</span></span><span style="font-family:Times New Roman"> &#8220;<span style="font-weight:bold"><span style="font-style:italic">Restricted Stock Unit</span></span>&#8221; means an unfunded, unsecured right to receive, on the applicable settlement date, one Share or an amount in cash or other consideration determined by the Administrator to be of equal value as of such settlement date, subject to certain vesting conditions and other restrictions. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.3<span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">4</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">7</span></span><span style="font-family:Times New Roman"> &#8220;<span style="font-weight:bold"><span style="font-style:italic">Rule <span style="white-space:nowrap">16b-3</span></span></span>&#8221; means Rule <span style="white-space:nowrap">16b-3</span> promulgated under the Exchange Act. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.3<span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">5</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">8</span></span><span style="font-family:Times New Roman"> &#8220;<span style="font-weight:bold"><span style="font-style:italic">Securities Act</span></span>&#8221; means the Securities Act of 1933, as amended. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.3<span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">6</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">9</span></span><span style="font-family:Times New Roman"> &#8220;<span style="font-weight:bold"><span style="font-style:italic">Service Provider</span></span>&#8221; means an Employee, Consultant or member of the Board of Directors. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.<span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">37</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">40</span></span><span style="font-family:Times New Roman"> &#8220;<span style="font-weight:bold"><span style="font-style:italic">Shares</span></span>&#8221; means shares of Common Stock. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.<span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">38</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">41</span></span><span style="font-family:Times New Roman"> &#8220;<span style="font-weight:bold"><span style="font-style:italic">Stock Appreciation Right</span></span>&#8221; means a stock appreciation right granted under Article&#160;V. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.<span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">39</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">42</span></span><span style="font-family:Times New Roman"> &#8220;<span style="font-weight:bold"><span style="font-style:italic">Subsidiary</span></span>&#8221; means a subsidiary (<span style="font-style:italic">dochtermaatschappij</span>) within the meaning of Section&#160;2:24a of the DCC. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.4<span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">0</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">3</span></span><span style="font-family:Times New Roman"> &#8220;<span style="font-weight:bold"><span style="font-style:italic">Substitute Awards</span></span>&#8221; shall mean Awards granted or Shares issued by the Company in assumption of, or in substitution or exchange for, awards previously granted, or the right or obligation to make future awards, in each case by a company acquired by the Company or any Subsidiary or with which the Company or any Subsidiary combines. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.4<span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">1</span></span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">4</span></span><span style="font-family:Times New Roman"> &#8220;<span style="font-weight:bold"><span style="font-style:italic">Termination of Service</span></span>&#8221; means the date the Participant ceases to be a Service Provider. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">*&#160;*&#160;*&#160;*&#160;* </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-15 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">MERUS N.V. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">2016 INCENTIVE AWARD PLAN </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES ADDENDUM </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Capitalized terms not specifically defined in this United States Addendum (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">US Addendum</span></span>&#8221;) have the meanings given to them in the 2016 Incentive Award Plan (as amended from time to time, the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Plan</span></span>&#8221;) of Merus N.V. (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Company</span></span>&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Section&#160;10.5 of the Plan, the Administrator has adopted this US Addendum which contains additional terms and conditions of the Plan applicable to Participants residing in the United States. To the extent not impacted by this US Addendum, the Plan shall remain unchanged and in full force and effect according to its terms. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE XII. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">INCENTIVE STOCK OPTIONS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.1 <span style="text-decoration:underline">Incentive Stock Option Limitations</span>. Notwithstanding anything to the contrary in the Plan, no more than 1,277,778 Shares may be issued pursuant to the exercise of Incentive Stock Options. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.2 <span style="text-decoration:underline">Terms of Incentive Stock Options</span>. The Administrator may grant Incentive Stock Options only to employees of the Company, any of its present or future parent or subsidiary corporations, as defined in Sections&#160;424(e) or (f)&#160;of the Code, respectively, and any other entities the employees of which are eligible to receive Incentive Stock Options under the Code. If an Incentive Stock Option is granted to a Greater Than 10% Shareholder, the exercise price will not be less than 110% of the Fair Market Value on the Option&#8217;s grant date, and the term of the Option will not exceed five years. All Incentive Stock Options will be subject to and construed consistently with Section&#160;422 of the Code. By accepting an Incentive Stock Option, the Participant agrees to give prompt notice to the Company of dispositions or other transfers (other than in connection with a Change in Control) of Shares acquired under the Option made within (i)&#160;two years from the grant date of the Option or (ii)&#160;one year after the transfer of such Shares to the Participant, specifying the date of the disposition or other transfer and the amount the Participant realized, in cash, other property, assumption of indebtedness or other consideration, in such disposition or other transfer. Neither the Company nor the Administrator will be liable to a Participant, or any other party, if an Incentive Stock Option fails or ceases to qualify as an &#8220;incentive stock option&#8221; under Section&#160;422 of the Code. Any Incentive Stock Option or portion thereof that fails to qualify as an &#8220;incentive stock option&#8221; under Section&#160;422 of the Code for any reason, including becoming exercisable with respect to Shares having a fair market value exceeding the $100,000 limitation under Treasury Regulation <span style="white-space:nowrap">Section&#160;1.422-4,</span> will be a <span style="white-space:nowrap">Non-Qualified</span> Stock Option. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE XIII. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECTION 409A </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.1 <span style="text-decoration:underline">General</span>. The Company intends that all Awards be structured to comply with, or be exempt from, Section&#160;409A, such that no adverse tax consequences, interest, or penalties under Section&#160;409A apply. Notwithstanding anything in the Plan or any Award Agreement to the contrary, the Administrator may, without a Participant&#8217;s consent, amend the Plan, this US Addendum or Awards, adopt policies and procedures, or take any other actions (including amendments, policies, procedures and retroactive actions) as are necessary or appropriate to preserve the intended tax treatment of Awards, including any such actions intended to (A)&#160;exempt the Plan, this US Addendum or any Award from Section&#160;409A, or (B)&#160;comply with Section&#160;409A, including regulations, guidance, compliance programs and other interpretative authority that may be issued after an Award&#8217;s grant date. The Company makes no representations or warranties as to an Award&#8217;s tax treatment under </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-16 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Section&#160;409A or otherwise. The Company will have no obligation under this Section <span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">2.1</span></span><span style="font-family:Times New Roman"> or otherwise to avoid the taxes, penalties or interest under Section&#160;409A with respect to any Award and will have no liability to any Participant or any other person if any Award, compensation or other benefits under the Plan are determined to constitute noncompliant &#8220;nonqualified deferred compensation&#8221; subject to taxes, penalties or interest under Section&#160;409A. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.2 <span style="text-decoration:underline">Separation from Service</span>. If an Award constitutes &#8220;nonqualified deferred compensation&#8221; under Section&#160;409A, any payment or settlement of such Award upon a termination of a Participant&#8217;s Service Provider relationship will, to the extent necessary to avoid taxes under Section&#160;409A, be made only upon the Participant&#8217;s &#8220;separation from service&#8221; (within the meaning of Section&#160;409A), whether such &#8220;separation from service&#8221; occurs upon or after the termination of the Participant&#8217;s Service Provider relationship. For purposes of the Plan, this US Addendum or any Award Agreement relating to any such payments or benefits, references to a &#8220;termination,&#8221; &#8220;termination of employment&#8221; or like terms means a &#8220;separation from service.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.3 <span style="text-decoration:underline">Payments to Specified Employees</span>. Notwithstanding any contrary provision in the Plan, this US Addendum or any Award Agreement, any payment(s) of &#8220;nonqualified deferred compensation&#8221; required to be made under an Award to a &#8220;specified employee&#8221; (as defined under Section&#160;409A and as the Administrator determines) due to his or her &#8220;separation from service&#8221; will, to the extent necessary to avoid taxes under Section&#160;409A(a)(2)(B)(i) of the Code, be delayed for the <span style="white-space:nowrap">six-month</span> period immediately following such &#8220;separation from service&#8221; (or, if earlier, until the specified employee&#8217;s death) and will instead be paid (as set forth in the Award Agreement) on the day immediately following such <span style="white-space:nowrap">six-month</span> period or as soon as administratively practicable thereafter (without interest). Any payments of &#8220;nonqualified deferred compensation&#8221; under such Award payable more than six months following the Participant&#8217;s &#8220;separation from service&#8221; will be paid at the time or times the payments are otherwise scheduled to be made. </p> <p style="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.4 <span style="text-decoration:underline">Change in Control</span>. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding the definition of &#8220;Change in Control&#8221; contained in <span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">Section&#160;11.7 of</span></span><span style="font-family:Times New Roman"> the Plan, if a Change in Control constitutes a payment event with respect to any Award (or portion of any Award) that provides for the deferral of compensation that is subject to Section&#160;409A, to the extent required to avoid the imposition of additional taxes under Section&#160;409A, the transaction or event described in subsection (a)&#160;or (b)&#160;of </span><span style="font-family:Times New Roman; font-size:10pt;color:#2175ff"><span style="border-bottom:1pt double; padding-bottom:1pt;text-decoration:underline">such definition</span></span><span style="font-family:Times New Roman"> </span><span style="font-family:Times New Roman; font-size:10pt;color:#ff0200"><span style="text-decoration:line-through">Section 11.7 of the Plan</span></span><span style="font-family:Times New Roman"> with respect to such Award (or portion thereof) shall only constitute a Change in Control for purposes of the payment timing of such Award if such transaction also constitutes a &#8220;change in control event,&#8221; as defined in Treasury Regulation <span style="white-space:nowrap">Section&#160;1.409A-3(i)(5).</span> </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Administrator shall have full and final authority, which shall be exercised in its discretion, to determine conclusively whether a Change in Control has occurred pursuant to the above definition, the date of the occurrence of such Change in Control and any incidental matters relating thereto; provided that any exercise of authority in conjunction with a determination of whether a Change in Control is a &#8220;change in control event&#8221; as defined in Treasury Regulation <span style="white-space:nowrap">Section&#160;1.409A-3(i)(5)</span> shall be consistent with such regulation. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.5 <span style="text-decoration:underline">Restricted Stock Units</span>. Pursuant to Section&#160;6.3(a) of the Plan, the Administrator may provide that settlement of Restricted Stock Units will occur upon or as soon as reasonably practicable after the Restricted Stock Units vest or will instead be deferred, on a mandatory basis or at the Participant&#8217;s election; provided, that the Administrator shall make such determination in a manner intended to comply with Section&#160;409A. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE XIV. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DEFINITIONS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.1 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Greater Than 10% Shareholder</span></span>&#8221; means an individual then owning (within the meaning of Section&#160;424(d) of the Code) more than 10% of the total combined voting power of all share classes of the Company or its parent or subsidiary corporation, as defined in Section&#160;424(e) and (f)&#160;of the Code, respectively. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-17 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.2 &#8220;<span style="font-weight:bold"><span style="font-style:italic">Section</span></span><span style="font-weight:bold"><span style="font-style:italic"></span></span><span style="font-weight:bold"><span style="font-style:italic">&#160;409A</span></span>&#8221; means Section&#160;409A of the Code and all regulations, guidance, compliance programs and other interpretative authority thereunder. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">*&#160;*&#160;*&#160;*&#160;* </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-18 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g706699dsp145.jpg" alt="LOGO"/>
 </p> <p style="font-family:Times New Roman; font-size:0.5pt"><span style="color:#FFFFFF">MERUS N.V. Uppsalalaan 17 3rd &amp; 4th Floor 3584 CT UTRECHT THE NETHERLANDS SCAN TO VIEW MATERIALS &amp; VOTE VOTE BY INTERNET Use the Internet to transmit your voting instructions and for electronic delivery of information up until 16:59 (4:59) p.m. Central European Summer Time on May 2, 2024. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. VOTE BY PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 16:59 (4:59) p.m. Central European Summer Time on May 2, 2024. Have your proxy card in hand when you call and then follow the instructions. VOTE BY EMAIL Mark, sign and date your proxy card and return it via email to AGM2024@merus.nl by 16:59 (4:59) p.m. Central European Summer Time on May 2, 2024. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS DETACH AND RETURN THIS PORTION ONLY THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. MERUS N.V. The Board of Directors recommends you vote FOR the following proposals 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12: For Against Abstain 1 Adoption of Merus N.V.&#8217;s Dutch statutory annual accounts in the English language for the financial year 2023 [&#8195;] [&#8195;] [&#8195;] 2 Appointment of KPMG Accountants N.V. as Merus N.V.&#8217;s external auditor for the financial year 2024 for purposes of Dutch law. [&#8195;] [&#8195;] [&#8195;] 3 Release of each member of Merus N.V.&#8217;s board of directors from liability for the exercise of their duties during the financial year 2023. [&#8195;] [&#8195;] [&#8195;] 4 Re-appointment of Mark Iwicki as non- executive director. [&#8195;] [&#8195;] [&#8195;] 5 Re-appointment of Paolo Pucci as non-executive director. [&#8195;] [&#8195;] [&#8195;] 6 Appointment of Jason Haddock as non-executive director. [&#8195;] [&#8195;] [&#8195;] For Against Abstain 7 Articles Amendment A &#8211; Approval of the amendment of the Articles of Association to increase the authorized share capital to the amount of EUR 18,900,000 and divided into 105,000,000 common shares and 105,000,000 preferred shares and authorization to implement such amendment. [&#8195;] [&#8195;] [&#8195;] 8 Articles Amendment B &#8211; Approval of the amendment of the Articles of Association to reflect the Large Company Regime and authorization to implement such amendment [&#8195;] [&#8195;] [&#8195;] 9 Granting authorization to Merus N.V.&#8217;s board of directors to acquire shares (or depository receipts for such shares) in Merus N.V.&#8217;s capital. [&#8195;] [&#8195;] [&#8195;] 10 Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.&#8217;s named executive officers. [&#8195;] [&#8195;] [&#8195;] 11 Approval of the amendment of the Merus N.V.&#8217;s Non-Executive Director Compensation Program (&#8220;NED Program&#8221;) to allow the board of directors to determine the number of common shares that may be awarded to a non-executive director for initial and annual awards under the NED Program to more closely align with the 50th percentile of the Company&#8217;s peer group [&#8195;] [&#8195;] [&#8195;] 12 Approval of the amendment and restatement of the Merus N.V. 2016 Incentive Award Plan (the &#8220;2016 Plan&#8221;), to extend the term of the 2016 Plan to December 31, 2031, which includes a corresponding extension to the annual &#8220;evergreen&#8221; feature from and including January 1, 2026, to January 1, 2029, along with other minor amendments updated for best practices [&#8195;] [&#8195;] [&#8195;] Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. NOTE: Such other business as may properly come before the meeting or any adjournment thereof shall be voted in accordance with the discretion of the attorneys and proxies appointed hereby. </span></p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g706699dsp146.jpg" alt="LOGO"/>
 </p> <p style="font-family:Times New Roman; font-size:0.5pt"><span style="color:#FFFFFF">Important Notice Regarding the Availability of Proxy Materials for the Annual General Meeting: The Notice and Proxy Statement and Annual Report on Form 10-K are available at www.proxyvote.com. PROXY ANNUAL GENERAL MEETING OF SHAREHOLDERS MAY 7, 2024 THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF MERUS N.V. The undersigned hereby appoints each member of Merus N.V.&#8217;s board of directors, Peter B. Silverman, Chief Operating Officer and General Counsel of Merus N.V., as well as Paul van der Bijl, civil law notary, and Sanne Mesu, deputy civil law notary, each working with NautaDutilh N.V., Merus N.V.&#8217;s Dutch legal counsel, and each of them, with power to act without the other and with power of substitution, as proxies and attorneys-in-fact and hereby authorizes them to represent and vote, as provided on the other side, all the shares of Merus N.V. which the undersigned is entitled to vote at the Annual General Meeting of Shareholders of Merus N.V to be held at 15:00 (3:00) p.m. Central European Summer Time on Tuesday, May 7, 2024, at the offices of NautaDutilh N.V. (address: Beethovenstraat 400, 1082 PR Amsterdam, the Netherlands), or any adjournment thereof, with all powers which the undersigned would possess if present at the Annual General Meeting of Shareholders. Such proxies are authorized to vote in their discretion (x) for the election of any person to the Board of Directors if any nominee named herein becomes unable to serve or for good cause will not serve, (y) on any matter that the Board of Directors did not know would be presented at the Annual General Meeting of Shareholders by a reasonable time before the proxy solicitation was made, and (z) on such other business as may properly be brought before the Annual General Meeting of Shareholders or any adjournment, continuation or postponement thereof. THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED. IF NO SUCH DIRECTIONS ARE MADE BUT THE CARD IS SIGNED, THIS PROXY WILL BE VOTED &#8220;FOR&#8221; PROPOSALS 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 AND 12, AND IN THE DISCRETION OF THE PROXIES WITH RESPECT TO SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING. PLEASE MARK, SIGN, DATE AND RETURN THIS PROXY CARD PROMPTLY USING THE ENCLOSED REPLY ENVELOPE </span></p>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>mrus-20231231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 29-March-2024 [12:26:32] {PM}-->
<schema targetNamespace="http://meus.com/20231231" elementFormDefault="qualified" xmlns:mrus="http://meus.com/20231231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
<annotation>
<appinfo>
<link:linkbaseRef xlink:type="simple" xlink:href="mrus-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="mrus-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="mrus-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
<import namespace="http://xbrl.sec.gov/dei-sub/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-sub-2023.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
<import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
<import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
<import namespace="http://xbrl.sec.gov/ecd-sub/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd" />
<import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" />
<import namespace="http://www.xbrl.org/2006/ref" schemaLocation="http://www.xbrl.org/2006/ref-2006-02-27.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://fasb.org/srt-roles/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd" />
<element name="AdjustmentForGrantDateValuesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="mrus_AdjustmentForGrantDateValuesMember" substitutionGroup="xbrli:item" />
<element name="DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="mrus_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember" substitutionGroup="xbrli:item" />
<element name="TotalAdjustmentsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="mrus_TotalAdjustmentsMember" substitutionGroup="xbrli:item" />
<element name="YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="mrus_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember" substitutionGroup="xbrli:item" />
<element name="YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="mrus_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember" substitutionGroup="xbrli:item" />
<element name="RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="mrus_RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting" substitutionGroup="xbrli:item" />
<element name="StockOptionsVestingExpectedDividendYield" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="mrus_StockOptionsVestingExpectedDividendYield" substitutionGroup="xbrli:item" />
<element name="StockOptionsVestingExpectedTermInYearsMaximum" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="mrus_StockOptionsVestingExpectedTermInYearsMaximum" substitutionGroup="xbrli:item" />
<element name="StockOptionsVestingExpectedTermInYearsMinimum" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="mrus_StockOptionsVestingExpectedTermInYearsMinimum" substitutionGroup="xbrli:item" />
<element name="StockOptionsVestingExpectedVolatilityMaximum" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="mrus_StockOptionsVestingExpectedVolatilityMaximum" substitutionGroup="xbrli:item" />
<element name="StockOptionsVestingExpectedVolatilityMinimum" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="mrus_StockOptionsVestingExpectedVolatilityMinimum" substitutionGroup="xbrli:item" />
<element name="StockOptionsVestingRiskfreeInterestRateMaximum" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="mrus_StockOptionsVestingRiskfreeInterestRateMaximum" substitutionGroup="xbrli:item" />
<element name="StockOptionsVestingRiskfreeInterestRateMinimum" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="mrus_StockOptionsVestingRiskfreeInterestRateMinimum" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>mrus-20231231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 29-March-2024 [12:26:32] {PM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpAdjustmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" />
<definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember" xlink:label="AllAdjToCompMember" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_AdjustmentForGrantDateValuesMember" xlink:label="AdjustmentForGrantDateValuesMember" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="AdjustmentForGrantDateValuesMember" order="100" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember" xlink:label="YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember" order="101" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember" xlink:label="YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember" order="102" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember" xlink:label="DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember" order="103" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_TotalAdjustmentsMember" xlink:label="TotalAdjustmentsMember" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="TotalAdjustmentsMember" order="104" />
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>mrus-20231231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 29-March-2024 [12:26:32] {PM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting" xlink:label="loc_mrus_RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mrus_RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting" xml:lang="en-US">Restricted Share And Restricted Stock Units Vesting Weighted Average Fair Value At Vesting</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrus_RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting" xlink:to="lab_mrus_RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_StockOptionsVestingExpectedDividendYield" xlink:label="loc_mrus_StockOptionsVestingExpectedDividendYield" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mrus_StockOptionsVestingExpectedDividendYield" xml:lang="en-US">Stock Options Vesting Expected Dividend Yield</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrus_StockOptionsVestingExpectedDividendYield" xlink:to="lab_mrus_StockOptionsVestingExpectedDividendYield" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_StockOptionsVestingExpectedTermInYearsMaximum" xlink:label="loc_mrus_StockOptionsVestingExpectedTermInYearsMaximum" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mrus_StockOptionsVestingExpectedTermInYearsMaximum" xml:lang="en-US">Stock Options Vesting Expected Term In Years Maximum</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrus_StockOptionsVestingExpectedTermInYearsMaximum" xlink:to="lab_mrus_StockOptionsVestingExpectedTermInYearsMaximum" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_StockOptionsVestingExpectedTermInYearsMinimum" xlink:label="loc_mrus_StockOptionsVestingExpectedTermInYearsMinimum" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mrus_StockOptionsVestingExpectedTermInYearsMinimum" xml:lang="en-US">Stock Options Vesting Expected Term In Years Minimum</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrus_StockOptionsVestingExpectedTermInYearsMinimum" xlink:to="lab_mrus_StockOptionsVestingExpectedTermInYearsMinimum" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_StockOptionsVestingExpectedVolatilityMaximum" xlink:label="loc_mrus_StockOptionsVestingExpectedVolatilityMaximum" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mrus_StockOptionsVestingExpectedVolatilityMaximum" xml:lang="en-US">Stock Options Vesting Expected Volatility Maximum</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrus_StockOptionsVestingExpectedVolatilityMaximum" xlink:to="lab_mrus_StockOptionsVestingExpectedVolatilityMaximum" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_StockOptionsVestingExpectedVolatilityMinimum" xlink:label="loc_mrus_StockOptionsVestingExpectedVolatilityMinimum" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mrus_StockOptionsVestingExpectedVolatilityMinimum" xml:lang="en-US">Stock Options Vesting Expected Volatility Minimum</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrus_StockOptionsVestingExpectedVolatilityMinimum" xlink:to="lab_mrus_StockOptionsVestingExpectedVolatilityMinimum" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_StockOptionsVestingRiskfreeInterestRateMaximum" xlink:label="loc_mrus_StockOptionsVestingRiskfreeInterestRateMaximum" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mrus_StockOptionsVestingRiskfreeInterestRateMaximum" xml:lang="en-US">Stock Options Vesting RiskFree Interest Rate Maximum</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrus_StockOptionsVestingRiskfreeInterestRateMaximum" xlink:to="lab_mrus_StockOptionsVestingRiskfreeInterestRateMaximum" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_StockOptionsVestingRiskfreeInterestRateMinimum" xlink:label="loc_mrus_StockOptionsVestingRiskfreeInterestRateMinimum" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mrus_StockOptionsVestingRiskfreeInterestRateMinimum" xml:lang="en-US">Stock Options Vesting RiskFree Interest Rate Minimum</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrus_StockOptionsVestingRiskfreeInterestRateMinimum" xlink:to="lab_mrus_StockOptionsVestingRiskfreeInterestRateMinimum" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_AdjustmentForGrantDateValuesMember" xlink:label="loc_mrus_AdjustmentForGrantDateValuesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mrus_AdjustmentForGrantDateValuesMember" xml:lang="en-US">Adjustment For Grant Date Values [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrus_AdjustmentForGrantDateValuesMember" xlink:to="lab_mrus_AdjustmentForGrantDateValuesMember" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember" xlink:label="loc_mrus_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mrus_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember" xml:lang="en-US">Difference In Fair Values Between Prior YearEnd Fair Values And Vest Date Fair Values For Awards Granted In Prior Years [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrus_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember" xlink:to="lab_mrus_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_TotalAdjustmentsMember" xlink:label="loc_mrus_TotalAdjustmentsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mrus_TotalAdjustmentsMember" xml:lang="en-US">Total Adjustments [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrus_TotalAdjustmentsMember" xlink:to="lab_mrus_TotalAdjustmentsMember" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember" xlink:label="loc_mrus_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mrus_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember" xml:lang="en-US">Year-End Fair Value Of Unvested Awards Granted In The Current Year [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrus_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember" xlink:to="lab_mrus_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember" xlink:label="loc_mrus_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mrus_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember" xml:lang="en-US">Year-Over-Year Difference Of YearEnd Fair Values For Unvested Awards Granted In Prior Years [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrus_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember" xlink:to="lab_mrus_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember" />
</labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>mrus-20231231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 29-March-2024 [12:26:32] {PM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
<presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember" xlink:label="AllAdjToCompMember" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_AdjustmentForGrantDateValuesMember" xlink:label="AdjustmentForGrantDateValuesMember" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllAdjToCompMember" xlink:to="AdjustmentForGrantDateValuesMember" order="100" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember" xlink:label="YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllAdjToCompMember" xlink:to="YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember" order="101" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember" xlink:label="YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllAdjToCompMember" xlink:to="YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember" order="102" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember" xlink:label="DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllAdjToCompMember" xlink:to="DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember" order="103" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_TotalAdjustmentsMember" xlink:label="TotalAdjustmentsMember" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllAdjToCompMember" xlink:to="TotalAdjustmentsMember" order="104" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="PayVsPerformanceDisclosureLineItems" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_StockOptionsVestingExpectedVolatilityMaximum" xlink:label="StockOptionsVestingExpectedVolatilityMaximum" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayVsPerformanceDisclosureLineItems" xlink:to="StockOptionsVestingExpectedVolatilityMaximum" order="100" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_StockOptionsVestingExpectedVolatilityMinimum" xlink:label="StockOptionsVestingExpectedVolatilityMinimum" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayVsPerformanceDisclosureLineItems" xlink:to="StockOptionsVestingExpectedVolatilityMinimum" order="101" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_StockOptionsVestingExpectedDividendYield" xlink:label="StockOptionsVestingExpectedDividendYield" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayVsPerformanceDisclosureLineItems" xlink:to="StockOptionsVestingExpectedDividendYield" order="102" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_StockOptionsVestingExpectedTermInYearsMaximum" xlink:label="StockOptionsVestingExpectedTermInYearsMaximum" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayVsPerformanceDisclosureLineItems" xlink:to="StockOptionsVestingExpectedTermInYearsMaximum" order="103" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_StockOptionsVestingExpectedTermInYearsMinimum" xlink:label="StockOptionsVestingExpectedTermInYearsMinimum" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayVsPerformanceDisclosureLineItems" xlink:to="StockOptionsVestingExpectedTermInYearsMinimum" order="104" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_StockOptionsVestingRiskfreeInterestRateMaximum" xlink:label="StockOptionsVestingRiskfreeInterestRateMaximum" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayVsPerformanceDisclosureLineItems" xlink:to="StockOptionsVestingRiskfreeInterestRateMaximum" order="105" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_StockOptionsVestingRiskfreeInterestRateMinimum" xlink:label="StockOptionsVestingRiskfreeInterestRateMinimum" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayVsPerformanceDisclosureLineItems" xlink:to="StockOptionsVestingRiskfreeInterestRateMinimum" order="106" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="mrus-20231231.xsd#mrus_RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting" xlink:label="RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayVsPerformanceDisclosureLineItems" xlink:to="RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting" order="107" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g706699dsp145.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g706699dsp145.jpg
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M$0$#$0'_Q "J  $  @,! 0$! 0          !@<%" D$ P(!"@$! 0$
M              $"$  !! ,  0," @4'"0(* Q$% @,$!@ !!P@1$@D3%!46
M(=68&5G1(K47&#AY,4$CM#96EE?7421A<9$R,R5U=C>W0C0U)K9W.4/4EUAX
M"AJQ4I*S="<1 0 " 00# 0$! 0$!       !$2$Q05$"<8$282*1L:%"_]H
M# ,!  (1 Q$ /P#_ '\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8''#QF\YO*$=Q"D]M\JN11NC<4O>K079[OXRU>
MPG#_ "H0.N)\/'A]S\?F'3]VD!@PT5[G[72U'8ZTI4]-#B6$*?4'5OGG1^?]
M;IH+HG+;K5^AT2SP]3Z]<*8<'6.N&(GO4TIV 7%2)4*1]%YM3;B=+]S3J%(7
MI*D[UH)I@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#_&!\NGSA>>/B5YZ]
M=\>.%&>7U_G'.A/.T"V3?-H]L-SYMEHH*V%"!(K/)(]%JFFU,M---MMH9:3^
MA2]J5NM]>L3%RT_Y_P#_ +P#\A-N=;;M?F+XL\K0JNQ#"W[1XN]&.H:,2"I&
M!(J*DTFL6!Q1:! ALSG)*=;@+8F-H;>4\AUM%I9ZQ&TJXMW_ .\:?)S7K,;"
M .S<&OH49.7%&W(%P!\2'L<9*$*22'#;1H/8849Q:MITB7%8>UM.][3Z;UO<
M6.L/]'/P%?))Y*?(92?)1WR3D4HF;Y#;N=Q:T9J%6U45R!5W"V63+'E1K$R5
M">4/EUK2V7D);6I,A25^OM3O(QVB(G#_ $&X9,!@,!@,!@,!@,!@,!@,!@,!
M@:!_%U_<-\?/_8]R_P#F5=,#,]#\*AD>Y'NS^*]^)>*?=;#-_&+:4J >/8.+
M=D*Z5K:G>_<%DS154O<^4WM;:[",?K]T;0K26C26D[:4&"K_ )J%.5FP_.?.
MNA0O&ZW%I\4%5^T##$FS>(W5"TK>F($>M=@FPA;W+;6;DH5IBL7J,$G.O*TP
M-E&=:^NH-_TJTK6E)WI25:TI*D[UO2M;UZZWK>OT;UO6!_<!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@<,?$L$#.?,;\O2#80.93'J_A2J/HL,@DM1]N<I):<
MVQ]XP]]'ZFDZ]WM]/=[=>OKZ:]+LNSLC^0*'_N/3O^%P?_YAD0_(%#_W'IW_
M  N#_P#S# Y$_''"A#OD?^:B$/AQ($./V/Q60Q$@QF8D5E.^'$EJTU'CH;9;
MTI:MJWZ:UZJWO>_T[WA9TAVSPA@,!@:.>0?R3^$'BOT.+RCO'D!6:-T%T/!L
M<^MZ#7"SR:Q7";RV!]BO,FG5RP0*""F.H_T<LT[ 84C>EZ5]/?NPL1,Z,_Y'
M^?WA_P")<NG"^]=NK]/L'01[IBE5(8*M-[NEC!L>GU[ .IG/05JM"ZZU_.]2
M"HB8?JA>M.;VA6M"IEE;'YS>)-1\:Q'F#8^ZTH7XU'VA3@;K3KI)VODE&C*J
MZ.B18L8<\;<).'&W(KD7[7[EA]IQ+K:-M.>T5-UNS_1_+WQJY'P$5Y3=%Z_5
M:SX^G!5/-ANHR%$)E>*"[_N!JG2X"1<&<2E)/_B;'T4H8VO6G/56DZTKT%3=
M;O7.\K_'0>-\?C,CK=34)\J30>N^/1.)(E$('531^N2K:'@UJ7 B26%+G5V$
M[)2I]3#>DH]NU:7Z)V*E!_)CSV\0_#HM5P?DOVVO<F)W,63-5F,=%6J=HH*#
M2HL(G-1(  "\:,U$E36D*^LMO>]KUO6MZ]=Z$1,Z(OSWY+/!/J7,>J]HI7DM
MS^?RKB+(9_J=[*;.56O4]%C1,6 3-FVP.$U+>-;@N(BMQ=/N/O:2VA.W%H2H
M5+\^.OR5>$'E;>WN7\,[V!M71DAG[)#I!FO7?G]G.UR-Z;?L%6#]%K%3FVP,
MTUOZBI U$IM+.MN*WI&MJP3$QJWGPA@,!@,#0/XNO[AOCY_['N7_ ,RKI@;^
M8&&L-=K]N!%ZO:P0:SUFP#Y0D]7;",A&@1L5.:5'FC"X@DQ)'DA\QA>T.LO-
MK;<1O>E:WK?I@:!+\7.T>,"]F/!6YC)/.HN]OSO"SN5@/2^.?:I4AUZ%P#J*
M(MEO?CA/=TES4<7N/8Z.UM>FHX8;K:I*0N+B7F)SGK-L>Y%:0UJX-Y'#![Y$
MUX[]EBCZ_P! >@0MN-D+'STB/(E:7VBA1W&5?^OZB3,#FD[2F4N*_M3"0VTP
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P.(WAO_ /CC_F _]U?";_Y5%,NR[.U.
M1# XR_'?_P#C*?FN_P#PR^*W_P C".%G2':K"& P&!_F3^1$#U3P4[EY9?*9
MXC=Z\>KP'(U3G57\W/$?LTD01=L,:B!A%>!C:F?&$7#=9M4VKE&'6PLI$=3W
MW"G4)F(>:B:K<9CYEEO!#J=*M/S1>:_0^Q1X5"Z'UKQ'\/;SXSA.@/P19@3Q
M*Q<U"G[M5:>X0^U86\%M$YIHJU"TE:I,62I2-:0][1,?R_GR?=PY?VGRQ\'/
M%FJ\JZ%Y6>/_ #]/0_,;R#YOXGTX)V&79(0W=KY)RJ'.#!S8H$H&WU0P8?,.
MNS$[1);1ZI4^KTP1&+W<Q8O5YUD^$^\^(?2 =I%W/PM^0/QTX@5I'3@;H"\1
M^.6WR$K5LY3&O5>DOR71D^152\L4]&VXXA"!WM0M:/:K;=?_ *O\3Z3"MWBE
M\@W@Q\85Q;,3:9PSY(X/D1XA6>>IZ1&G>*?::+TSZ-&W,<0C3LSEG1WY@S6_
MT>_WN:3I+;;?J-8F?Q_HC^9)MM7Q;>=3BD(4MOQTOWL6I"=J1O<%'KM"MZWM
M._\ Q9(8ZZN3OR#K%#O!/X,2G1D16_&J!W_P(G>1:R;3>ZDBKM\L%[#2;RE:
M-Q55EHAMW;VY/K'^IM'O_3M.(:ZZSRV"^3$S2KW\BWPK@>-EJY9.X!?(^T7,
MINDSQI.P!O&V'4(S_0IYQX.\](@T<H.;6AC;^TQ9"DO):]=_4ULD:2_T(89,
M!@,!@:!_%U_<-\?/_8]R_P#F5=,#?S 8# ISMOC]QSR,JC-,[/0@]V#P2#!H
M#)E*FB[-3K%$WZP;70;H"E"[A0+>.W^F,6"SH)&/Z[^F\GUWZAS_ .J]<[?\
M:-6U=>I]%UY6>*$4E!"1'+F9  O-:DR)_P#HA==J2W-!JMYCR7?MU-PA#30;
MHDO_ ,UI=EG*TA0=2*R?B6NN +0/B&8$&QA1AV%"L8(O5[!#BEH3$^/%.5JP
M0QQVOEV&G])DPIL=B7%>TIMUM#B5)T&;P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M.(WAO_\ CC_F _\ =7PF_P#E44R[+L[4Y$,#C+\=_P#^,I^:[_\ #+XK?_(P
MCA9TAVJPC\.+2TVMQ?K[&T*6KVI4M7M1K:E>B$:4M>_37^36M[W_ )L#6UKS
M$\8WQW+BS'9:@^.[2'"G^826'ISR;:'L=ZIG,@DZ&AN$IR(T1Z!T(,';U*2P
MK[^<EK>M*0[["U+ U;SG\4KE]JL!V 2]%(QKW-$$R(&X@ IZ#S$/.L%_G5LX
M?KHL/9(54"C)$F6] ?D-H:8<WI6_8KT%2UDMG)/B/[K;R7E]<>7^,G2[=7.-
M43RD/]C+4B ;?WQTP*/RN>=6LKZQ;D,["D!J#/V/<G,R9S;(S:4H3IM&L&8P
MDG9P?Q<>;1KQNK_;@/CSWNR]EI=@O_C3^90L4Q8;/0J^)39+(4J9EJ(R5&UV
M$-<V_)C2)$9E:T.)VTIUIQ*1F'@YMUOXM^"4VC^0?%HO&*-3>HCH?!*3TGC_
M "8P]&L([G-J>K ?E3,RA4N;+AMC[E/7''#)"653Y[V]QD/N+]VQ_4X8JV="
M^*JV2NMWFX57E-BF7GI?-*CUJQ$^#W K(Z)U[F5@GP.95PA(WSY]SH/0.>6.
MMR6HL6+]]/$2(B]+2UM&\&5E]"[#\;]R2-\L.D'^ VUWQBJM#Z6![D="#; 2
MY/5>WJ?8H%CKEJV)F$1T>[R(+B8J82U.?7;5I2$.:W@SI&ZX.N]=\3;50.V4
MGLUHYQ:><5>KTV)VZK6N*BP5S=9[&S].A"C ER%,CV)/1?>ED9"C(E/D'W&V
M6FUNN-H4,HQUSH'AE7?&"LPNOBJA(\8[T(!<XJO/3G*K%9PUA%1@,X@$I8WD
M$:H%K*]L'6ZC)E:@Z$:=&11;KZTLHC*6@1>VJ!>-W#/C@\79W,;#XR<LX5R<
MMY6"T_U5VJD5:/#+]6":IDCJ#0P!:'8C\_8EZE#G2[4#<EAEV/&4XAI2FOYH
MF9G5::/.WQ$=GU$<UW>E..WA 1RORFUE%B-LVFSDJ749)LZD;L)5(MTM8B3
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MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MS"-[3@;08# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# @71R5R$U^)-I
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M"5#]O^0'F(RXU*)>-7X/$D/I7M ]9RW-UL3-MTBMN.6. %&[-6DR"'AU$_I
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MY]/VP,0^KZDYAG33NE"H3Q_R%\F@%$&6"R^-TB58YUA<%R1-7<.SH0P?.KE
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MR[DW3<U;[+34!$=B2\E[8J+>(=T'SCL!#BJ3_+P5('6*^!I?2(U<'0C$NL5
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M?IOTWZ>OIO\ S;]/T>OI@<NXSOR<U@ 3ECX=#OUA+N"XKC-T@5(7H!*#LT:
M2/@H=7Z)"%SQ5EVX86@<XY"<:1%U+VXV\^F%LUA='5+1YVP+;<AW)^;<H-T^
M/67)M.L9XRB.0F63\M19"@\H4JT0'%(18]R&&''$QVG-::^HXVWM;J280^ID
M_/P97.SR#]9K!6SNA )[FL1YJL+&[MLN)4V#=:KR4=3TYNOZ]A9Q>C#@[\,E
MZ9^@Z596OT&'H D?/Z!T>O,3@5-G\V.=%%/VA1=NLRI=+YRI,A@D/ 3Q-U'%
MC!:3M+TIZ3*CR/LW/LFH[,AIV2B*,//(MGR,O3KK*@<SY1#&B+K>FJ4()2Q4
MN;;*4XNM0Z._,+0^C161$V B45G.;<CMKG?:L1W40_>IU0PQ.A7GD-K_ #VS
MQ)L@U91M7ZI'M=2*Q*$IR8>M/98L^EF)8>)U(16I1*O<N83'9':L#H\<R](]
MDN3*;:;?+A]P;OR$ )*T*K]3-+,ESI60HV6!'0@A2FXBX@!B:BX5DT%K+;+D
MK8Z0S!+3)$QMAF8U#CJ<DZ)AE;-)\^;=QIMUH-6.;=5DW*VBY@2FO5(ZWNC3
M>1W*-4RNS=BMJ(HV9$ZQ/#KD.1'MS&F(:UH:<:6M&QA(JT6\Z9A/I@F[57G#
M ,909$;FQZM+CCB=MO,2Q[BPBY!+UX*HK;)NO)<D/#E-.-1-_0]LU2U/,I&$
M1G&/D2>V-'N :/#:W-"EBAVK!*<Y*;&ZL')S!RM,0+1U:9%E2VP4JUAFW/:Q
MI_[9J8F0RXMEO8PSJ;3YZQOP@3.Y_3)FU#JR2LUP Q*HXB*\9C<Y</ *O5C'
M8!:R)BI%W[.P\N;+C0GQK,22Q(D2?^Z.C"(#2_R.!@@V'NLTRTV#8TCH@;L,
M6F18D^P1:Z)BH7.@ >FBV*\ 453,D#=CV9SQ)]+34UL4TZN0@83W1+SDE@.B
MC)XFKC#H:7S!=!M-<$5#2;4/'=/D,=,3^7S_ $0U&8G63F$%N4TF6^/;@/SO
MMV5NO,[>P8?=NT^<2N=P9J^?4I'0G>F+BRQBF:_]K'HVJDS,0MV.CJJX.@6^
MD[=&**-$7C.JRE!#054]2H21A2$ I\G5>JT1V+6*[;C@VL00 \+9&^:P_P 3
M/P#5,=)VFWF873G)#_W8]XQ"@JA2&]3(C29LJ+!E[1%<&%W#+)YI5L+TL[9*
MC33$2O4>SGJ+6H$?\0L9JQ51NHEQM<D$AEO(/%9/1V)IT?'VB!'_  QZ!%6K
MZWUO:X,,$NZ_(!$F2U)Y/0CD-UT5$91%?KHEN$_.&3U?B4&21ZIJ:6 #Y.HJ
MBVY44>0CR5+9@1B#&ON4C"37\EYRC^<5670!/,3G1T\UV2N< B'CQAB^DE;;
M2V7 8-MSH\5EH?3Z60.O->^6\T6F#XZ52HVG?:L80XM;?D-_[TV'YUSO\1T[
M<$,_<0ZZJJ:=9CI9J^V26^S-65T.["TB:VXX.1*D%UNCY#4*"VV2<&&:I\[S
M>B]XD;MH,,4Y!+LHZM2Y3$2H"H<:I T=5VS=*\RQTTR?9EV-,NMR"*90_<I4
MI:X;,=F/"^\DC"(B+?\ )+*&S"1GF?+A+K!,Y!8KT;8 H:E!)LBWR!E@BS]=
M8@@W3-:AP!,=@>\N+',/3=K>DP4)=4T,/LXYY^UBK<XV&B0;8:WQ>JPKJ/.0
M.=DGHG7HQ.PR; 4FSM](J>WDEM/!H;[42=+@0AOXA*CKDS&(T>8,+'Z$=\V$
M6FZL\WJ=!6$&"Y<VF_CD47(#6.7'Y>[.&"7#W]8XJQPR1;K;RH,I3X./$B"H
MS#C;KBY+SD<84XY9_DWE36W$T#F<"*$!U<@RTQ^5=1KS:9',KXV;!F-2NC3Y
M]8J[/2I !<IR(I4Z.W'>^V=EL+6G"_RGIBS^?^X'%8(*@<SV4,T<[OM%BFI%
MZ'5:X.N.,UYX37-]*:ER5P6FF7Y$:/-FQ9*GG6]/LZ;0K9,/W;B/GB2E\]%!
M*KSZ (7SRL$^AEX).+ *.=0'WN*Z>##Y#MIFH"5B;5QS*O:U&+*>CD)K7UD/
M,1E.#"$03_R3$@E==/U6D5NP1'@)8S"IX:C%QAEC5Q+1['5R,^S]<T^)<9KW
MV"V'H+#VI4'<A_4F/-TW!V,)=*-?(0V_.@PJ[RZ5N!$$R4&I8,7%&F94*D32
M\D>&BL]?>(M_F6[,H$S7)S<1(1MQIV+^)M*=?:&%Y<'G>0$B3;8G< 4$,Q T
M!;IZQ>PA"&0AN0%.%)<H_#N!8O.-_B2EMR8[XD=%C-ML[CO2_J.*;$TV+PA@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@0SH-T@\]J1.VD1A0Q%&.C&="PJ1RRT^65
M*P0XZ(/;*D!4%V7((SVD-H6^WM2E:TGU5O6MA4%-\HN;WVZB*%58=D(V$E'+
M3)&OPZ Q #1!!.8.(R"$]THEIQM2X[$AK<7[A,J-.C.-;7[U:06D2KWFOR*V
MRS,.N#[D1EUNM7"V6%MP8''?@P2F+==G.S7B1Z*RAXH(5#*#T:5O[L62BR=;
MTE:M(%,FQY@\N?-":RH=;HMG)$9PR2#F#A++P-T7 <(DGC1#1QP,S%A,0IR%
MN,R7])D#9+._1Q"4K%,-%\W^)R^?ENDO,VV "%KKD9,<B'&1RQ5ZU&[&'AQ
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MQ!@Q6]J4O:(\6,VTPRC:U[5O24Z]=[WO_+O ]^ P& P& P& P& P& P& P&
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M*E7+ P4%3:>$K?6993<*+'W CP#"7T-:]$:;JY>H)=OC_-]"@!1 +H).^ZL
M2='JJQ/;GFP5WL'09$:*P^#F2/R]7;8$*R5)=TI#+@^O[^DG:1Z%-IAE[Q=E
M\:/'QGOW+#/$B_-Z*?.%J ?;JQNP7R;T-O54HLN9L,'K*YMDKS+]=[/"DN[2
MZQ(9ERY;OZ%(4]LFJ.@6/C6OY*S4YNL%=$6@US[[<$V$/UL>_7DC+!^(VP^>
M)$/18<\1)51XE]JZYJ1+95(<;0I,EQ+@RR/.@7@I:9-EY^Q6K_:[%,#70Q9&
M.BP.DCW6&!MM5T$AS1^806-KX%VO$0:9L(%'^BS&AMJ=0GTD/*>&5.0^G_'?
M=@("%?.570:/M WF]LGD[.;MMMLL;L74; _#)4\_+%6P]92G4*H1KD*0;(:W
M(CI:G,+T^M#CNM%J6Y%_G>/G7P_);>.JE@O8&P6J!QBO%JC=;+SPB+@SI\..
M1EAQT$]6B5FBU1R-);**BZ7('"F#&E*TTB4RZ2'X[]9N7T:_T(40X\6N!0!2
MAL;GKM9OD"M@X*Y5MKP<!7+,,<L8@: '+DM(>$$R;2V5KARV8O\ I$N)6(:N
M!G?!ZOCZ'S=KC!ZLA.C=,I%/HSKW4YL2069Z&%59G;%)*O\ 062[!&ON]#CQ
M3 IMV03C.G8GM2O2E*CESJM#JA7PHY5<C7/;SR^RQV@0YQ\F=AIODVN-A[!R
M,V<D_2/12FQZRTRO\EC#&!OW*2LB0MEUAE2-O/ZI%RREEZ_X/=FMO"(I>S6^
MSG9@N1SCF\:&+Z1HJV]T=%.G"CM@/Q(#=F!G1\8"((02TJ9'D06S,<AMQ.I3
M<C42I?(9;/ ?B]^=M0F)9!EMH<ZPQ"Y%M'6K"-HQH3#?H5DD'(<N81""S]@D
ME6(4V0ME4HK/(Q9$A3BWD2,&4IL$_P ,KZ8ZYU&55;8?*U.W4T3T0^ &]+81
M9+9^+IY6!HL2,)F1(5OC$IS$6*0#L-.C9J%17YS;FM-N)&5&VYWX^[USD[5X
MZ>FA0=H M#6^@BQG5)4\0/K%3A!@I2$:L319"60P\XT#B*=:<3]XG<5/^E8]
MS:?U<KS!6OQ*L?+*-&DS;=T^!P6N<R 5N9-"VA-SD[Z)-J@OEVOPD#  -%#/
M25C!$P<VF*A#T-YF1[6F'%*V3-JJ#='\ ZO*L!.D5[H%@-\XL%F:F!PT?K9Q
MC\T YG/ D4-MB61E5^;LA.F!F0[:_>Q_]96C2/2:K9:EEJQ!\+:U+H%634^B
M5HEU2O<9LL:(/N?9;&UMRU&04OG\RZFH-@EQ(VZS8C4 /#(S7?:RR1^S1M$1
MQ;>#*/-W+X_*;--1+A4+)1C$#HUGY-''%G>GDV8\>M]&M[L A35L$),:)0;#
M>N=32"5#$IBM'9#R7_1]]Q;E,I='O/A_T$=QW@8>B]+,UBMMW2Q0(KZ>H "-
M#D5(1=R9.O6E^7/B6<\9L: 9%.@$AR4B7']JULJ9TRG(9U1"M]E\$!/.17$!
M9B]6WDI%B0;N'65%.G2) 6U\N(<TJ58*6.[C7(ED!/38D8/^%R(#L4=''-#V
MX[:8<V*G8S:6\Z,^!'0&8L:D56ZMQJWSLS<XS;@3L@%MZL5287LQRM^V:]$4
M?*CI?0'""Q.]2''ONX[R$N:;8V@F82:T]L\(K@#H]0-FK')HO.(1MNDJ')Z7
M HQJ !YI."'1.B8MV,.OL!GDUI0M3,U<N/*&'&'F_JJ?TK0J7FMY[PLY,/!4
MH\[T,;6:K=*1%'LH/=AGU+^LSI^MW"N.DW-FI$,W<FMGF;%(D/(DO#5R69RU
M(<1[FQE@$]3\0VN"<:'7VO3N=<W7TD^"J5-EHDW5!8S/JMC8M35I6S&-328J
MR1.ASFYTA[W.+G3D+6ZE:TJP9?"K7#P_M$_F?(Z#2>L2:_6ZYT8@*KFB?5ZT
M%YE,K-4-0I(MVM'SD..GHDD2S.4.:VG<R-]VY,TM"W_J*&=4)#=P\,VN87;F
MD\?U_C-9Z@KD(>O"MUVR:L[X,ER_E]@ QZ5-K@T[*@S*B)+-2C2ONII"%+?D
M3-R%;>9]A:E,3MP\-6^=U*W#^<W:UTM^];Y"2EG'^FP9%-!2^0V_H1>U$8AV
M7(.S0)7F9R<28<89=<+3#B7=K3(?=>03*1'?)_QOLY6'5[4(ZE A<R+E#U;M
M44MT2)T$39 @9<GH R4R#FQ[^-9JE>)'&3S$I]R$D<+D)]KC?VZ=EJ40".?'
MBQSWJ+O.*0>M CEPO\6N5:H[%_CV(.S.B&JY"@C$3S(+4:? C=)+P8C;<EI<
M1V),9;4EX8I+"3+[<]NO@Q;NO<J7*I5QKG>-DS]&I04['ZF0EC6*M?E="38)
M<EM^175 CMSD-2V"\GU:E27OH+=VA"DZI4NJ^1DP& P& P& P& P& P& P&
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MO6];UO6MZWK?KK>M_IUO6]?HWK>L#^X# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# X]5+PYZ+.
MKTO7"?,@,HU28=CY8'L%;_%"FZ)"-7.A=-O5;7+%7&7IPXN_C";V_NT.;;$/
MPA:V]-,+=4:MM-RSB?3^=]9*7:-VB#TMLP'KU4Z=7[26-N21)*,?LES=M4)Q
MHB36V275;1%'C0LIMF!!A(;?C;92X]J02\-;.G4#R$:O%)U2O*&KD?SIY$%X
M<RNO]-)TFTKI%6N-I+&J8'-;G22-DE4^8=8A2A$2+J)'C-(B+BO*5N3LN*;$
ME/';R-:YA2:-6?*$Y"L=<ZS6[H8NYM)XP?.4R"+@?CM*DSI!QR3/AFK*U,D?
M1F?<1DQ)*8R$MH8:VDEP\E \7NQU?J/)[=<?(0ST:I<RD%2S86T3[9,*NE27
M.;?3##^WY-C>%%]DSET=GZDDH\F2)C1&X,';4=YW6A;7RW>)/<JN+L9R\^9<
M6JTHU.LY+H$TA8+]5VK38S=)I5$ITPW:'+Y&E"%23U4@RTQASL/0O;RH(WUC
MN);26X;,#>(>1H/E-M )\B#EJZ#8.SP[=7KG/E?0B >;&C8<;9:S&B;C^YJ.
M-HDDI('QDNOM,%D1GFU^B?;HF$*F^,WE@J,7'P/+2? AF'[$S+ENMVV87&Q7
M8<%(DZ#FR;,O8@T3F,+>G0V_04-0[[!K32?7:A</7Y"56V#>G5"1/\G6N%\D
MD5#G]#$,F.EV(99[Q;()^YO6\# 5(/P&)!^RU::(]3;BY1Y#\-/VRVTKE*<$
M/%*\>_*AB ;L%9\I)I.:U%O1RHAWY5C?"V Y,!1W^;D3TPJ?(('"(EE@1Y1$
M5#3H.["F28S3:&U(5H83+LGC[Y$VX+&%\X\C25*(,\JJ=-39)LVX:*0;6!.;
MGV:[LP@9\:#+DKK!<9;>?(QI+H_[%+4?6FILK6A<(D(Y>7HG:J3<NF>5(,['
MY2.FV"UUNYW$I&FCS/9#G4*94"B )&VHKX(%:)-DAB!"I,3:]2 *H0Y6M2)"
M,#!"O%SRE"5H@0M?F6<(%X+AE]R6Y-M@>IZJLJ==C)H.04W9D$!VY&B0QADP
MB0HJ @P%HAR-;UI>RW'#R67DQ]OQSY:NC>9T'G-?K?).><T"]' 7!8ND62PQ
M+6"29/(+2#9& _/M T2L5%DO[FS82W'-Z4I2WM*)OHQ59H%CW9H-(K_G)79M
M8G]+N) R"']'/3^D&IP+H-POEZJ XQN\OO I2:C<FXQ2-!;9T,T+CO1FF&5*
M0VROZM*-X\7OH?CR;IP_R:*W:)T:5"MU9ZE&.FSCJ09WG+ >7^5[6-LFBC(,
MQ8GW"\!P=.:;BQY'TXRDI]%83=8/0^%]GM9,/,K/;WJ@,%TNIQT5MZ$:L@]/
M2*V5CN+M+A"<=CEYX>6#VZRN,ZZF4Y-0S,5(TZE7J+5Y,\:O*&9SOA=8UY9V
M:#:.>!.D#NB6> W);?Z(2M++[=*,$Y,A,F>4W1(ZM1DM2%-*E;=W+^JW)9:W
M@N+1\QXD>2WM$BZYY<6Q%=18[&4/1+6]:+80)ABC-M%C:\J<5L$E,L/$KI4;
M&>C2$+2Y,@;GI6B0MWZPN.$NL?BOU#=<YM"I/7Y( W1Q?6!9=Z,7Z!6A=IB]
M(Z;4N@[8>:J%J&/P)*1];D!U$$Z<(062CTF"XP\A*5BX>GIOBOU;HK_/)N_(
M*<,)47C\_E\PC^5]N2K<1N=<G5[I5N+O0C@R7!EG5QA$V*S$>;7'D#U:T_K;
MNEMB)4R_X ]#+(E*E=<K-4C'0HNN6*IT&FNUVJ?ERI]+O76J&##1 DVO1(6Z
MS<#PW3D_4-$PE 9F1Y6W%2OJZ+</:_X0]/>(3["V>X@R9E+OLY@')I=G*42%
M/M#=_B(%#JU(,L0H%,M,:]17K(,VT^V2GUF!)=5(>??<02T;ZAX*=J*5^TQJ
MQU4<;'VNM\'JDZ@S7+ $W#K_ !L+<144(S>7"Y!ZQ"V)ME9EH1)@#WIK[3LB
M2]N1MOT+<+/ >'':JQ"JL6M^4UZKJ*O6Q8<>.@/&EU:#-CR*O)DR6J6^==K\
MT?%TV=8BQ)*74?;SHB'%*^R:WHEOL \7_*4%41D/^UA9#5T;;#B"9NR3+*6&
MZ -Q;BV<>A#XA$-'?LJR!^%)B3I#*GM)'-L/K=;3I6"X9LQXT>0-GH%5IQSR
M&FQY=:'W&#+)CWK=(W=6[;; DQ#/0D3C^D6YH-1(Y(.TAU#4;;I'[EN/'4PR
MAL7#P]%\9^])MI2]<=[(BHE-\IY_31PM*SS4 G:*,LC$BR[&+<+.UF96WF32
MY3J]0]EM?:ZC-O\ T7W-8+93R#\5+UULK+W6KL$!"I'**G0Y9$Z@R9L]C(U+
MI=?O,=JS[>W)KQ&N$80A]B6AR(Z[)=F.?52MG:F]B)0KJ_A)=NF22LUR^UZ(
M5)\WC44J;<B&Y;]HEC;XU:@$TH$+OG  0#7M?6DH#P&=0);SR(:T(BQ8KC0M
M,^A>*O1;F< M"^L.!A%5>\82S!@R*E62?;9/";+8S!$0=C1[ !DP]SI,MDDS
M*3(D-ND9*E/LKU';]PM ['X,VBP7-^W:N8P*W)Z3S3H4Z )DV Q/GD:9"4W:
M##Q>Y/&IS]BM\6/%$Q_<^VV)C(>EL.I=F3([Q;60-XMY&#C?CK^#='@@*WRS
MD0P-=1+AFQRQ5EO$"$W!T)=KX^0/&' 3L?\ T"YY!+LB,TTAR*AN1O:]$PE/
M).$]EYK=95G-=YL?2!9A,^,6K5S)68H)B,$':;+^]KD.68DQ Q$=-$F?M]-H
MTSJ.62SM/TXS>M"X;=X0P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P&!H/8/C_ *);?R-&M'2NEF0_
M-JI;.?4L(N371XT31+,)9"M WHP@$/8+S1HYM3"Y\U$B3/87[)6W-Z]V%MC2
M'QO\7EB[P*@F[(&1<P)D&B8-%49HC7]'6:(,F21<[=3W)7]&K<]AA(K;RG-0
MA,B7'C[:U(WM(M-9GA'29%=H-::O5[;C44/UJOZ)2'04XX9%]E&#AMJ=E$GP
M_NB&HZ1;3D28TC2T.*7MQ+GNU[1:,2/C[Y_,BN2"%^O)2USK>]<3EQG1*6DT
M6FR'9TU4.,N)5H[=8:@%B+\D;)%:B3A"I$C4-]K[AW:A:MH7Q<<[<K$88:ZK
MTA9^1S23STT2K^Z]7P'H13 07(5JG10Z@%?;-MQ%I)(TT\Z4=<^[D.JG:W)V
M+7D+\(>? *??JH"M=NAR>C0J@R?L\QJM%3_XM3+19+,)N$:5+!;2W>8V[$F/
M&+[UN; 0.@KC+;<C)5L6B,SX[.3G9LF5=+A?KXWJ1)4&C6Q53)(!PY5D%V5Z
M*PY^6&GI\B2_!>C2)<G;LJ3#G/M.+4E6O06Q)GXT.)F!!^!^:.A02=GA+B'K
M)")"(QP_IVQD;3)18YT8-'DG8)0E+81/COKVW-CP(S;G_HDJT7Z;# /%^@UF
ME":0'G'HL,9TJ?U-XLE^"HZ8L<YTKM.C9)R"MXFS#ADT16G'=JE:C1&$;=W[
M/79EKZ5^-3B9,:;BMV6_CBEA#[#E[(/GA8ATK'W.MA!YDS/C!6)!6 2<LD=B
M?&=7]*;"#P6'/YC&L+<IS:_!3EMT-5<C83MJ("ZS2N>4?5=EZ $(!@3SF3$<
M'0C) H%GGYU?-L1O_68=<O8N;*^G,6SN6TV]H6_-H\$>76Z?6R1:T]!W,KM"
MYUSU;K!0-ZV$3RU$B33I=D^Y!2=E2(FQNH,LJ5M*&2K*7D)UK:T*%O-QOPD$
M\1/+*U;J-ZFH35^@P8L@YL.0(QKO?+%*+LWY$;8UNM[*U* 1G1(#2H"XZT$I
M'UD+3M"$B9M/F/'$\WR%SCKO8K H*H@'>=*LT^D-DSHIJ7^+7(1<6I F6.L:
M>F')$I\Z_IF,[,;E.M^NOJO*=%H)'\'*RS]& YU+HK]9TV9B2:_]"EPMK'/T
MW?/JHB$:%U: 9'%:13I$R#%GH=5)E-$96Y6WEN)4V+;)\=YA%XUSRM\U&66Q
MV@'41@T)7YEJ4(>,Q1 P7!'QX4B6&$AH\S7U8KC_ +U,Z4G;^VT^C2&T)(L_
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'\WZZUO>M>N]:WZ:
M]?3UWZ?HUZ_I]/7>!S/;^3GFLQF7(&<SZ!.:K8,D=Z![Y=3A.4U5,)4"O=9K
M/TI9Q"K!>>76OJ 8;.%0_>[(D.O:86I3:$/6FOE8M \V?SC>9]%)\>LU:EA:
MKV*WFR6CXJP#((WCG2;QR8HUJ<'BN#VY9NY<\(IAHEOP]+BZ;<UM2]NLLQ*1
MG@WR(U/O!3GH@5Q_I]=DW^N7FUHE%V@RAM="\V'#R=R=L#R)S4\;+A1[I3MQ
M([T9IXDU;8DB,ER*S(?0*4U!^8OA,VE2;FOG]_@-B^<UJYG0Y,G1!Y 1:35O
M@!3'*W7YMH8&R+K5*83C6R5IM_<5X#*CK8=<??;9V/EO#P?R?IGD#9.F5ZH"
MRL9OFLU$9XS+D"Y RQQ'[]U6A0R@-8^9)=5 FR.4R9C:G4M[W%F,?H]_U$H$
MQ39;"& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P&!QC3YL\F'C!5JZ7XCUX=#KK]JZ$?<#5H(;+!^UF[]1) B?3MFZJ B%
M3]QYS=!]MGFM28TS[B1'A[V]*]ZFS5-GN5=LY#T'MCX0OQ"M<](-TU9GFMVM
M8&E0#1T=?K_=@5E!#BS#DG:2UTL$9PD^'B/N3'&R.WR#:'92$K)LJ@=YK^-_
M.':P"JO TUZ,\4N--JH"I5OF@-8EF*:M+/1H\18\M$KNF)[7.8$U^".?=5-]
M&=+][S3:-%J6?LGDQXU<ZK_*[,8\8Y LU?2G8 XVLB^?<SDV2L%>65UVNV-J
M1*@$/P9QDZ) PQ+#\.:ZVY#4PAW:8S2OIDI^:/Y-<7"="L.JCXW#N>R>;\*Z
MU9+Y,@USG >^C6^96JK;E<_K\2L$''IM3F&K.1?;).O, 9DZ.\J.\M;,Q38I
MC0'R;@9^XL"=R.S3"T)>RMP>K9RO% 86J22E]CCY%=),3I+=[L<B'6!R8D.!
MO[<S)+(3 DN^B4K+\KJD>=-%A4#FE\G\_P"APD=5JMGM5:#R$533T>)2R:AM
MH6=,ILZJX%&!T/1)KI!^6F&D;+3(4M.FGTM$I]*+YRT/HULJ%&JU&O<JU6DJ
M-@21DA53CIK0^<!8LOYD,ROS*XPNNOAON'QTF-M_1AN,I4+3R%H5L3%,'OS^
MHSQ&ZCQO.;P19HA2XCCIM)GG$6MCFZC>Q/,G)9L[*NK<&L?6N)N/N4P1W&D!
MPR]%)Z(\125J%)#1/.*A7ZRUFKCJ%TP;.MMDK]1"NEA(9F/+/GJM&OWV[:XI
MV6I< 71&R9"3,UK<;3M?)PT+7+B[94*1)KY#*!,N-9H8CG'0#5GN2)?Y?'#)
M5(D.-R-=&%\X&C[2K5KTU3"\P@07(DPB"FI@MJ,M$MIIY33:Q3SP?D&I[5#-
M=-/T:S1JLKR"J7#:G #/!#=FEZL]'I]J<.'XD(P\+%3@KYZ6W.%ZD[(0E0]Q
MGFDS4N,Z%,I5/.D7>.B\IYV(YE;*X4O)N0BP)NDVKQ9 :L/<KLW3014%$"6(
MO)L\J?!&0$S=14.,!53FV9RV7WHZ'!2,R?D5#:G18$3A/4DN-#>>6"PN&Y]+
M#LB:_P!'IDJ\!5#G6SY)-A/N#'1\9F$S[&I926[!:D;E17&E"DK9\^J02^L2
MK?-.C6BH1K.FMNW,*]2'PSZ&7K6LF>%M.6UN>9!CQ52<E)=CMK7*U)8;82XY
MMQ+8I*IOEBN!<.PU>50IC4'E<&OSXY_\5@+?M'XMTN?SXE#%U;ZB#*V@6HK,
MEV>E2HV]RVVU);W[/JBD!M/G.2C<]J]RJ/$K/((V>R'*MH#;['4P$L85A\]%
M=,K#"%0RQ,<<D7.NFHZ&&8\Q#D21MU+^M?;NZT(ADQ/G_P _*C>JDG.==)"-
M<BJ=+LEB=LC=0 #WY=QF"A_X-%+E+5'',M!IIEI+Y20XR(<;9D.-25H85O8I
M&]_(Y1)324B.7="F$9:PL(7!ESJ3!6\8/!'B8R 299LI L*CF9WT(PF3]F\T
M;9>5.@?7'L/24"F @_*'REXJ'K4KGM\_,Q$C2!ST +*JIT:MVU4MRY%4UXPV
M;B-VJ15VHK["V(S6GYZD)5$2[]5I*A\I^W\@G.OR-RF\R^<]1%P^KD78(B"4
M'5R"^TB-.*0Y.QLUZQZ$W,LEL4M]L2#?(%W&UIU]LE>]HT*0@7\C]8M\&G2:
M7SRR?6O-\I%,$)M3X8)#9;,]:>YO99^IOXRYH[+CP&M$AL :B3.DQ?JOK90Q
M%E*:%)XYY[59RU6>K">-=E,/U3HEGYW/FQQM3B,RIM:LM5I&B(Z&2MD,M(C&
M;C<8,:&SN.B2Y$=U-VC4;?OP4BL_Y&J2^16W6>:=+G APH#<9]C)@8P^$9HM
MA G+"(+5>*LLDFXX7%18,J,_-8BP$L/R$OO,NQ'D:%/$3^3?EXMLA_\ \QZ>
M7E#70\)^'6GN?V)6R!-^OMJ=W)&79Z)%JTUFPM.!3TAQD-8_8I(Z0\KVZ4*6
M7U7SLY[R:W7RC%^?]6,V&@ UV$B@!7(,L;-':"CCFGH95XO'BH0S%.0/N5O;
M;1$3)VMS>DLO;0(BVU'.KZ'Z73@-Q"MR(C)H2)(R@Q!R"HS7I940/-?@1]H;
M,(1(AJ!%)-?7:0\XG6U:VE2D[2K9$WP& P& P& P& P& P& P& P& P& P&
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M?ODEXKC%5:EU)VU\IU7*YW:M;,O'W:];$&%0WHR5/09+6DI)A.+MS_RIM=@
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M3IT8](GS6\><1:[ Q_6?';QWI//I"YNK%:*5Y/7:_6<6VV.ENP%"ZB5\;*+
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MDB5X# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'"#X3
MO]OOERU_F_>C]Z_U0'AKMMX=W\,F P&!PD^?[^[IX>_XEWB!_2UOPUUU].C'
MFGQSB?;^<U:J=XZ4,YG3QMVDV"(2*6&M5ILH;<YUT"HQ(48E9G6H[) 3'M[I
M>*MC?W#,L:TYK^8A>$B9C1J1R7XVN/PS7+.H<I\@2%XD<QZ.8LY"R%!=%Z/&
MN-\31^4\OZB7,E(FH[<;H%@L_'GB\\@RO;T0V7G)TU[--MMEMB0GQE\5Y5#J
MG).?>3MHY[?=PDD*Q')2.>6:[F(<[A+WCYU6;  72,3)$P]PJ,%F='CM(4/K
M)>*XN TU$>D0UBY;$4SX]J91M]SA ^D7$?6^R\%C^/:*R('5\(+#5R#3FZ0+
MO%C9'0VV>C]<#@([,*/8R;>IVQS6HKVWF])VDEL*"\$N2<QC]8YROJY>#SGR
MQV4HA/DYQBG-PB++O&C8=ZG<WER(#9D:H8Y$/7!F-$4X[&=<D)1I,&,AML7-
MVNWCG-:]XA42BU"U]ZD%P$G[6I.ENG_DL*>ZGWOH]ZL%JL%]('H\45)*W_IM
MBL3J="8NOMD_3U]NSKT5Z#5><GK?*X;MBCRNE4)F33YXD7;8R[< ^ZJY(\4C
M P@^PQM3]OA9I<S-9BQFI*6UO2'4MHUM2M:PBPL#Y)?86ZZPAYI;[&F]OLI<
M0IUG3VE*:VZWK>UMZ=2G>T^NM>[6M^F!]<!@,!@,#%'3H6KA#-ELA8<!KM=%
M$#IXX8F1QPD*%$Q'IY0L4(2W&HL$<.@QW'GWG5);::0I2MZUK>\#(,/LR669
M,=UM^/(:;?8?96EQIYEU&G&G6G$;VAQMQ"M;2K6]ZWK?KK ^N P/DI]E#K3"
MWFD//Z<VPRIQ"77M-:TIW;3>]Z6YII*M;5Z:W[=;_3@1ZT76FTB+"FW2VUFH
M0B9&.'&R[0>% (I M+TO<47"D%I<1J61DZ;5MMAO:G5^W?HG?IO PT[J_+1;
M5I?)]*H YFC28<*[/3KC78C5/F$7--#XEI<D$6T5^3/=5I++<O;*W5;]$ZWO
M S)FZ4^NUR5<#UIKP:IP0<JSS+,3,CX0&-6X45$Z8?>+2)#<%L-%A.I><D[7
M]%#2M*VK2=ZW@2; B0:_4>QHMCM?M]:-M4,X2K-U=$FQQ!JIV(-$C3S *Q.Q
M9#K8@N)AS&G),=_:'6$KU[TIP/Y3.@47HPQXWS^XUF[!X\F/#?*50X-/CV9<
ML0+L$6,[,%R9+#;\@$<A3$(VK2E19;+NM>QQ&]AE3=B 5J/"E6$R+!QB1D+7
M1\@K.CP&9I^QDHP8 &BN27&T/E#1:8U&BL)WMQ]]U*$:VI6M8&9P& P&!@R-
MGK@@O7J^5/"!IVVR",2K!YQ&)%)V.4(&OF2L<)!>=1)*/#1,5R2^EE*]M,-J
M<5Z)UO>!ZI1D/!("Q,TJ-AE3BY;84;*G18Y PX/C*FST"X;SJ))!<*&A3SVF
MDKVVUK:E>B=>N!XYMJJXTZ(JY&R 8%FL+4V0 KLTP/BG3C UO3I%X0(?D-D"
M34!K?N>4RVO32?TJWK6!_)5KJT&PC*C-LH"':S4.60#5B49'1["6@0/_ *].
M&!79*"4^'"__ "KK32T-_P#TMZP/7,.!1Q 0)(&!<$J?=EL 1DPA$BD#;X^(
MY/GLB(;[R)))V%!:4\\EE*]MLIVM7HG6]X&.EW.GC[,+I4^UUJ%<CD.00"5*
M6=%QK,8@1$OKESA8%Z4@J0AQDQ7=N.LM+0C3:O7>O;OT#TR[-6X!T35YUA!P
M[*>CSY8.NRRT".=-112$.$Y(D2](1/(QQS;B5/K9;6EE*M;7O6MX&->Z!0X]
MNCT!^[5%B^2XNI\2DO60,W;I,';,B1J9'K:YJ3+T7;$1U?U$L[1[&E[]?1.]
MZ#(N6FLM6*/3W;$":MLL8Z;BU=PN/18I(9A[49\M'"*D:)O#&9&]-KD):VTE
M>_;M7K^C _N[-6TV)-0W8 >K8L2H\BK[+0-6)8-$K4)9I(3<C\24)3-WIG<G
M37T=.[]GN]WZ,#YDK950S\^*8LM?%210*1:"<<D9'07QU:B.*:E6*>U*DM.0
MP49U&TN2W-)CH5K>MKUO6!]TV*OK IM2#H9=76+T<19$DX2@*@JHWWJ3"3&G
M]CE"U0]_5U(TY]+;7\[W>W].!_(=DKI&<@8//A9Q)T1$L#8^&4@RIS@&>XIJ
M";1$8?7(6(FNHVEF3I/T7%:WI*M[U@9K COYNJNB=A#;L@)):I"QARU#5%8*
M9U;#&DE5B"QV,I_3HH:30"F[8??TAMW41[:=[^FOT#X#KQ2BY9@ )N%6*'90
M&):HP4=8!,TM(K$_:$P;&P-C2W9CP&:IQ.F9B4;CN;5KVKWZZP)3@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#%&CH.MCW2UB,B@ IA32'R9HC$%
MCV5ONI980[-G/,1FU//+2A&MJUM2MZUK].\"$_US\>_YL<T_X[J_ZUP5)_7/
MQ[_FQS3_ ([J_P"M<%2?US\>_P";'-/^.ZO^M<%2]$'KO)R9,>%&]/YX0,%G
M]Q10F#=:W+)DY.D;<W''P&";DJ:_I"=J]C:%*]->OI@6'@,#A!\)_P#M_P#+
ME_BC]Z_U0'AKMMX=W\,F P&!PD^?[^[IX>_XEWB!_2UOPUUU].IOE3P&#Y)\
MEWS:5^6FGF^A\=N\6=:*_'LD",WS7KM'Z$7B-P']:]LBP JQ*&)<UO24ZF;]
M^EM^]"B1AS;Z;\6/5SC'6&>6>2)/F$#J_1+??[16JV5OP )9%&.\= Z36@\K
M<"P38E2;K5+ND<?]P'@,_<3A;3CC2T+_ )EM?J%G=W^.SH77_(?B7:!':8M6
M?Y9R?F5%>MTZ :LG18]GYO,ZM(<N(MF:1:JQPO96.GNHU+*MN21,EI<R/[WU
MIV@1.*5*$^,[RD%3^(S8_EE&#0>;=+D7HW6PCO6I8Y4983F-<+P 1JV]!LMD
MFQNCL4LP3.PI\C<1LO99*V?J-)4EZ%PM7DGQT= YGVWQDZ.0['%N5<X/3J7$
M(Q+)-ZF<M4VX#.)=7YCT*179)WH)2L-!NE73IF[7-E$!\LTB8PJ,F3J/M&DB
MXIXZ%\;G0!_4JK?^H=K8Z/$H_D96>W!X$]WI$A\W,K(WR#C_ )U-MF[T6%B.
MG&T=@!CI+8IF*!0+J$9"(WH]IJ.2V')_&ITPGU"]WR'U+G=,1,ZUU+H]0,TN
MH6$7T*P#NQ]XY3UVQ5?JEI8.Q=E0E9#<X='#8D5&VGY4Y$EU3:&-L/%O"/SO
MB^[LE_G"JSY@WVK*JWCI9^8&)XZU=(<>WUNSBNE,6'K$>+.M,R2?:NA*\#G9
MT.3.ANC]5Z&J$\E:(_VHN'YL7Q@]1F.7$Q4+_P THI7H%?XM$M0$-/\ (%%?
MG3.84OK-%W7WS\7JT&\3J@%DWL+:PVUS$3/S#6F&I.U1'-;:%K=IO@)UFF]!
MXY>O[0I>TEJ7WV_]2Z0>MI;H1:3T2G6 &( UZL.5%VVJJ$,] A#GM)FMMLQQ
MSTV0['8<U(DM/BV*MGQW]7,])YS?0?DG<0#(/R1[;VR]BAMLOL%%B']#ZN'N
M7.V(.I!HS!;E\MYX&54VA/T(X27 (RM^QI*WFI(M$*[\<OD.,D<G5+\CAT=Z
MA#V81FQ""G=7+ 4-C3I0Q8>D0HQGK$\#(N?D;!G-#+TP4CSQT&%'3^#H:<4I
M6Q;Q5KXM.CUU@1 ;\D+4\,D[HXV_1';UW"4JVU<%_9#*VP*S)G]-E20SEKN'
M$[X27)BK9D:5?G$;<VA#R'!],)KXM.^0(7.183R^O \)5+IS2YV8)'N?5&UV
M4]4P90"9L[=B+VNRF815N.@8J#"3[8+FHJTN_37['=4N'EZ1\5/:KC2+A3Q_
MDPI\??FC;MP VXEV,Q5CMELC7DN(>N<F'"Z; F,3ZM7^N51(T6RZV#>=J+:9
M,52/M]LP^HX788\/?)"E>.GEN H'5E'>Q7;I3?;O&A^&5L#3U,OE3E5^QTX)
M:K%<K0ELO3R]IKS<<@*5](?%K[SHYOZ[.FD(%W.=$*%_'#Y!U.RECE4\I9[Z
M!8/G6J@JV%>L')UG)T.R< M4*J=33_6 T(D4483XX83%>$18160U=2&I3B])
M>3.%PMTEX0]F+T+Q0K+WD@7&'>1%B@WO)H-NVLM=CYL=N8/I12N!DRK3)G@#
MC=RHH-B(0FO$'(P19*%_.1,7ZBX:V0/BJ[=N.#+%O)>*YT6NQNL!*_?&/ZV"
M)6JS.E\#?Y04[?67K!TPG+'=FM%UCQ+,8C(=2!T_I2(C33J=27!]?XV%J_Q]
MV;?,_#JB7OKI@I+\:>S7CK)TN@C+M98XQ9*?U.NAJA73MW%SUPP8B3?8R-HD
M0M_3&QG(T;Z&_I.-DMKVOXC;49@ :Z=ZS100NC2@@8)<.=\[V$Z=T6M[\H*!
MY%'KAV,W8)MG"67J@YNA)A"'W8,R @F2GD7VU)E;AHJ_2P>H?&*;O_"?&?E<
M:V\['V'@WC3V[QKEGM@[NP)DC>L\R$4.-=JN-@6YI\<9&SJU&E/0YKDR,I$V
M2EI3:FHZLA':DHYM\?/6^>>2?,.K-^2=O*<EYF7ZJJN\B<M-\^QK]7N%YZK9
M:[6DNEC1[=SA) W\8-GI*NZ^E^7(:V-K2AEN.2\(O^[-O@6^LG*+V>%4ZH1Z
M]U_J9D1#<Z:U,!RNB]TM?5I:JQ A7^)42Y+HE$.0Z/:]G1\^/^#P?KP&VGW5
MZV7Z1+GOQ;=>HI+F++/D3#:K%8L-)*6*#7V.AUB;!8JM>X<!L<^F,@;N-!S#
M_4*YRB=6"JST4BQ$KQ;UB)2^AY,@?3Y4CXQ_)X&MYVX^;-DN_P!G,H)6LQY:
M+O%CA"M6OM B&7]I_.3^YL8WPGBU5$:9<]4IL,@Z25O>B:V]#ZCA7;GQ_>7/
M,NX>(T2JVDWV+A-"OU/N_3?ONU6ZN+!GQ%.\=J[:; ^BX6RQ6(ZV?N7.;+:5
M0X[,]N?^-/"74PVIC\U(N*SJNDAX#^072^\^05\N/69U*YG=.NBY *H#+QTV
M21Z#RB%T#QBO4\,=<!]"AA:0$:%<GM(@7'$PQY%+EKG.2W%L+VE\7%*LZ5\:
MGEA-E3AE5[^D^)O?4SL@[(*W+M 0<,JK]"\G4@NH7:(+ZK ,ENAU\WU"JAH
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MF(9X*^HA6B@8NUN"6@,O:TW(2E>T>BM*3O>MEB9C1S@__A_/B'__ %.J]_\
MI)[3_P!1\MK]=C_^'\^(?_\ 4ZKW_P"DGM/_ %'Q9]=C_P#A_/B'_P#U.J]_
M^DGM/_4?%GUV<VO)?XZ_#3P@^2[X:)OB[Q,5RN7T7R(Z^S<7X=DNMB68;J/.
MA,VNIW^;[)8-0MC91B2K6X_TMN?5]%^[6DZTM8F9B;?ZMLC!@<(/A/\ ]O\
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MOK@?7 8# 8'RV^QI7LV\UI?K[?9MQ&E>O_9[?7U]<#ZX# X0?*)_^,D^#/\
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MTZ;7ZJUO].%B:PV<PA@<(/A/_P!O_ER_Q1^]?ZH#PUVV\.[^&3 8# X2?/\
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M 8_+M_.)D#J+TB[$R]"?B1#[EG3QR:(K_'1'1"?VS$E,A-C>F!7DN0/H+WK
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MU7Y"^?\ -J3X[]4BTP]8>5]S7=)IZX++!Q*N05.H54D3=N5T&MK+H>"1K8W
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MYX!%CP9-;I?5N:**#XAZJV%EH@?YOV@^$G?4TZQN-(:?CMQYS#4M(>>\^"_
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MX0W1XW\LO $0X)/Q?K#;,-<-<)N)J4PEG2'4:9#># 8# 8# 8# 8# 8# 8#
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MO=Z_H]/3 S. P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P.$'PG_[?_+E_BC]Z_P!4!X:[;>'=_#)@,!@<)/G^_NZ>'O\ B7>(']+6
M_#777T[MX9,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@<(/A/_ -O_ )<O\4?O7^J \-=MO#N_ADP& P.$GS_?W=/#W_$N
M\0/Z6M^&NNOIW6?=TPR\^I#KB66G'=ML-+>>7IM&U[0RRWI3CKJM:]$I3K>U
M;_1K].&54<7[72^[U8G:Z0D]'B@[;8Z,='60)+!%Q%HJLM,0P,D1W_J1I6F%
M.(5IZ*](CJTOV^_3B'$(#7GSV[IVG@O+::?X/5FKA>++T$E75!MU5JY2WA(;
MC?7.F.Z'!)%^YM&>?DD^>Q8[JMD_KZAOO)B1Y,U49A8:D'_D]M4N:<9K7(+
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MM<YF.S)%_O,UN0^3,5QLAN3!FV*0/DLS&Y;B7&G&E-*2O>O;Z87=L-A# 8#
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ME;3MO7NUZ_Y,++9#"& P&!^4H0CW>Q*4^Y6UJ]J=)]RU?^<I7IK7JI7^??\
MEW@?K JOL_9^9<!Y\9Z=U^Q)JE !_22=/.B#9N,.8D[4C<B;# #2TY$)M"5*
M==VSMM"-;VK>OT>H4_8O-_QCK(XD6+WPLH,**6<:X8%<RZI8PT[=!C$YM\,
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M3#<:,VJ1)<>DOJ0RVG6UN+6M6]>JM[WO>\#VX# 8# 8# 8# 8# 8# 8# 8#
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M&FY4B=(?C,-2G7DNR%QV O+ 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8'"#X3_P#;_P"7+_%'[U_J@/#7;;P[OX9,!@,#A)\_W]W3P]_Q+O$#
M^EK?AKKKZ=V\,F P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P.$'PG_[?_+E_BC]Z_U0'AKMMX=W\,F P&!PD^?[^[IX>_XE
MWB!_2UOPUUU].[>&5:\L[#S3MH M:>56T?=*Z$N5OH!$P+:G(@MVNB')5<M(
MV.]-B1-$&1Y>$XVB7'^K#E(UIV.ZZRM#B@UN\\/)>^>+?*ZI=.<TR)>K%9+V
M1K&PL@,=L+J1P;D?5NISI$()7"(LI-?<1S74=QQ+NTPHLAV7MI_[?Z#H8/D/
MR \YZK;KS4$T7I0U'//P@<<O06J%[US6;8G]#&3L4-:*E (2%5@1,*(<:L$R
M)"#RAB=S]OLQMH4L*<K?RX\*L[56D#:'T5^(?LL\!.EL2^?*0/BM6CB]7#G
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M-A29MEFPW1TRPRWXT9IV2<ECWUL.RU[5(<96I"E[3O>L U4*E'F32+%7KK)
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MJ=[2K7Z/\Z5:WK?_ &;U@?W 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M!W78FE;;EQXH2SJ?3O.JL][[J<YO7&;/QGG<KF]9J5/M09I@#;R/1:WS<?\
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M]Z_U0'AKMMX=W\,F P&!PD^?[^[IX>_XEWB!_2UOPUUU].[>&3 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# UL\E^\%.!".6F!=&,=
M#7?.Q5SFDNN5I$9^T.0CE<MYIR76XA B'%S2L=ZN-Z^G*EQF-,*<7M?JE*5!
MKW*^4/QC8J1"^1==#(TW=;GV:G6%FL#QT+J$>O&*'7[J+YZS8+ &GD;%1C72
M1,:?!FLP)$AQUS4!,W3#VT!A>F?)?SP+1;)8>7T'HUZ*P%OJKTJ;66@]0,A0
MZ^2_FVZND91N*78IE1<[97(DU_[3[Q4XFE$>-(1'F+CA+O)[SWK/"AO70E5H
MESO71>?C"H<)I F'&H)CK$7G@'JK?.)!Z4>%S/Q@9S.T0[),]&F83@S3C#,S
M<_6HV!X?(+ST@<*LU:H_Y*)6:P#U1]=;.NPY(6BTZ1.X+V3L0D R3BR;$:5:
M3&^5Z4B-'@DXK Z0K;DG[CZ3;@?0E\FWC<#L# "P0>L!/J-=,*RC$CG)&>($
MT_EUFN5,+=!,+!RBQ&!2C=KYZ;A#92XWU7?P]<A]J/$<8D.A[6?.RCURQKYT
MOQ][M6Y\:K\M(TZL1ZOSQDE92O3]]DFB:0  #^@JC#BHFI\-.FGW93L4;L?%
M5IN0J1]-AT)#2?/[B'0CM*&U<3TJ0 Z)>H'/*;T0E4XP'GINPDJ+6N@Q663Q
MTT.>87($V\?'C1GH[9 A/<=8A1I.XDU4<,1*^0CE@2QVFMVVA]6K3U4ZI=^=
M3B;@:MF!6J]0[CS?GY?KC[H6U39D3GJ[CU@)!0A3&S?NDK=V/^W8?=:"+]J^
M2#FG%NQN<_-5JW3*A7$7"OW&Y00>Y.IW51LOQ]AU3F% BI(MO'3Y-_R"$IFO
M2VH0V/MY/MEJ^C*^B'GD?*%PX6_(4?Y_W0*-F67GU<I<MSGOWQ>\JO/% ?=R
M,L;28!5^]AU\_IAQK1J$2&Q"'W.T-06)KCB48'[N7G7X\6]D+6[!POKO3QYN
MSRXH 9*Y+5[*+G$1'8'.%5BQ,P[#9&X\&':>MZV+"RY"&'/3UFO:C0-*EZ#U
M _DRX(0?:>DCKLW4Y;H">U=A=8(S:[5Z=:A')'JS8.A_>LB25=E%;#V$:,3"
M@1RRVW-[=6I+3<C; 3"N^?/-[QS#F'6*#SOK]FKW4>ZTOA0V!*K NIG!A"\"
MXYP7=I,>W'PP\K2&PTZ+(<D#94U_6W]L?2U*CR6&0IWDGR><0(5#B8:UT+HM
M&Z5TN#27'.;5GG,XO&#Q+E6^;V15]&- WYKCW+%R.L"_I2_9HK]-];K\!I+4
MA38;&6CS9Y#3NK6;DAX5T**7K%A!4]^R)JS;M-*W ]KB,A%8"ED%/O99(:,\
M@ZU,E+7%:BH8??TAYQZ.XUH*O)?)CP0?.G,L5+M9D,*V=_&;>%Y^Q,JPC54$
MD;/;539RS[$OV5FF!Y9F4IJ.YI4)CZ;.W9;C$5T($/\ E3X_7 <U'7:CT:NW
MIF^W6J!*K3J9.N:KV#K71>]5"-;J'H7,D3# R.)\?C<B>R^W%G_<1_IQ8LC[
MB']<+TK7DOQ"I\_G6WGG(KH,$67O=TX[4JO3><UNN'>Q=3K!2UBK@6J@79<'
M%D1&Y'/#:W21MT4Y(:$.KUI>E1_K!$.<>>0.Z5SKW4I%0L3W*PW5N.\KX2V
M#1Y%W['/Z[SSEMPKDZ#"(V6)#@.6&?U:$U&CDD!]0(C6W9;NE*<1'#UG?/\
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MO8&*76DUXES&23*6KG4>B$X]4")'/KE3K!1HE%K,A,%CWR1K0@:YI#:8T;:
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M_%'[U_J@/#7;;P[OX9,!@,#A)\_W]W3P]_Q+O$#^EK?AKKKZ=V\,F P& P&
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MHO3OD;Y^0+$(X.H'Q5WZS#Y_0 SM1$)=JD/IG9NX\FHQIZ6%M1":;"<RI#-
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M:X%MI:BM#Y!*+!F/1V9;B]:TUOW,-!>V P& P& P& P& P& P& P& P& P&
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M ?6Z7:JLBZ]UD5WF][I!7F1H]/(P*CRB!RJYP+/8),A)G[%BP_:_5^Y#3&G
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M?H?>ZE*C,R0P1#Y%*]"[7=^/-\P-R&:'UP#RL[<H]C&S!HEV>0H4,B4LPL=
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MB#5TF7*Q6X%#.1:S]V2*&B4#9!#LY^.I08 A.^.&^#3DYR7S(TQ3JK5NS$2
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M9$X@0G2&8D&#!B,KD2YDR7(6VQ%BQ6&U+<<6I*$(3O>]ZUK>\#\#20XR.'F
MY"$6$%H44D+*#93$X<2'3F&Y4$@/G17'8TR%,C.I<:=;4IMQM6E)WO6];P/;
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@<(/A/_V_^7+_ !1^]?ZH#PUVV\.[^&3
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M_P 4?O7^J \-=MO#N_ADP& P.$GS_?W=/#W_ !+O$#^EK?AKKKZ=V\,F P&
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M 8# 8# 8# 8# 8# 8# 8# 8# 8# X0?"?_M_\N7^*/WK_5 >&NVWAW?PR8#
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ML])G=.W5+I9B$OL$H-%GS@OV(^!!BOM#]D&6)3(1LY\5\0I6YD"%W^WB[:1
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M%#K5/#GZA(,Q#CY&>2)!)2XR]I4K9,(& \6?,]GI?+W+28%S^?P?(.K=VM[
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MOD#GH"&T07"81 FJ4M2UZ=<4PR&2*>,_F#4X/A(YR P)KMLX]P'^J#HI9%L
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M1<E*R$I-:):B2]::7I@.M7'+?9K_ ,IYY=[G6(]+M5KJ (\?JD0FX9B BA.
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MT[//\G(%72@V!';LE@YRX.GE1[*GE!Y\EV&ZKWM>J@O[ 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# X0?"?\ [?\ RY?XH_>O]4!X:[;>
M'=_#)@,!@<)/G^_NZ>'O^)=X@?TM;\-==?3MS<#H"KU*T6:UN-LU:NUTV=LK
MKT1R>TT $#)) RX[!99D/36T#H[FU-(;6IS6O;I*M[]-F6I/%?-;F'6KQ5^/
MTCG'4 5CDU\R:EAR82BP _/Z;7J?R"W!2YZ:$O902@;9JYW"L_A<00LE-;5+
M6U*C1-QI&F@K&/\ *9XY;15U$@74@3MQLW.@M?AE M-<(SJ[U*SSZ95.D(&B
M;X4G_D;5G%O1)^]-[+#-_2<E0&FI,5QX/2.^1^IE"8I$+Q_[T\!M-+Y3;*,3
M2CD:"]QD]FZ[8N040+!K$GJT><*_&"=>603,(N1(S Y6UR=QUI2A88X-\F/C
M9T_<J#6.?=EZ"V+F\5?$[9YA V')W?J%BXQ&HU;$F[.>%5L==:\8[57I3VY\
MJ U'2W*D1)#^H#ZD!^FOD>J<KKM>I['.;Y$I<M=JJ5S(E1=?AW#FW1!W9N+\
M?JB[S6$W1PH"IEL)]D@.Q_\ NCYI<63'G?9('JW(V$WX;\@7*^S3( )JNW4(
M8=YL2OSQA\8+<II615>><<Z/>P=9EH.+M3C]<!]R J2Z3$C&)>WW$,N+<9=0
MD(A!^4KQU>9H&S%?ZM5I_0C(83 !'@5/58 <:TTCFG0*98[&(!WLU+BUBW N
MN@6XTN,F4F+.F?:STPWVW$)#&._*MP@<%<-V7F?D%4VY#->178!FE5&43N!R
MUM<)G *O7HE;Z"?]39 )Y)T^?[IBH<%I@DXVY(1*ARX[ 3._^>@&@VSA[TGG
M70"7-NS\3_K1;>C5I@9TBI$SG2N)\XI0JSTFU6&ME8>B9OLD6#*B1HTXE&GK
M1[VD1T/.I#V6?Y'_ !SK'C]/\F77+D5Y9#M"JG&FBA ;9@\2'4+^L&W*K(8E
M8ALFPZY^,AE(AN/%VY.AD0)1G3#B8;CF!];/Y^\[@72@\_IM(O%[LEWZ<3YM
M*3!?I86)4D!NB=7Y63MIE5BMHMZ6&CV_D)';<>,E<Z3 6AUMK;GJQH*KYK\G
MO++?S^A/=$YST8#=S]&H=GZ=6&0-7EA*?7+O6>&D7;\I<B\RG#'-YTWR# LQ
M8T3<^S;9D.?7%(4P]I(9KFGF[Q8%'J5?HG"K91:)<D<D(T:LUFK\ZKAG\,[,
M=[6A/0IE'$6V)!:I$,%Q@F?FK'+G'(HEB3+F#F4-IVL(O/\ E3YG:>>5&V<?
MYYU(J4O%AIR C5^IS%,#L<_/](X#2Y?2I4DM9QCY:L3(GD$'T/\ P;\3GZGN
M+:DQ&OM926PG7??D!$T.9>N>\LHEHMW50=Q"\YK<PJ.KB*"8N;UYX14KK!9U
M*Z%5#\MWG@WR!"D7VY?X+#*[]\>'/4M+BVPCG$OD,EVXR.JG3>:&!5WNAXRY
M2:?4&*ZX3@4@=TKR%I\BQ6LF4Z)*JCL.N .#.SYSL(E^(R7I2FHHI7TV]O!8
MG O//A_=3E4%<FYOUR.QU!^\VN-9B_/!5'K4NL5 #S4N1ZL3*G#XM1:NG8?3
M <:,[$;G%ON5J9E18^X[GL#?K 8# _*DI6E2%I2M"T[2I*M:4E25:]%)4G?K
MI25:WZ;UO_+@>:! @BH,(6+A1!HP;$C0!PZ!&9AP8$&&RB/$A0HD=#<>+$BQ
MVTH;;0E*$(3I*=:UK6L#UX# 8&-BAA$+7I#%#8FOQ*:9](L&*QK\7)*DJ(E?
M1II'_K(@J:]M]_\ ]*[MU?N5OW*]0^T(</&-NLCH,,>R_,G$7VH49F(V\0)R
MWIY*<ZVPAM+DPA.D.//N[UM;KJU+5O:E;WL/9@,"+VFCTJ\L#8UUJ%7N$8,4
MCFQ$>TU\38&!1J)I:8A<:T6B2VX)2*EQ6FY#6DNHTK?HK7KO E& P& P/%(&
M#I<L?/E#X4F<)<D.BYLB(P]+&NRXZX<MP?)<;4]#<DQ'%-.;;4G:VU;3OU3O
M>L#VX# 8# \4@:.F2A\Z6/A2IHEU]\5,D16'Y0Q^5%=@R7A\AUM3T)V3"?6R
MXIO:=K:6I&_5.]ZP/[!'P!C"HHV##'QE2ITY4>#&9B,*FE)T@F2EJ9CH;;W*
M(DI;LA]ST][S[JW%[VI6][#V8# 8# \TR'#(PY0\A%C3H$Z,_#G09C#4J',A
MRFE,28LJ,^E;,B-(96I"T+3M*T[WK>MZW@?N/'8B,,18K#,:+&9;CQHT=M#+
M$=AE"6V6&&6TI;:9:;3I*4IUI*4ZUK6O3 ^V P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P&!P@^$_\ V_\ ER_Q1^]?ZH#PUVV\.[^&3 8#
M X2?/]_=T\/?\2[Q _I:WX:ZZ^G=E:$.H6TZA#C;B%(<;6G2T+0O6TK0M"M;
M2I"D[]-ZW^C>L,H)3N5\PYVS$C\_YQ0Z*Q :+,06*=4*]668;!^4-G'6(C84
M="1'9-30T-Z6E&M)DNQ&5N:4II&TAK-1.%<*J5?BU+GWB/1I]6I%Y+$ Q B'
MYG,G.WFNE'!DN\;FV%V6>>M6IPWT05E.?B2T--JVYK6D^@6C^5A'XA7RW]F*
ML_BE3'QQ%5)?0Y;^(5D5$)PS4497YGUON P^,9'QY;;,93;:)3#;NDZ6A*M!
MY!U&K(@CLP)\5:>++*BUF%LH.@<GA$-PZ4\,D4V)N9&6U(^VJ;X2$L8CW>V
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M_P!)'M"ROS9>?^51C_BFG?K? ?FR\_\ *HQ_Q33OUO@/S9>?^51C_BFG?K?
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M?Z*BX1)L!@,!@,!@,!@,!@,!@<(/A/\ ]O\ Y<O\4?O7^J \-=MO#N_ADP&
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M-_[X=C_93\IO^CF#YD_>[^#?^^'8_P!E/RF_Z.8/F3][OX-_[X=C_93\IO\
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1,!@,!@,!@,!@,!@,!@,#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g706699dsp146.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g706699dsp146.jpg
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M$0$#$0'_Q "B  $  @,! 0$! 0          !P@%!@D$ P(!"@$! 0$
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M;$,0"! ((+,.-$ DLP82R6\)G)5I5! %)"E.<F-+*.+4%'%F$F%'@"80: T
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M_*$.]>OKH0O7\FO_ %P(PMVYZZHN'@G=FOHF&,&2^!P0*\AM<W@?XHLN9L$
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M'>];UO8=_P#\L#]X# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
MX\^23C*^^EYH]2"GTT=&0JX!Z_YZ0*G66BC*\FT+DE-&.T$)*-*2G'I&LU)
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M;UE5UU\_O/-<XC;[-+$='>(V]5A7*\AY)7MFR5KXCKCG!NGBD3([GBTC<4B
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MY([+.>K*N]TOJD36ML@&U%?3W<1/C2.OYS-AV$S.Y6Q%H7)O4B4KFR0'EHS
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MRE"5L?7@MVBL@.<%+8A7JB"B_D GV4K,]Y8Q>P0!K"1+CBGX?9ZJSD0YFZ;
M^61*8Q7LAE2IYJZ RRXU2A=:\FA4.4D_"V.T\6."T:KYCE*=-]R6A1%)0+%(
M31KWSGD>G9[*'*:.*)]9Y4J-IA8R/D7=_L2Z$.M#OT^?8(\0@29+L# O-U9K
MVWNN@A&G=FA>:A4EC3&FEC&L5:_&E27#;3'<DF73EOE#1^:C2]#')-IJC\I#
M2%E'VS5Y<D0C;U:LU/&9LM4*-DI%",E> _9:P*@)9'PC<>=_XMJ)YA-?0Y X
M3F**ZJF4]G-?3>-R!(":QIXLYVD[K.4Q2QZ:'ID=&5_W+E9)B)<@5$!*T0(
M0G)R3@#:SEQ\GUS>,4K*,3)[GZ954R@U1$Y@P28#;,-#<(4ZU](=N3@:VK&]
M8?)HJ]JR%1^D@%))AVSDAB8X(3 B7&AJO'YS8O5-"EP89*M+9^4U'&Y*(V6N
MY:)54![(;&0J5Q24Q.,ZP$D96+6TA_"("\E$XJB@"T$[?H->6-^/VCH\V+4!
M[M9<D5NDBE<H='N12U.:Z+G:84$+FISWLMI9FAH0(4U5^Q.E3)$B=.G5%A4!
M![_=[AK^)/'S0R&P&^PDJVQ2E;=I$J+CVI?K<64R!%0"GF0$J7H-M>UZUZ'3
MQX6_XS%6V\H\K2HI,6I&>8:-KZP?@"C80E94VG:TY>9&3J431A=/K 7RMPCT
M1Y]<G%YK&NVY4N3:$*%-CL\K%"LD_1RQQ&IWI2I-"40$D:E6A^9X7SPUN$;A
M$EL!RAPVILCT:ALMD*1Z8H%&&4*HEKCD3-+:$+YMN0HU(4Q9CDM<E@4Q!)?S
M^TO6L%NH&BOC9H&&1*4Q"//]NH4C^R4['6-T!/ Z>JY:>?K#<[1IHFOU@&8!
M#:I@TQ=3%!:E:4O4N&@ATX&+-^[8AM6)MOG"M;O'39]AD/;JLHRRHW:L,7)W
M@U K52>,(5J%,GDXTQ8 /\><_K-'+V\T.DRM002,8?4H/H);.$-LOCWYO8*Q
MJ.I6]GE6HK2MZD]#0XU1+'!2^'SPB0/;Z!%)'@X(E,@AVR7S;8)I/]4HFA*E
M2;ULL@'H-O+\,WCSYK8(36<!;F64 8JHZ&5=,Q8PZ5N"AT-L%2[N[GIK?'$T
M(CGF I4CH4VDLAOJC U-J%+Z; E+]!M>]@XDKNMJ65TW3[].(BS%DWBM1I%T
MO=75GD#]=3')F@[5B)#/XZ71V&A?R@,B(P00MB9M1E$[]$X,&L%2O ];5@WU
M>Z2*56/8=C5P140D4OE<W='S:,%/02<PR*Q!C+7E:,35\UCM"0K2DAVS5JA6
MX:-5JCQ%%>P:V-;PU4BJ42:2)Y3<#00]N]H2Y@BK/9#HAB59V/<S(_L%DVE6
M;6$@9\9GL@0RYY&6I$>H3MJIX6J$)"8]289L;4?3/QVU(O;:;A< 2EPNL:VZ
M@C?12F#A5N*AF:4L>A[@VN-?5ZW%F%D,40L"7DH7%_;% SVY88>XG?#]0I"(
M%-2?*>':$E\QO:>NK;*B)3T$@K8B6N;3+W=H-C;O5#@T/4.E]<_0&D_@F8$2
M&,,CBJ7)?WRY:PMYAX1_3Z"*&ORT\454TK(4_?B.T7.<Q&U'RWG*Q7F:;<9A
M8<FE,0;Z]E#=81QS;ID=XF_0%E;F8;8E0H4Z9O;DQ:32?9?NV-9&L>0X74$<
M,AL%L.YVJ()'" FQ6.!G)($D&C]=25+(V:"QMP3,B9^/AC@0C TN"9T6.1ZQ
MD]40CM%;P:U9-P?5#?%QPUJF]V-$?9)DU3NI4+?9*H .?Y"SN$C7(S*:T>W'
MA9&\1$N<4!B5ST[)S6=4)N$#:$($X1KU X/H<,7DD5,#.5::95=+JKESLNF2
M]?(9*W6!8;I:TXE3P\*RSE*J<RB>/:M<J7_D#K9VRRRBR@@+ -J9VFC8NPV(
M^64ROLX:G>4SU98LK9T,H5)XK*7Y55,1I].1(&(!6B')H:(S"4"E$F&+VIW0
M(U0=^X7IHB9\!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@0[=-4O=N1YK8F*ZK>HU2W/1;N;)*:705!('4@M"M1[8W,V?0.P&L;,88L"
M>()*4E1\Y!>]&Z!H8!EB*:PY>F5=3=GF#MV1UC:R!J"X!/@=F/5)JX4];7-R
MI 6)W3Q"CH=(3!-QJC2E/\#BGUI04#8_>#W $-8F;<E3F82^22E!W!V-!$3^
MZJ'-+#(6^4*1$HP2?[?:T1TB04!(7PIJ3>W^+"K7*SM>N_<8+!OTWU/0$H(I
M9948NG>BU+ZK==N8+R4.E4[N1$3MX3NOVA&N*J8J A:]$D;1>AD?,.^D,'KY
M/E]IH1J.HER).XQ*8Y)%G='9LP2,#VVO"J)2M^H$Z,28AO5%*36*1$LO/;(\
M&LKH O9*D*58D4;*%OXS2Q>@M#?ILUK\RS"S)JOE[/U_U34*!:C;DI<%JQXI
M='#&\:!-I.:M0D3.DYK( JW,6OE4;,<#2]F;_>!+#^]P:S\%H"40ROI_!G#I
MWHN?N4W*4E-UCSATJI1/J[$H:_MH#H&ICM31N,IC4IW_ %9?W)K<PZ5?E%H1
M?\7@0Z5Q5899A1@O(1W4=HHPLP11LBYOV6=HL81[*-T#FH ]EFZ#[1>W8=^F
M]^F];_+@WZB8+IY^E%N/C,\,73_1M&IVEG$U'L--NE4(61\.$L,5:>G@N?5+
M8#@-W  S1.A)U*<CX0ZU\7N]1;#]TY0,HJA5)E+WT[T5=@)"U)VU*DM]TJI<
MEBQQ!BDP3O&@P2IH$<4Z*=*-!,VK&L)V$H'M+#OW;$-0O^A-8GM]O^H;W=^Y
MZ>[\1<V^[]S]W]6?T]?_ +8-^DTV304GL"(U]%VOIOHFL%L&0%HG*95RZ56E
MEEC& :T+;MPGQTKJ>6LBE<8<B$K%ML0M9?U2@W>@:+V L 8:HN;)=5TQ+E;U
MUOU#<J(#6O;=PJV7>G%L0,-7;3[+=AD0BF(,^_<V[X-Z(WI?HG6C!^\L?[WV
MC6D2#CN>OC^^/:;O+M:.)GEX<W5/'6!_Y[+86 AQ6GK"F1D+<^=G1R+:&HL[
M1"8*A2I/T26'1AI@_4>QOTE!WH&3NE-1ZIB>G.BF9\8G(#@INYI=*K!<,C*
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M2*>+;"4*5*@/D%[F2A4*5"@"5-(><=)DH3SAFA2IM&\V&FZ3)@C]A>AC&/0
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M5E2('%.VD%0.KWFE4<*:A-Z$E$:H;$\QI&9R ![H83M0IV<XG!V>,6RPE@]
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MY/7]&;V?)_Z_N>GK_P"F#?I-EIT%)[)9((SM'3?1-2*(6VFM[@^U>Z56D>K
M-,1M:33G.3)C4\S;U#B4-N&>';:G;2OF5G;V7L.RPEACJ<YTEE42M3)GOJWI
MB[$:AE5M 8A;[M4*Z+)CU*I"I ^)R8)3L">=/*,",110AK1I]%'F:$4(6P"
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M_MV\Z?T[1_R>,.M/]93Q8_MV\Z?T[1_R>,.M/]93Q8_MV\Z?T[1_R>,.M/\
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M_MV\Z?T[1_R>,.M/]93Q8_MV\Z?T[1_R>,.M/]93Q8_MV\Z?T[1_R>,.M/\
M64\6/[=O.G].T?\ )XPZT_UE/%C^W;SI_3M'_)XPZT_UE/%C^W;SI_3M'_)X
MPZT_UE/%C^W;SI_3M'_)XPZT_P!93Q8_MV\Z?T[1_P GC#K3_64\6/[=O.G]
M.T?\GC#K3_64\6/[=O.G].T?\GC#K3_64\6/[=O.G].T?\GC#K3_ %E/%C^W
M;SI_3M'_ ">,.M/]93Q8_MV\Z?T[1_R>,.M/]93Q8_MV\Z?T[1_R>,.M/]93
MQ8_MV\Z?T[1_R>,.M/\ 64\6/[=O.G].T?\ )XPZT_UE/%C^W;SI_3M'_)XP
MZT_UE/%C^W;SI_3M'_)XPZULL/\ ++XTY[(VJ(Q3M_G)TD+VJ+1-+<*R6-O$
MN6'"T A(2H=#T2/Z@\P6@E@V9H1@]Z"'6][UK!UKH4$01A"((M""+6A!$'>M
MA$'>O70@[UZZWK>M_DWA']P& P&!PB\YZA[L"/<'<@"D;W&:Q[0[@JZFKO/C
M:XYM>GVL"P*GMUB9:PG>A%(7I:00,[]W0MIP:%H0-B"(UZ_-_D=%(UX[>"H@
MP-,98>,^8T[.R(4[>WE+*1KMX6!3)BPE%[5NSS'W!W<U(@A]3#U)YQYHO40Q
MB%O>]DVLY^@AQ!^QURU_@!5/]E,&T_00X@_8ZY:_P JG^RF#:?H(<0?L=<M?
MX 53_93!M/T$.(/V.N6O\ *I_LI@VGZ"'$'['7+7^ %4_P!E,&T_00X@_8ZY
M:_P JG^RF#:?H(<0?L=<M?X 53_93!M/T$.(/V.N6O\  "J?[*8-I^@AQ!^Q
MURU_@!5/]E,&T_00X@_8ZY:_P JG^RF#:?H(<0?L=<M?X 53_93!M/T$.(/V
M.N6O\ *I_LI@VGZ"'$'['7+7^ %4_P!E,&T_00X@_8ZY:_P JG^RF#:?H(<0
M?L=<M?X 53_93!M/T$.(/V.N6O\  "J?[*8-I^@AQ!^QURU_@!5/]E,&T_00
MX@_8ZY:_P JG^RF#:?H(<0?L=<M?X 53_93!M/T$.(/V.N6O\ *I_LI@VGZ"
M'$'['7+7^ %4_P!E,&T_00X@_8ZY:_P JG^RF#:?H(<0?L=<M?X 53_93!M/
MT$.(/V.N6O\  "J?[*8-I^@AQ!^QURU_@!5/]E,&T_00X@_8ZY:_P JG^RF#
M:?H(<0?L=<M?X 53_93!M/T$.(/V.N6O\ *I_LI@VGZ"'$'['7+7^ %4_P!E
M,&T_00X@_8ZY:_P JG^RF#:?H(<0?L=<M?X 53_93!M/T$.(/V.N6O\  "J?
M[*8-I^@AQ!^QURU_@!5/]E,&T_00X@_8ZY:_P JG^RF#:?H(<0?L=<M?X 53
M_93!M/T$.(/V.N6O\ *I_LI@VGZ"'$'['7+7^ %4_P!E,&UQ2MSHCD.G[KON
M-N_B4YD>N?.;.B*+YQM*ZF=EH\,T02:_&J"K8M(62EW"H$ATC8VY?.TR=64F
M?MK= "(TLH>M""%C4EOSYQ^$?0_(Q5^'U\_^)OE%)38^_'CQX-MI,::BWJP3
M[:1KRT+7*E%&*J=9G?<!6;4%&*U21W5FMY(AC& 82][$Q,^_./#,KVY\0U[=
M76%=^(+DR=\(\^67,:\G-K'M-0L-RRUFK26BA%G6O6%0[I9R8WB!PU_(5:+*
M<)&WN+HG0FFE%%:V'6BY\6^6ZVU?G"-4VU.: -\8?.$DNF0KN>E7&,3:ZUJH
MA!V!".@5H&L,V8GQ146P0%!4RU$Y&2PM02XZ;T*(*C1@PG!T%B9<W613W!Q6
M9;VN7#O%WS&7UF#LDKFLZFRX)5!B8-/BAGYV#.MRI**G"E)E5@J4(G *?;<$
MX3IK3=L[1F_DT,O/PZ\?H(<0?L=<M?X 53_93";3]!#B#]CKEK_ "J?[*8-I
M^@AQ!^QURU_@!5/]E,&T_00X@_8ZY:_P JG^RF#:?H(<0?L=<M?X 53_ &4P
M;3]!#B#]CKEK_ "J?[*8-I^@AQ!^QURU_@!5/]E,&T_00X@_8ZY:_P  *I_L
MI@VGZ"'$'['7+7^ %4_V4P;3]!#B#]CKEK_ "J?[*8-I^@AQ!^QURU_@!5/]
ME,&T_00X@_8ZY:_P JG^RF#:?H(<0?L=<M?X 53_ &4P;3]!#B#]CKEK_ "J
M?[*8-I^@AQ!^QURU_@!5/]E,&T_00X@_8ZY:_P  *I_LI@VGZ"'$'['7+7^
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M*])(B4YJSA#-4&-+0X 1$^[>_8E3% U^0.L+[<NUV&3 8# X1^8W]8OPN?\
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MN?)2'8UJ(1FQ\,6_^,":(T"T6M:!LO1.$WQGVOWA# 8# 8# 8# 8# 8# 8#
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M?7J4/448RE/U: A> PQ24 G8RMG WH=?&UK+MY=X*U\ZV+>VZQ*->(#VDNY
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M,!@,!@,!@,!@,!@,!@,!@,!@,#@Y_MY?U-KT_P"_7K/^MS5B\M>W+O'ADP&
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MH9%%[<?]Q.K9 SV+$E[18DK"G5*QQ6&+T[L--(Y.6G0'B&WI!&K :),]2];
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MV?C'<, ZA8A2W\-?4_>?PUI['I']=\/TWU6_B]_O_>X&TX# 8# 8# 8# 8#
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MH!U_?(*'FKRN=WA4\D5#39E75<Y-BM84>V$&UV_RRP?D<R"B ?5*#%I@5!H
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M@6UZVM. ^-OKR'6<KJ"23Q5SQTP?HSGZHG.HH6N(<ZNE!;0D10-9,)\X&/\
MLH(2U!^EP]JS/;[2P>F@Y&?&_3AO5"ZI+Q</%^JY'@JA78?.7%MIM/;EGPZI
MI'#6!CA"_CH4.#3UD3!7%F!MF\P?KB"E-0-037!2E5(SEFM%AWLT5:\S=5PC
M=/\ 0E@5GX_V"C(C7:Z?-_@6MC1L=N^GW*P&%_)(F\)^M@D?1*3VU#$[4?-'
M@"SK5Q:P@@?O <C-*.$($7^_J08U-*7@%_\ !TJCEUL-"T43XA*&B,=EG4O-
MKMT6[2 N-WO)2W^JG9M3GQ@B'VBWFMRT"IP+"(M*%,(!2;9(B\OPGGS^N@G-
M]M<O4'UYY)X/VTD8FNZKZZYCLRIP-BUVZS-;>//3S$H&T<^,]2EEQM_',6R$
MNB,]*-M;PF"9UVA&G%E>T9@(EELF<-D=Z45+?(%Y<6ZHZW9&B=F^/JB T@ZM
M4/;&C35;;S%NATC.Z1!Z VID[;)1R$])LU2E- ?H82Q&"_>A]!\3]4J@TSYQ
MN#F7PX<O<LQE,1V11W1G)\ILN#-->NS+:'/*>ITYYO64JN14>Q)%T-;7D1+D
MG7B<3R]2-4O*V7I5L6MAJ^=MO"*N?:XED=Z#YLMRVXVU)N9D?F1[:31]\@M3
MJV>]H5>KA+[10U,.S;'5"<W&14#/W!2K2"1MR-MT6J^B >>J*V'02[L^\7D\
M4\^::MZP+X^YOLN#==<@)*GMJSHO:)-1KH1>7(;H^6:@>S:,NF:G-#47*%4Y
M>WY4:2E<B$<DT:V:&J(+)(!K9+QMY;0[6YS-S'Y#/*&\=_D,307=L&Y_,Y[=
MK#@Z^3(+6H)AJ1P8)?4U4*ML3HF>G9-9(EP7&-HA?6+5JPH[9!OY# Q/-DQ1
MGE'FSJ8FRO%C6B9GKZO;-CWC0Z'6N27J*DG^YXS$X,[=/1F00B!ND732^#GL
M$\9X&],Z8G1SD$UO)3'IA)Q>N] +;//ZZE^9/G]IZ66>/*@92W'*HW973$Z@
M[ZO:VI2:EC@WGE*]4+/) !( H"TEL$B^E5IAC&'19Q!>M"]WIEB>OC:Y)059
M>W5MD\-]<="U_)V*>T#W3P]P$R('AI7#5ADM1--ER/K&VR"Q)?D3,]B6III3
M@6BT$KZ9G"6(>_;AJ^)9&Z^/Z7QE%S-VI5#M<%9*;#4UAY+3&/FLGF-W8+U8
M#%$XM5WW)G3H U6+4M:'=D4".3M6F\L7T[@G+":/Z;01$]D14Y0UK @L@B5@
MQ!D=+3O7_;Y/$1XZ!2M4K:Z8INRJ84U+K"JJZ4JC;NZS7I6.*_L8T2PQ6G1+
MDBE2:2C)4&""$MO^ZX*.ZZ ZXG/BRC\#DDBF\1YAXIZV.[*,AD5FP9'S_$I/
MQXP5 YM,L)3QTUSC]CJ)$!8A;V4HD]W/4I]C)3& ]FQO*>9OZL=X9K)<VJQK
M/Y-@5AU?UCS!0-'5253/8=>U5NMY @;#G9[:&;FJV'%&B3QR8SJ&L*+3F(]"
M()Q(#A"7EA5J! +)[?WY<DNO:OM&HJK\HO5M80J32!ANSJCN_C'IZ&MC,[*5
M+U!)TXLCMSQ>")L)2"&M-JVSG)0UFJRPC :T2(P&M^A8A:-3XCO9V W1SLOC
MKJ/D:MB905T?S'4-$6S'#W"&2)J;V6YFJ+-]X4<.&2A<WD-$A<U+I"@(EOV\
MXXQ!M4(D_0!BV'(S/%U7_B/JF)2A'U%Y?;WBEAQ"*VT[<X<MU4PZKJ7OTWCT
M&@R6-QJ0:0Q)I:5;\4QRGIVTGX1YP2/B D;"SS-Z #UPMG_6/]"&&# 8# 8#
M 8# 8# 8'!S_ &\OZFUZ?]^O6?\ 6YJQ>6O;EWCPR8# 8'"/S&_K%^%S_P E
MM=_S(LRM>O%_'=S(R8# 8# 8# 8# 8# 8# ^1A))HBAFE%&"('\A(C"PC$29
M[=A^0K8M;V6/VBWKUUZ;]-X'UP&!\SB25!8R3RBSR3->TPHX 3"QZ]=;]!EC
MT((M>NO_ %U@?L(0A#H(=:"$.M!"$.M:"$.M>FM:UK\FM:U@?W 8'R$22(T!
MXBBA'E!& LX18-FE@,]/D" S>O> (_;KUUK?IOT_+@?TPDD[X_F**-^$T)Q7
MR%A'\1P-;T TOW:W[#0Z%OT%KTWKUP/X:02?\?S$E'?": \KY2P&?$<7Z_&<
M7[];]AH/7?H+7IO7_I@?7 _@@A$'81:T((M;"((M:V$0=Z]-ZWK?Y-ZWK _!
M111!8"22RR2BPZ 644 )998=?N!  &M!"'7_ --:],#Z8# 8'Q$G($<!0(@D
M2@H(@%GB+!LXL __ '@ ;L/O $?_ *ZUOTW@?; 8# 8# 8# _(P , ,LP 3"
MS B , PZ$ 8!:V$0!A%K81!$'?IO6_R;U@?PLLLDL!118"BBPA 666$("RP!
MUZ!   =:"$(=:]-:UKTU@?O 8# 8# ^(4Y #C% 2"0J#0A :>$L&CC  _P#8
M$PW0=#&$'_IK>]ZU@?; 8# _(P , (LP(1EC"( P##H0!@%K81!$$6MA$$0=
M^F];_)O6!_"RRR2P%$E@**+#H!9980@+  .O0(0 #K00A#K]S6M>FL#]X# 8
M# ^0B21F%'#**&<1[_@-$6 1A/RA]IGQ#WK8B_D#KT%Z;UZZ_=P/K@?(!! #
M33P$E ./]GSG + $T[X@["5\IFM:&9\8=^@?7>_37[F!]<#YEDDE;,V4465L
MXS9IVRRP@V:;O6@[,,V'6MC,V$.M>N_7?IK _AI!!VRA'$E&B),T<3LTL!FR
M30^N@FE;%K>RS ZW^06O3>L#ZX# 8# 8'R+(()$:(DDHH1YGRG"++  1QN]:
MULPW8=:V89O6O3UWZ[P!1)) =@(**) (8S!!*+"6'9A@MC,'L(-:UL8Q;]=[
M_=WO]W ^N P& P& P& P& P& P& P.#G^WE_4VO3_OUZS_K<U8O+7MR[QX9,
M!@,#A'YC?UB_"Y_Y+:[_ )D696O7B_CNYD9,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<'/\ ;R_J;7I_WZ]9_P!;FK%Y
M:]N7>/#)@,!@<(_,;^L7X7/_ "6UW_,BS*UZ\7\=W,C*C_8'5-J<RKZF##><
MM74QVQ8T'J%"\%7#&JZ.9K%L5\.9(LV+6M^C[J:J931%:-4KB3-B(#OTT09O
M6\#7J-\BM(VE9%C4A.'5@I^[ZWL.?0!RKY]D_P!W(<#JTA$<GLM<$,RTQLT4
MVH;8\]GKQ-PE/W'3,@-<]E:1^XPL+&T?TM1G2*!^<J3L1IG::,J&LE[ D2/#
M4N1)W]!MUC3SILD#:T.2J,2QK")2SNQ))C6[IP#-1J#P $+0:P]=F<NQV+:F
M[[=4,:8EN-WM,-R%>I6)VPN+\QRA/"[]?3E)B+02&ZK90K+1NA@_;HLP7J#W
M@UL6@U'?D&XVU ?SF?GVC.XC^<8RI-'A;)4-]'8A,8!.C8R7#0L&YF8I+K\P
M,CV<%OVF_#8M.WR?;MZ4X&H49Y&><K=@7-4B?Y<SUQ-^FZYK6Q(E73@X+)$8
MSI+;,4(J[;W^8M#,7%F8Z>/*,Y!'1N1K=^(EQ(T[<!0<'9>@VAL\AW&CVE;U
MK%>+*_IW>P7*K68;!'9P^">INP[-+E+6RE-,86'.Z.$GD#)D#@F":VL"@.R7
M%0E-_>8&"</(ES+!R65)<%F0Z%RB36//Z^C\=B:J86MM0=$;ZD7/3,J=UD3@
M838RKDUA,>F?1*].0E!(MGM:56O,3".&&Z1_O3CN422QHFS=!5^:]5*S69(+
M$"M7+&=KC312TC_"-P*U$@>$2"/K-U9(Q%I)"6E5'FLQBE/M6$H*D@1@:9-?
M)-QO"JL4VLMN=A^U_<9?'FYA7M<N9)>?*H3$29R_LCS#'&,@FL03M447HG-<
MX.C8F0(&EQ2+CS0I52<TT/7->WHG7_$-;=ORJ,[9H9.HQR]+GEA<9*C2AA+)
MTC,JKBARYUDOVXQ(L35XGLWZY4,M,#ZXMO& O18C0["&87>0;C9NKV,VDMO>
M+D0J6/4V8&I?MME W1*Y5FLV@LW\2Q8MA'+(8WUFI]FI(L>$*!&P -*&O-3@
M.*$,,T[]R\G,<@M2+.-UQ@+[225@4VBC2)7]S+B1\N+AQL-8U2YL9UC>NELV
M+L%D$R,J0U0[O.G,C:),?[\""W;RH<EQ^V(S!I!8;"RP.9U GM*.6VXJG=.R
MB7$V^^TS)XE)V$R.A=8 9 I4RZ(D#@_";DK&L."D<-)3M;UL+;1SH^CI:]Q*
M-QNR&!XD$ZD5Q1.*LR02T3DZR+GZ0J8G=#7]&-( Y$?7,E2"0N0E.B0%J1E
M"(6SB?>&/D'45"Q6VVVBY%8C>T6@\$G#:XZL:I"!(N6$1=TFXF$B3Z9Q1(<N
M-AC&L=RF7Z[[L>V)351:81)8AZ"&6'R5<*2>'22P63I:O5D+BA%9+'B1B,>4
MC;]LN9\%%ZJ>VDQ:T)AR./3V5%C:6UQ;@JD*AU*-1:-^J*,*"'O>?(KQ1'H)
M#K*>>@X>@ALZ-G!;&XFI)*):E*J]X+CUHN$LCY3$9(H"S5<_'%HY,N?DC:CC
MRDTLMP-3#,!H08R7>0WF.J%\U2W9;%=U\6PV)*81%=-LA?9TZ2M%"JPJNU)4
M[*F5@AP5C*X1R,VHC<%Z-/MS(1L0BG0Q7H@P\*4/ G\EO(X[&O:MUT\=VI7S
M\TU,\RJ5*H9*ED&E"6["(^*ND]8R9D:G5)8CQ)ETK;$;>WMFCE[JJ6EA;R58
M=&# %HWN[:KC-1BO>2S)MCM3@C+9+QS!_)<&9,6QO0$8F<9K:Y(TSV6YNIS@
M0G3-XDVG ]8>6F 1M0,)6PA-Q[WY%:(;$K!=+I9&^'S)YD+ WO2MCF!!;(ZQ
M![01J7D6"D,CH5]5E1!_=$R-V.DY300V*%!0%(RMF!]0CZ_O)/S'1:6Q$XIT
MQRV45#-:IBEHL2)8Y-K9"DEA7#4]421S<IJ8Q+HBI=*P*MQ ZO+,F5'.J<GV
M$G%$#/ +06OIZZ:NOZ#I;'J"8-\UAZIT?F';FB(<$"E _P 6>%C!)8\^,KRC
M;7V/2%@>D!R98@7IDRM,:#>C"P_D]0J6S>5;QY2!0W)F?JJMUQCL?&PMPP:D
M1:=6WRQY'&F:4%K#V(I)^!-RDO;0KD.QZ8FYX_Z!6K(6;T3@2J\=S\E1]]M>
M./EYPYI<:1C,ZF-G&N'W9*S1R.U:!&.TEQ4C.; QV0&5AMP(!)4[8J6J6 PX
M!:\M.,6@[#4(KY'.+[ DJ*"U_?,0EE@NZQ]9F6%)RG]L>ELF9HJOG">+K0.[
M(B POLGA[8>[L29=M.<_M!0US8!6D (W0:717E&Y NNBF2ZOSIQZ+'"KFEIW
M-((<-]>Y+%EUXHBRH?&&!(ACI#G::EPEY2V/HE,;1N!+D\-RE*1K:@HPD 3=
M'.U^69C,:NKZ)W+&I+-;GBALZK>-,29\=75^AZ5U?6!QD2I.A:3]QQK9I)&E
MK4X&.FT6F]V)TA4_$K&62,,K:77O-=*6#%ZKM.WHM#)Y+PQXQJ8G/;B9I$FF
M$B%#X<OE;JA0*V6"MDREQ8VIG5/:EO3.KF6-*D&<> 9>@COE'LMGZRG?4,?B
M4,6L,0YQN%72B>4O*B3HWN;2B/$'%3!>.*O<#CS>P,;>\DB3(!IGAX4+2BQ'
M*"4 1$!/"J;'YAZG?.([G[$*J2PT[Q3\^?:T#S\<YQC\Y,XE&CT:ZOOPNL^N
MTRF,MC09V2R).M,$$I$V!6".UZH%'H%TX]VOS<]RJ%UVILEG9K*FL2CDI20I
M:4YG*&X^3P(5G-L1<Y D;SHHDGJF!E'.Y#$8M \*VHD2TA,8E_C<##P[R \<
M6!#GJP8??41>H0P57,KQ<904ED*9F%3U?!9Q3"RFQ:N94I3Y#67;\E"->A^H
M(-&9L!0AB+,T )=@O0]-V984\JV!39-*)K69FD\X0-C4_C:V->#Z+2QGW*C6
MDJ)N#\T#<DX'!O2+CUK:8< "HHD0M:P*1VEY2:VJ6W.S:;DE83O4AY(J)NM]
MJ<@JV(IBO9K30>#3FQ(]7JXU3ZM\HJUNM"-;=$K@$L0T[T0I(^0D!VR@MW..
MC8W770-8T7+VE4S);:J^W;!BECK'%O(BNW>EU,*52R!+RC!A6HW\Z'3 Q^2F
MB_Z<UO9W#?KK:??J$=Q[K1YFG+]*]&PFBYX_.-^/52EP.J]JDY$C+AMMSAI;
MFZ>R9W1('5IC+(P50XF3-P^JT *=$F$C$8%4('J$T5#T'3U]?BX=0S5+.$D'
M?3XV_NK8UOR=BVZ)5CDW'_87]R:D+++VTIQ9U:;:YH4+D/U"8TKYO> 0=!6.
ME/)3RY;!=A-K[8T3K":U8Z]+:G,3ES\)*0QP_F&W955\]FALM<&MGBJM(V(&
M)"]NR1*I/51Y"\I=+M T,!I@;J1Y!^/5-=.UJ)KF0J8?'Y7^")!M/$;!.E,?
MDWX8U./M[_7I<2%8#(5N#[T^:4JFLI)MEWI?\OTF]';#).?>O'C.[S5D7] 0
M,*NN*U9K@G2E,J7N#)%JUDS$SR6(RMWDC>@51U,AFS(_)3F$O:K:A]^00$!:
M@PLT  ]7*G7=?=<MMX2.N"1ZB%.7@[4J3(E)RPC\4*F2M:PL!U>3V5X:&)[B
M"EK6V,8TJVQP("L2JVLW9GM]^@ "N-T^6GDFO*3LRV*TG#=>;Q7R^M6A)!XF
M5+4ATE56_/R*UKZ3-SNGA3\H<*F>).)0#<N9T#TT&!1'E(Q+%GPI3@N-..B:
MTIVI(K;5YR1GK5IDA<.;@IM#?Y&:JF<Q2$&M\-B3<DC2.93)W.4B-TG(3LI3
M@<G3F'F)" EFA*"G-3>5'G^=UVDN6<2""554KC%S9$VR-SGZF2/:X+CTY9O,
MT#.3QAHA9>U##9C_ %\0<R*R59JE4N<M-^DGR$Z.."T+7V;S"\3]'6"2WXZ3
M-UK&6_ :'5*^L1"8H<&+L\QD='I[:6]A99NCK8S4A51U8J(?TC)H2XY&6E (
MW00@U>4;CF2V?1%5PN=2:;NO1+O+62 2&,5M8"R'@6Q-GC3]H][?5,=1@0L4
MD:I:B4M3L6 YI5HS/J_J0)/0_8;BC\C_  XOC=@S!/TE7VHM5Y<25S%^4FNZ
M)M3L\]FH*XA,H8E*UJ3@F<*ED^,"SMSXR_<&=6XBT06I$9^3 EJN>I:(MN;K
M*XKR=?B29-D69Y@[LY,8F* +(UOK)&)*WM[\Y.L>0-#%,-1V:-*Y1'UB@E^1
MI'%.:H1E ,"+8:]U7T4\<Z1FM%L7K%7;DTMRYH=24*AR>6M,&2&R28-TC=R'
M%XE#RC<4K8TH$$84",$%.>:,>P!"#\N]Z")JS\DO,4T@=22F:2\FGY-;"^3L
M*>OID>G=G2+R*%6Z^4)(P2:20L<DA;1$#K@CBID9Y(J<$S&_'_%]$H,&;HO0
M?B$^37D6:1"?34<TE,3:J]O&<\^.".75K8#?(9#8<">)6VNR:"1E%'')]G*,
MQOA3BZ[VUIU*A U)C%#@4BT4:$L)T@'6W.%JV4IJ*M+:C$]L!%"XW8JUEB7W
M%^2H81,X\QRR&21;(6U HC*1MF,:D:1<T",6!$YIA&#3:-T0H^(*MS#R.M<,
MZ^/Y>6TZ\N+,DN&HZ'5V*TS^%J) &PKGJTBU8PM14V<<FFSO7K.T*0DO3VD&
M=]L]ARDQ-M&E4J"0N;T)=#!SE1=O7Y*F>1R&-4Y74MLA]8XBWENDF=6J(,JQ
M[7(65$<H2)C%QZ=&((1''$IRORC-,++"(>@IA*O(6N@E%[NF6U-$4PQT#T=T
M$S1&-="0>?G3Z)4*U5^\)7.KY5!F1_BLOB<H3STHI8Z&J6\QF4 )UI(M*4@.
M %E7SLOEV,,^WZ279!V%K+DUOPU2I=%YZ0**4T$!Y'<;*O <E <A50+;"H K
MV<$ !F;( 2(P:I,$X-:3]\\AJB:U$3=3()?;TODM?U]&QL<P)FKY-X8J8$TP
MBJB"'1PN9L#[$RY2WJG-,Y($9B!N5!6GZ+1Z$?H(^8O*CX]I,K:$3%U16[@>
M_*HF0S[+W("TZ]#.'?\ #D8DY*P]D*2?@)QE/_PXI$(>F%,]?_'GK"EO\1@2
M:_=U<E11PMAME5W1>+**/9G226<=)DK_ !]MCT<890AA$DD25X>&=$T29@BD
MQ<TS6[K6D]<E:5Z@HA8,@PP =A+%,7O4G0T5736FYJWS:/-4D=H>\J$B5T:U
M[%*F,*4USC[^Q/R!J?F)W3I%Z93HA8F),-1JB%!>A$'E&#"$;GZMDD)N9!SY
M3-"R[H:V$M9IKJG;.QR^$UZQP2L'.3.T/C"I;*)XY(&QSFL_D4;=T["T%>PI
M1IF6FK5C>2668<$20[R=4'+C.A(DH>8U"[EH=VZ6;S*OG,K4,Q3ZCYLTK4R%
MR7S='%W6/,9AK*!.ZN+>E^[N;*SJ0K1IU";VF#"<=]N\U-\B00.0VC'D-BG0
MU)+E\494\HE928U17AMJBBS<^M$9VWO4W45ZE.?$$?+T"2.3*7I<0W"(%H6!
M%%*^0N"V+P4K\@T]B+G6U4$P20VDGCJ%0^2R8'P=M3;6,2;;:[0Z!&G3Z0A$
M6E V(P+6\3B: M(YKB!EJAAYFGR"-\&DS]&.R*C=^-AHJ<=[_8Y-.[ @DZ@S
ME6$7F,'@<WV^2N"KEJ**3:OY+9T<+>&XT)Z$)+R2<C<%I1:D9 22?Y".-T\
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M6%PVO6E&NZ:;QRK*NI6R55C-YKDE;7D5T/UQ-;4S(V)[8VAS D3M%4E.R-U
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M*0-[< K3<D 6)0J2!Y)MY?*X@UD2Z#(XBT6K&V&B[?MV,V%6%CMSY^+5U-4
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MNDBASCM:0YH1) :,)*T)N)-'H1OR#,#/U7R[!:@GS=,XFZ2,IKBG/E7\T5U
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M:)%Z&>F];]/3>!K:6?,BJ42F,? \)?PA'F22.LE7-*M'"34;ROE+<8C;9<>
M#(XN[ ?$5.W5*6;LUM+-3B/T#1Y?J&S;=VK1K:3MS;]'/(##6@K:U-HUU+)(
M"I-,;2]F>Y< I,/1@ME:%H(-Z%O\F_7 _9KDW$+$[<<O1$N"HD]2E0FJB"UB
ME.E]GU1Z=*,S1YQ*;Y _(((=A![M>N]>NL#Y >6@9"Y4!U;1IFP.QN2@"Y*(
MAN!I(6X;&N.T;LM('2 X!_J9L.OA'H?_ +=ZW@1_5=R0*YVV8N\ <U#FWP2R
MI[4TB4*FY8V@(F=;/I\=E25)]:43]>WIG-,+1*LKW)U)?H,L0@[UO _3]=E1
M1>15U$Y!9$-:9%;BB0):S:EC\@+43=1%6HU\D1<>%\VR7#;0U$"..V$7H$.O
M3\HMZU@?2O+FJBV8.PV56]AQ*90*4*1(8]*V1Z1J69W7!6&M^T")7LP 35VU
MI B]$_D-V+7Y []=8&^C=6LM3M$8Y-X%F@[%M(-8G"IT'1B4G8MD",T;[='+
MB ^OI_[C@:_=&'U#YZ>V;:1 OT[MFT+H>E3-BW2]+](XJ5HO8B3H%'R_"K/5
MC_(4 O8A&;_('6\#["<FX!831KT0"A&*R@F"5$!+$:@THVN+"/9F@[,1Z2F[
M-UZ^I?QC]WI[=^@:M+YZS1"$.<_$D?94R-B$EQ"F@3*MFCVZICSR$Y8F%F82
MU:UY%O9^A^A 1_Q>A"_<#O>!M);DW'*Q("5Z(U> D:@:(M40-6!.6H&D,/$F
M"9LX)(%98BMBV'VZ,#L.]^NMZP*AWA+N7[FLLOBBVV)7/I,=#&:^WIJ3M,D(
M9ZQ8X](G(^!6 ^64Q'M0JRD9\HAJT; K3."5R"H;C!EB*U[!&!.%55S4%%P=
MC@U6,\=A<,6N;DZM*1&XC4CDD@E2M9)'I^6/CJN7/$PD\G7*3UZQP5J5:Y>8
M,9QIIF_46!F*SM:MKEB^IK54VCD^BFWF1Q[[_&'(AS;=/<2?W*+21M$>0+>@
MJFA_9U*8T._3]^5O>O4.]"V&TZD4?VWENVGUFVU' ,-)<].:+;>:62=I.:86
MM^?Z88"E M %O0MZ"/?MW^7\F!HMIW+7U--\<<IZ\B;2I9/JVK5C3I$BAS<%
M<HMBPHS5T-+^WH0'+"VQ1,I>@3J5@@:3(P'?(<, -;W@?-3=5>(KC(H=8\&)
M+&4UX1:"=N4HE)#<?%%4KW"TPR7HT &PUV4R .RBT(3-JA@UL>@;#KUP)($Y
MMH%*A$-P0@6(T8'!6D$K3A4I4!@C0 7*"-F:-(1C&0/6C1:T#>P"UZ_DW@:F
M4S5R.;D3TI'%3+!=&!1 4<G#MN-D:R.,;JL?'"*-Z[WB6";T#R,U2K2D[]-'
M%Z$<'U*![0P53W97%U0\,Y@3\%:P[D$LC(A.*<YF<"7:&6#)ZO=RU#8Y!3KB
M"#YE#UZ9&:,&@+0E:&3L81!WL)2 >0,1X0'%#$E'HI2$!@!"3F;)+4:+/UK>
M]DCV0< ?H+TW[!ZW^YO6\#Q)7EH7)TJI$ZMJQ*N*./1*4JY*H3K"4V_10<E.
M*-&6H*3[_P#>(&]Z!_Z^F! <WZUY\@"F;MKU9+(L?JV=J89IU&(\,R0R:,J>
M@9JPP&J#W-D:@*%I3?)Y#)$N@J-!V40G'LXW8"]>[ GD3ZR!0I703RU!;%II
M!")Q$X)-(59RHW1*4E*KV=].H-4G;]A80"WL8OR:]=X&OS">LL,3)#EJ=Y>5
M2Q_C,?+9HJTJY(_%G2>2,,9)=%#,U@/7D1]E521,I=%P@:3MS?L2D\02@[%@
M98J618Y*XKB9*P&HF@>BG984\MQB5L,V,16BW%0!3LI$/9@=A]#-AW[M;U^[
M@9,;BWEKB&PQ<C Y*B#E29O&J("N4)DX@ /4$)!#T>:00(P.AC"'80[%KUWK
MUU@0%+^KZ!A3I+&!TL5F626!6%3%7SB,,6S7N11*8= 2F(P^K43^T-X#E;>D
MD#M.6T0E(P_ E3'[-.$  !;T$[?>F;Z5O7?=FSZ)V.2IVM9]>E^E<E"[_P#4
MB&]1\OQ+#EG_ /:"7L0C/_W=;P/P>_L242D*EZ:4XD:<:M6$]Q1DB2I2U&TA
MBE3HPX.R$Y:O6RA#%Z!T9KV[WZ_DP(NE$EHKGTY5+9:[P:KE%U6=$V-?('8]
M$RGV%:DD;F6"PY M<#?:8ZOZUHCZ%M2:,%OXTR0L&MA+!^0):+<FXY:<VDKT
M1KBF()5*$!:H@:TA*IV/2=2<E"9L\HA1LL6@#$'01[#OTWOTP/X-T;2U(D9C
MBA+5@)/4"2C5IP*0D)0)S%)XB!&:-T2G+6$B,%O7M!HT&][UH0?4/AM]8](T
MSCMY:M-ZTL@Y&NVXI/HU9*D].F3&IE/S?">6H4JRBP""+>AC- '7KL6M;#3S
M(C6:.R5]J&H(^FLS\ !A#E*#5H"G@%>,;T=*?M"L U022F9L>GP2L1@B]?&-
M3K8AZ"/6MAN?WEH]6P/W5M]SV'8V8/UR7U=P:3Z5[$V:^7U7ATEWHSU*]^OC
M_??N?EP 'AH, J-+=6TPM"L.;UI@%R40$;@G!HP]"J&$W84ZP@ M;&4/T&'6
M_7>M8&F*+=K!+8,7JE1/8L58\VAKY841AHGA)]\DD)C;E'6A[DS.DT9O:YI0
M.4L;BA& WOW;4AV#W:"/80W@;BWEK0-AB]$!R,2F+BV\:H@*TQ$28$HY8!((
M>CQI2C1A"(S0?8$6]:WOUW@?(+RT#(7*@.K:-*UAV-S4A7)1$-P I"W 0EQV
MC=EI A0' /WLS8=:)'H?_MWK>!'=8757EP-,O?(.\F+6N#6;.:BD"Q>B5-)1
M,WKN2'122(4@W L@*]$![)V6F5$[$0K"((BA""+6]A(RAW:D8P%JW-O2C-7I
MFHL"A:F(&8Z+"PFHVT 330[&O5E#T(LG7\88'>MAUO6\#2H[;M7RQ\LF-1N?
M11Y?Z=?"8W:32B>41BR!OA\789J4WR4K9NMMANXM)T"S8A^@ E*-:$+0@C"$
M)!*-*/**/(-+.(.+ :2<4,)A1I1@=#+-*,!O8#"S ;UL(M;WK>M^NL#Q_=FK
MY'(G[FW_ "LQ99KP5]:F^1J*.($J*-<@?)[D)9J8.S B-T'0B];%K\GY<#Z%
M.+>>D3N!"Y&<@5@),2+2E))B146I]NTYB=2 >R3@'Z%KV;"+>A>NO3UP/.%[
M91DH5('=K$G<])]MIX5Z01+AI6864DVA-T;L"O2HTX 2_CV+WB%K6O7>]8'[
M)>&A0,TI.Z-QYA#@-I/+)7)C1DNI9/U VPT #1"+< $?O]D[]#- _+Z>GY<#
M64T_8E$FET9&4[(?P4R1]]>)(Y-2I!"S4\@525)I&URQ2$ME<G9C-BQ^W1,4
M;LUM >FV?H&E!?J&!K*Z:[MR-&RV&/FCV4JQ;*JH!SJF/9#U<WJ:?RNLYFU(
M$KF%,>NTEE<*<2TYA6A@5IR='D[$4((MA^99===PJQJLJE]>AESBXWN1QZ$-
M"-&I</F<XM!)%8[H!X4)"S26 C<4BJTX@U7LH"@PKXR]B'O6L"2Q.+>!<!K&
MO1 <S4IBXMN$J("N,1%&!)-6 2;'I0-*4<,(!&:#[ BWK6]^N\ D<6]?L\*%
M<C6B2B* I"D5$*=IQJ$Y2L@!^B1CV2(Y(> T&A>FQ%C"+7Y-ZW@5\(ZWYY7O
ML1CS-9K!(5DRM:R:20J6 _;JUM-F5%%)Y,K"C4I<TVA(XR?'6>M7?1AJP91(
MU";10!"$8#0@L&:X("%2)$<N1DK7+2C;<D-4DEJE^DA83E6T2<8]&JM)B1Z$
M9[-"]@=ZWOTU@%;BWH!) KER-$)>K+0(0JU)*82U<<$8R4231PP;4JS0%"V$
ML'N&+0=[UK\F\"O3SUQSTS/)<?W9+([NY=[-G-CRACXC'LV*7$[0U18":*R[
MZ !H8W\<23_5G*56P)B0C"$8]#WL.@L$)U:P:;MC<D =/ @@:=B6)PZ=!C3B
M5@ W>IFOK1"2@$;K17NWLO6Q?N:]<#]IW! L-/(2+D:H]+HO:HE.I)/-3:.V
M:$G9Y90Q#)T:(@>@^[6O=L O3]S>!J9]@,0)3&HHD)>'<^3II>H)?&-I5N\3
M9384)F+=FZ429"$YICKLI,>@!1IE1@#58B%&B];V09Z!$M,R[GI*]=!1NIA-
M#&=";B+<+H5E 4H&-;:MMP:!VL8^D/;B;MK>C)+')ZT'&'HS1)]*C1$:]#0#
M#H+)8$46%=E<UBFB:J4OGM)FEKPZDV7;0E/?!:L:=NI;-'V-R"U@4B:O>O-"
M$\U1["TP=Z$9L.M^N!JS/U%13I1U9]'*[ :8M4%NI:O4065339L4*=#KF=&)
MDK=L/2/($JM [25YDJ)*6G.  PLT[^,]H0C$$-IK6ZZZMIQL)IA+V)P<:PL!
M^K26)%*10WGDR:--T=<W;;:6L 4-W9B$TJ1:"N3Z,2C,-]@1[$'>L"3$B]"X
M!/&@6I%H$RI0A4B2*25(4ZU(9LI4C/$2,>BE28W6PF%B]!@%^3>M;P/7@<'/
M]O+^IM>G_?KUG_6YJQ>6O;EWCPR8# 8'"/S&_K%^%S_R6UW_ #(LRM>O%_'=
MS(RYL=J<U6G;U[<DVM4T%KU]D5,3 )JN96A(X\[0Z&Q%XL6J9+/=G4]**LFA
MS[+7"+P$S<:DL9?(K*(\^E$!TL$V*EY0@YH2+QH=HRRJ'6D7.&T(.-5SR[??
M.5>O;E<4K4E7(KLCLWGV^F)ZF+0AK-.LK>+.-;5>K1N!9*AX<$[F8:66$PGX
M#S0W=X\<W0QI[=/(!0'.=92<_K=WNRL*=U/(W,.>>:(PYUSSW7,HV_U>^T*J
MBMBJ;-<ZB=Y6<;$BHA((P].90FQS^5<\'C#VOOBKL9^ATWI]HJSGF!0]QNCR
M:R0J1-A[<-KGT4['@5XD4<_2F'M->M8T[M4[K9S2R*4:@:\21,S;/0G;)"G(
MT'L?^%>LQ15/$Z^I"@H#'[4IKQZ02<Q]MMXQD:J->>*>H)I;TWU&&>-5$2TV
M$GM2,33:EL,3_8])G8M0%;KVC :,,F3XT+M0)I=#*UC]/4"$71_D;L:-W%6[
ML!K?%T?[ J#HUBI>9*(]&H=&71NE=)/]QM31M(8N4")2M9AZ%4$G1).!K<.\
M7=@R1WB"F5\V\RT=5*6RN(#I]S5 )F?.*WFZ;F%+?AEBW._)1UO#V)]D=A#L
MY@:"$"Q$:M=VB.EC>U)@ME)" Z"\.1&V>?&]LY*?:H3M]>5VR758*"T&1\5[
M@[$CLCJRW'BC*+A#0L8$);@"*4<<F-7%HU 4L8)(0-X21%*$YF@YRR'QN]/S
M:\^II[8U=U0[PRV:GZ?KI2TU58M>TL?:WYQ>E*7M2DG#9K#S*JDQ$CB5<0-:
M6^++&>K"2NDD.5I"TR5A<U(1A8/H:A;R3^+NI*/F54538ULM=[\AIWZHZZ9M
M0ZH7J-M_;572#4<D!5<0)$SQUD(KDLL,P=&F-)F("@#BM*;R6[>DX0U.E?&9
M-R)W34QLN 4U"HA#+ [PMN'4[&G $VB7+$DZ%6T<.DT%6-BV+L45=W6&+X ^
M2-0>F0-R%FD#P9]M ((2E.! 47\5W2@Z_%"D=?410$K3\^4KSB_6U6%C/[[(
MK&N6#7-"+%/\D+D$J%PEQ/NZGM1-P?X2F>%#@^N<FDBI*[N &XL9JL-EE7C&
MZDD%+ZAZ5+6T<<6.O.#(S)(9%ILV*V*\E?*5T=:RRVB7-QM*J+-C!.KF#;[%
M-B=2N/R1,JDHCD;N W18W$82I4?CZN*J;6XCF,&K2+-A=1-;\S6;)+HM.M[F
M-A]=2*T[@L=XKZNH>P\UU^C@LV:#;$*)BSW7ZR(M2%L']E<T*YM:6[Y0VKJK
MBSJ6Y._*=O*+,M.%556M@4#+6J;I%$'B]FMT4A6YLDMR(RQT6TM*K=ERN1%R
M@ 6=$SS6-Q?[6:K*<42I0+?U 5]8_$Y:E:U'7D1KRMJ+$E:>7_'G'[XJ0,E4
ML,)Z>N'EB]EUEW-&;)<OP@Z)Y&AL2)N!R-,_/*)?IQ.^)$XI_MOO"$+@TQR)
M?E5\"=5T;$8'SO7MKVW8O5T\J>KQGG3[G^'M-VS1_D\-@[X6KA3&C<&AN:7C
M216GVQ#:BC_4.D9Z(.B!A42@O%_<<%E'/\[LJDJ(G*&NNWKOM(5<2I[JYV4U
M[15[T% J_$Y1L^$\[UK5">30JSXTID*N-QZ-,+:K4F_4$JC%GO4GAJS+XLKN
MA]+5;6!O+?)=K,E<UCUK0WYL)'.28M71TSN:7P5TK?MIN+04ZY@331+$(N>Q
M.B3:,$L9D R_M;D;[CRAA80[Q7R!PK#H:/SIIK:V;5MRX?'\2YV_+SU0I?9-
M$<UQGA-IN-HEKT<@6O+*5.7WGR5.0F0E0:F=%*M.8K-V:<(900+>/B7NB2!
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M<E"-%'C"D#C9UBM<CIR@Y16LT\AE#]<RN>N.F0E^N:OXQS\F@TUBEF0E-!R
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MPN88Z4>E; ::"G$K8590-8$T>*[BN<<@QRQ2;!C"F)2641^G8JZ)&JQZJED
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M6?\ 70Y.XP"!6"Y09Q"RJEY))KB!/ZEEZV85H8:1$?)OSPY'U/%WEPFCQ*K
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M/2=M0,=?PWD2##LF*6:FD6W[5PQ:%575UBWBF)C@F9KW&Y-6*BZ(LF*0@6.
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M[D_*IJL1R!L=&Y4S.#<8(H"8@S>C@A,CKP?6LEY.8^/92[?/5@)5%W^?((9
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M(-_8I;<,C62R='MUX)*P27RICRM_=EYR5J52,],D+6B3:V)&4F3$![W'QZ5
M^J_=(I#-7QG4W]TG?KO'U*MJ3('AQZAIVQ:4GL-4GH6M,XIXN@B]EKC4 B#B
MEY:H!8AGC#H01!$-.^)JDZCCT.B14H4/L<@LZ9)2U$-U1<]5<\2)B8:5N>BD
MT3LN2TY5$ >[)$NB5WN1ZMT<S3' 2\@LXD9&SEFE(3/RQPPV\QS,4W,O2WKD
M<F^A*SYEB*:RB*X3)(C3U.OTL>8 T(OP%!(<>[R%,5+3B7)V<1JE;GLHLPS8
M-A],"]N!P<_V\OZFUZ?]^O6?];FK%Y:]N7>/#)@,!@<(_,;^L7X7/_);7?\
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MD$K&X.)^;HQ&H/=,X4E[56/3<DM>82N>)Y'78%-MKW]>B4 4'*STB]2 M*G
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MO38"QS)630%B>0&Q.;*/GK>MK^HGBHH7$2XNE3A:5\K?6D4A-:#$1(=J-'K
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MT1):J70LM)M4 A6MFZ, RA&@)$$+"\AGVT;SI4@^@9%M\OEYA+7.K61G)VI
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MZ&(8X_N42W\+SM(([:PT\,.WL/6!<OZ4L.,+.\Z>N'H:F_%D\1!CD#<XV01
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MW4W-=G?G/NJ[^HIESY6W1/9$ L NTXG'72)M/(E6<\3*YZ[LYT6QZM6![=Y
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MZ(YH#7-#T==+:V\W=UPA^6=((I$&IX0ZVOOF2/1MS,?(_!+"VBERE.WN)J9
M8A*&\-")S3DJTAG\<$(9BOBSN:(3*&,9CI14]C<<N?E*\1=2RXZ5D]4("^9.
M?ZHI]?2K4V)XDO2_@VSW.K3]'N89>F"ACTO>THVM6J,VJ5!JL;\974\7A=6,
M45;>9X@YTU;BARH41\\=Y^FY]J)PBU01N51-]-?>7F=%UDV2L-?+0I290W,4
MO840&@E/,1GI356@^,+\1,ZC9-_M\Y9(G=1TL9+R9(7*WWIZ;P$R>M5S=,16
M_A%3&+17F-:XP68,1D40J /BZ1V"2!^;@B+;]('%:F+"P7/_  ]U%6O07/EQ
MRYUH7;Q&Z](AO14\C)Q"I;94;86JY"8! XM5/YAHE&8))H.[62C&9/(L\Q$N
M0)"G,I?%_:N3EHPDT7"$G6]C-71CS^:UVCC5V+/.B4J=>B5+Y<DB\CX+JKF1
MD0(C%<<,3)9,W6C7NW880*PIP-X$QX#MJ@?" *V]!<77+T'W5T*YL=7U0SP.
M1M?C@<B.D[!22)#9T$_1]NBQ;?EA'/2M#"'MLDS^:0U)4!Y0GR/Z9ESDF5J!
M+BO1)L-4LGQ%SAUK&BFV*IJH4R.!6]VC.[>A#-*]U.Q6\EZKL*:R%CE2^R%=
M"74<?.Z_BS^%K%]PB:O9J%V<TJ9:E!\8S@_5I>*.[I8DM^ 5:_5C3M;V3S/"
M*LD#LXV)++AG-G3:LX-1$-@14B>)93+3+JZ9MQVGSXQ*W%LD3JW3%@/3*E<9
M YZ/'@;3"O% J4B@2RP:_J,](V*>RY-+X=.K$4=$-YE@]%5%3-4Q64QM>X<\
M4M%V<HAOK57]T2(XVA 1]8-0 :Q4M6"T%E. ^,+/Y,FE@KILEJ&1H+"ISEIK
M<K"C#B];L7\Y5,<^5E2$]8G)(ZPA%M\A<D=J]'($KP:\A6GJ%OQJ&X!@1*!!
MSZ)\276+^+HM\L>0<TR64V' ZB:HPC)-VV0&83:E^O0](-C@ZP:*\\0QHI^'
MRF*Z-8=)2]3MU;%*Y8I-<'+1YNC0ZHW?S3-K%N?@^\&&&4H:Y<V226AGT-DC
M@O)1,L8L>NRHJY+:HDZ6NG4]Q=ZW?DB=4U(E3>QIW,LO6Q*&XP(,#F@J\-%B
M-U&0>M(&[TK WMHY'YMJBQAP[;E%&ZV[;H?J6$=#/(Y8[IJY>1K8G/VYD>&P
M;VXM+NO2*'HX\UK6%#/3GA;Y%P=92;Q]3[D"(.K=44BOB>2 5LO6K8<KAU&:
M[N"RTCG?ZF#2-QI2LF=7+936ZMX+;FS43:F%,].>Q&:,)T:8<&BPWQASEEO*
M.J[+FU?]%\_L/6[SUX0BMZ(0XF9E3&?\D6G0-@L8(!"*PC5/!0DV$X1Z4-9Z
M=(D,^H7O!QVOJ@D#4A&T)\2TZ8:W8VY_'13Q:L,I3Q@U? )\-*\+'6%JN(^D
MI?<%C@C$F6Q#4ACC)((H\HD;)I%\0SU*;XU8$Y)98\#TO/CP[*&-WC\4D?+[
M%'X!#O)2PTI*WW4DG#O)W;NKH&+WE'E%DUK**J<J^CS3#6QO6,3B5[Y80I6;
M)<M)#R=#;!!O?$OCNO/GVUH)9%A2"NQ-[%9W9<]7QQ@F+U-7-M;ND8OS.UQ9
MI3R'=25&R/KHUN]..ZAX4$L;(F,,7%&$$#&8=[0][YPGTXT3]1'J\E4 )J8_
MN8GL6+6LFNB\JLMRO&.?7K#KQZ*IN25-7[ HK6_FN>J6M[8V=8_/2-*@9'SX
M#T!@TNSE@5<@GACL5FKRT*ZFI\ G#J_)8M#$UDRFVGR0L5L5V3V36'2<S+L.
MCR>>XXF9)))&&"J J#W&638>WA<J+).(1N"HS VN\O$/8\SD;RX1#\UZNM#[
MNZWDS?0[7/EE*1C\W74L"YWCYJ],_$<^W<S1J7QY\J1_TK0HHW[5B*6*SB'1
M,I$>6I":'3QO6C%:BZ$8ZC#2)%F6]TY4]E&2.6@2/4MDU$5S6M#P0^N'FY9S
M35J.<=L4)E5*CFV1FQF0;1G#+5EE)UJ@:A*$A^.OA"W.1W&*K;(D\ ?0,?+S
M/2)Y$.=) Y_#(&WIWHVZ"QH3GB*18HZ-(HA;[6@(,TG1CVJ1GA"D(("3[@IJ
MT^'.^4-<)JP':-4$0);Q[*6B509-J4G-CYWXVT=8?,U573]Q/CP/BK5'3=B@
M^[!^E^Y[?8PRK22!#(V+02?KQ56BLZ7L"S'J9)3V.:.JR:PVSH_<+U%II2LJ
M6\>(>7"FULJY+1BU38K;'#2UBIN$;8C"W;0+]:-;/JD@3%81O4?B.MBM(%6I
MQT.HU_M*I[<Y(E!Z27W*^3*N+5A_.44MN$N9:!M3<JPH%*.2U#;:E<B!]!,5
MZSZ-,@<',125,I"$ISSQ0RZP(U:S;)BZ*DSS(></)]5U:.,F;G%W_!=D=K=9
M26_*MF*,]=$5:A@U%XZZ)27A>AUMQ2.9._H]*"]:.V$.<H4S:L;\JMB6#8O.
M5ANR57<?4YD1LQ=%72,1^K(W,(O$V_5K.$Z<J&0L=KM%PHZP:&=E;$-JR)>S
M <1'#86L&E:=M"Q1_C>M1QZ!=I([-O/*V#;ZSN_JPN\#A2!7T5-V:WZ3GM5H
M^:IM'UD$.8PUW'13D#<>O_$R](MB;$WH0LI1^MGD!/RCCAY9?'ISUR*92W/5
MWN-8UK2$-G4-F4WF=005;)*XAK8E>+!K>QH)7$KFL/G2"PFHIW:'<AI2.0![
M&?H]*JV$>@J[&O%O<A[.ID-P3FL+?OHF/^-AN9+NE'W]VL!H4\A=2R:\+/3(
MYZ\QM9,@B<8*^)V-I=Q*/N<B5(OJGGX##S!X$-C\2/3DYF]YO5PR+G61,=JM
M,#BKDVMHA(HO.&.)=[5WU H-=*OC=#05@A;2IJB-+F;[4K<9FL5/JD\]4[&E
MKE!V!/,]\7DO>NSYO>38*,.5:2:45U/:[+26HXUBXT8\5E0B&F62'-M;L-#2
ML,X@VU2!0N*2)IK&&_9$@<DZEO/U[AK0U9/XG)Q$:MC4-KM!SNU_A[FOQF0F
M3U\) [L=7W;;'#EU3FT[):K2)9H4<8N@-MM4C3MY+RH;W-RT>#Y5K<H)*^F/
M#"2/Q37E*8E,=DK^?84XSU1U!-E5*LJJ7+Z+C#O<5_<.6\P4>G-+A+(M?*CG
MC-R<\)IZX 9FX:ESF2Y0F9SR3#"A!I$S\1]\S,3E+E;%SQ%RGWIGH>WW3FFI
M;'?*ZJTN'] \\\\4\88FL5ZYGL1**Q(PZ4X[#6G!@1!+NBE+@,E0@.-$4,+"
M.WBW$CA'1:5NKJIII,+&D''JBLG1_M25QV?QN-\M4?0T%8TKS?:VF+&?7-YC
M5CU,>]MX'.-/C,_>X.W9#KZM246'23FR,] P6#1& W@LJ.0"AE04_']32L42
MZ+CE-EMK&Z(+94&5V1&6.)0J%)UJ1LW'RVPT7S%'*=&(T "B"1!9# 8# 8#
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MOL[H\Z?.@WM_'$J[)3\].5ZHDA)<7<8THF#N9MNVAVETK;]&D_(I":#1.RS
MJ2Q>5SH26U5++X;*QHJ-5W$><N)+!6M4LDTTTX;M#MM[%"61P=)DF E8X[0-
M5/0RI Y/AB!0N=8N(P99"(POYAA_+8\K=[T6@?&2517G"P)5%.G7KD=ZFD%D
M,Q9JT'))32U2W%!.B%Z=P<I(YQ*A*%W8QC5<Y9JYP4QW>DRM,OUHW:7 QT[\
MD'0=9O[U6%(4QJU+$>KJ\@+R65(G^83MN>&7EJT:_AA,%CYLJLR-?F['.G"Q
M230G$KEC%"&Y/[BF=80/VE!?;F/KFR+:Z2N:D[98(36B^/,1\VJFO&M.YR65
M/M:-3\UQ1VGCE;#)*7ZLY$<CE+H%K=V$A&T.\9=0_3G 6DC+6#"@;;Y>+EE;
MK=+)6T0IB=Z3H^;I!SY-'%LLNO(-(F&^.W&/D%0;(0O#H\S64L#3I\TZ(W].
MT1T*]2D/3E-AA&BE1H6'B/>/4CYV@OYJ*HJ/RV%U39=<4;>LYCK8IC19,EEM
M 1BXGZY(LY2FS#A,T";GN8(VUOBIS2\NSDB+4K"W?Y"/I1A[+H\C4SKKMJ/<
MXP]DA<ZAB^<+Z<E'P1>;(9%";3'RA.NI6%$X3Q>_H(R_NBUCC+=H<>9V)PV!
MJ>2EAKPG5 $W;"M=F>3*_;)JNM%M!S#GNO)>[TSXA;ZG<F=$KA8K''5?<_49
M]46+7+HV)98U?9XPG:$"3XE*@\IRVUJEOQ&D*Q)%B8,W%>X>DZ(L3H!^GZ:*
MW11QO7_6=:L+$VNTT57*UNE+<3/75*9N@05Y[C$4%>N!]1NK*W1\)1ZLHUX)
M7_6"]#D@@]Z?R4=5C%'($A9.1)O9=H X6DL#F<"D5A.].Q&-=J3*R(?^&9R(
MEU6/S]+*^3U\)X;%J)2W)Y@WG;]J1H]GR[#<8YV!T FF4)K2ME=1.4_GW??0
ME.S6'V.OMF9*EE64_+XJ.W[<@4@=[1(+J>&P.-*E)*%D,2NK9^(7Q@9TA:?Z
MLPS81+7'EMZ;G]7RJX3><H=#Z[FQE<M-)SB>."F+0VNI7:75,$YI9&.[7(F:
MO[[,VZ,(;!!(GUR:FN,DMZAC7LQH"SC$RX09!!TUU8T^.CRR72TW/7;G?5"7
MGU*F@\_:=/%B5/#T%6P>OUYC=!&20/"D]J;&H@M>80UK%*Y&RO9YQ:CZTDDS
MYPE>W/(C?-33F;,.T/.4M:N=2^.6VXFU(IF+%.K^>>L)JGB6G3F-E'*'Y,Q,
M$:TKT%I+=!R,R2O258UZ.0;3;6#";NENX["H;I!JYP106,/\JNALI1XY?+']
M\$MGB4FPY"@[%2NZ1.K*^J7T'3S2CE24*+9>E0'0DD[T]-CV'.6SO*)U[):%
M;9- 7[ER$2*WJ%YSZWK>5P_\1V(72E<6'U)2=32&H;U;7E[2MKG+72/VP !,
M@2?:$QIK'(TY3>G-1$+0A=&K.^ND+#[+>:"14:T2*J*ZMPJ@;2L1B;Q,?VZ0
MI>?V:X%UR-;R_66I "&O$C?$C6V1(#*X.AS2L*=PO!H0&I-!^+!ZHOMEZ_L'
MGZBVFN1RV<](5[42.0W5+K6D\(B[*#@Z5]).$A9Z^97],D:5VG&%@0C:V<QG
M3.>U)BQ4?I3[C!AXKB['Z)G7!/#O3U(/M7TA..@KGXK;+!)G;$X6+"6F/W;8
ML5B,OC*-26\P]7]C4/#X$@2X9B5:8U[, 0-(M,*4$A ,>[_Z/YS=;^E=D-D4
MNJE-=$^3-I@S0ED<R,NM MY6K:R+_:(\WKG33A$$D"<FFLW.-M;*E2F*&T)J
M)9]4<$9Z,D,E'/(?TJ]):MF-O4N@B9Q;]:<E@D@8I1*(-!;(CS?P??=\A2+J
M\9[2FADL0Q>2U^4A"K?5 VUT2KTKPWI$2U/[$P7$>>MN@8+PA4O1$[9*-+N6
M])%S5'HXD;%,T04?60^IY]7,)B[G/GQV7CD[\RUQJP-'.*E/MIT]FI@$D@;O
MJ-&%!06E.QNF$"RT56E\1O\ N=JEGE7,@S8@NR5,E)NC[1MQ<<0:$0./(I'*
MD42,CH#[*4A;B'E2)8Q+ G-"%Q(TX*U1H68JOR)VE<4I*989(^:P,M7T[%[*
MN9VG+#9]:2>Q9)*+>ONH'>O*?KR12<]V@[_5DEH1:VO6W95(BE<A6%-Z80"?
M8X&!"KYY/>UV6!<KC;>?JOL2W^BN5W;M ,1KI'*%46# 24-5&,5)M<EF-A0W
MZ"9+%EA#T[350$]I8RQ(Q#8U)9XS@!FH5V!T6AE\Q<;LDD<L1IB7D[N*G8-!
MJO*EU>3J*5[ N0+ZNM+#96W1Z;J&:V3%A,70I&UN=DIB,]R&8O$)084W"2!\
M&#RA=..K%#$J2)\K2^:7E7?#MNU2LADKGJR URQ=C](Q.AM5_<;F2>[NKO)(
MRAEGW5H>FPIN(D@VIR)TV(@I?E,";[3ZZN1[\9O7=GN.H]"[RJN5=!\U.<LK
M(]Z21MME$(N5VH35OPPIY6+7^-E(F\XN0EI%2M6:V*21%;4J %:.,"-;-ZXL
M*4VCV1X^4"Z+0-NI#F>XIE&;_89S,RIBN:66H($OKU@B3R>\:6F] TM))82\
M6$(Y:I+1,BR.*]E;%(3 ( WR];+Z!NJ ^(-UBD]3U6W]-6G7LIOEF:U-CQR2
M29#KCZUN@S(0SR&M9W!GUK9_O4)/^=#LXPI<N*;P*M&MQ:]"N" R_+-T496<
M<L-MA'+\I67USW$^B*0B4?G$U&LJ!+)NH.>N?T]8]+N1(70Q3(E*+H0DS3JT
M(FP)#]&7INTW*-)='""\_4]G]6UC(O'2PQRRJ.BKK;/30JNZ$5ND!DBN'3%#
M^CE>5A?:(80OG1+Q$V]4\5Z(Q($Q>I<-N(6_6SS$H%J5:'..N_))TQSCSJ\S
M.UV*'W<QN56=O6Y4"W4EF1]GDJ:'[>A=$MK;<4@?1&LBZ)FME\-BL1K84C_#
MK3'#DXAJ@F%GD!>1-WA>]?\ !_4/4UXT%MNG'/)\MU&H\@+*AK7;+$WQR(/,
M>FI\9%-;0>:N9"'26'(79.O=G \@AF4.!8]IE! 0A4R8=_\ 3L3W6UQW)7#_
M !,JGD?>$M<:^BAQL#9NG(;37&3/>$67FP+<ZM9?$U"&4KE;0G3N;DY#^I;]
M.I&M$*RB2PW2#>1WL27'5E7#_5]&5#.[BF+\.OKJMS[U'Z1>8%%J-%;S^B2P
MECM232\^8!<P[0-ZDY_1HW1D+4/A*?6DAS9@8[77_1C'.[J56Y+H/9,2@7DP
MK*H:VAE-&3J!RV/P-RY.B=V&M:Q='YH67;T;?=2 .FUO=T7TCNZ'J#SO>E^@
M1H0^,?\ *+TV[QV& 1Q+E:73&]:TXDN*IE$.EL^5P6M6+L#IB"T#JOKJ<R#'
MAT=9''$$Y^Z-#TV$MQ,B-9W,C36CTE^4P+4&]YV)#^&;_P"B9W"Z]<+7Y\N.
MU:!?4C$\O<:J!XEL$OK=&M5C.+B\Z?Y'!JS!I>D?G\!YC@H9FXA;H)ZC1(#A
MA5&6]"]87OT/SISJML>J8J36WD 5U;=TPHISN&.1&]XVT\/2#K.-L4?<HU:+
M3*X>HBVM'(Y%'E3P](E;LE:5"K9S8:M:#@LI=_D0DM8]UU5S+&&V%3&%22UJ
MMI2S  CLR12FOYA<%<S2PHFK4V"X/;9#%#F)JCZ187'F]G>3E#4>:H4.3<8$
MI.8%<:^\IG2R:OH;:-TUWS^AB$FYRY9[0D:BO'*Q%'YMN:[5MTBM+R52!7(3
M0A=I!4L2=4\S"XDDIF_3<@<D)I!@B4Z]0%GYAW1;K=QM3?3#1%*ECKQT-T?7
M%>5J393Q(66"L])WK>QT"IFQYDZ)%&W#[Z\56Z,\@/2D[)3G+EWT1>R@B"<$
M*?O'EJZG.<(]75;\\0BV+6C)/33A/%4'VX*:ZM]-SAT<X4!M)3;S(+!BX( W
MS$QJ,5KWMV5R5+%' ].@4)EQ8Q+@A,MB]^]71F']!6JWQ3GMJJBI.K[0H;;P
MJ1SN:S.%592C;+'BPKSE\ ;9K#GBQ_I#&E&C41R)".=6IMVJ?=?<"2#&LL,>
MN\H=I[ESA)&-@H=ZIQ=?%[\UQ>%I7R5#OXB0TQSS85W);ND*,2TAEU6$N'7F
MS0,VF],N1Q1Z;7D3D8([:'068XAZLO\ OQRED/NF-TS'Y@/F;EGJ"%K:K431
MPCC:P]0-ML%(H/*D\K/(<WIV@[[4QXS'1&-"G=4:\L(4J0T@>S H)1GD/[%4
M<_TDWRZP>1WVZ)K679]^2.U[412BMJR!!^6;&B\)'4NVF/2L9@;-<%TR^J7.
MP3R$L>CB#2@]J<%'O$8%S+DZ@OV21SQ2V;3CU!*3CW7%LPK5N0VWHNOE+@7%
MY]R3;EVH:\$YHWV);:'9I<HGL@1Q02E1SR0BWK>D@%J)8%%:\\DG3'./.SU-
M+88H==S&XU9V_;=0+=269'V@0IH;MZ&44VMMQ2!]$<R+XF<V7NV*Q&MA23\.
MM,<.3C&J"86>0%D+DZHZFD'BX[:M>:Q-WH6Y:O;9A'X#+X@<BK]REC.!DA+P
MS6#&F19.+,<*G<S3Y4J9_A<GE<:0J;1. #=)E!&@A!M ]I=&PB0RCE@#RUME
MKO\ V++J\AKQU[9J>\X[1-6H>2HET*T1:06_63VP&WE-9TO1O"YI;#GA$Z,#
M<N.*6*%1+21]:&U0[S#S>:S+C1*VP:O_ +3>;OSC"[FB*!',W1=!)'T:_3N-
M1.4Q:X%SE'(@Y19^U#OOT:;R&)Y<'V-CVJ5G,_O3_,&D3CR/=@R[E)AD@C.5
MJ<F%Y\7=8];L4J<9+93"RP^LZ98H!&FJ$QF4GNR-6KNUX?+,+?!O)986V-(T
M@2=(',?HL$%Y)-U+;,%J+QX0*#.5>!M/JN"-)"BWNB%D@601A/A//.K6DBE^
M2,+U'7N86!-AMP@(T075!ZE!7KQFFZ1;3GA"/#M_7SV'UZRW9+9,VQ&H@<!\
M_65'J,B\BLH; CFMN6ITM!I5-"U":8-,"LYED:REQ*V1W=XX,_\ #AC2- !$
M?MQ.7!"]>6[9<4<:#M)JZ;M:>V/?GD [6H6Q^?)992>6Q!WH2 6_URS_ (AA
M$)-3B?J@/H&*54PK2WAB/0)M)4PTJ\*@;@G& /?!O)KT)&N7K$NI/7-</E<4
M+SAP=MI9W.6V7-K7E]L==5)03ZWNLOG,K?AZ' *S=+8VI=G%P4+GN0(R3#3E
M2(XH:E4$W0WO7K>6/U6U+):]HB@[.D:?HZ<O,VOU2]QB"36KJ">J.:T0H5!X
MY8DF>H/,YMJ[]"5)G61.HHZGCJM6).X$*DV@!&U1]R]BF,T,K>3V)R>\6Q;?
M4_D+A$=LZ>Q^6PRM:W@'(EMV&R%P631]FG93E)IX_-J!)IA+"N:C4L4;%K@N
MVYJD1PU@;56/D;ZUOF!V/9]3TO2!#7">3>:+E9J[E$P>29G+[7Z7B[PZ-47:
M98[N\)A!<*CJIG^I:SU.TRR7DK4R4K;4:9I2()]DW53G.>2.8KGC[\SRA_LG
MJKGZIW-WBQ-M4HPHY2Y]*HJ>EB%UABF3ESLI-$I*A5(GJ+N;FM;W(Y&H1GFJ
MD9FC!A W)70-OT_XNB^F;KMEHL&X[2L]Q5M$DDB.YY\Q+9C:-YHJA@L'88$.
M;25[2Z52!40W,L>CZJ.1TLTU,6/;< 2UQV$7%>5SJ61T_NR(?6-!IEE:\V]P
M]#7,AFBJ=(!OI/#W2CM1;W$8"W1U^D),3<K0;&!2L <X.3T1&5P@$F;=BPB,
MV%V8'W'8<Q['4<<#@\0)FD?G<SGLM6D*'S6T7%PZ=B4JJ>VT:10=K0I9+[EL
M5#"C@[,&@VKCK\82#^)*"$-6@O;]^OG4Z: 2&&TV51#]V;=_&$=.9%TT%;Y<
M@JSG.3="MUB.YJTP4.$UN)4+7,9[.03M1[CTZ\"O6M&(M!5+_5IZ'U5S)9R&
M$<QR8=X\\G=#4E"F*:S7;S3Y"?I3G^B2*UZ:<"=.@C7QT2W\5L;FTH&W3?(8
MX[MGV]7I/H_89J7^0+K=@:;A8K:A_/I\<C<W[*YC5NM1RBX85,G*PZ.XUL/K
M1@LMB=3W42^!QYTC45_#ZAM2K5+T@<QZ=DCL$ 0I !O$3\AU^LDD9U[U7M9/
M% -5U-?,Y;<T/EA2#H)\D>O'HU]G$RT+N^*U4?<A_=RCHY] >!4X.@50%XE9
M)I0DZH(<C7EQZM<:$CMI/?,34C4W?*N66*AI6@:C5<0)-Z0;;&?W9F=8G^=P
M4AL@VNV: IBFYW*=(>AF+E(4B4DAL-(. (+R2;KWI1HX[H2VU%.P2"=#7#?=
M34&X0&Q'IQ,A+ LL6]14[^.#C8<Z/KNG0KV/1<C1,^U:A8F"I+;51X5 #3PA
M32W/+O;=1P.).#E%J@?+-AL_N.,7O!8^Q6(K:WJ*4WV0MY%66%#9<X2-H9JF
MCTP>&HY2W%/!DJ=M.A@&\*!006:Y:#;Y#Y NXUMA/$=@D&Y*31F069Y!*^KE
M=+G&W5+ZS(^$)@YM9\AFZ-F-2H'M39R!K,1?;V\U"%C.V%PVJ7!$)K 'YK?R
MNWO;%O(P0SF%0ZTBP,M1'V9IO,)6S)F!:G(D0ZF',F67K9DR-BYM8E$];X\C
M8"HPK7/VB52].O)V7I#L-SX"ZGO/I#JYZ>;/G=4+XK-?'GRM?\1K2D)=)'V'
M0,5RV+=#L63*V]_7K2SK$2L*1&W'OB<",I\2(BS HD82PDZ#M/@<'/\ ;R_J
M;7I_WZ]9_P!;FK%Y:]N7>/#)@,!@<(_,;^L7X7/_ "6UW_,BS*UZ\7\=W,C*
M#[&A?.4]L.M6*V853LWM% CDTVJ-#8,3A\HF;6CASA$@2V3P'<A;5[JU!CSG
M(F3ZQ4AV7L@Y4DV,6A"+P,\51M)DSMUM(FGJM)LU^UZ/EC%5]$BYV\Z^RFQO
MT=9>!HU(''7X=/&@_CE _P#HAB(__"WL.!XXCS[0M?M9#) Z1J&$LJ8B4)DS
M1$:UAD;:TZ:<%M1,U3D-[,RHDA1$P)8D('0 0:"X!1D:/T9HHOVA$DOYYY5Z
MIU5+N_1J#6?"N=Y39,6C$&VU1F052E?V]H>J9E\1D<(<6APCZX,(,2*49"/X
MBM-JY)KVZU\?MP)=?6BC&%>BA$B8ZQ;%]XI!ULDB[HR1H@VU&Z(PR1.^X,8U
M'H]:ES9'($@=3@MQH#R$K86I]H E?)K _+/S[0L>CB:'L%(U$QQ)'&)A"4D6
M9ZVAC9'$L,L(]$IG\13,B)E(;"(Q.%+:F,>$ 2M)',:<L2DLS98=Z#XROG3G
MR=L9$8G%$TW,XTED:R8I8]*ZPA,B8TTN<-#"OE1#2[L:Q 3)%P3!:.7!+TJ-
MT+?N'OUW@;'%:DJJ"R263&$5E7T.E\^/2J9U*HK#(Y'I)-%*+1FD2B6/C0VH
MW.1GI-'#T4-8:<(OW;]N]>N\#767G;GZ-.$B=XY1=.,#K+WE%(Y:YLM8PEJ<
M)1(6V2(YDW/TB6H60A2]O*"7MR=U)5*1&GE.1!:D(M' "/09ARI>G7FQ6BX'
M>IZT=;;CR+[:P6DY02++K%8V[XEA'T#1-E34;)FU%\+@H!\1*H /:>9KT]!B
M]0_*NE*;7V*EN!=4M9+;;0IDR-%:2N!Q538J1(C3*T21*EFQS4.3)TR5&X'D
ME@ JT$!1Y@0ZT$8M;#6T/,7-;6PS"*MO/5'-T7L(@26?1M#4T"2,,X3#<U3V
M-/,&=.P%M\E(&\KCU>P+2SP[5'#-]/D&(6PRD?;*+.E[U#8PRUC^.*V=66P7
MR/LS+&BY!"GZ>1M]BS%-%:-(D"K97J5Q!M<6TAP] *%3:4>GT,1.A@P-7J"M
M>5SX>4[T56]$DP5RG:^7%+*S@T%01M;9<,?7&.N$JUN.M*= ?-HU(V=4D&X>
MFUR94G&#Y B#O6!DI1S]S1+I+&ELUI*C)/,&9XD4ZARN45M 7J2M4@7.["Z2
MV91H]V95+HA>%C\0UJ7%Q2[ >8K E,.,V9HG>!ZR^;^=R5EC.)5"TN4X7"E6
MH;;7%U;!P++21.1PU#BDL92%BT=-TJ]08(P\MS$J :,6Q"UO>][P-GCM2U5$
M(>Y5Y$ZRKZ+P!X3K4CO!H[#(XR0]U2N3:2S.*9RC+:VIF5<G7M"<M(< T@03
M4P E"UL =!T&O)^>.?TCK7CZEHRG4SW4322P50\IZRA1+K6#$FT,*=EKQP+9
M JX6TD!-%H"9M&F)#H6_0.O7>!OSG#8>]2*,2]YBD;=I9"=/889*'-B:U\BB
M.I*B*;9'J,/:I*:Y,&I W$ 3K?I#2OJR0! ;[@ZUK T!NYVY^9VNQ&1HHNG&
MIEMXU4?;+0W5E"D+7:!R[ZOZTZQ&],R%))J:K^O/^43D!3LSYC/=Z^\7J'I1
MT%1+=-6"RF^E:E0V-$V!)%(M/T=<0Y+-8U%T#88RH8VP2HAF ^LS B9CAI"D
M:8\M.6F'LH(- WL.!A8M(><YU:]AM$/4U1*+FJ5_8%UF:9$D;<YU!94^PM8Q
M1Y1)G%*G-=&J2JJ]5G(2MFFA5@:#]D;]J<W0!!N3M4E4O]>[J1]K*O7JJ1($
M34*LG:%QMRKW;6VJ2%C<V[A:QM.CFT"!6E*-()^F^,HPL(@ZT(.MZ#VIZVKI
M(H1JTD!A254W/K_*&]2GBS$2H02:5(%K7*)$C.+0!,2OLD;'%0F7JP;"H6$'
MF%G#& 8M;#3(MS=SO!6\UIA-"4O#FH]T=7P]LBU6P:/-YST^Q]PB;V[FHFEB
M2)C'1YBSLJ;%2C8=FJ&]2:G,$(DP8-AD[*34LPU>LCMLMU<H::5E1>O%\<G#
M7'MURJ2RI\98+$(8K87A,..GHGM_=T#4B0#)V4:>>20 &]B"' \A//5!)XX.
M')Z.I\B(FL\ACQL6)K2%E1PQ@EPF(<K8QL8&4+8-GDXXLV;<$VROA6[;DNS@
MC^G*]@?+?.?/>QU^;NB*:V94R(]MJLS=7PC8ZS;E7I]4@K\>V/W0Q$I]NOD*
M;OIBQ^GY=;P/5,*!HBPX]$HE/Z4J2<Q2 Z1:@L9F%<0Z31Z%:;41+:WZB3*]
M,RUMCFD#<G+()^C+)^(DL( ^@0ZUH,N14-3)98YSY-5]=IYT]O+-(WF:$0J-
M%2QWD,<C[I$X\_.<C+; O"]Y88L^+6Q$J-.&>E;UAZ<H0233 "#$1B@:)A)#
MNFAE*5)$4T@EK5/GY/&*XAS"0]SIB<RWMCFCN4U,R0MREK,\D@5I'([0UB=4
M#1I9@1ZT+ @ZRI9Q5.*ON*CY?.JE:8-9[5:$8M)B;'Q@C*A:=,+&.HFQW58-
M)],:1)U-QR/[*H<1!VI_$IX ['M3O7J&\3GDVEK#JB05+(8RFTBE,:FL;?)P
MUML<:K,6&6;&10ZT945,D;$6K;YQ9<=..3/CLF 2L7 /'[A:W[?:$X;A\1T3
M%"AQF/C)@1Q2J$Z/:&\[\'*4[$OC!2N,C.(&)B5%1IU5-^C4VRC/HE)I'K\9
M@PB"/(W1O/*0B3/<0I^F$R:UG%FF<R=XW7\()(LEV1.0)1'Y9)E[6T!+F+BD
M>!A<4:]4-2:6IWI06/0]Z'@;W,8#!;$;D+/8$+B<Z:6Q\:),VM<QCC/)VYOD
MD?5!7L,@0HGM&N3)'QD7 T<D5EA">F-UH98PBUZX&/U5=8!2E(0UQ M(B&:8
MQTE'J'Q[24F/V&X)W:?L12?3=\1;-.75(4I>$NM:(<U!0#%(3!AUO0>2$TY4
M5:PU975<U77$ KYQ$Y#<(+"8/&(K#5PWE.%(\"61AB:T#(J$ZI0:*4[&0+9Y
M>M!'[M:],"/#Z_Y6YG@NI"56U)4M7\-=%;@G4L%>P^(,C"^V$-JA"Y0UHX^Q
MI )WR<#4HFDWZ8OZES]Y*87R>H 8&M3&AN)*QK%5'YK0_-40IUWL&&*W*.N=
M/URBKQ;9<JD#5!(0]NS%J,_A\4F<)!(4C<E<5!.C2QJ0A^4 =[P)G!3=0%R=
M9-2ZJK<$R<%$45N$M!!HP&3KE4#1K&^#J5C]IKTZJ5$,0.*@AI&,T0FXD\P"
M?981BUL,9&:!HF%DO2>'4I4D33R26-,]D1$9KB',)+].6%T+?&*:/136S)0.
MDL97LD"Q(XGZ,6)E0-&EF!,UH6!N0(-"BV611LN'Q8$=EZF0K)8P C[2%EE"
MN7&*#96JD37I)I"]J9.:K-$X#4EFB6B-'L[8]BWZAKL/I>G:]:8NP0&IZT@[
M%!W1T?(4RP^"1:,M,0>GQO<FEZ=XNVLK4B1Q]T=VIX5IE2A( DU0G5'%F"$
MT>A!^7:E*:?K :[9?:DK)ZM1C3)$3+9;M HJXV SHT!JA0A2-<R6-1TC;TR(
M]6:,DLI2 !8S1[#K6Q;WL-1LSFBGK/J>=TXMB35$HM8-,OW/KJM@+/'XO(6J
MH)&UK&9P@T:=2&<_3%'P(' X*=(45],F&/WEEA'K0M!B[EYQHFU*VKJI+&9&
MA/6,%GE3/L3A0QM*2,+W*L7=O602$KV=V2K&Q\C*HUN)2&M(BQ:6)]?#K]W
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M<^ROFIIUT;IX;YK,7I$],T@NUP6G*E;RF7J6)W)+/9BD:8G10PHPS\Z]J6S
M9"]] T?U6OAD#Z6\=?0+14":TK>#.FAYC<ILA!UNDJU_E76EC6'.S8DB5LPQ
MKP/4=;7<Q+IV8V1$:()AP2K)N6^J*K07]&*;@W1<2BLE\D5@7'=CBR2NWK&4
MVKSM8M<S]TJQSJMOB?6%,V$Z$1VSW9J_&2&/2:-OFS2B=K"G5$C$G&'1;B^C
MK];+HU.>@;!Z*G*&!\F\I12O'BPI4_P.-2FR%*&[TMWR>94;&[)ET0.M;[0I
MC*9W.=E+[LD\LDY.J&JV<?L*9/\ PW-G.]KUCJ>L.AFAGL'RRTETP^60PV_.
M4$:?*!7\YIF5X>H%(P6:>Z0EX9+$;W9HD'V9*S/:=K5(DI!WT);=],&B32$^
M2MI3\LQ*.0KI)4[5E8;7I):6[.L&7NSM &#R#S%I<XQ:"5+T5 X"%.AXI;&9
M8HD,UCUBN<O;782,A,F<DRE2,.A'$/,PJXI/M"B7>O+@A*F:=)=B+2G"9V9/
MG5HG$'N2VK1EU9R>KYD?94D>F9.LKF8MOW):@&SN9;WM08J][@ U0(.6M4\4
M]*12D(1)*UKGK6H+:H/QR\=5?!8]^>:4M"ISZ;J*_+/6VZSN2+5H/C98T(3-
M2D0V=J=U2J(_AA\&6B0E%G%ED!?3E"MNT&SO&UI;>,YO%%& S[IL\+ =$I,\
MT#/J=D5@"4\S)VB<.O4$KKJ/.\!KL+8%,DCM9QM^ L^Z$/"A3\NU:H*ZW+S_
M -:O'>UCOU9PFU%Z8'=E3]%5HGE=>5>7RB-E1<-5GS_);KDER@7H;D1SB *A
MOA+;&T9BM&O=&Q(6>UGI%:A22&L1B%][,562,]GJ?L]<0MHWG"#=)QJY[WGD
MFE<GZ>_.TUBOF\*#25[T+'9PZPZ,5]]T-=&:%RF"L$P2J6Q&V@*TD5EA"0.>
MZ*\B;_"4KU8+[T+'[<KS@R\&6D$DWMIZ9H8'J59?72+52+M:D826=/6J<2B.
MTZKB7QCE#G*DI*!0$:U4X+BM*@!8_P 953V##KIZ;L*157U37$1GU)<81MD5
M]<V2.S;"D=AUR7T7^=\3>[.-C63($+*A?I@C/&2>L(0GK5YZIN( B4%;V'/2
M;<O]KW7SS<5:S:O^P72=OG*%L1WJE-8]YNBZN[RZSW<M22&F'[EQN:[9.0QR
M%-C Q2\SXV))&6 ,77-C4YI%"P B$@=<NP(W(Z[G7CYG<+J.WKG@O/EQV!N8
MM$!3JK2L%KBK_P DWE5$;>70<SDX)'*OFD\G;DJU>J7*UHS%/SJ1C]33=!S=
M'S'W''Z^41BN(O=='Q*T7+H.QD-:5)8S/%%U$-5X^3;EVRV&$IUL+E)T88;%
M9.;_ ,;N:H3,:K0LX5[LWHU!Q?MTH"2[&HSO)C[4D:2KK$O2)UM%BJ]2\GNA
M:2Q[?J917K#0Q+)*()><MDG5+?&$:M]N@+DK>7:6U[+Y8H)&UJFYS-^'1"0-
M7C7.LOE37X[;#FM"^0!9+*#Z<87?HPFTKZGTEF.YQ+.4[-KF8VI#B$'0Z]&X
MUB3>3JR?>S&GZ1F,;5"P:!N,:5#D2<$> J+R,/%=S5L9T?;$2NU11-DQ?J*:
MO%WF'Q.RNA'SH:EU=8S;CM,*R7AH@[1&ZU;ILH2*(^U1MM;HPK0-S@F/<@Z)
M2AT*A=8W!6'D0CZ"(L71D[YZ#5*>+*Y!:%FV.KK>G6]BA!ZE"[0A^<[SDC9?
M#Q8DV,+0O**71,<Q:W'8W).]":24Z7 K1:U+=-3/NJ*R&2USTM+/P7WW#[2A
M-A-UD!URI%^0T'*K[$F1O)KDVPTK&583+=3NY?6B!&1R32]8):-=MK-(!@5_
M:J&[;E3YR<BO&M^P)S8$1L/Q/3MLE15OE&T/!:RJF/4@OZD273#U-FIFB57$
MUW@S2EW=5:IF>7Y=\C4J0+=I$AX20O+W_2_5%AVA;TSI=ZZ(0$U_Q.@>Z";*
MIMZ10*'N_6+/<$A>FS;O$V:4,;--W\B)IDB<:-^)4L:ML6FD*2CMB!\(0/,Z
M'Z[M6W[6@[U'.J0OLRL_M-JL^=/%X.#3R5->,9[45QQWEVNJRBS/9:=NC-@-
M,F>X!\A[4PM4C;75KD"QQ7F)%8?KPE8Z@[C=O#12M"U!7EA5O><::>0&E%%+
MG"NGTC@<\K#H:FGJ:2F2-S_8#T;)(-$%\6<'PEN(? ICXZE F0:))VG) %=Y
M/0W=DHKM]>$H>R(K:51<7.(XBUI>D)&:W3?O&,]'3UVD<Y^1FEC%';/C<W;$
MY+A'$+N@31L,+>26TQH1:) WH0D=UH[LVR[XG\.$X=>5K,I9;W9398%^_GF7
M)^9".0I]5]P1[E!NI>&-=A&M;#:L E+Y7RXHQJCC;)&YZ9'Y4X+C4ZL/UX>3
MD9@\G=@]$U1*^F(_;%;UA:;IOJ2UXTMG[>!CI>8TK!IES.R<N-S?&Y"L+41*
MZUJJ*6P8D(T8VGK&]Q^I]#CA V&2[#9_);7_ $K9$NYJC-M6A4M;N<,[5@47
M9YV@3LEPS1?$HYS'/N(34L@DJ(Q%%B8VF>;03I3 %,Y4@4ICBQZ4AV'08-)1
M?<$%M>OH.YN/6UB6%#Y1P<FJ6_&6Z'']&E/3T);JNWW1^?J)K;&;D$FF]C/+
M?/SC /; \NKB2\1TEE4)OH1B0!$KQ7'?=F5PU4Q.*@Z6<@UC04[@-AO<WE\;
M>8?;UNI._.8IM#9'$3OSANKC-!H:)BKZO;WM>D2;(:SSD98PJ=*DI83YS/3'
M2&^]*FLRW:YZ6,D4$!Y#&BZ+8L2QM27G]WU9EN5\Y<X:HB(*;#?$D88U5.QU
M.F*"RL#*4C3(@HW7YG, Q:#"OE+]:L_;ET2.F(1TC#I7.>V6JSF*UG"QRD_'
M#KS8FXMK*OYNBEU9II\<V/$H>K4C!2(D*V+'/HW)$A6HU0$"-3\83KXG:\ZP
MAB&>K.GY?>ZJ2+(!3[5,(3;L3E1$>37<T F K5GD#L*8]0]%_C/<K4K4I"[<
M92Q.&;(0HCVYL(,.4$E!V.P.#G^WE_4VO3_OUZS_ *W-6+RU[<N\>&3 8# X
M1^8W]8OPN?\ DMKO^9%F5KUXOX[N9&4)W'TGSYSP0T*;XNRK:<(D!#JJ83+*
MG,<AFGI*PGLR=^4M.G]P0B<$[$.0HMK1E:&%(6I 8;L!>_=H,(_=<<MQ9]F<
M8D?0],LDBKF+)9O/F1RL>*)7.&1!P(BRAKD<F1FN@3V5H>29LT"0G*-%@7?<
MD_P?)LT/J'V;^K^97955"%JOVHG-;>A2L^G$;?/HVM5642WJS&]>9#R$S@::
M]!0NA0D9VRM"^):':<7H?K9>!KH>WN.1Q^52L/4E!BC,'DZ&%RY_U:T+^T1Z
M5NI;H8S,#FX?>/ID[F^?8UH$!>Q>JXU&>61\AA1@0A@&7OGDB2796= 1J[(7
M([ N*G'*^:T^PNZ)WC4PK=K=!-9SLRRA"H/9UJ@T2=6>60 P0Q)F]69OTTG'
MZ!GB.X..%4$=;02]24&IKICER"!.TV(M6&'1I%,W8K:IIC1KN6\"1[=W9 ':
MI(2$6Q*401*2O<0'9F@\-6]G4E8'*T"[ DLF9ZBJ&?,21_0O%D2..-2-"F<G
M=2RLY)SRG<U+&M4O:H@'T04J@[:KYB]%>X0M:P/G%.Z.5YW?D;YKA=P125VC
M-*:9[ZAB..N21Y89?6KZJ>26YXC,D;CU+2]&G)&)0M^(@P>](=!/]?9O AN9
M^4WD.(OU@1P-A-KFX4WTU N7;J,-<FB/M]6RN>LB)Y22N1.4B7MR,<*:S%NV
M]0J)&,>W5,H2%@&:2+6PL:M[ Y4;FFJGU?T=2:-EO/9>J==%-EQ$E!9>C%B1
MLT9#%(W;13Z2!V<$Z(8R-C 6N4DIA;T>:66(-=[![&JOB:N([9ULH)B[,<CG
M[!!$Z"",R9_>T)*](ZR&6S=Q0*7)L"1!ZMKV-O$GD:P(QC1,C0I- 6:9H!0P
MWMYZ>YQCMILU'/\ >U2LURR%4VHF.K7.?QA%/756]-ISNR)T454.1;R<:]MJ
M<PU%K1/_ %@2QZ)]^PBUH-<CG9W(\O4R=%%.EZ,DBN%J(VDEJ9DL^'N9\=53
M"7I:^C"9W+1NQPT)[U/%Q+*2 >M"V[' 2;UI0()>PR<TZTY?KC6]S_H.G(7H
M,Z<:R,W)[$BS)HB?LR=F6/434[<'-/I*\LB21-YJXHSV_1EKDXCM@T<7L0:F
MG[%J=% NJK0FPW.!0'D2P9U [,D+T0!>%5J 0:'SQV?H\W,0G)T<DRU!,B$R
M-&$G;@J6%[*+)$,96AAYH9UHE51V632\J5MCD>!Q>,-<T_'?1CA3S#$UL=>%
MH6]*4N=(3:\[U#Y8G5FD@4,CX%M< "4E   TS9@"PS+OVUQY'VB!/[]U#0C*
MR6DBTY5RZNMJPMO0S5N"^DQ=2NC:E4\%%NB-NDAX$"PPK8@(EF_A/V69K8<#
M9WOJ7FR-SF7UG(+ZJ)EL*OX@[3^<PMSL",(I+$88PLP)(^R21M"AR+6,[6RQ
MLTMR6&'A!],W&EJC/:08 P08-J[*Y+?'&MVAFZ3I%T<[A5K$-5HD-EQ)2?82
MI$_.,6,*B 2G06G[ZB2M"IO3"3^\*Q:G&21LPP.PX$#S_P CM6UKQ.N[D?Z[
MM9UK]OFYL&,@D-:(_(K+5N!=_*>??J6MG,D38TN)6W],)Q^("W2@3?K>@%C4
M^T@02#)>Z:28>AN8><6T4BF4EZJA<IL6%3"))&I?7L7A3'!9%8$<D$Y?E;P@
M5-R.S66&O(8[]&E7"6C:%@C-$E$",P-I([=X[50.26@DZ@HA97<0DB*'R6:(
MK1AZR.M$I= ;-:&%2YIG8U-MT>DX=G(2@"$):1K9I'R%ZV+ C27>1?E]EFEC
MU;%+(AL[M&NJ3KWH$Z,HYS#8XP2*L[,6NQ4;?6*R90]-=?G)MMC4%Q.-&O 0
M!"O0F:&+ZLK6PDQAZ*XU66?9;3'+EYV';\)8)0XV\0V36OBYW%XU6;IMBFJF
MP3R5X'AK::]=$@2'7[@,!;2+XOJ/BT,O8@W"H>FN>K^B\HFU*736MH0^$.:Q
MEF,GA<N9WQBBSLW-Q#NX-T@<T:HQ(TK$#4I+4G /& 11 PC%Z!WK>!5"[O*A
MR+5M41ZT(+:=>7T"971#*!B336EHUT)&MLJ:>Q:C;WV7.\B1QB*-B&,Z,=S5
M2P\(34 0#("=\Q7O"<Y1U>S,G2['RS'ZOLB?SXV PJU)ZY1916R)BJZNK"FT
MDKV,RU_(F5A123RMN#)HBX!<0Q=N?3FI*0$Y4 OZA* \-)H'R)\HW[5CO9K=
M;]<PX4-CALJM&'2NQ(03**E90R-VBY"RPDR)\4D1\E4[,XR0"-'H.CQ!(WZ'
M_P 7@2R@Z]Y8=2JJ-;.AZ;7AO-8L;J; CL.+J#[/<6Q^1Q9W;H,F*<A*)(O9
M)*O)0+R4H3#4*PS1*@)9GJ' ARQ/)!R/!6-BE+?<]:3R*GWG$J(G$GA]C0A>
MQ52_3%JESFV/D_<AOA:9J83-PQ4G*'H0AJU/\6GT:(!F@A+3SV5R5'FFK7Y]
MZ6HQH9+N3D+*A=G&T(<D;K'0J52%O*<(@L.=P$/;=MR<TJ42@D0B0*U)) A:
M--+ (('G_DPYLJFIKQM.SY,TU[NGIWT;73+"IE,(7'9;<$EYL0J%DI1UDC=7
MU*2[">Q@((1Z,&5LI0M3%J/B&>7H06$:NL.=E\E10%;<=;,5GGU\ELUQJYXF
M\:33UAB9\8(F*I>\1W[EM>D"V1D_2]1K8/4M#KZG>OI]Z,V'BB/97)L_>8-'
MH-TA2LQ>[-4/26NVR,V-%GQ7-C8]\OWC<8+;7)3]Z(1"3F!V:1[RAC+&$ A"
M +6@U5)W!0!73$\Y1EDXC$ MB*N-;-,79)G+XJS.%JN%F1%3+VM+7S(H=@OC
MJ<B(2#2C"). 1ZL.RR/DWK>M!.<1N>HY\;$"(/9<&EQ\_A3C9$()CDG:'@V5
MP!H<F1F=9FPEH%9XW*--SO)$"4]85H1!2E646(6ACT' Q===!T5;TDFT.JNX
M*WL25UNK+0SV.PR9,,C>8DI.5KV\H#ZWM2Y2I;P&.+4K3:&,.B]JDAY/N^4D
MP 0C9Y[?XT9VJ8.KYU!0B%F@LK)KZ;KEUH0X""-S=48_$?@M[-,==DHY.5^%
MW,1[>9_U2<IO4F&E@+(-$$-O6]&<TN,\04HX713KA84GC&Y4W5NKF\36/K]%
M!,ADGT[)6$UP,,<6TZ,)S'0&P@'HQL*&K#K:< C-!'*SL[A9LK]#9Z_I#F]O
MK.23M:T-TV66) TD3?+!82D3VX_2/![B6WN+ZRH@IG ]2$8Q)DFBE8C D^PW
M D?]*;FK\ZC91GY_*?W<KT).!IJT-B144]<1K(LFG" M'%PNFW@\;G#%8'5*
M$)6]JF_0E!7O*+&((0C8/D8Y-A423SEFN*N+%BB&[ZRHZ>OT)L2$.+15SQ:+
MP<SL\CGCF8^%(F:,IQ)C3?G$/?U0"AZ3?*( M:#.E]W\Y'R]L;DUB0]36+IS
MU(.D"K_)FD2%3A,+C=D,=7KT1TK^\?3@= R1[T4+7_X99Q)B<8@J-?%@9^VN
MR>8*QY:E?7,MLV*2+FUDCQKHZ3J**D4V87EO/=0Q@QK;0-)JM.\."A].VVF(
MM;^0*OWD&A",(PZ#")^XN7V*/2&53&WZ=K6L&64,$/A$Y?K9K=+&YV%WIZ)7
M(@^Q)DK^)8QK0PZ2_.0TKR4SD>W)M+R2!(3TYY@;FV]D\E/,=L.7LO3%$/,5
MJ4E@467)&>U82Z,<)(E>]EQ8Z0NB!Z4(F\J3J@B3-PA#]%RL TY'O/ ,O08Z
MW.O::JOG#752:3,<_ID;K6B,B9PZ3QI5&3FFR+2B56%RG4I5NB:.%1^+N4KT
MK<SAJ0_3ID2C6_XT'LP/V9VUQZ3#H?81_3]#D0:P)&ZQ&%RP^TH<2PR23,"P
M#?(6-K<3'<*<]PCJXP!3B7[M;0#,!I1\?O#ZA"S+Y+^8UMJ=2021SJ&U]#^3
M9O$:IL.U)U8T!8&%=;,H8$<C,@[+'5+]^+1&-B9:-)I6>D**6.3<XIT^AZ1#
M,$%C-=6<R"D$8BI?05,G2.:0'5K1)G(LF(J%LCJT3*_2,-E,Q1+L9]?7XF*+
MN*O3R7L3;LA$<+YO0 O0,.?V%S0*@['Z=8;D@LVI&J&.5/TXG,#D+7+VQG)A
MK5]Z>V\P3*J5>CV!O,),)2"]IQX%) @:V XL0@A6!>33D&P+%A\"06["F0BS
MZII>TZ@DTJE\7CJ"UB[LF5JP1DA\,;7-V3O3A+F*254<C7I_@T$"UQ2)0"&H
M,^/ M'%;_HV<V/,:?AEO5O*;5KXLPV;UVP3)A=9E%BR%*=&L$]1Y$N.<T.FY
M:L)(5^\O7TAYY19WL&8 (@U776_+>Y](:KUT/3&[*B2"6N<H@6K(B>Y;'D4"
M3"738UY8-.GW)N%%&X.U3@6:6$Q*DUL\P(2M>_ UP'<_&1B6"+@=4T )#:#R
MN8*Y7:M>%_0SEU;79&P+4T56?>/IGP!#\Y)D/RIQ&$B6*B2 CV:<6$0;N+IS
MG8#G'64=WU:!XELID$(C36*;1\+@]3&*3]%5,EBZ%)M=H\U^9+-<D\>4I?;H
MXIZ/+1[#]0,)>PS#W?=)1J#2^S9!;%?,U>0"1/40FLU<I6S)(S&);'7_ /";
MW%GAX.5A1(Y&V2K_ .+-0B']4%R_Z7V?/OX\#5OTL^7_ ,8UU7F^@Z<#.[=8
M6.3UA#Q6)%@2.>1^4)E"R+N\8:!.>EKLBE"9&>-L$4 7W#2<[Z?Y/B,]H0K5
M_D$I.=P$%K3!R8:6K<-51>TE\EM"QJY93V5+++2L:J&AH>V N2'/C8)SD->#
M W+C"=('=2KTC1&G+$ZDDH/'+_)/RK7TNAC#-K,AC9';6F=90>GIVS3F&R]C
MG[G:-<2>S6-R&CC#TY/,0C8F6,B*3N#J0F3N)ZQ-]((T!GOT&P6SY&>*Z9A=
MN3F5]"UNX-E%.T:8[7;(?)F>726&.DLEY4%9TCQ'V5:I<4PARD1J,W8@:"2>
ME4%CWHP@T 0VLWM#GQC8)W.9_:=85Y6D2F$-B#-84CM. ?8I@HG560VV(Z8B
M)1OQ[BQN+G')>$].UN)29S4MY'W$L@3><2H&&S Z[Y6-G,.K,GHZD%%@V&EC
MR^!PU-9\-4R*8H)>R;DD1<(TUD/!BIZ02UA#M6U'IPF%.).MB3B,]-X&\R.[
MJ=A[H\LDLM& QEWCJZLFQ];7Z5LK0M:'&Z9,IA=1(G!.O6$&)55FR]&<UL0!
MZT)T7E#(3_(: 0=!ISGUAS&RRJ-09WO^H&R8S&8/=?1:,K[ C*5Z?IQ')*="
MWR)MC><X@4*7]MFB<;,8E#KY?NX=HM:VIU\6!ML"O*FK3<9ZTUM:,$GCE5KR
M9';&1Q*3M#^="GTHQ>2<U2,+:J4::UQ*EI5DC+-]H@'I#RA>AA)@0A#+!W]P
MW*E[*UQGK[FQ_<Y)(X[$8^WL]SU^XK'J22XLD<6:6M,D?C3ERF0FJ $(OCT(
M"E6+2<&Q'_Q>!NI76W+ARZV&TOH>F-KJ);UKM<R;=D1,!E8-38J4H'1SFWO=
M0ACS>U.2,Y(J.4; 6F6%#3F["<$0-!"<"\DO(,TB=CV*X776<&K&"7LOH)GL
MF7V-"&Z%6/*6VN8'9"Q?"'S3X-(O0(FN<;)5%F"+4HC6Q8)06442(>!>M,I3
MK$Y"M(>2J2*B2E*54F- >G4ISP!-)/(.*$(LXDXL6A!$'>PB#O6];],"MB;M
M'D18R3N2INFZ(,CM7OK'&;%?OSIPP+-"7V4.9K)&6^2N8W@*)H-DCVG-1-XC
MAA+6K"3"21#-+&$(:#=?D+Y&I+GX_HQYO6J7V$ND$LF;UF4S63" *[D,J]C<
MG611FME#@^)&]\D!*]NTUF%Z-"!(Z*"4RD11Q@0;"0)ITW%H=(N;XN>SKU#K
MT7^*GA& ]6E0%06 P.KW*RYK.Y.<,)X!-D?$%J:1E$[V,;@]IO06B]&#T&F1
MGNB@["GE,QFIYG&;:B%RRZT*M1697LI9I#&HK<M;5VW6Z&K9.2B-,4H9#(ZP
M"ZNY&A;"(DEL#HP'_5D"P)ADO1_/\-M2,4=++JJZ-W'-"DAT3J][G$<;)U("
MW 2TMK^V1E6X%.RD;P8V*@H@Z*]RT24_1&C-DF:"'EJWIWG.\)#(XG3=Z5/:
M4GB"-,X2F/P&>QF5N[ A5K5382K=4#*Y+%*-/IS0G)1B&'6BE10R1^TT.PX'
MYCW3_.4LD#E%(Q>55R"2-%@D5.Y,K/.(^XN*2S53=)W4B!&)TJXT>Y68WPEY
M,^A#ZJ-::5FMAT)*?H >(WK'F(AYKF.G= T\4_6\YNS+5S,.PHN%RGSJQ2-1
M#7=!%4>W+YWE0@F"4QI&$D(O_E _2:]5&]%[#2^1NUZ"[/K]DF-0SJ*N,A40
MV(3&9U>FE\6?K J\N9HSU+6TSUGCKLY_9W$!Z)2E'Z[V7I6D/)T+Y"3 A"VV
M!P<_V\OZFUZ?]^O6?];FK%Y:]N7>/#)@,!@<(_,;^L7X7/\ R6UW_,BS*UZ\
M7\=W,C+E]V_SQT=<_0_/$@H8VK6!O8N=NU*QG$ZN" FV3$XZ&[E'-;.T($<<
M:IM"Y "2.39%W96F,+&H0*2&P]"MT4!8 T(10[^)8@NA[)IR*6SM N<+3XLM
M"MY6L02ME==F<5T?SK4L4C=F2&MYK!)XN32Y31BA88X,+PSKV8;N$]$+YTW\
M<'K8?&E8+ XT*MAL[K>F%D46V IO&75@?T8_V-8;'9MIR2SK(K[\5VU>TY*G
MT3M!9(!F+SYFD>5S&^G*WEF$E4J %)PT/GWQ%/=0):9;W^=0"1JZ&G?+1D;G
M0C.A)9*YQ5?+P;$-C,:?V.X[UL^$URN,=IH6YH4411MK.U.7U9A)7Q&IR$H2
M.U^,F8M1Q+0GN".%0R94QY"* ME,BA[L@DA$%[3Z EM^1M_JQR(D>VQAF-=.
M#\0VJON*1:D7DEB.)"F%H(-A'=3^+.X*A4U59$6L2D2[\I690\YDEDD;^GK0
MB%E0*,TA;M#EM<Z9;:Z0FS_#7!D8;D<G*/I(NXH6QG.^9"(*E*KV-.%@$?"M
MTPW@.B>1ZTZ#11>>4VOA!SY/&5FF=?1ZSV"-R)Q=Y#"!CK6=QVSJLC\K3N 0
M_41N0IG)'I.%.!0-,8< 88GC+Q\65R++J&>2;<A4X9H1S;*.?;51J(;+6YS?
MMF71/KKATL@#DXSV1JFLT#S8*A$ZD/AKRI4)DQ9@5>SQFC$&S2?A.>2.XIW*
MC['@YU:2?N/GKN%G8%T,>54Q:Y34U4P&JI3"ESH9)3(ZM:7%/5S4YLJXI G5
MH%AYX3M':)('@58F/AV=GV1MCU^<"$S!C?45^0:T:\EROH6$0E\K>W^QKEZM
M9RT"*A[SJX;^YLA5Q*65T;)#IT9G8Q$D5E!1;($4>%U^LN#T?8]K0=\LFUYY
M%*A@5/VU D4#JUW/A\CD,IN[[+&YV]2F4# YI5\:W6#,<R)VX",!GM>%XQG>
MT8 :" *U\9E@1B-$))S=48G$UU-O&G(W.<C@JY*ZR%!X]IA%G?Y'@Q3(%JHR
M068R1C?J<$WX&]S7J3@EF%F;+V&KNWB?E!M5U9"F"X(6SR:I:=M&(,CX;7"U
M0RNUAR7MGGOM.%O[XT(Y0VKCHH1)*'TV/B4M6!<M [&JB%!)H?081W<WBEZI
MN&J;@@B[K&"LBOHB9]52JVV:+Q*Z8-71BKH^#U+$HVYHFJO[UBTLF*FFDE<+
MT:=GD;LOB\B)?C%3DVB.2D$X%Z'/@UNF5&=LT5.)XK"T==VA+[$0R2*MA:%]
MK8]\K^L(O'%:,MT.<&YY?8C)ZV)=RA&E!1J-[ 2:3L&A^\*;3WQ2W+=#_;-E
M6?<%(1JUIBDYX5(G"AZQMBIHY8D[YVNE'<;;9%R',-Y)I\0_S,+>4R"%'7M
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M]'-JR-K9N399XG9MF2!O=AD,IA3,O5$_.+9(S#20EOI_NR.\U2B11<JG+7N
M^M*17=,7BNKC\"ITM14(WNT@9S)JX@F\QB:F7O3@=#GPY"Q,8%[FJ3L:P6@
M,^F+4A('/O4J;HN:W6Q12K)VR06F)ZZ5B*VI&NA145L"9,R1D=7)/!F=LD[E
M,SV5,RR-&=]P7MR%.8>(T@&Q&$CP+68'!S_;R_J;7I_WZ]9_UN:L7EKVY=X\
M,F P&!PC\QOZQ?A<_P#);7?\R+,K7KQ?QW<R,JQ]!\B4STPNC+O8Z>=-L@BK
M%,8<AE%96A852R=;7UB_8_SA5N^/]<R.-N;U YJ.,-IBYN4&#+^H0$'D[*/*
M"9H-4UP7S,GDZV3-,.>8\2O-YV6*8?')M+V6NM._*<@A[]13\F@"%Y*BR%\A
M94 9VS2@A,6)4S("T1_R$>X.P\3[P'SVZO()2SAM.O)F&96[,S9Q5-TVC6DQ
M6FWQ,&J?VO&7!_A\I:EB^$RN8L2%P^U&[&F0*DA9B+286A;$%BZSJ6#5$DF*
M*"-BAL3SVQYM;$G"I<W%T$NG%A.PWN5.99CDI4F)"5[D/8PIRMA()UOT $.O
MR8%26SQC<?-Y$\;U<)F4E8; A]UP59%I?;UK2B+12/\ 1\LW.KU!6C \3!4W
M5DY6=+ $+7!8Q@0JBS4I7TQA ="T,/FI\9O,#A#)G G@R\7^/VE-?QW<NG[H
M^\7=PNYS.@<,K-R:;=<ELZ-63J*.T,K]I1FM2L6T)($O_3ED?*=\@22KX:YN
M6HYN@40YS$EL. ]0UG*2@2Z4%Z60[L6QB[5OMM3[+=0[;S)1-2@J$IY'L.:B
M]?"C$25^\P/FDXBI=HF,RF45=[K@AMA(U^II&:^OZXH-!WZ2.4(05VHL,V(Q
M>9-C.@L?\+-"( 7E(6G5Z6HB%^][7EA58&J-?CIYH:VZ#,_TEIN3-#+.-NMQ
M97J[K7=66S[?W8;;;:*RKE9U<M&V6A,&:RV9(\HE;J4>-,H3%%!_Z4 2-!M%
M\<+<[](6 T6;9S),3I2VL<.C#D**V98$'9YG&JZL0%M5]'[ 8(G(FEFFS+"K
M'^1V0)G DXD*E0<$P)A1@B\#?JJYCJZG[#LJUXUN<O=AVHE96:22FPK)G5D.
MB*'QE[ELDB]?Q<Z;/SW^%X'&7Z>/*I"V(_B((&X&!U_%A) 6&H#XDYU&T)6,
M41<]MJ.+=4PP@C\6R?0@Q_L^;IK#Z"2;.^Z?*(R5RI&6>F-WOY6H&OB1B)+W
ML.!IT(\=W,%<VZT79$8W,4<NCSH[R-B9%EI6,Y5LWRZ1U.DI*43$-8K9*?!C
M95*ZW;4K>XKQH1J#]$:-T()IAXS0]?(_&,=Y*XVCW)T6?$Z_:"-SQ.]R\EI4
MI$[G+[)=9#(9&\I69>\/*].R(':1C3MB%0X*C$;2D3)/G$$D(L"-.=?&!SW1
ME:UA%7@<VLJ;U_&N7&@VP);8]EOBD*GDYQ22RLFB%-THF<CW :S:K&^M>RHP
MB/\ MVS5HB3]'E%$A+"5GW@WGQWM5]NA.RR=#-'J4KK.TQZL">'5&GO!3 1U
MD1>8J8W(P5P=::6%; ATZ?0:-%\85/Y%NM*M! M+>)?FNLZ5@E;R959<YGL/
MK>A(0EN0ZW[?13B&K>?VQ3N(+*->5<]=GRCHXDE+V[N1+,R+2T>RW0U$ITI1
M!+("%I"./:8VBEJ=Y*GDO7SR@#N99G)9O9DZE\LDM3*':</9[6ZR1^?%KL>\
M#<;$=1!<=&!6%%'%E%C 200 L-+J;B>!5/UA9/4C.)"!SE7/%(<V1%B2(G(I
M1'(74BR2N#JZOCNM>W N22:9[7,:(]7I*E- VQ9N),&?L&A!#*S;A/G:PKM5
M7[*6:;JYJ[/E22.4-".U+(::WF[U0CB)]I9=.:N:Y.D@4L-K.3[T[-?UJ WX
MW$LLTSY/C $(;?1G*E6\YN3\?5:^S&F-O&G #96;O;-ARBIX*2[/A\C<DM<5
MQ(Y"YQ:#HU#PJ-&62@3E%HB3-IDH2$O\1@1<I\=?+JVQIE9JZ/3M<[SN461/
MWR.K+>M!3715EVQ7CA4<VLYEK8V5BA+!8*^KG=8PDN:-"2>E0*SOA]AI@C=A
M];"\=_+EFEPM-)HQ,B6Z(5)&*"7L\;M2R(DS652$-4"61NI[D:HW)VQ%:\';
M%ARDP*-[ KT(*]<4+8B%ZTH\(NO#Q8\\6P"YY!'ELZKVRK48[X"RR J=3V4U
MY7$]Z,J5^IZTK(C=&NDP35II^F$;?C#'/XTJ8:I5H1Y9J=0:<<,/5R5P*XT>
M)@=K=M%3:3G7-D+[%HN+,JVTR(%1RM\JF0U),4L7/M>U[?L62%SYLESJY.)+
MN^*6Y,Y+?D0I$PP"-."?:EXSHNC91 I;5[9+XNX5Y2$:YW:D*>PYJICSU5L(
M=9$]P9IF,<6O:AEESI"7*8O)C6Y+B3EZ7[LJ#HW83-:"&MK>!.:'2['B^7>,
MRQYEDAL+5MOL8=[,L-RJ1WM0BL&ZF6VQ%].*Y*;6BB6,]9-H6I*JVV>I98]G
M;T)0 HXL/K"N$Z(@D-:ZZ;E%MO=?QB<4O/(%"YO=]JSJ/5HOY[ES;-JD9*\1
M2R5NVXM%8N]LR36T! OB6(TI*53\R<DHL :>=XS^1E1EAE*X;+UK'849N2(A
MARZUK+6P6NF7H=R&]7F53<-5RDZ/5.IM%Y,&I<CV-.D-#LPPI,).G.-)&$RO
M7*=6.MXE=#(%EE0VQ51<2)F'YOK7L*#Q&SR8%M;^"P6G!HY(4$4G>XZ0XGIB
MAKDAAAZ$>DBD1Z4LHD >RX.7:CO&71:<SI#)_P 212"6I5R=9&IM*XD0^5M=
M+8S-UB067-\>=F]OED:>3XTUKBTZXH[Z1R;$RDC99@-[$$<2?@7FJ5(PDJXW
M*VET1Q>@XK');%K&G46FL+)YE*L--33U"I6Q/R%YC4FC**U7]*>N3&A-=43D
M<E7_ %*88BMA*THYRKJ=4"[<U3I1.IM64DC)D/E>Y;8DS?IG+HZK5Z4N[;)Y
M\X/)TO>"'XK8TJW1JO>CT)HTN]:(%\>@T%WX:Y@=;,9[;(K%MC4P93ZS5E;A
M2M="V!P74Y,W^>UJXO<7C*ALC[TY1212MU$G4*4YAVT[BH(&(1)FP8&+6\#<
MQN#-83 JA3L-LM&MKYJ:9$ZF<L -P@_2MLRB[;=;$YP'?1K<H?[%F*]80I(V
M6H0%&A(3#*(   0UZ3^-_DV:6;)K3E4,ECXYR]ZGLF?X>LM2S0U4LE%K4F_<
M[6C* 54GE9$#32*P:AD:AJ=%A:$!YOK]0 1:H9QQH9"G?'SS;1\HCTWB#98;
MM,XS+4\U;938%N638KW]\04VZT U:4K)E)7@1S4S5([F-"1#Z:1IP  <$O2@
M/R[#:+YXJHOHB3_C>:)[!C4V50935<@E]2VQ8]/R":U2M6KG)36<[75U)8]N
M8PT+@Z*STJ=>$\QM.6*1HC$PE2C9H8)#P-SNR/CPY11)94)89-$$T+E]:0VY
M;2CU23-O05.W4<V.<LK1#*P1-\DC=5;(W- ' Y-M284UH33A&GI"#2P_LDX#
MYHD[:2B51F4M2YNA] 0R-2B,6+.HQ,X4DY?%8/YDWJ%RMC?D+W&I3%"K3?B#
M7!,<$]T1N)J5?M2F&(K89Q;Q-0+[%+/ATS9I?8C;=-'1WG:U%]AV1/)?))Q6
M$6<[->&=N>90[R ]_P#O)#A;SX/[D2H*7!">2 )H2TJ8)0>&JN&*"J"4,DZC
MJ6PGZ=LE@3FT_P ;6):]B6-*7B>6-5T*IJ6OS^\3*1/"EW$NKRO6E 2F,W]&
MB"DT),43O>_4/[<?!W+=_N,]<[=K8$S/LN3T',)<4O?Y$2D7/O-+XXOU4*$R
M5$Z)B6Y.WG/"U,XD$:+(>6Y8>C7!/3&C+$&,D_ O/DBD;A-6\-J5]/72=6-/
M5T_JFZ;1K*9J%UNE0,%E1\Q_ATH:59D*EIU81]2<T"WM$0M:B%*<!*@'R;#<
M&;CZG([:4OM6/F60RJK#4.SI8< ;[:L8FG)Y)WZ()8&]3.65(*1C@SQ+7>+(
M$Q*I8-'[E2A,6M-"-<'ZG T*'>/'F.$MM=M;:P3=S)JEEIJ-013*;1L&5.3)
M&>?+<7W734=^Z/TA7+UK- 9FO]B,E08;K;622A,V-,4$O051Z(\5#K/[A9+5
MY^O99S\K(168<H7IDEEN\NAL^M^Z9+=\]MNO7>,W%!&-TDKG))8K)3LDP;)/
M%4!/IHAO"4:K3J0Z!7SRU5?1@X,X3TR>,TKK8^0&0BP:OLJ<U'8<?23%K(9)
MJRHYC7+Y''K\/S)K2D%N* 9@DIQB9.?H 5*5,<2&6J'FJF*'=')TJ:'$PW[E
M6]/U)ML;W%T.94%?4.W2=IJ^/-34M6JDC<3'F^8+B]FEAT>JT8'9XS! #O00
MO*?'MS?/)',)/8":U+ <)8B?FM$GG5X6W+FFO&>6S2)6#+V:J6A^EZYOKELE
M,J@C.:K+;"R/1(WE(2=E(=;3;#PW!XX.5KO<9@\S6-3E(]SZ26-(I@]PFVK,
MK]X?2+?JRLZ:M*)JW*&RAE5@@T^@-.QI*Y-18@)336HL\(0&B-&8$A.G%W/C
MO!+$KM3%GE.PV9.J\L]\5M4TE[))F>R*FB=60VM)U"98SO2&10:40ELI:-G(
M%36I2C+6M_S[]PSC]F!@''A&@I!&Y5')H795A;G-%R7G*822P;<L27S.153+
M94ZS)X97"5O,A4O&UGWMX.^F5EF%GHDVBTZ<19!8"PABG/QX<NO$\F<^<(Q,
MCSYPYV;)G"&[M.R-5>SS^YH2^5U:=H1&L=2?4(B=ESB&2=T1K7E B)5>KHN/
M+V6I7*SCP\@O')RS^/XC8I<<G:9SA<DJ2<M,=26]:*2O%=BT=#6>N*WLB05R
MGEA<+DD[9JZCR!B,<5J(\U6VHR0'_(,HLP(96$\"<^0%GC\79-6LL@\(G59V
M!6M?2:[+4ED#JEVJ![.?Z_:ZSBTBE3DV0^+L"TW11;:E %+M"22CV'Z0@DD
M2?%N8:LB=Z27HQ-^.'RTI#'GV(HW*965.YFRPB*2Q\CTGF$9K>,25_<F"!L,
MLDD3;%RU*W)R2=G("=%!**#\>PAYT\<_*[U+YW+W.+3)7JP#K?=7"&FVK90J
MSCTOOZ)O\(N>PX)6VY1^#8/8=C1F6.R=P=VU&G5^YV7G%"*.7K3#PGJQN>*G
MMBBG+G"=1U0[U,Z11DAQ[&4]O3:XIVJ,B;#HVI;Y&V+TC^WO3 O94BM(M)4
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M+I._RZ11$]T>)1<\0OU_TI?7L;<YV3!ZC048P."EIVN^W&,X*S;2D"AMV7]
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M"LY,C8.!9$Y]74YSRL>[Y3(K.=W)_CZ*OK'D4O6(G R/*-B@;@>484SF&'I
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M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!P<_V\OZFUZ?\
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MGOC5+5A-;C/:E4*9YTXSRIU5EUS7[HZ1(4A0I@NJ8D.CM)#C %;" $O^XCK
M==MDB=>6[$B]@/DHY-;F:#RJ[.<F2)"AG:%96A:E+SR174HL7=<P(G;#4KD4
M\-;^>VN;8H-3>I1A9VC-!-H_-G"VGIN"<URGG"<H5DGD''D%D<TC%NT-.F^,
MS[M>+E2.KD,?C;%//Q1;4'8Q&^Q]D\63N;8@2:VNU\B76S,"45/F I&.<^TO
MU=8\$F=;\Z69T1?'.4[M20N,=.8Z)D5-SFWZV8Y79!;<M4'AA=HS:H#FQN6)
M?ETD7.[<2IT :C7H'QO#ROH**Y<XTZ+EO.4O8'OM.6L<7A=463;%-4XNKO\
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M6REA-XR:90Q18=)U7&ZIK"E.G9[R>1/K&M>V9Y#X&T&6Q:->K28HSD'JG)P
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MWVWGT(V-^,94K$&2/+@<< \'J8M&%$)1XNO(1757OU5UO#(=+[9I3ICHZW.
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M P& P& P& P.#G^WE_4VO3_OUZS_ *W-6+RU[<N\>&3 8# X1^8W]8OPN?\
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M_P"1+PG_ '>=G_Y59[_#QE.M/^1+PG_=YV?_ )59[_#QE.M/^1+PG_=YV?\
MY59[_#QE.M/^1+PG_=YV?_E5GO\ #QE.M/\ D2\)_P!WG9_^56>_P\93K3_D
M2\)_W>=G_P"56>_P\93K3_D2\)_W>=G_ .56>_P\93K3_D2\)_W>=G_Y59[_
M  \93K3_ )$O"?\ =YV?_E5GO\/&4ZT_Y$O"?]WG9_\ E5GO\/&4ZT_Y$O"?
M]WG9_P#E5GO\/&4ZT_Y$O"?]WG9_^56>_P /&4ZT_P"1+PG_ '>=G_Y59[_#
MQE.M/^1+PG_=YV?_ )59[_#QE.M/^1+PG_=YV?\ Y59[_#QE.M/^1+PG_=YV
M?_E5GO\ #QE.M/\ D2\)_P!WG9_^56>_P\93K3_D2\)_W>=G_P"56>_P\93K
M3_D2\)_W>=G_ .56>_P\93K3_D2\)_W>=G_Y59[_  \93K3_ )$O"?\ =YV?
M_E5GO\/&4ZT_Y$O"?]WG9_\ E5GO\/&4ZT_Y$O"?]WG9_P#E5GO\/&4ZT_Y$
MO"?]WG9_^56>_P /&4ZT_P"1+PG_ '>=G_Y59[_#QE.M/^1+PG_=YV?_ )59
M[_#QE.M/^1+PG_=YV?\ Y59[_#QE.M/^1+PG_=YV?_E5GO\ #QE.M/\ D2\)
M_P!WG9_^56>_P\93K3_D2\)_W>=G_P"56>_P\93K3_D2\)_W>=G_ .56>_P\
M93K3_D2\)_W>=G_Y59[_  \93K3_ )$O"?\ =YV?_E5GO\/&4ZT_Y$O"?]WG
M9_\ E5GO\/&4ZT_Y$O"?]WG9_P#E5GO\/&4ZT_Y$O"?]WG9_^56>_P /&4ZT
M_P"1+PG_ '>=G_Y59[_#QE.M/^1+PG_=YV?_ )59[_#QE.M/^1+PG_=YV?\
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MF")[7;XX=0L(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
D8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g706699g52q25.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g706699g52q25.jpg
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M P$! 0            @%!@<)! H+ P(!_\0 8A    8" 0 &! 4,"@X(! <
M @,$!08'  $("1$2$Q96%!65EE71T]76"A<:(3$Y05&1E+?4&!DB.%AV=WB7
MMB,D,C=35V%B<8&3M=+7)28V4IBALK,S='62-4)#5')SL?_$ !T! 0 !! ,!
M               ! @8'" ,$!0G_Q !@$0 "  0#! 0%# P,!0$( @,  0(#
M!!$%(5$&$C&1$T%AT0=Q@:'P%!87(C4V='64L;3!%3)2559BDI.5M=/A"!@C
M-T)R=K*STM354U1SX_$S)"4T0V."P\1$HF1EPO_:  P# 0 "$0,1 #\ [_&
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M;-227,L#71VLWR:-\_KI'IK1OR)J1Q5?)43&RF$;;TRHUS3MK8:'9($Z0SL
MVNCAS3>\V^M]Z3Y,WVX.,8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M? DD]C*/CP+O1^;O'B4'P))/8RCX\"[T?F[QXE!\"23V,H^/ N]'YN\>)0?
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M['I V02P$=6/B@][KH$^CDE%"7@XQTC8FU<,2C87>>?&_'/CQ>?6^M]9*;!
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M_P!8N!8A6MK_ -JG<5_39W!L^A9?8P!@# & , 8 P!@# & , 8 P!@# & ,
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M/7 NG#+-'\Y4[R9"Z+UBM0<%WKZ<,M++)6X+@2]  !8 EEA"   A    Z"
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M6U(JP:HO3,INB=:*@K271 +OD:F+L3%,H\YS,A_?Y%"%J-2Z6JA@R.1I8E'
ME.K:ODIZDAO&*MUWMX]>I7TZ^HV68*1@# & , 8 P!@# & , 8 P!@# & ,
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MWL6_P[_#FC^WS?KSVDS?NK4_.C?3P=I>L?9?)>Y%+QS_ *+-A/@^+_ 3;^;
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M76T?02V9-"]_A]<-UAVK":[D5J2EE;-Z6NC%64>E+I.%Z0 3$XRV/0G$HQL
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MI&>13C^\U2PVJ_(FUM8'"[X>Z3ZK-MJE]:P2]OET19W%J7O2-XAGB!I2)@K
MIP.:U$>N(5(BE"8T2K)IN]NQV?9GU9G7W:>.'3<<.[+?9EQP@/1RR"NTU2*Y
M#(ZFX_T$RT#!K@GR6PXX F''MZ.91^8)K=6Q)5(%T=LAY5FULRLI3JVO!)CV
MX(@F"N\$7%1)\+N)Q66O#.VG)G9ZUU]6NO75OJUUZZ^OJW^'77^'J_'@XS^X
M P!@%->7IGCK4X/L@=6UB8VE(<O=7EX7)6QJ;$*8&S%"UP<%II"1&D(+#L9R
MA2<624#6Q#&$.M[P#$37R5X^NM95Y<I=RUPW5?;"!E<:YFDDEC1$F:6E2%&%
M>T)&HR4*F<\3RH3BWHU@/()?42DI2A7MR9:E4IRA-FG;K,CS";PNO(\MET_E
M\7@T4;>X]8R>8/[3&8\@]*/+3)?37IZ5HFU+Z2I.*3D=^I+[X\TLHOM&#"'8
M@I#G;%6,JJ$(7BRX TK;,&276Z-SF4=0*K &I*3'IP0A.J<BCI6,\A:C.)"P
M@7[-*5IC :$ \K8P+_P!@# & , 8 P!@# & , 8 P!@&"+TY)T_QT8?7=G2M
M,VJ5!)AK/&4'8<)9(1%]8>[9V,LP!YI6S=:),<58T;.E-$ *UQ3:$'>[6VHV
MRV>V/I/5.-U\$B..&**GHI5IM?5N&_M:>EA:CB5_:N=,<NGEQ-*;.@NCK5-7
M(I(-^=&H;WW8%G'';[F'B]+NT*=DVKHUF&S;F7T@QIJ"NT2GCAQM6&F)U<M6
MF*BY!+&S8]E'!)7)]HG.0Z4%:-"-JCFVF+ZWM0V/DB7C 4(>%HL2\(WA:BBE
M81+F;&[&S(G!,Q":YBK*^0VX8U#,@<J=5J.'>3D4;IZ*^_(J:R:TF>1TF(8H
MVI2='2/)QN^_&N#LU:**^?M8-V#C#%'$3^XY<-Z4XT("C8:Q>N)F:G[ETL*2
M (7RA9LP'94$H#=% 31]M-WL0-M[,2FT<2$H+D>Y'E:4BROL?X.MFMBY4,6'
M4OJC$HH-V?B]8H)M=,NK1PRHMU04DF*[3DTT,"BAW5.BG10J,].DH*>C2Z.'
M>F6M%-CLXWK9\(4](4LK7;M<E9E]G=/++Z2+[X/S>_G77[^E"39O5L7[T-F/
MB'"OH4D^?^V_ORVK_M%C/ZPJ"%>7,6N, 8 P#T^>B7^]L\,?Y#(G_P"A1FCV
MW_OTVE^-:G^\C?7P=^\?9?XHI?[K-A^6@7F, 8 P"EO;&S25I<&"0M3<^,;L
ME-1.C0[(T[@VN",[79-3+$2HLU.I(,U_=%FEC#OJUOJZ]:WK@J::FK:>=25<
MB354M1!%*GT]1+@G29TN)6B@F2IBB@CA:XPQ)HIBAACA<,<*BAB5HH8DFFGU
M-/)HU*V;PDMCCI*UUV\%9&N;3.OTJ34HY+!K6MZ0DC$::A: N*C2=^0]D1@B
M&%Z/ \(1"..C;]I>-"A*P%C?@TQ[8^OF[3>"ZLFR8LXZW9J=,<V14RH6XHI5
M,IT6Y52K.+=I*F)5$IN**BJU-<J5#XD[#IU)&ZG#8G"^,=.W>&)<6H;NT2_%
MB>\OZ$5[(D)Q@Y[P"\EH*]G:$=27>A.&V.,&D>SD*1X=4HMDJR8RK<@)S_3M
M'!%WL8=0)WY(+9A*<+N4E/7Y=^Q/A4PK:>;]B,4E/9_::5&Y$["ZQQ2H*B?
M]V.&BF3E!&YF\GO44]054MWA@4^&"*:=JCQ*54OHIBZ"I644J/)11+CN-Y__
M &Q6B75O+,GUF53TQ@# & , 8 P!@# & , 8 P!@'Y&,!8!&&""   B&,8Q:
M"   ZV(0A"%O6@A#K6]B%O>M:UK>][ZM9#:2;;223;;=DDLVVWDDEQ8.A3TP
M]"*^17237;8[!,XDBJ@MAK!O.G29V0/B12ICM:QILD!#84WK/1C1M#BC5(7
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M(H+R&7:9SH^:%<!-H8Y'P]MT=K.RAM>]G;[7/C:]\LLSN08.(8 P!@# & ,
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M;1.*?39Q3*>/.)+K:2NW99[\"42_I0N%-N4I'2NT,H@[+)28[,#Y*J5A0O\
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MK)*[=DD>W!"H((($[J"&&%-\6H4E=\BOYVBH8 P!@# & , \Z;ZH2^^F7?\
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MO]Z/Q9_FY4A^C.,9H/M#[OXY\<8G]-GGT,V8][6SWQ'A/T"G)&YXY[@P!@#
M& , 8 P#RR^DB^^#\WOYUU^_I0DV;U;%^]#9CXAPKZ%)/G_MO[\MJ_[18S^L
M*@A7ES%KC & , ](CHN;R:([T>G$1D/8W%2:VTK%4QAY2A, LT02SA;$ (_W
M6@_NNK6A?;^UFIFV6R-36[4X[5PUDB"&HQ&?,4$4N8XH5$UDVLFUV&W>Q>W5
M)A^RF T4=!43(J7#I$F*.&9*4,3@33:3S2?;F3U_9%LGEUU_.4F6UZQZO_GJ
M?\W,[RY_9&HOO;5?G97</V1;)Y==?SE)CUCU?_/4_P";F=X]D:B^]M5^=E=P
M_9%LGEUU_.4F/6/5_P#/4_YN9WCV1J+[VU7YV5W#]D6R>777\Y28]8]7_P ]
M3_FYG>/9&HOO;5?G97<9MC#\3)V%N?DZ<U*2XE&&@(.$$9I>BSS2-Z&('[G>
M][*V+75^#>M?=RT\0HXJ"LGT<<<,R*1$H7'"FH8FX(8[I/-?;6ST+WPRO@Q.
M@IJ^7+BE05,$4<,N-IQ0J&.*"S<.3SA;RZF5[.F=\8 P!@# & , 8 P!@# &
M , 8 P!@# /.F^J$OOIEW_Q2I?\ 1-$<W$\$/O$POX1B7ZPJ#2GPR_S@8M\'
MPO\ 5M*:4,R88M& , 8!W(.@:_>2/7\NT\_JU LQ#MS[M0? 9'^+/,L;$>X\
MSX=._P *G-U&6:7@, 8 P"8W'C_L:Z_QF5_[J9\QAMM[J4WP"7](J3,?@\]Q
MJOXSF_1:,SUEG%^C & , 8 P!@# & 0;Z1VN;BMOB+8%;T@KE:.52^54RSR8
M<#EB&"3<^G#[JK[=\I(I+W)S9T;"\*Z6#.R"E1CDE..3C4(D0Q+U24 A,+2=
MWU7MUYV=O/8U.=#AQDM:@^4W)4B%0>R:_P")#$[<G84%PE]]AMB"W/*3>5*M
M[XP3&K8LKG$W?(SJO^,!9T2FLL>#F5;-EKVQ#<V]U?&US?#A7&TTNMV759JR
MM$GDKWBX<;9ZG9'P<9U_^D"Z-Z$\N>=$9M6O+[I-[Y35E1;&]D\1N5]4(N0?
M'YQKE/,'AK:9LZPA*]1]_@&I#)CUC0?)4QCZ8\',QP&]G$) M.(%<,5DU;)_
MTED_%?K77;SF7>AE#==,5S;? F]*_I^-3#AO)RE!LNIBV6Z9QB9E<DIK:EY)
M$Q=<K&"-3VJT,9:WYL2Q_4L;34,M95R8]C6[5,C^A0A'9NZO9ZJW#+5I^0W1
MX*"CR"0L$397.2RE\:(U'61&<XO+^_N2)G96E G#VU"YS='$Y,A0(R ?NCE*
MH\HDL/VQC#K[> 879^5G&IZKBJ[;)O6K&RNKN1-*VIY/)YJPQ!'.]O1"=0A;
M& B5+6=:JD&O22DJZ-;2@D#6X]ZUN;8C<2#TI8FSSR>7$RC.K!@57QI=,[,F
M\0KN'M@TY;E*YU)6:(QIO&L/ E2 7/K^M;VM(-4I-+3IPGJB]GGF **T(P80
M[$%ONMVTPPJZ_0/ENU@S+K8VFU5B)UGT4;E=E[6@2&H]5^F6.Q)TRVK+7H#$
MVHX!R[\"U(,KMA4D[&%GIPX]AD_ & , 8!Y(MV?WYK<_E.GO]:G;/H%A?N;A
MWP&D^CRSYS8K[J8E\/K/I$PQCG>.@, 8 P#U>^'?[T?BS_-RI#]&<8S0?:'W
M?QSXXQ/Z;//H9LQ[VMGOB/"?H%.2-SQSW!@# & , 8 P!@'EE])%]\'YO?SK
MK]_2A)LWJV+]Z&S'Q#A7T*2?/_;?WY;5_P!HL9_6%00KRYBUQ@# & =_3HY?
MWB_%O^2&,?\ LF9@C:'W;Q/X7-^=&<-G_<7#?@LOZR:F>,>P, 8 P"?=2_WN
MXQ_\HI_W@LS#6T?NWB'_ %8/\&69^V3][N%_]&9](G&1<\0N(8 P!@# & ,
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M"7LXW8-;T'9@]Z[6]ZMB_>ALQ\0X5]"DGS_VW]^6U?\ :+&?UA4$,,N8M<8
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MZ&S'Q#A7T*2?/_;?WY;5_P!HL9_6%00KRYBUQ@# & =_3HY?WB_%O^2&,?\
MLF9@C:'W;Q/X7-^=&<-G_<7#?@LOZR:F>,>P, 8 P"?=2_WNXQ_\HI_W@LS#
M6T?NWB'_ %8/\&69^V3][N%_]&9](G&1<\0N(8 P!@# & , 8 P!@# & , 8
M P!@# /.F^J$OOIEW_Q2I?\ 1-$<W$\$/O$POX1B7ZPJ#2GPR_S@8M\'PO\
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MC8F1*!0M-:V!^<V!B>',@MQ5HE9+,G4NAFB#0;BBXMNVK;MPU\A,_! P!@#
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M>:$#.=M,:3'CV/8S51PJ;CA5HH5P:435W9K-*).SRRZVLUV'9XP<8P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# /,GZ8[[YQS$_E2#_ %6CN;M^#GWD;.? /_SSC1'PF>_S:;XP_P#UY)K/
MR]2Q1@# & >CIT 7WJ3C5_\ 4KO_ $^6;FFWA:]_N-_U,+_5-";M^![^;S O
MZ^+?KFO-RF8X,FC & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M27K:!J$\IXK8,4DL?3O VIJ&Z$-Q:\QL;AJ!(R :LVO/JNI]?%&:L$# & ,
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MINKW6$3^\H!=U5,["PN5_P F.LR7[D#14#B[O+(Q1I6QA5KY=%@V*Q*8:QO
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MVHYQ/2..LS@Y*%4#;'5>WHHHZJ94#BRZ[M)//*RM;J["2/#:K9/2W%FB:TG
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MNB2K$ZA6UGJTP%B4EQ3%&#.0FJ4AI:I.6I 4,Y,8 \O0BAA%L#GX P!@# &
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M48>>862226,TXXT82RBBBP[&8888/>@%EE@UL0QBWH(0ZV(6]:UO> 6F"PX
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M"0D/I*U:\(2U$B<#5(#SPC=UFTVXFUG=VLK9W=EV/,[&F#C& , 8 P!@# &
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M['F"@8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P"CR)WTP1]]?=I]J],C,YN^
MTNC>XVITVHCUFT^CN[-[G9W<]WWO=&]WVNWW8^KL[Y),OIITJ5?=Z69!+WK7
MW=^)0WM=7M>]KJ^J.*?-Z&3.G;N]T4J9-W;VWNC@<>[>SM>UKV=N-F=2/[*W
M:OX"SA_XD4W_ "*S8'V!9GX4P?H:+_=#7/\ C"R_P2C_ $Y#_M ^RMVK^ LX
M?^)%-_R*Q[ LS\*8/T-%_N@_C"R_P2C_ $Y#_M ^RMVK^ LX?^)%-_R*Q[ L
MS\*8/T-%_N@_C"R_P2C_ $Y#_M!N%XX]*DCY"\"I7S634<LC#BV64FIZ(U'J
MPD[Z.66'*)C ZWK=K43@<.826%OED^L>-,[DY#C#EX<;S%3MI,[[(TA,Q-MG
MLN]D,9>$.N6(-4LBJ]4*G=*OY=S%N=$Y]1]KN?;=)G?[56SS#L/M8MM,$^S,
M- \.7JRHI/4[J55O^0AEQ.9TJD4R]MTGVG1Y;OVSOE>-\\L>1_&I#2S=<:3B
M1$'2Y[A7UZ@L%RL>R$%8QII;:5LZU%HY$2[P]L=D[QMYKY'$6-0E=%B.0>OR
MW)0@CQZ;36?:9>22=_MG97R2OQ2U>69>:GDAR4G<MGD'X^P"BYLZT;7%7R&S
M'R63V9,4;L.R[*A8YZAKBHSF6*/REH8/"XF5V#94MTXEE^,F)"3#7+;>]+21
M%DN+?7U9Y:YKZ^O0N!\YFBD7'WB-;%)PM+))=SC5U:V49&)R]*(TR-)]DU!)
M[[<76P'=G;']P2H('4\%G$A<D#*V+%C\\L22,(E+;MY"](!.[FT\MV]^=OG:
M*C)^79=#-H&+D@Q"762T1*3V?,TG'",V):T=BE+QIQ]!.MJ5DGQ=M>HFUF"T
MJ)\+%^*9"XJ6:0;B'B],Q/9S6(M?APO:[LL_*[><ITDZ1+CU'INO@A".WI8O
M13U@JA.^P.G)[,H:]6E,*G8[MA5?L4M8VA4R.;]+*YD"!^0'DJM,322,O<L>
M8Z4O:#7$+/CV7\BR..]=(YQS9HS'946GMU^0/M93.X7!'&*<GK^[PFOJRE"J
M&6F]3YL0-!BB+J*WDZ!P99.R+-"?CG! J1QQM?U0 DC$[K[.-N/%VNK>/J?#
MAJ7PCYP4 X6$37[>]2)>!;(7J$M$]1Q5W45D_6'':Z<;:>J_8YH42)O<I*@K
MYG>'PPP@&X^:L9W:*IWTZ9-JV.D"+.U].*Z[7M?GEXS'\?Z2;C;(X<NFJ8%J
MMC?X<HZ7Q1MDM42^*OMDQGDA,]5S3+W7S=(D+;I[;9E/?^K!2U4>V)FDXQ$]
MOAK;%'9F?W$-U]G7U\+9N_B7=Q31F&3\JH+"WFN&F60ZX8\ELQ5!V5KD;K5\
MD21ACF%D*1MT*@LH=S"= ;98]/?H\=&D3%."!G?G!I;G]R:C79NVI"W'-97Z
M^-N-O3Q$<J_Z1J#S"&PJTIDPNM$U^O'RG53 %IL,D ZIHUQD]:F2*5Q]Q:T.
MF\QL1-[,L<) 0O1"5D+2UD:: .+HUG'J0L_&[)V7;]>:R[3(ZCI :/;4KB3(
M(]=<8F3?(ZPC0:L?J:FR:TG$^["I?]:-T:X:F;U:Y:PSQ= 9FRH'4 PD,CY%
MY U3#4;5LCL!&&Z\N&?7=6R5WGV7[KF7X_R;J>0\?I+R7*<G9GK&%,MIN\V-
MDS(OCLAAQ](O$KC=L,,D8'0LA8VO\%DT'E<>>D(^T5IS95.D:E4D&G5'!9WM
MUNWGS7SD;Z6YX;>J.!,>0=:O-97LUW)NA)/Q^@A#M9,L^NF^L*.RX%%(N2G;
MFU:\*WZDI!&++=5RY(TL\>:!R-<Z.*9ECRMTP+9V3NM>"TOSR^;B59#T@M?A
MG=VQF55C<L%B])UW3MA/,YE4!D#20J3W >L1MS$LCKBVHGEA?&U<20BTB6 /
M.<3R)!V"DA<>.&K"V5^UJWB5[^GUF:)7RE@4:'::1NC-I3YVIJ?-U<SYDKJO
M'N5.32^N-20Z[@*>M.$AOVS$U_.XXL&Y'+R *GE9J,-A:^0C3MIXCZ_3ZB)R
MKGV\NMN15HK]MBTOJ":V!QS11:0(6&4'RR15Q>'%R]K_ /7#2C,>4&AR%6KK
M6*IXVE4,9/=M;JZ-[BUJ710D6MT7X=KMYF_J*K67;:__ /:Q,NI^2E27<O94
M%9ORF2;?J2J[D&C6D-:TEN)K2YCY*GK=P7JSRRRT+K)10V4F$,2C071,2Q+C
M%B=/H!>C)(::YM>5<2"/$OI'Y)>JQN*EL%A#XG?^.RKD*2DXZR.26S,J_P"X
MG4?A*&I[2A!$>"M99S*QR(;I"E29Q]%>DD+L<QQ;&)OB1SHJ$N'R6=G?)=>=
M_%U=O69R4<_:>3JT3\Z/*F%0E@KSE)+K4:)O"IBBL>'N?&-]IYIEK8!H:TKB
MA/.;@6@D,]6(=O3A-=/<4/@ W@DU;HP19OJS=NM==^/[^'67AQLY/.U_6ER-
MB2B#R2",E..-5-K,TSN$R.#6!Z1.(,.5.^I*WOBL]"N3@.$F&R.,=+TVB0GB
M3*%:IR3+ )0:R3UO]7;V]A,7! P!@# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@%,>
MFI.^LSLR*QG%)7EL7M2DQ.( 5!:=Q2FI#AD"-+-+"< LX0BA&%&@T/0=C+&'
M6P[KE3(I4R7-A2<4N."9"HKN%Q01*))I-.UUG9IVX-''-EPSI4V3$VH9LN.7
M$X;;RACA<+:NFKI/*Z:OQ3.N-]B[<#_\<O+CWTIO_D7F9?9RVJ^]NS_R;$?]
MT,)>P%LC]]-H_E6&?[2/L7;@?_CEY<>^E-_\B\>SEM5][=G_ )-B/^Z#V MD
M?OIM'\JPS_:1]B[<#_\ '+RX]]*;_P"1>/9RVJ^]NS_R;$?]T'L!;(_?3:/Y
M5AG^TFS*C^C$H*AN'LMX4QF46P]5I+)0MF^I7(9%&PV5&IB)UC4BCTGB[['H
M>P,K>\0B51".2J)GJXVX%)7QJ3FN1#JC[:(6.=J-I:[:S%'BV(2:214.GDTW
M1T<$Z"3N27&X7NSY]1'OO?>\^DL[*T*SODS9/9:@V/PK[$8;.K*BG]4SJKI*
MZ.3,G=)/4M1P[TB132]Q*6K+H][-WB=U:[I'P[L27CK"02;F)=+O9-/V.ML.
M"3P<$X\H],XW.JI_4+JQ^$FZH$<86I'F.6,^.#JO<T*YR]>EHCVE0T-24AH*
MMTN:_8L_'K?4Y<KX:O[Q)Y+,X?R?NFK9/:=>0JO[X=X4S4^,ZTU$':'!A;+&
M2$26M7])6]G',KLM9U#]!$[6R[;"F4H,:],C;$N0!?L3\?[FK^4OJ=\2*\DM
M/4Q4,)=9+3B;C:X5^\\>I97YK.?(*H=*SB3A7T9VUIIDT2F/OK6?7CU(*_D3
M-)V9W2/L1DCX@-VG7*4[FD"[NV\[\;]>=_G,2S'@L]3@]R>WGE9>0)M-ZL?J
M.MZ9-\?HY"ML*IWMY='I'&$C215 6*$+88;(94BA,EC;>6^HD4L?C9(KE;P)
MI=VD+VZN#NO3+1?N61?3-PGK&.NY3BQ.\G;$2/DQ"N3;6QD'-@VYKD$"XWQ#
MC*Q0Y*(]O-6"B((7#&QU.TH4G/8WTU2/3L%"(M&6)WGV<&N;;?ENR,LCZ.21
M+9\4R0Z\+"KNG7>B>1M:3AUC8:[7S>3CY(\A'6XIE&>YE4 D"!E0(T4H?D46
ME["%OD#":E;^_$Z"-5[4!O96MG=/DK:\S,,!Z.RG:NM*26!!%2=E99*Y25^,
MB1U:4X[NS,]RN#C@[P&/VV[U^LN%KCYQ8QR8ME+FHU!4C/6)2W<,*6J8:8(;
MOQS[<[\6]>TYXN!D-21)CBK+/'X@ICXO5%Q/V&3PZL+$C\AKJHW-:X)!2Z&S
MF&O<;?E,J+<#T,D3[1(TO<:*,9PM:D'?""^=^V^ABAMZ*FI&N74W*@V;9#P.
MEB>..X]XL9ZJE<A,4\:) 6_Q1,VSIYKQ1,8)%Y2;H>IK#*W=HA'UZ@"8QJ3,
MR 3JUNPG>>?;?6V?9>WIF7HX=&]6,CABZMIK8EDRFOA&<KT+''S!1%F5QN*<
MO /!L[C+>_,D81.BKPNY2%Y<(._N1JQ];Q&H"G58\>KPFGB+N]_%YK=Q=C1P
M=:SYJ@M.R[GLJV+513"CY *;O[97<=&='N/>[04UW!@1^$0V.L"9GV]7+8LF
MDCD2AT_/3](SM%.+>Q-S$Q-(7[%UZ]>6I=;QPUKY_H*:\<7602I77ECW=8-R
M3HDP;1Z9)D5J<G7[DW8%7. M-?HVZ_E3C)7JM'A.6G"]*:Y<5B'3N6]'[>0A
M?.^GU*WIVF+'7HVZ<;9BXSNEY!)>/S\*4538T<35RW1!1&HS:U6,5LP;ZX:>
M,RF.OK:Y.L_JJX)!55@)'$)J1SB+3&#6?U%(F5.^;>GIZ=0N^O/BL^WN>:[>
M-UD7',>##9/!VYN3WE;#E]?*C(#45D*MM]6I'-TE%7.,A=(/<[:H;Z\1H&6;
M-2R3KSE,?0M0:X<1I&H*B&Z(3+"' +_/?GQ7BR^?B8VD_1FQ:=DR%;/[RL>>
M2N97>?>DO?)C":+DK"\R%704/XZZ;0UD]U8OK,E'&X3"F=?7[DJBKC((I(BA
M.*EU?@+7I.[B=YZ)96Z\L[WO>]_-V<"_JXZ/BL:T65$L:)G/%PZ<-X\&L('$
MV/[ Y[XX4!/N/,4T[>C,A A:>XQ8+F]2'T/:78WY$A$V[0-^E"(Z+<.SARM]
M9#;=^WOO\Y6>$7%8WC(T7L<YZ+"[6YR)MB?LK86[;?4T)J,V7.R2FZX95^T+
M=Z''(_$-:D2*,%)S$D1>)G((^C7NI"(+HLD-WMV)+QV.:GX.UDV\/B^'#&]R
M!AAX8Q'8ZIF+:AB@)4^&1IY:GPA;+$AL?-B\L2OJAH(:IFPOC$K99=%ECO&G
M=*:VNBD&POG?Q^?TYF%6CHKJ201%^ARN93<QND<4Y.1A9N.M%:P).TF<I%](
M.\G=XDPPF"LD6C*J#/%$Q=PKQ(E8CF]$8K7^)DTI-WH\0;SO?M3Y<"5-$<>%
M=.2>UYY(;:G-P3NY5D*73"13)K@K$2G,@D<'%F9)'F. 16*M+4V^K-E[/3G$
M+U1JP)JLY<::H-WL&[V74KV\NOHB2>"!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# & , 8 P#XJ#>X(/.T'M=R2:;V>OJ[7=@$/L]?5OJZ^KJZ
M^K?5]WJWE<N'?C@@O;?CAAOQMO1)7MUVN43(MR"..U]R"**W"^ZF[7ZKV(M_
MLCEOE1+[6-_4,R#ZQI7WQF?)H?VQB[V1YOWIE_+(O],/V1RWRHE]K&_J&/6-
M*^^,SY-#^V'LCS?O3+^61?Z8?LCEOE1+[6-_4,>L:5]\9GR:']L/9'F_>F7\
MLB_TQ>KE>T=BE)V%>DY*]11.LHO,9E)]IC=K32F"%,:A_=#4P1%D"/5F(DIP
M$R4(>V>H[HDO8AF!UEHXUAD.$UOJ2&<YZZ*7-WXH%+?M][+=447#=XWSOP+X
MV>Q>+'*#U;%(AIFY\R3T:F.:OY-0/>WG! \][ANY6XLC7QPYK/$KBL'CG)J$
MI*FY".M]2?CA.H?%3%;S"(;9J>L'7D!!$"U_=CR'%$@G-%ZCKXT.2U*)(KES
ML&+$&Z5*FP*KR3WFEU.ZM=7R?&W;FGV]I\DO2<<:%RZ %(AS4]EGC=43R*5#
M;(VA9HDS<@)4;$J/=I&A<I:BE2Y!92KU>]H#8/&YD.*0]]89A8Q<+CKLE<1!
MNOLZ_-F^S+QYM97+P;>=$1D%?2VT(I2G(&20N*SB0P,IY+C4 C"64.$,>YC&
M9L[QE5/[+B"(V.Q:1PAU83G)Y5,@Y(ZJV='!4TK,<B]!$6SMV7YJ_CY+S%+1
M](?2;[(:L:X7&K0G4<M=723<V6,P,,900B-N/(*!CM2MT4K'+YE%Y4E,65D7
MN<.Q[+%GU$S-AB5J6*@RI>@CZH+/._%<5UY-+YV7?QSYQ4ER@D1T;K@4C(4+
M($@MB%+7\B.E(K'JIS=0,R.P(N6PR60.C4UC6JFG9S#83;!YTE1O["XJXD0@
M=$RD0-6^9]C]$^%R',!Z3"</[_/H5+ZWBD9ES9SF^L360"7!X4-=B\<@<Y)A
MPI=K+3#.-+,+L6'R^OY"*9QY*:I:F3<BK1W4@+039"@+%3AM;.Z<-_$]W>MY
MS]PGI$K!6UAR*N5]'4LJ*JR66Q7D/HV*0ZS(?,3)LQ\G'/CE4A,QN*22&10=
M4R3!U1-:B4+(Q!Q*F#4ATO(2'EL*EK<Q%E=+-9)M\<K7>5OK)7UO<=]QSD;'
M^./(=-4CXY632,_NZN9O3K3,8NVI"ZCFE5PNRX')XY,Y',5:M2W'W97CG%YH
M@?&PB2)3)"0MAT</:TNW 1;*ZX)I._;>VFC]&6Y67(ZX;&(G%_K!4K!>(<#G
MU]Q)R!)"INHMA1"^/4JGE=3"WCY0WKQ1%G1+9I7C\XM%?'0M>J' ?0GM?.4#
M\J-C20&K67%V3R[4FEX\\^W+JN_R=TBE1M;(Y.4IK>_(:]%)J.=XO!'ZO4!T
MZL.,<C+)1U+4TGA3''I0_%J$KU.UZ1E>H\_+H_.H28I1F3:)1X#BV^F!;.R:
M?'KT5^NWDU.&R=))3#GZS&]5[>\&2LQ%[-[DX36 M;:WE6)QM9W^26]4B16@
ME;J4\3:/1J,/K\A=F/;G6,E1MB]+&[#=79N<6U(&Z^S.UL^-^#],]4?<?204
M:B:7E7(8K;D,?R$].N4,@DVBS!%)=:;!?SA+&NI)%""WJ7)(^@:Y*L@<VTZ%
MV)(8$ZP!-%W5?939#D&DJE4%O%W6XKR=E^RY1';I0./K=%"YB@BMSREK;Z^M
M.TI\&)0EJ?!U5!J+L!XK*ZGJ=K2)4!E%];>6,#LG7((:[2]RE[:C,>ZR23EI
MV%9L+.]NO*W;?A;Q_P#FQG9IY90Z2RJ\HK#X-9,R%01@6N6O$>1PDYN=)>-F
MBDA!"6)O7SIOE2=X.99DSNB)\ET<BD!<FX#JY-DR6MS.Y*TP6R3UX>G#ZS"C
M/TA;#,)YQ^AL"I&TY*3<=F6W4\R6[7UPG64W+:B:R7)](D12"<.\>E:(*14G
M?#W:"RI_:!1,0W5C<) Z]S'CPMVKJ\__ (Z[%/:.D;K1IKIOETJ:IQ-R8[5Y
M-TWA-:RKO3="J2J=RF,^BC384^:9+/G"0HF4X=:SA:H9X:KL>7)F6&2&5KF!
MNCX4IP@LWFM;+5OK2].M+-F78US:JZ47*CII)%;40J'2V+!HAFL1WB"5#63W
M<M9PV26/):]:'W;X8\KG+=?1"32UM>RH[X.6)6-S9/$I4N1J(Z6%G9O3CXKV
M^?YT69?W,)_J#DM353M$197RL5:B"E<E9VN6KD[K4Y?(>9NE/<6C65,G_P"C
MEP9]<S ]1^3;=1DZ96-.0YI^V(_74"63>?9H[9ODLREW7T@C-6]=W]8,!HJX
M[=9J'42MA62EH11B/5Q*IQ )8UPNP8:SRIXD>WQ.L@\@7.#:^.RV&E,2UQC,
MH:HPY2%T9%J,H2H;M+A>WD3SO;C:V?GX-,S"MY?5LRD2C4F8)]%G>$ROC)")
M;&W=F9CGEBE'+":1& UFU*1,LB=VA2-!(YHT)Y@H;G9:C9R"URA"H> $%Z/$
M6>7;>WDXF";\Y[)(,U73$(I#Y/$[BKJ)%SJ*I[+:8XIC<XAS9:\%K*421I1Q
M.=.LA;4C<MG+%M.V3Y! I"O2R!E?&IG<F<:A04)4/!]3:3MU7_=^\_4)Z0"(
M,K/>9EVZ6-3O5;QS&EK."-1P\PB6U+QEY"O=.&ML8),=E2F266A KKE"Z,:<
M"/UN]SZ,Z:BP">-HT0BW"V=[>=)_^/$]#^\X.8\DXT2NE8VTR_C]6".RH'?4
MW<)+R1<'1N8CW.GT-9*F6N6-2PRZ/[)D\S-GBX@I0D!,%I'J86VB*OYHA$[B
M^=NQOE;O)2O?CU)6[;YOT1?D8YMLJQ?Q_BUAU-:%13'D+#8JX1[4K01I3'6*
MQY#33C<[C5[FG+E2"Q3G2,,K%)&=TDHZ];H.*3L"N*F2E%)SB&<4D6XYK+OM
M?3K(Z2SI*=ZHZJ9+6\5DE@3J61;@Q*IW/66M5:.G(*1RXFU;H&Y%)&I=/ULQ
MCCI)8=(GYY8FAM63XB :71,VP9,4G=&Q2]B;9OLWNO1-]VE[Y&VS!2, 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MFY*YL'=I@Z$%^.2SOGGU\>LV0X(& , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & 8$Y!\D*VXSQ9IEUEF/FFY[>P,#:1'V@3LM/7B1JEXNT 1Z1*024
MF1FC&-0K*$/?9"06<+MZ!:NUNV.#;%T,C$,:BJE)J:E4DF&DIW43(YKEQS7=
M.*7+@AA@EQ-N.9"V[*%1.]NM55<FC@4R=O;L46ZMV'>=[-]B2LNMKLN1!WTM
M'%7JWV2+/[75OJZX>@ZNOJ^UU_\ 6/[G7]W,>OP^;"6=H<;O;+_W?*X_*SH?
M9RB_^M^;7^<AE&^F)LLZ2,!,KK6 (XH:^-14E6,Q<F4/*6/#7D >5+4G4O\
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MMAW7D&ZMZWK?5$V#6^K>NK[6_5_VMYTG@F#--?8G#,\O_@*7]D4=#*_X4O\
M(A[B'T=Z-#B?%Y$Q2=MB4A,<HZ]-;\@ X2UW7H!KFA<0X)0+6]28-*M1B/3E
MA4HU!8R%).QD&@$6,0=X[H_ ML%0UE+72:"L<ZCJ9%7*AG8A43I+FT\V&=+4
MV5&W!-EN.!*.7&G#'#>&)--GGPX/0P1PQJ".\,2C2<;<-X6FDT\FKK-/BLB8
M7UL*T_Q>0;W28/F_,B?87!OO3AGR"E_9'H=#*_X4O\B'N*%9U+P*V*M?J<D;
M:8WP61$($ZUNC(R&(9)3<](9 0% -*G$2C[3DWD&G=VGWHP(C@[UH1FQ:[\F
M3)IY<,F1*ER)4%U!*DRX9<N!-MM0P0*&&&[;;LE=MOBRN%*%)0I)+@DK*SXY
M*W'L,)$\%>/*67V?.D+ ]()';MZ4UR%F"I*_*M$CGE%2!LF$'2-*4X!Q#1%!
MS5*]S5^CR, "'B63F=/9II:R2*!E\A5=Y=B:YJWE\O8N!4V_A;13>3#4^F9X
M6IH6LY,"3IW!WVI)?X_RYDS_ #*[X-*0>C ]<0J1RE[2/B9DWLC:%?%8D:%4
M;IH$%4].8O\ 5YLO3QEM0K@S7D(+/.16CR#>) W5D*FJWF4@M56OE],UB-[C
M$C412M7DEK1C*+<WB#P<^2/DS)F<HF26'1UIF;Y(&9#ZO,"_IJ]?/EIU6,LU
M9QQKZK8A8\3"?([ ,N63/4QN*464Z)Y%);/DC_$8[7Z]PE(D;>SL19 8#$(I
M"D;.P,3&Q(8Y'FU"D:RM@.-/!NY'4CHU./;;5=55+'GFVHRSU*RW)&6B2-4\
M])G4CC?(-:!QN5JETH?6AY5.*F<K"4ARF4-Q;1-V/2,DF*R=A(-6%*@WG=OM
M3\JX%X+N!M-#)1'1]^L^$21HL2$6?'IM#Y@2W2N.2F#<=D/%9()J5+69R;!-
MKU2255%Y WN34XE*E3LND"#;:^D,[@UAO/S-/MN[_/GEHC^P?@K5M5GPI14T
MXN:M38G!(O6#P9'9TG<5%EU_"9;,)M$([8RV8,,H<'4^/OM@SD:*5LBN.SDY
M'*WA OE"Q,<462%V^.M_+Z>0OV[^+$'O*1-,O<999U>RM!")95[E(JJEX8FZ
M2BKYRK:%\H@4A-/;'8HQK6+V)O7-CXU$M,VBBO2Y1#I5'S79V$M!.W4GX^PO
M6KJ'K:FW:6NE>,YK"5+VVNF56S$J1#9&IFJN%(*_A;4PH1 [3<B;8PVHT8BQ
M''B.&3HT0];_ '. VWQ],[_683KWANBA\IF,^D5V7/8-A+XW.ZWJV=R>5;<Y
M)1M1SUUB#\[PN#&/A3ZVN3PM?()$71\GLO;9!)Y"=&(ZG<3MH6O24\+Y6MHW
MQS:O;Y^K5^2WF#H_:VBT$KV&1^U[^:7.I9--I#6=CHIM&T]B0U%92 Y#/X>@
M<RX0%B<8=*S%![LO:Y#''E4C?](7QF<6QS9&!2U!?/@O%G;+KX\?WZL^Q'1V
M\=FU7%T\<!/HK!V%BI-@?JI8IJM#7=EIN.KB4[4XMLI YIW)^D+K%G!,B-=7
M%+(FL^PDS<WM=F[F;0C(0 #>;X]N?7FK->+YNHRW</%>J;R?7"13HF0&.3G5
MKG4"H32\[;B=PYVG<-L56 LKT8_0'+Q)!&$92[M;["(*Q+LH6E/>%B.JWB\U
M^\LFX^"M 7M'[BC-AM<E7-EY6G"[>G&VZ2*FE9N3PNN(14!:-F6(R@'MD>D]
M8P8B#S-H"(X$ACDEF+<><42_&!($IM6[%;SM^9Y^1%]AXVQIOMR26[%)S9\%
M53QUCLALN#Q*1-2. 6-)XG%6B#,,ED;8XQYT?&YX30V.1>,+C(;(XJD?F:+1
MY)(4CJ%M*WL+^FGIYN*LS%*/@55R9>&4'SVXW"S@7!$KK!;JN3QLF?\ BR%5
MI)J:9$IXFV&M\27-(JJFLPA#J8XQ-6_O;=(UKDZORN1)FIZ;@OU96LU;Q^._
M8RMI^$E6%PVT:J5RFU'.D;38K'85=*+9>E+@<.)M5]52:7+8$L;F1!/6)<!]
M7N#A%-JILZ(X"):8E@R..H$Z%*D"[O?*Z:=_%V<'VW5V^)D&D^.,7I!VL:3-
MLRLV>S.V%,76SR9V=*B9*^O"N&LAD;CYJ8A$TLK PD(V79*/;;'F1J:3C$^G
M$UO$ZK'-<O"_U^?TZS ZSH\Z[=:ZNVL7VYN1+]&^04S9Y]98G&:0XM:[R-L\
M/$.&][;:\;T![',&F*1Z.3B)NK>YQ64QIN&QN3*8@<WDIQ$[V:=EDK=??U=1
ME""\9UD3N&(V7(+3E]EM];5)*:YKQ'/"VA7)&EWLF9M$BL62N3RPMT>95^E+
M'!:VB<12IHN@61IJ;9:4)T7D2Q00G$7RM;BT^5[=O6[YZ:'[8^)T;9YJ\60L
MM6[Y5/1U[.JM@,KE\S:'MTIN%6.[QI_ES?6^C(L2C$X.CU"(.O.D<]23N2#\
M&L"$YV.:R%2%6%_%;)M<+M>G58Q]7'!YFJ]_HQ,T6C/9965(36X[<:(=8AK.
M^NQUO6>V.+$W2))(&5IC*=,PQ]NL.[W(U@<&=V.52>P&MV;W1G3Q5&WG@W>^
M2S2679_X7<9)/XM,QU\O_(8-LW2EE\A@JFMCV-)(HH1#T$.&!Z4-S4U-P81M
MV2"8) _+I:S+AOAR\J0]P8L4KFLKU6(+Y6]/3TZV7C4%#1RH7&9R8$GG5BV#
M8@H^7-;*LQZ0/4O>VN()W%-$(X6%D9XW&&*,1<#T_*6>/QB-LC6!VD4D?U:=
M6_R)Z=%P-\O3R\S.&"!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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@U=?D,^8(& , 8 P!@# & , 8 P!@# & , 8 P!@'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g706699g85y72.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g706699g85y72.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %W ED# 1$  A$! Q$!_\0
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MP=+3-$96<H62E;7%U#,W0E)3<[+5X?$8(R1$16*BXB4F0V5VI(*$8X/"_]H
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MK6C;:A5,&TJO'Q\.HDKTFO2 WIQ8?N#L!XK0*G+3F_-:X3ZKBKC;$@E#9!D
ME;?'3XZZZ<X7Y9=MO<U$C3FGN)9+@ E 3Y1.A5#/"(L1#"FHFVTH57"GTG9=
M'MTAMO<C;[Y6<-^4U(12EN4/$<V"+I?JLYJKG=73:+6*T@>V!]C+BY-Z%W:#
M@-RMF5FMCJ-8><B?$1HAH7!,ZM#<$4*242=88JTK@\,'79KZ2=,:Y7\=)@_\
M@8M';:BSA(.*HR0\AFL1JU$IJ@"AH=WXA5*.\$:4LI <SL+TO*<40UB PAK6
M["IV(@8=#C1X8/'5TD=Y[TL'1V5A7566M.>5==L4(NUI=)!5CALB4.+K,8XR
MN:YF=9*WQ-ICR^7)XT@=&QP0J)"Y,2)F >C/#Y]O1>]X)T(JM4>#H^Z]G=+B
MV!TA7":K(+5-GS[DO5<<KF\6*5R6I)PH?]*XM/&6#Q_Q/*53$]MQ"Q <8TM&
MP[,0G'D+U+F84PHDJE^-+;1B-%U:HVU@TE6F--G26HFO2\=&S7;55KS,^6]:
ML2"YX:VV'7FSR94H5N<$>%AS>URYY;4,=5.4+CRY<E5I$[K-TD=2&*$:TK1O
M;1JM%"5!$ZI)X.C[N742L:.2]$/]NV+0S-9D><+>J:&L5A6+!T^UVW2*PN3)
M"%[%(5YPD86XQ"XHE2925YFM5' )4D#.**T<7VA%'1.F#P3(]RCI0^ 4,HJN
M.2TEY/5\W4K;[O(&*K9AHN1K3Y^ZQ-Z7QV4)(K%&]C5S-Y\./3:J;WPY''3$
M[6;I.):<04M1&*!.C%5JCJM:IJ_SV9["13%?5>V)0(^1-.R5ELJO'2OGRP(7
M(6=2>%GD[>TMCBL*T4>:G+5I0F*F\Y K+4)"UB%26H(4IBU)!A(1%,:/!UIW
M# ET<O3TRKF-0O,%\M.H(75W(;COQ\F?)NN(4U.3^9#[>JE@B;XL)>VX3JI4
MN_DF":,R6.2\]$XF% !(FH"/2=P2.Q"0<XI:A:HZINC>3VK;3#%5ZS(G4_2C
M40U\#N+G,CF)8E<\?#>1$&8'Q*Q!4/C@4X2AT3B4+F."QQ(0_P UD9:$O19Z
M@"!O=#F].>2-P.+ :488U'%PO2B23=&UX$];R+7<R.G!X=<8.+5:<I:_F$4Y
M'QRWYQX.KQAA4RTPJW\MD7M2:QG$2M7'7D]G6UNC?&A=(8V^M+6\ZTYH"!%)
MMJ0FZ$PRXG$X:4IKZ,*K?L)^)>4E:6)Q2E?*[C]*X];%>IJSLV=P>1MPG $=
ME*BNDLG3K4FQ'IT+B6F*DD7<65?UD$'EFI5.BOC" >QQ::=&J/)[RTO1E\N9
M1S@X)T3RQL&.1F#26TVB<.+\P1@]PW&6?<2LF:P@ T)[VK5KP)ST$6(<5.UJ
MP[R)ZA0'1OD0 ZA,<.C$X:UI3'NI/Z3J:QZ6+HX[FNA/Q[K#E[4,QMQ>ZGL;
M-&6QV< (Y(]$",#MIB4M6-B6&2]R4"*&% BC$A=E+F(/4W%JM[UU@X(DJN%I
M9]TJX721\&0\D"^(P.2=?*>1!DDU#/N<HC'E>H)FGD3SMPQ5(T32HAZ*8%^;
M*"#8LKD)#^2M(-0&MX%Q8D^@T8J:5'3/PT^,_L7Z2/@S-N1I_$J(\DZ^D?(-
M.]O\8,KUH,>5I@Y1%6]>Z26+IY,2TBAJN3L")J<S'>.I9$<\MYC<N3*D)2I*
M>26(T72M'3/JKW*[2;N"!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@$2^>5!OG*3AAR?X\Q9<F;I7;M)S^%Q-6N.VF;RY6YL"OPR6YJ-!$).U*'TM
MO3.AX0#$2WFJ3 EC$'0!"87HQ)Y-,PG]&ITC]BT9Q\XR\"+@Z/7G<V\H*C(A
M?'MX0,=%K%%3^'V-Y315%;"VU53FE8T,&;HEYO()&^A3*VX9Z18:R+'=G5(W
MDP=D4*;BB4<.BVVJO'.E-=:NG60Q@?!?I'>D0+Z3WD.U.-0T5 ^?UCR"I@U]
MRGI>S W 91U&@VP4@ZQ8TY2P[@)99(D)Q)ZEC6:5RF))9"H3*4B=$2(-*&'0
MUO15:J)4J\6FJ/5JUK46I<X%RPY@<6^@:K6?5YRNIJT*#Y82?CS<-A1*!3&+
MV/4K!7G@2/0NVF^1O,4<DC" BO"&!6DGSTB5L!\E9I"/SI<)M6]@<JPPN8TX
M6FJI.E'5UI@]F2-I3A+T=M'\%S;7D<#DEM6O;=[/K9(;FOF_IQ]T2W[%6LA2
MTIC3/DA):F%M*;&?3FY"0HVUE1"'M8+;@>NVF1;3#JBB<5*THM22HEX])KP=
M,]2G+>F>:%WOG#VG+#L-@Z6GB3'>+EF.,(BLD>X_"+68+"@\*<9G-G".M:])
M'T"ZB5!D51+7DU"29X@ECR(X].SK_)#L@T6EI-+0BJJO6GC1)]*\:E/\B>,M
MG< >D/A\F:Y=RKJ3BUOH_:DXOU=??&;BS"N5 FLZLR6)GDE33^+S"O+,!#BI
MTN9G6?+7!N9R5TB=GT 1*7)(IE!K8":BA=5"WI.)J*+1KI;5BLL4<\'!6,-C
M'\'_ *OK^H^2MK<=XKRMY.368-O)BBE<>DL1C;_+V:1-RFV*\1,ZAD@,,?GE
MI52>)(I66C3/L>5)G-:E+VN5MJ81I?PCJDVH5@]>*K1U=736UTLNOTJK4_<=
M.74FNW@&S<MX#S775?5M4DT]$^'JRZ>'O+ZME#NVFCAY+N@8U\:AQD7;%"M%
M,UARYH/1FQ\I*SM+8O7J)6L"!)JD6CHUK72I$JX/#IHN[LQ.XG]BWKQ$Z6CD
M]<EC</\ D99YW-7@Q2D'JY'QVKQ78L8'=S!%(JP2.NW:7 5IV",H6J2-3P6X
M/KNY[ QQ\IND3DF$TN:588"6E+2K"J1-NKI@Z8TVKZ=29!^L:4W5O17=%I*;
M%1<[N+',GCBKYQ2&@;8ISBU++B0U]*99>LO(<*WNRM#V12N2!MUB5L9T*"]-
MS2U/3$BD9YKT:S&J4#D.3=8XZ:+ABT:IQ4K1)U3JGAC7K1LT\-9=R?MOHPH=
M*^5U:;KSDO,J1LXR<0%NB0XFYC<E2F:HXLX+8*G) ;')7-HR&/RA_C!*-(<W
MR-_7H--+4<#;2C'6]%1^A?H4U1]!JY2G@-R6BW0Z\">8E"U%8R#EI053<@Z!
MO*GM0>4)K%L7C!R L6ZXL_,;I!.[/%+DMAQ,\/DK$BTS&&(F*8/,U\F<&.-0
M@-?C_D=FDG''"VM&)IJ*N":Q[F.IE7R^BN4M,0OH+^23JV<IJFK>CN(DMJ^Q
M9E2G'IINVW.--BRUL<S$\A?Z3L.%RP#6BFS6YM$:='U1$Q.;4C:5&DQI#UIB
M0N8A-5F+T+K%55BHHE5O6FETZZ9["I>0O#P+QT/7*>;<<8IS%OI\G/2 1?DQ
M+BKRXU(ZALV4*#CX.*S["J.F8S&&%9X >C%Y W!>TQAD1F&1V0E@9D$>BNE6
MP47HX:N&%*%PIIU6II)Q5?=Z.Z;0@K&8>2/ &Q9[4M9V/"6:QZ'NY)"ZTFU:
MN->6*4?IGFT:1HSZW&4)R;E,C<D6W*/)2R!G/;8[-3FF+'IS*#L=35'1[/#U
MK UY.CMNFR)3T2A?10-/%SFU6/*>1\7.8, CUASSCU)Z^HM%,9:CO"?Q= MM
MF0K6W4>W($+VV1E Z.#.B"5*7-,A),T(2=4,=L:6GI5A<-8:I--TP3P7A(\-
M+7+>4'%/HF.CTIOA%R1J+E/Q/Y)T?,[SL&=4!(*U@](M54^(2K7L)5:3DA1H
MU9MB/BUOG25 C4;521Q1E$F%J).3'42X'111Q.)--1)8IMUI14QP6&O518:D
M2BA[A;/'[I0R8IP 9.7KC .1O.Z4R_G3Q=Y%\5'5+2L#3.DJ,36-RLK#D0X-
M8&UH9G!&WBE=8ELTC7#D:4<83*U*HO3/$AB-<%8J80TAB46.O"%PUZ7LP2W_
M -XGK[:H3I((547!-DY>N_&"XN1-R6'R[XW<K>*CK$XAQ@>7,I2!SM2O.0SJ
MUIT^P/IOG),):6>1.Z=]:B&UM<G*4.,@3G$/'Q\>O7+Q@K%HUHM&)/%ZO0N%
M;5C5[,.DVX,'2, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MW*%S)D<QPIR;55+2;I6BK370VK,T26#& , 8 P!@# & 6"OKC=7'(QOB;?8
MI4DU$)&D?$*V&RU_ACJN;O.T!\AACLZ1U<@7+H5-4K<E:I>PC/"2[MQ8"^V0
M<42>4)3:U'5'\0N.A\BA,C^YJD3;KDN"@A<4;I#+FJKV(VKRT15:.!-/-L@2
M50J>*\"V-0H,^+X8K>(F:T,Y["N0'-#:8E"KQZ=?C\>9U!/"+BL4KL%493<>
M7%V>RSJ.2MJ=W"1O<< Q6@_$2NRFJ)19X>ET:KM'8$K2(I7-"J\:HMJ3RE W
M2-Y\]>F]$N(#2:I1TI35AJU=VG3TYEV*GIBMZ18W5@K:/GLR60/Q\IDKBZR"
M33&42J2J&YL9AO\ +9I-7B0S"5O &1D9&%,XR%]<U:-A9&9D2&D-34WHTXBM
M2Z. , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@&G[\*
MV_;\#_\ 1Y.?[^/N6$YB/OI_(O[5*U^2&^]'\N_L<U <L(5K& , 8!L.?!F/
MWPZ6?ZL=D?UYJG-1<]7K1L_NW8OFMO-T<Q'KTM'N#;OG=W&_)E5"X P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & >=A\(3_?2+I_F=3/\ 99%\M[S1
M^L>[N^;Q^?3BE7/-_&!>O>UU_JZSF$[-EFK!@# & ;G?P5?]S+F-_/NH?ZOS
MG*X\^OW;R=[UO#Y:REH/(^>I_*;OR[OD+4;8N:%+$# & , 8 P!@# & , 8
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MRYC?S[J'^K\YRN//K]V\G>];P^6LI:#R/GJ?RF[\N[Y"U&V+FA2Q P!@# &
M, 8 P"R-]<B*IXV0XJ:6K(P-"->OTTQYD1 "X2J7O.DQ[@<SQ&.EF@7O[BD:
MD;@]N!"$ ]-K&VN3PO&F;D"E06)2;U'6KN5/'1MFT&KM;<4(*E]E)HXJ@S8%
MV"<1(03)(H7PPA*\$ -9"5\T1I%*F'-BQR3.,K*)&*/I7'XNL*.E::L&<%EY
M=\:I 99@6NX8D8EIM)-5UH/*LY:UQJ%(ZX?%D:G:AZE+HB11LHJ)O[>O:GP1
M+J=Y@L0K"CNSYJ?LL*/51UPZ\5OV%P*IN>K[O87&255,FJ8M3*^*8P^B0Z5I
M7"/2-(B;W0]AD3*Z)D+U'WC32[L[P6VO+>A5GLSPT.Y!)C:Z(%2@&FM:H7.P
M0, 8 P!@# *4GC:B>(-,VARBRB<MSK%)$VKX2C/;4JN8(ES.L2JHLE5/+HQL
MZ91("#3&D@]U>FAM)-5A,7.C>E":K) Q*41JZQT3R*9FVK^1T\XW-];Q6#<6
MZUO75$/7(EGG[0NLB!6"QM#RPSD*)\J6!"05H="Y;;4R<+/4N+?/'1#(99%P
M0MP7CDZ46*KC6E:4PILUZZTZ-N!0!=:<BV2M8,L!Q8LZ6NDTZ,,/"Q7!37BH
M4KG7MQQ8!C84*;C<;-+94=9V6%[&I/E\><I&-O:X.F%(&5(M7LC>J"JKK6$3
M:='MVY[%AAK)'2"+7% 9/P_F2:D;2LQIXD(9Y1LQ0QU969LFGI$JH>ND+-?=
M=MC]8S0G<XH7*V1TKE:FD3G&)\B5/;^[&13PHF->505P:KKH]O3@\-?<W["#
M\(X?\GJ]IFU./+G23Z\O7*6 \8BFR=QZ2UXL@M .4=FCZXV%#)PY+9>VOA)%
M&MSD"41-9"(_*6R9."DYOAYQCF T&A+:UIZF\\:I;LEBJ*FTV)\' 8!3HV->
M(8A:EDB!H0A"T !4:[(-;WO>@![<<&/LAU\0>V,0NK6NT(6^O>YJLEU\2*/-
M]7 _/<+AZWR3Y*,>[6*K)=?$4>;ZN [A</6^2?)1CW:Q59+KXBCS?5P'<+AZ
MWR3Y*,>[6*K)=?$4>;ZN [A</6^2?)1CW:Q59+KXBCS?5P'<+AZWR3Y*,>[6
M*K)=?$4>;ZN [A</6^2?)1CW:Q59+KXBCS?5P'<+AZWR3Y*,>[6*K)=?$4>;
MZN [A</6^2?)1CW:Q59+KXBCS?5P'<+AZWR3Y*,>[6*K)=?$4>;ZN [A</6^
M2?)1CW:Q59+KXBCS?5P'<+AZWR3Y*,>[6*K)=?$4>;ZN [A</6^2?)1CW:Q5
M9+KXBCS?5P'<+AZWR3Y*,>[6*K)=?$4>;ZN [A</6^2?)1CW:Q59+KXBCS?5
MP'<+AZWR3Y*,>[6*K)=?$4>;ZN!J'_"ID"A$/@KY=W<G7RH>3/8[P UA\AV-
MT!VO(]VMK=U^5[8?*>6\MU>3!Y/R?69V["<Q'WTX)>HN?_NN;96SR0OWI8U]
M7<O_ &?)(U$\L&5K& , 8!L(?!IDIRSI")640X+6P>N,UCC\X0A0B.V'4XJO
M6RMZ<$2\CR8MBT(6]$Z,ZPA[)@==K0M1<]7K1L_NW8_FMO-T<Q/KTM&-/_ ;
M=E[+N_-,WS.X7#UODGR48]VLJK59+KXEOZ/-]7 =PN'K?)/DHQ[M8JLEU\11
MYOJX#N%P];Y)\E&/=K%5DNOB*/-]7 =PN'K?)/DHQ[M8JLEU\11YOJX#N%P]
M;Y)\E&/=K%5DNOB*/-]7 =PN'K?)/DHQ[M8JLEU\11YOJX#N%P];Y)\E&/=K
M%5DNOB*/-]7 =PN'K?)/DHQ[M8JLEU\11YOJX#N%P];Y)\E&/=K%5DNOB*/-
M]7 =PN'K?)/DHQ[M8JLEU\11YOJX#N%P];Y)\E&/=K%5DNOB*/-]7 =PN'K?
M)/DHQ[M8JLEU\11YOJX#N%P];Y)\E&/=K%5DNOB*/-]7 =PN'K?)/DHQ[M8J
MLEU\11YOJX#N%P];Y)\E&/=K%5DNOB*/-]7 =PN'K?)/DHQ[M8JLEU\11YOJ
MX#N%P];Y)\E&/=K%5DNOB*/-]7 =PN'K?)/DHQ[M8JLEU\11YOJX#N%P];Y)
M\E&/=K%5DNOB*/-]7 =PN'K?)/DHQ[M8JLEU\11YOJX#N%P];Y)\E&/=K%5D
MNOB*/-]7 =PN'K?)/DHQ[M8JLEU\11YOJX#N%P];Y)\E&/=K%5DNOB*/-]7
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M?\O',FI@@8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M#,?OATL_U8[(_KS5.:BYZO6C9_=NQ?-;>;HYB/7I:/<&W?.[N-^3*J%P!@#
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M+!%(RRLS0Q12)1]G(TG6.QZ)0_O+X[.0ANO<6I9%\,$# & , 8 P!@# & ,
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MM3AD]ZX$8YK<^)^?-)=Z=8/9A?[TXPR>]<!CFMSXCS27>G6#V87^].,,GO7
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M_>G&&3WK@,<UN?$>:2[TZP>S"_WIQAD]ZX#'-;GQ'FDN].L'LPO]Z<89/>N
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MGQ:<V8I5Z6V3+THL*Z$J7!!#E#"D92,P<V , 8 P!@# & , T_?A6W[?@?\
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MN;T@]FI4"-,9L.P;,3I2"1[!O>M[#L98 B[.]ZUO8>OJWO6M[U\6L"B6I)>
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M5/\ C0<D/^_JX/[0I%E\[B]0[F]RKN^:23\[^4/J_?GNQ>?SV>6%SU3QQ@#
M& >CCT _[U)QG_Z_=_\ ]P%H93OG6]?E]_BW9^J+ 7;YGOXO+B_'O;]<V\S'
MYKLV:, 8 P!@# & , T_?A6W[?@?_H\G/]_'W+"<Q'WT_D7]JE:_)#?>C^7?
MV.:@.6$*UC & , SW_!S)>CA//:5O*U*I6$[XWV$CT2EV5HWMGS>KQA'UG#
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MZ=Q-E[\Q(S<8 P!@# & , 8 P!@# & , 8 P!@# & >=A\(3_?2+I_F=3/\
M99%\M[S1^L>[N^;Q^?3BE7/-_&!>O>UU_JZSF$[-EFK!@# & ;2OP>?]SKDQ
M_/6O/^!23-:\O/NB[OZFT?VY9LOD']S7A_7R?DXS8KS 3/1@# & 7]X\?X7/
M'\W#_P#B;7F&\MO4VS=_0?-[09_S=^JUL]SH_G-F)AYK$W", 8 P!@# & ,
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MUMF'\M_4>7W])^2M!F'(CU8F=XSOE;.;B&:G-L# & , K>MO\/8I_P!LI/\
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M .CR<_W\?<L)S$??3^1?VJ5K\D-]Z/Y=_8YJ Y80K6, 8 P#-AT"O^.I*?\
M5_G']<ZVS#^6_J/+[^D_)6@S#D1ZL3.\9WRMG-Q#-3FV!@# & 5O6W^'L4_[
M92?_ %;SR;]]1[Q[UF?$>YR:]7[J[\E?29"<TJ6$& , 8 P!@# & , 8 P!@
M# & , 8 P!@'G8?"$_WTBZ?YG4S_ &61?+>\T?K'N[OF\?GTXI5SS?Q@7KWM
M=?ZNLYA.S99JP8 P!@&TK\'G_<ZY,?SUKS_@4DS6O+S[HN[^IM']N6;+Y!_<
MUX?U\GY.,V*\P$ST8 P!@%_>/'^%SQ_-P_\ XFUYAO+;U-LW?T'S>T&?\W?J
MM;/<Z/YS9B8>:Q-PC & , 8 P!@# ,9G,JRND(8)RU1OCBMX-434;D;#HT5?
MW+J>3)S>I;9,Y<SFAGKRM:JB&HTAW(S7(3:VLVI-,U)\L<G,*!B8#E!(0G#E
M"H=NDWCA"M26UMU^+5M+'US972OU[>#%55CVIT9O*@05; XV+5\#DD[H/DY#
MH$[N2!(Y3YDBCLYSZ//+*PMJT3SI"]M# 8^Z)(;V]])/7%&!$M04JE&LFZ-/
M#5@E2KVX]S+-'@X&)^Q>9D$9.D+LWASRJF%'5SQ_<.)]<3^L(Y=:>-M;=>TO
ME$_F[58JDF4SEP3Q5S1P1KC#$SAKPM&>YK1N[I)#MJ4:#0$(Y*%Z*:J_1-8;
M*)-;ZO<6)Z+C7%=LYR]*'&>&,-I5%1C1OB.<7../X#TU;KIROB%JGS* )"F%
M_7U0XN$,<]C=E#G7+$QJ$>I?N+RTUQ.C[)YF.4>DX87$W7'!K&F%'5XM/=@]
MM3.M@ZQ@# (J2SDVH;N0C%0$"J2>6@M:10ASO68QP^*((]1T1M!/.4-=/KPE
MD,B:)!+SWR30TTIT;H0S/VXO%-.<H?5"3S1 V.HE+"M::Z=-"5>"!@# & ,
M\GGE3_C0<D/^_JX/[0I%E\[B]0[F]RKN^:23\[^4/J_?GNQ>?SV>6%SU3QQ@
M# & ;P_0Y?O==!_]9MG^VFP\TURL]7[=W++\SLYN;DIZ@V'_ /9^=SS)SF.&
M1# & , E]QV_P8>_^WM_\/19K/EOZH63O-?+S3<'-WZE6WW0B^;6<D%F%FP!
M@# -/WX5M^WX'_Z/)S_?Q]RPG,1]]/Y%_:I6OR0WWH_EW]CFH#EA"M8P!@#
M,V'0*_XZDI_U?YQ_7.MLP_EOZCR^_I/R5H,PY$>K$SO&=\K9S<0S4YM@8 P!
M@%;UM_A[%/\ ME)_]6\\F_?4>\>]9GQ'N<FO5^ZN_)7TF0G-*EA!@# & , 8
M P!@# & , 8 P!@# & , 8!YV'PA/]](NG^9U,_V61?+>\T?K'N[OF\?GTXI
M5SS?Q@7KWM=?ZNLYA.S99JP8 P!@&TK\'G_<ZY,?SUKS_@4DS6O+S[HN[^IM
M']N6;+Y!_<UX?U\GY.,V*\P$ST8 P!@%_>/'^%SQ_-P__B;7F&\MO4VS=_0?
M-[09_P W?JM;/<Z/YS9B8>:Q-PC & 1FY(\BCZ-2PM@B-:RJZ;CM-Q?FNK:F
MB*^,,+A*38FR&R>7."V43=\C428&F.1Y.:N5'.+R%>O4&HVUF;G)8IV H2E7
M;1;7ENQ?<)#LSCMX9VIW$W.30)T;4+B)I>4X$CPV;7)2E.VYU2E'*2DSDBV;
MYLN3EJ#P$JBC2P'&A#H8A!V6 , 8!AHZ7ZJ(L5%*)Y6I+[IZB[IXX7G6LPJ+
M]57=\QKOBM9,@CALJ>MUW-(R1)DT-\:.K(HDSO%)RCBR^?-(V(2%&[((Z-T.
M1CG#K:HVFL=%5B\&I]W&F=3$QQRXW<?[@L'C_/X_TF/"A%TG=D<N[BY+WI>W
M&NUJQLBXAMLVJNQHHQ\;..K#/6J8-\HK-D:72/@=8[-8X:U(&J/O2AG:W X2
M,\(Y-M)^@BT-%)*).B=5Z)ZE5XXK:S;Z[ O_ &QG^PKZK!U%@^0'%+C5RK9&
MJ.\D*+J^ZVEA4GK(^38D/9I(HCRI6$H"Q1'W%<E,<F(U<6004N&TJT>UI1)1
M2K9Q98 Z$IM:FUW&533-$TOQUA"6MJ&JN T_ D:I0X%1.NHLSQ-D&Y*PD@6.
MJI&SI$I:YW6@3D!6NRWSAQ6:)*\Y4F^3!V0;;UMONXEU\$# & 8U^3O'BW+D
MY'U4ZPN UA"28V9$)8EYDLDME<=O:O8_7-E0612BA3XPPM*0FR([=#.X3!L0
M-<EFH:T:&DR6+I7"GEV S(Y()3HL^C9BJ5\&_51Y3GKZNF^N4KVD;Y-8,F ^
MOBE^..L&>2:>*F\Y4644)N9%,F<' YF8R=$Z&F9D R4"<P9IA9(1FCWL07!P
M!@%.CBC$,8AB2';$,0A"WIP<M:V(6][WOJ"LUK77O>_BUK6M?>UK6L''1ARZ
MWQ/SX18/XF=](N?YY@:$.76^)9U9Q*XP."M4O7T!4:Y<N4'K%JU9!(ZI5K%:
MDT1RE4J4G(!G*%"@X8S3SS1C---&(PP0ABWO?HPWO>T$,,$%Z7C##"E####;
M;3####"J*&%*:DDDDDDDDE1'FQ7)<T<44<=TW;''%$XHHHK%9HHHHHG6***)
MRVW$VVVVVVW5XG'_ %'W%7^3M3?]'L9^SLGRYOCVUO+X=:OM2/**Y/:B[/@-
ME^R'ZC[BK_)VIO\ H]C/V=CRYOCVUO+X=:OM1Y17)[479\!LOV0_4?<5?Y.U
M-_T>QG[.QY<WQ[:WE\.M7VH\HKD]J+L^ V7[(?J/N*O\G:F_Z/8S]G8\N;X]
MM;R^'6K[4>45R>U%V? ;+]D5\R4I4T:;$S+'*_C,?9D?EMI&ED;BFIL2[4'F
MJE&TR!!Y!*1Y=2<<H.\D4'RIYIIP^T88,6^B.\+?,B<<RVVN9&Z5BCM,Z*)T
M5%6**-MT2257@E0[X+KNV7"H)=@L<$"K2""S28855MND,,"2JVVZ+%MO6SM?
MN90+U8;O]A_UV<>W;9[+M/O\WZYR\K[!["LOO$KZH^YE O5AN_V'_78[=MGL
MNT^_S?KCROL'L*R^\2OJC[F4"]6&[_8?]=CMVV>R[3[_ #?KCROL'L*R^\2O
MJC[F4"]6&[_8?]=CMVV>R[3[_-^N/*^P>PK+[Q*^J<Y+!8HA (M$T 1EC%VQ
MEI52Y. 0^K0>V()2H 1"[(=:[6];WU:UKKZM:SJF39LUJ*;,F38DJ)S(XHVE
M6M$XFVE5MTU59W2[/(DIPR9,N5"W5PRX% FZ)5:A23=$E5XT2.3X18/XF=](
MN?YYG6=FA#EUOB/"+!_$SOI%S_/,#0ARZWQ'A%@_B9WTBY_GF!H0Y=;XE%3"
MB*;L+N[Q_6L0G'='G?=/C!G32;NSS_S;S[N[OH*WS+SWS-'YWYMY+SCS5-Y;
MM^0*['TV>VVRR:?:EKM-E[)H]D[7GS9.GH:6CI]CCATM'2BT=*M-**E*L^6T
MW?8;9H=MV.RVKL>EV/MF1+G]CT]'3T.RPQ:.EHPZ6C32T8:UHJ45^H^XJ_R=
MJ;_H]C/V=GT^7-\>VMY?#K5]J?-Y17)[479\!LOV0_4?<5?Y.U-_T>QG[.QY
M<WQ[:WE\.M7VH\HKD]J+L^ V7[(?J/N*O\G:F_Z/8S]G8\N;X]M;R^'6K[4>
M45R>U%V? ;+]D/U'W%7^3M3?]'L9^SL>7-\>VMY?#K5]J/**Y/:B[/@-E^R.
M^CO&?CY$%PW2)TS7,7<S$QB,QQCL4:65<8C-,*--2C5MJ9,H$F--((,,($9L
MH9A)0Q V(L&]<)EZWG-AT9MY6^9#6NC,MEHCAJJT=(IC555XTKBSG+N:Z)46
ME*NN[Y<5&M*78[/!%1TJJPRTZ.BJJTP16OW,H%ZL-W^P_P"NSI[=MGLNT^_S
M?KG=Y7V#V%9?>)7U1]S*!>K#=_L/^NQV[;/9=I]_F_7'E?8/85E]XE?5'W,H
M%ZL-W^P_Z[';ML]EVGW^;]<>5]@]A67WB5]4?<R@7JPW?[#_ *[';ML]EVGW
M^;]<>5]@]A67WB5]4^A5;P<@P!Q$=1$G%BT(LTH2DLPL6OO" 8 \(@BU_!L.
M];U_ER(K5:HX7#':;1%#$J10Q3ID4+3UIIQ--/)HY0V&Q01*."R6>".%UABA
MDRX8H7FHE"FGTIG9^$6#^)G?2+G^>9\Y]&A#EUOB/"+!_$SOI%S_ #S T(<N
MM\1X18/XF=](N?YY@:$.76^)'CEWHR \3^3T[AZE<Q2V%<>+JEL6?$C@N&J9
MI''*VDKPR.J8*A0<G$H;G-&E6$A/)-)V82'1I1@-B!OU^3]GDVN_KDLMHEJ;
M9[3>]VV>?*BKHS),ZVR9<V7%1ITC@BBA=&G1X-,\7E).FV/D[?\ ;++&Y-IL
MERWK:;/-AHXI4^189\V5,A42<+<$R"&)*)-56*:P/.__ %VOI'?Y6MF_DY]@
MY;OSN.1'X/6/\^U?;E+_ #SN7GX26SWJQ_NP_7:^D=_E:V;^3GV#CSN.1'X/
M6/\ /M7VX\\[EY^$EL]ZL?[L/UVOI'?Y6MF_DY]@X\[CD1^#UC_/M7VX\\[E
MY^$EL]ZL?[L/UVOI'?Y6MF_DY]@X\[CD1^#UC_/M7VX\\[EY^$EL]ZL?[L/U
MVOI'?Y6MF_DY]@X\[CD1^#UC_/M7VX\\[EY^$EL]ZL?[L>D37,59WFO8([N>
MG16Y.L-B[DX*AR&0!&I7+F1"J5J!A+= %A$<>:88()8  UL6]!"$/5K5.[9'
MV.UVJ7!!*A@EVF?!!"I$FD,,$V*&%8RV\$DL6WF7;L,J&;8K'-F138IDRRV>
M9'$Y\].*..5!%%$TIB2K$VZ))9(K+P'&?XLY>T4C^UL^;LT>4KWB1]F?5VM*
MSF_")_VH\!QG^+.7M%(_M;'9H\I7O$C[,=K2LYOPB?\ :CP'&?XLY>T4C^UL
M=FCRE>\2/LQVM*SF_")_VH\!QG^+.7M%(_M;'9H\I7O$C[,=K2LYOPB?]J<H
M$.CY8 @"D4[T'75K8W5W-']_K_9&&+AC%OX_OB%O?5\7WM:SK;<3;=*O)*%>
M!0I)>!([%+AA223HLXHHGX7$VWX6S]>$6#^)G?2+G^>9!.A#EUOB/"+!_$SO
MI%S_ #S T(<NM\1X18/XF=](N?YY@:$.76^);.2\:./LS=SW^84U7,K?E0""
ME3W)8HTOKNI+2D@3IBSW)T3*EAP$Z<LL@@!AP@DD@ 47H( A#K[9-Y7C9I:E
M6>WVV1*A;<,J3:I\J6G$ZQ-003(84VVVVEBW5XGPS[INNTS'.M-W6&T38DE%
M-GV61-F1*%)0IQS((HFH4DDF\$DE@=#^H^XJ_P G:F_Z/8S]G9V^7-\>VMY?
M#K5]J=7E%<GM1=GP&R_9#]1]Q5_D[4W_ $>QG[.QY<WQ[:WE\.M7VH\HKD]J
M+L^ V7[(?J/N*O\ )VIO^CV,_9V/+F^/;6\OAUJ^U'E%<GM1=GP&R_9#]1]Q
M5_D[4W_1[&?L['ES?'MK>7PZU?:CRBN3VHNSX#9?LBK8UQ]I"&%*B(?5D(BA
M*XPHU<3&F!"Q%+#20C 28J+:RTH%!A0!C"4,[0Q%A&,(-ZT+>M]4R\KQG-.;
M;[;-<-5"YEJGQM)ZTM*8Z5VT.V7=-UR4U*NVPRE%1Q*79)$";6IO1@5:;*E3
M?<R@7JPW?[#_ *[.OMVV>R[3[_-^N=GE?8/85E]XE?5'W,H%ZL-W^P_Z[';M
ML]EVGW^;]<>5]@]A67WB5]4?<R@7JPW?[#_KL=NVSV7:??YOUQY7V#V%9?>)
M7U1]S*!>K#=_L/\ KL=NVSV7:??YOUQY7V#V%9?>)7U3DI:^AR$8C$3&G1F#
M#V!&)3EB<8@;WH6P"$4I +8>T$(NSO>]=>M;ZNO6LX3+1/FI0S9\Z;"G50S)
MD<:3HU5**)I.C:KKHWF=DNR663$XI-GDRHFM%Q2Y<$$3AJG1N%)M52=-54GL
M.=X18/XF=](N?YYG2=VA#EUOB<U"PM;:=M0C3F%';+$5L0U:T_78%L(A:["A
M0:#6][ ']EH/:UU=6MZUO>MB5"EJ7QG;X)(5\VZPF%KPB&QF,T#3?()*9-&\
M"]JM:826NW*MUSB,EH;+@@4[B4=D4DCKQ T2]\6.9D5W'IDM:E)B2,2=L5C.
M(7"5W6NOP-=.[/HN!0%!/M2QRNS9U<UJV_9$:IN"UE-)-*)Q*SXC-'^+QV.-
M+U88*[<'MS86F4R9Q8#'5:\_\M?CC'5T$XO#BL<G):K!NO024P0, 8!CCZ4N
M-\GY1Q86(>(M)<:;\MY--&=<GA/*)ICKY#TK"6QR9.X2&%MLP<F6'J+-0+%3
M8CCWBIY;6,#4XR$:LU2()3<M>/CXHY0Z-5I5IT:_\L]IA&Z-^GN&2+EW3\EY
M?//(Z&](XTN#XIJ>IKMX]P?B31PI,"-.Z5\<J#B_'5C.HRP_-&0YY(;5[G:T
MP>7)(24N+8B'1(<,H<XFZ/1:T7KHVW2N&DWBJOH2V9&VK@ZA@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & 1
M6YU_XD7,?_56Y"_V1R_/=Y+^N;D[[NW1^L+.8]RN]:G*?_X]?7ZMM)Y5&7K/
MSX& , 8 P#UP*F_<KK3_ +OX;_5QMR@5O^[K;WW:?EHS]&[M]3K!WE9?D)9<
M#/D/M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , PV=)Q&+
M5M QNK6R.C"9^D.XBI%L;L!O+@=^MD"MR$V8SMTF8E2QSK63FQ F6(0M4B6I
MV-5$YT>H 2Y+@NS+L025"<<X6EBHW"^XZ4\%7X*9=T@#Q8XIQ9DO^J+&XQ]
M,=Q@?H;,FM:KY <F>1J.)EURSJA";).ZQBLXY+;1D\ZD@HNN>DS E[M;F<IT
M.2G.+LB+"$6QRBB=&G,TJK4DW7'4ZTIU]S/:1P=0P!@# & , 8 P!@# & ,
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MZG6#O*R_(0%?]_KO5*2_D][P9\A]H[_7>J4E_)[W@P!W^N]4I+^3WO!@#O\
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M!_/*(WE,8;!6VLT]FO=9@D+R;?T/H:0UG%K[DL.#&UPHUNN7>W$X(<I3LLO
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M_P"PHJ^ M4\=)QPW:NT%/9+H^C!U]8&>"3;?7O7\ 371B:TX^O\ @$$[8/\
MWNK/!M'/7S=2*Z%\S[4U_)L]UWGCW(I]ED0/NZ5.FA\\5]W=#JG11_BRIGQN
M&%=9:IWZ7CC0BV(MJC%NOYW7U%;2QR-HDQ@NOJUK9CC,$ZH/7\75U(A[^/\
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MON#]2+TA4C_PMYM;9>W_ ,YX.42<KL]?W_)=V-\*ZOO[ZM!\E_!U=7\#SO\
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M7KJ^]OSQ6UGJ^O\ AZ]G;^/X_O\ QY[UGY$<C;)1R.2O)Z"):H_*BP1S%_\
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M/&&&S6NS0PZH4E1+R9UQV2-Z4ES+-'K3EQ.*%//1B;:S]#'"6M^YITG7'/\
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M)ZDBVV6TT[#/EQM_R-*D?YD5(^JA?',G/J& , 8 P!@# & , 8 P!@# & ,
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MO7#'Z*%]U.J(0V'T6_&&9Z.5QY%**U?1#V>0Y0]X!I"!3K>Q%C&PNB9<VE$
M%O6_(-(6@?[$.BSRMZWO>JK\YD^1%[.*=8[-:;AM;]%#.NF>X)*C_DMV.>IU
MGAA3IZ&S*S-T5(DZM^7/N2PSJQ0016>/9%)BI#7\1UA7<AT>Z6/6\:>D3H4K
M_P!"/((NY8LAWO::)3-<-&[B3@ZMEHDR66JW)O1I@@#V.RV3=HWL77Y%.7H>
M]!QCS'\[_)''DQRJE<IK!+])=U[1)3W L89<$%XQSI4J!+"EGO2S-O5 DW3Y
M>T[WLB_V6UJTRUJESL(J+&BTW%1;/0S8=>HXC=TA%@U:N3L/+*A[:KM6(S1
MI/%CU F=:;^U$8WM4D*(2JDH-Z$,2AKF;UV@:%HHHP8.H?9)YY[VN.;!9>7O
M(N\[GC<2@=NL,N9VM,BVQ2I%L<$$R6J-N*1>-IJD]&%N&CE7Q-D-07A8YTEZ
MNR2W$X'W%$TOS9D7<)OU7R>XWW+YL1![V"<[J>P$N./KWX6D@CA=6MIR&:1(
MVU6X&%BWV1C:@KT^]_& \8-Z%O9UQ<X7(WE'H0W9?UBBM$=*6.U1NPVQQ/7!
M#9K6I,R;$G@W(4V#:HFL3TY%OL5IIV*T0N)_R(HG!'W-&-IO_P#&JZ22WAS?
MI^2?20/S;,S/LHNG>^(\.;]/R3Z2!^;8%%T[WQ'AS?I^2?20/S; HNG>^(\.
M;]/R3Z2!^;8%%T[WQ'AS?I^2?20/S; HNG>^(\.;]/R3Z2!^;8%%T[WQ'AS?
MI^2?20/S; HNG>^(\.;]/R3Z2!^;8%%T[WQ'AS?I^2?20/S; HNG>^(\.;]/
MR3Z2!^;8%%T[WQ'AS?I^2?20/S; HNG>^(\.;]/R3Z2!^;8%%T[WQ'AS?I^2
M?20/S; HNG>^(\.;]/R3Z2!^;8%%T[WQ'AS?I^2?20/S; HNG>^(\.;]/R3Z
M2!^;8%%T[WQ'AS?I^2?20/S; HNG>^(\.;]/R3Z2!^;8%%T[WQ'AS?I^2?20
M/S; HNG>^(\.;]/R3Z2!^;8%%T[WQ'AS?I^2?20/S; HNG>^(\.;]/R3Z2!^
M;8%%T[WQ'AS?I^2?20/S; HNG>^(\.;]/R3Z2!^;8%%T[WQ'AS?I^2?20/S;
M HNG>^)S4#1M"=L[;H[K>LL1?DEZP)Y.NT(.^WH&B2]Z,UV>H(NU\6A"UU?'
M\04IGO;^-G;X)(%<[8\!S9:H>F^H>0<]FK)-SV^N; XP3V%02UJAF<S1DQ)O
M=SSY]+8M%7>O9 F=%:&=HY2FFD-1HD")UDT%>B$*58U"5X/"J_0Z=U4?26DX
MZ[O.K[LMTV_X^;;G("3<+>$\J>"*Q!$FM-9$XK=1=$2N-BKM1.'JNX40&*V$
M^H)8:6ZO$09TB:TF-4F*;1. &].)=-FK2=*[%A2O=\.IEGZ#J_E+2\1X,V"L
MXJV%(Y5QUXR\@>+,_IXFQN.B24C=[.=>,\XC%J1E^/N@VNUD! Z42YPY]"IE
MZ*PTA4B)=D<#7HD1A*X'3'%8NNWIPU:\>YTEM*?X-\EJ<J$/$A57I4N9K GO
M1QV,[\@&*805-7E9)N*M?\1(C;435QQ^DS5:ZIS)6<57)SI\$4@,B87!78;(
M.1/L2TUO9Q(EQ5==6$2HJU>DXGW/Y5'CJS,DO Q*K,J"?RO91J>/V5RDY:V7
M!2#0"+ ? YAR*L9PB\C2 %K6N[9^@UJQVLT.M>=-TO2JS A//-#H<8M?@6^B
MZUJ\!-;! P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MC]_RCC1R9,F4<1]8DT L/8B"@IP_%IO;T#[J3Q39@PZT Q6G.B(MZ_9EC(&
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MPQ0NJ::P::::P8UZR'MJ<".+-M^<J7BL6R,/2GMBW(*_%X-<0G&=?;4F)&L
M6!>I&+?;&>[,K@,8_P!D+>][%UZ]OWFJY#<H-..TW)(L5ICJW:[I_P##IRB>
MN.*"0E99L;>+BM%FG-O%ZW7SI]U6&T5<4B&")_RY7^KB[K4/H6_QH6:WW+VE
M6?CW?,LJI@?'B0LT?1QQ0W.+]YKMT\V>6!N=PI%(D12=*9YGM:), PA,F 8
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M4F DJ5>:6#2?6MQ'BO.=5YV<5!^0#2" ,E!2;E#1_&8^GUD1=UMB[0W%":W
MIL/=F:EZ5 D?8]:MEHR4T;U7ZAH55S'EABE3J0/9+DQ/'QRZPU3#;2M:X=:Q
MPZ=9._AW9DLM6AF5ZGSD![GD/GEVTC.)$! WM>I5+^.MWV)0<BF&VMI3(FAM
M%,76ME4I$WM*)$U(A/&TK<B1HRB$Q0AJC\">]5^DD]@@IP<J: #$ 07CM $(
M(NS&Y&,/6'>];[(P-(@"UUZ^(01;"+7QAWO6];P#\^+6;\%Y]F9+]D8 \6LW
MX+S[,R7[(P!XM9OP7GV9DOV1@#Q:S?@O/LS)?LC 'BUF_!>?9F2_9& /%K-^
M"\^S,E^R, >+6;\%Y]F9+]D8 \6LWX+S[,R7[(P!XM9OP7GV9DOV1@#Q:S?@
MO/LS)?LC 'BUF_!>?9F2_9& /%K-^"\^S,E^R, >+6;\%Y]F9+]D8 \6LWX+
MS[,R7[(P!XM9OP7GV9DOV1@#Q:S?@O/LS)?LC 'BUF_!>?9F2_9& /%K-^"\
M^S,E^R, >+6;\%Y]F9+]D8 \6LWX+S[,R7[(P!XM9OP7GV9DOV1@#Q:S?@O/
MLS)?LC 'BUF_!>?9F2_9& /%K-^"\^S,E^R, >+6;\%Y]F9+]D8 \6LWX+S[
M,R7[(P!XM9OP7GV9DOV1@#Q:S?@O/LS)?LC 'BUF_!>?9F2_9& /%K-^"\^S
M,E^R, >+6;\%Y]F9+]D8 \6LWX+S[,R7[(P!XM9OP7GV9DOV1@#Q:S?@O/LS
M)?LC (AVSQ%XK7;.'2Q;$ATM=I6\$-J9>N2GV6U$FE-+>G;$(0HFTM,D*V6C
M2DEB$62'9@@[,,V(8A"WK^_^;#D;RFO.??%\7=/M%OM$$F";-@O"W2(8H9$J
M"3*2E29\$N'1EP0IM0IQ-5=6VSS[1==CM4USITN**9$H4VIDR%4A22PAB2U+
M(IR&\&N'<!EL:F\8@LQ12*)/C9(F-6<OM)84F=F=84N0'F)%7E4RD!2D@L8B
M%!1A)NM; 8 0=[UOX[NYH>0EU6^Q7G8;KM$JV7?:I%LLLR*\[PF0P3[/,AFR
MHW+F6B*"-0QPIN&.%PQ:FFCA+NBP29D$V7*B4<N)1P/LLQTBA=4Z.)IXK4U0
MF_XM9OP7GV9DOV1FS#TSCJI%'%I(TRU(XJTYFNHQ.JB<A4$F:_R#*-9AEBU_
MT"#O6<(Y<$R%P3(()D#UP1PJ.%]V&)-/PHAI/!I-9-5+4O\ 5?'"5=O<DI:"
M/9AG7VCW*FBU2K6Q??$!6;%!*2Q[_#+-"/\ Z<\*U\D^2UNJ[9R<N*TQ/^7/
MNFPS(\<ID4AQI]*B3.B.R669Z>S2(OQI4MO>X:EDW_A-PCD?;VLI I$8/KZC
M&!!9\;\F+?\ _8!+">WIOBZ_B"(@1?\ E!O6LQFU\TO-Y;*N9R9LLMO;9;1;
M['1YJ&RVN3!X'"UT'S1W3=T=:V6!5_F11P4[FA%"NJF]EDG_ *,7AX[]O;:.
MY8L(77V-,JAZ5E@W_!^QDD+?S!!UO[^MFZ%O7Q=O6_V6L:M?,'R$M%>PN^K"
MWBNUKPES$NBELLMJ;6STU:;:XGS17!8(M79H/Q9B?]N&,H3];8;([^Y?RHO>
M"=C?6GUX3E"OR75\8==J/*X=\>MZU^R $'WNO0=?>SR_.*BL?J'RZY0W73TB
MT7'HY8V.UW=O26=-AU>43@_@+?:966W^Q'+/Y^IJYT1+_ 7FW(G_ $5_S(9V
MPV>8$6M?M=& =F*P0ZU_!V=Z-#K7Q:Z]8\[WG9L'J7SF1VO1]*KTBMT2=-2B
M5HAO9)?G884H/*^]I?\ !7FX_P"MT_!72[-E_G5G][XZ5^'?$"05W:0"?B"'
M<51(_+A#][6S#X=7IV^UK7[8TT ]]?6(?7U[QV#R0-W:K7R>OU0ZEHW=*TDJ
M[8K-=$6.<42>JKUC1Y02_P"79I],U+5>E^AE?YG+3<N>D<C.]!F/$!KD0"OB
M&.)L\G"H-T'?5O?E&J32\@0Q=6^H1*30/CUL)?5U:R/-KST7?A>7-[8[:H=;
MNWLTR.)+ILEY7G"V\X9:64-2.W;ZE_PEW01TUN7I5?<T9DSJ7@.X#TFUCQO6
MM6=POMN)!+_Y]66>^!+WK7QB&%*_P-B"6'6NOJT)Q,UO6NORG5]Z?/JOFQ87
MYS;<H+O4/IYBBM26%:M2[7=5E4*Z'.>W' GRZG0?PUVVF736UI4_ZI4&ZN>)
M4K'TNG&M>/1#[&;:BZ@(NP=M;'&!P2%"U\0M>4;)2H7"[.^O0M";2Q?%\0=[
M^+/LLOD@.1DUZ-JL5_V&-81=EL=DFRT]J3D6Z.:Z;:R8>BIRAY06)X1P6B6]
MM8(6O^F-OJ+T,G22<-GL(?\ TN::#Q=6MIGN'3E ('7][M*?#AS?\6_BWL*T
M6M??WU:WK>\DLG/'S=6NB7*"&SQNGH+78+RD4KG,BLCD]W_6O<?5!?%W1_[P
MH7E'!,AZW!3K+?\ )7I$:V@E5"EE!SRK['FVI"SH/#3FI<E>],ZP"S:]>)K0
M.#"ZA$E&2F#H[9VB2MG;":6+8@=GSN6W.O=-T<GG>?):]^3U\WCVY9I*L,RU
MJ?'VO-4QS9KLEGM5GM:['HP5C?H(-*D:JU3JMM[295G[+99MGGS%'"NQN.KT
M75-Z,,4,:HZ8ZNC:L=WZ\1R(_P WM+_0\X]_<TW_ *0_*_VHY-_![T_O4\?S
M16O^@L^Z9]H9C>*G(1PO"A8+:$T;4[5)9-N4:<D$5CDJ-82.Y9C(8^C\Q&<%
M[,%Y5 U)3E7:<U/4L,4:UY$.M)RK)<@.45LY6<DKJO\ M\FS2+7;W;^RRK'#
M-@L\':MY6RQ2^QPSIT^:M*79X(H]*;%6-Q.'1A:A626"TQVNR2K1'###%,[)
M6&"NBM";' J5;>*A3=6\:DAO%K-^"\^S,E^R,S(^P>+6;\%Y]F9+]D8 \6LW
MX+S[,R7[(P!XM9OP7GV9DOV1@#Q:S?@O/LS)?LC .:@?6]R/VG2Z<-&:+$;O
MSIF>$!?8#L(=]1Z] F(V/K'KJ+T9LP6NO80[T$6] =Q@$$.>-B75 X;!2*R7
MOT%A,FD;PW7%>42IV:\@)33<;01Q<[L#RWU57;XSRY4V/\C1I66235"ED:&$
M,HE*IU9$R5Q\4QD2DL:Y8*M*^'5AK.)7-[69=-G66S5%8-7S"-PKB[QOE,0E
M"=G/#5E@V;?RFQ)$MLHHML<W^7"@;- XA#GB%19HGFP/A,R>VEXDVU*5IEC>
M%*:ZK%U6U4SR=:Z]Q'%5RUY3//%OA1=C?M*RI;4KI\FO).Q('QCLCD AA0FZ
M&)'AJ4LE4P:;DRQK97EYVXA,,[RE*M$E2A3EA5G_ -\-$T56L<'ABEMIC7Q\
M&KM))S5MYR<+ MRK9=5,EX^4C=G"ZF79IU"'I:^W@T\HF'C5+I':<4FY,Y2I
M8>C:(=RFA3Q73!J*R(ET<HF_MK^Z*B)*W*8P%-CPPB>ZN'AIUI[,9J\2;,EE
MEUE) SUS"]S:M+MORE9 _A0-[9XC+J:WYC#8M)E"!I2H6E(YR6#-L6?GQ(UH
M43:C?G%S1H$Q21.2'!#5-R>]$G\$# & , 8 P"$9O!:N9#+K4D]G32TK823=
M%9<<@,9GE@S*1L-+0>Y8&TQ"T(["F]_D+RB4N$D5AE2I#)71(8X1.*RC[G,4
M):(H@4$.XFNKH[FROCT[3JV;@? WQIK1PN%_E$JGS'6U$0>X3(E*9'$*XOMS
MX]JQ/L!?[ @2=><G7E-DO4N<@+;// Z<T+@&(3%5+HHWHFPL*ZZ+"K:VTKT^
M.JN!5EB\(*BM'91\HDMT=Z&-UO19Z?FNXYPVR&45E>$R\;SNGY ]$N>W!36A
M;D4A;88RHST#C7$;;4K! 'B-MQBXI:%>Y3##I6WNYY[3FH>$U$M5GIK-:FV4
MM@$<U8[035BWS!Z14T7:L9@2"LH]9 :W(."Q@DS1"6EH:T10 :CI3DTMDP[@
M%-F]+(R@J]7^>NOQX^++@\:J>4T33,7KMS>4TCDP'*;S>>2)$E-0-\@LVV9]
M*+8M!];4)YJA0B:WBPYM)G%L1J5"A2E0*4Q"E0>>68:,&ZNO<7@2HNHOM@@8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & 4V^0V(2<(@26*QN0@%KLB ^,;8[!$'6NK01
M!7I5&MZZOBZMZZNKXL^.U7==]M35ML-CM::HU:K+(M":R:FP1JG0<(I<N/T\
M$$?XT,,7QIEE7_B!Q<DO;VZ4'5NAF=?E#FJ(-,?4#WO[XA*& AL/V/?\)FS.
MWU_'VLQJU\WW(>VU<_DI<=8M<4B[[/9(W76W'98),;>.NM>D^:.[[#'Z:R2.
M[#+AA>^%0LQD](1PLH*IZ.%/:BK54P2_QG'FH8FM]F#R08W.!;F)8'NAT>79
M&5KM)R.HU.G)\EU=6MZ[8NO2O.WS;<D[AY+Q7KR?N6.R7CY8V.161:KQM,+D
MSE.<U=KS[3:)</I8<8((=&F%*NOBWO=MDD67LMGD."9V2"'T,4R)-/2KZ%Q1
M+9K2,('A>3>KK[]$.'YOE9.T;;[#M7P>;]0QCL<S^CC_ #8N!M0=&ZE5(N&%
M.)EB8](I*%8?E$ZDDP@\OMVI-S =LHT(# =LL81A[0==H @BUUA%K>[T<S<N
M.5S<<G8)D$<N-.]ZP1PN")5OV\VJPQ)-53355BFF9U<R:NVS)IIKLU4U1_=$
MW8R<>;./3& , 8 P!@# +!7U1BJ[F^)I&^V;9J-5')$D7+W.JYU*H>IDD64*
MT Y5$74EA?&I$:)_;4.FYLDZA,KD,),4*G.)*FQ<K5F*!*=,O"DRV,,X>1>L
M)C)?N4.ZZL:KDW&^F:!*B4+6KVR10W[@#M-P5U(8A)U1KDH*4GPZPG.+R%0Z
MA7.*HN+Q-3YR>?MT--!NNO75MONTX'&8>#->1>G(G1$;M3D>P5Y#D+TPMR)E
MNF1-3FJAS\W-+6LA;@\H"DZX;(F2M -LBY(:BE4;.<'HZ/21K,>%^SPKC7!]
MU5Q[FKP:N@Y6N!O'9-+(_(6=DE$;8&$^F' VJH[,W]KJ*1/O'1(R(:+D<G@A
M*O;>[/58)8K#BF _9I*99J$0D4B2/8HC'Q-X5=*=>WIQZ=I=3CG3RJDJX41=
MV>4TBE,EL2V[9FSZB2FHT*^9W+9\MM&0$-J=08<H+9&)9*]QF.@4F;4@CK(U
M%J-:. /6@>XOM@@8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@%K6>[:ED%KR^C62P8
MPZ6W 8M&9I,8$C<BCGY@C4O<)"V,+BN3AZR]"4+(PYA6H2C37%F3G,BUZ2-Z
M*3QI0[!3"NS4<%!R$HAS-K=,DN2L?/KC9D$BJ9K4SB.('FS&%T)"I;7F",RY
MQ3.LK;'!.,"A$M9$:U.J(& X@P98PBV)H\<'A@\-3R94TYM&LZP)95%E6)!:
M\(DCN0P1T^<RZ/Q(E^?E.NM,R,IC^X-X'1W4:^,AM0B/6&Z^,LD6"*-ZE4_A
M]HUFFGR2JE%B04BT5[08_H:V.EK 7/UK$2$X9KTCAHG#4C5-)04YXC'$AM,2
M T0;L1VM%CZ@H]=,,SN8A+HS/HK')O#'MODL1ES(V2.-2!I4!5-CTQO",I>V
M.2%0'XC4RQ(>4>4+>@BT$>M#"$>A!T!46 , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M(*<:<Q6$T)X@E"!HS>@X%'JICD=DLFT,;ET>:W"71A YR[_!1N6/[4E72?\
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MADNHP[O*M -H<W2&M;:\NL@$*(-14S<PI75W%7"KV_'MI7J.G=.D0HUOFBN
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=R&+$R=8-KVD$J(*4;,+"#Q?Q=Q8(D-@@8 P#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139727671764352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">PRE 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MERUS N.V.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001651311<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139727665757440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">PAY VERSUS PERFORMANCE </div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Pay Versus Performance Table </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">The following table sets forth information concerning the compensation of our NEOs for each of the fiscal years ended December&#160;31, 2020, 2021, 2022 and 2023, and our financial performance for each such fiscal year: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:21%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:12pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:12pt">&#160;</td>
<td colspan="2" style="BORDER-TOP:0.75pt solid #000000;height:12pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:12pt">&#160;</td>
<td colspan="2" style="BORDER-TOP:0.75pt solid #000000;height:12pt">&#160;</td>
<td colspan="4" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:12pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:12pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-left: 0.75pt solid rgb(0, 0, 0); padding-left: 8pt; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="border-left: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="border-left: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="3" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Year-end</div> value of $100<br/> invested on 12/31/2019 in:</div></div></td>
<td style="border-left: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); padding-right: 2pt; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Summary<br/> Compensation<br/> Table Total for<br/> PEO (1)</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Compensation<br/> Actually&#160;Paid&#160;to<br/> the&#160;PEO</div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">(1)(2)(3)</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Average<br/> Summary<br/> Compensation<br/> Table Total for<br/> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-PEO&#160;NEOs</div></div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">(4)</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Average<br/> Compensation<br/> Actually&#160;Paid&#160;to<br/> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-PEO&#160;NEOs</div><br/> (2)(3)(4)</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">MRUS</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">NASDAQ<br/> Biotech<br/> Index</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Net<br/> Income</div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">(in<br/> millions)</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">$</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">2023</div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">4,671,327</td>
<td style=" BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">11,843,191</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">2,875,609</td>
<td style=" BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">4,616,893</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">195.31</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">118.87</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">-154.9</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">2022</div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">5,744,794</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">-2,256,931</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">1,997,552</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">-53,411</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">109.87</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">113.65</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">-131.2</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">2021</div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">7,540,935</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">11,523,096</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">2,031,414</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">3,116,021</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">225.85</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">126.45</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">-66.8</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">2020</div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">5,049,022</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">5,589,212</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">1,453,520</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">1,380,032</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">124.50</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">126.42</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">-85.5</td></tr></table><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">(1) The PEO for all four fiscal years is Sven (Bill) Ante Lundberg. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">(2) Deductions from, and additions to, total compensation in the Summary Compensation Table by year to calculate Compensation Actually Paid include: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:28%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Non-CEO<br/> NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Non-CEO<br/> NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Non-CEO<br/> NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Non-CEO<br/> NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Compensation from Summary Compensation Table</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4,671,327</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,875,609</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,744,794</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,997,552</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">7,540,935</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,031,414</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,049,022</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,453,520</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Adjustments for Equity Awards</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top">Adjustment for grant date values in the Summary Compensation Table</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,556,800</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,244,060</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,791,732</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,367,010</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,550,400</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,389,468</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,062,203</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(840,427</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Year-end</div> fair value of unvested awards granted in the current year</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,479,906</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,359,964</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,381,092</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">669,935</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,516,254</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,531,846</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,598,303</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">654,243</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top">Year-over-year difference of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">year-end</div> fair values for unvested awards granted in prior years</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,154,165</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">439,173</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,187,745</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(949,302</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,568,931</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">739,590</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,919</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">129,725</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top">Difference in fair values between prior <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">year-end</div> fair values and vest</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,094,592</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">186,206</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,403,339</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(404,586</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">447,375</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">202,639</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,829</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(17,029</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Adjustments for Equity Awards</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">7,171,864</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,741,284</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(8,001,725</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(2,050,963</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,982,161</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,084,607</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">540,190</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(73,488</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)</div></div>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Compensation Actually Paid (as calculated)</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11,843,191</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4,616,893</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(2,256,931</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(53,411</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11,523,096</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,116,021</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,589,212</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,380,032</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">(3a) The following summarizes the valuation assumptions used for stock option awards included as part of Compensation Actually Paid: </div><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Expected life of each stock option is based on the &#8220;simplified method&#8221; using an average of the remaining vest and remaining term, as of the vest/FYE date. </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Strike price is based on each grant date closing price and asset price is based on each vest/FYE closing price. </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Risk free rate is based on the Treasury Constant Maturity rate closest to the remaining expected life as of the vest/FYE date. </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Historical volatility is based on daily price history for each expected life (years) prior to each vest/FYE date. Closing prices provided by S&amp;P Capital IQ are adjusted for dividends and splits. </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Represents annual dividend yield on each vest/FYE date. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">(3b) The following table illustrates the valuation assumptions as of the vesting date for awards that vested in each of 2023, 2022, 2021, 2020: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:22%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:15%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For Stock Options Vesting in</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For Restricted<br/> Share and<br/> Restricted<br/> Stock Units<br/> Vesting in</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">67.42%&#160;-&#8201;76.20%</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">68.94%&#160;-&#8201;76.55%</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">66.41%&#160;-&#8201;74.18%</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">66.60%&#160;-&#8201;73.37%</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;">0%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;">0%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;">0%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;">0%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted&#160;Average Fair&#160;Value&#160;at&#160;vesting</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top;text-align:right;">17.53</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top;text-align:right;">14.14</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term, in years</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;">2.8 - 4.5 years</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;">3.1 - 4.6 years</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;">3.0 - 4.6 years</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;">3.0 - 4.8 years</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;">3.48% - 5.01%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;">0.97% - 4.56%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;">0.17% - 1.27%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap;text-align:center;">0.11% - 1.69%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td></tr></table><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">(4) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-PEO</div> NEOs reflect the average Summary Compensation Table total compensation and average Compensation Actually Paid for the following executives by year: </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">2023: Hui Liu, Peter Silverman, Andrew Joe, Greg Perry </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">2022: Hui Liu, Peter Silverman, Andrew Joe </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">2021: Hui Liu, Peter Silverman </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">2020: Hui Liu, Peter Silverman </div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote</a></td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">(4) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-PEO</div> NEOs reflect the average Summary Compensation Table total compensation and average Compensation Actually Paid for the following executives by year: </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">2023: Hui Liu, Peter Silverman, Andrew Joe, Greg Perry </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">2022: Hui Liu, Peter Silverman, Andrew Joe </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">2021: Hui Liu, Peter Silverman </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">2020: Hui Liu, Peter Silverman </div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 4,671,327<span></span>
</td>
<td class="nump">$ 5,744,794<span></span>
</td>
<td class="nump">$ 7,540,935<span></span>
</td>
<td class="nump">$ 5,049,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 11,843,191<span></span>
</td>
<td class="num">(2,256,931)<span></span>
</td>
<td class="nump">11,523,096<span></span>
</td>
<td class="nump">5,589,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:28%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Non-CEO<br/> NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Non-CEO<br/> NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Non-CEO<br/> NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Non-CEO<br/> NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Compensation from Summary Compensation Table</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4,671,327</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,875,609</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,744,794</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,997,552</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">7,540,935</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,031,414</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,049,022</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,453,520</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Adjustments for Equity Awards</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top">Adjustment for grant date values in the Summary Compensation Table</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,556,800</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,244,060</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,791,732</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,367,010</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,550,400</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,389,468</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,062,203</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(840,427</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Year-end</div> fair value of unvested awards granted in the current year</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,479,906</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,359,964</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,381,092</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">669,935</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,516,254</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,531,846</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,598,303</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">654,243</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top">Year-over-year difference of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">year-end</div> fair values for unvested awards granted in prior years</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,154,165</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">439,173</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,187,745</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(949,302</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,568,931</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">739,590</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,919</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">129,725</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top">Difference in fair values between prior <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">year-end</div> fair values and vest</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,094,592</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">186,206</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,403,339</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(404,586</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">447,375</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">202,639</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,829</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(17,029</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Adjustments for Equity Awards</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">7,171,864</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,741,284</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(8,001,725</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(2,050,963</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,982,161</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,084,607</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">540,190</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(73,488</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)</div></div>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Compensation Actually Paid (as calculated)</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11,843,191</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4,616,893</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(2,256,931</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(53,411</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11,523,096</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,116,021</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,589,212</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,380,032</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 2,875,609<span></span>
</td>
<td class="nump">1,997,552<span></span>
</td>
<td class="nump">2,031,414<span></span>
</td>
<td class="nump">1,453,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 4,616,893<span></span>
</td>
<td class="num">(53,411)<span></span>
</td>
<td class="nump">3,116,021<span></span>
</td>
<td class="nump">1,380,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:28%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Non-CEO<br/> NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Non-CEO<br/> NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Non-CEO<br/> NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Non-CEO<br/> NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Compensation from Summary Compensation Table</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4,671,327</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,875,609</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,744,794</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,997,552</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">7,540,935</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,031,414</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,049,022</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,453,520</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Adjustments for Equity Awards</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top">Adjustment for grant date values in the Summary Compensation Table</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,556,800</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,244,060</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,791,732</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,367,010</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,550,400</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,389,468</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,062,203</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(840,427</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Year-end</div> fair value of unvested awards granted in the current year</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,479,906</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,359,964</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,381,092</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">669,935</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,516,254</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,531,846</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,598,303</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">654,243</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top">Year-over-year difference of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">year-end</div> fair values for unvested awards granted in prior years</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,154,165</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">439,173</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,187,745</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(949,302</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,568,931</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">739,590</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,919</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">129,725</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top">Difference in fair values between prior <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">year-end</div> fair values and vest</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,094,592</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">186,206</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,403,339</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(404,586</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">447,375</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">202,639</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,829</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(17,029</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Adjustments for Equity Awards</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">7,171,864</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,741,284</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(8,001,725</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(2,050,963</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,982,161</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,084,607</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">540,190</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(73,488</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)</div></div>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Compensation Actually Paid (as calculated)</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11,843,191</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4,616,893</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(2,256,931</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(53,411</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11,523,096</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,116,021</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,589,212</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,380,032</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text"><div style="margin-top:0pt;margin-bottom:0pt;text-align:center"></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center"></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center"></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img alt="LOGO" src="g706699g52q25.jpg"/> </div> <div style="margin-top: 1em; margin-bottom: 1em"></div> <div style="margin-top: 1em; margin-bottom: 1em"></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text"><div style="margin-top:0pt;margin-bottom:0pt;text-align:center"></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img alt="LOGO" src="g706699g85y72.jpg"/> </div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock', window );">Total Shareholder Return Vs Peer Group</a></td>
<td class="text"><div style="margin-top:0pt;margin-bottom:0pt;text-align:center"></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img alt="LOGO" src="g706699g52q25.jpg"/> </div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 195.31<span></span>
</td>
<td class="nump">109.87<span></span>
</td>
<td class="nump">225.85<span></span>
</td>
<td class="nump">124.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupTotalShareholderRtnAmt', window );">Peer Group Total Shareholder Return Amount</a></td>
<td class="nump">118.87<span></span>
</td>
<td class="nump">113.65<span></span>
</td>
<td class="nump">126.45<span></span>
</td>
<td class="nump">126.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (154,900,000)<span></span>
</td>
<td class="num">$ (131,200,000)<span></span>
</td>
<td class="num">$ (66,800,000)<span></span>
</td>
<td class="num">$ (85,500,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Sven (Bill) Ante Lundberg.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mrus_StockOptionsVestingExpectedVolatilityMaximum', window );">Stock Options Vesting Expected Volatility Maximum</a></td>
<td class="nump">76.20%<span></span>
</td>
<td class="nump">76.55%<span></span>
</td>
<td class="nump">74.18%<span></span>
</td>
<td class="nump">73.37%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mrus_StockOptionsVestingExpectedVolatilityMinimum', window );">Stock Options Vesting Expected Volatility Minimum</a></td>
<td class="nump">67.42%<span></span>
</td>
<td class="nump">68.94%<span></span>
</td>
<td class="nump">66.41%<span></span>
</td>
<td class="nump">66.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mrus_StockOptionsVestingExpectedDividendYield', window );">Stock Options Vesting Expected Dividend Yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mrus_StockOptionsVestingExpectedTermInYearsMaximum', window );">Stock Options Vesting Expected Term In Years Maximum</a></td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">4 years 7 months 6 days<span></span>
</td>
<td class="text">4 years 7 months 6 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mrus_StockOptionsVestingExpectedTermInYearsMinimum', window );">Stock Options Vesting Expected Term In Years Minimum</a></td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
<td class="text">3 years 1 month 6 days<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mrus_StockOptionsVestingRiskfreeInterestRateMaximum', window );">Stock Options Vesting RiskFree Interest Rate Maximum</a></td>
<td class="nump">5.01%<span></span>
</td>
<td class="nump">4.56%<span></span>
</td>
<td class="nump">1.27%<span></span>
</td>
<td class="nump">1.69%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mrus_StockOptionsVestingRiskfreeInterestRateMinimum', window );">Stock Options Vesting RiskFree Interest Rate Minimum</a></td>
<td class="nump">3.48%<span></span>
</td>
<td class="nump">0.97%<span></span>
</td>
<td class="nump">0.17%<span></span>
</td>
<td class="nump">0.11%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mrus_RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting', window );">Restricted Share And Restricted Stock Units Vesting Weighted Average Fair Value At Vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.53<span></span>
</td>
<td class="nump">$ 14.14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Adjustment For Grant Date Values [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">$ (3,556,800)<span></span>
</td>
<td class="num">$ (4,791,732)<span></span>
</td>
<td class="num">$ (6,550,400)<span></span>
</td>
<td class="num">$ (4,062,203)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-End Fair Value Of Unvested Awards Granted In The Current Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">7,479,906<span></span>
</td>
<td class="nump">2,381,092<span></span>
</td>
<td class="nump">7,516,254<span></span>
</td>
<td class="nump">4,598,303<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-Over-Year Difference Of YearEnd Fair Values For Unvested Awards Granted In Prior Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">2,154,165<span></span>
</td>
<td class="num">(4,187,745)<span></span>
</td>
<td class="nump">2,568,931<span></span>
</td>
<td class="nump">14,919<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Difference In Fair Values Between Prior YearEnd Fair Values And Vest Date Fair Values For Awards Granted In Prior Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">1,094,592<span></span>
</td>
<td class="num">(1,403,339)<span></span>
</td>
<td class="nump">447,375<span></span>
</td>
<td class="num">(10,829)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Total Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">7,171,864<span></span>
</td>
<td class="num">(8,001,725)<span></span>
</td>
<td class="nump">3,982,161<span></span>
</td>
<td class="nump">540,190<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Adjustment For Grant Date Values [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(2,244,060)<span></span>
</td>
<td class="num">(1,367,010)<span></span>
</td>
<td class="num">(1,389,468)<span></span>
</td>
<td class="num">(840,427)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-End Fair Value Of Unvested Awards Granted In The Current Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">3,359,964<span></span>
</td>
<td class="nump">669,935<span></span>
</td>
<td class="nump">1,531,846<span></span>
</td>
<td class="nump">654,243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-Over-Year Difference Of YearEnd Fair Values For Unvested Awards Granted In Prior Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">439,173<span></span>
</td>
<td class="num">(949,302)<span></span>
</td>
<td class="nump">739,590<span></span>
</td>
<td class="nump">129,725<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Difference In Fair Values Between Prior YearEnd Fair Values And Vest Date Fair Values For Awards Granted In Prior Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">186,206<span></span>
</td>
<td class="num">(404,586)<span></span>
</td>
<td class="nump">202,639<span></span>
</td>
<td class="num">(17,029)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Total Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">$ 1,741,284<span></span>
</td>
<td class="num">$ (2,050,963)<span></span>
</td>
<td class="nump">$ 1,084,607<span></span>
</td>
<td class="num">$ (73,488)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupTotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupTotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnVsPeerGroupTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrus_RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrus_RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrus_StockOptionsVestingExpectedDividendYield">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrus_StockOptionsVestingExpectedDividendYield</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrus_StockOptionsVestingExpectedTermInYearsMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrus_StockOptionsVestingExpectedTermInYearsMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrus_StockOptionsVestingExpectedTermInYearsMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrus_StockOptionsVestingExpectedTermInYearsMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrus_StockOptionsVestingExpectedVolatilityMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrus_StockOptionsVestingExpectedVolatilityMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrus_StockOptionsVestingExpectedVolatilityMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrus_StockOptionsVestingExpectedVolatilityMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrus_StockOptionsVestingRiskfreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrus_StockOptionsVestingRiskfreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrus_StockOptionsVestingRiskfreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrus_StockOptionsVestingRiskfreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=mrus_AdjustmentForGrantDateValuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=mrus_AdjustmentForGrantDateValuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=mrus_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=mrus_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=mrus_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=mrus_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=mrus_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=mrus_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=mrus_TotalAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=mrus_TotalAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M.I.FBF8S^%=9L^$028ZN[F(PQNMD-CM&9XLB1K^L%E/PCIL1 ON LTQ7*H
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MR626685.+A<CUX:SZX("Z(#D(M@#.X23_^[WI>C0XQX-AG,AT]Z %!8=6KQ
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M,U\-[\GF$U!+ 0(4 Q0    ( +5"?5@'04UB@0   +$    0
M  "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ M4)]6/V+*,KN
M    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L!
M A0#%     @ M4)]6)E<G",0!@  G"<  !,              ( !S $  'AL
M+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "U0GU89^RSSG("  #L!@
M&               @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ M4)]6 EMO[+-$   -F<  !@              ("!M0H  'AL
M+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( +5"?5AO%^U.+@,
M ,H2   -              "  ;@;  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     *  H A (  +8C      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>44</ContextCount>
  <ElementCount>28</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>7</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="d706699dpre14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d706699dpre14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="PRE 14A" isUsgaap="true" original="d706699dpre14a.htm">d706699dpre14a.htm</File>
    <File>mrus-20231231.xsd</File>
    <File>mrus-20231231_def.xml</File>
    <File>mrus-20231231_lab.xml</File>
    <File>mrus-20231231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g706699dsp145.jpg</File>
    <File>g706699dsp146.jpg</File>
    <File>g706699g52q25.jpg</File>
    <File>g706699g85y72.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="4">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="88">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d706699dpre14a.htm": {
   "nsprefix": "mrus",
   "nsuri": "http://meus.com/20231231",
   "dts": {
    "inline": {
     "local": [
      "d706699dpre14a.htm"
     ]
    },
    "schema": {
     "local": [
      "mrus-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_def.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_pre.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-sub-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "mrus-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "mrus-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mrus-20231231_pre.xml"
     ]
    }
   },
   "keyStandard": 20,
   "keyCustom": 8,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 2,
   "memberCustom": 5,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 44,
   "entityCount": 1,
   "segmentCount": 7,
   "elementCount": 262,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2023": 88,
    "http://xbrl.sec.gov/dei/2023": 4,
    "http://fasb.org/us-gaap/2023": 4
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "P01_01_2023To12_31_2023",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d706699dpre14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To12_31_2023",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d706699dpre14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "P01_01_2023To12_31_2023",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d706699dpre14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To12_31_2023",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d706699dpre14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "mrus_AdjustmentForGrantDateValuesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://meus.com/20231231",
     "localname": "AdjustmentForGrantDateValuesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment For Grant Date Values [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r96",
      "r112",
      "r140"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r99",
      "r115",
      "r143"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r100",
      "r116",
      "r135",
      "r144",
      "r148",
      "r156"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r92"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r119"
     ]
    },
    "mrus_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://meus.com/20231231",
     "localname": "DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Difference In Fair Values Between Prior YearEnd Fair Values And Vest Date Fair Values For Awards Granted In Prior Years [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r119"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92",
      "r136"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92",
      "r136"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'.  This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r96",
      "r112",
      "r140"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r93",
      "r109",
      "r137"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r103"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r100",
      "r116",
      "r135",
      "r144",
      "r148",
      "r156"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r160"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r160"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r160"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r108"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them.  The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r174"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r108"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r135",
      "r144"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r98",
      "r114",
      "r142"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r89",
      "r101",
      "r117",
      "r145"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r89",
      "r101",
      "r117",
      "r145"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r93",
      "r109",
      "r137"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r94",
      "r110",
      "r138"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r95",
      "r111",
      "r139"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r102",
      "r118",
      "r146"
     ]
    },
    "mrus_RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://meus.com/20231231",
     "localname": "RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Share And Restricted Stock Units Vesting Weighted Average Fair Value At Vesting"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r97",
      "r113",
      "r141"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "mrus_StockOptionsVestingExpectedDividendYield": {
     "xbrltype": "percentItemType",
     "nsuri": "http://meus.com/20231231",
     "localname": "StockOptionsVestingExpectedDividendYield",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options Vesting Expected Dividend Yield"
       }
      }
     },
     "auth_ref": []
    },
    "mrus_StockOptionsVestingExpectedTermInYearsMaximum": {
     "xbrltype": "durationItemType",
     "nsuri": "http://meus.com/20231231",
     "localname": "StockOptionsVestingExpectedTermInYearsMaximum",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options Vesting Expected Term In Years Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "mrus_StockOptionsVestingExpectedTermInYearsMinimum": {
     "xbrltype": "durationItemType",
     "nsuri": "http://meus.com/20231231",
     "localname": "StockOptionsVestingExpectedTermInYearsMinimum",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options Vesting Expected Term In Years Minimum"
       }
      }
     },
     "auth_ref": []
    },
    "mrus_StockOptionsVestingExpectedVolatilityMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://meus.com/20231231",
     "localname": "StockOptionsVestingExpectedVolatilityMaximum",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options Vesting Expected Volatility Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "mrus_StockOptionsVestingExpectedVolatilityMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://meus.com/20231231",
     "localname": "StockOptionsVestingExpectedVolatilityMinimum",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options Vesting Expected Volatility Minimum"
       }
      }
     },
     "auth_ref": []
    },
    "mrus_StockOptionsVestingRiskfreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://meus.com/20231231",
     "localname": "StockOptionsVestingRiskfreeInterestRateMaximum",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options Vesting RiskFree Interest Rate Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "mrus_StockOptionsVestingRiskfreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://meus.com/20231231",
     "localname": "StockOptionsVestingRiskfreeInterestRateMinimum",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options Vesting RiskFree Interest Rate Minimum"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "mrus_TotalAdjustmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://meus.com/20231231",
     "localname": "TotalAdjustmentsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Adjustments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "mrus_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://meus.com/20231231",
     "localname": "YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-End Fair Value Of Unvested Awards Granted In The Current Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mrus_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://meus.com/20231231",
     "localname": "YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-Over-Year Difference Of YearEnd Fair Values For Unvested Awards Granted In Prior Years [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation",
   "URI": "www.leiroc.org",
   "URIDate": "2013-08-21"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001193125-24-081577-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-081577-xbrl.zip
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ML\QI=S7G=.VYCT^L'8!"A+H8NPX]/P2=$8B6M86!5;S_\J?J;N6HNKW.-[#
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M%;CXOU.%^GQZ[;BL%7JI@_1PX9W^=$,&_8%EZ9D6M^TGL"CO+30Q Y=Q,,W
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MDICC!D37,Y _YO3YS!H,72^@,'^\2X1W06&E[#GDP7L7^6^(&:,XN4E<"*+
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M#UW+"30NRQ_75U]97<I-CJ)3!HC[N6*70@H?,3X1A6UH6B!\)\C:;?IN&'I
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MZHA1@] G@>$10F22_:SX\(T88^1 F8<7[(. RBP5_27/<:82@?-P6MZE+Z(
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M^+<DKNR\B[JQSUG5+;[%>7F!O0]3&4Y)1M.-R[\]Y1=_*T7UC)Y= >[5A=9
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MZ[J#*W,E^AY_X1I'OA8<5"I*\65SJU5*F)N*^]*&L2$]XKA.RU?/'ELZW?Q
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MTHZ=U:"6K;<?PEY!+0B&GW5*%?2AAK!3T$<Z%WHU**-00%:$,L8XCE>#2E9
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MMH*V2/8E*'H#"U6@>VZ')-2(6)$V#7)$$(%6RI6#C;)R:RY#OI&+\4V9_YM
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MY(_71T\ZXO/5;G>=LE30<4''KZ;C.)C8U_K!."'>';FXS894S<L#-3:P:;F
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M^)^M=I-GZ82\ +W.!*4I;=_*SHM@RV+BF4R!Q@9G50F[83[):Z!.@9'I";)
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M#5-VI7L3<:EJP91'#=$*VW-+LV1+6R<L\,';&0BFL^$2?I<*GX9@TU'@"P6
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M$2_$!_[RY<:S]()OA:_>KH>OU_NH\4^_;&S?8>[)_YX/>7'S"CH9JL>\N(V
MNA7F!=4/20FG+H4?9@0E06T:XQ3;^C%@0$M]I]OPS]9P#J(4]QF1 T99/E)Q
MR5J&^CZ-<X*WT.U2I2;?+W,'^>35N+>7N)^J!">A*]U;Z]M!4RFD KZS'/S>
M&C?6A#QM_5 -,FXT^C-5L"9@U_STR^]'9_O!R?[__7IPLK\7.&+Y/B=W-N8V
MMHP/(BU<J<MZ##<']FW\=Y;'Y0S5O\NLA)\&45$B3L((N"+7  QZA+5@Y[S
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MW2:D*.S5!LH=^IHTM"O\)UQRUAEC/1.L7H&%DL0*4:;HQ <17)1Y0'Z69&B
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M4M6FLQ9XF@386,!WQ9C=9IQK[DZ>[E1<YQ3,_6ZO?#&F&&0T'.:X*'*=U*5
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M@II&O@-[?\8I!KV82$GMFFML_D?EV>H 6,<TH8!;-;+)1IA' L9_PGGQ6 S
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MYFE:6T?5PW,VU547/>,6)E_89-BH,=7ZTGK++X?11!F59/X.:\+5Y&M>HH?
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M0H'%LJ&_D_L[^=:1(ZUGD@4*%TL>_X>SX;%%6'PA.B'HB9GGG\-+2!Q8S;3
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MGY]/DMX!ZI9Q88HP0^DJ0 VK$-?W$MT4@B(<Z<+1MLS/Z IL.$[\!N5.1;G
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M02=OB+5'<)7 O(3Q7_@PG)"YZ/0E!R35.LX_+JW*?N# 2BC=(JG5Y\=1SHU
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M=VR #7&FONO8,]'Q/1.4?\5M41T/YS;KIPKVSGY)+GQL$U<V^\T6!?(!F&
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M-)/@$+M6((8T@$.KA"+I;E%8:.$- "N'5WWLP"4E2-<9\*0&9E@07HV&H!2
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MO&-:O*W*0._,&UJ_EAW^SL!7+5;"5A/A[<$"_:>+Z^N+[WL%]J?6#!@QOP=
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M\GEOQHB&NJ*FX$Q6SA25&%3!2"^>#+A@%=FS(SY-]1'A8+&FL)^T_MT^W[B
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MFF_2VC*%L%V@Q29$=2?>H93^F0^"&.]6J,RY5>1E=.9AX8:E8GK^$A$V 3B
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M[GJK^MNII17(@>MVO7M _W24PJ>N-7M/&'R$&#N/:6OJ/>= JZ13UQM*HW$
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M-"M$.!/[OW#,-Y8Y %;DF6ZA?D?EZ7(E:/$*.]'U..#A&'X%N%LT"56426L
MV"   $7CD;[]P[S][]8O9Q)/]N/Z18S^B](2T3?N.J=4]JM;[K$WGQS7?<N.
M 518&H#ZO79:VQ/ WS)T/[&Q:KG+FL]]>P?_5UA0ZBG+?"+V/?& -4SN-TR:
MK:9H#*M!4H-D-4"RV>X:;0V2&B2K Y)=LZVII ;)*H'DTM1Z#9(:)$MBW+VZ
MII(:)*L$DF:GAF7$-$!J@*P&0#:-=KM#)?6J!)0%OK[U#WUW"4ZYW+^GF&!_
MCQU&.?Z7X[VSN.X&A%<Y8W:ZB@?;4RM#R_?2EZ4!3*G](,^V"BBU!B\-7AL
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MLBXQ"#);="Q?H"I$/=*P9C@3#YN8XU]<&S[6SGR]R[D-JJ2,J_F<HB0B P?
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M:XUR6;O#:C.IG:HK>I*. (CA:JW0:5MC^_I;8?ME+=ZJ9/RX2^[Z<1( 89?
M?LWGOOCR.V%2)FY!=C%9CI=R8"_=\)T8V)EUJ9S=.<?.SGGP/PW<U%X)V.?%
M<7+D0,Z+2*,T<_'4NY6U,5D?TD2;UL?8Y(5UU.H-53)H?7!IQ[I6J<*AY/!Z
MI5SP^D9XO7'PO'[)Y^>2#GIGO-?J9;W1:G+HN$CS(@V^&[S7*I6*7N\T4@AU
M$F8N&'L,?#TO]/D\0)P*IW7J;;U6JTKL.O36IB&8M#B0(?LVG[T2IQ39QA9C
MUL7H= EDNA0870SHG(GM5Q#V!@B[>72$76DT=1P3DB0Z2=GU1DUO5FI+D&E!
MC ='C*VC(D;1 5:0VC&26ONX2(VWAQ6D=HRDUCDJ4D,5VZJ1[9BM89LU+*XZ
M%%(\RFZ?3KGH]GEEM\^I"PUJ\SL>J<$; 7<G% KUM#E*._S,O4IIO#OA4-1/
M06HKD=KAIX%54N-EY 6I'26I'7Y2MB"U$R&UPT\$JJ3&NQD*4CM*4CNN/!1O
M8BA([2A)[?@R0[5V16\V:SEQ*T)=UIO5@XFB'F?HJE*$KHX%J*881W["X\B;
M%1" 8O#X?>]K]^'J]@8'DO=7FS*^ 3&!?3E8IV11-9F8ZQ9XAN,;IIAS:'CP
M)Z^#X@+98S85GV$QFD\= :&/)6C,]AD?U6;AB$/+U^X\]\>+U@^,@'[.9]/%
M I<F$\*)&7C]*L^D6C8Y6_EY[.*==)+W^/1AZ"G#""UW"!H MLC!#_]I.$K1
M&PGYFIX8;0M/S^@3E#,RY>@\]YENQX?UT/1F,;TTMU5)%],/J<&)_3N4$RGY
MISA#D<$&X#O"-M&(4/$'Z#C8"MQ3$\[1<VWE9XE]PKF,B3>A"_.F_<IB6:KN
M9;[I68-H)JDHSHM!S%7L<JKDDVLMB6*]><,<-T&F:0:J @.A3 5!2]RC=7^Y
M[_6N>S</VN]7#[]J5S>7?SSTTJM2FPYK&VDZ7*S+-\.EOU-A,HWBM!Q@4P/A
MM&QC(%L-\(!L.%<'S"'CT6.\;/$=\H XS,O$]5UY351L23R5T<0@*S7Y5_)R
M93PM46M4/IWS&* V3D7B";3&(1_Z*'_ ,H=,PI\,#3.=) T.MN5\,V1/S':G
M])X(.&7AKRR@;<Z1CAO];3B!-7"'6-,-U&Q;_T'>1$;!*9.>Q0(0"-HGR[1=
MQS+]%2NVX?A;]8^B:CM@YM@!E?7XHDU!7F&9+J\Q3QZ6,O750<8W?)RD"H^%
M5ZZ4<7@M P8;TO!-SWWTC(E?TH "J#$,]X0;P7CYPH82TST?A5163OTDJ5V#
MVP]#,P!A8-&$5I2\ED]#7CUWHKD.^$I\&W&8/5^+3MNOCNT4(AS$$]<C<#LB
M49_A1UEW@*NIWM8TJ+T,Q).0<BC###%/EZ]OA$-U2:$PH#D+R_%)H:"6 .$/
M]A?^ER@%^9H< P//R9HB25E8$)U8 5 V[1[<?@AG#P2!J@@TSQ.O^\]Z%I>M
M#JV)#_*-SN5JA*0=]<HA72U[*/!@>2[B1/GK1]L$-WYV0ZS()#Z8HL^$5BA>
M)FZ@U1I1LRS0D6ORCH51&(2PA8^V.S#LQ*F;KJ@,U>DV\O#2+Z;G/]ECUF00
M>D0F@IW5.\T^S'*(XG'W+=>3C"U>6>X<;SF1!$EGZ@H5]2Q(7UXZY)IV$TP0
M$W[TN@IE_^5:V/.HO!"PM</U*DHBGS&'>F$RKD3E;P4! \-$%:WP(L1>H-[M
M:!BXD.'TROP4Z#'(4X88LHS=GV$P._I6U30;F9K\!0=F&S$EZ&+\KCP$' S-
M;$9SKU\K@+SXWD.7[LQ[7W$+C/792)>;;?FR+R)-PSCTF1,G[&T&E^ )XPDB
MP8&T_X\XH4A*D#SV&#==I>RA\T/2W)8R426>"7(+?T]+7;A54X^=RU_(S3+1
M3!V2>,-[")$A!8 &>MM[C%4!ZDNYC#C$ M8NN'F\S<)TIVR!&; ;\A6"FFR3
M,8OT+;P:BW8M>DV/C1@))U19Y++@YQKX!O".O/W$9%.I,8*T,B<AS0F!\?'R
MH,OLT$>K.5)(@K)FJ(HI\LX9RC_4@\E6?'#"0,>11-G"<Q-F@*H8$D>>6%9)
MP[U7]L^F":;@6P!]DU*"[5U(J->77[OGE7HCZH!-VHUH4(0D>\@(X4WRX$W1
M['%^.(*I)T#.]*DP-;.87&%G<(.%;X@^85475$P]2_ LQPV!#(:<\L5:5I&"
M()C.8><B.372T*Q9^#/VX_Q;J5_*L=Z6WLSH!K$13PU*:RQ[U27'@G'IU<J?
M L4] :6!9>RO0> NQ@RQ<6Z=YW+>X"1COZC.3HKY!2E0G!G=<PN;NTB+3]'.
MY$$(P1+<N+.M"3%- ))+,/*J>ZH8JP3L@*$3,KPY,8:^KK(,K<VP?5?J*R/>
M/P,5HS4$1M$\]\6P@Q<\8^Z)U'_"-D'?L+D!(M3#K%)<A1 CKD:K:XH'S(9"
M)QQG1+U:1-37C*AOZY@HHAF+\DI+!WIVG7E6"5C]0-:H[MAHQ)"Y6,39$V.(
M"@CN :H0+EU(ZHX+K\K0+L7=CF2*\4)/(O;$(_A[I5KF1 LO84O?3S$E060X
M0121FVM3I4WVM/.DVM89_+N<PZKHGJ1LYZ$=#_6A]4@&=H"BQF0HJ;DH^3L0
M9?)E00Q% @6EYB-+N4\\Z/L8@A&!( /P.^8'(.&XQ2)N6VW,WG;V!>/?)D,&
M%H73N-Q#68JAU,CF:?[$HS$_*0Z"PP(N#Q=O^?;\U3F;;6@-6.],\.0=!J]#
MGV1_@[\0&C6VBV&G]]GQ#MSD%38HVADUJ!29BL)N3AFQW/&6 138'1Y+PHC0
M&IZ?D7<2R4-8D]*E7TGNQ+/0J8X+>^A@.WI\ $M&K@9A$.>F,TZ2_"F$TE?H
MGG8=OUAC=]0P QKX_'SE0V8..LX'@+QYFHW++ES!4E(RWFHF25TQP;AW1G$J
M'@ZEJ"W?3:#E1X;^673*YMAU??8J"IJ)6^E18BPRCU0NB*TDE?ZSSGO[7N_#
M'.66M$T)(.+UYR<.Z'SP<B[^F3K!@>%;8+G#4U%N6I2MPKCL"XA&G^2/-#BE
M:G0'P @\R3=#<$D/U"/AP0S/!L+5HQR$)/#Y(0C4=_AX>3<TB$W3]88&.'@Q
M2L8R20T>V\][SL1X0?:6*Z/,#7E]Z)> *?Y"&<N=GH>.P4HU9.LZ3\RQ&+SY
MXG<A%R+Y0G"WQ-%R6R4**?/,IN69X01SHB9)?0><..+E"88'T$%#LQ?S.[O>
M#=H"3!(@PX_!T6,@S+D&HP]]Q?8"9\6V3+*?LY,80-0^" &X)1"0-=?<))4W
MCT(1MR27:GA94Y(]*. E\M!Q !]CG,*8% M2[JK$OS 2J?B-N?(6-D8FX_!I
MJ6!$]OUU-9RN&,&""-$4X2N +5S2 TWDK)Y%&$;4@_DA5VVHA$%F ,7YH]#6
M4EF)[."N:KDDPE\Y.[=UJ9[.>=?.+KK??OG6?Z"JA<5L\N7VZ]?;W\]O;R35
MWW[YTKN_NOGE(-+B&]%[MXX U^./Z\B"CN=TNMSAO/R,T)28[LM,D7]3+\G)
MD/\3743/0E'VR1UUM7Z$=TDN8TG7?@D?P9N![9PDOD00,R2\W]%5 ;WSR38L
M3T! &Y/I1Q4@Z6OILD2^BL>FR'(.F!%@%D;ZR$>. <D9O1.6I/!"#Y2Y#.C]
M'0:JN"]KOW =F7Y+^)%\-UV4ESC,C+$]*?CM^R$I1@JW B>BS ]]GE:=AJ"R
M3:PH851Q@U7#>KO2UBOM:JHH,U*DXAT=]+?A#9X,.Z25U9KUC^52N8,E._Q'
M%("??<C4LTP2''^O5DOELGH] 0@GSIE*!D)91$0I.=_G&6J2%@:71EB1(SU_
MN!FS4=(]6GX@1+,O*Y@(. LS( N9KW]>BUP3%$BFR5^=OP(5)P2PC^_NU><L
MO.N-*V!Y:K7:>;71Z)1K[^-(.1G# V:B31^_#T4_1CS-35B6HOJI1<Q2X;%"
M0UT4!B]M_KY$3K2EN14?V5S#'54T&60@(W$M8:\[J1RP(;-S->'64X&N6NG+
M]8+AJ)9Y1<=X?:O:2M<.B^AK%OVL1"LE+25F*F4I9V;>*?8VJ0!.O!]%.VR;
MVUC12DSPP-$M3=V\+F^.RZ#D$OF$0W(RCCA46BM"I0<7*OT;<+W)V%"$))O5
M4C414 ,B'/$D'MI%Y/7FL\R(2=#GN,13]%LP7IXHE(H32BR^),=*-A]*>S5B
M%5 Z4>7EB-NY5$?):U\PL).XTX>TA;.)II%CFE':J*PXH[2N#!M-_F<C-RFF
M9BZ>FKGRT)$-SAR)9K-6=SZ;59W&ZH[X?PG_W>'_[H,\_OZ/@??SQ9T4#Z^>
MR7EL>_2 4S#X@N0FB+_0F'G%=A2C07-58]9P@@V.]YD5.7FT\>H[2&HEJ^+L
M NSE1EDO9\W8>_VBMKP7?]_<-H"%#>IU@_OPUN=M+49]/@GV:38J!?. DUH#
MIWO#S%/,"2MF/<$2NW%LAS=H8!STT?"&HJO/9\E>/)'+MCS95H=?P+6\.DY4
M$0[SFA*5)(]I\'"-")2*Z.V+=JM.*;L4V:U/,30__Y[6$8N^1&?<7$2#;??*
MU<\NKFX^]ZYOKKY<7::ZY?H'D0O85(L<K[I)!/YE/%+DE#%4,'"!EGA/A=HH
MB5]E='["35 M3AQK1!7&$[@GG+\?P,78!BF*96S+&%@V+\H4#2X8\F-T':48
MIYA""D3:U#:>*52BMNOYDE;UK.XJ]D.4H?N\<4<N"H?JR?(QZI*E;D^QLBC;
MJFL&>%2/(B<KO\<0.[R_PUY\41-,01Q=%K1CEZ@)^Q(51%"IJ>E9T^@3O)[&
M)\ M/2H&LP*:]\5O!#]X8K;RP&%(B=2 ]\?2+::>Y413S@:6[)WE#V0VFXXQ
MOPE>C_>(=YBZE([$-*5M43N@S[PG3 K06J)F(^S+<5Y$E)K:S(;6$]6Z\O0%
MUG6;L@).Q,'@R50*KG9$4^U!:K<INBU.:QY-9= 3D6%TE=QV(D!QB?Q,DM0+
M/-T//8.R]/F!K86\NO? 5H%I<,J8!HVSB_ZOW?O>K[=?@4[ZDHKO[F_O;OO=
MK_O -I@-J]"_/Z [;\'>WX?+5-]7ZL9Y6R;9[K"!U <9(CZ@UZQB6";*)JYQ
MU]@&Z<E.V*X9Z$D[!X$.+,Q&4)4_Z3J#-[3">C![B]2)DH^K!VJ6X,DGT>P,
M9H\LNA'%+U%R&0MO KJN6JXVM*[C8$_ +V),SC5C)* G(:@ST$V@QV1G W^X
MZ'N3_3)@.7F\K5K<E(LVRLE]FT[A%_#_X9S7EJ[55HQ[>F)$EIHZKZ]XCV L
M>NQ&?/1.K=&N:Y</VK< Q/)8X%3<,-25-DAFTA<RYX&5U+RSB3(0GYE)DX5$
M\J[)<8/@0,4T6\;K+46N=-[FXF Q.GI277&.HR:!BF0M2NJ&]9P;\@0B/S(X
M89^;+Z#:P4CVA,$A[L)IPPNQT ;^/0GM1UG?)29&;;^$<1&OWI+EDL-^?95/
M.(^0L^ *"RC!*:*H">2Z,S2BLOLY1Z-KEB>JK;@JQ[95 >;!7M(\F6 ,\?AA
MD@O]&!&%S@=K ^R7N.HB<49<-N"/J:U=%$/)7F\)_O Y#,!,(;.2Y^FC#R+C
M-N?G.FP(/#PA:J*Z$S++@."9 <NL1=DV+ MAHO\.W2:*C^*_08./70^.G/9C
M8GR/NGGEENBQ1T;-=+2%0S"SW/A!$ILKZA=?()BV3YUIFY SE(29P2STHXM_
M99S<"@=!<!A)4@#>B]KU0@?M79]WKTJ&G:LDT!$S+8*1^"&P#61GFF*K\FH<
M,N1CB!JE7"=:0'0=4:VT?T$BHO5-IYG*]*JCZL36D%197D56.O-U)%7AQ^)8
MQ7#C51J-[1-'))0XX(XK*Y$5+#K4&E$AAQ"KO-,VQJ:@6GM>!HO'\(QP$J)U
M9P)TSNLYP1]Z0CM#)30]ZB50C  LO9[02$!@UPER']9*8^UU5,IZU)UW]:*<
MY/#*2?YP0ZH5QW8#<*ZU.P2XT#Z5M+YE@^B"B[!*$DW0R:RQJ!^K>:B+UE[3
MG<IX0\RH)"6ICDPJSSPUG@AR)C4)WA^4*7ZG2/M(I^Z@P^1WCL3D"0,GZB#V
M& :J=-)%V/!%+XE^/0FR  T  54VY7!+U'VD5)DJ9>RB+4.X%"@ZAR[S20"F
MU*+/(C&IEN:K>R:%6Q'D*((<FPMR-,$1>?BU=Z]==Q\>>O?["&K<N-H /'L*
MLOK8MH**_\D->"FIJ'K-<V1X%%G$-,$'(: EU4G)\(R6M+E?$XK,NDL1SRQ8
M?9^LWCJ[Z-]^O;J\>N YL]LO&,O\/U>]?3 ]5M6F>PC  ^0 5^CBR80'"8$!
M [DPDO;&;&X"$82P7?:&>V[P57Y,R@C DAMS?Y[RIS,A#-E+S#O4*',3P<F)
MU1E"WW-A-<"4$V\DF<FVX(U"G]8T,2P>+2#75;13)EZ70\!2F"7 '!![5C)&
M^A*X*N?X#+5/8V28OH5-UWC[%"QLE,*)\5<96"7N"WK$Z'>+KO" UHEN'>$/
M1="N(C(K,M@\9\6!Q%2(EG^'F#,DZV?@N=\I!R?];ETSP?%VAU8$0D>K&%G#
M$!Z&74GXA&<\;K%/:J-EE)B<F2I/QY4< $VGM\8"XO>1,($B B3A>L466)BM
M-/#T4&0K"4NU#8FZ3]#FV[Y]*]/Z:L2"O!C"]9*U RG:%[#$/-)(!>NF&4Z%
M[T\=4[*$("I)$#R92CU+RH)'#*@ GIIVDM$3$3R(PL!Q/C/G;CN)BJ6;QO#E
M$DS/VRI_6"P&*%8C>9%E\LR4N-4(.="8V6[JG_OUZJ$GOC&1TM50&3B::C ,
M988[X,W(L\%7[1UU/F$>&/X<QF#3<?^3STDP<-\KU#YTS5!<S*]_1E0(7')R
M,?0'ND0\=1V?G!K3>V8#WT*7"!STY^?G$E!,Z=%].NK03*,(S11C!@H3=O\F
M;/OLXKIW_RW*Q7=O;KYUOVKWO;O;^P<-;-HOM_?72\3AR^?_.VHRV+GIVXWB
M:M?,"Z/J&*$_[AG/9BS;EZN\2^3@(ABO0^;0"S/ J'/0%TXF=FO1K( 8P"+^
M6:12A/Y >YF2J4)[$-X/&H;QC]F/L36P @Y)-:L[XI"^SYPH.*;&_@B- 7%+
M\ 82F10[2@D-708(L+ETZEFVVA]?3RLF,C8POPWR+[) @>S!'J1.5G>FGVX9
M2T*E[O9/*QXZ';5V4_IMGA&31UZO>G(W(.!(U_F04<ZPX[4D@^&[?OK^0^\[
M?^-DH'_7CW](59ULVWSOJB[8B+$XC4AR82@P@J:6+/'D(JND89J'W%7"!2*8
ME6S_2&:\-R"LC13V8D:)"-K/M *,AI; [Q:_S5[PAM8EE<A"U;'L&TQ0])4<
M.UK\=LD@HQWU]U][%..^O==N;A^T/VZ_:7=?NS?:PZV&4>^;SQI\+8V)7WHW
MO7OX[W6O]W!U\XNN_=[3OMW_TJ.?P2]^NWV@?]]K5!W8U^[NK^#&\$W^3;3?
MKKKT]0,8M.=?[GOPK][7WMVOMS<][>;;]2>^N-O?X+]XV=7-0^_^IO>@:]V^
M]KG7O[R_^M3[#!_#MU=]"MO]H?4?N@]\0@S\]!/\??7+#2WX<Y>>V87WNNY>
M?<5_XTWYKRZ[]^)&/:UW<_GUM@\WON\]?+N_@;]_ZWV]O>OA#7O7\2_QSG 5
MWA#N#?]2;H5[^,LU:N'_CTRSTLW7$GY_???P]0_<++R)NEV_7WW]"D_J?[OO
MB67U^K"0'L8CN]J_OMW>?[N&8YFWF[@0NDV_^QL<3I^_S/^Y@[O2;;Y\NZ?S
M5L.=VP\>?'K1;CUAR5!4:K:$>NN%&S/IZ1V$3'*RWUM_<FYQX];5#!J@VO\%
MP[W2:7S\?\(&/>+X1K.(;^RX]&1A$UE:B:DKY#V+:=^X X3I..P'"-'7,<"K
MUB8WNGO_<'7Y%<0]2O5^__;RBB>==KRTLXO/O2]7-U<TD)#T!JE6T#D/B];3
MW,IRNKQ61JOD9YN;Z^:)3[S3<P&F1*54F06..,A^T 4O(M[BRA&9M;SRJB !
M3#1D(\OAT\I$%076$;U\V.H :A2GFZM32$4F,^3!^4(LFO3)</+JU&9"P5RV
M+XX&5]NK(0]5(\R@%(7G!I5?'_TM+X6JL(CLU*^%>JZPFH$0)XGOTNVQ6-46
MPOFC_D^'ECGQ#S&N1T3[@8J>L2<7R8A $OL/]TDPV_7@7Y;$()C=B5V\*@9"
M>J'G F>"7WZ.<(,:#8@D,#]_'-=0XU53!BNX!$6*E0N?#.>[0+Q'F%I*V-&(
M)P0YYC=)3B3RV-0&WY["%2/YN\R'SWVDB +P8G_UF_>EC'.:S6DD4B79&9$F
MI4/ROE'QB;:3--D(VPB%OGVB[3I2$\0MP#FJH?3&S^23]+SEB%]_^\?SD-%>
M,AL!*$X&=P2[979T)%1(1?,.*'^EU%:+"I=96J$,UM SGG%(CA22LY>]]:.\
M[-WNAZO,L<5&LT@$;_X\QH:%$;_='(HIGB:#G05_S)R'#1J9;ZNH"=O-R4Q$
MJ2N<A0(Q&\.6&_%\:USAFS\F+EUVQ#4B2![-<YKOX4_Y0;WU(_I\>;F;XQ'.
MCO5DV:!UANRM;_S._>3/-*A%P5D\^<A 5PRG$1/6IS'"4Y11P^(FT<@T 3==
MR/8^+U+F+U?]4&E4->"3PC=/" YAB^S .8>CD1CPA3ET$+*DAY[?U$/0 3"-
M\7!.7IA0F''FM25-=B<^?#4T,%<?<L",[G3*L-NZD!H*I?:^W5]]NKW?C<DA
M'L;C%%BFBI%9BD D0L,/8W?B@T5XST(:RT(S_W@P&*$;K2#D#3[8!>?DQRQX
M8[_M&G(DH8'-5+RCAZC$8PC6:/W0-= SU),>/#,;G.P);-.8^NS ;,5I333V
M<&SP3KDQ;!\N'FXV9MC@8R)\#LYTPC%K3RRS+/F=G \<(0L8GAC0XXYHC*ML
MI2> (F$NQY</<<Z0->!O;ODTV9A/(A5HB+!,A^.I\'H^./3_,,]%LQK3U&]=
M(O>B",H.]:2C!&[D8]_Z0:2:5/<357L4BU#"!RH.TYL_(\\-IS->R5;YQ DL
M/AT3Y:($;.9R$"=Q>8_@"_@&!Y:FMEQJ7%3[+J0'0?)0 Y,!VUY-A-T*EO,J
MJO6!\"K>].%?2;!<V-Q;'FW>A4M!N+]\P"_VS2+TF@0XXUV=44)X]DH1%,=/
M9$]WVJ]$'*W UU3*QL)XPU<3RD7Z(X<F)*+ /0VDW3XY_)["%DI,GXP0C C>
M@(RB")9;7JP$@X=LZOH6G.(+;\.>XD1=CH!(%0,\5BP,1#.=?G$1>4T _,7]
M7PD0)2.@QF=J1^9M5W"C--[*&R>@)69C.N>1C2:[,W89TEAJZ#W+6Z%ROK+H
MC!<6[[](>I62O:B@];Q25$FO5R5=5 FN525XB$+KCD!/N&K8M0;LJ@Z)#@HE
M],.1%YI!B-TF:"?;;/A(77^PNB>7%B>T(L$9QHW&60I0T7Q"%Z;MZ"P5^-:U
MV!W5(B(^ZV<E'+-]8MB:[*>4C!I9$I76T^A%!9$01*:#8TA"L+S9OT,.&X_7
MQIMR)<-Z]UAP">]@AGRB2104,QX?$2<3$5/XG::&A7 Y_+G8_IY^,@;AX*:#
MEP^;:R%8NR>XFC5NK3H[;FWQMB\@-$,&J47;%3)CN?*1H]TLMW':N]A<1:0;
M-*=#F\*+AL.9GJ/[)'_V7AN&7H2,O9$89E;H4E3M$W;Y@!'2J"-F_I@F?T&$
M$O7(X0^B^K5X]C ?+HXX6\PVI@AT$*T;/EMMX7Q*,M&]\4*EQ,^&6&;N]N8C
M'YX@.0ZRR+%*Y.CQV=)N5!LUC\5G:'27M+9W,D-,;YL',N)=0TICHQ'%LFB0
MT.[IJK(WNC*SQ9P@+VN4?Z3)\Z=]IFJOY(GP6(&@0S?C=A%EO(H,Y.-GR;B4
M[$=ZXT93PC[847U@1HY.SS1-7B]_C&Q2S9![^@S.>&9F5-MY3EV\=-RLI+T#
M^>3#*LVY\='W&!S3F &[8!H^2V;8P54)?4J^HH@A)"4$,F8"ANF):6-8 LV6
M,'R$(7$MQ&)ZURB7!U,P2!"!"?M^L)>'\!QSE\%7@),3"-6/0,QYU$&?U3TX
MV$'Q?1!1:?8:&]AG^$)Q9L)M53@][2=E355YZP[3/7M$EN %GI]WQO5RQI*G
M/IZC_*<Q<@T_GF@C)CN^\3/K6Y.IS;1KXR\72R6V?V+7T; LB7N,[(4H0#Y*
MDS=?NM /!_!PR_!V<!9;C33XT8NL5?59K1N8GU7R,$5, &,",GF.8^[(5TU7
M-Z3RH"ZO=:(9=;#+F!:-2,PBGJ.Z%<^T?*9'P])HT%2 ,O+)\@(>/,"(D)Q_
M*P"$Z5I4DY9,JB5BD[H"?,RG&P$/VGPTF_VB*X/S4K(@OL6;\Y)RO>^H:D+U
M@%<X:#14>"4OQ8QGQG(C(1A3,L?P>[!N)V#D' 9)3'!4-T%!1,:?&Q5_^N$4
M =I]#'DK$/!8(J>!5XD^7_YZ2.<(D'-20H43MX?JWM]=[[N/M;O@D]F[KF7>
MHA;<2YGT,VVFR3<SSW^)46=C4+?H(XRMS/2KI(9!?DB?SZF*Z%T<VWK&  ^9
MD6.KR$W4 PD2X'&QJ?LL2F3PKP3#Q>,:YS3L1<$S:2R@!S5+ Z=6&5$M*B.*
MRH@3KXSX^2 4:Q)A_QBD-L\5"BF+@5,P,XV S%@QNXT2!MB.;G"L=T.9.,L!
MC40$DJ9?:Q&"7K-47UIH&\K<RFPI+9*:":7@:W^AI6^_?"ST^,[T>(YO9W'D
M HY#E;3>L!-IP,"183X*4MXT-4IG*U1C3OX;\PZ;T/M/F)\0T9K,-<YTV&5.
MG1!6P$:@^2*MLDAKG#HJ9/6D4"&_.:*9C69CXTWDD%@_GK*MQPAQ-",-6:A:
M_L@S./1'Y2.R@?JYB'+(;V7^9Q1Z%*P04[U-(94])D=X$(B(BC#BI0O.1890
ME^E!"F*45L&E+!!1UZ3]VDG1_GV"J'$H0T@EG,I$:D&8LD I_IS(\(5G."GQ
M9<KY99@:Q9_ ?PNBW 51UD^**!^8-Q&%,$A<!,,;3QX&,^,QM WLEGYBU$SC
MH11T'<KTR\2.N'AJAV X%$2X"R)LG!01@L4ZQ+8]AT?M#<QW#0D;@ 9A\R(0
MGG7@WQ1$M@LB:THB6^H03X,4>]RI-Q1S5%JHLIR$^UP!"4YA@HIA;=+ZQ%2;
M^,;BD]S@0.67DJB#>+(R56-YKF.9)%/)'C7=R21TA,5:T/LNZ+UU4I2<,C>Y
M>S-@*& %;8*#!%8HZ?*(<KD!*J[F)=$X@FO5,CE90 F?8$)93K%.=/4'/L/L
MKT>#TN,\]C*^E1J,;V]ET,5-][HWN\\Y/Q=AI]&H7"V74^>3CB1A$.D\&'MN
M^#@&NNG>?$[%5E9\Z%9C77JJ[O/VRY>KRZON5ZW?ZSYD3$_;XU)Q.,K7+@XZ
MN[R]ONO>_*'=]WZY@D-,OL&^!J94BX$I&Y;7U:,9F/*@2CVLF[:MB875U[9E
M#"P;"WXD=N*[11,)'<.8V.Y_F/;$',=U ]\<&U.Q#WPH.A8%.<:$,L8+02#D
M5%>5/0HS8[MD>UH1796X,9.!Y$?H+32(F?'<F)AU=QAF[#;RS =.A@>0%ZLJ
MT=R<HJ_#YX)=E7<IVL(/!W\)S!Q1/>UKB)?;UH01B7\U"3V7Q'\:6+=9IZ^$
M[<XAHFT#QXQ+G8,]%1-6RC"4]FR#WW[Z9^_RH;\WFZVVW2=G ]FY=-R4"I@9
M\UXHWU<JWZC([BV%M$!R#-D3L]TIII2P39D7@_M848WA 1&_!XHS4$X,+#<
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MXK-0#$("7N3LQB2ORQZ$G$&3D2WM@-WL^SC23.4QK-DFD%4@]9'ACPF4K8L
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MCJGAF++'U&:9:![],371J;XT'BHGF*Y9IQI\Q:2*Z!+^.?6".O_#S$YP=(1
MHJ2*I; H[<%8$)+/D<T7HR^*9?E+,_4]F=5$:(455[_E^%8KJF?^)!M,3C/;
M,PAL3<S2_?ATLMD9Z"]'%_HZEZO*/%.ZSA6I=QP%?CB@P <4^&X>.V^&8V>5
MB3S^T3*$A9? 0X!ICE)5&5(*2=5-U*VECT@*B"E:G3DZ-;DD2C3101(DFJ9%
M/F.C_F.CM1K''L58@$:-CN516B"ZN\^,#5ALI6;PBP<#90W4V\% /8B!DFTH
MS9L.D?###247:(^41TDBMI"+SY)[L8KG: )3=1,ET]AP<F$1> :3?]672'>7
MCCOYA:06H"<+J@$^N6T!/NXU9K9^<$H[,F1L>; =__E@Y08KY]@9G@]F;I69
M_#HW.)&QEZKKV-(^8?4/(Y PID=$+]+$B(UB?!/G!)@V+$&:W0JWN]2%$;@T
MTF-52X4;VZ9TD8!'-P:W[Y)D-!KT8"')69LQ34JL? /8T62R&:[%F)Y"5]C%
MY/&*KH-)VQCQ8.K-B>$#MV6<L<N2VPIM4MH*[7I.%N(!(J![=XVYU>_?U0G7
M*B2[80[V>2OL\W:T7!T>[HQ]OE\W55.?X!A+@HTMUNBUP/RJ5#_4P[?.WLNZ
M]'0^1;;!:V1C[1#E: N)Q&5=HM83OAHLAA'.OP.G8GI,+A'58#M&>ZP6M:>"
MG<J+6W1I&4X!QC[?#OV"73(X]]\F3PG4?X_I^=H%JF86'L]3,7LN[CS$19/,
M(I=OKIA.G7<67P8;:BSH%Z[908*#-9JRKX5I"\_]87^MMK]V!W=[C^DY]@_?
M'B>8BGYMHK9VGOH_ZX2 ' _61!HTNW@/@@ZYP"A]#BJ5+H#B_[Q>R\$:/")K
ML#O(O_O0$S8U@UQFU_ #](*JO)9S8R*0CMUJ)& [$65D2RXY^6POE'IH9F1;
MR=]4S8<(>[NVX*8SH ,?V4HS^=M&T+7=WCAF -NPRE5:"+/\&?)NPTK.QC:U
M)Q'Q6BC,O/'8]KX%1%_^]_&I3&=H5ZS_HSBM%L%;1_IZ<8/#X=#A,)A.SW3N
M "'4P]3(O5W>C@C\#79$5J"1\G/EYQZ5 89<ZB[V);&MEMO-'XFX8Z9LA)G"
MI#)TA1Z(,^3*<=$8V' X!4C*!JP("[MVF6OXA2LIV3 JL<IV5B'+PN[;M(&>
M)$X7,Z"Y:MPW34W6EQ^WICW.;)."C^>SW61&^*G@480*D.U^QZ4'VSO87F=[
M=R>E^]-Q^T'KS0+3VT7%E<QF>I)@C&FIQRDE!5_\87^Q#<7O9VVR#=K+&XQ]
MX5U3"/-U1=?BYW;<VNL#4$6!2 /,M#=Y.4P',JEQC[7-Y 4P3[R#>8S;-34H
M,"""6\361N?")YCSK#NY6GRITU],-J/9T-']/@>;/]A\9_-WI\SP<^D]IERE
MIC)XEJ^#6(AEK6.!7%%AH0&:"HZ2V#=GY3H,32=?9=/W[+ ^4F[@;7[TZ^&K
MMUAPN+-9V9"NV(>O7TY/+DA&[-/Y'\=GIQ?'7U!7;&-*8J\');'-@*\.7S\J
M);&."!2\@-4UW&-?#%TJDU7!,-"2M6J]2!']&M/HCLYI6>;C1#K@UU36D=:<
M#3/ DFP\B_,*7VMV&^EKG#]PHVQ+O4RB;2>:YVDR)@;7W>X7/1KZ18=^T?N(
MSJYJ1_^/!]_Q8/4@^+Z\;7HL$#M#_(39/,>+9K#Q'5[399UXO45.;C6TNI34
MDX]&=9F@U#<:VXQQ[F2V,4.ZZ0ALJY?7.H[ZHT=RU"]#C/-3]#@$@BDLU$U4
MS^4+YS6>X1Y;/&:(\^)294DIC2=-]19:L]P)@LLZ4ZF1-^9.-M@62(!6ZN):
M68V8A2[#HKV%6Z/%-3.F=!DREZ9)2%+K/=6 &'Z0K?-BY[:.6VXD49&F*.BD
M@W49J5F>77)6=%;J])J]PT8O9&-!1J:%Z@83;OX77<(8KCS)YU[-O+V/8R?0
MAMG<7X=EO@6J]VJW5.\7UP9&NAU9-D.@I?FGI5^8J%N8AV?P/PU7S/90E^^&
MM;\%:W^T>VN_4N4W!GG"6D.&>0GTQ4WQ_!I/ "!T51S$NE+?=!8I"&@=BO0'
MT[/#PM^&A3_>O87_'C4DX1I6/^A'6ZK?4;PPK-;-K];)[JU6HR<ZM7BLTE+>
MMIKOG%*&(*D,Q"M0:PWD,.2S+D_(F7<3(!#&0W5IT0^1Z(-$HB]W:GWW)'&8
M ]2*%F?139%P3_K#Q9\$(O(1/L&VB*[A82>I(.;]2X? '$D:"51SBH$%LW=>
M)>5_^,'VL'T>9/N\ZBJR]2[/G=YD'.;Z B#:T<>6'7PU)(9)K:1T"A#6UN9)
M:;N%%+1,@5/@&:1G_!N&=<$Q5B3"%=;7]+E2>G</;O\?"+#FXJ6!%WKF8)^4
M0<JF5.A]D[\X&$P>NV<<]NV#[-M?AGWK'XX2HM-:1@IG*A?T=44;F-+;EWN'
MW!EMQ! 8Y)^PL%J17[L^["9*?GO!3"?O3R]./YT]^_/X?YR>_;$Y$-.;#8"8
M=GS;OW'HI">T[?\MFW->Z+_K23+6@2;+FX-7,1/4!V2?8R.PB-P-YAQLGFL+
M.!:&0^P!5O-N%>"/0T8M8GUV/('(Y9>Q$V6_AF(,Y%]1/%?I##,:WV]M-L.0
M:9FDLTZ3D:F"> F-1[6H=P';M(ZU_^()6O)S+RW0NTQI81?M;ZZMF^;!T65[
M'(Z96*OCV7[TD2:Z'!=@&R9ANQE-I7=2'CY?\I[V'635+[YZ$L+8*AQ'22$I
M'6$D=41E$!/GXW&-KQ&)$6>.Z,]&Q7&7')E'C^0GKP3T$$V2*7CR8$G3V^TP
M8SMOGUX^0?MTFE$6D_F^8)FF*OLFY%^XD]2H1 @Q;=Q )G6<UX:.SU&%#>OT
M0=;I4TQ@_MM((Q::^""C*M&F3X'BG=[#520$3+V75S$G+FG1HJW&*S3@9EZG
MFT?,@$19'?UK!]$G9^H#Q8$6;0WN'[K[2*/S2Z?+L&\>9-\\U01B/\"-933Q
M09*YZD\:>)GSO62?E];*A>6NN^/1LI?XEX(E4!6U9>/'-E!P'ROF/J'_Y&)W
MEM64Z:3S!W9@-RNF$0JY+!2=4E24\&XQ;+@'V7"OG^"&\U(B2_98,[.Q<E8#
MN7F4E*.XUIPJ0]#.)3OXV16U44_H-Q'5Q^2_F509>8*D64=^@_1MJ(=1.JSK
MC[;SG$[CH)N;CM0</LS\4KQ)'0DIT\)Z?)O73>.ZN-(42JUP$1P/&(V,JOI-
M*"//F9D(*O39&5"-D)/K)OHZR6NPIICPRM /V+'&QQ=#X^-/;GS<^4/@S4Z9
M=_$P%B7SQ)R1NJ,11D</!ADR9[,Z,^QO4WA%:<+=7Y(+\L![.76I;YDLQ!/,
M9&\#0\V;/M'$K?*K-I$X!Q<@)L=>JXDPVML,;!P2OEK\8!CFHXOF>0<0[M-S
M)*IP?E"H@>/Q1X(;Y'D2,[=I<\X+-UTZN/48]OF!R5"7E**V5@)=9E+DNHUF
M-8I?E?2_X+D-E:SM.=,>7J[JS2 G> =6PB:.Z8=9JCS,(Y:I.XI975Y B#:<
MYFF:WS#'-L$(?QT(Z!Y'@\FB9;O$.*QK5:N#C>[^K=WME2&WYUK5&#:I82^>
M,MV]<!EA<F5420:0J>/4I<)_!FD-4@7M^9Z*TF268'H#DSD9[."K9(Z_N)3<
M8_!QE]8GE2VF=0JG.[@7N!_E)^\&4_ X3,$6^ *CS9J"1^,(<"7"J9"[G";9
M"Q3\U400C@*,<&;K9%YQ3YVS&UWM_B*?,6S91[)EM^#T'N_8Z?U T[8\X_$0
M=H2B<73;;;OM!,G*O7IG"8%#06F\9N\%'._J$B*,*SCX#\@+&1WP=0I%T#BJ
MXYA_7.NLUG&_L!UOC,-?#VW=HJ[ P_@]R50V1A'R"\/A )<]'E<DITUW*&_+
M2L^H, LC0E."-=7PQN0G121M*ZY+PB54%?VIB87\ O\61Z[KV.J&XR,AEB)#
M0V#KOE1SM;,U&,S!8*ZZYYH:C8/!?$0&D\IIS)D-5@:MA8&($.H_S>%*J<"N
M5"JT=HWR,AHN8C+0)'"85?8O.B'0+7ESIK< \8D5_<@+P6*1!.Z.N/CRJP=T
M,0--,(*S0_:>C%5-T>;!ZB!Y'QAR@BH+%7W7G!WR%(,M'&SARMMIL(6/UQ92
M1JK@=G('MY'(4B))1KNQ)1N+E1/TBF<.L96JPQRR'40B"HYI+5(5BU+3O"[@
MST8&9H:(N462D)YN&7*:8EF:10\2UIGN"H='*B4+5UYI7?%P2&T+K"(&UAFC
MRL$.WVCD,R6.<91%DP8)F#;S+W87O6GR;&DZF,S!9*Z\ZZ:#R7R\)C/)P/"(
MN@O'H5:Z/C,V##X :X4Q[%K-74LI(K!^2/FQBK4;+-5@J59=[$WER<%2/2)+
MI9SB*IHB,%F3Q?SO@V48+,.JB^MJL R[8ADFX'SDZ;4>,D"#*;B71SR8@D=L
M"AIELI'*OA7UO&+1-*,YS*GQLBZQ<5+*9W-U2U'08"H&4['J:OM[QTS%VL!
M7@D*3V$]FZ<Y;2]2?"R(.)%*0BB@#2N'J^19385O^ /_0+=R! LJ5<P@$)40
M&$05S A^U2I4EU=Y41F=:KPD?&'8Z,-&7W5!?]NQC?ZT?(*@3#R^4MFE[0J_
MR0O#N#!);(O!&NW28&4&*[/J0DVW8[^T;-TC-7(_)[U0Z$D]UIW%V:ZJQ[O5
MQ9H'&S#8@'_.!D_C\7H:A*E@:,EJ38NJ[/N+1YN&+)C@O7!7M6HT1U-/M9Y.
MD6F&VZ,K_FX@TQ)P] [6:!OZG+>#Y^#P</G.V3&B@ZZW,)T^/WK^O'&%YL3B
MG#X3Z@ FB6APV'8T0]_%%BYXD8T;->G7?KACFMBM=(%=#1(?B?E()@[M2R Z
M\&W4N.)HJ!$ ^>Q4<>0(B84U4E_#I091X6WHHMPU4>%"926V\)A\H^5((Z4&
M7M@I*6ZW6-2X,^<J*1B6?CL(H&[# MTQY=]U]FA<U"-X0XDJEC5GC VL;HL;
M,P8-URW9<#NF..P: 1#TGI38><X,GTL: Y:U!'B[;V$O )\HLH7M5P@H6Y:Z
MZH+ZKP)VA7'$AH/7#&U>Z#EUT'/6.D^3"8G&!M?KN%__E_MNWM.B/\O+BEKZ
ML7' RGPVF(-WCJGSY<#4^9.9.H>DP*:2 D=#4N#>28'#YUU9@5&I/9]N(6/:
M@Z^!>U"TL1O72"0VLQ)TGGK9RC;3@M$-V@S#7[1D:>1%YS;H'.T]UHH\_(93
MUHW%RBG!AQY$'#FMI_0V;LPWI\*%TEQ\D"Z]CY'&59?5*;<:H54.Q,@;TJR'
M5IIU5%<>=[SB9#KQC><W(D!L9?8"Z84NJGB;&;N+*)[O)SR@D.O[3W]^/CF[
M./YR^NEL<RJN;P<5UQ]R&CK.\+=/4L7U2X<RB8B7BW!*=]U^#F'0^+;)(-K4
M5>G9\!0K33"^&V%;HY^ZL48*:7YJ83ZC-#TAC;>#8GCG=\)N*<!^Z5B9S:KQ
MR"D%+93F6+!T94OT^&MH7X;5^R"K]\7.K=Y>L$-9CV9)9<%688&R*+ LR7WJ
MX@-.\V+F$<]BW1/O2#4=N!9KQ_@4DY+X:AX11*<F$=E!] 63VQ;P-:N1BM9D
M]KBFR8>( X6N?G_$:J"(#GRL;F 6%L$TR(<5I: BH1J64-73%8F] Z]!-^:B
MK2=>L4+0V7U2KN@!;Z]/>W[R^?SDXN3LRV:]VJ/G@U>[9FMX]-QYM;ML#<'^
M4!4O9?-@-Y[ONPZG[X.LM]WS'<F@]RXK>+HRCZY)@,U4>TX^D9;==3*I$471
M8)<B: ^7GJN;O%M\<DSGR]]Y,FAK/]C*W3V_T2Q1=*!(9]1S3A2,ILCT[8*%
M39H$?A:@'.=S;8ESV]=".<5(R8;Q[P'VV>B<(GHH\[9'O$ W20:-M$KHB<W!
MH:NP5;%B?F >!6E%;H5S=7KVX>3/L],O_WMS+M3AX$*MVS </MG$H#$$'.;
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M.$KHW$UY8##0H2=K&S;UCOFR37<)-A0NUMZ=1*Z/V4RD6S[.X5%AAQ"0D?.
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MD,VX>]4:*K# Q?RB1(/MT@EM!Q@#KW(?1W593S&<KE61B)CX'*YVJ=$;4*7
M7DHM@7_,*+@)[EBIH8@\XD+Z%V;C@I\*[0R&\N"+T&4"BAFMBC0Q'@A1R^-7
MX%EL_29\Q!N4$#3<,,->>I"]M'O%E+;^Z"WC0:]AP9?UZ&^L]/G=SK_$O)Q%
M1].$A5P,]-9G0!$[THG1-A6VV+A]P*R#GK;KVTQ9.^R0!]DA3U6SNL/R>UL)
M=] ,I6D3(A*=A>Y:[!0L:6LE%?;M:,0/4*'?_,C'<9'L)4'@*$+%/Q43A>E=
M*N$W*B^'SU_MO61\@<T+"5>*(!@ZV?4QT>:)^NK*9K>3RL"[\1#J?"QV*XD.
M/49=7DN?*H\A KG(RT+?3%@(N"OPIHA[V, /LH%?[]36/.YQ"^?JEC,'F9Q<
MZ&MU+NX6BSJ?7HG\<%P76%6YY9S1<G^0<&^+;[#:>;:D_&G'0E_CR%)5?!_>
MYZT3FUQ5GQR1M7)-=:AKF*VA&0M%1FB"T>P(,\-*ZD[8RPVK!F<>B9GVF/_0
MW,'[JUP(_P*6(1LGX)F7^X,)>! 3\&;'3, X57 VT>I6MX9(OC-@%&UVTK.?
M)G!NW](I3*V#^ON<J,7XKZT=,=)CY.44PS*LU =9J4]10/IWH?<62TT,4RI%
MO*F%0YMZ7H%1FM<WBQ#7,$:3.(L(]^3,,EA8,/&V:USBK2!? 2X=,=@ZC^X@
M.LM[SEN_0.G=0#3NO(C/C 2.R/8 MA)@<'YR<7+^U\GF6#E?' X(@W6;EL,=
M0_(=PS:T1?JP+.]O20>=,Z52T5]%$4K7E._QV0T'W8.LQJ=8T;_HRSZVLY98
MW+=@3_Q!,^^RJGZ;V2/#LGZ09?T4"\6+R$1+.,P/7C*VY BA)F%9EY:M,HNT
MX5WYEMI(#A*/B'.NX$9<3#(DZG09#QDS+/L'6?8OG^"R7RU)/H:%>NF0!9+H
M%GR!=3HB=:FPNK30A,=14C@-;;SKS946C!?&3>92A38BQW W_1TVG+0YN";O
M;0P[/I]_^OWTRP:CCJ,AZEBW93AZDKCF#C\/"T^6*9L$=<LKS /TI9T;'8%A
M9D%U<YR,- M,SXN$=$:PK9;HB1']D4U<)MY0%K=J5=M!7+S5>^)!&8EW8C=T
MH/@Q,F_!^9P&U1BK*P33OQ'7LI6<[BRJ(I@9\1OJLE#SJVAT@-<D@B]2ML)#
M%[X]K9%6)',7ISP!U8[T-!DGV <^*E%Y*JO \^R_1 -33;P.?GT7TY7>OX]B
MZBWD3"9<'C8O9AK-S?<*C6D,N->^&XC9U_;9^5#G\_[F*N?L8C<:T5#!S')3
M(>#Z'D^N,CE^A&I>1GHZ9;>BE\_UL:*_#P?T]U-&?P^<T6NRUY^M>?&!X021
M)L@<:8WET_TFZZF%=H<^"S>.8N7E5E=;9%TET= TI@/-]3;LM!VCN<:%UK.M
M[K(V&]$!^?AA?&#39%T<:G.8+-@:PPK?AA6^8^39*R*Z>'$:Y#5C.<5<>_&R
M)<69&"^X/U<VT,%ORXK6N[6B30=!LX"W:,':^'6>EPCR[R8V0SA7"#?.ANKT
MAK*63[$Z_:6;;2$LV/6"V5W>I8S4@14\&A]0A$ )GR!*&&.G5V6+(9B'L;V@
M'0G2%F-A.VG3Y3$M+8MWM025W"9 -<OG!T?#EGN0+;=;#+(+!3:Y&*#ZFDL:
M97 'SR4Z0*]KNL6&C'L6MXW\5PL/CX5Q3/ZO5!=_D K@Q:>/5  D[8&/I__S
MZ^F'8_KWQJJ +X8JX+HW]XL=PQZ>BD+:M78<0P9PR(VAL.L( 2"D[VGRGW4R
M46%DSRGW1:TU<51G<!R5G>ZB:'4[@>_AG'J0I;QCE("!TP?Q29G 6XZ7"%OQ
M&N:0!STT7LK1I"X,8-];\<.Z?)!U^121AQTA"]I@[B<TZY/])[]1*DW[.A$G
M>L2-B%A0E<MT!A8#MN)Q9J-V#5O105K45R6PZQB[[).)[10>2EW;N%"?1E%Y
MYT! +H5D*14?/?)GV/=#B7M+P"1-#(FG3-XJ>B>]1&,-<AAG+-1!E(_']9W!
M*3]UUP^(E"W>KCM8KU^&2#'.8Z>3:1KW>5\T4"E^@7\MFQ5EU=1$Q\))J*.L
MGHTX[)JH6TF(DTNA4E@TD]M($R'&Q*0JV 'N'=: (MB6?;9C* (\!1QB8%&B
M0<XVC]EVP ,\?')MMRAGCVU%T50MT-T9:U5Z/8,Q<96,\OQ;&0MQ%E/*,JU\
MDB&CEQ+AAJ)(M"]4]$W#XQFCS/*W>%88EXFU$TSA8TY2?>A1)2B8*;HO/L6L
M2:\Y7?<^$ VSY$OWI7O 12),QM7S[B\B,#RPL(3CP==0LVGGR/*/AG:)>[9+
M_+07U=['OY]\( F@WS^=?_T3&V?_.KW8:-'\Y<^]]3_^>?)]C"9%>?5.4FW2
M665=PYN"]9U""AC>OF 1B [1D0J@D:F91 TM()RJ\Q1I9.@T9M$H!9:M9D(J
MQ2)5JDA0Q#<B^6JZ\-<LP1%<5& X2F0IK7$4\)_'[/<>OGWQ@LBWU4RCA%5L
MHU4()'59V=(;0F$K*0>'K((>LS#]4$_(?K&7,$;FQ;H@-=6. <&'QS.POV-U
M(!O[D=JE%X-=VG:[Y(^0QO"/*)G (^;CU\]_^>7MV__O-3ARQUFFOT>_+; 7
MAT<_>6QFHO\\.?]Z$9T=_'6P8#0_>Z+,8(Z>'_X2G9Z]/SG[<OK7273\[^/S
M#]'GC\>+C/J#S53;K>RYF&R9H\/7KZ;3QN_8[S?C/ 3S,LEKV">X)\GQ]_[$
M@YB@UTDNYJ]D<-,DT__XY][Q_UW.T!YVN+E)!H=#4O%#T=_AEQ!<=5P//OW'
M/R_ (\9K_3-:XT7_/#G[</+!7GE]%SX^<U<]7]]E3RZ^''_Q!GRRODO__OO)
M>US/]MK_S__U?[XY?/OJ7?@__V\<'3T_>KEOHRSZGVU8^<?G7T[??SR)3K?!
M1GS^>O[YT\7)?>:%KI; )LJJ7U_^MSLZ7\AT\SE5F85)V+","&UT=D5TR)U$
M%J,D11)TS'Q750%N% :3K)\.WM@LKY)K9*J>&[GV*^$W(]1X022UC)(3XK/]
M*)FA:@^JGX #Z$'3&V2<HULAH1=($D61<+0FDUJEPN<LRH'Y#42$Y54RC_(Y
M7KO.R(4[B-XS2R=,$]P?'+0RJDMMP1XX)31&3-]G026 _:3_M7#5'+U\Z#6\
M%8OXY./I'Z>_G7X\_?*_'WPA7^CB&K'8GUF=H&"R) WC0]2;D#,9,=OC&X4I
M#^?JX_L.^@4X+P!NNVHV1V"R(<FV[.UOQ>L__O#GZ1DR/QU;V/>'DX\G?RQ#
M??^<!?'BX# *G)0%?L?Q9)9D&'/17^2,8AUCL@0(KI>OZ,+!>KV?Y<6B-_"S
MGO!HY2?\ U=^=,R\D]6M?<2+<,F#V44EY3SC?*"_ P++"'\[=H'L1W733_&/
M.3AE[HOWN>2A\!;$*X$[P?\40TQ:KFX@&,:W=C>_G.#I;ZX@.GZ&F67]:Y;?
M%&K^CW]F>?9,?X?('5$0QO>8V+'EO=+7-PE'Y0V+T:%>@A?X4Q=U*>'&LB&=
MP9!.FD-R-\8S3F<E9U_A<6$ LTTLK1?1RI%!\](/$2GX._9:NX5]$/J9JS[#
M/_Y)ZRG8T+1R"87GK]Z*&%H1*#!V^V1F/C1]S[)GF@<,);/@&W/PDQJ[B=;_
M\66A2>2&5!%'^DJETV87 GX;72YL&(HY]42?%7JN52I7#&>GJ%-LA[NL8>O@
M](E^'+ILL*E0I ,IS"=P:[1SUTG)J@#M&4$"1'@;!2'"-8*+^%)J-DK@ZNA9
MX2D*E@$\KUE2EG:&L,J0C9,4/35,[J$EA7_KT*Y(PHXGPQ]5IF&<I2INZ2N.
M"8UGPECF<$KME<J.1_%@P0O>&!,N,K4[I1DG";@!FJ'O9WF%!J $?Y4<4;A?
M=<7"0>X"SJ["?8O;.%@ZS$K?+\?7&(Q-%98K&VTTK6 _P4S)H"R<A9:1O>TY
MKA T,[)Y'MK:O%S]J 8W'O:00;_!KJ#<JB[=J=W )34>NG%N27:V]_C")0^[
MAL5/<4FQ4(%1%Y_G-[K]IN#%Y!D*1D$45&AOD/A1/IW"KG.GC]G8LOCEPG P
MEQ#@D-PCK]^N)B(<G0)_+"FOZ,?V3KAU=(D%*_@3(HV*Y2=3H9]=PV_,F<3K
M7J=3 ^<DKI_43<?$LXP"_JK@U6Z7:[P5&<"+?QV?GUQ$QW\=GWX\_@V&]?NG
M<\X#+N)$_3F;[>4=_.(SB[FY($A"E]NH)G_7)>]'W@5!G/P7Q";6UK![1\O>
M,3[Q]T[_BHV/Q0JFW"#;V%?C_%H3N*>>&^/WZ1HK)BD/,/J(MN_@AUV7Z?3Y
MT?/G#=>E.4\X1<^D&1X6G-W/03K%0G!9M8N?)Q"\.WQ^\"(.# 'YGE2R9_>3
M#I=6Q$KP2+Q7^2ZZ BL$\Q![GYK9Q(O=VR?RSX-'65WZ[=G $;AMQ26X]@;V
MIW2,-5PGSR(%DFYN']T_H+@0!B_FZVY8,O:DR0^F&C0?I)B,'-5H2.57?(W8
M7&M>%^,K@O((2#.?H]:E*KYI4E"J8'V6-7C)%Q9!MA&'[N4=,A-LN,_U^'8,
M'US:(^9T:F1[+<,(J4))=, *9S UA/HDQPI3UN++8S%>?X>YRBX%<R0ZOJ2
M.,$D#B:K[7S&TD'AM:3X?2%8T+^%"^IB3*(=K!T_U0G=B!+>MR2_S?^ ^<PR
M+3@G&&2=5DUY8(@!4-$4[R#OELXV+[?$,1"J>$.H,]:$8X+P4%6^[#;_:0]3
M+'0,&T&1:8J+'.]SPGGP<W#L2#^\(%0Z 7WE3I^I%3B98U8&9XH04C(H^"?>
M%U>CA#B+ALO'6)U1)GW18]$)1[SX1*)TK9*4MAW>GK]!!U_3KSZ(?J\+Q(C8
M#8'Q+%]_#UX&@M<08H$RZ:GY&SO6X!.7'!3M=U035# )J#<)7RVGMTVS8%9
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MCA*KR1+C&Z2CT93.* P?W0:%05.&M4L9$Y;V\&KD]G$>S*T/P*.4?#:F($.
MD=%HHOJH\<:""FC7.8YY%7=VKS!'-\2E1M/CG>:6];QU@T)+7I2;=6@>D G1
MDHVX&B.M^[Q2:;,,RRM'KN//9*6^([&:2??$#C/%M53&Y"J3)W=86UV1DRC.
MPL-7&5_=H<KXH2ZL=R(1A+7:)YZ'O?"M2>>#[[H:Q8F*!D?@ZE(L<^*:YAJ&
M.&[DUNYNJZP-9HL$O\ZBO</G$@L13> 2NTEC%:9][Q1P^ZE)*-'.V_M6=X2)
M0;K6?<WO'H<@=)C _W6'??* $+RVXJ05MUY"F<ZK9)0([42(>HZ9YK!Y*MI9
MH,C9Q)RR.]&A-;(^#H94("[>7L [+<:$M*E,XENW>W@H+2,^O;%,S/F$0"9%
M+W.>P_5N?5#$*%7C;R2_0M1#Y3Z[YDOSINAC'#U_EV*-L)[3OP[?F02J,FN6
MT[*,R^^PL-0*AH4(#H]+1PG214QB5L9=CQ2J/TPD8:X,QQ+#9C%YO_?"; %B
MPG/$Y)SHGYA[(DH[M>N DK]+IXFF]QG,K\TMR]U7P(_+W+8F=?%JZ[3),/=9
M+KN0Y\469BAEQ[M1W^8669R)'*8WY]YJ7&'Z/3T.N^%N*'-_G>0IH_\;VV@5
MIZUQM,8AKZGWMNYD1V(SJ'*UJ@'VP6'Y45>\$&P;_BH_Q"+Y6$)N\T,NGT\1
MZ%,EBOK Z366)BS'W<RN&^TK;H#!%O'FS[A\F&%G39J7-9R];C>ZXIK]:*2K
M&_2QFBZ+\?F6=U.(J!][PXW4SRHSK_Q<%K5@]"SP9I!AL(E1,@.?".N*J:2-
MZ'#E-TIUD5-LX9K(GDVF:ULTS4F#8^(2#A_<;-@)UE.0[G*QO?M[&1&$]6/C
M'+PQ[]T[J(:< (;V%_OR8X,K6?4'.&AW?CO )UG+]TCJM.87[+5=@<O#AMDD
M_] ALO4$BS>4LK1,:EXTW H,MM@+<+-'=Y4+)<A1(#5@*3B =:H2,8(*G#WV
MFVUVVSIGTC27A-Y.X4T8[23/(_.6@PO#.UY%\ J"&FC7*P@]"!IVV C1?E0S
M:XTEM70L>Y9?%@&X/^/5+]BXW4^VZG-T+>_]3408J[??F920#2M,.651?L<B
MI8+ 6/:+4#OZ=D<1WUOE[)*7J!:$-?J4'5E7 :F4T1XO"7-?A$,7>9:,]^&E
M)I>>D99B@ =3N,^ZJ?)+3:\4O8'6,C*!J^$8M_NV&44%]<97!Z\ZR(\[@W&.
MO/RL>:-NM/!&;^']&WA="%+&%H*OSB\*Y[HCOT;UJE6<+2^8<$-F=]>$XG2L
M\>-N8DN\6GE+?):W^Q4-0FM_>)URS;:OU_$/QSZ]1 SM6IY[,;.Z=.JL(U$O
M^H'9?7O7V=U3^U)YN4F0N;5063GEY>U;6 _2 ]--G@5LVO&5AC750#]92::>
MP */NS 'ABN0*DGTJ5!!2D(Q3"'8J9S!%L\1BSD-NGO#4I_[VDA#6$:1N.%_
M?/>(>1I_>S;0-#YX=>?N.VNT+T%G011>*IK7([ .ID>,N%0"(1GCP;KSU0N$
M;2#0:>KWCDT:PGB^GJV"':SG5WCD(B"V :T,&%&]&^V+H4J*0E_G;-,X@V>!
M!2JU.1HAA%71J,B_89 X1EBQ;Q;,^ E*R=ENL FS>>5&9'/B-;;E)S@ZMC;P
M=S R'<:4TV._>;YMEP]MYZ1Q'SK5QOF<PZJ%SXE09NS92H0";3T/2FTX7,XF
M2^H]>.\C-V&2#.QCD$(B\F1-'\Y+&:,_))Z8S<UWQ<CO'OXD&N\O6YJ-*-ZM
M]=4;SIS;AG1TG54AASV OR1%NT2W@;F9W'5N;'>E5[J"KV6N:F6#ID9UV"ZW
MI?-@\O'V%QAT;6!R]+T7#ED W)U(9E^0'ZQMJH66E.V8Z<&S."-,&9P\9W>?
M,.>4>_>!XN\H=_O0TS-=.CTV52X4W4UD#0&T;>B$\5X9]""TIF6K>$?^V@I&
MOO.3BR_GI^^_G B"^%W4_"3Z>G:Z 13Q+T\01>PW3$;WA+@^)D!P!QS7H7"I
M'ST9,YT]]01*IL/F[FQAO_U5*1HV"XHM L]FJZ*]MNO\-QP#AE^ ?)9 :C$I
MN$O,1-*N[Y!2GEYC#W_!YH:;X%.Z+WD_ACR@+G3CGN2]>R#:MNTW:9RRI^I.
ME&686N'6\\1U/S9*!UZFIY 9IK8B6^^3)$/?(>38I4I'&T"#:=0OVC]URZ 3
M9]U\X:1[ /%&D-+S7C625IE:OS>SWC1ZZN6K/C8E\0+Z--O>[T'-OK2>K8'0
M-OR6(0E;XY692DHG]26!Z5I3@E_LG"?#Q+ Z1QR6YI0A.::%2_V,RZE#WOR<
MDV%U?&)S MP1<6?%DA_.9ZT,T1%V! ?,\>Q$&1FXDI@@V*NMMVP!.AY^G:T8
M_)(Z03'"FYC[<'36!&%[)!]!Q!\N9HGZ @!:#^@RV/)WN*#!KWL#1@_7DPED
M)F<CTFG&+/W;AC_'_KSY:T+FN=[(]]P;>6%Z(UUS>H#+Z9Y+MF6.&J7AK9L7
MT]AZI9H%MH;:NDW.TY"H>[;+?L03N' E]"#K;[EW#^?LAW/G]\I!W8W\YSV*
M\DS!*E<^C6,C66O.SJ[*)1C<>5XF5&%!SRN_:=,7[$E'/VN!:;T?"102CPIO
M *8G/-2X['\+C>(/+$6^)C%#XH&;%]+P.P*[^FWA^_A)%G5U &'WT7M@X2+;
M:U<O"*>)MF@!3AW7D>G#X$26_57G!J.GYWU-XL&<O\!8'?E@<^HH1LJM/ .'
MXM8PZG(ZSS8%]UP5O9;(. R8ZM-JPH!B%D6-T4P0E11)T]TBYIKA%8LJ]RG'
M&H]9$>JW9R^'2L.CJ#3<R<KS(2R  +M'CP,S3GN!</19SM$:8\G8I,H5FJ=>
M!X-)=MOC'(MCPKEV@Z@Q!9'"8GB$H"$P#KU;>0,G[/CN_J;/QN5S[/7[:! !
M2936;QI]@ZH:KU+.7R_HYL[)KA$==+.&2:Q'OI\ BE-*KX_A%27"=J>8D[_.
MG"QI +AL(/@CKP2&P=E:G;7>$Z2O!;+SL7$E&E*AQA@=<*P5+#;CU4XW?:M2
MI%N1(_WTY5\GYY(,_70>O3^^^%?TV_'%R8=-$31_HE=\86BMWN.:_8W0]MVT
M4[ J_!#2[S^7'W"DB!\$L::W)TVQ)F</Q#."A(6H*:&"Z\WO;<^PZ.5W52?Y
M)!GC)VF>73XC;"KMN%&>U:7A1=F[N6)O>62(3!TRZ;,N2'H8\ZOO"]C@1:("
M^.(^P;\H)4)HOX;17TV^!$$YV NS;)Z9$#$M\Y /45%9W:M+F&N'YP7/"E^*
MDTD($E<I0D?DU[:5Q@.(I8FNA<3'Z8!8DZ&:\%T7F)MTP,'R!_/-JA=2&^L8
MAK5Q'Y.9J4$]WHS\:I+:7MZ>K?$C2MU?W#=U'YZ*(;3?[*.NU&X'047G864I
M'Q:OU2:91MCM%Z/1L0;C,@=S%.(^1SY7<I=Q 7MBT6?^J<^\&R:Q[,9MDM V
MU=,\<+WT\L(._ZTY@K?B##[^\-^_7GSY\^3LRP5)([S_U_'9'R<7T>E9]/[3
MGW]^.I/S>0M&>O8A>G]R_N48AL:>P\E?-.R']A+>W*&"VL4![6* KC:W;M[H
M-EFEU;QIZ-SP=G B#[32XDT<%+B/;[:&[[;'8))8):60F$60;6.+$SD4:@I5
MD SG-]ZA^]TYR\@V5<O-3&5,,.;42'4[;S8X>IY6W^"$]=J$'7VL#H[4D<G+
M,?]OK2889*MYD<'$B<?2\G%%=<M(N9>NC;[Q54X#.G)&CP+04/ E90C-QJUE
M#+QTIK'F$RYLBOT2A.?A?XT2G@$Y8A2U@J CV]^9UL32+3U#C;],NEZ68Q+!
M_K)J],9X_M_<H5CW/B_F^+&.ON")*QI8OAFJ_ XIM$%+NQ/+.3Q-/K4;,GK/
MU)RP:S$;5^16/V!L_T"R8 T-J+PP*00"WL-^@7>7FE;!!I!K T9L+0:LR6*'
M"_/>AJS!==S*1'29J3ARD$GG&,ISL W)#9Z2HAYJPPY:'RD+7VC3?TTC<*L)
M?\X+:,^G&#:7RZG94?JU&%#KED6X)'I71*!.A*^%NI%L#4#[W=J$?*4R  V4
M[\4]&S(1F+:=J4HPTGGA\)%=R7VL@(%)CW'OXRO$F0K:EEB;$&&$[?8$UR5N
MU.? KF3:L'[U @P]O"]/8Q(>/4DFS1=P_[WO HI&L3!\#9,DK>V+R5*P/D$Z
M=00#F&)^#+..><4]P>Y3E$JD=LM&6RIG*9AZM4%P;$(3RYSL)=V<LJ E["ZZ
MU5GB:._6P+OS:*K&F./#A^U?< @)_R_Y36.5>2^_;*^T?N/SZYJL^KW*;E]R
MF]<U25562'&<SHR:-Z ?RLL8:F3"K23VU&*@."8U.C,,IFY*V%\\U6 1R'Z7
MG](B;-+HYB.!K;A.3(^AJ)V\?\P5L5=#16S[5*PP/8#D\8[7T=L..2844%\^
M #5WFG6N<SD3M.BZC=[2AC-I&2?6N6_6^IA-M:32[7?,&UNBM?_211YS\X#S
M#N3L]1K.C5B3./\;Z ,8!;;2G98\8FX@IU*_RKH8YFV/<)-QJ32PKC)D=:WX
MY+]K*.YS9#;S>6Z\FVG 63!_F'B'$WKFG #X(]*>YJ3@4=;%=7)-4# .+@A]
MQJPYRM /E4XCH3+PZ[P(U'1%8H);D-&MXJC3RDW2C7TZ_?6,@L\]SYGRPU1>
M 8W ' +>B0='DI![)84JWGDHE0$?E:M0EFRFY0A6 \MI>W,A2[@K0V%Q60&R
MSY']>BF,W+D<^T%-M:T])1/;7;?M+L,U-0ULXCHF23^$9%,]BESU.'@\P]<4
MEJL:^J@F:A.;W9 WZ5@<02:<_=Q]\V RH7VI>;^/\\H06J)/%V1R]F/'^VR*
M=9):0G<P[IC8S31J?2'$?ZK&VK<M]'*%4$2@)IY/6A*4JG=GR#QNHJ^J:2[=
M^4B)(\=60N]59;CRKBEN#-@6T-+I<3[3MI?>0=9\@W*]!#?PLS)+JX,6O5?#
M3'K,1>*$;[NS2\CE8Z'6'L:7_UW"#!!;E=>85K@(QVZS6 2EXH:<E#5  1C9
MI__+L!B5-M#:^V+*N(>V!&^,C@$/_\389]<L"/-2*(M7;@2G,EK.2YKM[ #,
M%E_L:")\,]JLOG7EE<U@?#L+=S-_$B,,EBU5A3^ZF.D^PE<'4PAO*,'\3D?J
M;0.)MW@]M8,[%YKO7V%@J/04"2VPB8JZ+AM._M1+A4PIZ41++/F.HT=&06D8
MPO?CTE?>N]M@OGEUIJ)FV^ )9P05UB/FL/[+]-8%3QT^<K#T/+4[VEK-?%&6
M]^ 8<:;E=/'H+L'Y<(NG*43G=8OSFQJG"GG^;8>#!#NT.PN2":>4G?QWZ"MU
M7TR:)."F->_%-(&M/1'/U1BTKI'Y>3B[O3V_=\D\MW-RW4:E0R<=JS+<$WS/
M%V29.YLL=SWSG0?.(YDF>,/,O>Q@I^%O&#)$UC869D._:&.J2I2[+/2E*MA!
M['QA ;;)A=OM^EJ/>\:5+]**TI[5XOEP%L "%!QO]G&HGH@FB>?3$O+R(W+T
MSZ@)$]??J&!V&[V7E.B]X6PQ>?EYX7+8'B]6=NM-&RHUC]4<?&.39\!/\N)2
M93;O8)>B3>AW#4*N$IFE1O?'5+,A]HU]SBQL/.D\V[VM0UD+MWDZMDBI3#(L
M.-1S(LCS[\5?+'H89OVSV%N6O*'8P)0U%1^D6)([PF!WX"]:T)Y[8W74C(YX
M=RL%RHU7(::0"*D$Z$<ON["-K'BN[</<H7? 0%ZO !L$.\M@*0^.DSG]7]N
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MY;=CQ^@Z63@]L.S-TF*LI!#(DZH%*@*-]'_]ER6A@AUF=9AI;< GF&.I15D
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M7:<@LF)BIGN*\/W$3O*7G]J]P#[U%@,FQC)":?Z1TICX>#+5M3$O4/D&K;(
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M<V<)]/U6^J[(Z39.RE3 *"U*=%*YLV7_^9&[ 0&$$2)K?6IP?("I4>RV=#H
MK"L4;KM"YLQ^&LDDXEGA4D2@H6_2T&3(:K+3$UD=Z]D9_^X]$FL0==O+/T^P
M[[,\JHOL"/1^ML3>.1I\IT8F?LI*7Y['->^Z/V0I(YU)!;D4Q!.MC?=,$(=\
MP+0RL-+TY":8#+C1A'W(+&25H?>:UY/!1':Y6/)Y<":B']0#9F@C-=6]6)'4
M^[+6J2E$3E_I<] MX.YV[-JTK5=2KP?\6'I3]PQ11BA2.?)53D;MY]0C;-D&
ML 7<8#,^B'4E[6"^XGSG:Y*A__/0BW^Q X'N?,DN1DHW2"S+C:5(Y#H%/)JX
M +Q(&;"J6S+OJ/M5(X+[KQ'!%Q\1W$!X ?><=67!71!R >X?\V)N08', G=N
M+GO[@"#RL"=MVPHI#>0[SE0+D#"#-Z8\R1@1<V-&:/!6\W.KVC;DK]^05*PK
M\<A)A5G$>T+PBW0(^4J.EX3O!$R2*#4UWYJ9K .@/%#:6C&-9F>[MO<J 4M*
MP+HRJBX8[+ [(LIK<P(3LR@NK#%=F$(RNA<R-:DO,GT0[!?\')Y6Y?O!*I&4
M<*>-"\:74X1]NBBO(&NJ:?T.1FUV\U%6DM8I#WOBA[-*W8NC?FFB9SHB%' P
M:?H)EGOBV].(%,?CGHF.N7C+80G2J(,:32 S:EIZV69%A)SNB#Q)6)N@ "J+
MK>_\ZJKM'.YN[;X!<[JR4ZVI,?ZK+3>4_1>M >^N-R%@A>WA8.4Y71=[2)ZQ
M:MY^HI%Y/%AF%WD)Q  +\I>&C\ER#48S%@*33X>!Y2Q;D[771](C_'B3H?V7
M+;E[&Y?<%9-I_C+)I9*9!3K19'@S88RKR9".$/124.6BJT@,-,/%8RATSDJM
M"AA*RA^GXA=Y76T^&G&,]32R/)W-DD]%8!YS]F?!62>Q+H_NMMB-U[7U5ZRM
M_8VOK3>;7EO/AG2:M_!6 (A"^(A)_S;*8SKYM6^OXCM+?%=4*=8HOF\W++Y>
MN>02I9;YJZ6F<J]84_DJ:V6RMN:,VA5D;>4DV;7)6CX?<X$&XB"+'/@1Y?HL
MP"[:I B^: G<6_&L7*,([F]O6@;),)LG>>5YW:]"-4NH5CS!UBE4.YL6JAG$
MU_/3T[D:,Y?,F(>&*7,2O,KA+#E<\71;IQRNZ"-;GQS:%)H%DN=P]1;3;*;7
M=VB*1]$X Y/B_C[Y)JTN1;6Y^WYW/_) H#8IO_LO6H!7/!G7*+\K.LK6*KZ8
MP#:.YU91,NP^E;'P97;#M!!8BL%>@*-,*!-_,KB7Z@"&K!@R]P4^6#+D? P1
M6Z()V_1#DDXR!Z$<:%(I;]OHR;KJ:RK?&--6OT,3$\J>TWK/',\*<E4I2JD2
M',VB<?*P,%.A?9T.R$Q?*Q0"&U6*7_:Z6U%Y6.>YL>%UUR5/JRV9$3-MD2^
MPH)%6,=K3.;.Q#L[78'W9Z3P.>E(Q3$HRT_Z#SZ@RO_YM9$8#E[SKEX8!?!2
M$GD>MB\[!,0])PWT9W6&\S2;QV&SV_@2FOKO]?:)N3BK-U=)45UWYRZ;C6YX
M8CK=>C?LF/K)2=@\N3S_Z<FSQPI"B"%>JG[!3'3DW$ANDFO*)_:P=2C]-0]6
M5^]A7=IDP,18Z]G-082TV=(MO&KN(@$3%:4=%*CD(1Y*COY T[]G9NH2'Z:F
MP$ZEO*Z3R&MF1C%AG#K@^G6.WSS$_.K/3]"^\*"9BVEE!WXZ6AGH&!:[1[V4
M$MI9_)QPB/J(%1)<\]#C("B"(3#-*16"VM"H]R@_W@O=\A0 8KE.F')O.(W.
M6"3:(; D*B92O3??Q\ ]DK5^9N SDR$KZ#W!S@ M&[Z$$PJ3H!!;@[/R.==?
MZC$Q)Y->;-X<[N[_I!VLWNXVCL]"\T>C\1)V>[?1=[JMX\^F==%MM)J=GU^.
ML%O;69JGK1Q%BT%@N,A(5F_---,QFDPVOQ,6.+HN;CW.,U@RHR>56EY0P]2C
M<YW"BI%: #$U?0AUEG#!1H=U4][1351[[-9VEQ[>+M=SSNR^'=QN*5 $&<FS
M[C7IL$_ YUHR/%T/YG$7*Q4GM"SF-!:7\@>9;^O:?$-&/)T&MLL4V6Z_PISS
MMHK- [H+E#A+LL4U"=QC3*4:)IQEO_L"5 G=BV%Q);([*GKWK)%P,7L&V6O<
MS$:((UAV'SC\$S$/CF *4$*W_XUEDZO_@[P<<CF\I9.Z0K";+!/9WG%<Q=.H
ME)+DT[*X@93US//+R35*@X?[J[8C/;8/C'\@1:BYP7?"FCD0_SI\-6M8% _6
MR]N1 PE+$F/^"?-PJ7R3_"'SP0L_:'$7K_\9#PZF3%I"RB>3]I92_D'?N1]K
M]FV!MX2 URT9L >V1?7:-T@YXE-_ES".1&:*RK[J0_VHD\A)C8SS(.K%ZI!U
MU8>/*8^UJ&EWL3=MA8EBT%-=#<-88(CR?*0W@GV$*5;2)1D";\@"48&?E+79
M?UJ.++DX/%:0)$FL.!<@[:1M!YH^%A3 S(*\@P_+H^,K6"U,1EN::A:P!Q!!
M9^=U#<X0J6_U)WPH'L 2K%=<8(FJ2%%^?,1/)WV/J./)O'6/E'4,4F$=+"M@
M?;+0S%\F=>C7C$Y@[C8BYO!^,(KIOF@LG?NKNB100T]2UNO7AE/^.:'%\"9'
MHUUD/A0Q!:.'%C[V=J2Y\9PVR#N3"NN_[FQO!]O;VPR0PUXQ[N4ZDM7AY;;V
M+8NB"LH2W(,+X4E?FEK[(O3:3GB,BJS9WWY7__G:UMXSE-E/7(*<4ZI<W&),
M,#A,7  B(W&/*Z]HOTA6R@@4=/[C>87[?U!89S FPM*@#,=1#RNY8ZJ@QDV2
MX!&N8XI;*)06[@(Q6(FD Y4M7QQJ-!"?YJC=GIJMFR'[%^J6EZ:@F9>9MZ!F
M!L;"<Y<R$-%;X)9+_HJ<L5PPAZ&]NH)RHLD,>QW8N%H@CTP8<8\K[7'/Q]".
MV\(%B<6'C:'G"6:#MA1XS5"KHQ@.^(AKQZ2-*NV>H$,.J7A0XCT>5 ;A>:!"
M/!(OC@. AEDC*FI%)JK;H)//Y<:\'!;VR:%'5^IR^HO,S!\L-V>D6Y2(%FH4
M'RQ(@*/1+;G4]=!C4@[,[22A4OW  V?",00E9N G:Y-TPJ",&0L@FH!(4,T3
M"7;>4!.4, D>EJBS^;4W(&;=8>I8S".KVT$#>%?"&(P>RZYM-3\EO%I^Z=#"
MX6MHX86%%J#MZ?U7U5?$ ,[+,ZD<Y $&F?;BU6I0))FNSXT@S]96S^7RWYD6
MXT.:B%G*Z(_NV$I']D";>81-,VCK?H?[3FX8'>6H7.?;+'E=G[#.6->7YH(\
M;J0U/)B_;YP5"<&(2LE5Q]"I/]2\B6$ZU)URK HX?/9/51S1)1(3*8?_4)M9
MX6SM589L<SD&>\]P:W5B,+AXK.7@\L/=ZG_AF78CFSU_-&>,$GNV[J,GA3/R
M2I74M.:G4YEO9,;Y\'RYGC.%=<OP7]#_N^2>I#5PGDGVO5O]PJT5PM2<V6\$
M?D,O _GNJ',%^]SV1L8J*PRU  7J %66R!_#)U<1*):H/GATEFN=$+TR[F>:
M<V3DQW/6.\P=T1HR&.8JF9=5EIR"ZX-%6KU,Y")S#)Z,TRE(=ZQEZ AX;Q+H
M:T]_155RY*?$ENWP8+GZ=T7MT\S ^4-;TYLWL,#WEE[@%SJ$:/QS+!96J%83
MS(T)N#@ X=\1IE4N(K#DW.;6>(49&9^]?R X72*&G2X]7IN1![SLYLR^JCJE
M[3KS7.$S#;8AT7U-VU@.MJ^JQ*0X!AA<A(:66XKKV'XJ4;6R6P5[ G'[<\[Z
M*SP/^]&3("7@%PN]*5GR8VL <VV!G!F1.H?,;F&HG[/K5(H("H@AUF?>@=()
MHKVF!Q;"7=4I%@D<.PA5?!4S?2?.8,9D4Z"4B$069*ZJ?GH$FI_S'BN/#2-[
M9BGA&8.-;*6$PB2P8M"FE* PN@=YQZVH?:[:0Y5]C&ZC6V%I>$RR/ K0&CW8
MA>O@+0R]1>8-P)\[K]1;1U,B .F4^8!21UL6?F)?+$_$D5W?@>'?SRWGN0'
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MS\\V\^>=?.1/X.'O^PL]NXX![\:)R*,80@]$N1\ A. /P"TBDMBK4W\(WT'
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MS3O0ZG!CJJ=%V&UUMPO6OY?.7;WQ*9#6=,PP!CVQLLMTOT;[T@?NFU>E*?S
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MPO:%:W2JA$8A6Z+.@B7)W3$ F\@.[[JC9^/KX^WV>7=:NE'/X\)3"H,J%KX
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M<F;RGS3&\0CKWT4GY"K@\O8=!&OXW>%R5VV9QTFT,#G":B&"HU\BO+O#*9S
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M(V;NU4CQ!!/S DD'XW:E.TS$CO:O(8"D)KH>58Y&RNG4A"+S0$)84AE[LCV
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MUA7%E@]V [F=L. YNYB[ L%J,6DW(G2,?ZLFA'^5:1NG+WV&P S#IV!U:&@
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M_P"8?M/+1:Y7NO%;O69#Z[X>T%XB%/LX*$AA# 8%B!>)UHN%\WX2X 8T?5U
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MKG7L !%[.#+31U2X/%*P(]!PU*EWV&)W</5R,KD2O.]*[F($N5+R'/]X\YT
M+K) EX6#U3C>_ I%AE<*]OH,5J)"0_?+N?V2O-/XD9S:QDQX1Y2F98#9>CH:
M=><!G3O(U%^^*983T5]:2*2 ^#=*SMJ7E+*?.R1M'7\994O6,J+4N/&7I\91
MHF\L4RWDQ.VAQS/@G?Z+W(<KA]\BPWF-UIG$&LQN5J52 /N=4GB/WU7D1GO>
M.JOT$9RH_>'W*%W?7?<S(LFE9Z,*BJ=U%!<PQ+=\LQ84!$<F';URV W8BLGP
M&G.):S"492!)T=MG;)B_W?D]M_9^K594<E46J2>HC/7+S)9JE]1[<@U /UNZ
M=!#H+":[6_-&_\ I0#],_H$V#'H+DYL9/9N)PDF@XK1*7,<&U!.QRJC+)35Z
M?#ENI$MN#-R>OB:G]60]PV9KWNNOQIO3.;7 D*AOMV[ I"?,YYTVLQOYK=5-
MQ]G;5YE$0G0X@UG7S E_4&@=V^A7U;3%5OT G>/3WY\J%?*3@75U\C76]<@G
M.,3+=4]MIRF::_E'S\J"2\S^TA;X.GQSPU3Z3047'R,;N(-!Q:C3Y.7E&/&J
ME]<Y27\QQ-B+I/KCY<V(/6;/MYEI3>I /]/P2&O[0NPKISZ1E3:AQ%)%GV?]
M8*P0</9IM47/E$ZA\P^&.$NX7-(B,X_,H%ADI4Z9*[%=_4KQWDBV?+M;&2'[
M]$=%J$1PRWC7WW5^$95I]D1X2^FD1CSFX\-&#+LWS)O[,.6J!N\P3DNUB]I4
M!/H4*T:)8.&I]3=J.'2(#&??9]Q1!;LY[8I?O+-G\=FZ 73S,I[W:Z*L),?D
MR.YY2<\*MH.:I/:^E8W=QPDE7/I5G]8 _S9O%"<\7!J^%)18KS[6\ 8MBUQL
M8PPONS,!:OG5N(97E.^U73^<5LHQRZKM_-0-RTO*%_I#R0&P RE:OW@%(]K2
M.(&%'6XK+].7_W@8=5]\BNK==1Y5/_-I^D:X8Q4&P4LAG"H1QK..+IH!B?W7
M0,O3!);"D$-8)P?6W_]H>I"XM-](#<*6;#A G,E;EG05 [(P6VC<9#GV8WH7
M+2M LYCTBMC>TRWWGI!S.,9KG<9#ZZRA*P%S4DQBYTFR.6=.9O=77:C*'*A%
M^EPOADR!,Z2_MW?:Q^I"MB&QW6EC*")<\2K+7Y&4E5EP[J-[!.=07R3; &O/
MQ(*EUH;YS!Z@77P9Y%N9S_L.,^T[;MR@/B2"]\7 OJ)]H;+[ W+<"),KO[E2
MSG"&4!18OG#Q@F.E]NQL&(I5B15$=4>7.Q3=2K<<[:L!R2QM#TMD+G^0=3^*
MEQMW?C8,T\CF TLR@89"]CJMDWD?YDL^S02@='R'^<9SYFOS&>-#YK?DZZ&0
M.FH6G4IN5JY#0Z8;O;0N5I03='@L3>\![#%"3B;->-\&9:2:I3$L3'=N;Q@B
M]GN 0H,L%R,G+>\1$9/Z*51U]1[EVZD?Z@H+ =_92G,4\EI6PC@ ]_"C^1*J
M<I94&I+B"JJ@X>YEZ>02Y-*L'X=B[1D4'A5:6'5LD,8IT%\?RQ?I2?AU,[KS
ME^L/2F:?VCA4-#?LK0S2:BV]/D3%[JD4NYU=#,+O.-7_HAXVST^MU%R*5$,E
M#E)W[3A(RK1;0BGIZQ:ZXQX9%#+X)EP[^!#]8=T(I+!N!)N:M[MF=-UP#E@L
M,F[9[,99ZUE M"[+F8@2E]=4$V@#\W^>#!-C&#^\P^3I^=-(U;E6)IN+\);I
M\=^R4.\N2H-Q)&J1S)F_;4118MZAC!/SU[,W7ZM2*]P1G"8U\D'=\9=F*$A>
M#'5:NTKH3P/B7#Z:$].CX4E9@_VE=?-0TVCUS^;NZ?RE(),F01&K(RXJ04,I
MY,(K<^ SZEG=+*P9<VUKGB*H=L..JOAMV5NXC"ON3HCDG>JOD)7,1-F_;X<A
M^05Z2A*I,]QU7PO/^IK/%^N '#0[%]EC$;N!!"?#\OHGWHLX*433C#;<0/M0
M*T6-KZ/A6M'K)B5P89VT]G' \*]B!3)S?"O/H>ZYMBL$_8,"SM6$)I7E,_A^
MTMP)DXK8T/-VHP^'DNR8^L&VF;B G]JKO&N2!?'<LQ.);I.ML<?%=L[NK)XH
M?T.S88HWRWY"W ^=O;B9?C&<7A-#\$0>ZCFGS6N1FJ226/!GUO=Y3V5C"#MN
MFZLP <@[K(TT='KX86,/I[L'EL-)KDU&4/"Q1!(\V%Y3(?Y#;Y(Y@847,[J?
MCLW1%6TGW.$,W?!J34'O[V<E5EFM=KAJ>C_NKVD!"'_\K ]59)>WV*A.:*G%
M:$A%BNW-09RJ9IF$W)X,QHETK$'*T4]W:TM_:7@/WL*9IOTR4&'[G] L$^EC
MR9T.JP9<2U\5MX?]D*-3JR=<*V?SS7\'-H;7HA-Q2]H,NI<"P5A!H/5G(7<+
M:*$?S]<TCJ+M1HO.:$83C*J]TU\'P6&N%;X3#9B>"5P[<*:B.I]^UTB;^EAI
MWQ3U8,"%BJ0.5#4RCD.[E?1<>;1I3 1L*=EJY0X2?;4M#C\@PG^Z3N,@)4,<
M_AA@E9UIQ-OG^&I)YGS'9@\MYK _UU-LSW4<S^\F-W#(UJ,%SDYY<+:*'>C?
M.E2I\$&"E%DEPKF/W)6;X1@L9,*K6WZQE.K)$3&-&(JY02#(^-=.G4B?+G%&
MF;6.^4I+%(URNB,I]WMC:8@O?*KEV,8?L1IX6C9&YG*P,K%AY7XVG8@R4NBB
M*$T%A6<HIU[V7?L$3P N3*L^,X4A>,Y4S!ZA)0 82_TC]8/T@;'T.B?$7B;#
MV-F M[2HTX$]P&9E1_F(*Q")HGMD5$0*-E,^KU-WUM)4%OJ*K,]:X7*S?GV<
M1T5,H/73W DH"9 8XK#*G9=-G";22VI,WM98:AB^W# A +N,;/(0652O?)B3
M0D,R2K-5"8WJQV37Q[K<DDDFE+&^YKDU;7J':5<XDEU]!@F#J>IH(T7^]\:[
M%.-/)WH;_^(<.[_TVYO;S>+#1>C1S>T& M?J(_]^+5$*I177(4XZY!>M1X[W
MWMP6OZ(F>]+']@4[$3G=/J9NS[V%CAQ"^RV5U_.AV),5$UMU:_&%]$>=.@Q>
M_Z\;5M.RER<\MCI J&EC!EW^=@4L)7@GD_YR.(*GM'N[2:C9\ES_;X1)GM[?
MFZ86T#A(?K6B%CLN"^V*1OT"CO\P0-^_>-%\\R0E TA'8,T9LBAV;=([O)99
M)1@^KDS"ANM=*.!$TTY4',X#"J?FU(\8"YUB5!1]C-SBLE%SL#NX?T"+/. I
M3YO:'9Y&B,6RX7'\B3O([/;8$ (_U#+/&+2C1V?3>(_WAS,?$JKO>[>\].B(
M@7#EE[:+EE"D7?9Q9, Q?5S"*FHTENW;**GTQ;I6,&H.3TP:W?RW#)K$X=25
M3'GO-=THOQC_.;E/_;QZ__=%</_SP DL;']EL@,';#$*N]V:.H&NM&#=PVH%
MDK!0U&=TJM(B9BLMMY0@!BNO>8Y/^39X0F3!7.>TTJ'M[<P;1>/J5LW:]KM"
M" W"F)V8$)<9M%DMJ_1UB+&-"AH9F5_G>H"N*#I+;[Q[_*+\)RLD87*:<P6G
M&@&?7];N:M@U]F4(GM =_Z_N5<CE7;.&49?R8-ZRCX5Z^S\7Z%*+("PWUI?X
M@G5RYZE9B_P!/ \TV6[JOD0SKQ?<*]S 9+_AW4&P_G'GR.F H%DLR_Q-L3$Z
M;\V7;!=^7KEN0UT#]U8S6XF23R+P3@EYWWJQ>__NMZS&SO60K9AQ0XOD_*S?
M%)V^9R+WEL6 >YM/LQQ[6N;C'SG17'XC=( =TX!EJTF3)Y?,GTB]0$HFY?P$
MJ[0G8Q_2  (CT5<+8_V\C. /5P[P?MM=F4.GLRABAB-KY)#?4%QX_%+:PKNO
MCW@S"DKQZ^>#U&3&SJ;B 9V-7+0U.!_E.\+E1J]:"CQG)8._[:<,O[S#Y/9(
M:Y8MGVGF7&%IS$YOJPV7@'*M%(HFROZH!DS=R%;&^@%-"NSKAM1FB[+E)8IG
M(@]8,?+UF'!MZXGOF>9MF'@_Q<7CJ4>G3SUVZ=2\F7,Q7S-'L;4\.#;YN*:N
M^DN11!6*S0X!\:HY%,A?WO(%I8X%'?G;L"S#U+:_'M6E'6#9F664;/1=,]!E
M"# =KQ$/+C1EQ#0K8*W9?.C](LF0)RA)9XL;.RVXG6M449_>=$R@0 )8-8?.
MB;7HR%B:C0I[08A?[\XJ&9=M]3^X2@W')G !UT "1@QH*/I-K19B<?0=XI]Q
MV'C2":.=IM!TSV52'GV^#VN$H_/1&! :?246GH$ ;^;9VWH^$5 K4"/;&C?D
MLV*OV.QQK_0+_O43+3U3&7>=O;'CMJUI"RS]OO(;9O(3GV5*N1!YMNWWK8?8
M*$$6C3_0K.2U+:^$&LPD#*<L&RZU'0#NB*;@$<&/P[;BS+!]K9$M^>%FQ"KZ
M(UXH_C?;WK7*\5E1/#A,NK"V#,'2OU+?%-8EQ:/@-/:7?S<8>0%(<:.&'_'0
M2J>-);:$9-FX^;)T6-A(LN71A]+?8:2+Y-K@5 [TA&5Y<<Y177TL3;A.;75E
M';IMI?8DG0J1Y9:OCV/E3[ AUTI@ZQ*IVJ*&LS'FN=!>X1##^HJT+1 _R,$S
MUJQ?XW=BBEE#_<A<,HD)&W\C]E)!F6,R<\#W4QY/#4:PZ-YWN^N=[!>MCYMU
M?JPS!]?;*OWS'7FHD!Q@Q%B*5:$<N'T45$_7_BQ<4@ _>\#_>>T.ZEQRR2P8
MR.M--=+P<_74C1U[ "]T4M)UI!=1@[-OD#3.I3(].H0HA@-=(JY1[:W^[OQ$
MC"H!Y^ =1H2)KRS>)=,U%NS,E,DV;.H^M/X-YGYOS1*9XH%;;8]5=9!SRJ8(
M*+]'^W4HE,12'"P+)-2Z8R39'-K#5I>5B3:8*L)*KJH*[DX!), Y$@IB;9M1
M8EMD,'[LR4_+O*%!2KASY :E) $0%LE[9U08?_ZZ"ATQ9"*O9\[:%.'"HI$A
MO8&I*2N6@JQJLH[&:2Q&\3K0N)?BN>=U]"Q%+61G%="I8E_\6^44C,_^E+]/
MKO@8VT8/A"3TA2LEEZ@I$\GT Y]EP%\+^ 5(>$[(@]9&Z:KE?:LI-RD-!A8R
M?6NTV_/%8@/\:6XC?8A=TXT$:WSMQJ_B%# SU+<"Q2UJA6S.'2VR2SNCFO-K
M=KKL)$*ZB,.Y"OJ?H)!$#GRU=-PL_H-ZW5'-K H&L+LZQCR +CMS,H,4I$3#
M6;1040^4"HL.D5M&K0L;<. CY,BM;3J,WY5VX[.> SW_56,6V;6-?\1KU-W/
M9/M.U?-SS6II."!*&"N=-0AI%#%P_D<Y2[S#5WT-'<Y\$9ZP*NS>*^SGL5:L
M76OU/N7=S91(^]!WF&OR+$.51?$>/S*;<W]3K2$<OXZ5S+6X%*L\R7)%RY[9
M &49I]@%$=-X@/C(W9%8LI'F=6W6E9W;5911]JT9+S$,SY),#IPS:G6MM/7G
MG70O(NW(P8@@+MQ=C&:]51 6#H.=BY?\%]!'ZE75"6CND\%7M#YF9VI.:YEX
MSE^8SLA1BX5)F(*+?Z172-B#9$)R)&D7%VTPOF:"@"L:!6=,RS@^_QO.N+]L
MU'=>G>B] C:/_E&#A=MVQW<8\D:H/@9W*GL1$].^>"3C=PMZ5SK9Z-GC4!XT
M0 ^]I'J)ULZ(.">IU&_IO)ND<L..C,T2:7MN)J$&7WM(4;9.=4)1XG)+'&Q.
M"%Z&+D=[76<_S' FT7VP\E,4;V?9P%1GR0S>R;D87TZREYU?5LL[#/VKVSO,
M+[^,Q<K.T\VBOR)9Z;<;KSS_2(O>9O'1?[$7[W>8+T7_^;7!7M>;-\X[S$WQ
M2_CB(\^;A.,\\3L,PR-.YRSTF5V0+1SWY9".G.3#C#CU1!# .XY0?PAS^)PX
M7#*43O'L</J@Q-6W+0C$Z'&8OPYY5C\D?X=1M+MYLEN\L?N/%)$K8[.!4&QB
M\L$P0D%].)G,+]]#>V/0Z?=PTRC#&05BR!J65W<1Y=WN%X_.W0YPZQUMM>ZK
M7F5Q.<VK"^C1?S%]]RB0Q>&4T")/9)-HBNE*HO0^IU+J]9,@4JJI;ZPK5?Q:
MY^@WSZR'X1"?Z;@HJ]3X<C$+L=-[<[^M]W]=7:Q\ASGK>GM6/SHZ6RR&ML[.
M&F9=>+2N'[W#.+;>/+W#K/Z\6:QL/((:V'DMO(HHU7<J7@ W'WWYVO^-G1[A
M>B7SPG9%_:33H;%3T>M"9F,.[.B_MUFMMW'[#F-Y'_"Z4 _YSR=OB-TL</%P
MH1YZ90=\A^&M_R<4"BUJ=X.<_*<%>WVGLH'7.\QRIZ+_;I<C<+.X\I^:IY/%
ME]5WF$:CA^\<>[#A_&A; R$8;,)B>9 'VJW!3*S;[L2U0SDO[N1UBWZ)]!$R
M1]N%UV@&N<6B6\@?[]?2VWMO]?.%5[=_PSKQ6IB%_)M*RN(*Y.0=!O\O=0,Q
M&?6J<(/:K'*%SO!L1,Z90D"7./(XA,CQ\)4SIV BZKDGC$IU1<W S-HP>?:?
MX"&I&Z+2#WVCZ>R)N6:[<2C-MAA"#T[KJ8SJ2\\V(V1T W,WK&,Q;^#UAH)7
M"7\>PY970B(*6[>CE[EW&#Z_TE?B-X=[R+_P\35CH['SI0F- ;C2^.\E:+V.
M;-1#0'HW,[Z:[S .KZ4+G9=V'\X6*^>/H.ZW!6>&_Y9D??L%<.,=9K3=SG:S
M^$T0U4=EVWB(@0VS^^\><1*Y33A'[J#)52WUMQ VEKPOW"OZ&=3LW9<[#8V\
MA50A*F!'63&WG"%'X$;COT?]'SO[KVS&&_C$:_,_.0#X>HA_ G#Q[<OTFZ*7
M_TM]P.O_UTFR_P;_#?X;_#?X;_"_!:B\B4TINB*[^;@Y2_9PZ @))"@GEUF)
MUEW7H!3E%VDDS*S$*T$L*CH!.&T[%FI-YX#MQ,R+0YISX>0;XMOA0[(37[J'
M16FO5"=YL@WQFV=9X92'0LY-_'[7X X\AFA8TR5+MZ]):E$I0E?II-@2!D>*
M"AJ/=@I!R5LZ_06>WQ^\CMAJ8:'+6_V9E@5+QZ2A4)22E0B'7TI8"GOKIAQA
M*0 7+(D;;WMON-@H#6P'/1(V,EJ:KP%0WNGO?2L/*8GY985(;QQS%02ZF\M&
M6DF+3_-+/_,FHJ-"7\!Q6B42I_H-GYLDH@=!_8-$@+;&U(W5R':N1D*=7K-6
M.[+\O&M;FM]4T0%*]2I>-\ZT-(1T+;\6IGT&:K\GY"!HR+PL(S3?B[:BDY(K
M[<K$-:ON.1B5@VG4>)59?RA*3V;/  7-V)2MJMIW;;X5"7QRVEE@/%:F7/,G
MM-T,YO8,=-/!L5SM]_T]'HE!F4C8-\]!H2>OT\-^07<]Y^.R@F/1UK&UD?O8
M?WAXQ&2RZ.G7N/O,:TO*F2S?#]54BC%'!!;BZGX8&X"@QO[QE"$AENG!UM!G
M<:1BS-)-/6OA&\2:WE(CW8H+B@SI7S>5$JT=SGG$9<_G6KA7,Y?'7\*/A&-3
M(_-J4]-8_FY6FH"I"Z:3I]44'OSX:.!0=3CORF!8LF+EK\&T=\!"T/+P9B<*
M9V@1UAYF97$0X$B;MXH.M!RD/$'W(W<:9IDD:9HQ9:,-YF2_$BMX% [U\4E&
M%/' T8=P6A@JSI^]1O%[.TKPW;?9?$X2JV;.U9'&^)FP$Y&XRN*'@_OS1]]@
MO[W_-MA7-/1//<V(VX]1WGRXK)RS-F77XF;L<=XUHZ?9CJL&ND7:E8J&@ \O
M/W&J$M9^-Y_*8,+OXW^Z,_5=D_FUG/+@#,]*FK\H.%#1)/'ZA\!0P#+ \;*D
M8(BJ\A*-$P@V+'86?;5G#T\0H'Q"(@H"T8P/9:*E#UEMJA4TWU]G^-8QI<K(
MS?HTNV;&]P.#%VC6F6M;T7:+HFZQ0-?1U;C*,D2>ESM)4R<D+4H4*JJVJ98P
MA)[?/U:3A7\BSGI9'Y(([D5"X#_H,.XZ()<(;UTZ-V>#?42K:>^-Y/<DW%V5
M/,F/K+U9+L(^54LWIT*W<ZC_5@B7\,7IKH_I'6;>QDCT#)#+G7BUHIW$,TF-
M!U@QG33>=K>SBN5C)/GB&BS@JKW!CMXYP1@%_R(Z_(D1'U!G&85@4_<UQYR8
M=O;)AC.?1LRVNBSL\@VZ#Y%L\28C1C!@_N@:F(?6SGF 6E&-3T) 5:9M3LZ%
M^@YCU!:7HH$P(S'.D(>%"&(;^GU=)89N)BL.6;!)3=&Z.EWSTQ-\B&[])/DC
M!;'\!G#BH760)D ?,]QJ?)[M8I%.X7@P(Z=U1D8^"%0S_[SC;"D$AT.'YAMV
M!#+O.3_F,:(,\T":/5%TU8QV[^\KO!:0]'O]),)4,A-(%L/0$G3$+;DLW6PA
M8H51.B[I]G> ]ZZP2T$[EXWF@I=#SC)A]*4=\J/0NV@-Q>B4#&A1/#@*<U3E
MB("*9:"]VK_KSBXF-W+ZR^&(9320%8D++]*ZI" [=OM7*U(XB+W;R<(5(_W\
MFIG@,Q--@>V%3X53^HMPEGPQ/#I3/*&U3 ^@N6\-CJAI]3@3L6MKALQ"!9[0
MG3_\M/4^03BR%E=!.)AIPVJ)L1W60O+F>_MAMF IZC[OR* <WJO\[%APZ4]8
MU^6R((%U;2N9["-,Y$R+^X%6-A4Q3)H\#9YJJA"4H-5"ETZ&,_U?F9IV<$])
M<BMG7$4+3YY_U[G5W4- ^RR:7ZO/?U8 J9"9SX1#HG JGVD&ORVQU9*I;'G9
M$B,%.81K7(?[^J5[%P-\S]V9#FPH_&!UVB+#\6?&Y(VW2 ]RM<URSG\3R+E_
M?5U"69@ON6H0=LX]<WC-_S64@O?T? ,L3@T^\ZTJBG,A^79H9RF$:O#Q(8&7
MV.^1;KNI7[/4C0'D4ZPY<N .L1\=7(?J89JH;$0E"<'+ ^5D@[;/)E]*ZY=@
M@'8N]6+4)'V_V,VT,MM78K3A'ZF-=3_OY'$Q"<T91Y+4SRAS%*96!U5))Y!!
M6!%MSB#>B"!NOKCYRDA#;M[B75('(:&9#P2*;3?'MW?'Q"-2/[MZ^.19MH4^
M;Z?(N2^L,D>-TM(WX]M[.N_TFH2#GGOAARA8[ /X%XJU6V,S8C?DNX__(#?/
M,/_LFA> D^H7>;IM<?_0XX6;^HH(UP0?6D82W2]P/YV6W*NZ->*MU*$O^--S
M,".R<0S'NN;FP>=.0X]5:!7.[UX]S187)0"N%FV/8.5&S/)NK+4X@:[2:8C
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MY->!U4 #R$P;M(27A9'9FNE1RG2A@'K<)$\:CG.#7F:A@HE']07&I'XR@;+
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MJ/',[>>)IVU\%X>W+)3Z4+_)X+)=K^:W X,/<56X8C35ED_ P<FP\MVGZLY
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MD^?&TN%6SY*=&[:2=H.V.1J"\^3=C[!%_I;YFA1O!ODE?(E17^]\UFCJ.3Q
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M3Y+HCR-<OLTPO0#;>%>%Z:<(@;JH4Z*4BL?"=&OF' 4D["%F\8&DM.T>Z3<
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M^<@* +LT;(W*4.8/J[#W'7_R@=O%8I;HPAQ4'H'QL:,U[WXZ]*BBRY6)@Q3
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MOH9:[OCU'<VDC=[RNZB\&2-93A#G-CC,44XV*8G"\_^%P!?")T&LKM6+=(:
M[+NBN]H;84];\ ;A9B_E^W=!/4KY%^='6Q?WZ9Y!+PR.O09 V.%@EJ]KU.VK
MJV:E1UP*6^;LP'KQ$BDFC3%(,YO:?@(X1<M"(DEA 2P_3<#ZOG'D664:X#16
M#^*IW2?QE,Z,Q4L<]N=L>6;3;RQWR2>6-B1W_1YG,B$ZI&R 6S30LHDEM<??
M59[.JDI9!,'_I4W_[+5]/<0*A6(L>PW/&HYSKIJ#R:D&C+#WE(]SDO.]^*P.
M(.L],DA]+JH\>UGG)@3GF'?QN9IV %SIOF$L=*?R;@LWSS,2L1.*[9865([/
M1Q@+C'J?Y>]O2U4@:UOOCW _WW2.=IO>WT8/!<W_#>[5(I[-+D;NT%XF1 5[
M"^FCP?$Q%RT-0RI6"18*H9#L&?<D/23D;D:9,=.;.)?.&D-TGJM!<^K0!YX!
MFO$>TM$.JR6/BK4-_4C43+R".'$!)PMV">Y32_V$%&MF4Q)P__C*V4[. G0;
M&S-&N?FNXN-OF2?=Y)*V@-VZLK9\G\.[JH^5W7[$WOPJJK*;C_;1?<=NE(R=
MRT)*1@X34.Q##D,7[TVZ\+-H_II440L%0<]$]Z51"."ILI6LG^S])\%>?+7;
M>YV2L7$+>HOBDF8HR1PXUEYVH2X&^?UN^I)>35U$EMZI-;1S1%\TUU+)6M;6
M 0(ZLS^:*_-1JFD^7X <!=W\9X] 49DML-E"6;8+BWA7LRB!P>NY%94XB(CT
M15ZJ+(5>.12"%_/!Z9!ES>LN5U7/NIA&=J,9=/&>N/=TV#R39=W^_@K/_I;(
MW-JY+!.(YURFZXR_0F#?1Z<GVPS]C[NLZP1;4-"3\LW1FGHVK-&%RCA[:9T1
M@6<<()KUIHV[DM;2))"]8=8F1.^%^_.)Q$*V= R2_<RJ3KDHI22W<\,90A@@
M6K@)RN0LT9.@JR]9DIA<.@]><K0!^J\_4OEG_^Y5/'YNTM-,'X95 O:M9HQ[
MV@5X=PPBYP6-<=FG[M/2R3_;8S^PK6LFC;K<CJQKOF#]*SJKQ9%2S2*%/KJN
M;7>ED\A(XU@C%JL@QM?Y%A457N.[&.F$-9Q>B=!C0Q?%19CR3!.H2F8#$D3Y
M.PJ^2^74"LQG!%F(;1;CEFT$NLG4]^%5+(6(Q_+_IL.J-^-="MXV'K,>9ME<
M(32F6X32_'Y5X_V(6X3BN2G4LN#0O3,<CWJ5*A:B%&^A7P]W^MF4CUD_DY[S
M.5"*1%Z4$T2C8MYPWGSJC+]DKK 4J%G4DVK,2D]@(BFZ*#5$Q\L/;Y%?G_3S
M*\"J1L:Y25!YVCI6,KK' T+D-U> MY(*^F'A]&]XPZ/$YK400[T[U?\&E=DW
M?.JK0LB1)%=UYQ&%[S2K=DHP!&+*\K/+:Y%WIJE"FWIMG VC%NZ"CE/,^#'A
M^L9I.;^IQ:0MJ3242<0)]X;LT-K!D,.ORY-$G H*E 1*DZ#@!7")-Y5ARW<>
M<&7+;"'MKEW@#YUJ!H4$N';VW_=EBLP<4%Z)+3BBA&4X!6%;_X.44=M9F1?:
MC>:@YU3;*I&ZG^7C#8$1MAQH.H#Y*$DIJ;JTH/=O@%K%K]C+U!2"!$QO -H3
M!0;4-P ,4HVNWQLDA8%!'A3D))OOK@>0E"?!I'GO&!^Y^W :&?XTE"2SI*RK
M-DF14FO?D OZ3SWBTEW+XAN12Y2:%PKTX\02A"ED=::=JP>(Q>5.TKFU<4N(
M*SXY)V.OMYPP,'R:M;G9@+;#T.7;.1S>37-X+6 XG9853::AM=,W?3I0D/@2
MRJTHG<@D+7[%,LBYK?ZX;&]M3KNP"+7U_+K8]A%-H$W@W5.S1,QN2UL^9M)-
M IO[$;/[6!1>YG=P:P4KS*#^\_R+>&.3#Y[ABQ\6])"54=>60;MH=KT>SF:5
MWK1T>WZ-40"'AB3#1R6?@8"TV"J[]ULBE+,5T=:>PN?VS+"KZ/U3.X<])_D<
MUP^$*I.^\BO:)X;WFA0AXB!1G>+0M?B^% HVCU(/*@4_0KXNR_;U1V9!,U"J
M\N1DM,FH$3:Y,@U.L//P-\*/E_/E<305FC1GLDFS"=V20'RYI+49TP+=#3#4
M49O(;:GJ!"Y;%2W<P, $YHPCGASZBQ:I?-,[&9&E[)9'=!X]0$N5_6!FU6CB
MSB= $>&*,*E-T@4>71#'F4I<O(Y3\)LT:QDWO$^T#6*3N/'-D'9439&UA6(R
M3%\34ESELP!O"\?WT%95Z(ZQV@ G8Y-0'\$@IJZ)9*G9BR>C$4GOSIH_6QB>
M+$S3;GP'"U^?DP+G7AS53@F^K_U2N)<!H-S2I'97_II6WBVE_6&<@;1>R$H>
M'_^]J9R[Z6^+BKZCS"C)G=9FVQ7HXPF<VO^$^E@DXT) \6[-D4._X#+4I'TS
M"UD^QIL[MJ5IBS5:\O=9S%V/RGX&5>FI0D"VL LXK!?7RXN'^G&AG;:N$WUL
MJIO)P:[]0?8W0-SQ&P#DI)Z_*/3]#9!-,/O*5_7:W*T*$SGIR,EDV9*$O7H*
M=UO>?5'.X-)=:S#;/<)W=1[\_2,[J;2KF,KFEC.,;M:P,P/G^_OWH42(;X"S
M-\!H^OW_ A$?.Z;RPZ,G^:;[KFCME>8Y%ERN=N@L1#_[D'\:OS9LESJ4V.9Z
M]V*[2OH;J9[:1'\!EG)L\?*HYP^C3HS@?'3LC]?B'M2V3/,B5<H0/G[!W QH
MTJPR=_P-I_/%M,,-+5D7G<Z)'LM$/1ND>IXX^/+;$^6E;\N>>T=.] V0:>]?
M8.D1$#<1MO@<L6WP2\HZ1C,@S<7?7,)[G?==%95$O.7^-6]3!"/I<I9$97W/
MK2:O3_E< ZB57#XMG54(>E-F]9F[1!9KAV]$1.W^Y]*KCB0J0K9;*VX1L"[N
MIL(T]9LQ3ZQ3!T 2!(4?-<O&+ZJ78Y8_I;GB^MQPJT-G><R>2G&HSV H<SD]
MQ9-O?YE<E'#J[* Q@:Y8TD>&.<Q5D=.LT(*R;6"4 :/!7J;R1I3M%6G3F"UU
M6.14>7<U3FJ*]#.3-[[)FG0[CQ=WX$"8:*X2\EJPLG1X2?TJJ>GCY(FU?H1)
MQ,7:P#7$_0;(50 [P+2UXW+L"0._'C%$6U!_02Z7%"7S%B@M2EIR"<#+9<Y7
MAFZ2W#!ZR(M/-,^U"0B/,Q88XTY5OV\G\MP3<._7.DY+0^M?5DY-6-N:[C61
MD%SQ5]^5 2H4Q-9=.GYZOH@Y/TU_Z*D2_+%I,U+E>62Y#T\5U^P6\7U3KS'Z
M2%[;N\^S$<1&GF]S*/N79WEJ=R+\\$6KH!)K6)?LI;S%W\[HJX"D:3H6-O(;
M@+TP]1#[E0%S[L._CDFL8I3+EJ'Z.(X+O)OL/YYRQ*I\9[;1L])K[_J9[1K5
M.KSX3(5@804'8MT)!\QR%-E)KSU#,IS13=]T?)$K_@Y..Y0HALD" [\&<ASW
MIN+:5Y:+"<!A'#1E@L!CSI,*":?N!'-1#((,T6!?CQM7 :J<39$'*F? D!"Y
MCZ,=-!K?KK-;(C) ['CK7/\LDC?!:@QG[VK#\YL&9^C+IRV*WV1T_@-)D*PD
M!HR:9Y<'-%8I*O4NL@@I[U"!#$D[420/+?J/J+&\ROT1Q:(_+:N5WI,>[-I]
M&T>!,JOR7TX92RG].;3NI]'#N=3L9. 5  9AX%^)SOT=YBN*[1)WOUFCH%W5
M^OB2,+(*UT@9H)!*SI;6'H'5B:F?464AF>KOC.]J)3;DY,><==]TD4#BFFC,
MW]F!CJC>YBJ7FT'NDZ]N[ZXVSVP.R&R$F##9-F2&:K0<?BUG3CX+WB\$,;YP
M/!'.,WXW3+Q46ZEACPGC#TA&\O5[*')8 ZQ&N;-AFX+UR SE(KT/* D8L^%,
ML8[G7UO5I:?MVI:X<LO!F2SJ\9!5YL<X7.-X=-^$$L^CO18D!$V5C7[W(X7;
M"SRB<,W?LW.C>XH:_H.*B#;U^B!$.R@_M+1CS04N%1;17]MQN/_:SFO]"=<U
M%Z,@@$!09.ZT)$Z#OR3O\6/(@6XY[9)6-4&N)958@Q.R.FV9FM)-X%34%Y70
M^ZW0?D]Q;0DS#B!)A2*3C!=;6,\ZQ1:Z!9/HI6C#7=+' <)=B6C4"\H0AY51
M@_ALPM:0(PFZH&3:64K/][%KY;^6(D5M^PA^?C8K".#!PCUFQ%M^OUT%<>!F
M[>](CSZ0J!DX>4=W-R $"J:P:>0U>A^0\N7L)KV:D#FG?CUK&AB/.6;"2BA-
M*%1"2J; FROCY!<0&U;U[+<,&7OF+31\/ I.>K8^78QK<&O[--J<QMV?E#]W
M4E")/0MQ=EU$^1K%M32T0BZZ.8O_;6BZ,_PU.39IY;8K<E4E V!;YCW^!:.-
M_5=0L#[/)M^28NZTK<]5<-"NRDF$*=>/;$M$\^.0[ )*C(CU$%8XQ*0\B=NY
M3+WPZ"XYA')?D^RNO_G?'O1M'?F(C/]LL/]K@+V\);YV.+/8$_XA"32.E1K.
MCZUE@]_P>9OQU*;V6UE9$SEE==5L;'@;/J\DQ=E?7B\\'"3Y]E9Q[>9VE%'L
MFS]65G5$C2I<G]K>^(0=5"[;-A>W:4^?K6V1HS[_6#ZB/>],WQNR-;65_>;
MP_2IZWR\\V-G@TO,\I;Z<:CWG=&QA;B8:VDS,T%-S#J#GZYN%0:)T;:Z7-)A
MBEC"X2TTETA0Z,]?_P[X%;_Y$_-'\=:+?HAA8=(^?>.N/&<5=@PJ>4DTJE]<
MA';VQVB03\2[^LE25OAS=H+>%]'6$2I-I&J8*KUX+<Y-9$IG1#*QGZ!Z_,\
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M/<MU"+^F0;9JVAX]'%$R_KN.QRR;[RX$X)T+;S_G?#'\&6CV[(BUM:.WT1M
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M2<7(UZ;1V3GK:TH&"R,J'6ID80B'C,$_DS!*<^"8>LNG;R:3DZD'D/A+]FS
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M?4.>Z#G=NZ_D=()V$;_5I=2J<[61-/L(!RE>[W* C8HAVQ!K7=H40!:9X*C
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MINVZ72:J-N"4:5Y]@Q-R'6%8.-^8RBKYN68;J=WBS$=&&P2_=EV\'T8!.72
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MAO)99Y+I*,UA8&RN##\?#A_<"*]LX:3R6F/]#IXF;=4 Z[AO^J:55/NLU#Z
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MER#;@]9(^T^^3,#$ 4_W/+CC$OI#< 9^.A%;NP_+Y^-BTZ,W@-6B!G#!92M
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M# MRV8Q(FD/EIFT_F795S;I9'](W.-"8!SM]6##:X:CJ QI*6V)IJ;?$'F%
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MQ1-V1E$>\3VPUAN/)*34<E)JUFK)Q1W/$CQ/^L\?)Z\'8KQF3)QX]O-E[G[
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MDJ(?IE1H$+M2K(@Y->@NGYJU*P=5/QBM0M^Z5_2EES1=CX!)E+RUU\ZJTTC
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MXK7+)?N"":T UJ/Q>@\QSH 3>7)"] 49?ID@9<Z:V5H3.J Z+0FGQQG:JU9
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M](1K0)LA$\4=I-7V5Q)'*M<LS /6WF$016RMZYI)8C+*%WJ++LRG$;65A/V
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MOKCNF97U9AB[0#3JC]$M]0;;&X5:4R(Z(DKP7$M@9= ;5SW2 M;3&U>N!I?
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M=AXCHH0.*B3F>0>OXC]P2>J_8ZP,OJ9,[ [Y>W<),VGHK.K3[DFYQ*19;^%
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M4/#24,/^2[%>DY$ TC['<1HF[C S"^[?;"0.&)*0V<^INY&.:,.%G> :91O
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M\I$^M^$/[0!;RH'N83[.A)_$S$G9TJ[S"RES]NH9PJMEIV$VR!:').J7]25
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M\V+V+IH>/DVE$;.LQ'N5[(,0^]#QK\J4Q&JTUHR]N[C'@U&RZE6;PH1B,7;
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M2.W(05KRN_GJ<$IS![[Y&L-G]GI*<=#C'\0J"L$_",@ &S/+Q6:_U!G:L.N
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M%96B %B(1V;#[< 1>5>2D51">QD7_4=6!O%!!=8\IK>(^,,T3.'1L7X7!P_
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M.K>[<+E2Z;[X 0-BTQQRUQ$<#U\3A.9)<,/>!$FGG+EF&P558-RTC=J[(">
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M*& I*S"T]$X*XCGH5354X82\5Y?TSM43F!E+^>,R5B0,87/L39LPI PJE]#
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M,- \-@:[GLS_=59RM^_O6\+_S$_L*TS14O"376UO[L8@W7\'*F[E(2VGN2?
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M)&M0(C(A"A+_MBF53!&=Q,')4_B-]68<V>=<OI,,9NN+FREZD$YL8@QV UT
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MYO_,C^8B*A+9+B[-A<];_*[QS%BHY9T-N@R*Q/]&ZDW:E7%#B,]6H_RK6AV
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MV/2GK@E\UU!^<(/U.EZY<!RU*^%97#^BWOO2I?6LE6I9/)K#NH2AW.#M<+V
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M,-@N59MYW#&>S']S-AA,_+YX426"&4CB0ITE# XAM!R;H'C:$\:7IC@,"7D
MWOM8(@V_USO+2C3O_(/"^WDJ%J!YQS92FT[BCY0Z8/CL_<6CV<K1G4+E!$+9
M=]W9DD"%S?Q#!8&7820!.PJM[W''5^@.3?/*;UEIK%E+M^BS;5"<:T:L)FE2
M&1V#&^XKY[DG:3OO.40I<C)AUI\I,:)/]I!@A)KWM5W>]3HA,V'5B<R<ULV=
MJ0VJ<=631DO8)+</UJ:2!%<H1T)$*5[*@A_,):Q44<9&.@*BN_[*@A&U5T_S
MG]4J=!KU?(2X8M;"M\JUI;/KAJMN3GA_S=HAM[175">#D?*8P), @!O?00Y)
MJ;0F>-A)<E:X :S\"?3J\)1CU"@&&KA!!ID^T7S6,[1\)'FZI'WV]2O7B["H
M5++E\+8H+]?9]27)P_!]"C:L95(7TC<&M+U>/T[(,"2JGHV3UFD)FV45\0%W
M40^53>C\DAGK_-,+P-_9)S[("*J DV=M#+IG5QH^ E>]1%;8TC\_\E%QQ.(-
M*<GLLOH.9U-YN<GSK.\!S7KRKPYK$ZDD*[VU,2S3'\5_J34JB??GS0<3>Y7'
M[%@Z:CL9+L!LE32?0OT! OW@I\ECA[*34;LJK6.UG[@=R7736B@FQ\;V\O#&
M4BX@NT]+/NWJ^\:&_<D-,>S$#%HVCZAXP;1"RF]^B'=N]V@;L,3-611,EQ:?
M:AU .7DW&@/F@M59D6:H=7P)D<<?)HSK#O.T0SK/E0^';6GOK!$:>P#!T]&*
MZ+9CN6*3]UGY>KES]UJN0MTO\[9]^<(8UO+GS^9XWP8JEG*M!N",7B8ZXX:V
MTLM3(IA<(%R,G 9FP_"K\Y\8A]N"[3,7L@XBHNB!.9ZH$8Z$W*R5?EY6-P3&
M'2_VU-O9M'MP9K/DO!?O;0(CP'@ ' ]K>AF#JE@[H+/CT\%KXX^\R]&&#QT6
M88##KHB@@W9ZK@".0.)&;/7V3_UUV?,P>$"T!6^.7Q0O,%JB@IK*02$VKB=#
M,G#1%LSRJ5"-B624[B+@:2.>"&"*GJSKRX.S6$S:*YL>\]("T!XV')ZK;$K6
M%PGM5K>"PWW_7Z8WA KOLD'!P"1#_GKVHVWY'@DK%AW:B#I!TX$*&?(AF-CV
M5ZG?%A&J6%JN56IC+>\>+TL?9*,K69KG&:0\N0FCNP!>#:F2 .GM4_'F==8V
MMC3HF@(3XIR8IIDG'&ZD^52^LJ'/>H1DWAM!]HW8#[WD.3HQ[3+[\_.&J$=5
M^,_NSN5KO*\]!H,)2&DND6OP1X-G&TVS[ YIP_+ZR&G4R_OS!\;U>"=2I'"/
M_/;>Z;$]&SW9>:Y;R!&2OWTAI'?7-\J >UX1T7O=MMQ+ZW=[JBNUV F_84\_
MO?O]22(SI6?,F,Y?A(LQ!EM2_Z *RWDK+]PU@$B=N]!^^3D!E^EZY#;Z)F6&
M>F=@M4[O2IUSRO,I;&H%58X@VFBG&0@K7I"1P3\HN)1_4$X0K(6+A*JP * D
M9P@1WV%*<^+!?>7)9P*5QZ\4@MF+4U2@@TB!MOMC5P%!L[LMSX :,X2;D1=K
M^6*0_"ABOQ/OWA)FR,IM9>=O"17(_19;R!(Q[5F!E'P7V](17\7(Z@2>3'E#
M]WA<>$/:,/8.48YM;ER'<36"&3U>+VC"L7 @#Y1NE#R1'=NGX_2*NGL<+:AC
MDGH*/,<G]%1/F>SC6?V^##)H6'&4"XA"Z:G+/MT7I^C*"*&SH*Y*B1T(*QU-
M7QRSM$%",HG=.6*V/!B^3QXV@+**6+X<O&BQ9U>NU_TJ[9,@<?D#X-I'-ZET
M:13YO?*\,;6)"VV$8Y[2M8SWY*4<&Y=7M<N+G*(>) @9H/*BKDX4*" _#A\:
MIPI03M .$#D*%+E1*PSEI]^%-?B<(F_DEZI2K;#XWG&)0Y((L3U9(A<C_N2[
M\@,V!NKISM(Z04Q121N,X-1@5DBX7! J701MZ,U$H5*+[^*E0O_HR.L=T\WH
MB_5P<:G8^AKL>O!$I]TI>A\5+#?['=:OXJ-F,03C@A>.4%L6BL*:YFV,I58^
M.)F?)XJRK$(6W\,VN]CFL<R_@VE.NC68TJ]LP79?'7H%?^<?&C7N3NE=^QUW
M/%3E&ZDS,E<L3O3Q:IFDDPW(VF>)5>%FF]AR_3%6<(R$*1QR1/<9*V!VIM-(
MGJ2"I[BK Q3(U.EV[MJUPC<@'C7])./A?CHA!:[JIJYBU2EWZ(UJLH((70>^
M''6[>Y32D[ DXV"5U/4G+DUW/^S7A_BAW1_\\$FE/YQW#/7:N.@;C&Y'O<IH
MZ#M/*]NM\<=9GKDP*_:0]7&-O/B" \*UB[I.DT*XF;A*2<Y=NX;?4#U<[=)'
M]DPEOX_]%!Q^O[?;E*U?4GI"*>&>;I[^C"E3MZ 69]Y;4)ZN^W+!?8!CH%21
ME<,9/53&?-$U8 9?!?KM-F]^LI3-/U//&&PX.1ZCZWR2SM5<WP;C8? G'S+'
M3".%RBQZ<K?@B>';$WGGBDK%I/?"(&[.-65'G5:*N)&W'R&=,/0T?DL6&YN.
M_"*(*"^$ +:];!R1+5S:TR@T>*MDEJ@+$RKC@ZW KI[F5;W$V_)(%&,M*+TD
MK_9B4J<@S]OIZ7$G=$Y;&0^^>*BBG;BZ3JC#9T98HF_M+]D1-/(*O4EA'-29
M!"=DZ#T7C?9\DJ@[I>"UX==WV7GI=4?TWV1-?HAAG[E]AD'TJPT/T^)J-AC=
MV3(R]O1]*/9?3NK:]1NOI!UNU\T]W F^NA]+YWV#8"3"8,Z]1SJFRJ*\9HS^
M@W+.7K*=^2'!=05@\ @_2<[C:VBG:="]-5*-,BE#.H?//L?$*Q\5)4EE,9-K
ME18G^WS]<!(L+EM30+J..&P?=VL= (WX];<YL73X2=.>E/?/%:X[#0F,"C4L
M8-;Y-^E_8!/SRRH0AKO!?65-<CVD)LYB4CD:3[P9N#X,H'_ZJWOT<Q(6PK\?
M3Q[IGU.^#O.72U2(%^/2[W+[:QHU(+2R.XW%)5YU>8++#+#F1/3]-UPR $0M
MN/"S].>GKS<UV5O;X(Z"3,>6]",)V=^Z0;7:0ZIAF]:<$7N'BSZ!%(<O^971
MK01[7/D!@J+7D<YK?*ULQFN@=:J@.\S^!#K[IQUOJZMM_$NU,\._FVILE4."
MD)FMI\XSW7R0[3DOC5G--BD$+?!TPL;\\:20_]QS$7X[U60N6<:0'K!\]A?A
M#=O]2D1ACV;*_F> JD_<O&GPX;U!ZT20091C44Z!L>Y!THVZ.K6V_1A0_\N'
M!@UW1(UR/WPI76842.*^RL\EJ\H#ZB7Q#STE\C)&AF_W"H,NW6,DK?70>8#*
M_<V3:Y2][>9B"7*'1IXVEZH;9[:'?>(8M>Z<9$SJ9M!R]_]+S"SQ]M&B"!C4
MX\@<F=H0GRO6_H L@B^B)TTZ'R(<=8B! 8EQ(KMS0)<2D<Z=RE(9 C4Y2L<>
M%%^KV)_7"KQ,_H/R<18B.@SDH11L-*V$_UL]_ C\$\LAJ5.*OBIT0-*L.2-#
MX1U@N+^O)-\M[3E=L21Q +O7=5'@:+>UE_M#H3[=X!IBKBM M X63A]33"=N
M$Z1_U(CV@V>!SPD=['2O)^-==5=V2)V$L$@W^;U=ZYX_0S>+-J,1)%Z]=LFI
M]U6:?/T^$)'#N>[#ZGOR(+==A>68U"G?M?1;\ ZJX?V6I9D0W0$)<&<FL'U(
M:_DSR%+.4-_))I311$6F;!3U=DRE]_12Y+)T_M.L*+8YLN(^NVA>G;7U)]97
M#0?\:C'K-+Y;02*2S)!%QT-GGNIFV#!)\L89F1SF6XNVM/,SL[T(F[=ORCY4
M[@W4=5QJG8E-V%7=FP5CD$ZLZ9P:^:XM6=UK""6'[<J<V> BHB+YPZ!LL8!Y
M* WW(7@T O>;ZL9?W?&*TO.N4S'P1)#?F4958K&6O16)6Y5!B><#Z1ZI6VG]
M[_TO! L.9I5J)^,:VL(6P19)[08R<T7]/UMU J2M"Q@YT11%^M(DZSQR+!ES
MOEWXDZ=Q:!D7:_2/7#CSR;3$.XW.YIP^%$H7L*3"Y;X42UGGZF2O;*$:2$\>
M22<05)8MZ\=+=LQ"-KYOM< DR2_7\GSKFN[1QES(L3X3KX*C53F;#X[E8DU&
M\Z?$,4D=1._*F[ 0!OWU/@$I%FRPDC1M$EW\"!1@TKV<XL#N?"H:\KIYFVAU
MZU>L;'7.W!N:#UI>-SX$"T5ZTQ0SV@#*F&T]F"YP1#4%TNQ#W2,'+]O4."S<
MM;:==1J*,-<'!]-T:\[^08ER#Y%<-EWA_0Y=YUB:Y"VE;3JZ8/IS:6N_$7Q_
M-N6M@ECN#6U>O2)$ECYV'9[\#PJ3&V/3*&<HR"6B9JN/73:((C7S'"3>1GZ/
M-7 C/<)K:I<*" CG>XV6=1R;"@MX*TA#/C 4@.^JM*6Q#]/B+!,J4+.8;5-"
MG;E-W^B>)'WNBFFTQ[??GB)SZC%'8Z#%P&F&X\-^HJI\*(&WTNW^+-6#>7SH
M+DFJ&YD*J/]1-R]&5N-^D:KG,.\SZ@W&),$@LI\\=?R\F56OU%K/-@>:R;5(
MY3295W$\0Z11A8H?;Y-Z L0;D?8N$(>-WJ=$ \71KJ4 1M62YWDY'?=VWRK*
MPEJQLAT8.$NYQ'O7##,W,13QFJYXR\DW:*11Y9(2:+W4;EE@5X+76+;:$U[7
M!5</\_*GB>'CO45C82(-IZK7AZ\^)W<56%3F%O*U"B3NU$F4^Q31N^,4,W%-
M Y+N?PF7N?[>NBFBKSRV+L&#9BA;9GJ*$5G;%(^7KX:ZI+*%D.[-Z+;H8<,G
M<<JHIFYU,&V<EK%?*[<1%"2LF CD1HDN'M&' V!U#Q%4&N"<1;Z@'0^60)S/
M@*9F(\'KL:D);& 5!))-4BVYNXG:! CJ8M2F ;K\7?,815+\X1CI>6S'T,L^
M@D$";,B$K9HUE\4W^^.X'%AI:KL])-:U!+ZCD]ELTCS&2G>6ZQ:D6(@<&4\5
MM-FNT.PX.FSF!AK.$7.B(2ONTQ"H&@\0;10:3S;=Y>"S%P,OIZKCYM-UOA,'
M Z:W,>MUP1>MD#-KDH_-ZY[ST!RY]X_M9202ZHK7F]RXX@O/=#+=,XM7+!WI
M(D^8B=X(UD%;LP]R+*L$8R8JL! ER%H!8U9:5OY,<1.T_?^'S?_#ND^G#&IL
M?>17KZ45A' D05>W(4OV=6*H_L:\+%&'L'?GM2&]6O#P[>>XRN\)\+[(1-*1
MJDC0DL!&.42=G4F2FE[5@WJ7!J_\L)<TOB2,V_X[,(=8@Z RI1TWU]FHG8GE
MAT?Y(QY[MG])I>N,.K0A6PW]^<:M9R6/BB=Z=I)0B[)\,$?KPJ3P&#1=D*(+
M4!NE].P\\):F*&JAQ!%H4I?MPET=.%G(D\XY1JZ"M_&HL;5'PDNBJY6C\9G#
M4#Q^5Q:)\)%X['8_<?3DR#YV6T+TV&5L4946K'3#9;SK:Y8+]LO8>$>[.#,S
MQ!B4SP;]53@J1\;-]SG4#W%N>7WM!Z+'ISYQDWH)U\W0-"M$&#0%T+6/36'2
M*9*1K!WH8^(F),>/DV7?+9!SK?8AIHR_8RI1&5,M.G)>I1.Y"@<6OO3H2I>E
MJM*0DNGFX*)228P@3EC[!.]%[$0_3G,>>A&QA=P#EP0<8,[;O5+H)<;:DM."
M3#*$T'[8.E>WSPF9"/(KS/IUND=S9&M]0>PXP#8Q#!5-CFY(D-P,;[T60E;_
M!R4B>$F0?6V'"5VGPUSF^S,:]OEC5+*A6LB#]Q=>1)0!"]QAR,G,?Q0769L4
M\9[<9KZ2*]+#/Z@%Q>^!LA?A-%W>[6OTAN]\J(>D3UW;2XA2A0OF.W+Y ?H3
M>]Y_VD=]\.+7K<J5CO'W6L57LT>ML__0IDP(D"8#E%,_=>:)E/:LNL/>$!@.
M1]7.Q'.+;RN6^O1?E>&$!4]B4;G(5T'H\RS;U+"G0!3/'ITIE"92TC$)TK75
MHW(?C<TZQI/%PA&9-_8\Z@G\UCK<PV;+Q\$6&.S17:NT5$W NQ'3SW !CZ3/
MN_=9K0YD]!]V<WX>. X#""BT"54BZPX*<;BT',(;5^DW1%]*X>_^O/]Y(XL9
MZAIY6\07V6PU+?;&JV.VS6E<X2H2B(7&_PG"**-&6U9TEAS!(SUH^[BVARDB
MN8]QJU/:!GSTH<YTC10^Y_^T;3PN@S6O?R.H-*EI36RCSZE?EQ70LRO2L[U_
M3GR(E8P]9._(K-Z9FX%W.QVOM_E"D5]L!.6?KV0_Z]RV]469CK_[;]$D<Y/P
MLELJ<WR<"2M%#:80-$64SB8-R&!$<>=X1">BMS,_ 3[-]XWZ+,Q[5-((-KV?
MP+-V(6Z]AI;9<[1^XHI]]5VDK;3"SQCG>YYNV//$XQBNY8W%V^TJD'"__Q_4
ME#>&[9^PX\ W^ 2IA(/@UHECO4AO[O_X2A;MV%J>A^=2(K NA9,Z;(L9#8IJ
M+6E+T_I8,AD!]W=LRS%-%'.N27%OVK<GF\!0UYMQ_;U_4%G6'M_R<I^Z&J8?
M6_1P@X2_TN5>#_#;*PBDG@A"!U?5"B Q'0Q'$W:WJQV9LP$TZ#JP*@+DZQ;_
M0?')5GE-T_<I=/M=X1<IG@T/E@HS#<N.VT=UO2C\YT#,-MB-+73CQ=2[%EG2
MK1T-ACJ*D11[:C 2W>TW\_!;EM,\+D%T59CG6*-;)8C1XK$,5( <PB7\$"+N
MG2$5J5E[(7_U8]\<XURS7F6?T _80ZJCD?C/L',%2;2N^Y8"5<^%!=Q66]%?
M*Y#-A4#9NJ<@#;YY1ULHZD7."!Q^ZJAZ.<TXX%HR@(49K>BNI+<#B#2(*4)&
MJU;67O$$_OA16A-8LL1&BB9_/_T3SN:RMI.NL%@>WTU( 4"6N';FK 1D!4^?
MMW1<Z#]?VNV6M_<NOG-03G9N%@:@TRY3HU&5*<+B'%5ZGLB-1>Z?ST=(^5XM
MX>!8\"YEV;QG*W;M)%U"?"$BO/@!_Q5HRUL7' UJ9+L$ -'9#X=FV2_T^V06
M<_3F^MX8-P1[4?%5D='/:6T@FL7=>J>,OWZH&?\5G-T8&M_Z/4LK)@3W9H:'
M3!]5W(_R4--_WW$RU55BE]_X-:"7@@BJ4QGF:4;J!\C,+0[3A9Q*$^R@[KB(
MXE#=LVPC0NJB=-)3P4(*R:7G!AH_+M)L#9Y6%GL?*GQVS_J6$[[Y[,H<^;F>
M&UK Q;!;_UJ'F?.V::LJNVW8:$Q3&CC&)*Z%^XH5A*4M:$I=9E'$9?Y'2G+1
MQUW! -0P+]MC&/%'WS=F9.0;!JZ3/NX 6 3@KS0KRC,_\+H#T">?0-XQUGUO
M.5UVSY=@(1D..$MMCUTMXX@D7^6^E*!)NG=TM\Y7.&=_72?E\6X.MCNL6!?,
M*C*?RO\1E73=3( 60NKFDU,/-!V*QD_XIG3]H1Z<1.+V];;J>LVGRWF"=,>>
M?*Y)E-LDIT#^3+O.W1S%M.@;G+&8 Y'U&?30JHDRN0OG*=F!9(B>+MEX8_8\
M"2R5@?=YK5 0@_OT?_P&Y_&61=E*\"F@_=$>T=G<(J*L5\(C-N#'9O$<\Y("
MI>OC):I.S[!#O3[-)!3T[L &.QHCP:I ?5GK5^:#?-TW?;F[G.P=!TE&.':(
MT_EQHGE8F1S]HO ?W.A KW;7?F[*>8%(KS8-S(F3.5/I<%=DK^1<!3Q.Q2;N
M QCKV;_B[THW%2->(KNC.!PWJT1C\#\Z^L^""<L!B7-=XPPH\_G-.HQN[[AC
M- Y3*KR<+#9N83RM=H)6%6MEB"/]]XH6T@^=#Q>8\2DWPU[;^]HZR"K=F56A
MC9)$*O<JRU9)C*MOWL%/#R%D=VU*>HG+*$KF@9G2X^;&^SU+$2%HP*.#$Y@Y
MT=SOPR34RH4, "%3-TP%_,0/\SP#HS9<%+1+>)4.R5+"3[Q7)^(HC"\:H?XK
M;9,67TJKS.(A?N%/D4>=VU1UPERY1M&@&6/BS4Y=#9W,<#L+P7;R*+OZ>Q'Y
MH\/VN7CF7 ^Z+M X^L]EV[QJ33;%!:QNN(*4@%*$Y*>5[0-D0FQ+V#I53'+(
MLB79ENVS744<0?EVU^2W"3L.)MSW:9-QO0MN,U5Y)2)04^4B!L<&[94([VY2
MSR1^:L 4[(A:VA.@%H:?(^RT>I8>A_OLR818D.S/+^'\P%D6F/TE:(W/GVG/
M#+(X]%M5VNNHGEQHC HVK&RG]\@,B<^#PG($!'0+:+&'G#[V<,/Z\N%!M+=-
M:$$\[:094MD;E^7?)W62/5'&6H;"GP>3'E\ZD9"FO\^HI,SY)>]O29,>6?-^
MU&7YUSQ5-CL,L4A?J9T_LC-2R='-FBJ=["<K)H^<Y=HX/=E[FF;99S!&HE#4
MUY:Q"..(RM[.@1\G6G;Q*V25CTR 38B,7/6K]@V!;.XQUA(5\3K'VS4\_%PL
M[@6G_Z"B<BCP5I^,D<SAP!"NG0,2E*[^^V&K"JUK,JQ;#!2=]NH"TJ:']SRW
M;2^G)ROM.08#!E_[2[)CFII[4P2Z<?IX1!Z,;TA'+]\;R4X).,D+D!]V:8TP
M6N<":WS%$M2NX#,6/^/ +&G,138>WT!L G-1RQ=78C!W0$2.4V41=2>R="_U
M25_'U5.9 E2W)\:.Z8B^T7$3K4IM='VV?)JI\",S%UJD!+V+>]4$J77-;HN/
M]1\T5F]&@O"BV7#LJ31'RBR0L46VU5@J);IT_>3?@:P4-'G!''P*$7>E9.:<
M>:?V-JOB%Z%TL'B$L?7848]O.N,>*C_,,-A^Z59[ ]XC<H+E2O79=:SDO--+
M[!=AE(_;<\E4\U-O#$/B'R(Q/.SJQ428"FR^>J6&8"LRI-*42OW'9TZ[Y^ 2
M??KY1;P8F1Z<C"^^>,ZQ]E=;VP=*I-_NR+\Q3O]"EXQ5NS3\._P-QL]6>.OA
MN:FDU@CY1TZ"7N53T# 9Q;@\%*INO6QI; IM7T?@#Q0)N;$M_)S<F9)PS9"W
M>_?>G$LSV=_V8H)QL]YPHO$<K5T3&.K%M..:3)Z-!W+N(]@(BW!FRD"^(@OU
MB@-L&X<P1O4MH-(5#W[CO>(QO\\3S/!<1^WWJE-ASUF*<>BG+J/JVIAZ4)+1
MR4N7A+&%S>,]!Y-P,2)39U_S&NV8?$&C^>!SK^Z-I))MW_I7$UJ$?8W3QYI3
MV&7J4$$;GX<1W:7O^GF><]:C]H$_*"KK5LZY+C69K%%@"72P% 1D=ZA-'SW_
M+E<L/M=%E-YF^X>4NJC<!X;/V2W]W9T1;"<Y\9@GJ$*\?3R??<*(F65VM=ZB
M6PG7/DA8"-F@K0SEI[6<K:N0=XEQZ(H;43,]]'[SL ^J&--HJ?I]H/Z1]TA@
M=IBP&-^Z4O.9S7-9>L?4OA;D^/;%N#'HFG)4,ELZG3:>5A3W[5M*.>[B.$;D
M/0G\SVN4GN4CL$V&*@PMEG'+M#*3#:%3UIO+-U\YO6^Y&0*O2>9R+&$<$>2@
MV3;7,D;@!L2%90L!#K6BX\'#W00@U5$#,B]A?.4\%D]/I\LFPU?0ST$^NS]D
M7+ME)'].#[M4^$/R7Z_ $3! >D96X[/'B'X?&"JM*F3?.GDGU?F;BICBW/(Z
M[BE3N7B_C"F-H77E54&NF1V%5IX@ID!^-#37'Z06\K(&!CF@HD5#QR'G>1M7
M[#P-_+S_*"%YG5:(\]\M[.I0(U.O&T>M_UA>&XEEGNF3.M]V^]2\7Y11V1L,
M3)(X"2+X"G3%FE&N&%3*8.:=MKS+@$RC3:+_;J.T5[:#FU']WB978*L=1.4L
MC27]"S(=UBJ(%E(GY9^N)[JEPT.D/G\%P$J?+ST75$FI5ZKY]=V\2C&&R&YG
MJ:QA(A7\#RK#3M-VYZ7W4VCGGN;V_P**=Y"/0#^#-FWSB2\?W!!%C3:W_I_Q
M=DK:%KY"[.!_4(L:I.^<^V- N^<:X'--0,[*[XFRO1Y1]UW2ZM(+OQ?9@EB'
M;AJKZ/5I4:]]_6(FGH  5(W3[G#U-@EU6VIXV042F1=R&/R;[<3V?!<QD8]Q
M#)Y#=''09=N67ODJFAYQ+7)RX[&B JVC1)P^11B<C9X4DKPA\;)#%,%S^$OY
M 0!D4N&SH$4\;_:@V>?R92)<R+JZ4>#F3%@ZF.3SI*^LHG.5$)QGVI^^JO?T
M.:L%,^RP,%ZOX(853'EZOBV3+[ :O!]Q$IBP6#2:OYP\-@503Y>!4#OSGWU?
M;P_5?BEPIWI6 #;;8V^TZ:AL"T;RAXR):]XQV%FOV-I95AB*ZW(G)&%2@!O"
M\-BIEV=&USNO84N6BW;M/#F>@X/?OX2L8]%K@Y(TEA%&+L/WZKCIC^2]0G57
MZ44SB"+RY)3MR-U?Q^<$O%4&I7HG.A80=L0?K K FC=6Z+E=0 WX]Y^"$',D
MQ%I>ZVLU5MCC <.OL[P=31X'2Z%M+XLH[OE^.:\?9J< ]CP<"16+SL?EG;%8
M%]:!9?Q.PY!9K^6]H4VJ_C2DAIH;F;RMOH@8<K?O$Y0J]BP<&SL&&S8L\)_!
M7G>\3<--V74%"T-=BIEAB2]"1T8P(W/->>;_H(Q.>;+O@AD1<3DVN=UYO9KH
M43PUY%M$#!+#2176%XL8ZMX@AZU-\WKENK7IQ>E 2**R3R:GV+=S0:,ZHC%=
M ."6TN*7MA/I7R ;)K_P!2NR^V_64LV=9(CG2BYZZ_]T;>#-T-*^-VT&MG<2
MP9%4OO1= +5V3,S%.?O^(5Y9[KW?"T/OU!'8NN]46H8Y)JSU2C5;,$E?=FV\
MRT47)AX3?2R_<@[<UG-"C7ZA8MY(J3\Y!^ZT-K5]08K=-E5D5&Z+)9\YFJ71
M%X'!]0"W+5,;-FH<CEBK"+>MRVQ[#U4LVRF +B\AER85,%!J53FX"F->C\!4
M1)KU\Y2C*4;R7G)<N2"5.!J1<[9OYLDW+5MZ,8^+-JX*)L4@\/O[GN%_DY^,
M1"%),]HH$76![A+E%P,U=8)M-3ZD4?,ETN$/$QDU3"G/7T%ES!?VP)W-U5_R
M3W^=\!J])/_[OH31F<KG*!Y[M)X,5%UWXUHI8;D6'2R=J&P@542CYZEUA$EM
MRQ1&.7G=^D@I^0<U3V!%3R'I2>0<G:;%NWX6,?S2NM2KT9$#AWKFZ17\J\X>
M:5:*^3!"O]#5*<^Y!9;;[DN:K^Z7KG#TY^C<HV1-JC!+%\VGDF8*":?FTT#1
M#.:)U$%HD;4>-NTN<+R#[CBGZ/2\6!7W3,1"FBH< ,W&#2JX67(N84A3Y*C8
M/7(IO83J;#(11\;O\N[X\,LE,KM7P#K<89K7<E!W044&JTU3 JV6=*:8J(VE
MC(*@4&K5W@GM9-^+(/_*(>MJ>OK335^LR+WJ_@2?E9)Q&??,^7,('A"CQN\?
M5/&ZIZBT@_;9=NYD%ZPV#42;F?HM+&[]F.\<A5-2[,;];<K?]%WB#7%O0E3)
M,DEG)X#0\&\?F2?JL=HKKU7:@>?DM,;*V=IU;/92US[!6[]E%-730C([1Z1C
M^TM=L>B O?)#R(AQB/$-;W2@7*PA7[P9JI[/4FLD+UW7W$_E36X#JRU>87O.
M.5%_K"F^EHW4\K(X;]0%T)7&0&VE7^9K@VK!0TX"X-?04;D/FKSC18X9B)=1
MPB%(#I385CV8;J? P@/+:7?:$1=.6L51#L%C:\8T_O,U\V@<>3/ WZMK_P 4
M."OSQ1S9(4*-ETR+Y.8D)(>MQ W"KW>!#320T![1]IX_=X^:WL3:*U4\][=Q
M/Z?KJV.AH%KJSTTH>:9:TLRIT_QUR[8O#O)+E$R\>LC3 8\Z!+&=/LTSFXTM
MU,BI&MK+:=[15FO9C/F#:VXTP@>?%-_H]TL1AS.6#O0[4A_"'5R8>7YE<B5?
M.0]6W647V(GF<.SU'Q?76!"B]#,)A> ?WC#)'1>UXQ^"VQO:<^\_\@A*%^NT
MOO(*B=Z0-74.KM=GU1E\]53'!S#-AWQ\,VB#"K$,HV6%$4YQ+:[#T5$&RSJ6
M,6BH70#B*CZ+O!YM2V39&IT-TQ-7A0L]NB EA?,WYG,N(K=Y8@MZ,,HLJ[2(
MT#XVI+);D01WR)H*LM9NU&6.8' MKU*@?\X\DV%*H=<?0-KZ5W^6A8/T5KLA
MMACB: 3LTI_<-H4UFNJS^-F4*1H+'=CF5<O^(1LOYT!KE? VV;<OY#$HEW0=
M:5TL&R\2V\S%V 3VE;EUJ[)3%ZGD3/CS.MQ#F=./7^,]ZGXF294,.D:$3B%8
M1GBV[S<M-20BO4%7JK3<HTA,0&_@U9=O"OI[C$TV[CE(G4X].%-:OZZMQ.E=
M3+1IGZS5_2%G5D((7EJ226T/B-BYT"CAHN60$I5FGOMEM)O -X4^9A6Q"G7?
MW/[U^5LS0I2G-PHN)QW+P*AXMDP]O1;PWG*UL/?69Q!7GJY(_>_J?%\CS&?P
MZZ9;G*ZL:!-Y)U'W62Y3Y)E'3@M5PGHQ\,IP3]M@UCG#2%DC4F%\P9X3ND_=
MVQ68PF6S"00J*CSCJS)=OZ J_U5ENC <$6,]8W6[(Y,OG&.;NTU<H0U[OI;/
M@;;<@\<DT$3@,282 ,HN*<S9L@;RN.9N#.!PS=S LRQ%WUEWD<F5!E0Y'DU*
M%V0:F??+*V0HA8SR.::;>@6;#;GG,*@P$G*$N)=*1_&Z1SL#5=92'B5/7=[@
M[XA#[,Z7/IR-@BG;B3U\R5BW?[:JX&GY!0GV<7.*-_2EF#JZ)NQ )P2NM=IF
MG5"/ZORMB5:01!,Z4AV1!7-4X4MFL/DZLLX["Z\1D@?-7FN?CXRK.:A=P"<D
MK(Q.VFLC/W=>HX>)'#=EG%P[7'\%JMHVQ*^+RG<'V.7"C,XNN_;D-.M7!LEH
MD9[F\98;4"I",F*C$[R:SXZ)V#7/>W_^\-F7LY!O)B9"&.=8=#H'>BLAZ/R#
MNH>>\M[53)N96>QR4.?)#W$\S4/X_0=EGY+5S0@8MRQD_QS$ EU?$# N':79
M+JL.V&FD05[ /=S<M#=3"8V:%1-VS)H1JE<IU[L2X6"(OR^1.@OQ/I;:OT38
MRO0(LV-N=9V5(5\N)PVAJFC).! ^%%I"S+AY]U%(IW#-]W_M=CL"YD/_RA;S
M0IX[O!_@,17^^VG3;=^4T_NU<E2/")B:_EW;Z-A3)G;252Z2;JY)DW'D']3\
M==^$FS._G]NU+/7/X@U'BA^"O9RS,$;-&8\74/+[1=J,J\?RP0$/ZO4(Z5?Q
M@7. ?,OT7<T9),JM/)KU"I$@+/#;^DR7KL'!9V]B2(MA]@6&T1A%<V:5![$A
MBK9"C138N.99ECJWI&@!RT=ML[+]I[R_B\Q,9!6*%&3,6EV'9#(HM#$HR@J5
MGW2U;"1! )U.PU0PG'X$%+&11BZE:VC[G/R 0PA8O 7,0R[GY7<@H""*&!E-
M:2D\&N=V,C6!9"3Q4.W?C,%93?!)F)T8A49^%A%:6S@)YXR;/=.,!CJ+D$OC
M(*$^4S\+CJW*VQ%?H"8G$2@"!+X6VG2F4JXWT('PYETS[9ZOGJ_ 6\VR638>
MPO:"NE50&/NJ396J0+NMWHDX15-D^(KS->J1 F08??:*C_YLK(([;?6+W:B*
M_Y5=M57N*R^_",/J H?4:-6T(T*_<4*>IP<Y'RNL >:23Q61Q8(]=T,5OOXJ
M14*KQ7] X#T#&P 00"(#P=K0"+U<]7U4 )56&/]ZVOG#4XNY\G_Q@:@2RFG9
MO?&/-2E4Q/]L\\H%.B_&"J%,B?YKHA#<?PQ?BR%C88I,%K: >?1D^,7AF+/S
M0/KG#Y&K[@-<O)Q\RM>UYK@-XJ/6-7P+((^/4:SD"4Q^AI-6\GT9&:VI!+^4
M@A+SZ^+4[$<&F012W&@<'=MH%%ZYY,!NV X[#U,[:X\04#'UPS"FS @B+_!L
MJB+7J'V]X6#S)WT+:?E5IUHN6!VVK'> 2H6(Z/4NVS6562*1Z( @#GI178E<
M0'VEDM>N=2#KQ4&)NGHY/IYS!S]32B%R*KVR-W701'&0=*;]D4HZJRT+0"(I
M+VY![=7:3^G.\+HE^@,ZWF:_7T>N50N_\>8K%R5=3)YQAG9V"1.CJK*3N%P.
M\5S%?I, &AUVX@+/==\(YN^7$2KM!3RJ+8TXC Z-$NH(?DF:7"5=.S?IA[U)
MC#A__TZR\@BW[ TBUU:J9UQ\YCA6#)ZR/?([U%$!E/3+SQ7F!8;5BZ>F+V0-
MFUOY #S:O4TZJ2CDBP8GATM+ASF;! #_90P/Q;4!@,ZV;2$/L:WU(")^Z0 '
M9?E-V86*[S2#<IV0F7YK/H:?? K&CY)32T)5%X92>^Z7:X3XEMGO5!7-I"S;
MT2V#X#=B0<J@P:$$1Z4^ I2O9TK@TR-P96*F$[?5*K5FO7QB*>=_B=;6#LCE
MLL+."V3/]_]#2?V?6YAF_D&I[1-4Y_FT'WUY6KFX?T<755;.P1NQI'%[MUF?
MP2YN-F;BO_:+C;&GHW&\:SSL[41)GC"T)7%MN::277WE"R7+*4AL@Z_6FM;L
MSL0T=JE=TF?I1S(ZP+/BV?Y9;R\[2H:K]/$A+UEB\*$OS7#NAL+]F<??C6:4
MU@O;J=S>J.,8PES(^F+L^7LFG79.Z$U@M9IUPE\ET4%9NTHMDL<CRZT1&"0I
M@-_\8A%-3 =K@75U>E@E\9-*Z##\E?OHE.Z!1DFSNM5I2NHGP94C"=R77T;(
MY-5Z<"IU53%P[A#>:QQ%I3[RWF'KL<1*A7BPXCLF@LS2ESYRA^HU8)H;1-N^
MB\>U!;I^C1F"0S@\<G;5/'735!9,A0AXXU:,[=E9TW<]:<*NDG;P^6ZS=4Z^
M'3ID0OH[IDK3VCA%Z:2"R8BLR]F0^SKJM$1V]\1>VQ>RC$& X.:+4E4+7M,2
MHMCH&.+N4E3I.02ZKI/H*1L?]S#J6AB_Y9Z17KE]P+E!K"ZG)S>2*E>"8%AR
M&O79;$J_\'>X7'2U9FHUS0Q&]JU_H>?O]#'8,>GX>O-G^B\_$^;*^$O=C[&2
M\EOR#PMH44>.I,3=D#&JD=H_3#N?V6M-T'8@;IQ3[@'X*84MJMA.%*';GH+J
M^US44LSX?%HM!\]?B7847.1^Q\7J]F8$I]]8R];9YVY<+60SD)($:&3MUDGJ
M\C9,J<I+)K6#%:,L%5/+OHH\_J4X.!6H:5:J7CD+NG3QR0O8"YI=(Z4N?S]F
MXS%TM'-?C,W*E=Y4MH.W$-9KW/)6C",GM=+8  *P@PR3#_,Q0,:3WRW*:/+U
M!><*L06QUYWJW!4Y86O"FG76&_Y,<GT/:Q_.QNB6+Z@L^#4WLN4J_TZ2UBJ(
MGV2LW#^-0D"H,H2@9!RF<R_NT:6O5Q"5V+1@B+3)NX(U>^"$BZN'914RJZG,
MBB/3<XBD06J@6[@J"'(_3#Y'21FK^>E]1_;("(&#%\K/(G .,?=(H*C.+-X.
M88&OBDQ72-T!J3;*DP]YQ_6[>/ 9*'$7L3:V($Q2G M_&?7BG@$ZM,J>'J!$
M\F'4'1=K@^?J  A(3YG=YD:D*Q7HT2;BXLG9H3A,4?<;D1]QMM-MD#,>KIS5
M'IYPV?U$1FHHJ5"413/$41ZSF)4DE!J'6CNREC"LU)J%@(T*8</X'^1]G&W^
MKJ"7$!(64?I=@*4#:X_(@-_7+O6W6>-C[>KCZCC<IY1R-;:F6ETNM7PN\R[I
MMC6,3J8=)Z5D]=+'[$,&CZ$_0G@Y:!8IMJ7*_Z"Z'>CS<!&C7<N0CT5(\? >
M7_(3S)J^ ;D(;N&V!,7G<,3(:+_;:89DT?Y.9(XY9U1NIUOIV68$_GIVH"SI
M_ <52FI>S#*%,LS9 ,6ZTR3ZY0''1R*R[2Q?,@ .;6@I-XEZZ %6Z*E(A=]
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M^GU,BH4"Q% 1F41,&3X8#E<PZE"20L[%'#.1"V5EJW0JUU')=FJQDMY][G$
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M2]^S+)0ZGJ,^^/;=K(8M1=4X]<DG)?8ICDC, P:-:_N_)I7#CE#YM@^F(QA
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MJ8YY3"LR&I&S)/K#M#X,8_L0<J/X_*D(:3)3-)EP(AB?#R*O>X'N.N(.(__
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MHSXBTC064-RCS53E=9LU 9:$AXLE1SU )N+D<$'C5[\=C]-M%7QDJE^)ACK
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M7R*I/IIYHH@=)FQ?["R/']T:TI<OLMBHU9@\<4='>0U/YP>*3\)7?C^<B*U
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M^O!=HU9I"IJM/IIWQ&MUQ@Z-GNYQVE>%X]RX;*6*\/.O'=&+<MOM77E3U1Z
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MQOH34SS2" ;=0$ L#V&OM%X=:X,^PL^*O8:$:WYWC3,(RFH@,QQUW1J2P@L
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M;X\5]4B<Y.Q+8:)0TJYN+$%S3H)/7<OP\XDCBMD,5DQTC[2V<?5*C;Z^/D/
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M'5=WTWSQNO<)E@2EEY+3,!2/H[8M=K0F21;DLMI5>&0.KI#1='CN?BQ0*^6
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MENATQ)@>8:)5%Y2U[(4LV!9,00>S*"47UP$U\H2'2[6*P<TLRR+M\L3%BUR
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MU+FI3 .KN#=H@-^(',K^LK^G+KB:?.;MUQSL04Y.^K-G[S@'3_:6[6@)T@A
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M?'0:6R8=GL>R'-M0ST6.?V=1 ,/Y+:I&2V1C/LJ0RY'2T=QJI?!IUUKQ)V5
MICD&6C1B0[[&^E _,:K*%D,)B"UOTXC6=K>Y?LP8$3/)"M2\&\W-FK)OH0R+
M0 .-XK0F,UM04%)";W=5=B[D\W>IUP&QO^TUR-B+2DM%J9.;17MYY;^C^@]_
MM#9X:5:NF^'/-7M46Y7'A6%+KD0E^F45J0X999@?3A4/<D:;#:XA-CGF9Y0L
M]*D/J8. 59:6EF'N6!@'W.D<7 R63]TA+%6PJRZQ6'=4FYGC45/X3CX:<-IY
M+>)J/L%*;^N^_-2%BIJK  OF1U%+KDJ5R&J?9D(KUN33&H&%D59-C*XP&G>'
M#$J/V3G:#R:GKCY%B"G]$.] _B.,Z#E+=>\7(<%;Q<.$:Y]/-(-WAC*#H[MD
MFY,2\2-S.\D=0YFVA(1*AF"\A"Y%_LA2PU+4=VR"%!X\8X,:JN8 8HUWW^)L
MUP8;U_WP-]@(13P;[ZU10(#LZAAY-:&:RCVWDL#$1G/D>!2][C(X9$=:J*E9
M>&D(C(6KO(X^/1[O]QT2=93J%_\JTWU$I6H3.]E05M\W.21YID3.G$7PWPP;
M.U2(\N?J%+F@YG$B5>O<:?"2M) ^[=^J2(A8[?EI9<%!WKN%=2/QC<U]#;+V
M';@;^O51C3V0*EZ"L!N<":ND$>L@[F)I#?DB;0V^W7I9 ^<G^90:S:;/!=GG
M2,O/O9H5D\Z/02&J48/,15*^>:F*<V5%NOPIFG&+BG,HR4\2OZFK"M[:HCR(
M&8.99(I;V(U]S!;?A0_W8(9&V^^E&U\H8M&7J@T>U+?I7\XTT$U[N^2P5F05
MP7C9&@RG]C*D#;HI7%5+-Y\!!>B9UB9@2O6$M:YDH$.ZTX^23#\U/OI^L"&L
M'..2H])Z<4G4RYD?SN>-53_]7+PDDDG9DBOKTQAM3:(7A=3W)&8<[2"'*O F
MUXA*_9?!<*;"Y-QIGKH2)L=X.IVK*4;B#'4:%*NSLP36/8J\8.&XRT;^^BM2
M<Y96S"L@?I$^"PN]E@S4'TD'!6ZJX.>N5;1(=O>::^#SX%A8>BB5?*I<S^75
MY$I?3?D0]=Z(HXUIR\(R*6T36+3(0FN@.::E$C^[F!$<SG#DO:'U.5G36N]1
M)(E<2$&-;V(Y4<5QN'ZW%I- .\2>0X: <XPZT>NGBS0<L&635WDL+2ME: A!
M)6QY<6M<NYK*!*Q*#LWA(!ZW+XS6B<XZ&( =0?)N7 8OM,@ZM#*DE"<UBA7&
M\6<T&[*DPJK%-*9 3/MFA[NY'"6K:77&L\U]<T,R1B+=/UHHGK6-54<1-;E;
M+M%RIQJI@AHQ 8;&E)%A7'--+<"0X]383, RO09/2 2U(8+YI':H]#>33]*H
M":$@D(Y"Y?'P%MF4,[O:B7VO,+\G:@2B_/O.%:=$MT^,LL^?6.J]1/D+?8[C
M<=J9M..64+K,/BMBCKP!B1FAU=="M<%TB<2LUYM>W<AI0S16Z<4&*PVK\;*5
MDC!XML[ER\DD^F.#YM;X?F<XZ/M=<>\:8P^I(JL7<VNJ$T8@]DD:OBUQX)]^
ML%3*X;09->M0)!<?G32TU5S\?@VMV$KL0"$+5 J$-)AZAE]=J21F'1%1J<\%
M5?EY)P%V&MR]U3],N28VRVXC/(I/>CR^&^Y7?G+6/#EMR1='HESN<;:S[.TL
MC2\P9I:3VZ#;"$&I2BO+'59?OJ;#HZ%7W!A72VV\_=H.K@GXAL :H5M%4?0B
M3K\&G+Q/X_2%AZFA48QC_/4AKVI:6C"[K/^W%= 2]WN85N517< $&R\0W^ :
MK"6H((9JV7)E&317]3M.(Y=_,RT42T&\45Z9Z'[:FRPW;YRD+(XA7_\0&%N&
MQ_5>9NMEL OS3*I/-=\L'C.03K&!@YU?QV[#MRX(J]P#;&*+2QO+69;&6:-=
M/YQ*^\6!<S,)M)#V6TKNJ%AQ=H1FW39^7$I>7VZ#UQLJ3>VD4[-XE=FTA,('
ME$$:,X&[,^BO0+;RHW;Y]G%O/?((QU0J04#%(NJT,N7.U51Y'PH?D#6<Q_(-
M(EQSR*E(ED6624IH>L^FHQ"13J$E#IR#!4A"H2J ]6DCOWRC;4[@.">7;WZ9
MMB8#K[2*V6<Z./LO4LZA0BOSI)T"1.N-/>;7X.KU)ESRD@ -A7#[@S Z 4H.
M*B.P;;>_J\6M,HH1@56UHLTA+XDCD!I4=UBDK48V:F_%I/LN97!?J%^!4*^U
M)?Q'!.J8]%Y% :J$L'^PB=Y._+J0R&HKS,6R4:)A290N@YMOHJ)FUG'GNKD$
M:E;.?=.Z?A81)J6R]B-.J5(BE=O)$AXNS)N^K0NB%YJKGU*4#<3?::KM-5+;
M(=A%^^OI9RX@+G@MV#PK^$H?]-9SGY7"A9'0OGU.G8UQD5HF1DY;6>^PV/H:
M\@"&54D=K76/EL,C6952'%E\U1J$ZW:D&[E\HQP3.Z+S3HV#=<Q"Y;@9YG?,
M-,\DC8.VGJ5,RLC2\(F5.N%'7J8BO!VRN]B&,.,D?&6C-[;$K DE/A:!LH22
M%6D=!TKSZYB]#ITHO)1*^G&*1FD(G/#I/Q\5EQL,*XB8]ZT#PZ1+.9%^/G>%
M4C_2"I-:NL'_$/*I,_!^^.+: BFRNPVPAD&O,EO UWR'5PI17.P 4RX$1O-?
MK(8M1;;]'FC]-**<;YYP=]H4TU3L4<,)]0Q68]:FCZ$T".7R%EC  XB-Y+PT
MR[$[\0@IU4K QYC?,KP/,A20LN\5_=T3U%AQJG/GK5/44GNJ*B45J\[BK/'+
M[T<DW,8QE@(9!E+**.4&[4^'((C8$D,6=JE"CWT3S#'?]1.WU\^C-B1E&QA'
M4 I,5,4QR)@;C^/$,"A<RAZ7[>+"Q\[/A8=*\ @VE;I0N:2)^#0&7;E"X\$>
M6?&&V.0.@Z;NS%;?F%^U3X6*92C9JU8VT:UG:2E/_-F=<RP+8RDB86:_=&X5
M;#H.1T4-C]E&YR"K+GRC@D;T6:/[K:$.^JUO292VY:H'K[.,-(W&;Z.MN9_@
MSZH2]!RC-1(QK8?@P:6?>N?(*/-)I,TZ%3J[Q=I5(C*XWXE6EW\LR5>ITR71
MIVRBPXM^6L<^0JH633@.H]5?O>>F?D1(AN@XF%/8#-LTP7-]2TPKD:M06:_<
MM0VAH1-5"+-WD%L0(VVENEMWQ < C=@::[N"^.> 9KLZ>X69I2P^9%_7]TUU
M:X<R]-'446%-@/CX=T-PHIWFX1VY/YXE$R+>+>8S[JYCFW+VE-?5-A71BL('
MM5$9'"VP>X+Y^"ZU!'A$I4IO9V:)5+]F!F(3?*&.*AW[Z-=IA^H='O)1M2"*
MZ*GE2D9KONG=\Z^X.=><00>Y">_Q(>\LAV%S\[%23L2'.[4M<Q)7QTS2/:=9
M/)TC\S9:R5 AZ[N#H9+Y#^D7J\NRC0<"QA(D7,0(#1<>%4%R2,B->E]M: )I
MB,2,%31&UPH:V^$G(_/CPP0P8]#9D'/Q!,D:DY<PX^8,/]?J\[]90K]R^6)0
M=F\I_2'):DFX4JU]C2D XV-"<X?\"C57UMSY2&ABM[1BCAI!ZHS*V)2-%MTN
M'%@2?I?H%B[XV'GH(%$33E G"Z2K6-7IVG22='M-R.P>:-YEL!"I^66@:5JC
MRI4A3[3:J/+C 4:;QP1+T3@2*F ]<QV\^@D]XC>(JW>:*/>0>RF-I387K5##
MJZ;TM[8F5OE"(H4%C 'E6&$1-[)X*;9Y]'KN++46Z6/H21&=W_\G_N;W-_P-
M?\/?\#?\#7_#W_ W_ U_P__K "_LML3N<>!=&QEUVEZQQ#HC\RF;IBQ=0DV>
M5)X59='7TI7O UP#T?"D>32L5Q!00\OO +^'N !L1FC!6"/H S)67CO"V$I<
MYFM"+.B _T6:<:M0'2KJX HM08C<$I&,"Y=7PG&IXBD5Z]_+-U!3XQ/S$NW'
M7*9S&-/,#.E58)38)(V%EWXY+9QBX<+[+9F('8/]L7U]CI1*0ES>%,56^?R%
MA6F%6=CDTST!"_'-CN8L=A C*)6@R[-HL;?:?2.#G18C5>5"6OI\5[A^':N.
MJ8P)%J\'6W;.AY"<X[*$P^?W>U-((5%<D5&D< S0,DDF=VZM&3[FK4,]2I%&
M^RG\\6!&V*T,(V^4M"*[:),(T?@Q[!TPH50O478<[X5;$;^@A?^DV>!I@J.9
MKOKP^_/')5X4A(J-I'2$:C)&-^?AJP+EDJ-:2>GIY*Q1V-I)@]]:]B-PBFO9
MSU\5WUXZVXDA%-!BCC]\1'0^V8[.[U0>U]!TCQ=PJTI1K6YDL'L$8P16QBW.
M=8Q;:N2^ G1,-[,VOY2:IAA@?1SZ*E7JHAVF'TK 3DFZZ!'%T0ROWL3FM&8#
M;@SQ9=B"RPH037,,/L=O-]\INS_I<;K^NE.1P9;GGV(8'S.#9BPVUV+KD>;"
M2_9%N4L;29\< _L++N3D:^>MHID ^B: 6_I88;&<>A>C]<JW1Z;A>2$%K:A"
MFT[C?J$'UP-6<C&WE4GQPWR541J+"R(CA\I5P6<F,-:0$.-\+/Q4-=& !W;@
M.8OPO;V46M^QLH7OA[Y3XJV=SI.+)YFIWLO-YYVE_(655T ;^H,RGS("?0,5
M[XUQ?=D#78,AHK@!/6,J]$2[-$UO&*86U7&3?@1XZFU'E3I,$@$<:AMD!3UK
M!'L6@'L"&A")BH[&W(TYV71NEY^EH$5P!G=; [7I/B[VXE]T'=Y/>!!B1EF@
M/=[S70;[4/N8%KD7O[ED^=AS%PO!QA#.ZQ7K%2V[9%N.H_/V<G57)37[^*UI
M50_)Q<!G(),0U?6;C1S5.E&TL#0=2BB3ZAQMN"R1V;-<8Y^"Q'9@<I>F^FE&
M7LYQF<TP/84 XZ<L8Z8&(RZN@,XYZ_6=%=;*%?$I!T)'<0H#8'_*3B"ET%P6
M60QAL(',QW%NL,B\*"OTW+^W,:&1E6B(P_MLZUT9,0T+Y%W9/"$,5A81QY,M
M!;ILW')2!RWW(0/QZAVYLS3O;:.WCIUH5M_$AK!B7;7T6UN<O#Q4DYZYRL+$
MV810)DXZ<RI-:6#^A$K)X(::=4H'$]Z,@"]2T%LP+&\GIQJ7AX&/NC;#R714
M@NCH)H91THF?6]5DNP4HAR\QM(VCM:O<(1A[6S8;$1-BB?+E Q[YJ>@EZ'MC
M165V[+=S=E:,\OL1AYZ$Y=/- U?JP> \Q.EK($((,V_A*I+@%.Q5:V= ;D(!
M#0/%>9)9"QPJ?L$-_RD-<7@.;5M-!W:82N/)N#XFX1RO([&Z\,)QD359S&TY
MP0V7#<_F^>7%V4 -;0XKVQPQ#,(C"N(-:XP=LYX:U.>45RS^D]N*M,%XV?FN
MY!9#,RE3*U3H^Q:_8,%C"MIJJ#J&K=)7:B/Q<E^H_)'N(BV]_XQU#$P@BG](
M&OO(]U> VLOE[9WO>]5!H[5KG\</HB]]Q?SM.Z^ ^@L?GU? 2;!_D6U[!:%H
M&4& OH]K467L4-9B.RNN_(DVU;O1)2*)@D^*'TFT?M:2':4?AS;=A<LK+"\2
M7["8%-R]&4[[-J8L1^7F_^&4+;X[69 KLB!C:?Q,LSZ>)X]V# ]R55.!+F?:
M!7- 6XK] >E0COX7!K<I?M\Z1XA\>;0]+8I6Q=L$DR,@+HH6 ZS6/)G+O%6A
MR&[6N\H6)SXBQV0ZI.?08TN"&\#9)J73BB_Q3?J1%GR1OOYGYD51T3GG=#V3
M>8>!^? N;1I]OC<+_ SBHBK:[Q=GKFB)]" /&DX;6<0?M/#0P]??NE@0K3!-
MFV?J+'AT!O>9WSJT!;:$4ZD$KK_EJ1K5;,C!)(LHQ8#L+L9P27*O3PH#<>S3
ML:6*)S FYP)N$8>?.;C9Y'(5:9L4A,@.OF< ^>]3I\?,9^_7_R]VWBJVCJC;
MUMR)F9F9&6-VS,S,S,QLQW;,S,S,N,VT8V;V-F/,;,=,L=WY'[K[MEJW=1Y:
M5[K2>2PM:<XE58VQOC&K5(B1I<9A$?8+:Q2EO6YW;_/R)Q"])E\T.W5>H7L#
MK)]>G)T61):^T/Z=="QYI^EB<>KV!!<<3UZE*1UGB)^>*WX"K!<^ =/<OTE:
M[>/\4=K__+NX][O_Y[_[SDZI_D@'/HN*>@0I]5>*XSD4"3U%GAHHF8)S5L.4
M!^0\U)GC%%0Q!9G$<5;.R*"(,/*#B N"G<:Y__A:><#B$5U<"K=[)H<GB:9Z
M)*%:6Z(Z<H-/F<I =NAV:*IDI;T26ZFE*X#XQ(1?N<**)Y<HG\V^,1U%V-K.
M-%P9/3+-CK\AP_U:8GK+LD#C\4W2]%2#Q.R?0:FNBWD+0=";5&62VWPD+G!5
M-G2T\/K2L>KA=!"'A=J2* VGH\%CY+.0@F9*_PG@AEJ%[)BH0A5=X4NQ?(F$
MFX[D)5\<Q*H P!B[C^D50>]^._Q=O-/][J)\,[%5$.B!(C5?E:/CON#NF.U1
M-2>U-;MP*"?X?*+^6MIH 'W7M'@JU)$F7O$,#_V+);##%/]U$1.QN':Q6\F
M=UY+:"^\9;JRW:%+0\X+B5=HY2VO.##HS)MEX*3F7.S6P6D%H[>"85W;'^8:
M/ZQ75 ]G[3^RN/J/+ +^(XOKA_O[I]>/V.V=P(_>SM/S3T YTFM4_4SAP2.C
M96\"YS_Q:<C^OGP3W:>K(Z)O29;#W&KG(GU+O5_S4&&U4=TMT0NOT+.77-9:
MI.?_)[Y)1F"M@M ,^GJ]/J_<CH[[Y5RD H+N U([T>D#D)6P\2 \_1:=='$3
M[?IJ3#15F%+/H(D#(O8I5>#-$ZWR_3SN^.J:!7G(J]<!F'AV<7 D1O#M$_ ]
M?69"+AB\C#DSI_OAYFP(7=XT,P\7[!LR\S^XL<9C4$H/&.A;):3H+@>QZ3*4
M-G%5SBU;V>VKJ4+-CTN]QKZ"GS<![^;SZ@:0*K6GG7XLH9CSW8Y="RK7TJ_A
M#)K6IKKRKUC1U(66H,>D"UY5<K?--(^D*5*/I3.*C%%!T[K#H&%33,4IG8&3
M*IF 'B*#V/R"]!K 2*R:HVB9C&?G9.=QZ1KV8&,+%OG-XJYK;6\/D,YBGAL=
M2U%>B-A+RN1XX]%5_UTYFSI_+3;G7P2[?#8K/+Y>586E&*CHK@;>/T^*AZM?
M\9*M]$*T+\'FK ;K^[OBYR&BEB_TK;.+E<G#QSUKY-5E >V!V)PXC2Z;+W$O
M<9=*/H\]4?S?!LVJ(^_N/@$"F4-_Q5P7L/$G'O6<^-IX<>?.=/C)I-6J% /&
M6749%T9/!)!>G;BNN>3JZ"(/[4$.BQP+9)R%#HOTY5X5:.( 5S(ZM/@^<B=Y
M1:. D]V2AY*GUC<:7UKB@?ZW:V=+.UUX)2/Q6MS!"H5[A<(FUY_6>I9<_&6:
MU5KZF5RME^LN/_,PJ\GEHS+2;>=JD#?GNK >9":V^YONV4=0&_Z'P[_.KQ?-
MS:D[H.#UH_8CO_L3\&R\4SKO,H<>8R!O($:C>&] B[NO&CYL4PTC6P7OHS.:
MF6KBE6+KH::$Q#O/E6)/=8D[GU*8+>1BNCW8F/1<UOFJHO*KI^?7_2= <EMF
M*VM@40QJXE2=V<R<AP%>H[W<]3<G4\ >C,M/4 J0N$R$!':X(6;KA D+)6=8
M$Z\\U_A'J)<,'P=8'DY"NG-0 J,$FNRDN$70%O=>11>G1? R)F#+;L5OY["_
M5R;:15B66N, &G8'#,+YZA::FMI.0(U^JE[1:*]0;H=A/9U/E[BXP-.5@I7-
M4L-]6:>0O5YG9S(G]\$"W?I:D47-6;KVR_!FE4C#L5 T:9PN44YF+T,'P84@
M6(6:SO3^SX0L%BEZ6W_,H4)3KBQTW/(OX4R2[=_+[4P',IO%:A3)Y%?QTQ&4
M@;XN7G+HT4+*E,/[E"RJIL&9):6@N_W]?OGIG\31BEAR&I7S(BL]8*@SIKA7
MZ8@Y]) J]S1<7Z]B\*]RC[?,:W0B^CS]&+BW_JM>:_6.B<PQV.Q?$"TQZ[#/
MR*_L@PTIAP\<8KJ(#,D5;'#NKJJ]'7[$[E%!:PS9E?;3CV&"5#14K.W YK$H
MXT**6<M6AH=[#CH<2B'?E6L%9*172R9DHRQML)=/B)+90YART")2'S6,SO<%
M&S+Y#>'-K"_E'#09\W=X .@#4_\JE;N.@KI*#C_HG_^ADV;Q$SAQR[J<Y7,^
MO^(CY#N(-/S@]30^#1J=/\)5XE&D<&$U%E599./CTJ9LQ%J;>+D2)0G?3%>#
M&@%?T(KWWJ#(%^40;R$V8V(D6\F;46L3[S*3F+]J0.5S,(@6Y*A5HG,&L5CD
M%$\Q3J<SO4FB^2*(!227S<ZRU]C*[Y"9G3FFE"P4F5/ECK7RG*L6Q77DJR[5
M<+WV5%V*"7EBS _7PD&@R<$K_4DT;-&,*(HU.:NBI1,P3+;,.O['JON$K4!^
M5ZST[C)-H#KA KPKHV+CY8"M-R\D+]WZG]CI!H@@?G15_[((7>)8_# A43F<
MO>=/P*)0CT" D-7D<T*.H)&14_O!PSL>J(#F__9@A?0\*)HF'=+82R+N>4[R
M2#V;NBN45K\RS:2S/HXA!QN.8UYV,[6IC46>5*[=?**V"@>&(TW/1\/!I@%M
MLZH9]W0-]%9VJU]UIS% _' -AR^1>E=+\"=-9HO5HJ4H4>/!:HTT>=]+OK)A
M*H>WV-RK'%E+P.H!?G(2\+GD_=P[.=I3"O!\DV%FEMN$M[%/=&LDP(_6K3V4
M:.,*LN)AU(8^^D-0+#T_2N@8#7#_!LVB8N^TH)VDS.YU%DVA1?V/+^,$)%9H
MM)L.$O@T)/2^D8\QS7T58=0]5>,;0!&O<!1&RQ8?"9V.(B.>C]#])HEDJ]'.
M.,WPTDS8#V[N6I\3GC+MKPS6OE;WK=3[2..N$?VZ#1ZF[4C].3"/6R$K\^J%
MN;$0+ *T%WX"B!G2'=,H'*70$0*[V][@?XG^W:,Z+6*UFB#[+LBN'$79T"85
MF33G*K60$TS>)F"C^F#Y-L*R+R# 651W^BLHE:R<F%Z-SZLXMX#( ')/XO?O
M4PWX?0L&1X<K$EMK_?1RN:\0QK*BE%WS-W<SKQ;4YP<O7!  3KR1C@\_XJ1&
MH>JK*W JE;FOG9<*7K*0VREP#0UI4D;3CN!&X?N?N3.S;Y7P:_"B6;H:!)2F
M\Y;I+"(G3F"7MI=R(ZNI13F=KO,JND6:=NY"1/)*[_*DP93L4.K048X#!1N;
M[L=<_3;+MA)39S2]58@+1I(,/<0M'^'QWXTYT,2'X#PL<Y;<4@$&^ZN^?P%Q
MFB$I=[&HA8&49H3>N\6?O0E92+:_G>M8V%]%>'NPZ7TXDBSQ1B"JP>D3</^M
M&^IRU>OM%(<[X&T#Y#1GF#O?,,:B-'GZCX53F*:%99DJ>-Y"2)3<#4C5"&2F
MHW5/5V3+$.QC]]4!?WJ$@GW4E-*RSZ1%;G[**,I*C3"]I@%]$<0#Z>(#4]7K
M9V><\@3F,X)8%*@X*ZPZMNC3IE7N8M1:";Q-(>'+?C(QK<XY[:&FYI<F)#S!
MS_7ZAXF9[<6@ZA$_'+!T?[E"#2L,EIC>_OGDY#<G<G44Y+2.8J3@^WH--LI8
M@7ZGMOL:E*I(VOJ7K;O"E[[+.:1,,6\B\*M[=8K"A4GBHIQUFE*J3+7/=P_9
M-!BL5DL'8&LM@3J;/1E<0-A)+);"- ;\B'6Z[MU*GH)SD?SV7JBSG\Y>E@Z2
MINGM3QU%^L@PU<:(]P:'58'Q1Q@ 5A%"P!\4P^QYW=2"1)ID.L9PX91N/TG:
MM)O3Z2T.0_;WV6$IBE">6EX=>7DH_KO)0:#]M##WOWQ89IMJG0CSCTA $O^(
MA,[C"ZV.7.MBV/VU1.$/!W=PTDHPC6PE-P%0UT/W\#&#<X+> I6LS3[-1 :$
M04)Y748*^E% '6X\-D_:D\,3+F^6W(Z\=<'[2@W#OHDE6GZ=RA<9FED\R0%J
M'8N,GU-I!^O)KV6CMJ3YBOGWH11EK]2W&;SZ7?S2S=96\^H,T;+T*-,-^BT=
MF@^G!U*%,Y'GD]Q.@PNR4&(LH5KX.M"SN*'JM<A3N;U(*!"R^A\#;I.LQ!,/
M*,O4A._R*BY#82^+UBCN*'5,4VEK882'LZ>D+6; M[6,5(%#C^HP8Y'+7$D0
M4_?J$%V>G#?I4N-TFY;#T2/\T<F4 ])M;V6!FKBB:DQ;,*>DE0ZCQ4TB@ @1
MQO\ZD6H=ZF+"AA?-81OB/Q+)#Q 6[_Q?,[ORSLW-R<K)Z.YA$5]<6(Q2BRDI
M22Y&;>=J+R:UU6PP;%4)HY:,(C<--2G/)/W9"&.*_5#GY$UXX7'W9>\E;=Q.
M+L'CSL4N9Q$_31EC]>)\_,M!@D4F^C(I?JDL1!%,0 AC?TC@JY.W86O")T!'
M"5NHW8DO4''^$T 3RP=^M_BN_;'5<_K.+_4WG_5<Z2'UQNS-\Z[B_I+DUGNP
M3FA9;3CA<F.F -P2.+Z/W/+?!?Z[P'\7^.\"_QL7L&_\!##^XCANXJJ,56M_
M&5\0?:QL46 ::-+>&.HT&9B#E9:-$)NG> V9P@[6YK(,-7XJC-#;?J@ELBL2
M095$C22?"V:R%D'UJ@L5V0:YDUX;=FVWUWTH[))L_C/SH $6WC/B"]@G&%=
MJ9-+]F@+?W!]>?W=OEV\@Z]_+<+7BG;M+#NX[5!5G+)2U&^]7J+KSM:ZJ%RD
MD2L-TQ]2$A2&_-[TI'U@/)-]03/%F;$P?C\?.3K\RUUC-6I&*IQ6QUFV)Q@O
M3G)8?WD!F6-B:Y X6Z3>]J-"[?$)V1 )<(4I\">6TJ,:-/@>=0]E]3R]MP^^
MXHTNQ.85U@7FPF/2Z#>4VGMJ?\L[)$_((]]APY^O51\3QNL!P80B;T2N*\]?
MU#\!%JP.0B+(I._QG79_ =6!39E<!841J &C^JT?  VA-7D"I3FQ2"&S>MU/
M ("^X*(<J>*_6_]OW-I%=O,D7JSBJON*ZWI/+8NX\RZ'CSSFF$#VS,JB9)!#
MA+H7O[#&= %;UF"@4-H]+J[SQR6[AP5UP/H6@)RC*:(.ELQ,5>_NF"34'V5L
MV"AB9?:#^D6"BDOPK_?-[PT;MO+B[5J,RU*[2=$5>A5)^@J=O*<O.JU0N'6J
M4AZ6[<EDL<:X<MM#0[.]/'^F&AQ_B!EN&9@8/ <?C._ WAUFL#70< $O.1&0
M)IDLZZB*0W6602;*5^FN9MY!@T9C&L43SDGM'5TTHC9EF)IM1-:=-T[IYPY&
MN13J&VK9@!W<'[N47>8,G:=:N$/KY[J5H41!L"=8A7:(:U$W$A*-PLKJDRJ\
M>(Q,(LQ\3J*1]!S& \[NV-3Z6^9JFX2:%J!Z??[A';:,9>.+Y,[:,_L.*F53
M8_!>>( GXKEK:7$%O*J%)GPJN3.\?SOD+I^=P@:_I-/!W.3L8 /)_^/V4?]O
M^VC\=^O_Q:VEVBIBE4C:$:'E]"=Y$0J2V,<WU-MI72.66+W5JRJM4MG'W1-D
M2Q@=&NSK3Q"Q8TGW%%=:3%:Z15$J/:F RM\A5N\Z>P%H: 4RFT=VO!_//;SK
MG-0_E$U'*W Y31@6I*,4;6=0IY7-Y,1^HF%<;;]'J6$B!0B?(UQ.MJZ:_XLC
M/%)'W \Q?SH_ <GKUR])EIH@[][X*W/S_W*:05;4_,5$/^?II>(Q_(+9<!E1
M0WQ5S^0+*+.EJO'2/D/3DC#]JOT)P'!6S8;>99&C->-TLXN8KU..!/Z4(%9^
M%\5?<<+#6FL8^KZ.X]'U$.='5K[.ER64+(=1L58+I7#+]%5A/+T/G7W&9]NS
MHTV"8<J7+4CU0>$87>8TD>^O&>5O2'!$T<:((5N(ZTW%^N7W3X"?]]W/U9ZS
ME)@&.=') *2>5XMP*XD5S,M9$[I&1CY0$TBZC_Y5BYIQQ0OZ<70)96S\JP8?
MZZ(?ZQ?DHF:OPTZ##T86!/:]@-/*UE[8R.T6B"W(X?W"$)1,NF!U]RUAPUX>
MU#?[9()H]=?]N>%??"6)<>06)K(_4Z$23;(9^R[L]W<]%V[N*EY3,K9D/P'<
M9:THL=+'&DQTB8Q\KOIO=\"JSEM5HCA;,CS@G^'>Y[YL"N$6W>6@IGM%C!]6
MZ^^[__4$^?OXS2=0S0[\\>X[^[JY%#-IN-D]&BX/#0$1&F 6J-V+4/#"5/\)
MR,*VL%N)>;XZDC0*@6J,6#',_]7UOHER?-/[\2\:3O_\X/X$_(.HET:2D4_
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M0^GL#*< $YXZV)>[\:Z(6;-ELPH;/UJ/JM37Q>^>/850X[>Q2A:S;D5N$1N
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MLS#N6X7.I@^'A!)SQP,!E'/W1Y;A4*@&%JEL:"GS.T6VAWU%>EW"$^9F51#
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ML?UQ/M>('@8IUFWPL%7NNI-R@:G%8@Y:%IC9<Y/J4DGC8UB@EWO5M;]R[.:
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MMQ;V^#V%G*;H ;A0-^^!$E1K9-'R+OT]0I9?VD5FZ9(4XFRO?NZ)[?D=:YB
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M^@9QC_W@C'A7D<]?64L=G:^21O\61GB0NI.:4U)*JTF%<D-XIT80LW_%[>W
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MA8'=UVUVSE/_<M/S2?Q!F!$X3.>F_;*<0%17ZNKYTKJ@D5?,U-8:W)JN%LT
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M1\O#,*XT";X+K\M&'8MW GIWUR2HAYDWYGF**[=2<#B=_W9/89E4:MRPV*[
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MT-&!]64:G6E>/]Z6;0AQA"AYQ!]-D+U /A>-H-%DMT!QDN%LB@]+N;/M!:\
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M%;SD6OEDM]%L<JSOH7[4.M8@V-E[$$'$I:GEBF:D]4G:\36FD6-LYSMD((4
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MA87M_E"ZKZNT'DR1SO_]S!BC'@;93P$G?'12;QE\K^[:$WS*$I(FVZHE_E(
MD]>;*YSO8$DG5[3C1W*/MO!66/RX:?WA$Z=U3SR"/8P>:9NFAENLS[T?+XV.
MT7+:::5C45TTEE\T+1.55"-\BH[T_@B.6&N#*E6 ^YH8*'CD[$0JQ]N:567K
MV3S-"Z N<OE](<V1#RBE)T.!];=.C21L(\^.:_Z@, =>0LM_LRO6'Q7!YRDO
MMO^B:I%FB'KUK1B32X&3&E?2$-24KC^90=KIV6:EV)I?A#I_7CO5R6I.AQ#G
M'$]-,,G(PMR)ONKP-6YD,[1_CCO)5X[ ));+'+"-:<?]"!U<T0CXN36!/X1#
M)D$<YFQY&LLK3!<WM<&^VOZ&Q3G0 13JR5$LC'*0^??*L[]EKR!I(YR=/ZHA
MS8@IX&<-9S?Y]OJ+6*<XJ(1*MY=U@G@[=Z9 ]\F1UP#016FK4\M_/[.6E&E\
M,,,+P.\&6F2FB>*F-TD4KF -_<,E)!JY _V/\*X1,!0M&Z)'C#\Q8^\ZFAT4
M-B(]56E"(D'_C W]E&8-*;URXSYYW4-P=4Q;$AJPMIB.]^VQPF\"WEWJ?O\(
M"/WM?QALD,(]=*1*1,!;X7_:$K[TBU[JCE6AALYDU;W*\[#?+DFX+$CE?/D(
M.VOM>@XX!Z4DL:S9FB8EO J^<PTB=#/A8K/)YF:IRL&R*=)9S=#ADNX0YHP-
M:+BM19&TW\0K&R%IS 6#O$)973V$AF3T3LC+)6B'8N<QT;3?OXZ#<U5KH#OD
M&_,>D?&\.<]KYO5U><F]\JE31O4=/LQ0CLS8YDH5;KLZ[6[#6[>44C5974,-
M2G54#OW._4+SY,+3#ZH);YFY(+,YV\[X5"O;G^?LX.#W?8?39=#91Z_M;,EQ
M/1+^+1C(WN!I.TV+G*Z'B48:JXN,C&FZ;I/O>Y9G!)A-6^'/A5@K$WN.'<HR
M.*;,Y!C^!T>S[G;*4G<S:G;]P$CC89W-/;JEX&ZM49:C'83@EILLAZ\[1)'@
M\W.Y3>6&VKV!#MLMRS>#"[Z8X8S1^+K\I=NX1?.Z A&= WJKB&!A&*31W83O
M%TK>@F3;:C;F[Z"/7HD87G1S\E>Y0?7/\]77*P]M+F" ^QTUV?^WK(GWEO#7
M_(/SVW%[SS]+O8P&8ZZCGAPRM^%)+)RSS&<2_&D60*HY+%:@Z^K/7*^9LY>G
M_7<]WG-PO:U<$(]YMN0H+W;L60/-L5LIME')39-%BK.,PXGL5?%IX.<)V3.3
MQ0]_D8BK8$XOJ.443-;501ME;#?3QF2'6LE1UZ(5L,#8_8FCP]*;$@7FQ2]=
M*XHQ4:+VA"ASWC0(E@:#0D7W^G*6!)S\O#SJR,<+>8RNT\]RPNHLGV?U2[J'
MOS>4,]<NN?G+V31)I].;I\ZR>8&PK/A;?W9-X $Q2WEB)# TU6QF[VISLJ"=
M%:6UG,(GHVB9'*="QV_O;LAUR;Q&N+4Y2.M=XE \3CH=0.[71.*V+C8?5@1!
MEGRGR%E6!2(Z#TC5H"VK%0F+#L)9+OW@OI355  Q]F2?'\=U>O*I<#HTQ2+=
M/:;9F-URK4Y]@W>]//??9RA$MHU,HCS-"F/Q9KTT1." '6?H0/]ON(6)(*6<
MF9'G3J3QPXW57F ?D:*E#B[QRWK9,<K4D=^?_.(<Q9FI'F\V$U0#?YC4#,%/
MCM76.QQ3%3H[>YD\,*[8J#A,Q",I>V2;;0C2=LHT,'-'7".1*8RGN_#OP'<Z
MP#//E3%FT^+V5F9T*^37#WMO*E%'>2Y=!D6Q@WC1Z>%5Y#:A>B>4N%*)&AM@
MM3_D;P6NJJ&YDUJEW[% 7Y&0H-0)ER//Z:EO)S61/ YM!H9^2IFSOAF%&@CI
M?#83]T!&LOZA"B@2ROE#U#W6HOYC8-/#)/L(P&D)R>*77>]#FJ6W=..1F]6<
M53;19/2"+306N9(M],FNW4FN%H(&6H.L/J<JW/!.G)Y-MMS8G*+D1S]Z4.X*
M30IAB S-PIC9+%X Q;0-<B'O-XH-M',GTQ.Z;@K]-FP[Z&:[/\4*XD5>"<ZI
M@]B,:$K-'^6>'IY^IL7V"Z)O66;P-O5 4G3#KW<*X&^5K9*;&+]\YK'A7LD5
MLE-Z'YKF.,)^192<^<1,WE@:9#-90 2W?&^>^/5LM^9"OFI&7O5R4;78S4$^
MZ?#5*[@DLL7"*0W,2'G/E55$)>4GS\KSC&$&0)E!>0V5_R%F9*(DZO4-(K,X
M0W;:YQHWKMPDZ)6#;@846U P>*FTD-=]*N!K9A"/&-RM92-F0+%.X="C=G.R
M"O" G%_&+X8 ]_45N"3], M'@'H8%+D\M+[5@=XS];\1Q=D-1QRK3OYXBZV+
MEZ!6:U47" WH(=Q>IPIJC1!U-X_IY^%RI?Z)R%I?+@,1H83:O7%V6+I-IPY7
M<]'GL6'\G4Y3DOH8-_C<.EMYHLB25V'FJ9...%NI#;J:%.\],)77'<KHNV>>
M9^'!.'_02KC#P""#7U!E4D9L#_3^:3'.U*@&:"7R<, \E',2&[XNQ[M8^:/2
M#D9'R<9"G-%62/QR60O^@G>N@(7VU^>&0Y<HZ?MMU_+G*I'5'U=6CT@:N36?
MA\3BNK8^@M4"]?]DBRB+%,>V;T?']&'&,:\8)9,Y6EG&@T;+ZQ:EB4NT[63+
MN?RQ/^7M[M9N15^:GWDUD;*:X& ;80)3?EJB0^<2"'QGFY&A]RTI#A!:P_8I
M*J/QG\V:7,C0I=#C+Z%"4=BL"_X#>3WV,O_!C=0A&W@A0^DMJ?XN-&0A_\I
ME#%6]]^J1JO5,VLB'R^@L%%#YS>OD!F9QDVBER;4EC882>GJ/$P6SKRVJZ0F
MR,I I*]T-Q!>^D5L9.NB>H^>F>("9ZC!PG;_O,/"#D= O_ ?'*FA#(]1S=*
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M''')E>55*Q4E&IOER[-2IU*[:G3ZETB4F;4Y80:6CY,RW7(9B-U9)'[5OZ!
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M(9<JR]% DN3$L$;6C0P*4I ?UPDXR@F_;P_P%V=/O=V@!KV5UJF1@8W<%/A
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MR8C<-?_A>>#/O-I@%2$W-[Y3J%_M8"T@1S%/SV+;A,K<IDC=O(Y];*LGZYS
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MLRKK@A<HM5?I-^*ZB)(;WX:GHR=/<>(_)'PNEN3M=>QR\:^\W:L.FY!JW&3
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M67[\#V4HEB[NH+'5!IGQ1/\;Z<6A[4J5$]MI#]8SMZANS0M]W"X<],*J31'
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MBT2+N+VSE32:<R1%EB@V*YS"<="K7M7'68POHZG<SMVS],+MA1"0W_SEBO[
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MGC*S0",Y66&^K5= 0 +3RM%^,0Q0?)B[3BJOIW+$QLE>.J-9;JL#BKHD7(S
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M_..]]A?DP)&^I%NDS^"CS,ZF:,JF(R/ENK:RZ%"=PB(8F7O($:K=R2R$)V<
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M\DJXP9A_%+1?";^6XI #B:"DO)W?%VC!GY6U=J^>AQPB4"F0G_B^3[RO7Y2
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M9BRU_V(F-,DU6,Z#AO6>9)1T*D>5C:<#NY%)!^Y[4OI!W3@CW]R72CV:PNQ
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M<3$JIDAHC%A%-"ES$^9*J[6.P^&Z9N><\5L0Y><2!K \UT9VW823?;O>AH\
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M*J="U:L)65_*8'8J70@S- AGT#G%'WVT :F/;$W1B@<+0:*\!O@';JH;V>+
M1<1[/59F(JWY3PW\=,38#8M^>U-!F\TXQ9L]E_\2.EU=;X$CBX0\G?7=+!B6
MJ8;O(G+D64@W3@TI_\P4*:=S"Y<'-#IGN(V\X8*Y(]\13ZL-BQ"B"PW[)$V
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M_0$J "G\)6.WK,U)2:V"?5A *&6#QJ*L^6)BJ)GYX@DB#=T@J M.J<H6^>M
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M\Y;5OQVOYT/*<DT]K[56Q'D\0QOE[=OB.+%3"\I;"<H(XG=07^G7@S,SJ-#
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MJ?YX0*CBGIH[2TC8;*B2TO4?16DZ?ZG>4.A.)66DK6#A'FM^K&%_N*_5LPZ
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M@!<1H+46 (G]^!IYC4K14(/V'H3;RCC:>AK58>WZF0+_%CS"K$G,'X08Q->
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M&T+R9WNPDAD+]V-SZ=,4B%F^5(F/&PE0[A&QL*7'*'ROFL6LO[O%MIX]<./
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M4V0#1JU7/2%;M?Y;I;)#F%8K0#EX^H6GGMWPL[ \>Z=JK@.9CF<=$WYIVHK
M5N9DZ ,>P;E$(@\J*C=^)D]*1*78K2Q'(YU^BW-.-XO:/<TQ-N.JM\,^@ZN'
M[Q\B&Y\.(V6WZ7:KA,<E C Q/U%2-Q#X(X#"98PN5_15G(G36-02RS.2%SS^
MIV8C"S-^7I^L6<^72B<7MX5(WHP.][59D"M^=/O124@CO\J&S:='?CBIT<'>
MUED6/)G=\FY4$3.RCE2_H)5-^Z\@3)$RU"=-5.!^>D/@=?[Z;/CZ?22UP9*.
MCU-(>N&JPTN-"Y41DG "_PY$)T60<N"6YR'>REG]1&9:^W7S .E/:1*E45"
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MJ[OU#H[;'^G_&7]0Y7Q;XQP^_JOJ-' DGVO\^/.O:%=J-K W7Y--)%7>PYO
M3@WZLI<5:8SW-Z:NVBD+J/G)VLG9 .43>8^5LNUDHG.W-4&@CNJ9(#')N0E&
MB-:O'+G3*2O(7"62GN6+DU\]]!L%ODSM)EF&\?*=":5W0Y[-3%YE?)$8KY[1
MFK/P'"NH5%^H55PC?12* 1%6P0.4,.^@$!K<1IQ8UIOV,>YHOQR+]8U>U"OF
MJ"H=SQ^U'LXN.B+7^$I.6F>.2J97ILHM?&2',RJNF[SKW+0:97=EY&2G^7@M
MXXOHYO'-B8L=<VJ;T ,W"=5 BZ'T^WQ?__S)?>5\>.!G<I4>H*2XL'E5&L#4
M;)ROQ.+*;KL]VA$"&U!(OV-&*UH291NL9C,W$ &8Z*ER1DV/QR4:>%!Z_E1%
M=M)M5N=;CKK$V@[$!Z8.P6URT SW6S%U'WC*L#2CJ+6ZUCCH4(P^)' >$7]F
M3V;U[2,,O4W3(SC&0-3#/UVO5PR 2MOP$H(7/975V4$[6AHQY@5#TTK'@&(F
MLXUQ?M-#:->0FF^ &HSGS6&W?'!"XT\*A,+N[Z,A"'\<IHI[=G:'>&<$8GR)
MN.SZD9T%(_U+K$8HX5PSFQCB.B'BWJ3,QPCHLL:GZ9+LK/".P-[2^N1J?9Y'
MNW7*"DUO-Z3A+_EUCWL/KNAUTC@&9DJL)6K.>2@Z[F<V3C&'U!THTF5T(\-V
M(R)<L&ZSM=Z$!XV59@RYBESZS3F,3&#P*1,YYMB]]-*C4U0)=7(3MNX[3%K+
M?E&/Y!1=,AJ,D=+9-=#@<N6<"-UGC24*]$=F; T=RPB'<H7(Z)CG9)"$3]A?
M,$M<\HREMWJVJ79'W9'(1@6?$8^1RSOBSJ_U2BT9%;-":HL,QUUA FN_JN<X
M.>:5XD&-'9]3DLN) SF2Z71$SMM+=_:Q;2+GB^./,4ZG%(>(\FA295RX[R+.
MJPVUA32)!HH2!KK9K1,Z'#R.?!@Q0ZL/RJ-Z&77?"3JSFN4>3+\U@[N77%"Y
MCKOOS*_5?D7V5WK:R]43LI)[?_)Z)'F4CS?M%@!F\0<7<A44(VK&JH1/>VX;
MEP_@EK$"Y&/#!0FN*--+V#2^A'RMB-O%]^C[O.9=BX'GU+JD-[UVJNK!NZY;
MX1J*['_%C4]P'OI(5LL*"0)2UI6:HWUZ#'L0I@[?^SJEJ)>@/0D@U)#+V_3Y
M(F2L^CYWL$P?KT\4-]&G;'HR^B])?DRV7O("?/I%/(@Q:JPJHX,Q1[!@ *R0
M;#_3N&-=$+J(5J$%A;<;: MK'N\^+V9<K%%9-[3;J63I9?SI9Q$-V0E5HK@$
M8%3_:!2"E],7VW"SUMK_)!I'@416OK9\W)!KF\C:R_NZ>E<;L><9+7O>U90Y
MH\XH5"C$'"_K5&U6OLJEX6ACW6,:"QWHG]TN_>",H_35% K=I^^HLC:?=< 0
M&IV)($&BX%]-E! 1:S9C%Q3W.0[6ROX*J@A?V(+<6NG>/! X4PZ86T-PTZ1N
MRIXJQDLPS"TQG?#K%::?_,>J7N'*O,=HYCMW=$$KR[DM6(OW&6VU!:K[6=NQ
M;;2Y\?AG?_W/T6K\L@J$$S,\HP]FU7!AK(O&JA#RA"E6N%YB@##*LHO%L.NI
MZWYCE6L*^!A)RW#D3\V)<SFE<%#3VXVJ?:QRXP&3* %KM]S9]&OY X48/$DW
M@ZG=///=8IK&P\/&$_EA2V^)]T56I$NZU*<N3US:CBISK_. /0/L/XI61"H&
MA%0@D#=?5'&?B;DYO+UKQHSN:1!!+91Q"X_4B3Q16/UT3DYF,7*I5O2\C$UB
MQK\H51L&8"GI[D O<F'%C>U5^^R:4G[\Y!3J/;EV]V9;C4#3 ! <371)I>;I
M%"&'-U:Z]Y+BD*9+_VH,*/EM>_X;]6M5._3 <W-!R: -((RYRM%6=A/3PR0D
M8@#7 ! &O&2^\2AD;GE$AG[8VIRU5SMN8V#3#<GXG4#L5\\Q<9*[CG1SK0G"
M;@NF$3IA_1JWS0:P=]8@9 -62/IL-!DF]/,D*KMQ/7ZVUKKY!4#JM ,:_]?%
M=^^56H<S #@? P=>)?-WW4[-4C;QNZO5(9KI CF\,D;DDS,PQ#U]6%W\6XG8
M7M>R!BY2"B,#=&Y>8&TZDSF.3 8,_*KKKA# (PLDOZ."-RB#-Q/[5(MB\TT>
M*X%A2L3E@!@^PLEDP9O@YZ!(VK/;0CB4A$V6*&W]D :]8_6]"T2ECW4D0$Y5
MYS<>\JC_N6MHV$VDZA)>NPI?3]9#JI=N@%!JD]H2,I41=O7QZBP#Q[%$D(^Y
ML.@]NT?M>T6A:LWV G%H#E(:RG754B0R<KDH604.6ZN>8Y#"/X2NK?)"O=EP
M >H>H%I&7NDEF8?'*"GN^V3:U.E4N82D+[^9E4QB_$' !%5$+QDB -]WF':Q
M'<L K4_F&#-S%@G=42//ZL.%^717026;0+ C8Y--6GS [RJ*\^F0WE3E!9_P
M@=4T8UPGI[7=3*4X QI#G0!+A*_6H:'H_?[BESZ&1*R)'5]K?@.^G=0;^%PB
MC#J5>49J6PPJR^H1CRFW3=D)X N>,*@2&LHNMZY*:3I:LRF-"O #"WF_D%09
M6$",28+&QB_2%-D4<K+3>^(*PJ5K[LI7#\Z8S0>[$%^[X2.V+DNGW5%.-F,1
M8XME+JX^*E:\.U%6MVC2D8)HU$'$8L60_5I\;A:EKZRJ1]F9OB/MEZ!F$M;"
MNB_K;&;)<&X1,KVW\2/EJZOZ.Z5I$OM=8\H\=%=:)8%*6LA&#'.(#J);Z^O9
M0>!MWKI/8%+I8L]T;2:$BE]XAI5N+TUAVQ8G/G,K8G7@(_.AU?JO3:6\>0X9
M8WF55>A&62I!&PN"?A(7G8E@/1NS>NDFI8061[S4=C66?6>%=MY;E!<OBU57
M>591*&>#(:TF8Z^C8]][565@1*^AC# X;8F'+8EUTP0_8I :\^ZQ^17E[,NO
M<.\X39U5ES=^Q_7FO,-<F'HR>9IRRGDRS#6<!V>!!F;O;K_6_KE/1O-E\6(?
MW;2SXH9E"3;6(--)S?.G!:*=F>\YXA+A^:?<]G'!0R*FC%;[973%B06IV;7H
MN/ZSIN%#3RH-A%LM5H4C@GY.I)76&0U[*;OB4I );D9.W?NF:?_H8DU["Q\A
M;ZXZJ86U+,O4=N.:E*$HU5-PR[X*F^L3;=%$<!8 ;O'<=&_-8T9#N0.R,3LC
M!TS$1HN,,QV\DGKNE)?)]^<;>$7-XJA\N;OT"OI<=3&\@;E4]FD5T9<G9H"M
M;0\E*CDGVI-<6/:(51/I!DAR!,8]DAX##K.T3R%*%?0S?_R'@/J(K6/.1[A=
M27X7U*%==8<X'=6VS:9^.QD^&P .LM$QD3ZJMZ&!&WH2V9SOYF-31]EB(2<[
M9N#@1*KE^/Y#T!A]-C'U!;K_0\!C*53< ZR3OC)Y- JXYD<MF]HL^,EGYR'N
MG*U]PM.* G69R$"N7#5D7[/>1%)A.'4EJIAPS /?)N"$OM[(VR<%7=Z>.*L_
M(J]G'1*/5&7F%MI@/OW[5_K&+%&0.J>$!1'7Y?N ]*]+I1 ;=MD?S(]ET0(6
MUFWK;\03HMV9)FDGXNF 4'^NNAK2+1)U$I'0&>L;00Z-V-VHMCHS*BBA61]9
M\,H7$1<W7_F'I*OH*K'K@$]%"A$2W/\0F/H$KBFBWI&K9I8ODZVU_E2-J]#&
MREK(''+2YQ@\C6%_7_-ZYD4]$:UH1.Z!='R5B*T>T8%'RU\PF\A?"O^4,=B&
M\EP0B_TC[Q]"B;U[]^/P^O%,TFK1)Q"W6-]X#6JL,^!UEW356JBS]_2O(DK=
M4/DIU==!_R1TDKP8DZ+"4KDO/R*ULQXX#<W?L.?SS]HG:JS*UO:D"%8[(,-Q
M7IW6J61[ LLC<*R6Q";%G5+]>+5ZRA)V&'F2/.5_1!AKTJR?B=[N95EKC(7!
M[/N"D[8FOJ[GQ6;93L =J<P.;L]H0?AP,85?,9!C2C +'XZMU;'H%&^7Q1>.
MK9%(M?0X>O)-S^"G!$=BJ8\CE1TA>S3T5D":P:]D#KO\WR2+8Y2[9K("911*
M>CV;\$-<NNI7.Y1@G$ 0LB>>#)$CLBK 6Y,7(Y:^PFW9$Y6>(<4B5J-/RN@E
M&F("VW%1?QB1 Y4G]4($%=<)#L'J&;<TMF$M<%_8!00]M^E((Q;?9>2Z@<"D
M5.S+0]E%QC&'V8/\15$,(Q+S[XFL^DKA87$S_3^W']K9':;$^7Z(Z:%NAT'/
MOJG/4Y#_D'(!"MQ3-UI]_R(XJP;F-G[NL/74;5)\OURDE>MA#?@>,6/U?&V@
M8/F&#.X8$[ZLJ:H6Z5\L;K^I)K]RXHW4RRAU;OHYW'MX@[)9)_QSXE665+M4
MFSSVP[%^Q6Y-\/H.&O5X\PAESS1%99=71&IB6'1 )=$GH@'^L1^.GX"R S$I
MR^3WEF93KJ?HW.PTV7H1G=Y'<^\%\I8Y%/$#7/SQ4L-$'2"$UC$!S?^M0N3E
M*;\K!-4FCMX?N1J=?3#>@LDM#0MMC:Q@M@\I%=V5W;5,>@7XA/>O3"1,R%G+
M%*R2W@WC5V-2!W(Q 4D.))MTO=[HOW$T^E,\G4#7S+Z&*%T&:N.7M->%HA[F
MD7*B4:BVYSS4V:',N9OQO);/#XE%-)W\Q&02KQY2[%5 GNT2"7M+4Q0#;;;N
MKP#2D[W'6M!7NS [2LX/.9#'CG?27<VJG(:$2X-C78HWRZ<9FY$\I)FU%^AI
M]SK*OAC'6F@;WT\QJGDEBXJKLT<Q>>^,[^O[O'5HL:]DV007R4#).HHS=)Q<
MQJB#<6?C?]H+F%_&C3I9*DMBM4Y@:7#7H$462AEAI->(0*5_[K?#_.O4]R*[
MP$^;$2'O.6/(XP8\LWA#TP W<Q;CN80:;!/H!;/+ARJY?XD8,\=3JELU$ 25
M,W"+(LBDGK(5ANEYD@S?SYC8UO]#V&@^NR.]76\'!\Z+RJU6^;, %V&XCL@#
M1N*-9/[J]JI+O1R.SL(_\$K?>^['&19KL],'.[AH77/=^]?-) +:AVK_(;3N
MN?[9Q^@J8<*=W262I@\F?1--E#OD=@KURO"D/B0,61&]7JJX(RXTI;*VWBJW
MY_V]_&>H3$,LV>=C3T:.31AO9O54Y/'8KO7:!:B2A#UC> :[[C2+"<FQ!H\D
MH_ BT;BG[<?=+/N-&S"+< /.%\JH1#YQTBCM3[^KZCP$YJ3$8>+-]"/3K/F>
M2,_4T4UC$VJ#&_%+4^QL+8TY1&GXD2(PQQ#/LN/#AR7D5=1J:?->N[PR$PT_
M&3'1SY_$H]?K.FS:U;9QJT('@]YL%:LF>^.FR1"%85U@2"NI'A^[C&.X&OJ\
M;6I=^2@L=7=/B/<? A8QG ]!+F1'PQ2GS]]UTT.1% L./NTQ#K3^5B@E:AS9
M]')G9,N8-4IQHH0\L,[V#R'&$B==)_:U2"(T3D^-5=7/2AS1!:C&5SM<Y(HV
MCO \U M]H'?*KE.M%O<RE3# YQ1R]]DRVCEL-]U:S]ZF\ 9I:<*NFE]F8;\"
MR!%;(.T"Y9MC0S+'78@\:GR'2DE,8#VD7<QK\XXL2;TVMJR^$B91$86OI96<
MO$Z/JCM6:/RU58PUPC"<8BV_PUB&@/#9HZV>!Z!R@8U&25)E4JT^_142BWH1
MDHOV,Z=5SMQ'V,$3(V.O">$WG1>,"$7GTXL0DX\P)S]46A,?,AIW([Y@J(].
M!M3OSU8H0XXJ^E$I:(R,L)-C&UJFB&GAHI><VM_6;^$C_E4'_A"*Z5ZH?A2?
M">W)4*-4SIVY#,F.[Q7AE]^R3;JZR9%VKSJK^%SM)*ZQS):=UL8#:E]QA(*H
MO]KLZAX+'R19=>U?S]Y%_V:LZ7JM]/*-QW,!)3 =<@2SQ!5FT7A',:=GBS+S
MJ:A$@ABK>O*@:\]TJ54*_C6IN:4H.() ".: YJ]NS@K7'MN2H<Y+5O$Q$[DT
MI:3CK]SL.5N"4)8H#%3+4"P78*!J.0A93I!GHO2L-!4^Q\]MO>V.U#9A241P
MZ%5M _E[$1-L+5UA9'SOYO[ /QOE4 /YXE9V\ZPBJNWF08P!\7Z545.?7G2V
M #6B"@F+XY*84@/L=N,_)&R8Y5!Y;'A13FA/O \?18,J'GL)7[0YHE/QMYJ:
MBO@ 6:HO6QWQ*6#H1IQ=SKI<I>$M*.'@_89Q /9/E0^R^F%/;Z\O*Z=% &(7
M 3V<M\V.S\2*&C9F? 3]IF%UQ\*",AV&24<P+JT?_)V9&*;C@<)(EXJ=#^>#
M#<9+,:T$JF_& 51Z7L#\*-Q93\L]L3M?69!6!7/=NAO?"]JKSM>3-%9SJ#NC
M1AC_[1+['_WQ(WAHA_H=\7Z/_?;JJ43RAEWY7ZGNW="*'U;MQ7]>@SP%!2_J
MK?7/M:<YB'6GID=*.]=&SA4PV&-7GK4Y0R<*Z+0_C9R1@6"@A]#9 !^E"QPD
M9@2R4<U)[]<I>GOS1_,U3?SW>BOKLX<=?!*&(*RPH-3SB=)/]GCL&#T_V[2?
M:=YV2DN_2OD1"(D@:Q'%&C%DT)^%D2?Z>YRMDP)$'<7O\4#\@D&U6895CL8H
MI7JC:()E9,[VSW;VAE^/W4%DU%N74,2<BF// IH3.PX0?JPR32,<"R'L3KG[
MN9Q4Z"JB?46G48E1UE1P5UVZ4\I9L1*/A@V#S61%]WH_/#%:1**G4J8O67YR
MB??2.#(VK*Q]53%2"E.,1IU]@>-I5_%]K)"P? WJC "99.<^42^AQ)@5JU-
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MK^F-F31*+*PBJ6#*R]FXFF_".3S.\1L59 ]WDJ.)#^3]CW[Y7CY:9VZP86Z
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M7W.4 *TM2Y$_5'\,'Z7$I$;6W^5%*JBA_;.*;PZO%A.+Q=7.AIQD, (EYY'
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M)_R-S&<2&S6)R5>V<<%6HT7H&#3$DNY_EFH!51196]2SGRDKB)@_%Q X^6H
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MJ_Q-(.ZX<,/O)"4H*<0PC9$MMCS:BFK]'^<]1JRFOJU2DYKBP&-.@<*B;2Z
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MO+'[A&&P-2IF]J96O2^]BRC:Z#Y28&<CCGF>E5&QOZU5,<([JB%"ELJK,^)
M?0.I =4@<OTL I%ZKLQ=@83+RD?*?H4E5]AIBVZG6EZ;XBYX*#>6(/I9+:*>
M(*(YY4!*G!U>X$M.^,;E9[A>YX]K9Z&OZ^7W&$\)!C .],$#%_ !1%&NFS*4
M]$F;7KN:,WM.W5LY#[++U>Z"=C4<-KQ,F"Z39HD\:1P1<EQ)W1(?NT7#\H\P
M[P0KJ\P8@AV:V=8NY-6Y+\[0[#E3M;<IYT)+?RAGBC-YNBNW21C_0+*1M_:3
MHS*1%G3-?_>@-:A6,X_S<7E11+[WSL4D3*!U\DY]9I%2WW609'W2DI12+5H5
M9$TG)W/=.^1N\-7H!N?795)'FXB6Q';R)%<?'0;0\"?J^_Z'X-2=AU6V4"/0
M?FN=3_U]16MU7UBS>/H_!'V@2R,W/K>%3Z-G!M^0X !15\F((@5>4>7K!R2L
MJ1/P+[7;@EJK-;S?PC262P&55Y>)XZ,U)HW7!NX/3L2\A42R=@M9MBM;I]8S
MGC5&FOHOEZ2]'6[J;8E+VA53*LS8@3T39D5$"OHRBLW3'W*YJ*>6V"W+DCCJ
M>E@)]Q:3^_MKIW5^+>00]6%",Z&,#K4+BEE.1)$N G,Z.++X[RA9ENK\YI@#
MYG=Z!@\D&QJ%<(#OX]_U8!WBIBYB9QB\J)IK1_BK%1"N'U6INK/!:-]G("J
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M]\+6=M:Z%:SN0KYZ'H.4RU0)ZIO99E,B?7!]FL: SII5.;PLF6I$8EF:4)_
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M..-J,;7F)26?TK>YPV9;;J'V24T4LR3$0DM07$KEU<R7H:<=2!19'T.66(1
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M_#AOSF:28KRW/>4S48&Y$F2U9GU4=()>_/ABJ$:S-, YOF/H:6M'%'4!%S5
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M_S\8EW8=LEK" 0)OQ)0K.D=H=V%Q@RWB\K_/H46\[QZSNX0_?LFKUE62D)%
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M8)+G%R4&Q\PM;W4Z_U[5S1[9@P@3((YDEHV\J58Q9'RW[@E5>P(GLV#=^OK
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MC-,&#?7Z-8+8BIC60*K8[Q_ 6ELE+[$!+5Y_ E.^;YRB3]M:EJ&D-@TZD2K
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MA%&9#^97@1\2TJ_V]&>NWI^WZS7_ +6S6CVMU],]7F8#1BP\4J?<SS%WG?\
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M1)OK;21=B<'V-OU$DNG&-2&";IP#K)9<3T?$>1\GEX5/;^NL<R 9FH&#_J[
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M+)*WG.XE2IRGYN/).6*WP.[>5@E4B0Y_3Z>5AO4VI;<'3)-#[2U"K1#P4L<
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MW.X2("76.4S@W)GHCGW_N]R;Q'\\2O'N=[DWNO_\7>UW!136/+WT*^"%A=O
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M._4[QPNBJDE+=K"3>$@O9'1%YW5<95 >Y;52+=,[0UR)]D?91,F-CAS/2+?
M3'VGUVYCR\@57TKC9KU'#VC@YDY7506BP?DIU%39<1B K1([M95K4HJ$--+N
MSK 67&.C';(LFMGDT5(/J1V$AD:D^Y%A\VR7,GO=GNGV#CJ/H>C%FA=@S"+9
MBS/VO([G/;8VV"J8I'E:Y0<2GO(#T=$MQN"*:^QI=R\OCZ<DAH0<-98(7-:[
M: F7@CVK33B4+9/HU76Z6&*S% WO#+$=[B\#U+,27A3$L[[5#-SJVHB+ (B#
M-S7*-[V]M8='1D-S0U%<W&;RI8$;V1;73TYVD&R%+<2"5:[(2BH6W+4EC+R;
M>=NUY054Y6L*/^%P#<EQE C,&2%6RJG',3(Y #T8$ W=DFD$#+T"@.X-IKN[
M:-T"GZ]F?!7RT04G0?,>?&%GK0L%+1#'.T.)Q#:RARWQ>6_[)]Y<[&A+6R;J
MAD'A[E)LVX4. #T:O*VX);3O4]QD=EV[ZZ):Z*BVP)/TU(F"O2XU]<YP<32'
M5)<V$HS#[&*P.%PE+$BO*QO-NEHA"&\K"D"!9:FZ4A;N9J?H^3S.#4J<,;+E
MN+N%M+3FY)FW\LD$7.!QPUP&"R_>]]-I35P@M]7H,C0R--(/LSM#M3YT0G$B
MD4@)-VC=+/I39I3R;C2*3JGH<IA=!1\_'>'+PC]'5TYDEW:>Y ?6'F"BOCIY
M _-$5\*INIGT(4='O,J(L+*Y7BMZM+'2P)@TU.4*LU*W$@B"$UNM(+M!++8"
M25Q5%\WZ$5]+0A\+<X$,]ML+&?MMB7"3&5U;E$.HZ&I+(MT*[76M7BXBTIG[
M@IFMH"MOL^*<5X8CDNWC>+XAAVN?$;31Y/"+P5\WSI99K2%M<N>ZE=1-O_ZY
M/O5R1+.YX)G!#JGO#,<U[Y/[P+#YT8-X3G5'90$OAW%9C[O*71VQJX(LM0UP
MC:@M7Q.KK71Q(Z6'U$A587-P<QAT?0TKH7>^W!G>6E#68\!#AS&ZEI'<%/"&
MNYZ)KE>O+ (F0?'1!=$Z=<MGQZPK2P$W4<RQ#\<S06B5+\_/(KL>_5PC[@S+
M7&*=Y1GOZS-RB @>FCG%OMB'9PX6>ISC[8%?<J90"-21X\T6Q4>B[-H8L2'&
M.#O7C7^!4@%QEE5T<%_8E -O0\)RN2:E8U6N/3A5B%5+C5OHU)0"A6VW*V$O
M7:\28>/SI29RW"RI%BL2M2+00E!$1 19 8?*Y*1@R[8X>)>AY<A3DOC^ZJ#L
MI.O28^>[B-" P"TAMUBFL&KL#E20MQ13KY/-,=901N'D_4R#4G$1G ;@5>E3
M!D,SPHS?UZOY/H=9,48\^NHP%KHR-(_>V0G2:.U<E.>#09:;U6P1*Q=^61<7
MC/./;GKD+]5I<QT9R/<1++\S5#P2]3#:5VJ>"^LKL=*#M>*H%!C*)H<.;&U$
M_+YT:L.KL8O4E HL]S";0YW4O?'YSO!=A6]^[B5@LW-!)YKZ#"0J4\/+@+/=
MP7$L092T>C_)<K:@NU;;!72+8.52;MF561$<[47\A?%9WYDK:M:0N8OM)-<\
M+7.MADP.-6!6/J#X\@"O\:M[UJ\C19RG.83E-0*OH8#!$U(=M+6[OL+L?#14
MNET%\'5%=\UUV6$%1FR43C<$Y9H9%3N/A;4_(DZOK/&^B2QEV3+:8II#.0).
M1T"%5#S771DFN"-\#,[YAO!EAX8.)+,O]8U.NWT5)EVSZOA]JX>R70]%9*B'
M1<!&N!'"6)2FPIWA51\H9[NG*28*F'%39WD%E/(VB>5Z435S<[DN=J'M'#9B
ME^#T"-- <\PJ\JV?[PS?5?CZ9SJ_Z<-T$.&Q'M?)3H.2P_98PEVWQ[<.[. ,
M0:\GFT)I<'>F\!&KTI@WEXVQ8P/=QQU%564&WE!Z&:@]@JYL>4>6[BAN#JC;
MQ*L3+ENZ L_3:P)A$"I2W'PS>; 4YC;K&<I<VX _S@QG79%J18V4CZ-X89V#
MO7QT9]E)(VS)% _GR-$+F),851B'0222+;D69=>(KAOX(DZK7*>C?1%=JBG7
M30D#YV<'>;5Z%7VX0$A1O# 2P>'Q:H]8X5(*@:<(?&^K-/W*3P5\42^9#<+1
ML^)F:^\,O=HJG%J7+S*3(3W6&P8S*SW$:)A%&URM(V[Y4ED3.F+0X\:XLLRU
MAJIA;Z>KA:9Y!6J00S+G3$:1V"E.:13FN&N5QMIU'9D2=@M?'<1>, AAU'*S
M7B"H6)\002[2625(8<*HAH0ZQ\MF,YA,NB^V<UN!@G[+E(1Y9]C6(='503ES
M3O(UM2V].,9RRG(HB)P7+;\.3LVB&F(0O:J:X!T,N"")1&CZ^CH4)L$N#L-*
MC0>KLU%KBI=94>&%.;E*PS1!^(CR%[5J[2\>?+3A,J[[;_]<K7IFCU#&;/(<
M]KT8:>=:T\?6.L-245IGBA,<.3DLB%6R+$V'"= $V>FD6I9D9ZGH:$:$4  [
MW[DMW0S4Z*CD,F*2"+TSC,*SW["PBAO!%J'H&C\V1:1S^[9#SHER#?H8$G$O
M.-/7#*$V@W9**L%76]8ZJ9=H P5+FAPCNC$,^@)/^>X33-D*T%!R/D]7 /M$
M2(S!&F;7311"Z-=#RQ40!FT1HQBWI;.:<Y)Y.!Z9G68L3^;),SQ*7]T9NM[N
MZ'AFUF2)[A_SV/ Z#:)42(].D'TX#4#49]">QIE]P%Q7%2&F9=9AJT*ZQ)O2
MUT!D70OGC;(TL& *'O$KZ03Q5<M'@L%-<=ZNH*H_ D^,W43(B&Z^PZK4AC%4
MI5-5D]6+:]DZL&QP;>-Z@&FX]9"]I8I^T*\5 6WY2%,VH:;QLTXO!56WKH.5
M*^%0)@Q?Q7X*!I'UP9J JW8R]&UPR===D%\[K-&P,5/U0JTN0N&EYVL''(X>
M =IY):R\HRM<\:L^@TE56H\DT#Y!U 6"?SF#%2(8DX2GP.>$J40*[?-#FBGD
M251T QUA:]%H+)6%L4J1&TIEK&C>0W,/RGR2D2C4HE?PC.^!2XR)O%AJ?6F=
M8&"D[PQS>@R=6< E".H<#*DK0%C2RS*_X)E4K,VLYJVU%L"QXUN'4[DFB'#/
M:/UL8Y"Y,B?+=A WPN@+@[JJ)T./'=:G8=?O$*]8><7<1"HWM-2KCEROZYIR
M5<]6!DYH.'Q=ZWZH\GO@0\]KY !Z675SLZ3IT+7::*OTY919PG)7";<PJE 1
MR8B+38IDJ2L,6BV-/7D*.IVWG!V+!B.[J)&>K49]L=!F>'*V\%B4#;D0S691
M2@DC59-O<ZB0C8NQ[/*>IIQK#>L>(^"#6,84NI@UVE_%<A4OUHR@MVOF0(3I
MH.7UI1RAD8-9#DP>JRJ>FTU.N[$SK<L%VL+=\5 (<%(6]#F\8 P]E(2SI.4Y
M;8RP._2=MLU)HVQ[/]I['<G#E;9B\.T( RE='J&5$KV(4RP(%@_,E@T%J-J'
M$1*,NR4*M78/P0F !NB7W^M 3HE13G2/[M8Z?Q)@=&1I4Q40:-/(UX!UQVA^
M8:98;^%K]1AMUJA-PO@( PD1X3*C9P/>JQ"O=ALI&I'&J]1K6MJEKJ4;PZC'
M14@&I]V)#TMA;?4-TPS!/ILV8H3E_NI?-3=TQH7ES9G,M@@/;TL^P"B_$%%N
M:/5T%QV(8EWPWCU>Q2IW[>)4Z<^SMH:69DN12]HQF?.TRD[$V]B8;XY+!C)/
MZ&YWG 5^QVQ3'4$9ZTPDFWGE'P00*F(<B-9R]1CT+&'+Q!$,5"VA@6?(D$CE
M?'F:$D'V 6%Q4=V!Q4I2>EP0B8LC.DNFVW+6R]RE/5SA]&H*P-;IY76U+7J7
MG9V9_ I<]KYS]R.AA(T8A)TQA17+5869!SDH2C"'@3N:]%Z$;([N'(_@AG!O
M,/U@=\QQ#6_UQO<CXN9,NB<!11>L%!]9=K'='UBGVUXU>X*-U_F;=@V1:A]M
M; \EB+0G=!@R)+H#_J#LK.&U'%D1;O8^$9[@ONA;=>N':1#7C67KNYW>KI#&
M[1##GS*<\7A,;4%*ZGT1;I:'JK61UC2E1':K[7%QY IM%LZ%P0H;4V]'B[=:
MYL)R7:A!- 6<GI9F=M!!@]S52;\S)*.UO[CZ=@&"W@-5=CL[Z Y:$3%+E><@
M&FHC9Q\HM%1'HMV3>:42&5F7)HH&*E^6G<A)*<QX;;D3U8FAK11)BYYB";BP
MA$0F 4-;3D 0=$GF1!RW0LV9Y]*[A/W8)7-7XY0%XO:K=M<K.G;UEL$9G2\:
MOP>1??7"@T6I1>-!#B'H70XLI3)?T=$2 '99+/2J%S4F02"$-4XM\-UYS2B/
M5MP3,>3/8#%*+R0J>FI8B<4LFO(V]D[+&6(?)594&I>1FI]H?<\%RC:293\4
M^@V0T<(-1R"&99C!I(["9.GDT0C"KNLQ&NMU)\US>+L8Z"EE"AV4)>(Q*\/F
M#'R-!LY9;B[S;J6%^_5IS>3G&6%DU#9?J4N1\X">6%UY[+3R3TLN8VJD!H%Z
MD):TTJKN9%/V?G,0W%D"0D'%B@/R=&[M?*]$RR7G=Q<M@OA^D\-6VX*>)AH/
M7XTD 7AJ"1\FV[8&]CP6>LCUK="#7_@V$.D=2 /:4WB8[33,0AGO:*!4P,=1
MC$L%(? *ESG%(;;U<S<+N^0PBW?NABAA ^LB9K^Z&2P-R9D)A_C^>  /7#4A
MU_20P+D..8X"[4,0G 20IRA(1G:B2'DF52WPS+7P +'P63*D\8ZC]_Y:]BS7
M7;/ZW)KV=J\IN;&,V;#,* I'(R_4U8V_7/J[EO>'BF><XUQ MY1<V"40+HJQ
MUJFJ 24!UTN-6FV)7$^WN49; 7R: I\Y')!IM0C74-( 41M]8E91S-P]YL!7
M#69]*VS"78C;PIJWMIZF>&D<BHQMN^*@S0C*6IO P=G5HGE83!I;TZPCG/FA
MTV_$EM)15,':,O0&;5>-]8HOM@(!' C52W=!,\RRU1(Q=C2,R*'ND?LBS_9[
M16XW(XRNMI/&Q@.I=O8+G>=V"*$OE%GG8+!;R='BG."B>,8#=:#0"ML-KD,D
MNG) >DK'SSM3WZ[0*)[39UERDB.[.([[25**ZU6(6A=XMMS)12 XE3"I5_HK
M=.PWZJCR2A6,BM'"-:+'V"P\;C5=/].)DV$E<I410<P;%_/5O<X.D\;6#M&V
M)W7$CQPD5H$?8R($;(Y$IW)  *#+-J4]'I8AI*GA36UZ*PH=5:UV1QOI6C,]
MGTZ!G0"0;/?,%)KMG9&5X.8LJ_9!7*E\@$+;<T:NS=VL6VK%"*EX7QNZM]"O
M2#6VXK[>>!=-VYKBC$YV4JCLE+9!J,ZTIE@O@DP<GU680*YZ$3B^<05TF[IA
MJ(K&4M7%=VU?\5A[E6QBG53'8\7/V>H"K;K![D6CW56-@?1THRI\/BV*G6)X
MMF8(9^-)B5O[JZU!5J=%*]7&.J'6L[7; S_AC,TO51:E&[IO]PB(?VY&O#?<
MTP)9)D*[YTZA,4YA1><0^E8A_0R#$*,W>'--G"*3@*\'Q!V/:*SCP+-K4+1L
M^$$=HZ.3S9-C?'*66EP=>U$JA/6Z!F0<L9G.C]3NM<3S;(9R).C><MR;/!ZI
MBM,#P#7B 3EHHRHCQRC(9%UVC^N9!8E6MLZN5[':G@WRD.8'-8JI)+$G9TGB
M[=",MW+''N>69C*VB,'IEC"E8>'12+0]-@>GB*2$3B^!<NZ(PEC[&YUR=Q+:
ME7(4%25#,K+4FPMW2O>5>^PBT4 -;?TS=H#3AC$EH"PR&P+J) WG6Z=W@$B&
M\/S2(2J5P'.Z)/H\7QEP>FZA0Y1>W1XB5C@&3[DODI,4 PY&YIJ0*L2 6!PL
MJ0=''M!_"QB]9GB)^QB,8SB\@"]SWPI>E&[@/;]/<7BK47(T8F'%3X:>D5OF
M:L 2O?"OX16F\-D6:&38SV=JJBHT/;O%24%_!:;?LV!<P" 0<G#(RG1SB$JI
M7$0BAEKC?>ME4\H4@C!XMH<Z'V.V5(:__%7JB!;NVQ[B04Q>=UY$41[,"N\J
M.=T2$U.\_"8/FIV*7RGI11CR4TR$-^,*#(T9Y168X;[;7\2K2FWA7CT"P$[1
M*(. D,YN\//UEC9@RSD\+O?:BAK&'MB*=KVD:D@8<W,Q6RI0EF@@?"<KV,C*
MB*)!1%C#AF+-EFLORIQ)EBF7Q"OQP(Z<#X^@F/67YMF\.L+ZD.7S$Y6?X;T\
MQXQUO\TSPU*XN%DCT+ M5/]Z2_7%HRIHETW$5NS$<+#.W:X09RT&XI!#E.7$
M-4=RL\Z R577H5V<W.N1V<Y*J1[]M5B< U[P9@O\*N"7ZFJ,^QJK7:+D]ETY
M*8<#E.!L%LIVTX9[?E?B!.M55YXS#JFNM4?KB&<9<8YA-1I14::@G'>AN%U:
MB$451G7$*FLC9X1 !L/)NC,,")9Q45B.;"%I"6IM>+-]TC;[C+]RX:CM ]$Q
MW:VR/,O>5AN<+#R;-0@SD;,9N,C5R(_GWAEXT4^'Q11)K9R,44(OBX]9?*Z,
M%EF;9S ?*4U#IF ?[;U%.5RP*_W=/&>)05<&:Z LB*J"4UR%!^#/@0!!@^FT
M@E\8>FYE ]$:VLS#(OA5"2M>2M@)B**Q!)1,N\)NGX_CV012@V_PK5' % 9\
M56\+@'QGN+WO\X#:EX6? '$;;2#7JNQX,,VNL)L@T^R;S9A1&JM0 "-*1P=(
M$\/DR#93RG1VEOQ9-_<8V1W9OEXS6S>%^TM$+WI&1O?'7=!"3HYWKT*/70[T
M8@$#Y%$BC5(-_F+[:<+AB]VH!(BYH=(LL>G6<%L CAD!D';MJ>ML.\?.<  $
M-CTK,YH&KATG&?!X",\PB>"P&!L2<!+FD\;V6I4Y1$;H,MB"4-N:'HZ2=G7*
M#%C/TP:W K5Q/'M%9DN_I412J=>[- ]38\>N#ZR74" :J<\T#.G$9G*)0\JP
M/:MVL:5GC*=AL)R3K9RII8?2"K!8+NE56$;F+ +EN!R@BW.[O YYPI*,!BE1
MVB.#18#Y=_)F,QEZ&@]X=#%K CT)5R@S]SK,#FW@>AY'J7"$.C3]W052&;HC
M3%J79I93'R"K732!G:,NVL8IX\\O5*9;R'K*BLCKA-F*F;M5LTN%SX$)V;-U
M&](-Z=2GUHA"L C2BM)WX5E -*XY&>FX.QU'M"KG\SF0'!" P2#"5)4I(>GI
M!F9<==O7=S:E*E*X-,.+R:4[[JC?]L:$H;4/2S8^\;NP ,/;P]<D6J]ZPMM:
M)@OO-Y'/<I GXPT\^=@,Q)V"(L)%B".,:Z1NY?RV'6>NZ8LR/U#QECZG AT9
MZC9':-<QJKF_6 M(4]U !G2G0:NW^C50?5/.007^,=(3^VN 0SZ=1R4$H"8>
MT'OP#2M;%13M:8(0<5)6Z1CVY6&MA/N()M;#4$/V-;58%1UQG&4GT<NN"J7"
M?72<[=TU RPY9-+X]7J6U'$ 3$T&V0/5?P72LSH[5@8E+99#C5IME)":8U)S
M?;D]Y::333%Z[00G>^H4U^__:8S :,;]^;RG>T&?).6X9H2+=[P).SH2.9-'
M>'[QN:_CTP'$IS"A1Y#!(4#6T;*'C&5F.7"Q"4JXYDCONN\NGD&YTY#EPR+Q
M,2>6A%6A[32<7;DE+MDD0[A(O3?; Z-KY<'3#_N%-H^KACS/0DMASGU+=R=!
MJG8:G,Z)>=QZ\908/R,,VGJE=<Z.3!@=3>.PV?7(+*GIV/>LQ#Z%>T9$)&"S
MD7&-".O$M=*-# \RNZV7V=':%0P8.\>X+31)"M&3&ZFM@Y'W3)JJE#6S4$)Y
M5B#E2:I*$1+G\E:;62N,L$CN:(%EB!"2IA&%*% ;[[Q]6E0*NUD1HCWM5DC<
MTDX6M98EZC:U"1,O=Z9BV;M5JW2]Q]LBG!F$F-$$9)^+'DT]O4%\O*)UG,'W
M;HX044GCIW&6Y>J4Q%CIZF*? NPM@:L.HY$%$_P:ZAR<+B$#1)O6NI?<T%8A
MWR_;)0J-Z)Z1-PIC)@24DLYZ<SC7S%;+L=,P;=!4SHY2SDMLP>CP!=_ [ 9$
M?><,X)W.*.!H=?>G/1%U ./UN >/2A2"X#$:KDL?C7$B@72GWT9I,9G1#>/8
M2*VL%;)?MG" 8B6SW9.1,O,[L;S.M.1\20D-1KZY_S2;KR5OBJ24J&DMV%A<
M(TO<1B#(UD;@P<-&XC"%OZLR<WL]#,JQ-WM:&6%JZC_-9KW8P5+HW9]>%G *
MS:9=,QB41&.>Y7N*@D5X+6M76X(SC:#5)!^AK-&Q""7V'>B^!MI5]A8P#7$=
MC>$*#(2;)=V*='WH<)C1TWF;\  SG 7<2;-3@;2(NUL&((.G# !\SP XH=U#
M?G)0?/KB1@7I+A'./:EKKY:]H\S+9W^GJP8?3OLINS'(@3_N$3*]=V5G7.ZX
MCDGJ *BC)H+G:RAS80=;414.'$\@>A<-+L]-1U(, R?P^:@/*GV-A ;/]]-1
M-S([PRQ?>L;)%_VP'C;1P4++6ZHYG-:F=@/M-($K@G<5C<,6LX<3,R*)',P5
ML9W#HAG2Y4!,1NIFX(.RW\"9=$5!#W02J"K>["*=D>-^JR0D3&T$@]K-3I9<
M!-D0>_,PCV9>"N-TCZ\E]0I,< 3<YW;RL3=)<5BC*::$ITN41:* @ 7:,78'
MKX"U](>]K*M7+P@/5*@:7.%K64!!_ 83+3/!ALJ1.ARH8PQ7U,.DL9?'697[
MG*'.5PARB#-GYP@77):&%4E7BU9=95)-6Z'O,H&K!5'&(HN+FT;[M@JV%M)L
M2,L+1'7O[B)[PJ'+IPLH.X>%G<Q-BDW=<V*%YQE_(*H^!Z&CC :,V$66 B+
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M$!<?FM_Z&;B?]WSX(X/%!_J>'YP._VG#XA:+R#>G\_#E(S,C'WHXYZ'?^-[
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MTU.-XY__!K3]#+2>A=^R1M_;ZV,C'QOYV,C'1CXV\K&1CXW\J!KYS1=_.I3
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MC#?_K?@FJ@,WX./SB)S!:WCS,BL(H>+;UQ\=G',$!I\%;+.3LRM;,R-&<Z7
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M4]YBIE$!$BO;J2?X.;*:W&"1N%E5PS=@)IV1Q0WHF-=II,KX4F3'(;R\8#6
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M)BFXVG+9"Z,0HWC"/D\.Y"J*M#[8Z6;GY\7189]%1*73L,X>9Y*4SM_]04*
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M)^.>RDR7X="NE;;.7\#;CK^ >SC%"W%A4H,DS;.L_!WJ7\ 9MM#SP-Y?0+A
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M*DWX\2L,8BA'E#XB#,PQ$/,[)4@?\6\9 L2_@_[]9'>=4'->B$,]1*EQ':+
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M>/?1&,F\9F L)WU:M+;2-1(-H.ZQ6U6JR1I#V()(.HW_')<PF)=K1Z+(TL-
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MVG.;DP:_._^+&XD9JUZ(-^XB]:4/):)7MTRC-D ]<)WRZ&XBP4H'_0:)^=)
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M"Y]5HA]X]9RP/!#0]*WCOL:%G)H@93=[DNFF'>U\(#+NDK"]B^;6V03Z"Q3
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M:%+@DFIE?Z^_-NV^7C[IWI3D5.>,[YA4F!4_RTJ?WW31W^5TN)EK"YLX>@>
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M3*L9XAO,,YVTQQO,U62[,1XO,3GAN'.@#MJ Z!M,.8-ROPBBW\>!H?>A&,?
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MG+[_O&K]NFIS&?(B/P+Y2X#6 3(NZ+>B3VV0R463>T!_5'2 .*G"&XS)SK/
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M],('=:6Z]&2HQ[Y\G[JJP(7,HBWY 8%KE@(3?&$LRZL<EEX2CT)B2<^XKN'
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M[%_B>]")?71EEXZ<C0QS&BRAU/W++H>)+)-^7VK ^T@12R.9C=FS325<YJM
M*9Z7,RZ9S[ 3E#M=A#\1EAO$EAT&$J<GI.[NP8<FA&@H][[[LT07L3KHZ4H]
M<\CN[G'F)/-K58>MU9G7E#NNZE4JRIT"XKV[T10I>C]G_]??0?<LK.5?[<PV
M[[!2^7"^?L<J$G>&@$&<!4/(%M,24?#K A>RY(._UO*O.G*=:V@[4E\#R3.D
MAQ5DANF"TNWN-8[%FTW]Q1-F: T4%Y9D7)DJ36]2G7V<OI84=%F%& 2*ABML
M.+GY(V4RL,65B,G/2)%C2A593&W8<K\.]%M2-WBX%6Z#1F\BI=X O+Q7\F^
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MGQ6E'&6)+_:T =]]^1IS-I?KRUNLY@<DG^'_;>SFR(@-$N(]ATJ6G+^/5 R
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M[:_%C^H'HG^SH7\(VCCG7^403N!_7TKCZ9EI$19"J:C"'/@.BB#80$]^@BG
M[R8SV+A=J8JP<RV? BO=T^TM*[5]&=88E"@;$$M+HMLFI2/0L]8#':@HK/C/
M8%;3-]S-AAIAD)\Y(7)RBE<4#G;ZH4<'&K):4K\PMZ#$SQU+%!MJKOTAC%<R
M&DYA'IHQ3UR1\_3@0?T[BW2@@1=;@(^RD?CZNX.F[91JT-G^RA=W6*L;Q0S:
M\_0>6+,QW CQ2D$51,0,Z?!K>V*LE[#I]POTO,U'1W,5)31!2R/B,4+VL.#J
M"F(*X&*$;G4T72Q0C8[9K3TG=G/&5C28+ZT+SU]JW#]Z\ I(J$K@B<C),(P>
MD(@8H!ZKUZ2T'XMMKTE6>UIDYG+>RW=[+K1X9*=7ZK75/V/W\)("3Z0+:[2Z
M/9!T5O8\>CQ6>84=S_/]W@#5#B\"N/VNYO?L01Z2E4N1^FU^SZ0_FL9>@EZ:
M/<+.-B0@WP"Z)X\!W!&WR^>V\,_)VG6X@ZZ0]U*!MNE/"$]V+QCKW0E(K[W+
M-]"N."<-/W<)'KYTF'#'W"*=I\+N<=X2SQ0YXP&UZZYP2J4:FQ:45N(L\JLE
M]$8I98QML8B:;\&_%3"=1'VK]]^I=G5^1. [+A*WJ%N"K:59=@I T?97&LWJ
M,<[)+8O);ZJ]RDV$'C0Q:S0<7A-G-7^P[L(<9].5*6LZ/]:&[=W?T44WD&2N
M55CI)2T0;*H63]J1BI <76AF=A^LV?*AK@E!#4O<G'BP4#]FY%'GT,16ZWH8
M]-SE7*7FD'P>6;^$0PT<MEG72;Y<V-^<@QN3> /0'^A,&>T:O@&BG&IYU!.>
MH,<3^D50JSQLM!\")6!C>1E9GWU[LR]7&A8,W>HYV.I\KV)^"Z0X5.R2'Y([
MMGFR8LTZ;WUQXDPU7>=/ESI5VN<?"B@AFCN&9V<[NEKS"]+36\,%F[J7KN)_
M( 9K:K\!FM&SW7+$'B+7_Y E_.@_%=Z?6O!]4:($G< \LW/\&-1OT4+!YOE&
M)XD9\["M;/Z7409N<TFM3UTX=M<)$RP5D/C3H3:9(KAQD>U$+:PNGWH7YKK-
MP/W:4A;;DG*ZK<FT2K:ERB*,^$0+AE8S@2QV;0LK"[1W1 &OLZJKAJ:>?C(?
M6^1JGX#:83JAL';V7XJR$@]#^BDM;KBQDY%8\XL9%BV'0QV7.4NY*O74._[6
M1#L__:&SJ/^I%ACO;YZB\J<?P/V'&S#VPQV-"WS;$Z%Q84M9/;H@2SQ>]3+8
M6"V<Z^-!RRSM\:0^!0N)CW2HB\)Z+?69V*ECUOMF-#/-]JP%+)D-)"-K,V',
M$A&-'4I5^4PQ\:Q0#XC=GLL#+>5PU77YI\7*3UAR_CH7TTK4O/DA!?JSD[.-
M&RLA&D7*%HKL:Q 5Y=G5ZW_JN)V6OQIJ_ZXC*+RIR!W>V_X_S/C%7R_Z_C/4
MHZA:/-',%ZZFZEV.AWQ*W$@M[1P2XLLG7_B&0KCOKO+:LD\]?3>!H/:L6\?Y
MV\<Z W-2,JF0N<&B_ ,.-HIOL6ABG[;5ST?3L6I:@>H@@K%GRP1A@45J0M#'
M'X53<\7B9D.+L1O[N0<$^YO1,C2:2UA";914I5:@=D/Y"_3G%I);9[P*@U9-
M$LUWJY7$(N:(VYR0J73-6J(0;)I\$"V=7I]2RQ/;YXWX3TQ=X45^Y="M_5K$
MR]K!\O?7LJD MUF5<4P50<F6B>LT<0[';JY0@B@[/E#?CJC-0!@,XHH.[QYU
M#54=-)*[YV>/HV&JCL'"=+0%KLS6(/MFEJ$0IPS-CQVLEXK\"'!>W#$[T]-C
M?BG$J!F)1<$VJTX50G1F")YW^,AMH;A3JJ82 1$9EF[<39 WJMI0 UXEFIWK
M$9F"@$B8_@D%\O9[WL#"[P$/$(?QQ*ZE0_CE,C+J:I'$0/*=6#\0XWB( -XN
M;5"6A?'2(\E1?&D26]\SC NS1/+8OYWNR+ _[TB/I#695#I]H,^JGAJERWW'
M5&L\,G@]?$Y"(PA>1F2<__H=1A^/!HLHK6J='E-K4:>\LBZLZ"5FKR\QB/B*
M./@P</"= 9+2 3I6[#@2:W]ZXD!4/B73<Q'TI?S2Z/5/,JC>E!KIL2,'Y)/>
M&[+E[0ZYA:>/?TTJFV3>%"+36;4.G=/&4[LA"\TB)A%!::GXTNH:R]@NA)=U
MBYT"3?3AMR#MVYQXCC^:IM@*$F8)/3CP(\575N(1JF2_U:6U##HT'9+SK_\A
M /RO3\%V9:9Q[L;8@Y^+P1_+<49_,Q%G1$8\8&^ O;3OD7[CGJE2%X%O@$KB
M.0^M_)!??^7&X0"TWY!A=CS&KS^Z@6RE6FE<7_K> ,7^K\79K):==U?.WI[:
MJ"^V6A8*#%VQPO\="P@6YC]22'M:<^>W^[ZX;F?PK'T5PE3;+#N\>54<ND!P
M\E6Y#/HZLHSLTUT.#B\=TQ[31,(M:1:(8D0".Y^CIS)%^IJ1<A,3^^$O72FV
M2 3V)WZFR,AUV!HG.:&T\:3TDC!+!8:>W\^"& N5Y1J41&R$!AT*Y@94#*8:
MCU<67%-M6ZY%:0-Z4M43RF3GVN0+M@L_9Q^-DAF67;9?&N_]H+I9F/?G[N$)
MHK76/F%!0V>/-.I1B5JQ/EKKWS\/4CLJ2>D3L>7+"(J*)HNW%N_Z]CVY#PWL
M!?"1=,4Y^SW[LJ0QP];"+:,2-J4%FU*.OY6QX.QJRBAY+&B8MAZD&6@4AJWW
M]T[4OSOE&GS4:W_H9^"-QW\#*.4VM7C NF^;[77R/E^%(YPGGUT9M]._ 6ZV
M4\:'9ZI_S0!X;N%7M+6\+> ;0+[E#2"38&'<X%_IV;A^0]\QRT1Z<H_[:DE/
M=[2Y7F$Z.F3(]N7[W\6.7QLA5X[G1B624:M/.*O07%.O ?*UDRG91XYTB#!F
M55;J3[4>*</#>E8F]E@?&&(T-DA4U%B)W[-)^<.;]!2/LO/QZP =CCU8]5<3
M3>L2(WV9U$=?[>Q4;<:ZJTLQS(5Z,_A54#HHV&+%YA'K#[+BEQMNW)TJO4 J
M"K2LJG4N3C-MY8=Q,6+;,.*0WS*'B (;@60GLP)JB;N*Q2+$]#UE5V(_D#5#
MYNLO3>8<AMX <DL<--@6@7U$T:C>C>C3J#I&$2SHQ]M-.S-]N\+7)T$!V^>[
M+HED0+ "<=D$=C8*V2:;]*1BU=T,XP (:Y3C7^\HE<85C>"IW( Q^\U4/>V7
MB9TEA$1.9_T$>--#=;)().-GY7/+>.#^[N==AOVEN,FY!HXFM85-(];=^D%H
M_PLJ3JQG^#MO&K6E]E)[3G76\C> \S-PA+U6B[-?S-^_;S#.!<<QM;]H.T)Q
MFJ-R'0&(RDN,N[ I1^ZP=8BC6G#98YT<ENP=8TLLAF9,4$R4L)ZBOJZFMBYM
M#$5]M>'JL-#BC#2,(#>%($B$@CRW%\<X$VMZ:#8.YQA4C8%2_-,T-54#^VN.
MUN6$P':SZ,\Z-5$F(8AAJ(WJ!XATW*V>7&%3+Q)[U_QTT/SA1=)%;!XB"D52
MOR]J18&,G5_$HJ_L(/L[B3 =+B/EWNCWW](%4_D09 \A<X)B<@VLDQ 7K<UU
MEK!0?D)G%'#'0Z5%HZNGIUZ26? DV\=H1Z(!+%T\R R2>HM*?T1/?=_N(T7C
MU4Q$J#8=M+VQ-Q04<UGZE,U5&++ ($;MSMFYE!*P+V!M.F)F@>E-A(\),ATO
M.71WDTNI^OO5FG/L=;_[582N)R7?:ZF(K<,S]M/ XKB7Y\,>)M$&X_KNM)O.
M&^!HD#DSL5CW]TV (M)>=&UB?96O^8ZOF=0KTY906F\ ZXY#'<^2[U++Y]S/
M:]^TYWL[-.93XT:L]"?_.PX^<'#&UAA5*+-=K+64*DN@'S%93UL&!U\Z<1*%
M"0ZC! 4N/0Q1(;DF,0_N,.@/?JWLBR$V$R$F4?5GZ&4F]C2.966$K =N%,CP
MTJ7V]ZU(*GRW"^LNT:(9<A;!K\RS/![<NY/4;?3^H;&<5H J*1T=/3XQ:$;<
MXO@>20 +/^O&;FX179E.5DU%G*6V4Z5&^=J'ZSN)HUESZ^WC:NBETFB!2F_-
M!>2L)I-]^<9=G4R?V,U<]!2YH@N-DZ:Y%<HY^:*UO?2.^#HZM*;9;'3PA_(F
MM!R0N!&YVI#@M@1UOBF\.BW[18-NVQ-'Y!GA0]5X_P&,S]SG&E/=&CF[+3P"
M9Q2RL"8A]2G%F17_0X>I52*:II?5]W&S5Q,E+3SR);2=TO&D8=W8R.&&JYJY
MU&=>\8_W+72XFJ]IXN*XUE$OW^H%<^N0T_;=#E>;[S=DE\>F1)O1-<ZBXB0^
M)AS1!32RX"N?T84(CCD4E*O$2E[H?=Y4'LBJ"*[MDP>*E@Q"J--RESMPVCJ?
M3X<*IF6?%(0>QI=4)!!_3L&B08=6LY(@O *8AKD=0'&(H%3W"T"!&9PL<33>
M4$<T P#PC?CR,!\XX)3]N%+5$%CSQ2]8(]*0FLJ_SLJI]R*2A2@CO\A);NRJ
M0"MCBR]W4!Y&&*"?R^(L^)*X6(=(:_&AF2CN2K@D"R=?;XO/O5#RYRE];JD[
MB76\('W-592+4.PDFE[#[6X<G6 >>AQCAFQ54\75+G^-:'QF"W%HJI*R$:.H
M.DPE9&2.*JW,+V,$_P09EJP>^[GO0-$8.IQPK^@J*8H[&DV-1Z8QU;K5U-?3
MW+5]U;+S>#Q&]I?$,3/S_(S/=U5K]4E1E:[-@VA"47*_>"6C*#B\4Q%\O?32
MG%7@A(**?P.0<HPDGGZ=E&5K::UA$(ZO]E=[L%-AH4),,L7J)!CJ!=9HV/RR
M>,_/;JOYQX/"EQ6#2=:&/U,Z9J.+=K25YX:EM\H>D8C<U;4T2W)_&-<9@<4(
ME/DA% NNEL?W3B&H<]!:V$3P3U)Z.)E\W=PB0,JQ1JN;:_-D!<+8#WM;K6"K
M;4MY4SE5Y=PQ2Z"D29E()$8H,$M0BJF#$%T"#'39Q$Q4B8W+6'(,O&L/]VMF
MI>21<'#@ A=LR +!<S )I(KAJX-H:X]D(M* L'"E_LVGJE45D<4?71[PO/K-
M%O:=0!@=I1'B+-VH_*N*RT(CE/>"?-$!2%LY.WY]DH$XW_B2S&ZD??Q.OQ*8
M]R&JN@@6<WDC34]/QFRV.X#J:GZ^<-:"8IYI*W;J*O%4L0K+2?L+IET_W;7N
M6/M_1BA10G#?-K\PT![>"$5N(%=9<MFWGE/>/(HP5ZENW0DG2PG7[=FB$>O&
MM:1!G/:1."21AJ"9[-'M@Q; =D[20_=C")(:="" 4%_K(; TN#G3_961Y&GI
MNJYU:7'CMO@+=^GYGH-BIT_;B.2!6O/PH=H@9SO0-R=#P^#61CNF=ZWR=VPF
MIW^1_'^2)*(!N^4Q37E,X5)Z91O30P.VD70Z]E!8@X#FG618T$^[A;75?1+N
MP^V(@Q[.)9S,]8/XEI/T*D>\QI-(YN.S +8J:"38KC9+ > A) Y<B1;U-OOZ
MD CNG= MA\/>\M(JM1N=VW&5\M0]DN_WZA49K)M!%+Q%S(C,F5)PA9G,[9^^
MC@5/9$1Y3Q+K.;[AY?$K5D_(^MH_FH"O&+]Y3)E-)Z[<_?=4< <-KU-.GKV[
M<-W['7QT=]ZWY ,=@3:5SXR_J15>Z^,[O)]EO 7K3Z*O=/0>:$*/D)ZM<-7"
M0L^<\9X;:94/3Y%&C6^ CSHO+&^ )9$+9]_S9KH)B9>?[B%?Z#962M\ T#N>
MXRM_/HDW= 3/?]+#1_L,7"<"PBJ&M3N#%LAEH41L41_I59Q"CGVC3\$D)K >
MNB<OEO55#R+3P%7HL$KTW128^8UE/AB$TJV"XVN(,,[2:':H"</ABN5,>_:-
M;KY6OA)LML0-,W&(^O4J=/C+:Z#G&T <9_5DW=Q\+^66UW!CD3LCNU-)N_1%
M"$5#J]3N,'GT1DG_L<4.AUEX=T]F\@UPV-O6TG'BV*#8?FZG,!S6/B9QJ6KQ
MVT36[/XE74Z&]LL3.]W@GQEUR)=;=+]IEH0_,^K^1?)WD2A%L;#6(1*?%,5D
MX1N:;<1$^0Q0"P?A \+@H2 $JH\_>G&BWLQ7>7$<'<[5T*ZCV9@E?M1+]S(=
MNMR\*7:V<:E,:B;/UYO-%Z(H+Q<U*!E684<:W#6(*J92KXT)-P6U-[5'I+S_
MGK2T*>732!^#B6.:+-#F9&;@.ID_%ATL/9P!'.ZW&"N[+[UE6^K(E9K;VTSS
M24J4-C-Q&0SL8K?O$W^4[+E=V()Q+#9/97^8(Z-Q#ON>GVLG\24 OVR%5.H
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M.RPE_Z-'70T&^D@T.RO8XLH)!"=%W:<9:D;UN4[IQQLO3[CZDMIZ1+5PJ40
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MN&!F$<RCR6XOB;EZ0L28(2^3MO\8I#:C\]807<B7PPVGDDIQ[C18[TQ5OC@
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M#D?^%S<+1V$W?1_#PE;#*N?I/T&[YPXW=UU\5V-OH9J%'8TA,-CZ?=B%KT?
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M4Q]*4S+HCI(H&\'VE?'*+\8EV+.Y>9>#M_;,:I!HD^9T"INU5@;F=3KH1+O
M S.KH'[[/-0VK#3'OOJS$U!EY]LU](L3PZ?%6/^;;8'Y=:T'E,UW NZ)^ Y/
MC?XGY@&[?Q[\_E/^1<3/(DS,DN)8OH[1)*;O)NFM3LZ+?1O=0KPMTJ 9@(@=
MJVP^5-VP@S]O,U'0)_IV"<:]VU'+-REEF$!)_S FX7'K?W='2(KZ_TJ/UJ7.
M 7<WBO&QDP\Q!KE:+!0-[J#HD<"&6,MQR5_S-ZJ^Z^78QL@GT_[Q\X8JL3[&
M%/<$PL>JRS@5Q4S4NI6-&7].2H3/ G+F/_.#Y?AOS8X(FGTJ5@<3NI W[&82
M1J^-DVU[MM3DM&NRE]0.?:H16N[PE'KVOMK]I>+QHK!O?^>]6MO5(77EJO3W
M9[]%KRG]_;S3BWYT1%-*O?]6Q,/>WDAW^J_GA)'&C,6PLY5_*& ;J?.ORUAV
MX4]N'\?K9N[2[KC6W_]#H>QLO9^#_D-)"_SO'8:\<DWYI5[X:$#^,N<ZGG(X
M^*/,G7HB4)<\W?2]?E&#5HM'N5FT @4.Y$-6'$* +@6P<U%_&/*&/6203A\O
M6:7 L3*IE0AR62Y2(R]:>%9 (K*:5%RS.JF]L_PM!T",FZ<NI*2$>LAP#O!J
MM3A]O,6_Z+KO?%(58Y=M[%9;D<CXL?S,?JI((=I0\'WQ4T6[RB%R$C:GJ;/@
M>:&<IL[MQ>HR4;@YM<GL!VQ7&N@@L!#MEV':9YR[L)N_$UW#?2=.29C"<C,M
M)%H1H=5>_P!H_Z%$9I*V+V(K*2Q:ZR/;-K%47"!1+">GH_,!$ZZ:\S=!BAJ^
ML#?^X/)RR0R:W'[^WNZR(E%J(5OY9WN3:$HS\41=GBJ_+ZIA6%D^HSD"8+HR
MPM?!Z:CU%U4#,='2GZV"#9RG=U5-1?M#>/FR7[O'7?Z+@'V,4T)-CR?3F%,8
MFE1#_&>&NACR6'4PRA:C,LVP;:GHC\BQFV5-Z6[^;B&AS/Y(R _+WJ _551^
M^+Q1:E8LEB/=T>$A=MEC$? XJ<J[U;BP=<\,SS.PD(:J'X\<BVYF"XT<(ME=
MV6!G>[-'E-;T &)IHWPLZ^A1>^5\/J.U((^R--6/22!V2.>[XHTB;O<:W)-Y
M3M)S8])YH7<G9"=M&AP:5_Z#RH^\F,@U4_*W@CAM-3*O=T/E$JNTD 42G8N1
ML9&DV*Y^8BI$N7="\WHI&GVR=+,9S$%WGD"HVZ/[Z 3](3*-\SO1&&XG!]LY
M+* @B,)$@\K6NF9I"KF+3*&E<F=-=VR#2#-@D&O1*["$*Y!DUD5U2_>[&+P\
M:T0*6"R@WQFT!&B"6CHG!UX=GI:ZG*@ K&2(F>WM06T R\0X*A/=Y//)&>]6
MX:V+5REK[K=/$U$UDEZVE%DM.ON%6GJ)MW&J =BL+EG.D10]E']\>DANST1V
MMNP$& #);!/BX30EDMQZ9IK+=K^/^P=31H$525/ 2!G5_,8LX+K;HUH9_,W/
M,<(S OZNX7C>7$X7F5\8W+ _'OGQ%,%L+HIM?D)L.% [<=P,YF2QE,#ZO K(
MJ)KN<-PKCTOYJ<;2G$OYX7>DZ=#\8R!V]48!_NTQ2M9PT>0HZC'BE#GH8"W,
M[;O]V5%VL+"OAP&?L,WQ*M#&F"_G0=&["XLRM$_>&#*\D]OYIJ^Q=2+DFL&:
ML* 6JTW9PHSFXERQ*LP#OPS3S^CR^'=.8$+'KZ%]N)<_OZ=?U6,%EL9$VVFE
MS:("3R'R-;2GQ=!K%D:]NWF&)K!.AO\@+RC:F_W=PY S@0DD0A"C.:,Y]ZE)
M-R&$T(>04-FRWN]D*:,8<3E@\O@2F7,YA)!A,[0PNO?[ZJT1Q^-&G<VDX.+M
M]P?LCV:VQ2GP)'CRJ)L(.6X*U##Q[&*M,3.@G6_S4#I#TH9>E"Y4'ZW:C%@D
MM7NUV.R*%2,)+*2D,+7UEF<'%R=\9>1=/@'U$PTF*4ZB\SZQ)G>WM(G.'%=&
MRN@;O:.4=5$23E"S0D1H*V?K=KL='1TM<#U=[S2>G0?5; H9DU*.?,4!]ZU!
MP9L& YE+XXF?%PQDJ^&+Y90;C,0^B5%S[WU:RCQJ\7_80P4XP+4B:F%86L 8
M_"(7S%CW6+6Z&)2>F?!0PP3N[W%)17_)ZYU7^(@;_XR/Y*GL&P;=%W5=V;XK
M0%9Q\Q'[$DDEM[OAV-T;<%>-*5%\Z\]>6CI7*:CAPRB*S1<N]PM_O51TOA.0
M%V?OWMG8=1'R:VJEMZ<R.25^N,E8F\,I>X84-U<H!;WNR^#R2^]!M[ 6X;GX
M$/_9X>0W#).01",N#YV/<JOF28\$^()G;\+3Z40Y!QICV,/L!#?^A%Q<0_+P
MO8PV^?@M1D0.ZSI,<^-:F$^KHSK<;OF9"@7-3D'0&G+#,ZR _!'Z2QP7^7@>
M'1\">0LF;XPG@?,B.JR",9S-C3ANJF27<%R$>J<D=PRVAS<Z6: M_O)Q=H(+
MV0]&S6C%/)/O&*8<RJZARYWU[,?1D1]*7+D355;L9^V3+TM]2UK:6='['W^-
M'-SL6QLDQQ\#4!6>*&OLA7C;E8B02&N'W6KBJG=B@-PB2V6QL8T=-9XL=@83
MO@KL2_FA=?;!.*-D#WF;YA<F=5:A8'&9SHOPA4=/1G7\D2A?9-Y2GK);^52?
M6)N!;*8:@RY3*SL^ZV2DTEL2!P"U[6<%FVI.]>ZJE1 )D4%N/9?>G*J]X9P?
M&Z<479DZ79WM3W2 K?]_L?R',J%6FNLFZB5O0,E=\%.'^3*JY(REP5/[4WO[
M$WSQ/A@.F8@)%Z;I@N]&4URVW  L-OS;Y$?A-,EBEMX8!7"L\Y*S\,KEA(@&
M$0\(P1^C7PN?:)Z&(??#CF/Y?^L3NM+V_QYE7HWVS+]?H82/QX55>1R3W2:Q
M7R3.@.7^6)^F"%VH]60HO&2%C^YUZZF>V49HC50Y6X8ZA.9\7'MO%]03;/_<
MP'TS=+P7HF23#HL*UE"Y)=)H2)ATT DK$0*JLT82#>?__;G0AV^'<>M I^))
MR(@1XEAV'L=M0_X%82*,(,<E-#U6=A0Y*<@4"F<A@I_=-VQH*PP$)%WWO'Y8
M.;7@\/ZZ6*\<G=UVS7#C8IO3 ]:2.#M ?2]Q3M%FFD!O22E2=<D>W[>;F_.M
MJ+P-XR0,\+ M&C.D9G"-$;U2?O+60EH&CS/"7SR&2)F9WZ*P-@E752>.KLVG
MSF:0HE@%^KIR3&(_4[>]>?$JU&TM)ZRK=(P;,/*!E.LS4:R/[HICTB+A:+&<
M:U*^0]PG[]=ZKBHI_FGYWAD%$"X9>[;;D-4W5I=MJ3NI]PCRJ$0S+M%3R*!,
M^Q_1YY7NR<Z@9LA$'QR&3XX6QME$EUY*8Y?:6K4C]X85V;KPFB=#:QL[)&O8
M8?H2HON'BR9V^=1$"<//6F1L3Y<&F5RQ,MNGJS+IS2V#[WJV$N[R(JDZJ3-[
M$S/GT?"AOH;T0Q.S]H2Y.</ZBBT/S["6++V[>.27Y(7J6941[FR%/8":L3%I
MVT#]:;WC@MI4-*.+41E?\2']<>2,V*69H84Z-RPS@O)Q". =*>_KWDJ4&(5%
MH\P9J[-T15],5W]<*J3UB;Z.;J]NS XW2=W6I+S4D6=9O2YH3L_CE(MM1Y[&
M5ZU(>K';<?DOX;8W96^P&O/[B^M#O6YXO*+]5.[^TR!"FK%O6\X\883&!V3=
MGPGDY)GF;\2JM[YZ>I%ES0UBK3#)%J*KIEKXW$1HQX)%+.SF>IXK="FQ<1(T
ML\Y<I-)G:N3-MA=&I<K&5I5A2HR43(J7JQH-'1QK_,A,^;"G0\C;6@0B)Z+2
M9>A;)#2)DQT=I%3)$J"=NR*@-L7,@/.2&*H*@-PNQY>"3$\8PSR\?GE-*XX\
M[([Z+M+O0L#*,^?'^QX:39,V9^589?L0,ZZ)+V.[8!'*(9-FSI$-R&ZNA=.7
MR[HX.ET&!LX8I?= 5?@KDO&32&>QN\U5I[_D[@9FR:VN-LRD3WTZ=1:TO0=+
MZX!1 MF28\XHO&X)E5+(0O^FI-9FIS:)KZH#9/<Z02'4ES,XOS?LW5GHWINK
M0EO JTIC+W]-KH4<"_'KLXF*BZL Y6)%Q"ARC[7Z8A0X"R@[".S$?^J2]CT>
M2/3F&U/269@+U*4,UGHV^5:KVWQ$;E$X,U%X70:(U\X6C%/ZO+-V],7U-"<T
M^,;P! [6C1Z; ZB)/$UZZ)]=H*M,*IQN(K<%/C>WP"$V7LVP%X"'7ASQ#TA[
M^J5@BF+A^]I1\ZR[ Z,Q[19N58JZ#7-HKJD.^LGI-&(FZ4%*[59I/8R!R(4I
M$^)-5MV&'4$K(;J'':E>,(D/\"OIBQ!6_7 ,(**!EWLK/Z&WL8U2KFE$+8/(
M"*M>\9LOAJ6OX,H45>BC=9HC=CIAF:=M\OY'TKLGOEIM\1C5,ZQ C]IJ,950
MLG3&\M]^>A\2ZJC9V<N/_9OBM,@5;N$9/&+,9I$?SKB],UL*><\; "+.RP:N
M'!?NG=5KX227_U#VA_V=]])%5=DZ"^H>!,!\Q*A6)GNU^$A/,!3&N.L0KRSS
MSL;#4M0#PAPHDF$W?1AW94X9+VT&_7R,7.$S69]&5O.8,MQN'PV<\!1**9MB
M]P>-'+IBIC4AB];][>&ZDQEG89XP>R'.LIPQ[S Z>9UW YW!!K&LQ,RA$JM8
M;!%.1&IR?K:>J:+WO+O]&Y65,_]0DCN([I+3VF=+VCTR57)*";UMFX.$U+<%
MJBJ[A&3+V6#CMI+Q_,NZ^]D<C_VR<>G;B,:H"O+MBM,@;P<CNVB#MB_MDD2E
M&!R;0%-.TQ/5^6J.E4Q;L]7*8E(V46<&@P79_+GE.J=H(/XF#>0_L,(;X;G"
MF,)8:_+1_\%V_(!S:?8=?W/S:=G%UPQ&6Q^[2U8=I M]<10,.I\2?_?XXFN<
M><_S_1A755=?3%X!<E5O4(!IR.@(S*C1.-'-' V"%DL,%1KK,O]#*<Q$#_/A
MD5!"KOF1B]K;:LCEA"^G+&DQ@H/NG,Z@R$;6 $ME>@$/\U\(;/3XUC.$"Y5\
M=91=<3Z1C8292BG>.ULSKK[HQO$\AI!0C8;W-&9;JP^G+1]T"9;()O,K>/9H
M?>U,$O/9*)I:+3;EK[M:5U<>'_@G^^&9BXVL!$F +.99QT"UVL34.%>WC>RL
M@PQ6)0ZF-#(<AX4BM09F_RAZ&?H<?N8L%G=_DZ3<R"46V?PM5-+"0>.]M9 @
MX2RFYX,&Y4_Z\WCQ<LA+L?CV.%+1^-*&5=MX6Y]8'_M:M*IB L5T+Y'YJJAF
M>N^5"9+Y%LU4Z2+VN5%RRP_9Z]G#^3*R>N(?=9W%_"SOPZ]OWQVAQ/(U;CJ8
MMQLM7.AW^GPPF<98\+S&R%CHM$>R;P@#7:W 5!!6D+&3=$V;[.%P+L9?]WO)
MQ*.RNG>[3K,8<"S'D*"YB(=+B?<7PB(I#+OR-9"DIHF'OT;T#3\"%C;Z5<=(
MWRKNTZ\?W0B 2DSVDE2QVZ4:[*X_.2;$LLI*JY&D'5N[%;"].'W3V'E<J^\V
MN&!D_Y6B8W#6[3%+BK2%NE:27KYP6B\@HA1XD1R";-O4"]6HSFI^\2.I\QI"
M8DD6^[EM.EA$!\H#[$1IL#D5T=MV7%:QUZWEH'0=GUA'HC1WD:J.LS#1T2..
M(];-LN,25=,ANPS48V.2K<&*  G[:OW"4IHB[QTWTQ_N"@PNYE*FO,FB .LY
MYH,,INA%\ [-!W-"P3XP$6RV7G49ZO!'J/U&_=XY!.G6B$;_/X5[WF<7?]M)
M8@@+^ZI*;G/\R^ //6X_5_6M1V68Z2^#_T">GCZ('&$DBZV9=9Q\;?_OIL7G
MLA)A/<^A-UT%4?UGP[-,L [72<[;R,A_*-_"[KY\+-N;/YD@FP-?XX<O-/RU
MVC)9"BUXOYQ2143Z3'_1A/%7B;JS/HE5BI?T3*F*$LOD(EWF#_Y_]WMW*8.W
MF'F?[F_9[=<O0/.K6"D;'==N?D/!(>7VU,QW9_J^]ZS1RGL<5A)%5PXXL^^J
MW%U#231,H9_BE<@H?RZ/!RX<);(JB[S0[-\-DZ):>9-O_:ZGE"TD++M5UU2:
M<Y?A?A0VPSOO73,6+@B8^B5^PV7&C%725QX&4-R_,6?P\1 4H RY)F+C=LW_
MRNU2G6&2MNHUFS T)NY^$#-@;,%B-+4:#Q4X2TF)VQ8 FFEX*4U\9-16=4#Y
M4D$4K+R7=:[;[U0T]KO?C +Y<_DT+,E6V!=B _E+.+<9Y-CW:__:SHZ8DK8*
M?RT1@?P@PU2M1VM34<BME37IGAT>K6)TE%:NB29?>9*I.U,\2UMHI=L*VEM,
M;,'8:A>'U(D9Z$[(J8[3J!<ANJ7*G^]9^,Y1%ODJ[JIJ)K*-3IU<*+CFFFQJ
MWTU4%IU,![>2&E7:'\)67$WZW=",4JN-&XAFX;(%[^S30 !IIFQ:3/3?/JV6
MR:K\F9;Z'2$8/N\/YQJ.J17[]A?%HKQ:J4)Q^:5M?(Y6'[Z53+CO[K&K+Z6?
MGK<'QO=XY4B?AXX/)0\?X!R5$'^G81WM,'(<DL)]4RH(4,&25XV_[[KN ):W
M7(2S-Y;_WBWI%1X;=(H@AJHF]>Y?*RV;REL7$&/&CF<Y%V!\'<P2?)VU@J=J
M32S.-9KQJK[I&\=@ZTJC\WQ[.F<YL3"WR8-MPO@E#GSDY.G7E$UOZ.'Y#Z18
M*5&MJ17)M>)5Q>)>$Y=\W-]BBMEKBIR_8&^-_Y1*7":1HN1;0DCN"Z(37X:>
M=H%!>HL-%\02EA)WY@0[^.X">"0&7ZX=2%9U8L?\J#US<7LYZCP@\JL(J]D1
MC9;WXU\>>)VZY@\M'CYAJ]U/57$@]Z9)4RA][U[#8]_ +JJA^KX(Y#5F1FFR
MD@G'Z,$&N:P<A$+:-SJ#R-E*=@E,C@<-W:>XQ$)22:)_%%;97HM]]@M6T!I_
MM)WW3;L3(+4IK<3,8/@^!$(7/NEL>YR6/&*)T"5/*M6[+VD1'+[I"Z]DZ!+H
MX$A?IXFA,[=MH&NI*4K7K[MV&2T5MV0=;]W@.[P-R&207)1@3UO,ANM^TAN7
MXTJ;HK1);/D3*E_NTW[/SP'0K1#!Z/\;?XP(^L5%Y;]M/U"6S_<;'5UY+7/:
M'6M\'517NYL9S8AX4VRG>^K./G3B5W):LU6]U^<RJONA1<FY0U3WX*+6=;H%
MM0LW7JW&07K-6!.(=<?5%;S8+$FRA&K=T+[J/H87E@;A,Z;9@\%P*:.V6\O.
MJ\[U$/Z)K_YR)+I=ZN/2?FL.\UE/<=98U\I;Z\)_=[PD%2QR1!KI'W 95+UN
MK+;QP3. Q8:@FMU_Z_MJ.5D9TS"%Q*6ZQOFE$?Y(UT1&WVXJ"?AH4$MI><>0
M@GJ(=L^\\G7>6"F.=S'J%#75E(<MH;1E/5<8#'ZL:.RW->5!'S=I<Y7=%?OD
M>ITD6$K" 'H-UM<6(B;^VWIW?$\;*#^!4EF@%5W^U3FY4':PJYT!EHXQ5R)P
M].5L 9B+B#J=!YCS/SUUNC9S:B2O=N]#U(OG3Y@0WEX01,5Q-&BVL-@D/EH.
M,@4,>;OHK _7==XX-5AH,&G@MQ'>.SYP'51Q,6:QI@Q$.*O.,<KJJ7NJ)CU=
MCU5[MP>M;MKI;76BUIZ V4?(8(5N+0#@&L(Q%,*HH<"?) ]9'4TDQJNSND@;
M/@XCPF_O@?#A:3/31@T6Z#C03[R.+2K_U@L,I'OV-GYXJ.D6#VXZY12 D=]B
M[$[D)R*B=DF_J;DX'+,=QC:(+]&[=+,Y9.O'L<KAU2UT&;Q_[[KUTPWZ@:?^
MKMR_NFC:BURG)(84HBA8Q^F$]7QOYAV6?<<EM.7HO\F J-81=H6Q5TT MYYA
M]8]6TS+)'-W?W!(<%P4AXB_3K06[>SEVG)0V:R .1U>-8,/T&:<5HLI4+MEL
MH$\L,_"N4M+YKZ)(BZBH<%M JR6?J21NO+F-1;_<<DN>T8]S QB'*1&F"$8L
M6$;=C X3Q@[:5MU=JR^D0($EJ=KW*!<EJ%NHIIKJ1E\;P U3Q-=FI)AC7]H\
M9:D/R+LJY]U#?L87_,$IV+\W*/*L&$T8. @@1!2#)YCP]FY+*5?$LX<]0R;W
MZ.7S3%EKH<@&QVO"?E]$/J%IH(?)]/A)K?A3X_0ZWQB78[]M;VO3E5V\(WV7
MQ_R,T>5PMGWR<)2;]$*?Y_1#L:1S?<51U9F8GRALJ'[R *'8SYC87 F+P ES
ME_[V0Q&O0E&V-_K>Y@1.65-U]KV4D+KIQF@61W4?*"0&)RG-4G1UBOGQ030-
M?<68$ZL!/VQ,#(X032HQY0S"WD&=DV5EA-+!1GW[B\<([@5.%H@.I6$' \U2
M;-L[QMU40[*(P[^):D7KWK>8B]2D-2(0NZOV27.:</XVK#G6W4[$IJD17[Y#
M<JE;4)28-]YXCB)RA%8OJZ&0N)_.@"NU'85"G'!WM:IS_+EV1M9NC'6YJ62S
MLB93@/L51"\M1)*93#[WAM9&*W)9\G5HG&Z#[EJ*14@DK2''%WL)0F@0JW3U
MDBIAJYNL-EUPL#?K,3QA*OQ*6-P3MSP$F9:;H\]3KYI.X2!HNB\_SE7'QR^R
MIO_!D1K,MI#D9E>SR2;ZX:8/&T^'\[7543%Z!9@^A=G;I,KQW:8_4-]QI^O9
M+ 0+GUM1765N #MZA'/BBO=UDIQP/1Y(EOP7T+QQE>GWX?)6>;;>6=]TI3>X
M)"T]CYG*(S,:Y1\*>HHJ= 4*:JL+</Z:C_: ;.P.NKT\$92+_%]'(/H?;N1^
M$7D[AKF6>.F0[9=ANP_-V^SM794/^Z$QH6G!X)*9T/2*.HT5-3V;O)!L@9U%
M[I<= XEG1S!:97.'[5=7<^Q$N0_QY8#R<CV0=5&I'R%]SMZ(P(9P\40DF54F
MH;M(:LMIOK;86K6^(5,R&I__W:FV>_5R .STEXW*1'7-1-K;,$Y*_>-?=@E2
MS8O=-:W!N#7=M<U+_U",7@XL-R:#GR5=&6'YPQ>N/?>A-5+LHA\=67J>?D$M
M#VC3/4J8)D25>]5JFC_3QW]X6-"#V/)ZV[]GM1VPD*;6:V;6^8=R."*2NM;,
ME,^H^.<K,>H/BNY3V4D?A6<ZWJQ*9]K:/L]L7WQ]Y>@6-[[JY ),)4$T72IQ
M_$5W!5%RL4N5:"D@T1!F M.,)'8X,)F8,EO%XD;LG.KO'AKB.DJXNA-RFF?(
M%'#6Y*7[C)9_'A(Q)S[Z,@-]=R_\Z_#(\GA&[G2/]!^*Z37P>>_1ZYIF2)RV
M\5%J>*NQ.I4'_H0MGJ C?"?\Y"P#*G'J;F:UM0VW]?4"*MO6&7PPI830I&?@
MI>O&*:'N3(Q!/S6U.B"L^>ISZ5@OM:>@HBKZ?&9Q/Z?2J)&C-E]:\_W]75CH
MD]%A<'@Z(%BOF:!BK[P!#J>("['O(-[>J3IO$XP]83JBJL_]\""?TQDMJYQC
M*LCI^'&OD2@]9L3&V:XF]'/"I<90[;+\PO.T-SLV:67G=@7![[_P#'WLA>I8
M@2J@WAG>V/WT\/&,)*68M_L+N\D+O\VH$$#]'PJM=\]G*CV"/H-%*66!9)8*
M3(?UFDQ]1B^=7Q"$[_RWR "NQCR;I3_$A:W;Y<56E2;YQS:U<20DQ< @AU?D
M/+#G%T<;UX;=D %$8WL/EKV;^;DJ< TB_B6&HY+^9L.'M)XI0Q/M46)T 5^F
MN9/#UZOQ:.4C;G:!6OV-\YY:=X.U!"E-*1:,3LQ(+=JH.8=K?(0SF977)O,=
M+0<TR(1%]^K"$I*PV;4WCXG+O&P&RM9<\T W21PS6:/UTU=7*8]3$ZBA067?
MQ_:)UUBJLR,45MN$6^M4R/&GC&[F?%>S5C']ZFO6C&4*78IM\=\.)[TX.PY]
M']4S]]9HP:O#P<Z7SID]5M< \VE'E\T]0ZMN^1IZ(F!+V)3W%<L'SN6RE9T6
M"]TKDA\#6L_!FZ\1QI1A[%;@1G9?%,80!\ASA$ZX%+YJA4A.O&:PVLE]FHCX
M\,'ZEZ^+3:];,A1O[)L:)3QQJ29)T7SD(#6R>X<3\:J"KP50"_U\:*<6XW*1
M@#5,K:U-QEJ^CN?*X,#$"/HCSYUGJU%ALWF5N6-#S#BC&?FV;MWZD4 U+B\[
MU8K#W8;1R0*$/7C&@"4\4A5&.E(^',(D/T5NMP8N--&OU38H1V$Q-32O'&\,
MYV)/B@,$726U9*<+R60?A^@<0S^:3YPM977IF0>C7<9/XW7!RC<U3BO&ZMA;
M("JD[5U,P,1AHW5SY!5C7.Y@4A&+22XI,UXFN%)*(^*!Y_L'D4^B2$?FFM]-
M#!FTN^ELC<7KQXO[@OK%@P>6YJVF.#F1OLU]XN6K&[1G&U]NA>E=XXWH9[_Q
M#DZ,,"G+MR+?W> 8<_KTB)G&Z+?]JFL*' C_=<<_=VO]78W]3G5>S>.]5_C'
M&;8UKD*?\K$DY05YXR(6-T-GU#:JO[H])#YL*U2E!C)1E(+*ITE\Q(D=WIH4
MKNBM8O;5B B)[]:*M4&&8V*1;P<><IW'LZ(W.K\Y(-5J@.)^U24Z[1N1$B-Q
M=,H)<;PN/Q/<>6EYI_5I,_J:OFL@X@NR5U3 >31MU6OAX"A0UQ.L]>'I;"7_
M6_X&O5E< ]O(M#0OS_QEK +NXC!J9K'W+GF6,A+\Z-:P34W<_6$N5/Y),A)[
M #,9D,I5@_H'[7L5I)-9+^IYN"B:Z$>]P;&Q(^ST M(.'=L ]J\'>N4\1^_3
M/.QY<CM!E-*[%[TV.:=JA7;HU';\&C)&C3B?:EI=7%*(6N1_#I=C?@,OQK"X
M:P& Z9R,-'-M&03#45;%[+5LYMF_6E]&VAY-/C()4MD9WD51T0+K.#X,&^5-
MH'G[V/%9O_E1F%O(V':G9+G<6':<JL9BN-?X,%YV4GAL1?@^YY,RCDVP/2?!
M-A>%H^]5^V[_W8GJUXG]MN2L)[W6JVM;0S]0M$B3NY*8OGR="%R%FG4_3B)"
M%.G*QRA:;07*^>G?UM)1V;+*_-MNKK3]!4L@6@'&F'24R]!/6V)3PT%1LW1Y
MDF,>T-S^W;C7_8A6-'!ER%E?8425RQX/&4%#79Z6YSJ1PC!*/[KJ9*JR\P%2
M%5=KFYR@KO7=,@ND;J%Y3YXIKUVGD8-,K ;KT,ZVF9Z0[.88 &YOFU?61J*_
M]!37QI]LG"[0""K:NOEA=3"SFN>85[3IC#6ZH3')X4.%&OH*!$UO,TF# X*]
M%3$?<8JQ:P=$Y:TR/WUL>(6@V0CR;VI_>O S+9M\=D 20[W-* OC-8!!^EH9
M9:::=(F&UQO2ZN#F9'L42>7S_'XY8S4.X<*UD(H919W-\G9EI&U0B$27B6_"
M7(6L,C](X[[K>5->RSG$$6RP\ :4-'.%B=O<PH8KUX7 L#O:!L<U6WZ,X9>M
M.-K9S5VE=%7Y^V)UM;K!'^R(^L/C]D0ULLB)(=[Z]+"W@L^)']+:-!<<\-=!
M),G;^[0A<'%8'[4Z1>F"6MTRGCVV:)B<7 #;^BX[<D6W33[^'TK\(-.$0XQ2
M%B<URZ*& 245=M*<&B1>R;XO.UU,@BP?/QGMZ-:'!-#=E(EU^_MT:S.X &YZ
MI?@G;$]B8\1G_7BLHJR9_Q^*C6Q<0%D-M4!2C=,OJ^_O7>)?[?2E:2(V%Z=G
M65P%#7T7\&85"C7RJL_2 ZN$&[&LC-U+\]QG^!],*YGR,G=T?GKG[(=OT1KD
M?,UW>N2VF2RA#*V>CAU9*HI&/PA%HA8FWPYF$^FH/')Z4?J+-G]RB^%R\PGU
M?\7;0LXVY!+OKN8)CH+\X0MJ@E4'K(2)J19HCUK(+PF]I0?.;\]22-14;-?5
M'GMS$]'^5:AV5%U9=\1FJ%?9Q&1L$#3M^GQ"H)+=+8#WA4CU]1(.FMCI9[9X
MQ<\<.6:Z[1K/GWJ\>K>Y.8LSAY+<].?:IG2!5&\JA/^XY]=5?'AR,ZYG(E[>
M]A[YSJ[4.KCC)N5UB8WSE&-2I/$C1-%K:LXWD5L-QUMX8&QB4  4*EPI"&V'
MV\"I<?R\E_<Q_B>Q&:9M([O8E:9TJ+-KL%PCBO^L&(W*#KB;NWD#>CB!*9SW
MN_MG![J_F,P95F.7WX6PX[SNHNIA11&@'-)9<'@P'NG;M1>BT,9'EK]IZ._?
MW@$GH(LF@Q1$R;>N,N1TM]C7MW<WD;10+:6Z_[==0#WUKZ;'F^W=B+^6=W 8
M<Z35E, =,_8,]\OKS#L%*NS:A_\ *CKJG8]*P?S"WTG3> %K-CJ$E(6UZAZC
M*-N< 1:?@3FD>%OI6*8+6?R5VK$W>U$J FB)40RG=A]>D?"^#3Q/Z6WITT+H
M+ %^5/F4'=OICT?[TVJ+JD(U!<GG%E:TX:@K[L($R6;. Y1"T0SSCM]QW\NA
M>@[_2/X]6 @87A>**@%K,M4T:L:/9EF:8LX_6\ATS5D]]O#]I[E37&B07V%:
MKE#'R+&_$/6,QK3F&R]T8BY76I:/43@G_3;&QR"L=D],C*8%Z?K,D;]Z)<U?
M/J@B.0\.0H=ME&XF8B3CWN:3UP-[F-1R@CS'TMC,XK3,9=C46NTGO@BN:?6]
MCB9S7W,?,V]Y:&C5B6+$!'"]8V>7%&'W.N5)$R?>'3<.^RXJVWL3J>2^F;Y$
MZX )ZF&;I<_3UD$?^T9%KZ+[V0L'7V9*IVO*LG"T]S4U(SA[?J4DHT'YA_T5
ML?G><LY^]=[5'1>:>D]4DVX0S\*30Z!)#DDC^+4&K.^7"R BY6I?[1\*7\?6
M7&HPCX079MJXQ9PDD]WFZ"KQI5%:OIY[#BJQIH;-/Q1#*+<FN9MLZR<+62QQ
MI$$*S28#SF)J><6F/4VS?FWFO$#LYBZ! +[*(C*CR98%+A0K3OE(CYS,SBVP
MRZ"B<L[N5B9/?>KL[2FIM90T\3.:$'"D!!ZWT-H.]H<F]_+M@274W%D5T@_S
M%!@;D2F79&?A7?TZ#&ZGIPJI9-BRK)B*T[V#PX/1(M1NLFE5U9]W-='/E71$
M!83OUO07]3F"]E<3&Q>JX SV!<J+XC?9"\E"HP(_O-I,BN=B$#$0#39']G?*
MWMER7FZ$_A+T#%E5L&]?#8C*A&!K9YKCK:21Y^CS<HSXL_<GDO@,3O6T)*'!
M;N^S"#;8DU6LUOWEANPB7?2:L\?JU&OU0/K:06]"P+IQ*A QKE2:-> 1]CF.
M=>?SE.1:Q_/C7H%473CF8K/Q[V)B_IW]:O6X/KK;KWUI*W,!Q"3F$>\R)IEF
M,<X26ZP&6#S])"7_6$TKQAN,UHB)B%!6;[]^E!T<(3*F]7\XB> N3>UQ?^&0
MN6 E5.L:-G8T;&C"B[.WV*.K*-Z.:U=A>QQOB;J*)?HVOT85SUMM<\=T.Y62
M)-\T51!_TR8OJO]18&5954;,CWGWE-ND/::Z'.X,+ Z<!K[3N5L]@ICRLLD+
M*I:XU!!%]D0U\^3CB:F/0FUQRF9CZRD#D\E%^>40_U!\/J^%AGWJ05B+WD<?
MYE]E)SXI^)O=X7SK%A*K/EY9S].'BS!2:,^8V[R?_MW*FQ(EV=(FSAD:*6_^
MD;GA;@4U3];71A0V>)8/G-/M?S19%1H1K/7X7FF(A&>)2@&=F@BZHI7.0AZ+
MIXO!ZD4"L.1X-PI-&SEM8V5<.:F8'SY<>"3,9+Y50V\[N(&I(]3Z]!%SI,..
M)"."BFB<,J$/W"3^$[4I'W]52@[Z^E^N-)N9BWL2'E911<6#K<(KC$HJY<Q7
MG%N/=W2;A5O&I?=A8T^R)R2>:K%+AD0-3(VG#%-39_[N^VX8H](HFQXI[F%!
ME0([C^V)<,]+B_+.[V8,N@5VZ"(BBS5^K_/Y.\]:80.P4L\U8B,L]MF4GY2=
M %1K<M4.TU,ZS,$.%A/=31+ZBDUN@3\33+M;U:]"E,Y9IJ*7&,U6@DS^0V6]
M6H[H2B!0</])K(*TB:!][/BKL[0C"5MTNO>?G#"24:-%&+/@U%[R/60$J"6+
M'<2=9X]YX?*6UKNNSMWK(--ZP-1W-'UQO^11UU9Q%?F%Y%>V@!TO@]A/V!F*
MR[O4OJ'N@>HXR0J[6(G1HSOE'[,+9I$@HN1\-_80K"?GH_V=JDF=E"_ZWO;;
MZ1\E6M<YMLSPV:M(CMO$7;/_H230ZA?EY-BI!$*MJR\9I^@J2AHQY,J3>04\
M+MSF!&HT:L>1@)P\:.1?8Y,ITY'='EMVYP>  2E.DTNQ-U1[.JUIN<J?V+=@
M)5AGRW/'S7!1Q]E[F6!X7YX0P=@;9K&U3;1:WE@@C)&1E8&=+/I%E*C\]?G]
M^%%I!*GCVS4__X=L=/!NHD6J?WW15".[8,BG%J(AQ R3OV]9-OM)?RN0-JWU
ML3Q6?FZ\MU]6T!R4XE:_KU@"3M0L)30=/*Z?\O[=LW1P<\(C.ITB>H9H[P"2
MKD'3N&>[9=16#A!&N0ZI.XB.T35Q<;GH^Y;5RZY7IS[H647!(L)Q[?"V(7O>
MDNWZ-KZL+U/(4GRQE5)[$-PRPE [G:;3T9BPU4;0+'(^<\7MMAG 6@,<].E?
M)1[[8'Z:#96/'P*UB=?!E;(-CU0I25KB!G5*$GX8?W!QRTAG5D"J$N'E*EPU
MMS8]6FQTN3\>Y?^QW?%URW.YM.-H=G_4N_$[/:[^/+YW+1@#5W$GMNT8_KXW
M==N=F$"0J(&;HA4K>EWDLP!NHWG^T/OMP#9G5"_*R'+(%6K&M52JGQAFYAF4
M4QM12,AO\FG%WEY9W5W,JX#*YL/TTZE?EV.+<+V0,DB9W,26=9YG9*U*K&L4
M\18]P!8".$6'.]PK^E[JN1U\#>A6Y<\P__Y@/@R02E ;L>1^CL9I]"W.'+6J
M -HNSRD7?)/[*1?]MAAG2EV][YO;"DT6P_N)XJJ)Z ?OJR*)O@2B&B#[H@W6
MGH>FID:+A0 :#F69F8.W%># @/.K#::D&6*\D3I50G5S=>?=NJX\?5146IX0
MF4VB0N_-<W&>%%E2@\"7506&" .8Z7/<T:RGT,3\Q.0T&<W_.F+5_]!\\^J*
M-"TU7$#A0_%URXII8<C$MM>-<X&;4ZZ!LW,LI/:""&=V$=+&^XJ6O,O\Y+,>
MI<0) )R+1TWG$OF6HL%9S%+H'PJ(0C5I-* [0U+LUJ,1JUW,W/3T=N3'7_,P
M2V!MQ=#)\<F?_ZU2^^YF@W$<-MZA[5U:5;LH+8D]8^^VE!"["8)0(U5B--0>
M;:D1.R%![5V;V+-JSZH9$C-F:M4LVM[W[_L&GC^>5W&=SSE7AYUG^;ZST%/>
MFN.0/M4=W<T#?K6@HH2MP^M\,:NPQ(B0-_-4XWL#&[:/?OYWI1B[DVAZV=]]
MZE>ECJ!I5)[\O>0H_L6+[UQK'UZ(<'Z==5G=_;=J*2B WF_966@)DD-Q7&O"
M[>?XY2X?<PAO"\SR>C:7A[S^L[AQ[.=U.#\0UI@*;-XWL=PP-,P.IV<KXF2>
M/:,](&Z^KB)H2->!Z24V:H47>LO;4-B/]*I?=)F)T)3<L&9J1/?N^1E;U[05
M1?5GI_X%6EK-NK!TKKA\ULY)=\[QZ5K)O0PW:X<&P%?<!>\&G>M$F^L.8R7X
MLL.2P;SW0JC*\;,86QFVZ%" YY.RY&/32J^WW#> YJLY')X9X]G(!N[-=\ -
M&^=7_OH[C"GSL'N"&ZQ^LA*2*K-&BB/!@G0D!IRQ_=GB"R-=9&PA\SJH$<-&
M]Q;?@M4^W.0?E_E4ZAD'-HKGJJT73]ZI@R,HM5MS4T?YU( -/@ PQC.@C\7'
MQ%OEORN)?\"YRG>&@3/67Y.^/?V<H[U'"\ZS4C9C $NQ!;&6MC:"H<]-@S+/
M>3P?6YW'N-YLN/OM,<J*MDENNEFQ-]M\=,1V:Q];X#<BJ?D4_K!\-M#(=D*W
M7T)!3W3=B2(LH6&E58PC(\3X)3I*3*S 7G-C=ASICZ]SK2CS#0EGQ,!H/>SH
M1UV+0^T'6?7#I#U2LB8?L2#Y)K376ZY4WJ7,9A]25 996]HI>:P7]QEZ5%@E
M>5-?S*+_$E;^42>C7.[NX^CS)YHM98W?':,0\37$U:R]H&7B'XF><MB QMW)
MAZ,02D*C*'A1(Z" XL=:S4UC#>'@J8@]]H8ON@N_E]/A!\V<KA68_RB[F%##
M]I:R1?Z[,CK:0Q;Q*L'59XI Z40TE%_A]PE&O]8&HBQB2*]'HB^ZKHYO?%>*
M\Z'N?0)7^K_E+XW29OLZM\;M:M<[3,(QZX&"9.;_JMQ*H]>!FQ#P@E9++ZA;
M- $U-$&II0"ISLH_+X0;V0E9M+*I2;\T "-$4X:RRF[SH!)\_KO"(F2#)1;O
M?S-%&Y631 EV+CV52N'M,*(9U9K\N?=317!$"M3&H[!Y,)J[(*A[;HB6NFO8
M6IWUA^!;MTJI3JK6"C3(.V-.D3Z7A_Z2:UK>0F\;F-^BKZ-A"MW7>MGJ+^?D
M-Q!M[)FJ)'?@<WZ?CQ. B302#,2.>:9@7KS95-SBY/!DF[NC%&ZG6E'MKG(P
MLZ&$UG"?&PW^V/*8W4?WY;5Z(6RF5[$ T<Z@]%EVVKM._RWM(;C8!4CPMFO3
M1<Q/Z^0H;:]T%LGUW0I;27L*PY](E?27CGEN1%1XJ*IB=DBV33,/(31Y\,E<
M(L' A<&7A3W@LX186(5-)>+-V1JJZ45CA)\1Q-' 8#?91T>W,*%NQZO1/9P%
M9-:]_/@Y@"49=TZ3\+@B+-$CWR?49W6YZ'^ ^CG\2T-6PPN<L7OIP" 0JV$R
M;KH$3I 8]*](.7>;%\A2.OZZ;^-U4^I1PK C/1^&Q?3H$[)])DK1)<$,\X/N
MWVY7V/V!:VR#^7]4$>UC\<L2L\;#J;/>^+?X 8'#%.+M4PXD*6ITA<TPSUAA
MR GF#\GIWA?S:"LJB.6S,S5DDYZ%K,DRN#;!'(&IS:R1,CQX02\W'USUD_WO
MRP)^.MGNJCY6!R-OB9>)X1QZHVQ0MB47H=(2TW!%NR46T=,LU5W>%Z<K 7E2
M9OXTD3#2/3>I 9GV+^ *TAR]\+4>]J0A2>>:->///-?(0&<F_O'-X_(__=H;
MNI(\YP-.NC,=]8'D"L=59V5E+0=0?>%C@Z&O?AP6AQ'68E#[KU8GAH481V"1
MLGX@,F^"D9'?20YB@HL^ #/C21XG(N]^>?KQ$SS5C0QVBUL1 ]9/B;\MWO2Z
M_E,DV6EHC@F.L)G-3+.K](+)OFHI* 3&8XNKJ]R>3[X7]H5VM&K=L^9S,?B7
MPW(GHRO6MQR5;6ND9IN#R!]5+"*HV\%D3G_5R7[:$:=>/'QE6  !G/0*6K.4
MKJ@5MY2!4UPU.4U!'L;N5N '8C.CT:OREAMBA:Z/&0=N7S@>_S$I?9]%^;G;
MA'*QTRC*VM];5-_Q0/2[?=.&JR%18884-WWOV6_LF'T,923AN<.W:PXOC/2Z
M?IKU, 3I!LFH-7<\8ZYG+X)8YA)DY=H,I- O\[SNNR63?ET&F+X.SZKQ8?20
M24D*,*U[O9,JECR:C[+-Q4[95[2;H%T\WN$'U\U:('>>$Y0U[Y"+_,)5U#7E
M\Q=\IQ,ZP5 BX,E%X\^Z(V1VL)T%HYHGU<GS+_&MK*(PH)-3SR7OC2I#LO3.
MI#HG;G8V7+O^AQ\&<*2>UGP#S^(=F-CVR(0D&%U^[:Q)!Z:7<[+#CA4T4BCJ
MC9- +9?:54-;)S(E&+&NN-))*L# HY1COYV:LAI.\A(V>!JQ:"$)(#EY,7>O
M2> 'N1QKWVC'Y"./E*<H9*H)\.4\+R\=YD1;IHRN>NMP(R<UX?GFQ-B/B[78
MKG6J<'M67XOVJ83VU$U[.Z;0P!2K_5^!1JK:U,/;SQ[P[EQ<%]^<?.ND=S\+
M+V+,@G@0[)[27.VJ1>M[S*!*J2(=BB&.;,#CKX[YMS^1>0(*Q<[9,$8&F<J1
M:SI'2BGW6%'')VA\<LRDK6%-2;3Z*/-87C4V?=KFO!??_R12XP%(0;AWZ4Z\
MFJU_1WP OWMRL%?KVB^]@/9.J).1CLWL]"T\#&)3[!MRKY_0 ',L $:T>B"<
MNO;%V-W^VI-D SU6:PN\;T;&R'2(J2Z&$JM\LF0;^Q8K;YT?CV.0K@7/JMBO
MZ8]7;J5:P54K&M:<NR_$%G(I-@V=(B)^X%>%F'(165T^I3J]93DUGR+<LVEF
MA(1RHOBJ,)?[;?Z24U>GY^((</=2#OO )WZ7M>V'M@^XS=IXR ]4!^%6'!6&
MFLR+&P/UM0CEQ\.?QP&49I4U1Y(4.VN_]0MEV2.ZF*1-HB.^?1._(9\LA+HD
M[_MWX,FN,?"^*$'AX9E[18K\T7.O,[,_Y63EWWHHS""&D (>^%922?)SNS-'
M0Z\O7-P/(M]D8'H_^U?*+7RO4,I1MOR #?2//02W&CKR/*A#8L_8C"$$XDT$
MAR!$-"Y?_9!B6L+A^SVM=)VP2+.TUAA!A!I.?AGOZ4TL2-23?6&7P ,]G%P#
MB? @1HLY@^,9(KRHR +1E9-O2+9&2P=LO2P;L[96$/\-4?1[$6QCO?M?Z^L9
M*O5[.@]YX8]1M'?WV5>JJO92XP7KCK;RSHB7QB)*XEAM>!9S@&@$LQ=UPD5V
M)M$2=KK0HL\5RN [3) ?=RN%^L2Z.$Y C&I>B^=RYGFW][OATT6?6:\=<S2O
MX!E.##N_9!6W2>3 SO?5 >+WQJK^NV(UW/%W8GM?2/&(P$ZQ'WIT.K*;EZ!K
MK6P9AWF0B[NMHNQ45*5&YR) L%ZW:1C,PPW05=#'\S96COUC_7OV) 21C6#0
M.R[2X;!^7I9'.:759K ;/WW:<L_A&<O<J9DB>.&:[^5_5W@2*ZKG[5X-\>Y=
ML%Q,W':*(%Z]"CS2C\>D&"8X2KZD<28,]OC%-PMY_IE'>K3-M0UN!E-[UW,>
MVIMPG2&X"C8M#H1%MC)D=LF'UO*?U@; P-$>$93;*Q%:=Q"K?MAJE7F"])%"
MX8T1.-6H'";LX8I^K?OHOEMVB!ZEGX1L5C=8%J_W4#J0IUFE]=5(F/E&: ;I
MT;L:=!_Y1%"'2WW$KR$RD?I\]$C]T5QVU>1 RZE@RQF5D[NJE<FEY"-X>KB8
M7=7.>.@:ET736-[-IA:=(3\R; ]K>'B9$4=F&0$)6$E49OQP(>9^ QRUUK[Z
MECW.\H6678J,M8QA$K6C-H?;1,0[88-P#Q:<P1\I@'.%74)YQ,5&Z-VEA0=\
MR,RP#1\I&[2&IVPZIW;V:A94TASI([&VV_'MWLU77Z3J?U1PSL0/;:;JE$WF
M:NG,-%Y'OH,6A!HD: '2GW!'6W'+V"P4WC4V# X,]&$07,:+J?Z$(_L6#X-E
M??7G#<K.9IIFO(624OK>KUX!M41/I,#:K(KC:MN:.F4!-;NVNL^RZ3\-(9;9
MA;#-Y7HFH/9M0S>9R/Z'2KR#IE):S]RP"SKFQ@.;30'LY N6(2W4OOIRW!'8
M!9\JK!S!98!/@'&C?9+RUT*JU5!AIO$S%WO?L&?;@X4SCA!$#S  *YBFQ"&:
MT5S3E MD'WFK<Q>]"S_?KZYFH#22=C4%CWGW[3>F7S42M@F?I[_@)WG5'I?@
M36?YV8I@]L5%WLWREQ/!7+F#-A%.!%,VX3Y#;9SU55-GO]=YMV.RGB[QI-XF
MULV(+>W$3S94=Y/&8WT59L*P_S]J6D?3B4@AA0%%-SP#ET:4:KALSQZ>1@5=
MZ7YT$+A,F?U5W?"EJ>)Z>*,Y&F5/>>%I?MKA^?NY9.?LZ<R7IL67]P4UNS3$
MGJ_?P?E:K9HYI^WTH([UDU\E1T0P;7^O3Z6[E8:UB3Z)B16Q\HKC0FKSI/V,
M0O*:1OSS9#$$X&X=)&8U:Z/T^D4;_8_CSB/KR_2<E>+E4;,_!!,HG!!A0=^,
M(EVVOB&[SKFEI-"I-.9:%N7VT+O[/#M) HAY2D?<KK]U<[TXMEGZ8<W[YPP5
MUSE]>3-'[PNN5#] SA9AO-2?W'P[N^"=G^VVBKL\TZ*CC<<?O3VZS'+"2=]8
MRGNCG$YKU%#4(-^]J9T@P>490G]B"$BN5?2%0"@CO9N#YR[&;7I%R9RM.Z <
MK.%()(<07&?^F!XO4+,R"(R_*YH*TK+)L&2O@HY+6\YMMZ"L\*[1SIA2X?5O
MIN;R@]T'4=/I+S]OKU"'<AG,S!FN?F+,KZXJ3;]KQ]LL?D9/];:&N2SCM!QF
M6=V+H<DOBKNQ0SDF@[AAMA:LXI-M:I@;-(([]@-]3\"1>T6J'9]1R:<ZD-:O
M._X[P,3YW7M,=#%1'D;11"31&*S6DOY"9_GV-;E3'L(5JZ X;@;^6PRZ=QYC
MK>1J>]&1'\?6"68A'^W]4AV(A_[-/IWN:?E?MVG%Q:I^"O**;3\6RQMPRQ7B
M3&WJ&T@D:P?6Z,5\'WPO9?H[<UGI5Z\,I@]C"]3Q6B&PZ%#8S/&S A'!+19!
M X[#-Z@A&JE_WG96QZK9/]'2EB@H$GRX-*H+=*DJG-&*S?)S-BR;&'[$\GQ7
MDC@W\N]*HD&,H4<@.D&AE DKIM/!/L+))&E,_EY_FV(LA?R3A;Q!"5<+L?0L
MD9;3+V]:]U::WE<4K-B<5(+\D=@7TY=&+S:(&SJJ3&+<$_B,=<BKW]!:4^()
MRLS@AVR-G&?XCB%.Q/EEG=[I\M8.]>I7#45F?$1A=,:J:7&9@^? UF!:\>0&
MFL);5JON%5REZ2KPQM\\)*QAC P!8G. 6%$+(5-!K-J7"G_H>G//3\4<[M/E
M$=JZ1A6/5*6M +I1J'3Q\FCO9AI_!HEPO6CC947MSE:AC#+=O:<Q$ /?D][!
MS#RS%CE7<'I7T\,1$_4R#2AJ!'MW9^+V4J DN^OP>!2?J'$_XO9YAD&)R/=:
M!;W4M%,7,Y)LV:^6=N*3HPU[$QDR6<*ZL^6+1IM2ATIV?'%)I,M/CRH&XY0J
M<,?DLZ#P\+JPY%[$GYVL@V/B/'IEF7N)']VLVB[?UR_+6KIW"<->Q0V!'">?
M2HE$^*EGXR %0?F*;\?[(:+-D%%?:+P7G%4/]00ZP).1PBGPA@45E3B5?F*_
M^IQULJ64MLC:W972--=33Q@5;QE-0 OB]$XAX_Z7\7+8(/+4,#JV88;=IE^)
M<D]"]/4P3(H!H%'.@_5.)FY-2U'AUL"9H(M@3XU)%:M%SM/R1:-@]OI0/&X_
MZ0<,_\&P\I6U-P@NRF4^E@AWAP9KF,2X4E0K'/9'"CXSBQ&ZESXH\2;)<)[0
M !!>YR=)+.,:2T4D$H4:@%[U3IOHTBV)3  T4!2N*7>'RGKIZ+W+,RJ\Z"$3
M-D&<R*(9UOI "U#*H"!(R<='#OW>T"BH-MMND8]7]'RB5[&.-3T=X$.C51<(
M!<436QOA 6X-8]9-F75M2GTF7G<@ \Y$I3;,<&*'TF[U:SL$_+>/IT#L>S;7
M^EN&92^V&9:NPGO??EC_GSO:M O<HTK(&XB5C^25RZFC\OD+R9'0?NH-^?]5
M_-7![<T[W@/PCXRA.!^&3#U^L^;1SM8H_?+FW].PB2STM5=RVZP_G!E#].$Z
MN>\2AY:85 K-V%28Z&S["K]V_1#DRN:'7D4TV)9'*XS,7;FXUU+A.R_W24*)
MR+=7LCU-U7_[P7&W@[>$F,ZRH]HS>0J:.SRH_N" ;8HX/3#B]_C+#.+1C)F>
M9IY#MSL:)$176IPV@DJ=>KTX?!B]'=Q*_B'^8B]-#?WL!$ZG]CU=W9VI"\((
MXFT&'&F6_-RNKN8_\%V2Y":SU1Y)]8L=TE?V]I*/-NCTH8L',DG/"*5)7L4<
MO&$VJ!?#@&AUUS$N)(37T[S+BD-N)1K,*B_7SZ(*=K1R]PWX"05XZ*?$B$_4
M?_6MS+GELW9R,KHF_28P' E=H5*701FJG89""G3IFUTY^D7[.,QSK-Y \RD(
M>EXZTSN6O42#/9\OP*3A/G"SW!=YNGJVF1\+P(4=C+GA$'X_]B0$)1.65&H4
M- H>[?B,K=*(22B(8A*"8'UR)FS,O;A9+9=>@[$NQ$!2# 9E&NGR./6<N=Z"
M?+=T6>NTO8QMP?U'W.-UU:7 ;&- 97I687# >T.7"%:G#2>J.PLTKV-T:PAP
M!JWJIHO'.>&ZXR%,XX->$$%G7.^KL4IF,"H9M/E7FT $L? "6SKRKH&N[:E6
M+6L82]XH9Z!**/[C$S-D)DCX,L8_.[6W+C+=C^)/,0#,!D=F!^3.@C>J&6,-
MN;\S0SWY(T"@Z'Q.3BZNN2$D2NM'2ML_B"URI5,JP]("*6Z%_ <2:7.6Z>JG
ME ;_QD1H[%8$%L02*P!XGGW$ WSW!CZS48M>2T+O <>'69VEL%:E%WR?W5B<
M_C'.*@JD@^5)?U"5JA:K-I8Q"EH%BHAF(V3G8S($'=X]VG$4^6TK!J@#EJ\0
M508%<M)(=R4E.:[=EVO0&:LOV=*A^PZ 6!HG2YHL521WI?2NMN\2X*HE;@>I
M7NMF\EUETH9A)ZFJ/MW^#Q8\!K5\E6U8FA@:BN%,$9VS$PUWS?F;'!'WY1HM
MB"W!2J9)',U3&=!AA[R-HKY-\W^W5S@"WHR4#2_!2*%[;$2,C5UQ\M2;'VQR
M/FBV>G87^%Q</ 6K*>JGX@ZU,2T_D@>&)$N]L7B,;:]NY(\G7G@GK^%.IVX!
M&3?!4"E*Z]]LCM#,3L??O&MLFISH*!5YZ4KZST#,H)B1:I&Q$>0??OLAVENR
MYQLQ\RR]3>8.EI/([A3A9W,5-_.=C&I2W#^6&&"57]ZG#?;=-TI<4K; 5R(L
MS=VGRF9:TP+3U6>)T;!$2=<<7=V7G!6@S61D?XN85VA\F^)G\-AJJ>32 R9Y
MW;QU^3SMMR#1O%S#I1"_M8*-X]2%< R;7#>"F3 &FSL.^?J)ASM_HB4^3PG;
MQY7)ZSIT5_!"[/J+C*%-/O'0"N!D<\]4:U&4R^"0P )6'SUB ]6,D_S++%&L
M<7^Z]KW%IBY0$<72$42'*AM,KE]DZ05AW.WYDEJ''+XK[Y#]3,3PLEH+?+QZ
MT1*6C\!K$M\.[HZ.1T]VJ+&W2_[FB_?9H0U4;/6=PW1Z]B++(^(PM'L3E&OC
M]?SH(G:G5:0G4^8BYG]E39QHI4$FL JGYM<SOT$$ I<H1I-PAIZ,6(XRN>WM
M9]^7?!L1\'G;X5F+-:2G06PQHA\L/GL4YG67#'$1S)K=YB'GOT[?Q8@9R+!
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M?RG_ML/#25O]D@!6G4'0%VI#+27Z2"I7![V**P>;M$N6HZB1)M?V]@ND$'G
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MB<*9E/:^;1QIS=HNA;',-2T-!=)8?NY<(W-+9R!*K?S$-L)*G8[+SZ "E>B
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M!1%M+M3]L6!W(7Q7W*,-GMECMAW"X=-B=OZ74P,J#K(UNN?U*Y;.T71G5&^
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M7C63KQOU8?Y5_=S_.)(Q,67>BS4^D-5''L<PH:'O+:\_=)FI'[P"4WWC\@9
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M)[@_BBZLU0+Q4B)T]F4KH2H-PA$&]0#G+O1%UM$PID[>W^$3:[A,#>NP,A!
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M<1TCA+S5@R"()B:2;3CZ?WA0E-%I7C\9U8?&>2%%C*:)Y1Q)DHU&3DB%H]R
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MR7Y$0]N@,>3]UDH:4Y)-J:I<W/QE:7YR#FL\4[60T=9Z4EX@.J'TII]C"*X
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MA^0!A*Z*/TM@39KUM'_P^D*KQMNGBY$ZGQ,]:@XK/=E829$ 8'H'U3,^3_O
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M( P^+X%7L-#QBHY7GSM>N-2%DZ,A 0L.7^J5$JL+-S#JH:V&4F<$EZIY^Y5
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M>Y@/P;>?.!IQ65PDMHX011M7C4O>M0M49R%[9A*AC"A:9WL[1S<F_B 376O
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M9.A&6]W:M340N9,QW3[>\*V+V@;2' 3.,P<5&MT;M31/V5'/S+_Q-D_M+:1
MU1"1U]!>W%-FK3,$LG\I HQU@(0^#R+_:W(W^ FOG^:+5WR(OS44P[,!]B^N
MH@M.@"AS4OLX39>=7 >%;)R)B/G'_"&#0,02_&EJI(PF[U 8-+-C^#:LM00D
M.R:M'LBM"BOVE=-',ZK7%_!.0T#;-GS^N++_84'YMHYBWYB!Y$M0BGYZV#<<
M__/..U;XH4SI>:RFJ]U-5;->2FZ($0 +/;R[!R@/3PIWWE_8C&RP"KSQ4F0^
MI8=T=#6X)E7IR&IS(6OD,TTI1+XT.?6&1C%]&B[-H3;MRJLB]6:[)RC/BUC0
M!^\6Q!7L-!4)KP9K'96KHLN9^]I@>^PAJ$&89AK#J=VC(-4EH4!!$KYOG<2!
M0:^=(0[>TB?5EKZWMW]1"+T_VT8AM!TKM[2Z:O<WZT:/@,O%6\RP@O'+#H!.
M /'-+MX4>5IGV[<\)J[P_H"2O'6K&^7@JS3A=\FU5R122Z^?F$>_O+&U4<?'
M>8E_QI'X7W+;NK\22QLE\99V8::C18F+D8]M.EBU,K)7ER^H"_=ERQ&O<60(
M[J*-HC7^Y*]P-+ZVQ,XILRW3G%)W0@5G'"7J!&9VZ6];,+*C5^^6';^<GZ=7
MJD*M?]958>5= 'ML79-UC_4(L(Y_'^K6?RKS@V0H*2G ?XYQ#.9^3TAMPE,W
M5N5":##.<!SRX?%)TF:\!11&;01\*235XN/)R5)^IG&7=1[<*!+35UL4IJAU
MSM"K%+E2T4>T?V(9 E#99#^4F64E)B224*M1%#L7F1BT,%=_Q'67G SX+E6H
M:'[X"]+DX MPKOM9H%I7/@/.%;!/3E;E)$Z;%K-_$M1.H94_P[$-HN)=4%.Q
MW@LM# 0TJ6;6!ID),G;II%-C-&]LJ06D@N79VW=$WM_A389I&H"UW]%PQ=/
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M?<U84626-LUP:8RWBK=UG7''UHJBH1;8@)\W>G]#+<=+H&#:=D&>JZAX!?[
M&#>50"RQSD;Q>,(96MA\7(ZH+-/#<RAL<\9*EDF9C]SK<E:8= %!R1+T+IDL
M3''2V@_N1OX(YYD.SR3#P9+[M6W_GYB=!-VS:EY*Z&"QYH^:@X*Y H@WS]:U
MQT+[]6S1<*>N)PXF<^U7%9I#PG!2?]_=81YWO1$MW8J/44YF/P6O*C .C+U3
M9.S_&1^?V36:6B/7UE'Z  H1N0=[??JFMIH=!67% PC^\!KE6)+;SJ^_*%Y\
M(_LJFVL3Z1]VS<K&F_@K:(\<AYB&ED%FU!SZ&CW\PQ39"H923ADJ*67ZI%TR
M5MSPV;+0 T8$'Q-\RH3_6OW(O]C>D$*F0CELX<9 B)I;1H#IRS<12KB[_R0^
MQ<;3J_8EA;?Z/I>(?=@#\4-VIOZ=%(O$W0XM*;DMJZ!S-PG-C !VCJW..,,"
M!F\LF?'V,K.G4\[$$7-Q9-K$?DKF&>-%V%IY&"O*8+$:A?^SFIJ95VJ-F8RY
M%# E $OM6,'*>*4\"U(-I'&I6GE"T)ZQNK1-)86Q4>I1HKG+$&D+V&9.!.5R
M%*C*X:R_8@W,4MJD1H,E4=3H[5 @#+9#B7+Q3LI)9(2[]M-4CU?"A?2R'[G&
MX>NF:8SGF7T.G+UKK+ F]U]%S41!]<;6,1>+<2\K#2/'..0H58M,]SWQ12&Y
M;7) .,*PLS%FP8!_SGE%_Y<0V++!KNWS'BRR=!EBW((1Y?&;SBV,5(TL1T@B
M6CE0"PV=CP]0I[I(N-N."<BD,!0DL']=W-H=D**-S%UNU*8NIWI*EX-V;C+&
M14NU-(19K$H0(+S-)1F#\^OJ:QM0D;]@R_GL@,83P#V_"4MF+RQ<C"2URCL)
M?V5A:\;D>B; @$6Q2P") ,]K#'\!YO+&'9I]I%-PBT?9JXF8BN^&?-A&E+-^
M530@%H[NGMO'52Y_P>F4*<*=4 Q*$6%61=5TM<X8W=+ "+O+(1/Y+24E.2;;
MQ_H0/7$-C\/*-27A$--"*(&/+^@,B6EHK@9*S#Y2LRGK"_,YZNW$$F S U@G
MW=^A6C!02NTG'4V\]2.0CT7UHLI3"S)Z<&W8WB;+!CT.L,T-ZO+39*6:8=7Y
M9$$2UZC6#/I.-++WS47Q4.3](RO3*C5=.T+/'YH!-2N2(G.XZJ\>5<GG7@ZC
MZ5*XKC9BZ?23"#:4[H%U4QLEXL&'$UNEFA[P#?>4+U5EG"U&K9=2SB:J@:\B
M6[;1A1R#@8V*DNE\K7;*^&+-X1)VQZSQ0L<CPMZJ,@R!KVHT3Y:0E'&N$=@?
MK>9@+T#R1_#>KN_[O^GNQ$R.I3Y 1<\E&C,V%$+ZOQ>-VS2]W?3M_DAJ\+LN
M[<1OMM0[RO$J=)2EY4S4+%MM<?A54K)M]@<-(.*\@K<F^2[^MR%ZED;->I![
M*Q  P9M=$P!QV\Y*<H^*]0\N*RF H!YE;>]KI6FJL#=P0Q)RW^487I5^H_Q]
M.B)Q1]HV_Q#Q>R*T!B6PX)VCX!.WQ%"_*^G [HW</%V0^C\6?K>5W!*J$"X;
M@?$U+/PHB;5A]Z.CV6=6GD^P]6O+IV[)AKZ&7I]''Y^+FQ/R@A@/&:I0XZH2
M-&W=MHV&>+?,JRK59;.W'B<<!?I\+IVANK!UA@BLIQ_>RW%R0-\T* =0WY!O
MS<LPAUM"[P.0:AA#19*R-?TJW(VP!"%GG#E.[-P\_N=FU5JK4K'=;>HB1<.*
MQF6H;$:G"_<!*#C)_(_R@P<@>9F!?&=!I I@[J ;;C:RY:TBD>]TP*UGP@YZ
M0'H+.A=[ H_.),QQ%2P@5LQC)L\=16#< ,[NGL$04)]U;29O(J8A3E6R'4&G
M =Y>5(VWFF\K%'*4IT..%4FG<)A7:5'8"SP@2HFU3&,S+F3/M';.7QZVTEX#
ME./4IC<P1Z"8E^5"5)EHE5+5CCUF-,F TQ7KA45_Y[%N \"J:4TWLVE5GPVB
MZ;NZ+[^UTI7J3*X:0W>90$.0:1_O\(KHV+EAPI@^P4TANE8[4R(27&/RLTE-
MV>9MP8@=#NY-PJ%Z'44"EO^C_[/JB[)RL11?Y6NNT6O[JD-/L0V&MU%]!M-Y
ME41GQ*W8'UM*N!8J,SG:@%>U#39OTK,S-<_7M489H)KQ3*K&&6T2C.Y$I3_8
MDL1YO$,YS(=O0[U$Y6VB#XY(J:SBN$G'.Z]D3&1 W[T^97JU&\.R)XV$*:FM
M/>T2@)D=\I_I=;[+M>I.<E#,8WO=8V7$RPH,D&\2J#O>N>/XZB4]O5:ED"V^
M)_]M/XG%S1R>'\;M0IB@LGXLLOV6E.]&!2K\CGO1W5T5%.EJQFJK('V86/%&
MTZD<8Y>L4"#R:?%+1NM?E'STA;H/> T0__-W<GXLUS]?*ABO9&R$2FC4.U'+
MT?4ZD(26IW]R(HGE83FG]6"> +Y"'O&MVT8[?TG]PJ''X6GCE$!,$&)DE<SR
MSMY)1(&$:Y41ONHFL+ZUD322Y"::''MDH8B8?'3)]?H\6JP[.B//C"K*_CG]
MY.M?%'#3F@TD2IH#NH4YXT5UZ/'GCKD+XU \'G>!>HA.3&2Y%'9:F?7#9?YE
MG_X$VZ/ SL#D1,<P6MY\T<1V?NV:.QGE"?]J32L_FDLNH&+1U$US9H:UU#\@
M4$>NKC6QT ;KRULJUA@T/B<U=?E!@,:7TRXSB6#/&AGE+G7_3AK%N:_$\(QX
M@0/#E6?^^B(Z#6-"^U@SL-><O4\YTYVGB6GPB?]F:OH$533?!:[>"MLT\!"$
M(\7?YK(DJ%ZBM+6>H#;>75=]\]X4*YO,))]@Q%V)[6?B1H"9<YE;E9WSY=/W
M3"] K!$ALU_UK>WW.M;7YO/6_-%5#DKR]6XN'Z"C55Z;2VU7KZ(33A' 52R#
M?*=VU.OT<H[$Z_AB>JM4E7+MR7L%UCO,:0G>7VO>$DF*G15VY8OS!?I,RBU\
M-Z)^YCMAZB?"- >X-R2()PK_!+6TU^CLJP> CV\-6FL9RC]"*.E=#D]K)R&*
M)3S=&_ZV8VH&&A3T+96:_%,8,=M?(KJ*UGM5MVCGZ_"913G ],M[SC-2?*!%
M5T+<-O2W0)-;DQ_PY9=[ZJ+A:(TEJ4$OP1;;S3GYUT.@GT,_9B<>B+O!+9[6
M<44L=9OZW.[J:S6#,AP30D(MFF7@5D%V"DLE 1:>*,']INN#K0'8S-:1!DON
M/-WH@*W/S=9)#B\W5VW*A[4B0+/F;,I83KFL!:'!'*$ \JZ\?6@D-ONCN)/R
M;&75"7HIM[0L(YU&+^Y>2Z;1:E5=^5'ZDL)8X=C6L=I\*[DU17W6ME8<)=20
MCPU]5$MH<N^6E(.BF(G?LTJTE5 X >^E)(-ZN  D2'Z#]<_2V)>)7QN]TH6D
M0"O@4J:15&$DI,+=W_4\PB78K,N&VA]:>6R8?AH23NP9/;V?EJI GXY\T*QO
ML+IRS,X1.*?F=#)*>531:YO0CAS& #,-ON3%U7WWXHV3>:K1RF!Z2LM/-P&L
M8VK@9YJF6E)FF1YUTVLWH?5643L'I75.%XU962\+-CA+YD,N()2<1OUK]8C[
MXYX,CZ:.]3*:6G1&64,(7ASL2\,['%"S_FK\]ZV!7?!@;;NS[',R0^;B,]/:
M(VOZP!;9,X:,QK15<W9T-EP?/;<B#I')L5QYF'@]G8?Q8M%V G[5:0D0B*U2
M]:_H'S?H.9.]()KZ,3F1+D?FTF3?\*.R9G,=8/\6PR<PI6O W7#=U+=/)XY,
M0!N=4VL/^R/O-SSGS87139WGUI\1KW99JXLK_6TT-B9"'+WC1#.T/2FL"J/F
MZ$M+3-[=^:+9:ZZR.33]T\YAMZ$A>"F"63]F&)E'"JB/KS19(U0^X31'\;4U
M7*P-T%-%5H,:!3LK_R3URB^%W265M1SBY]1K3.[9)GGKGSN_LL-16^*V6Z5T
M,:C-VN76TQYX$Y.4:#3O"N8!M <2Y:<UN;:KZH0AT&/+OG7=RO.$>T>K?/[.
M6%GBEVCP@1?AE\SL-%3V.-,BQ])?/!OL#5&WW?41'36-BQLY^JJ2LX^Y=P80
MH(@*))^YZ[)R4V,04X&R$)5%;ZO 'VUJ#!VB%A?/*ZB??IL@[M,?)!,+Q0VY
M WM?:ZWSYD?3_$6A2N/)<J!R^2,O#)45P"+F8V ;8T+G^I:+_2E^#'!5S0A>
MI2W.3@.B6;/M#6/YZ5Q_$SP/+-3L"SM.<Y._0S]&Q8]5(P,1=NR9FQ/$3+_J
MRI$NORL]N7?R$N?_R7SX*B5J"/^1S-;%R_5#97F:03MJ%G-:"K):03 %5_>7
M!)7*0<2;P<HL&44J<!AKFAIY99YEV\MISJ9+&QX;D@?\L!?($3KWP 4YZ$T0
M$I8*T!K&T99?X1DJT);?4"73J7/M(531;X^0,VC!H5[2']K'$P@W92"+$QB*
MY+,DL3I,5$BV7(L7J?:8$BEQ-[/+,XHT#M^)?N$BCGRNVS_YG.]/'T\Z1;+%
M*V(2?=97&M5VNL7+T5E=$D2O4=FL49E[)'Y^I=&PYB]FQ>YE_JIBL2%-R'2;
MVZ=<]#L479*(_<!:9X'8S7W*[##SZR8U'&9,[XAM\POGB$,68,=D?'*8(._N
M#/\,O(M\$S0<H'08UNEVH1=G6M2]REK?O+XR^51]13)=,='FJY+2+98*ZBI+
MLM;9BW"PBZH.H8GBP&X<=SI"BP/+UM_]M";%M8X;I2HDJT4F)7KF^]OHG4&$
M2)GKSK0.O$LIHO87@K?->"15[[*&8QT*9]5D<Z+L >&:Y3A-$2EL&P\E7 :3
MG!049KF'N#MCN#>2"0F?-14W&\X,$JZ7KL6'6(^'^:ZCYP/-M:8B,)/(M9^V
M\RZC]4*RT"I%]-BFEQ;BH7K7J:%K95FEGTDM<S;K83CK;2IM105\:3YZWL Z
M624$U=*!_O:[#ZA0E[#W:L2EP%X&V=B>R4CG96$B&+9OIGJTQ$KL?7HEQ@J$
MS5F^7&5*XBLA?:R(]$P#C6< ^11H"+OVJ(^X=I?/=+WE\G;-G9(C%RW'^_A4
M"=2BG G0DBYP0Z?)CR KU8+A:(3 @Z9&G7/7RC67<I:=2=$FV+.XDT3H-!,H
M#-K&<OCP;]TKZ,S.L \H"_ZT)R-T39S]>XL0R6R9;*8(5.B.?[:+YTX#S.8#
M^V8^_"=Y[M 7B 8VDDL30D150IU.L0%+XK%3I"XH^A0-@7J[.J\J9KF/Y68[
M6RSY:;7)+JB6(!#C(I[@ C X$^V]AY_1#&2CZ\BN*:N^\>I)WJTFD=<%K/I5
MXHSHY5+>4;2*+H^\[2S/$>&3 ]W+F KGH"7H^]$]>!L38.?*@J33?]FH,@EM
M1'B"BXC*4(PBD,5_K!A?EAD3$]L#Q4JQ%ABPZ>[!)#-P+S4 -TJDZ6I2X&E4
M-;D8*%F]CX]U+N**$F/+;X>5YJN=WW3%QU(E^]!/ZZ"2A.2J@[R)K'6H"DT+
MHY+>,7,I3ZML8=FFGL2*>^VO3Q&5!>*2+A9R**G?KC_8U!'%3L^Q%TG/:XK"
M1ET16#>M-"3ZS0NKYWYTZ<-&9 >$#D'DA-*-A+I[U3G,VNT$N'Q'A/R^O7*>
M_GOS./.SLU:*%XL-'<$!?U%RM3>>"QH8@@Q]&(4$](I!-91_?N7"JS2MXXA:
MF=1=O0CC9.C%-QZ4%R9/TD$:6.7<W(P=)=BV;+=-(Y,KW0P>JH#!OHSVU1CC
MI*N'9+/%:XY)T9=KPXJ[R^.42=#$MD7!MGW-=?&Z**LJQN=SFDGKE &;)?\K
M&!$;5B1XF6FF_J(B>1Y(-!/*/+.3/2^_R)SN"AJM]:-IC][7>G\_RC_/\JU,
M43?113?^.6610-4V&V5;WTE").Z*VMM,3\1FIIQY*4#TGD2,WOF,21Z**%$/
M"'<1#0WS8%)6YU007'W55 4N?]8G-(E_.A@]&_^!G$ZG<W7)[19HM&DR,98N
MAPM=<&/]N'K9LM#\PCH*)#N2%D">RF*WA& G\3-VDC@]  3(7%*4W2):M6F;
MI/_/-5*2NVTH64-\T7R5'?MVBJ)K_!T(J+S*0P/A.&=FVW*=X[R&9NK&OS9X
MF)O<W-:CV@@\'@?8UK]@9I-N"H.(?C;;=<WW,[DTC(RU&Q<;!+6:V X+*@"J
M*]<=9*1,^>DB1,&=;J).BB5)& 5<U391BXWQ=TV3O=P7(>N.\;:$[RB):X>E
M1+G)'.285^GMBFQU2I,P4^3XR)CEOX"GDX@)-5GI]:.^8/_,GGOYL?#:,NBC
MVE^4'_^4L\U\?V;HZEW0E^SLY^:JGCU1ZJMD-BERWX]>R=<6(IA__#K#KWZ_
M^XMR\4?BYW?#JX\L?9@!'X/>B&@J!=E,?8@V^[QU\#\^,UGJC_Y/B\F;"'.+
MG>$YHM2=M;OTO6R'9]$,918E.QEC\*O6O4,:=Q>!L3.G %\N#>>"VS>&;D/U
MC+Z?CMJ6.57[M3QI&QS:E<NY(:]:):2SE2SHIA!CY:[<9X8=%(W NXB?L+NT
M9]BNT)EO@%"=.^C)V%>9>3KU#6B]?-WRTF.N4,JZOA-?@29C[8(RKE9VA</I
MSG.O^<[ZN-G4%S,K%ZGVQL67/&OB2+U-85.HYJFS,$V4S^5NFQG($(U+KJ6#
MCA6HS4)YM2L2(AF:BA1BGS/?SH/7 ;*&Y5P_51O2Q)R ZX*[^C_<FLG'?'!C
MC\N%*6C0>-AIF3@M$:YV*N. 0STU.^GM;RC'Q\'7AB4N\W;@U24?W3YT^*R^
M*42E<;.(SM!36];N5V)-&1J2<?QR56Z/=^/8$=8G?V#>H7$1MM&4TRH1.J[V
M(K4%O[X4V2,OAY/9+:Z<C>YCV81H[#8+HH'F5IIWMR;A^@[%MRB1%TP[!=&G
M^?A:&*T1GRNGC;I TT1N4YWT!)'\@I I:T(,]=SLF01/.],I=!4J8X9Y=>[$
MN<OJK"S,I4[)4-$L9H<! -%R15[Z'?V5MUM'W;=,ITG[(PRVI?"/"E;)+<_V
MAXW1POJ0'^%YA_.B*:LM1"!ZZ\(C<UQ84UAQ*HPA,XRC#OU3[6J,14SW@EGL
M*L&7Q3A3"M,D)0Y);ZP__=]Q-@I5ZG\JM^A.^/Y$A^M,=3 )DOBND:LTFRF]
M?>D5"WY1G?^TW^OO7?XZ*I2Q73<<-_\';V8VAW]CZ&46]ENR]J$&ZEM1I-""
M76BMG%>35OJUIN3,.J<"'N+N\;:\X39?B&9"]S'XC-+H"X*UF;(M%^N.P=WE
M(#V^8YF:M?14O[+"/ 9J:Q9I1B%(!*3\([;(:+Z*W\]@&FT)=E<R63Q2V_]T
M.+ADAWP9'60KF 5]+:"1Y(6)U>$E'ZUSG%G!OD2V-?9M8&5F;4MD%7!:6X,X
M2/Z>_6IC#TUU!1=:QO+.Y<@T92,450CD&:D'%W":XM*D;R5L*>$3M!\X@HIK
M=>KG5'P[H<77C<#$ 7+6=,K@1O7Q][WTKI*K76W$R9MH]VA(/*]]$V+H-Z6&
M-YHBB=2Q=W()D1C%=65.J_=R.&#?X239^HOBUC$P"NZ2'\<T"J[GQ=5,:WHU
M"@Y*IXI3)J5U=R0J/T6.9WHUU"Y;R-RZG\XW3-:#@+W(;?@._K* 5\AK7>4G
MBL<N#8QX.<YXJ85JFJ6""!P3_I&^JK3;ZTZ=F3,Z.Q_W5++4"<^GF)9L5U&9
M\O-M$N[&B@.S1SMD]%>XV.#[!).6.KX0:Q.<=E#4Z4_^$#5L![2*7]>B4QU#
ML^1"DH"$%CX^.0;BK?)'5]S+R?2NZO04T.;R<DV#FT(U@6&='=NJ.3Q)]IH
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M=BV3I-:GE#]O+IJT>Q*,[.LZT&6AS()/FZY'+EM6013L$/?H,$&V$DBS3D(
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M*S<S+ECLR?O872*12F=(2#)W#XD<&-?<8 I7./L\94K,5BE(\"M#/G9SXTI
M '2[,QI6'!%-S1*06WD8RUK>1("O>W>GSH:+[2=X!)C*5PY,DX@PHKB8W>"X
M2"2%VH3$ERMH.-[%;FY:I:?$6L *.S2[VJQCJDZUYG@U6R\(PAA71"\L,TH2
MRD*N'W77-(M.ZT%HF3YJZAPM6](XB723F'<C 6'+UFO *5K^*]:J@L0*%UV4
M/>UA:H8A$E>:(=-= !<I\M+N[W-,PA,0BF)U%LO$/8&@ ,*R@C"$,OHRY41D
M4%8.AD!T!B7N4M>YJ_V(,KA0%MO8J/?M7-D>W^6^2;,G1(^<(L[1KYR:Y]1K
ME:D,<FXE""Q4E2-0Q)4DL&-KVX8M=[GK!],2QP Z,AT<#8JQ!P-_=Q_;B?^]
M2#.6AW#8LD_O%;WA[T*DI-FZ#Y6]<[\_%MCD.&ZZP0_*3C>&Y/A9[-' 1X,>
MU5^X"*]<H3>W U>Q\=9K]\JI>H[WV\$2-ZY1!P(6 1KS5>E&TCOUCS:2R;%>
MWOR>;/!;]G7P3RI5?G&^%82I-MZ<'DB4@KR#> #"MK*C:GYO:08\)I1U%,1]
M'-L6&4@E\-[4LI5(]6&F[ZY-/$0H#_I9;"H,==MB-,+C21]"F2\-L@/OZR%$
ML#NEHLI\7MP*GN+--,.BR&6KO#8-0Q#XD0,==D.HR/*] S4!8!^1H/@"!.W!
MPGC-@@>0!GWQ$CE=3X@(I&$&06<1?-DR75)0^7+W\4H0+6;RLJ79!5Y>AJ["
M^Z42WH>?V1A+",%:S?HC^",56&ZE0RZJ]@<Y'E>4^S&8%EETX7VXT6_86CNH
M/-.:.0OS\@7L86)!?<SW:83 N"R7WBCN/WW&;Q"IERIEPS^!#D>:!_(FP\7"
MO5:YPV;ML"HF\;;JA222QY;OU+S+5\Z@W"?F7Z4\S?MI II FXYI@)/XA4(4
M;*V)CWE.79+#"9U4;!]$W&%9&Y(IC=.X4)SE+)A?4.XV2F?3C!_I+TUS0>FD
MFA]XA/0BJF9KT_R<C;V%U+E$K\[S"Q%]TIGN4?D4"L!+G,+32*H>7LY>P%SO
MI74^X<\_WWMI'2+<S;[1WOP/4$L#!!0    ( +="?5C'171N^0(  (T/   5
M    ;7)U<RTR,#(S,3(S,5]D968N>&ULS9==;]HP%(;O)^T_>.FU,0G=-%!I
M1<M:(<%:L;;J-$U5B$^*M\1&M@-4T_[[[$ "V8)&2UIQA>T<O^<Y'W',T<D\
MCM 4I&*"MQVW5G<0\$!0QA_:3J)#_-$Y.7[[YN@=QA? 0?H:*!H]HNYY[S.Z
M.QWV48\K[?, 4%<$20Q<(XS&6D]:A,QFLQH-&5<B2K1QH&J!B(EY?KMPB(:-
M6MU,S<AKXH$O@S'VZMXA^N9Z+>]#J^%]1[^N!K\QM@@1XS]'O@)DD+EJ.VM.
MYB,9U81\(%Z]WB"9H;.P;,T5*UC/&IFM2^X&_2_!&&(?LV4<^2XK4[;/;3:;
M)'UJ3!5KJ71_7P2^3I/X7RZTT<+.<&:&[1)V/=QP:W-%<RYC0W7N9EW@/5D\
M=&RZI(A@""%*25OZ<0)M1[%X$MD(T[6QA'"AHS(A!4'M04P)!-0(>@T[L"5I
M6(*#J^FD0W\D2MLRJTL>/3K(NKD9]HH\ZS+6@)3M));2U#P#70[_$;/!,:X)
M93%9VA _BIRM(BM)<Y8EF]_W:5RIVBXX9@S<=C2F$/I)I"N$*]&N"%7$/N,O
M0[J4W@DTU< QQ".055(6=7=!'!L:&20CP'GH%8*6JN^"RX7N5/K>9((IE.E.
MQID] OM&JN $YAHX!9JYL31//S#2;X ("LJ1/76%?/:)9B;W)@3CZEJ<B7@R
M*'1;Y(\@:CME!F1KFE@F*G7H>HN#_,"NW*^B.Q?R0OI<=\VW]=:/$E#E%%ML
M^*L0'5GD,XV0B2Y[XIFO82A%7)Z7I3NQ':^0%*2Y=M3K%63T*_CR$Z?G/I.I
ME\OPAD]!F0M+9^9+JE(&H#U^/8:S1$I#9K>4)GM'K7VJPXZAY"5R*RK1I;EM
MVM\N"T,PW@)#9.>PQJA,RVR@O)),I/O+WY(7\;!OY:P\P+S(7@5%7E'U^ KG
M%/0,8.6[P-KA]-:0V@.B$,#3:O^:CO>I)5XS[KQ3&A5TRK70?K3VF2^MZB:C
M?:K )L8\6X=+7E*\):5+V?^]XS]02P,$%     @ MT)]6-(:113:!   M"D
M !4   !M<G5S+3(P,C,Q,C,Q7VQA8BYX;6S-FFUOVD@0Q]^?=-]ACKXVYN%4
M%92DHI>D0DJ:B#2Y5E55&7L<]F*OT>X2B$[WW6]W;6-,,!B#';\#>^<_LS._
M&2].3CXN? ^>D7$2T--&N]EJ %([< A]/&W,A&M\:'P\^_VWDS\,XS-29)9
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M-C8Y.61S<#$T-2YJ<&=02P$"% ,4    " "W0GU8Z0R)% 61 @#XOP( $0
M            @ %O?00 9S<P-C8Y.61S<#$T-BYJ<&=02P$"% ,4    " "W
M0GU8,I92**=9 0# (0( $0              @ &C#@< 9S<P-C8Y.6<U,G$R
M-2YJ<&=02P$"% ,4    " "W0GU82 YQLWL+ 0!4U@$ $0
M@ %Y: @ 9S<P-C8Y.6<X-7DW,BYJ<&=02P$"% ,4    " "W0GU8(HS*^GH$
M  !D&0  $0              @ $C= D ;7)U<RTR,#(S,3(S,2YX<V102P$"
M% ,4    " "W0GU8QT5T;OD"  "-#P  %0              @ ',> D ;7)U
M<RTR,#(S,3(S,5]D968N>&UL4$L! A0#%     @ MT)]6-(:113:!   M"D
M !4              ( !^'L) &UR=7,M,C R,S$R,S%?;&%B+GAM;%!+ 0(4
M Q0    ( +="?5@%RI(EN0,  'P;   5              "  06!"0!M<G5S
G+3(P,C,Q,C,Q7W!R92YX;6Q02P4&      D "0!$ @  \80)

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>d706699dpre14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mrus="http://meus.com/20231231"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mrus-20231231.xsd" xlink:type="simple"/>
    <context id="P01_01_2023To12_31_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2020To12_31_2020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2020To12_31_2020_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2020To12_31_2020_PeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:TotalAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2020To12_31_2020_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:TotalAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2020To12_31_2020_PeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2020To12_31_2020_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2020To12_31_2020_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2020To12_31_2020_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:AdjustmentForGrantDateValuesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2020To12_31_2020_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:AdjustmentForGrantDateValuesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2020To12_31_2020_PeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2020To12_31_2020_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:TotalAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:TotalAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:AdjustmentForGrantDateValuesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:AdjustmentForGrantDateValuesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:TotalAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:AdjustmentForGrantDateValuesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:AdjustmentForGrantDateValuesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_PeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_PeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_PeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:TotalAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:AdjustmentForGrantDateValuesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:AdjustmentForGrantDateValuesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_PeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_PeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:TotalAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_PeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:TotalAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">mrus:DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <unit id="Unit_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_pure">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_Year">
        <measure>utr:Year</measure>
    </unit>
    <unit id="Unit_USD_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:DocumentType contextRef="P01_01_2023To12_31_2023" id="hidden107868301">PRE 14A</dei:DocumentType>
    <dei:AmendmentFlag contextRef="P01_01_2023To12_31_2023" id="ixv-14236">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="P01_01_2023To12_31_2023" id="ixv-14237">0001651311</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="P01_01_2023To12_31_2023" id="ixv-14637">MERUS N.V.</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock contextRef="P01_01_2023To12_31_2023" id="ixv-8303">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"&gt;PAY VERSUS PERFORMANCE &lt;/div&gt;&lt;div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 11pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Pay Versus Performance Table &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"&gt;The following table sets forth information concerning the compensation of our NEOs for each of the fiscal years ended December&#160;31, 2020, 2021, 2022 and 2023, and our financial performance for each such fiscal year: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:21%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:12pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:12pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="BORDER-TOP:0.75pt solid #000000;height:12pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:12pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="BORDER-TOP:0.75pt solid #000000;height:12pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:12pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:12pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="border-left: 0.75pt solid rgb(0, 0, 0); padding-left: 8pt; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="border-left: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-right: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-left: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-right: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year-end&lt;/div&gt; value of $100&lt;br/&gt; invested on 12/31/2019 in:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="border-left: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-right: 0.75pt solid rgb(0, 0, 0); padding-right: 2pt; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Summary&lt;br/&gt; Compensation&lt;br/&gt; Table Total for&lt;br/&gt; PEO (1)&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Compensation&lt;br/&gt; Actually&#160;Paid&#160;to&lt;br/&gt; the&#160;PEO&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(1)(2)(3)&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt; Summary&lt;br/&gt; Compensation&lt;br/&gt; Table Total for&lt;br/&gt; &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-PEO&#160;NEOs&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(4)&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt; Compensation&lt;br/&gt; Actually&#160;Paid&#160;to&lt;br/&gt; &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-PEO&#160;NEOs&lt;/div&gt;&lt;br/&gt; (2)(3)(4)&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;MRUS&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;NASDAQ&lt;br/&gt; Biotech&lt;br/&gt; Index&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;text-align:center;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&lt;br/&gt; Income&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in&lt;br/&gt; millions)&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top;text-align:center;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;2023&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;4,671,327&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;11,843,191&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;2,875,609&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;4,616,893&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;195.31&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;118.87&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;-154.9&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top;text-align:center;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;2022&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;5,744,794&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;-2,256,931&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;1,997,552&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;-53,411&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;109.87&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;113.65&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;-131.2&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top;text-align:center;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;2021&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;7,540,935&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;11,523,096&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;2,031,414&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;3,116,021&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;225.85&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;126.45&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;-66.8&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top;text-align:center;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;2020&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;5,049,022&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;5,589,212&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;1,453,520&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;1,380,032&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;124.50&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;126.42&lt;/td&gt;
&lt;td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;-85.5&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"&gt;(1) The PEO for all four fiscal years is Sven (Bill) Ante Lundberg. &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"&gt;(2) Deductions from, and additions to, total compensation in the Summary Compensation Table by year to calculate Compensation Actually Paid include: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:28%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt; Non-CEO&lt;br/&gt; NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt; Non-CEO&lt;br/&gt; NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt; Non-CEO&lt;br/&gt; NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt; Non-CEO&lt;br/&gt; NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total Compensation from Summary Compensation Table&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,671,327&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,875,609&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,744,794&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,997,552&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,540,935&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,031,414&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,049,022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,453,520&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustments for Equity Awards&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;Adjustment for grant date values in the Summary Compensation Table&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(3,556,800&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,244,060&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(4,791,732&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,367,010&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(6,550,400&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,389,468&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(4,062,203&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(840,427&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year-end&lt;/div&gt; fair value of unvested awards granted in the current year&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,479,906&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,359,964&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,381,092&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;669,935&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,516,254&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,531,846&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,598,303&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;654,243&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;Year-over-year difference of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;year-end&lt;/div&gt; fair values for unvested awards granted in prior years&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,154,165&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;439,173&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(4,187,745&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(949,302&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,568,931&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;739,590&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;14,919&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;129,725&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:top"&gt;Difference in fair values between prior &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;year-end&lt;/div&gt; fair values and vest&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,094,592&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;186,206&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,403,339&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(404,586&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;447,375&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;202,639&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(10,829&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(17,029&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total Adjustments for Equity Awards&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,171,864&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,741,284&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(8,001,725&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(2,050,963&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,982,161&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,084,607&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;540,190&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(73,488&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&lt;/div&gt;&lt;/div&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Compensation Actually Paid (as calculated)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11,843,191&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,616,893&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(2,256,931&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(53,411&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11,523,096&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,116,021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,589,212&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,380,032&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"&gt;(3a) The following summarizes the valuation assumptions used for stock option awards included as part of Compensation Actually Paid: &lt;/div&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; text-align: left; line-height: normal;"&gt;Expected life of each stock option is based on the &#x201c;simplified method&#x201d; using an average of the remaining vest and remaining term, as of the vest/FYE date. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; text-align: left; line-height: normal;"&gt;Strike price is based on each grant date closing price and asset price is based on each vest/FYE closing price. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; text-align: left; line-height: normal;"&gt;Risk free rate is based on the Treasury Constant Maturity rate closest to the remaining expected life as of the vest/FYE date. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; text-align: left; line-height: normal;"&gt;Historical volatility is based on daily price history for each expected life (years) prior to each vest/FYE date. Closing prices provided by S&amp;amp;P Capital IQ are adjusted for dividends and splits. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; text-align: left; line-height: normal;"&gt;Represents annual dividend yield on each vest/FYE date. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"&gt;(3b) The following table illustrates the valuation assumptions as of the vesting date for awards that vested in each of 2023, 2022, 2021, 2020: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:22%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td style="width:15%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;For Stock Options Vesting in&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;For Restricted&lt;br/&gt; Share and&lt;br/&gt; Restricted&lt;br/&gt; Stock Units&lt;br/&gt; Vesting in&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected volatility&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;white-space:nowrap;text-align:center;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;67.42%&#160;-&#x2009;76.20%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;white-space:nowrap;text-align:center;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;68.94%&#160;-&#x2009;76.55%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;white-space:nowrap;text-align:center;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;66.41%&#160;-&#x2009;74.18%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;white-space:nowrap;text-align:center;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;66.60%&#160;-&#x2009;73.37%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected dividend yield&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;white-space:nowrap;text-align:center;"&gt;0%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;white-space:nowrap;text-align:center;"&gt;0%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;white-space:nowrap;text-align:center;"&gt;0%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;white-space:nowrap;text-align:center;"&gt;0%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;white-space:nowrap"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted&#160;Average Fair&#160;Value&#160;at&#160;vesting&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top;text-align:right;"&gt;17.53&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top;text-align:right;"&gt;14.14&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected term, in years&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;white-space:nowrap;text-align:center;"&gt;2.8 - 4.5 years&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;white-space:nowrap;text-align:center;"&gt;3.1 - 4.6 years&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;white-space:nowrap;text-align:center;"&gt;3.0 - 4.6 years&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;white-space:nowrap;text-align:center;"&gt;3.0 - 4.8 years&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Risk-free interest rate&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;white-space:nowrap;text-align:center;"&gt;3.48% - 5.01%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;white-space:nowrap;text-align:center;"&gt;0.97% - 4.56%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;white-space:nowrap;text-align:center;"&gt;0.17% - 1.27%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;white-space:nowrap;text-align:center;"&gt;0.11% - 1.69%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"&gt;(4) &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-PEO&lt;/div&gt; NEOs reflect the average Summary Compensation Table total compensation and average Compensation Actually Paid for the following executives by year: &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"&gt;2023: Hui Liu, Peter Silverman, Andrew Joe, Greg Perry &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"&gt;2022: Hui Liu, Peter Silverman, Andrew Joe &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"&gt;2021: Hui Liu, Peter Silverman &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"&gt;2020: Hui Liu, Peter Silverman &lt;/div&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-14641"
      unitRef="Unit_USD">4671327</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-14642"
      unitRef="Unit_USD">11843191</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-14643"
      unitRef="Unit_USD">2875609</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-14644"
      unitRef="Unit_USD">4616893</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="2"
      id="ixv-14645"
      unitRef="Unit_USD">195.31</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="2"
      id="ixv-14646"
      unitRef="Unit_USD">118.87</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2023To12_31_2023"
      decimals="-5"
      id="ixv-14647"
      unitRef="Unit_USD">-154900000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-14648"
      unitRef="Unit_USD">5744794</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-14649"
      unitRef="Unit_USD">-2256931</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-14650"
      unitRef="Unit_USD">1997552</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-14651"
      unitRef="Unit_USD">-53411</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      id="ixv-14652"
      unitRef="Unit_USD">109.87</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      id="ixv-14653"
      unitRef="Unit_USD">113.65</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      id="ixv-14654"
      unitRef="Unit_USD">-131200000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      id="ixv-14655"
      unitRef="Unit_USD">7540935</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      id="ixv-14656"
      unitRef="Unit_USD">11523096</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      id="ixv-14657"
      unitRef="Unit_USD">2031414</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      id="ixv-14658"
      unitRef="Unit_USD">3116021</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      id="ixv-14659"
      unitRef="Unit_USD">225.85</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      id="ixv-14660"
      unitRef="Unit_USD">126.45</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2021To12_31_2021"
      decimals="-5"
      id="ixv-14661"
      unitRef="Unit_USD">-66800000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2020To12_31_2020"
      decimals="0"
      id="ixv-14662"
      unitRef="Unit_USD">5049022</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2020To12_31_2020"
      decimals="0"
      id="ixv-14663"
      unitRef="Unit_USD">5589212</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2020To12_31_2020"
      decimals="0"
      id="ixv-14664"
      unitRef="Unit_USD">1453520</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2020To12_31_2020"
      decimals="0"
      id="ixv-14665"
      unitRef="Unit_USD">1380032</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="P01_01_2020To12_31_2020"
      decimals="2"
      id="ixv-14666"
      unitRef="Unit_USD">124.5</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="P01_01_2020To12_31_2020"
      decimals="2"
      id="ixv-14667"
      unitRef="Unit_USD">126.42</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2020To12_31_2020"
      decimals="-5"
      id="ixv-14668"
      unitRef="Unit_USD">-85500000</us-gaap:NetIncomeLoss>
    <ecd:PeoName contextRef="P01_01_2023To12_31_2023" id="ixv-14669">Sven (Bill) Ante Lundberg.</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="P01_01_2023To12_31_2023" id="ixv-8497">
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:28%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt; Non-CEO&lt;br/&gt; NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt; Non-CEO&lt;br/&gt; NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt; Non-CEO&lt;br/&gt; NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt; Non-CEO&lt;br/&gt; NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total Compensation from Summary Compensation Table&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,671,327&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,875,609&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,744,794&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,997,552&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,540,935&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,031,414&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,049,022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,453,520&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustments for Equity Awards&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;Adjustment for grant date values in the Summary Compensation Table&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(3,556,800&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,244,060&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(4,791,732&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,367,010&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(6,550,400&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,389,468&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(4,062,203&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(840,427&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year-end&lt;/div&gt; fair value of unvested awards granted in the current year&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,479,906&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,359,964&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,381,092&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;669,935&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,516,254&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,531,846&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,598,303&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;654,243&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;Year-over-year difference of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;year-end&lt;/div&gt; fair values for unvested awards granted in prior years&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,154,165&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;439,173&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(4,187,745&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(949,302&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,568,931&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;739,590&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;14,919&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;129,725&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:top"&gt;Difference in fair values between prior &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;year-end&lt;/div&gt; fair values and vest&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,094,592&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;186,206&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,403,339&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(404,586&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;447,375&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;202,639&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(10,829&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(17,029&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total Adjustments for Equity Awards&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,171,864&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,741,284&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(8,001,725&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(2,050,963&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,982,161&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,084,607&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;540,190&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(73,488&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&lt;/div&gt;&lt;/div&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Compensation Actually Paid (as calculated)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11,843,191&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,616,893&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(2,256,931&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(53,411&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11,523,096&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,116,021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,589,212&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,380,032&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="P01_01_2023To12_31_2023" id="ixv-8498">
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:28%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt; Non-CEO&lt;br/&gt; NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt; Non-CEO&lt;br/&gt; NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt; Non-CEO&lt;br/&gt; NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt; Non-CEO&lt;br/&gt; NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total Compensation from Summary Compensation Table&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,671,327&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,875,609&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,744,794&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,997,552&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,540,935&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,031,414&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,049,022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,453,520&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustments for Equity Awards&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;Adjustment for grant date values in the Summary Compensation Table&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(3,556,800&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,244,060&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(4,791,732&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,367,010&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(6,550,400&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,389,468&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(4,062,203&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(840,427&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year-end&lt;/div&gt; fair value of unvested awards granted in the current year&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,479,906&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,359,964&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,381,092&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;669,935&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,516,254&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,531,846&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,598,303&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;654,243&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;Year-over-year difference of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;year-end&lt;/div&gt; fair values for unvested awards granted in prior years&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,154,165&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;439,173&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(4,187,745&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(949,302&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,568,931&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;739,590&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;14,919&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;129,725&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:top"&gt;Difference in fair values between prior &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;year-end&lt;/div&gt; fair values and vest&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,094,592&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;186,206&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,403,339&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(404,586&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;447,375&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;202,639&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(10,829&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(17,029&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total Adjustments for Equity Awards&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,171,864&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,741,284&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(8,001,725&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(2,050,963&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,982,161&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,084,607&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;540,190&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(73,488&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&lt;/div&gt;&lt;/div&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Compensation Actually Paid (as calculated)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11,843,191&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,616,893&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(2,256,931&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(53,411&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11,523,096&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,116,021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,589,212&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,380,032&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-14670"
      unitRef="Unit_USD">4671327</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-14671"
      unitRef="Unit_USD">2875609</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-14672"
      unitRef="Unit_USD">5744794</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-14673"
      unitRef="Unit_USD">1997552</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      id="ixv-14674"
      unitRef="Unit_USD">7540935</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      id="ixv-14675"
      unitRef="Unit_USD">2031414</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2020To12_31_2020"
      decimals="0"
      id="ixv-14676"
      unitRef="Unit_USD">5049022</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2020To12_31_2020"
      decimals="0"
      id="ixv-14677"
      unitRef="Unit_USD">1453520</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-14678"
      unitRef="Unit_USD">-3556800</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-14679"
      unitRef="Unit_USD">-2244060</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-14680"
      unitRef="Unit_USD">-4791732</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-14681"
      unitRef="Unit_USD">-1367010</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-14682"
      unitRef="Unit_USD">-6550400</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-14683"
      unitRef="Unit_USD">-1389468</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2020To12_31_2020_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-14684"
      unitRef="Unit_USD">-4062203</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2020To12_31_2020_AdjustmentForGrantDateValuesMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-14685"
      unitRef="Unit_USD">-840427</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_PeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14686"
      unitRef="Unit_USD">7479906</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14687"
      unitRef="Unit_USD">3359964</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_PeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14688"
      unitRef="Unit_USD">2381092</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14689"
      unitRef="Unit_USD">669935</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14690"
      unitRef="Unit_USD">7516254</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14691"
      unitRef="Unit_USD">1531846</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2020To12_31_2020_PeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14692"
      unitRef="Unit_USD">4598303</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2020To12_31_2020_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfUnvestedAwardsGrantedInTheCurrentYearMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14693"
      unitRef="Unit_USD">654243</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_PeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14694"
      unitRef="Unit_USD">2154165</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14695"
      unitRef="Unit_USD">439173</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_PeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14696"
      unitRef="Unit_USD">-4187745</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14697"
      unitRef="Unit_USD">-949302</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14698"
      unitRef="Unit_USD">2568931</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14699"
      unitRef="Unit_USD">739590</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2020To12_31_2020_PeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14700"
      unitRef="Unit_USD">14919</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2020To12_31_2020_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearDifferenceOfYearendFairValuesForUnvestedAwardsGrantedInPriorYearsMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14701"
      unitRef="Unit_USD">129725</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-14702"
      unitRef="Unit_USD">1094592</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-14703"
      unitRef="Unit_USD">186206</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-14704"
      unitRef="Unit_USD">-1403339</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-14705"
      unitRef="Unit_USD">-404586</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-14706"
      unitRef="Unit_USD">447375</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-14707"
      unitRef="Unit_USD">202639</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2020To12_31_2020_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-14708"
      unitRef="Unit_USD">-10829</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2020To12_31_2020_DifferenceInFairValuesBetweenPriorYearendFairValuesAndVestDateFairValuesForAwardsGrantedInPriorYearsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-14709"
      unitRef="Unit_USD">-17029</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_PeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14710"
      unitRef="Unit_USD">7171864</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14711"
      unitRef="Unit_USD">1741284</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_PeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14712"
      unitRef="Unit_USD">-8001725</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14713"
      unitRef="Unit_USD">-2050963</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14714"
      unitRef="Unit_USD">3982161</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14715"
      unitRef="Unit_USD">1084607</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2020To12_31_2020_PeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14716"
      unitRef="Unit_USD">540190</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2020To12_31_2020_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalAdjustmentsMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-14717"
      unitRef="Unit_USD">-73488</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-14718"
      unitRef="Unit_USD">11843191</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-14719"
      unitRef="Unit_USD">4616893</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-14720"
      unitRef="Unit_USD">-2256931</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-14721"
      unitRef="Unit_USD">-53411</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      id="ixv-14722"
      unitRef="Unit_USD">11523096</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      id="ixv-14723"
      unitRef="Unit_USD">3116021</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2020To12_31_2020"
      decimals="0"
      id="ixv-14724"
      unitRef="Unit_USD">5589212</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2020To12_31_2020"
      decimals="0"
      id="ixv-14725"
      unitRef="Unit_USD">1380032</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <mrus:StockOptionsVestingExpectedVolatilityMinimum
      contextRef="P01_01_2023To12_31_2023"
      decimals="4"
      id="ixv-14727"
      unitRef="Unit_pure">0.6742</mrus:StockOptionsVestingExpectedVolatilityMinimum>
    <mrus:StockOptionsVestingExpectedVolatilityMaximum
      contextRef="P01_01_2023To12_31_2023"
      decimals="4"
      id="ixv-14728"
      unitRef="Unit_pure">0.762</mrus:StockOptionsVestingExpectedVolatilityMaximum>
    <mrus:StockOptionsVestingExpectedVolatilityMinimum
      contextRef="P01_01_2022To12_31_2022"
      decimals="4"
      id="ixv-14729"
      unitRef="Unit_pure">0.6894</mrus:StockOptionsVestingExpectedVolatilityMinimum>
    <mrus:StockOptionsVestingExpectedVolatilityMaximum
      contextRef="P01_01_2022To12_31_2022"
      decimals="4"
      id="ixv-14730"
      unitRef="Unit_pure">0.7655</mrus:StockOptionsVestingExpectedVolatilityMaximum>
    <mrus:StockOptionsVestingExpectedVolatilityMinimum
      contextRef="P01_01_2021To12_31_2021"
      decimals="4"
      id="ixv-14731"
      unitRef="Unit_pure">0.6641</mrus:StockOptionsVestingExpectedVolatilityMinimum>
    <mrus:StockOptionsVestingExpectedVolatilityMaximum
      contextRef="P01_01_2021To12_31_2021"
      decimals="4"
      id="ixv-14732"
      unitRef="Unit_pure">0.7418</mrus:StockOptionsVestingExpectedVolatilityMaximum>
    <mrus:StockOptionsVestingExpectedVolatilityMinimum
      contextRef="P01_01_2020To12_31_2020"
      decimals="4"
      id="ixv-14733"
      unitRef="Unit_pure">0.666</mrus:StockOptionsVestingExpectedVolatilityMinimum>
    <mrus:StockOptionsVestingExpectedVolatilityMaximum
      contextRef="P01_01_2020To12_31_2020"
      decimals="4"
      id="ixv-14734"
      unitRef="Unit_pure">0.7337</mrus:StockOptionsVestingExpectedVolatilityMaximum>
    <mrus:StockOptionsVestingExpectedDividendYield
      contextRef="P01_01_2023To12_31_2023"
      decimals="2"
      id="ixv-14735"
      unitRef="Unit_pure">0</mrus:StockOptionsVestingExpectedDividendYield>
    <mrus:StockOptionsVestingExpectedDividendYield
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      id="ixv-14736"
      unitRef="Unit_pure">0</mrus:StockOptionsVestingExpectedDividendYield>
    <mrus:StockOptionsVestingExpectedDividendYield
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      id="ixv-14737"
      unitRef="Unit_pure">0</mrus:StockOptionsVestingExpectedDividendYield>
    <mrus:StockOptionsVestingExpectedDividendYield
      contextRef="P01_01_2020To12_31_2020"
      decimals="2"
      id="ixv-14738"
      unitRef="Unit_pure">0</mrus:StockOptionsVestingExpectedDividendYield>
    <mrus:RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      id="ixv-14739"
      unitRef="Unit_USD_per_Share">17.53</mrus:RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting>
    <mrus:RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting
      contextRef="P01_01_2020To12_31_2020"
      decimals="2"
      id="ixv-14740"
      unitRef="Unit_USD_per_Share">14.14</mrus:RestrictedShareAndRestrictedStockUnitsVestingWeightedAverageFairValueAtVesting>
    <mrus:StockOptionsVestingExpectedTermInYearsMinimum contextRef="P01_01_2023To12_31_2023" id="ixv-14741">P2Y9M18D</mrus:StockOptionsVestingExpectedTermInYearsMinimum>
    <mrus:StockOptionsVestingExpectedTermInYearsMaximum contextRef="P01_01_2023To12_31_2023" id="ixv-14742">P4Y6M</mrus:StockOptionsVestingExpectedTermInYearsMaximum>
    <mrus:StockOptionsVestingExpectedTermInYearsMinimum contextRef="P01_01_2022To12_31_2022" id="ixv-14743">P3Y1M6D</mrus:StockOptionsVestingExpectedTermInYearsMinimum>
    <mrus:StockOptionsVestingExpectedTermInYearsMaximum contextRef="P01_01_2022To12_31_2022" id="ixv-14744">P4Y7M6D</mrus:StockOptionsVestingExpectedTermInYearsMaximum>
    <mrus:StockOptionsVestingExpectedTermInYearsMinimum contextRef="P01_01_2021To12_31_2021" id="ixv-14745">P3Y</mrus:StockOptionsVestingExpectedTermInYearsMinimum>
    <mrus:StockOptionsVestingExpectedTermInYearsMaximum contextRef="P01_01_2021To12_31_2021" id="ixv-14746">P4Y7M6D</mrus:StockOptionsVestingExpectedTermInYearsMaximum>
    <mrus:StockOptionsVestingExpectedTermInYearsMinimum contextRef="P01_01_2020To12_31_2020" id="ixv-14747">P3Y</mrus:StockOptionsVestingExpectedTermInYearsMinimum>
    <mrus:StockOptionsVestingExpectedTermInYearsMaximum contextRef="P01_01_2020To12_31_2020" id="ixv-14748">P4Y9M18D</mrus:StockOptionsVestingExpectedTermInYearsMaximum>
    <mrus:StockOptionsVestingRiskfreeInterestRateMinimum
      contextRef="P01_01_2023To12_31_2023"
      decimals="4"
      id="ixv-14749"
      unitRef="Unit_pure">0.0348</mrus:StockOptionsVestingRiskfreeInterestRateMinimum>
    <mrus:StockOptionsVestingRiskfreeInterestRateMaximum
      contextRef="P01_01_2023To12_31_2023"
      decimals="4"
      id="ixv-14750"
      unitRef="Unit_pure">0.0501</mrus:StockOptionsVestingRiskfreeInterestRateMaximum>
    <mrus:StockOptionsVestingRiskfreeInterestRateMinimum
      contextRef="P01_01_2022To12_31_2022"
      decimals="4"
      id="ixv-14751"
      unitRef="Unit_pure">0.0097</mrus:StockOptionsVestingRiskfreeInterestRateMinimum>
    <mrus:StockOptionsVestingRiskfreeInterestRateMaximum
      contextRef="P01_01_2022To12_31_2022"
      decimals="4"
      id="ixv-14752"
      unitRef="Unit_pure">0.0456</mrus:StockOptionsVestingRiskfreeInterestRateMaximum>
    <mrus:StockOptionsVestingRiskfreeInterestRateMinimum
      contextRef="P01_01_2021To12_31_2021"
      decimals="4"
      id="ixv-14753"
      unitRef="Unit_pure">0.0017</mrus:StockOptionsVestingRiskfreeInterestRateMinimum>
    <mrus:StockOptionsVestingRiskfreeInterestRateMaximum
      contextRef="P01_01_2021To12_31_2021"
      decimals="4"
      id="ixv-14754"
      unitRef="Unit_pure">0.0127</mrus:StockOptionsVestingRiskfreeInterestRateMaximum>
    <mrus:StockOptionsVestingRiskfreeInterestRateMinimum
      contextRef="P01_01_2020To12_31_2020"
      decimals="4"
      id="ixv-14755"
      unitRef="Unit_pure">0.0011</mrus:StockOptionsVestingRiskfreeInterestRateMinimum>
    <mrus:StockOptionsVestingRiskfreeInterestRateMaximum
      contextRef="P01_01_2020To12_31_2020"
      decimals="4"
      id="ixv-14756"
      unitRef="Unit_pure">0.0169</mrus:StockOptionsVestingRiskfreeInterestRateMaximum>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="P01_01_2023To12_31_2023" id="ixv-9345">&lt;div style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"&gt;(4) &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-PEO&lt;/div&gt; NEOs reflect the average Summary Compensation Table total compensation and average Compensation Actually Paid for the following executives by year: &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"&gt;2023: Hui Liu, Peter Silverman, Andrew Joe, Greg Perry &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"&gt;2022: Hui Liu, Peter Silverman, Andrew Joe &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"&gt;2021: Hui Liu, Peter Silverman &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"&gt;2020: Hui Liu, Peter Silverman &lt;/div&gt;</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="P01_01_2023To12_31_2023" id="ixv-14757">&lt;div style="margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;
&lt;img alt="LOGO" src="g706699g52q25.jpg"/&gt; &lt;/div&gt; &lt;div style="margin-top: 1em; margin-bottom: 1em"&gt;&lt;/div&gt; &lt;div style="margin-top: 1em; margin-bottom: 1em"&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:TotalShareholderRtnVsPeerGroupTextBlock contextRef="P01_01_2023To12_31_2023" id="ixv-14758">&lt;div style="margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;
&lt;img alt="LOGO" src="g706699g52q25.jpg"/&gt; &lt;/div&gt;</ecd:TotalShareholderRtnVsPeerGroupTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="P01_01_2023To12_31_2023" id="ixv-14759">&lt;div style="margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;
&lt;img alt="LOGO" src="g706699g85y72.jpg"/&gt; &lt;/div&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
